0001493152-22-008934.txt : 20220404 0001493152-22-008934.hdr.sgml : 20220404 20220404070048 ACCESSION NUMBER: 0001493152-22-008934 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 170 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Draganfly Inc. CENTRAL INDEX KEY: 0001786286 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-40688 FILM NUMBER: 22800358 BUSINESS ADDRESS: STREET 1: 2108 ST. GEORGE AVENUE CITY: SASKATOON STATE: A9 ZIP: S7M 0K7 BUSINESS PHONE: 403-781-6671 MAIL ADDRESS: STREET 1: 55 BURRARD STREET STREET 2: SUITE 2300 CITY: VANCOUVER STATE: A1 ZIP: V6C 2B5 20-F 1 form20-f.htm
0001786286 false FY 0001786286 false 0001786286 2021-01-01 2021-12-31 0001786286 dei:BusinessContactMember 2021-01-01 2021-12-31 0001786286 2021-12-31 0001786286 2020-12-31 0001786286 2020-01-01 2020-12-31 0001786286 2019-01-01 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2018-12-31 0001786286 ifrs-full:CapitalReserveMember 2018-12-31 0001786286 ifrs-full:RetainedEarningsMember 2018-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2018-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001786286 2018-12-31 0001786286 ifrs-full:IssuedCapitalMember 2019-12-31 0001786286 ifrs-full:CapitalReserveMember 2019-12-31 0001786286 ifrs-full:RetainedEarningsMember 2019-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2019-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001786286 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-12-31 0001786286 ifrs-full:CapitalReserveMember 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2020-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2019-01-01 2019-12-31 0001786286 ifrs-full:CapitalReserveMember 2019-01-01 2019-12-31 0001786286 ifrs-full:RetainedEarningsMember 2019-01-01 2019-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-01-01 2020-12-31 0001786286 ifrs-full:CapitalReserveMember 2020-01-01 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001786286 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-12-31 0001786286 ifrs-full:CapitalReserveMember 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001786286 DPRO:DraganflyInnovationsIncMember 2021-01-01 2021-12-31 0001786286 DPRO:DraganflyInnovationsUSAIncMember 2021-01-01 2021-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-01-01 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-28 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember DPRO:EmployeeMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember DPRO:FirstAndSecondAnniversaryMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember DPRO:CertainDirectorsAndOfficersMember DPRO:RestrictedStockUnitsMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-29 2020-12-31 0001786286 DPRO:VitalIntelligenceIncMember DPRO:AssetPurchaseAgreementMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember DPRO:AssetPurchaseAgreementMember 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember DPRO:AssetPurchaseAgreementMember srt:MaximumMember 2021-08-19 0001786286 DPRO:VitalIntelligenceIncMember DPRO:AssetPurchaseAgreementMember srt:MinimumMember 2021-08-19 0001786286 DPRO:EscrowAgreementOneMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementTwoMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementThreeMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementFourMember 2021-08-18 2021-08-19 0001786286 2021-08-18 2021-08-19 0001786286 2021-08-19 0001786286 DPRO:VitalIntelligenceIncMember DPRO:BrandMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember DPRO:SoftwareMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-26 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-25 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-08-01 2019-08-15 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-08-15 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-01-01 2019-01-31 0001786286 DPRO:DraganflyInnovationsSharesMember ifrs-full:WarrantReserveMember 2021-02-03 2021-02-04 0001786286 DPRO:DraganflyInnovationsSharesMember 2021-02-04 0001786286 DPRO:DraganflyInnovationsSharesMember 2021-02-03 2021-02-04 0001786286 2019-08-01 2019-08-15 0001786286 2019-08-15 0001786286 ifrs-full:WarrantReserveMember 2021-02-03 2021-02-04 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2020-03-26 2020-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-03-26 2021-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-05-26 2021-05-28 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-12-20 2021-12-21 0001786286 DPRO:InventoryMember 2021-01-01 2021-12-31 0001786286 DPRO:InventoryMember 2020-01-01 2020-12-31 0001786286 DPRO:InventoryMember 2019-01-01 2019-12-31 0001786286 DPRO:NoteOneMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteFourMember 2021-01-01 2021-12-31 0001786286 DPRO:PublicCompanySharesMember 2021-12-31 0001786286 DPRO:PublicCompanyWarrantsMember 2021-12-31 0001786286 DPRO:PrivateCompanySharesMember 2021-12-31 0001786286 2021-03-09 2021-03-10 0001786286 2021-03-10 0001786286 2021-10-25 2021-10-27 0001786286 DPRO:WarrantsMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember 2021-03-09 2021-03-10 0001786286 ifrs-full:ComputerEquipmentMember 2019-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2019-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2019-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2019-12-31 0001786286 ifrs-full:VehiclesMember 2019-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2020-01-01 2020-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2020-01-01 2020-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2020-01-01 2020-12-31 0001786286 ifrs-full:VehiclesMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2020-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2020-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2020-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2020-12-31 0001786286 ifrs-full:VehiclesMember 2020-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-12-31 0001786286 DPRO:PatentMember 2019-12-31 0001786286 DPRO:CustomerRelationshipMember 2019-12-31 0001786286 DPRO:BrandMember 2019-12-31 0001786286 DPRO:SoftwareMember 2019-12-31 0001786286 ifrs-full:GoodwillMember 2019-12-31 0001786286 DPRO:PatentMember 2020-01-01 2020-12-31 0001786286 DPRO:CustomerRelationshipMember 2020-01-01 2020-12-31 0001786286 DPRO:BrandMember 2020-01-01 2020-12-31 0001786286 DPRO:SoftwareMember 2020-01-01 2020-12-31 0001786286 ifrs-full:GoodwillMember 2020-01-01 2020-12-31 0001786286 DPRO:PatentMember 2020-12-31 0001786286 DPRO:CustomerRelationshipMember 2020-12-31 0001786286 DPRO:BrandMember 2020-12-31 0001786286 DPRO:SoftwareMember 2020-12-31 0001786286 ifrs-full:GoodwillMember 2020-12-31 0001786286 DPRO:PatentMember 2021-01-01 2021-12-31 0001786286 DPRO:CustomerRelationshipMember 2021-01-01 2021-12-31 0001786286 DPRO:BrandMember 2021-01-01 2021-12-31 0001786286 DPRO:SoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:GoodwillMember 2021-01-01 2021-12-31 0001786286 DPRO:PatentMember 2021-12-31 0001786286 DPRO:CustomerRelationshipMember 2021-12-31 0001786286 DPRO:BrandMember 2021-12-31 0001786286 DPRO:SoftwareMember 2021-12-31 0001786286 ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember DPRO:DronelogicsMember 2020-04-30 0001786286 DPRO:BrandMember DPRO:DronelogicsMember 2020-04-30 0001786286 DPRO:BrandMember DPRO:VitalMember 2021-03-25 0001786286 ifrs-full:ComputerSoftwareMember DPRO:VitalMember 2021-03-25 0001786286 ifrs-full:GoodwillMember DPRO:DronelogicsMember 2020-04-30 0001786286 ifrs-full:GoodwillMember DPRO:DronelogicsMember 2021-03-25 0001786286 DPRO:VitalAndDronelogicsMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2021-12-31 0001786286 DPRO:VitalMember 2021-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2021-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2021-12-31 0001786286 ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001786286 DPRO:CustomersMember 2021-12-31 0001786286 DPRO:CustomersMember 2020-12-31 0001786286 DPRO:GoverenmentMember 2021-12-31 0001786286 DPRO:GoverenmentMember 2020-12-31 0001786286 DPRO:NoteReceivableAccretionMember 2021-12-31 0001786286 DPRO:NoteReceivableAccretionMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2020-12-31 0001786286 DPRO:VehicleLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:VehicleLoanMember 2021-12-31 0001786286 DPRO:VehicleLoanMember 2020-12-31 0001786286 DPRO:ShopifyLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:ShopifyLoanMember 2021-12-31 0001786286 DPRO:ShopifyLoanMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-19 0001786286 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-18 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-01 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-23 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-22 2021-04-23 0001786286 DPRO:CommonStock1Member 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock1Member 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock2Member 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock2Member 2021-12-31 0001786286 DPRO:CommonStock1Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock2Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock3Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock4Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock5Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock6Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock7Member 2020-01-01 2020-12-31 0001786286 DPRO:DronelogicsIncMember 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock8Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock9Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock10Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock11Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock12Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock13Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock1Member 2019-12-31 0001786286 DPRO:CommonStock1Member 2019-01-01 2019-12-31 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-01-01 2019-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2019-01-01 2019-12-31 0001786286 DPRO:EmployeeMember 2021-01-01 2021-12-31 0001786286 DPRO:ConsultantMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeesAndConsultantMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeOneMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantMember 2020-01-01 2020-12-31 0001786286 DPRO:EmployeeOneMember 2020-01-01 2020-12-31 0001786286 DPRO:EmployeeTwoMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantOneMember 2020-01-01 2020-12-31 0001786286 DPRO:StockOptionsMember 2021-01-01 2021-12-31 0001786286 DPRO:StockOptionsMember 2020-01-01 2020-12-31 0001786286 DPRO:StockOptionsMember 2019-01-01 2019-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeandConsultantMember DPRO:RestrictedStockUnitsMember 2020-01-01 2020-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2020-01-01 2020-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2019-01-01 2019-12-31 0001786286 2021-03-21 2021-03-22 0001786286 DPRO:ExercisePriceOneMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceOneMember 2021-12-31 0001786286 DPRO:ExercisePriceTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceTwoMember 2021-12-31 0001786286 DPRO:ExercisePriceThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceThreeMember 2021-12-31 0001786286 DPRO:ExercisePriceFourMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceFourMember 2021-12-31 0001786286 DPRO:ExercisePriceFiveMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceFiveMember 2021-12-31 0001786286 DPRO:ExercisePriceSixMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceSixMember 2021-12-31 0001786286 DPRO:ExercisePriceSevenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceSevenMember 2021-12-31 0001786286 DPRO:ExercisePriceEightMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceEightMember 2021-12-31 0001786286 DPRO:ExercisePriceNineMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceNineMember 2021-12-31 0001786286 DPRO:ExercisePriceTenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceTenMember 2021-12-31 0001786286 DPRO:ExercisePriceElevenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceElevenMember 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:TopOfRangeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:BottomOfRangeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:TopOfRangeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:BottomOfRangeMember 2021-12-31 0001786286 ifrs-full:TopOfRangeMember 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2020-12-31 0001786286 ifrs-full:TopOfRangeMember 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2019-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2020-01-01 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-01-01 2021-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-12-31 0001786286 DPRO:WarrantsMember 2019-12-31 0001786286 DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2020-12-31 0001786286 DPRO:WarrantsMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:Range1Member 2021-01-01 2021-12-31 0001786286 DPRO:Range1Member 2021-12-31 0001786286 DPRO:Range1Member 2020-12-31 0001786286 DPRO:Range2Member 2021-01-01 2021-12-31 0001786286 DPRO:Range2Member 2021-12-31 0001786286 DPRO:Range2Member 2020-12-31 0001786286 DPRO:Range3Member 2021-01-01 2021-12-31 0001786286 DPRO:Range3Member 2021-12-31 0001786286 DPRO:Range3Member 2020-12-31 0001786286 DPRO:Range4Member 2021-01-01 2021-12-31 0001786286 DPRO:Range4Member 2021-12-31 0001786286 DPRO:Range4Member 2020-12-31 0001786286 DPRO:Range5Member 2021-01-01 2021-12-31 0001786286 DPRO:Range5Member 2021-12-31 0001786286 DPRO:Range5Member 2020-12-31 0001786286 DPRO:WarrantsMember ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:TopOfRangeMember DPRO:WarrantsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 ifrs-full:TopOfRangeMember DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2019-12-31 0001786286 DPRO:WarrantsMember 2020-12-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:WarrantOneMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantOneMember 2021-12-31 0001786286 DPRO:WarrantTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantTwoMember 2021-12-31 0001786286 DPRO:WarrantThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantThreeMember 2021-12-31 0001786286 DPRO:WarrantFourMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantFourMember 2021-12-31 0001786286 DPRO:WarrantFiveMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantFiveMember 2021-12-31 0001786286 DPRO:WarrantSixMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantSixMember 2021-12-31 0001786286 DPRO:ProductSalesMember 2021-01-01 2021-12-31 0001786286 DPRO:ProductSalesMember 2020-01-01 2020-12-31 0001786286 DPRO:ProductSalesMember 2019-01-01 2019-12-31 0001786286 DPRO:DroneServiceMember 2021-01-01 2021-12-31 0001786286 DPRO:DroneServiceMember 2020-01-01 2020-12-31 0001786286 DPRO:DroneServiceMember 2019-01-01 2019-12-31 0001786286 DPRO:ServicesMember 2021-01-01 2021-12-31 0001786286 DPRO:ServicesMember 2020-01-01 2020-12-31 0001786286 DPRO:ServicesMember 2019-01-01 2019-12-31 0001786286 DPRO:CustomEngineeringServicesMember 2020-01-01 2020-12-31 0001786286 DPRO:CACountryMember 2021-01-01 2021-12-31 0001786286 DPRO:CACountryMember 2020-01-01 2020-12-31 0001786286 DPRO:CACountryMember 2019-01-01 2019-12-31 0001786286 DPRO:USCountryMember 2021-01-01 2021-12-31 0001786286 DPRO:USCountryMember 2020-01-01 2020-12-31 0001786286 DPRO:USCountryMember 2019-01-01 2019-12-31 0001786286 DPRO:InternationalMember 2021-01-01 2021-12-31 0001786286 DPRO:InternationalMember 2020-01-01 2020-12-31 0001786286 DPRO:InternationalMember 2019-01-01 2019-12-31 0001786286 DPRO:CanadaMember 2021-12-31 0001786286 DPRO:UnitedStatesMember 2021-12-31 0001786286 DPRO:InternationalMember 2021-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2021-01-01 2021-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2020-01-01 2020-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2019-01-01 2019-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2021-01-01 2021-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2019-01-01 2019-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2021-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2020-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2019-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2021-01-01 2021-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2020-01-01 2020-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2021-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2020-12-31 0001786286 DPRO:CEOAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:CEOAndDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:CEOAndDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:PresidentAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:PresidentAndDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:PresidentAndDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:FormerDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:FormerDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:FormerDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:FormerOwnerMember 2021-01-01 2021-12-31 0001786286 DPRO:FormerOwnerMember 2020-01-01 2020-12-31 0001786286 DPRO:FormerOwnerMember 2019-01-01 2019-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2020-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2020-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001786286 2019-01-01 0001786286 2020-04-25 2020-04-27 0001786286 DPRO:CommonSharesMember 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-12-31 0001786286 DPRO:CommonSharesOneMember 2021-12-31 0001786286 DPRO:CommonSharesMember 2019-12-31 0001786286 DPRO:ConvertibleDebenturesMember 2019-01-01 2019-12-31 0001786286 DPRO:CanadaEmergencyWageSubsidyMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyWageSubsidyMember 2020-01-01 2020-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2020-01-01 2020-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2021-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2020-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2021-01-01 2021-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2020-01-01 2020-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2021-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD iso4217:CAD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 20-F

 

(Mark One)

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

  For the fiscal year ended December 31, 2021  

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report . . . . . . . . . . . . . . .

 

For the transition period from ________________ to ___________

 

Commission file number: 001-40688  

 

Draganfly Inc.

(Exact name of Registrant as specified in its charter)

 

N/A

(Translation of Registrant’s name into English)

 

British Columbia, Canada

(Jurisdiction of Incorporation or Organization)

 

2108 St. George Avenue, Saskatoon, Saskatchewan, S7M 0K7, Canada

(Address of Principal Executive Offices)

 

Paul Sun, Chief Financial Officer

Telephone: 800.979.9794

E-mail: paul.sun@draganfly.com

2108 St. George Avenue, Saskatoon, Saskatchewan, S7M 0K7, Canada

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares   DPRO   The Nasdaq Stock Market LLC

 

Securities registered or to be registered pursuant to Section 12(g) of the Act

 

None

(Title of Class)

 

Securities for which there is a reporting obligation pursuant to section 15(d) of the Act

 

None

(Title of Class)

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 33,197,984

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

☐Yes ☒No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

☐Yes ☒No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☐No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)

Yes ☐No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer
        Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.

†The term “new or revised financial accounting standard” refers to any updated issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark whether the registrant has filed a report on an attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP   International Financial Reporting Standards as issued by the International Accounting Standards Board   Other

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

☐ Item 17 ☐ Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐Yes ☒No

 

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court

☐Yes ☒No

 

 

 

 
 

 

Table of Contents

 

Table of Contents i
General Matters ii
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS ii
Part I 1
  Item 1. Identity of Directors, Senior Management and Advisors 1
  Item 2. Offer Statistics and Expected TimeTable 1
  Item 3. Key Information 1
  Item 4. Information on the Company 17
  Item 4A. Unresolved Staff Comments 33
  Item 5. Operating and Financial Review and Prospects 33
  Item 6. Directors, Senior Management and Employees 33
  Item 7. Major Shareholders and Related Party Transactions 47
  Item 8. Financial Information 48
  Item 9. The Offer and Listing. 48
  Item 10. Additional Information 48
  Item 11. Quantitative and Qualitative Disclosures About Market Risk 55
  Item 12. Description of Securities Other than Equity Securities 56
PART II 56
  Item 13. Defaults, Dividend Arrearages and Delinquencies 56
  Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds 56
  Item 15. Controls and Procedures 57
  Item 16. [Reserved] 57
  Item 16A. Audit Committee Financial Expert 57
  Item 16B. Code of Ethics 58
  Item 16C. Principal Accountant Fees and Services 58
  Item 16D. Exemptions from the Listing Standards for Audit Committees 58
  Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers 58
  Item 16F. Change in Registrant’s Certifying Accountant 59
  Item 16G. Corporate Governance 59
  Item 16H. Mine Safety Disclosure 59
  Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 59
PART III 59
  Item 17: Financial Statements 59
  Item 18: Financial Statements 60
  Item 19. Exhibits 60

 

i
 

 

General Matters

 

Unless otherwise noted or the context indicates otherwise “we”, “us”, “our”, the “Company” or “Draganfly” refer to Draganfly Inc. and its subsidiaries.

 

Unless otherwise indicated, financial information in this Annual Report on Form 20-F (this “Annual Report”) has been prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB. Unless otherwise noted herein, all references to “$,” “C$,” “Canadian dollars,” or “dollars” are to the currency of Canada and “US$,” “United States dollars,” or “U.S. dollars” are to the currency of the United States.

 

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and as such, we have elected to comply with certain reduced U.S. public company reporting requirements.

 

The Company prepares and reports its consolidated financial statements in accordance with IFRS. However, this Annual Report may make reference to certain non-IFRS measures including key ‎‎performance indicators used by management. These measures are not recognized measures under IFRS ‎‎and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable ‎‎to similar measures presented by other companies. Rather, these measures are provided as additional ‎‎information to complement those IFRS measures by providing further understanding of the Company’s ‎results of ‎operations from management’s perspective. Accordingly, these measures should not be ‎considered in ‎isolation nor as a substitute for analysis of the Company’s financial information reported ‎under IFRS.

 

The ‎Company uses non-IFRS measures including “gross profit,” “gross margin” and “working capital” ‎which may be calculated ‎differently by other companies. These non-IFRS measures and metrics are used ‎to provide investors with ‎supplemental measures of the Company’s operating performance and liquidity ‎and thus highlight trends in the Company’s ‎business that may not otherwise be apparent when relying ‎solely on IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Corporation’s liquidity and its ability to meet its current obligations. The Company also ‎believes that securities analysts, investors and other ‎interested parties frequently use non-IFRS measures ‎in the evaluation of companies in similar industries. ‎Management also uses non-IFRS measures and ‎metrics in order to facilitate operating performance ‎comparisons from period to period, to prepare ‎annual operating budgets and forecasts and to determine ‎components of executive compensation. For ‎ reconciliations of these non-IFRS measures ‎to the relevant reported measures, please ‎‎see ‎the “Results of Operations – Cost of Goods Sold / Gross Margin” for a discussion of gross profit and gross margin, and for a discussion of working capital, “Selected Financial Information” sections of the Company’s Management’s Discussion and Analysis for the year ended December 31, 2021, attached to this Annual Report in Exhibit ‎15.1.

 

Unless otherwise indicated, the Company has obtained the market and industry data contained in this Annual Report ‎from its internal research, management’s estimates and third-party public information and other industry ‎publications. While the Company believes such internal research, management’s estimates and third-‎party public information is reliable, such internal research and management’s estimates have not been ‎verified by any independent sources and the Company has not verified any third party public ‎information. While the Company is not aware of any misstatements regarding the market and industry ‎data contained in this Annual Report, such data involves risks and uncertainties and are subject to change based on ‎various factors, including those described under “Cautionary Statement Regarding Forward-Looking ‎Information and Statements” and “Item 3.D. Risk Factors”.‎

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report contains forward-looking statements that are subject to risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

 

  the intentions, plans and future actions of the Company;
  statements relating to the business and future activities of the ‎Company;
  anticipated developments in operations of the Company;

 

ii
 

 

  market position, ability to compete and future ‎financial or operating performance of the Company;
  the timing and amount of funding required to execute the ‎Company’s business plans;
  capital expenditures;
  the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;
  ‎the availability of labor;
  requirements for additional capital;
  goals, strategies and future ‎growth;
  the adequacy of financial resources;
  expectations regarding revenues, ‎expenses and anticipated cash needs‎;
  the impact of the COVID-19 pandemic on the business and operations of the Company; and
  general market conditions and macroeconomic trends driven by the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors.

 

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those factors identified under the Risk Factors listed below in Item 3.D. of this Annual Report. Furthermore, unless otherwise stated, the forward-looking statements contained in this Annual Report are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes or otherwise, except as required by law.

 

iii
 

 

Part I

 

Item 1. Identity of Directors, Senior Management and Advisors

 

Not required.

 

Item 2. Offer Statistics and Expected TimeTable

 

Not required.

 

Item 3. Key Information

 

3.A.

 

[Reserved]

 

3.B. Capitalization and Indebtedness

 

Not required.

 

3.C. Reasons for the Offer and Use Of Proceeds

 

Not required.

 

3.D. Risk Factors

 

An investment in the Company’s common shares, without par value, (the “Common Shares”) is highly speculative and involves significant risks. In addition to the other ‎information contained in this Annual Report and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

 

Risks Related to the Company, its Business and Industry

 

The Company has a history of losses.

 

The Company has incurred net losses since its inception. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will be any earnings or revenues in any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research, development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

 

A shareholder’s holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎

 

The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎shareholder’s holding in the Company. ‎The Company’s articles permit the issuance of an unlimited ‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎result in further dilution to shareholder interests.‎

 

1
 

 

The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎

 

‎The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, ‎and introducing new products and services that achieve market acceptance. The Company plans to incur ‎substantial research and development costs as part of its efforts to design, develop and commercialize new ‎products and services and enhance its existing products. The Company believes that there are significant opportunities in a number of business areas. Because the Company accounts for research and development costs as ‎operating expenses, these expenditures will adversely affect its earnings in the future. Further, the Company’s ‎research and development programs may not produce successful results, and its new products and services may not ‎achieve market acceptance, create any additional revenue or become profitable, which could materially harm the ‎Company’s business, prospects, financial results and liquidity.‎

 

The Company’s adoption of new business models could fail to produce any financial returns.‎

 

‎Forecasting the Company’s revenues and profitability for new business models is inherently uncertain and ‎volatile. The Company’s actual revenues and profits for its business models may be significantly less ‎than the Company’s forecasts. Additionally, the new business models could fail for one or more of the ‎Company’s products and/or services, resulting in the loss of Company’s investment in the development and ‎infrastructure needed to support the new business models, and the opportunity cost of diverting management and ‎financial resources away from more successful businesses.‎

 

The Company will be affected by operational risks and may not be adequately insured for certain risks.‎

 

‎The Company will be affected by a number of operational risks and the Company may not be adequately insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal ‎injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, ‎potential legal liability and adverse governmental action, any of which could have an adverse impact on the ‎Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact on the Company’s future cash flows, earnings, results of operations and financial condition.‎

 

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and ‎future prospects.‎

 

‎The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company’s ability to do the following:‎

 

  generate sufficient revenue to reach and maintain profitability;‎
  acquire and maintain market share;‎
  achieve or manage growth in operations;‎
  develop and renew contracts;‎
  attract and retain additional engineers and other highly-qualified personnel;‎
  successfully develop and commercially market new products;‎
  adapt to new or changing policies and spending priorities of governments and government agencies; and
  access additional capital when required and on reasonable terms.‎

 

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

 

2
 

 

The Company operates in a competitive market.

 

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify. Some of the other publicly traded companies we may compete with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, Inc., and Red Cat Holdings, Inc.

 

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

 

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

 

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

 

The markets in which the Company competes are characterized by rapid technological change, which requires ‎the Company to develop new products and product enhancements and could render the Company’s existing ‎products obsolete. ‎

 

‎Continuing technological changes in the market for the Company’s products could make its products less ‎competitive or obsolete, either generally or for particular applications. The Company’s future success will depend ‎upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the ‎markets in which it offers products. Delays in introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and potential customers to purchase the Company’s competitors’ products.‎

 

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, its products could lose ‎market share, its revenue and profits could decline, and the Company could experience operating losses.‎

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada.‎

 

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The Canadian Aviation Regulations (“CARs”) govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

 

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of remotely piloted aircraft systems (“RPAS”) and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit beyond visual line of sight operations. This report was the basis for the recently released Notice of Proposed Amendment (“NPA”) by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

 

3
 

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies, including the granting of certain Special Flight Operations Certificates (“SFOCs”), or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company’s ‎business, prospects, results of operations and financial condition.‎

 

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.‎

 

‎A significant portion of the Company’s business is based on the operation of RPAS. The operation of ‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎there is no assurance that an incident ‎involving an RPAS or the Company’s non-compliance would not ‎create a significant current or future liability for ‎the company.‎

 

The regulation of RPAS operations within the Canadian Domestic Airspace (“CDA”) is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company’s ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

 

The Company’s business and research and development activities are subject to oversight by Transport ‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎SFOC. The Company’s ability to develop, test, demonstrate, and sell products and ‎services depends on ‎its ability to acquire and maintain a valid SFOC.‎

 

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎adoption of small UAV by prospective non-military customers‎.‎

 

The Company may be subject to the risks associated with future acquisitions.

 

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if completed, may expose the Company to additional potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

 

‎The Company’s inability to retain management and key employees could impair the future success of the Company.

 

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose experience, know-how, key professionals and staff members as well as business partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

 

4
 

 

A significant growth in the number of personnel would place a strain upon the Company’s management and resources.

 

The Company may experience a period of significant growth in the number of personnel that could place a strain upon its management systems and resources. The Company’s future will depend in part on the ability of its officers and other key employees to implement and improve financial and management controls, reporting systems and procedures on a timely basis and to expand, train, motivate and manage its workforce. The Company’s current and planned personnel, systems, procedures and controls may be inadequate to support its future operations.

 

The Company faces uncertainty and adverse changes in the economy.‎

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may ‎result in a decrease in demand for the Company’s products, which could have a material adverse impact on the ‎Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also ‎increase costs associated with developing and publishing products, increase the cost and decrease the availability of ‎sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the financial condition and operating results of the Company.

 

The Company is subject to certain market-based financial risks associated with its operations.

 

The Company could be subject to interest rate risks, which is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities, however market fluctuations could increase the costs at which the Company can access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate of interest. In addition, the Company engages in transactions in currencies other than its functional currency. Depending on the timing of these transactions and the applicable currency exchange rates, conversions to the Company’s functional currency may positively or negatively impact the Company.

 

The COVID-19‎ pandemic could negatively affect our business, operations and future financial performance.

 

In March 2020 the World Health Organization designated the outbreak of a novel strain of coronavirus, specifically identified ‎as COVID-19, as a global pandemic. This resulted in governments, companies, and individuals worldwide enacting emergency measures to combat the spread of ‎the virus, including the implementation of travel bans, mandated and self-imposed quarantine ‎periods and physical distancing, that have caused a material disruption to businesses globally. Throughout the course of the pandemic, the impact of COVID-19 has varied significantly due to both global and localized infection rates, notwithstanding widespread vaccine availability within Canada and the United States beginning in spring 2020.

 

As a result of the pandemic, global equity markets have experienced significant volatility and weakness. ‎Governments and central banks have reacted with significant monetary and fiscal interventions designed ‎to stabilize economic conditions. Such volatility has let to significant challenges to the global supply chain, disrupted labor markets and has recently contributed to rising levels of inflation. The Company has experienced material pandemic related impacts, including the loss of its primary customer engineering customer in 2020 due to mandated stay-at-home orders. The duration and impact of the COVID-19 outbreak is unknown at this ‎time, as is the efficacy of the government and central bank interventions. ‎ As such, the Company cannot predict with any certainty what the future impacts the pandemic may have on its business.

 

Management of the Company has and continues to closely monitor the impact of the COVID-19 global pandemic, with a focus on the health and safety of the Company’s employees, customers, and business continuity. Since the outbreak of the pandemic, the Company has taken various ‎steps to mitigate the impact of COVID-19, including following government or health authority guidelines and restrictions at its facilities to ‎ensure the safety of its staff and product consumers. The Company will continue to follow government or health authority guidelines and restrictions and has experienced minimal disruption to its operations and supply chain. However, there is no guarantee that the company’s mitigation efforts will prove successful in combating the spread of the virus or that supply chain disruptions will not occur in the future. As the ‎Company reintegrates its personnel to its workplace, it may incur additional costs to adapt the workplace to ‎meet applicable health and safety requirements. The occurrence of additional waves of the virus or its variants, or insufficient vaccination levels may require the Company to revise or delay such plans. ‎To the extent that it is unable to effectively protect its workforce against the transmission of the virus, the ‎Company may be forced to slow or reverse its reintegration efforts and could face allegations of liability.‎

 

Given the uncertainties associated with the ongoing COVID-19 pandemic, including ‎the uncertainty surrounding the remaining duration and outcome, COVID-19 variants and vaccine efficacy, the Company is unable to estimate the full impact of the COVID-19 pandemic on its business, financial condition, results of operations, and/or cash flows; however, the impact could be material. The Company cannot accurately predict ‎the future impact COVID-19 may have on, among others, the: (i) demand for drone ‎delivery services, (ii) severity and the length of potential measures taken by governments to manage the ‎spread of the virus and their effect on labour availability and supply lines, (iii) availability of essential ‎supplies, (iv) purchasing power of the Canadian dollar, or (v) ability of the Company to obtain necessary ‎financing. Despite global vaccination efforts, it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the Company in ‎the future.‎

 

5
 

 

The conflict between Russia and Ukraine could destabilize global markets and threatens global peace.

 

On February 24, 2022, Russian military forces launched a full-scale military invasion of Ukraine. In response, Ukrainian military personal and civilians are actively resisting the invasion. Many countries throughout the world have provided aid to the Ukraine in the form of financial aid and in some cases military equipment and weapons to assist in their resistance to the Russian invasion. The North Atlantic Treaty Organization (“NATO”) has also mobilized forces to NATO member countries that are close to the conflict as deterrence to further Russian aggression in the region. The outcome of the conflict is uncertain and is likely to have wide ranging consequences on the peace and stability of the region and the world economy. Certain countries including Canada and the United States, have imposed strict financial and trade sanctions against Russia and such sanctions may have far reaching effects on the global economy. The long-term impacts of the conflict and the sanctions imposed on Russia remain uncertain.

 

Negative macroeconomic and geopolitical trends could affect the Company’s ability to access sources of ‎capital.‎

 

The COVID-19 pandemic and the Russian invasion of Ukraine could negatively impact the Company’s ability to obtain financing and access sources of capital. Both events have led to significant market volatility as governments undertake measures to prevent the spread of COVID-19 and discourage political conflict. These events have contributed to significant uncertainty in global markets, increased inflationary pressures, and could lead to a tightening of credit markets and a decline in economic activity. These impacts could have a material adverse effect on the Company’s ‎liquidity and ability to obtain financing in the future.‎ As the Company has a history of losses and present revenues do not allow it to sustain its operations, an inability to access credit or capital markets could undermine the Company’s ability to continue as a going concern.

 

‎‎The Company may be subject to the risks associated with foreign operations in other countries.

 

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. As a result of such expansion, the Company may be subject to the legal, political, social and regulatory requirements and economic conditions of foreign jurisdictions. The Company cannot predict government positions on such matters as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

 

If the Company expands its business to foreign markets, it will need to respond to rapid changes in market conditions, including differing legal, regulatory, economic, social and political conditions in these countries. If the Company is not able to develop and implement policies and strategies that are effective in each location in which it does business, then the Company’s business, prospects, results of operations and financial condition could be materially and adversely affected.

 

There are tax risks the Company may be subject to in carrying on business in Canada.

 

The Company is a resident of Canada for purposes of the Income ‎Tax Act (Canada) (the “Tax Act”). Since the ‎Company is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such additional ‎adverse taxes in the future‎.‎

 

If critical components or raw materials used to manufacture the Company’s products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎

 

‎The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell ‎components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will increase prices for the components, ‎subsystems or systems and will perform their obligations on a timely basis.‎

 

6
 

 

‎Recently, the global supply chain has experienced significant disruptions caused by the COVID-19 pandemic and by geopolitical conflict, including the war in Ukraine. These disruptions have impacted a variety of products and goods and have had various downstream effects, making it more difficult to reliably and timely source and supply goods and has also resulted in shortages of labor and equipment. The macroeconomic impacts of the COVID-19 pandemic and global conflicts have contributed to inflationary pressure and increased market volatility, adding additional pricing uncertainty. These conditions, if not mitigated or remedied in a timely manner, could delay or preclude delivery of raw materials needed to manufacture our products or delivery of the Company’s products to customers, particularly in international markets. If the ‎Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it ‎requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or ‎cost-effective basis to its customers, or at all, which could cause customers to terminate their contracts with the Company, ‎increase the Company’s costs and seriously harm its business, results of operations and financial condition. ‎Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. ‎It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to ‎accommodate components from different suppliers. The Company may experience significant delays in ‎manufacturing and shipping its products to customers and incur additional development, manufacturing and other ‎costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign ‎its products. The Company cannot predict if it will be able to obtain replacement components within the time ‎frames that it requires at an affordable cost, if at all.‎

 

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company’s products.

 

The Company’s business will involve the operation and flying of UAVs, a technology-based product ‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎businesses operated in outdoor conditions, including faulty parts, breakdowns and crashes. Although ‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎outdoor elements will not have a material adverse effect on the use and effectiveness of its products.‎

 

The Company’s products may be subject to the recall or return.

 

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎or inaccurate ‎labeling disclosure. If any of the Company’s equipment were to be recalled due to an ‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company’s operations ‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎potential legal fees, costs and other expenses.‎‎

 

‎‎If the Company releases defective products or services, its operating results could suffer.‎

 

‎Products and services designed and released by the Company involve extremely complex software ‎programs and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎Company’s products and services before they have been released into ‎the marketplace. In such an ‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎services, which could significantly harm its business and operating results‎.‎

 

7
 

 

‎The Company’s products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎

 

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained ‎defects and errors and may in the future contain defects, errors or performance problems when first introduced, ‎when new versions or enhancements are released, or even after these products have been used by the Company’s ‎customers for a period of time. These problems could result in expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of new products or enhancements, significant increases in the ‎Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and ‎harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ‎ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial ‎and could significantly reduce the Company’s operating margins.‎

 

‎The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s ‎products could also lead to product liability claims or lawsuits against it. A defect, error or failure in one of the ‎Company’s UAV could result in injury, death or property damage and significantly damage the Company’s ‎reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to ‎cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.‎ Although the Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎adequate to protect the Company from all material judgments and expenses related to potential future claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company’s brand and divert management’s attention and resources, which ‎could have a negative impact on the Company’s business, financial condition and results of operations.‎

 

Shortfalls in available external research and development funding could adversely affect the Company.‎

 

‎The Company depends on its research and development activities to develop the core technologies used in its UAV ‎products and for the development of the Company’s future products. A portion of the Company’s research and ‎development activities can depend on funding by commercial companies and the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a number of variables, including general ‎economic conditions, specific companies’ financial performance and competition for Canadian government ‎funding with other Canadian government-sponsored programs in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to ‎commercial companies, which directly impact the amount of research and development that companies ‎appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, ‎company funding for research and development could be reduced. Any reductions in available research and ‎development funding could harm the Company’s business, financial condition and operating results.‎

 

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company’s business.‎

 

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In ‎some cases, explicit authorization from the Canadian government is needed to export its products. The export ‎regulations and the governing policies applicable to the Company’s business are subject to change. The Company ‎cannot provide assurance that such export authorizations will be available for its products in the future. ‎Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but ‎could significantly limit them in the future. Non-compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government ‎approvals under applicable regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which could adversely affect the Company’s financial condition and results of operations.‎

 

8
 

 

Negative consumer perception regarding the Company’s products‎ could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company.

 

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, ‎could have a material adverse effect on the Company, the demand for the Company’s products, and the ‎business, results of operations, financial condition and cash flows of the Company. Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality of UAV based surveys in general, or the Company’s products specifically, ‎could have a material adverse effect.‎

 

If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company’s business, prospects, ‎‎financial condition and results of operations‎.

 

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, ‎‎financial condition and results of operations. This will depend largely on the Company’s ability to ‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎products and services. Any negative publicity about the Company or its industry, the quality and reliability of the Company’s technologies, products and services, the Company’s risk management ‎‎processes, changes to the Company’s technologies, products and services, its ability to effectively ‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of sellers and buyers with the Company’s products or services, could adversely affect the Company’s reputation and the confidence in and use of the ‎‎Company’s technologies, products and services. Harm to the Company’s brand can arise from ‎‎many sources, including; failure by the Company or its partners to satisfy expectations of service and quality; inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other claims; employee misconduct; and misconduct by the Company’s partners, service ‎‎providers, or other counterparties. If the Company does not successfully maintain a strong and trusted brand, its business could be materially and adversely affected.‎ ‎

 

The Company may be subject to electronic communication security risks.

 

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Cyberattacks could result in unauthorized access to the Company’s computer systems or its third-party IT service provider’s systems and, if successful, misappropriate personal or confidential information. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

 

Since the outset of the COVID-19 pandemic, there has been an increase in the volume and sophistication of targeted cyber-attacks. Pandemic-adjusted operations, such as work ‎from home arrangements and remote access to the Company’s systems, may pose heightened risk of ‎cyber security and privacy breaches and may put additional stress on the Company’s IT infrastructure. A failure of such infrastructure could severely limit the Company’s ability ‎to conduct ordinary operations or expose the Company to liability. To date, the Company’s systems have functioned capably, and it has not experienced a material impact to its ‎operations as a result of an IT infrastructure issue.‎ In addition, the outbreak of hostilities between Russia and Ukraine and the response of the global community to such aggression is widely seen as increasing the risk of state-sponsored cyberattacks.

 

9
 

 

Even the most well-protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted security breaches are continually evolving and generally are not recognized until launched against a target or, in some cases, are designed not to be detected and, in fact, may not be detected. Any such compromise of the Company’s or its third party’s IT service providers’ data security and access, public disclosure, or loss of personal or confidential business information, could result in legal claims and proceedings, liability under laws to protect privacy of personal information, and regulatory penalties, and could disrupt our operations, require significant management attention and resources to remedy any damages that result, and damage our reputation and customers willingness to transact business with us, any of which could adversely affect our business.

 

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎

 

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with ‎the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders requiring that the Company change its practices, which could have an ‎adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or require it to change its business practices in a manner adverse to its business.‎

 

‎The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company’s teams.‎

 

‎The Company relies on various business partners, including third-party service providers, vendors, licensing partners, ‎development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these ‎third parties are given access to sensitive and proprietary information in order to provide services and support to the ‎Company’s teams. These third parties may misappropriate the Company’s information and engage in ‎unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or update their services and technologies, could result in a disruption to ‎the Company’s business operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect the Company’s business partners and they may not be able to continue honoring their obligations ‎to the Company. Alternative arrangements and services may not be available to the Company on commercially ‎reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner ‎or vendor. If the Company loses one or more significant business partners, the Company’s business could be ‎harmed.‎

 

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company’s business, financial condition, and results of operations could be materially ‎harmed.‎

 

‎The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and ‎other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may ‎be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. ‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise ‎obtain and use the Company’s intellectual property. Moreover, many of the Company’s employees have access to ‎the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for ‎one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result ‎damage the Company’s competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, then the Company’s business, results of operations or financial condition could be materially ‎harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the ‎Company’s results of operations.‎

 

10
 

 

‎In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the ‎Company is pursuing a product or service development that may violate the rights of others may entail significant ‎expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the ‎proceedings could result in significant expense to the Company and divert the attention and efforts of the ‎Company’s management and technical employees, even if the Company prevails.‎

 

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎

 

‎The Canadian Intellectual ‎Property Office (“CIPO”), the United States Patent and ‎Trademark Office (“USPTO”) and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company’s international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company’s business. ‎

 

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.‎

 

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does ‎not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s ‎scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

 

The grant of a patent does not have any bearing on whether the invention described in the patent application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

 

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company’s ability to use certain technologies in the future.‎

 

‎The Company may become subject to claims that its technologies infringe upon the intellectual property or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and ‎could divert the Company’s management’s attention away from the execution of its business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of ‎the technology. The Company cannot assure that it would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to permit the Company to continue offering, and the Company’s customers to continue ‎using, the Company’s affected product. An adverse determination also could prevent the Company from offering ‎its products to others. Infringement claims asserted against the Company may have a material adverse effect on its ‎business, results of operations or financial condition.‎

 

11
 

 

‎The Company may not be able to protect its intellectual property rights throughout the world.‎

 

‎Filing, prosecuting, and defending patents on all of the Company’s product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.‎‎

 

‎Failure to adhere to the Company’s financial reporting obligations and other public company requirements could adversely ‎affect the market price of the Common Shares.‎

 

‎The Company ‎is subject to ‎reporting and other obligations under applicable securities laws in Canada and the United States, and the rules ‎of the CSE and the Nasdaq. These reporting and other obligations ‎place significant demands on the Company’s management, administrative, operational and ‎accounting resources. If the Company is unable to meet such ‎demands in a timely and effective manner, ‎its ability to comply with its financial reporting obligations ‎and other rules applicable to reporting issuers ‎could be impaired. Moreover, any failure to maintain effective ‎internal controls could cause the Company ‎to fail to satisfy its reporting obligations or result in material misstatements in its ‎financial statements. If ‎the Company cannot provide reliable financial reports or prevent fraud, its reputation and operating ‎‎results could be materially adversely affected which could also cause investors to lose confidence in its ‎reported ‎financial information, which could result in a reduction in the trading price of the Common ‎Shares.‎

 

In addition, the Company does not expect that its disclosure controls and procedures and internal ‎controls over financial reporting will ‎prevent all errors or fraud. A control system, no matter how well ‎designed and implemented, can provide only ‎reasonable, not absolute, assurance that the control ‎system’s objectives will be met. Further, the design of a control ‎system must reflect the fact that there ‎are resource constraints, and the benefits of controls must be considered ‎relative to their costs. Due to ‎the inherent limitations in all control systems, no evaluation of controls can provide ‎absolute assurance ‎that all control issues within an organization are detected. The inherent limitations include the ‎realities that ‎judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors ‎or ‎mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two ‎or more ‎people or by management override of the controls. Due to the inherent limitations in a control ‎system, ‎misstatements due to errors or fraud may occur and may not be detected in a timely manner or ‎at all‎.‎

 

We have limited operating experience as a publicly traded company in the U.S.

 

We have limited operating experience as a publicly traded company in the U.S. Although our management team have experience managing a publicly-traded company, there is no assurance that the past experience of our management team will be sufficient to operate the Company as a publicly traded company in the United States, including timely compliance with the disclosure requirements of the U.S. Securities and Exchange Commission (the “SEC”). We are required to develop and implement internal control systems and procedures in order to satisfy the periodic and current reporting requirements under applicable SEC regulations and comply with the listing standards of the Nasdaq. These requirements place significant strain on our management team, infrastructure and other resources. In addition, our management team may not be able to successfully or efficiently manage the Company as a U.S. public reporting company that is subject to significant regulatory oversight and reporting obligations.

 

‎If the Company is required to write down goodwill and other intangible assets, the Company’s financial ‎condition and results could be negatively affected. ‎

 

‎Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics Systems Inc. could have a negative effect on the assets of the ‎Company.‎

 

12
 

 

From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎

 

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the Company’s business, operating results, or ‎financial condition.‎

 

The Company’s directors and officers may have conflicts of interest in conducting their duties.

 

Because directors and officers of the Company are or may become directors or officers of other ‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎Company will establish a special committee of independent directors to review a particular matter in ‎which several directors, or officers, may have a conflict. In determining whether or not the Company will ‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎procedures or mechanisms to deal with conflicts of interest.‎

 

Our Articles ‎provide that the Company must indemnify a director or former director against all judgments, penalties ‎or fines to which such person is or may be liable by reason of such person being or having been a director of the ‎Company and the executive officers and directors may also have rights to indemnification from the Company, ‎including ‎pursuant to directors’ and officers’ liability insurance policies, that will survive termination of their ‎‎agreements‎.‎

 

Risks Related to Our Common Shares

 

The market price of the Common Shares may be highly volatile.‎

 

The market price of the Common Shares may be highly volatile and could be subject to wide fluctuations ‎in response to a number of factors that are beyond our control, including but not limited ‎to‎

 

  revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎
  actual or anticipated changes or fluctuations in our results of operations;‎
  announcements by us or our competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎
  rumors and market speculation involving us or other companies in our industry;‎
  changes in our executive management team or the composition of the board of directors of the Company (the “Board”);‎
  fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎
  general market conditions and macroeconomic trends driven by factors outside our control, such as the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors;
  actual or anticipated developments in our business or our competitors’ businesses or the competitive ‎landscape generally;‎
  litigation involving us, our industry or both, or investigations by regulators into our operations or those of ‎competitors;‎
  announced or completed acquisitions of businesses or technologies by us or our competitors;‎
  new laws or regulations or new interpretations of existing laws or regulations applicable to our ‎business;‎
  shareholder activism and related publicity;‎
  foreign exchange rates; and
  other risk factors as set out in this Annual Report and in the documents incorporated by ‎reference into this Annual Report.‎

 

13
 

 

If the market price of our Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against us, regardless of the merits of such claims. Such a lawsuit could cause us to incur substantial ‎costs and could divert the time and attention of our management and other resources from our business. This ‎could harm our business, results of operations and financial condition.‎

 

There is no guarantee that an active trading market for our Common Shares will be maintained on ‎the CSE and/or the Nasdaq. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎

 

Our Common Shares are currently listed on the CSE, Nasdaq, and the Frankfurt Stock Exchange, however, our shareholders may be unable to sell significant quantities of Common Shares into the public ‎trading markets without a significant reduction in the price of their Common Shares, or at all and there can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can be no assurance that ‎there will be sufficient liquidity of our Common Shares on the trading market, and that we will continue to meet ‎the listing requirements of the CSE, the Nasdaq or any other public listing exchange.

 

Future issuances of equity securities by us or sales by our existing shareholders may cause the price ‎of our Common Shares to fall.‎

 

The market price of our Common Shares could decline as a result of issuances of securities or sales by our ‎existing shareholders in the market, including by our directors, executive officers and significant shareholders, or ‎the perception that these sales could occur. Sales of our Common Shares by shareholders might also make it ‎more difficult for us to sell Common Shares at a time and price that we deem appropriate. We also expect to ‎issue Common Shares in the future. Future issuances of Common Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading prices of the Common Shares.‎

 

We may never pay dividends over the foreseeable future.‎

 

Investors should not rely on an investment in our Common Shares to provide dividend ‎income. The Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not purchase the ‎Company’s Common Shares.‎

 

The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes, which would subject U.S. investors that hold the Company’s Common Shares to potentially significant adverse U.S. federal income tax consequences.

 

If the Company is classified as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes in any taxable year, U.S. investors holding Common Shares generally will be subject, in that taxable year and all subsequent taxable years (whether or not the Company continued to be a PFIC), to certain adverse US federal income tax consequences. The Company will be classified as a PFIC in respect of any taxable year in which, after taking into account its income and gross assets (including the income and assets of 25% or more owned subsidiaries), either (i) 75% or more of its gross income consists of certain types of  “passive income” or (ii) 50% or more of the average quarterly value of its assets is attributable to “passive assets” (assets that produce or are held for the production of passive income). Based upon the current and expected composition of the Company’s income and assets, the Company believes that it was not a PFIC for the taxable year ended December 31, 2021 and expects that it will not be a PFIC for the current taxable year. Nevertheless, because the Company’s PFIC status must be determined annually with respect to each taxable year and will depend on the composition and character of the Company’s assets and income, and the value of the Company’s assets (which may be determined, in part, by reference to the market value of Common Shares, which may be volatile) over the course of such taxable year, the Company may be a PFIC in any taxable year. The determination of whether the Company will be or become a PFIC may also depend, in part, on how, and how quickly, the Company uses its liquid assets and the cash raised in an offering. If the Company determines not to deploy significant amounts of cash for active purposes, the Company’s risk of being a PFIC may substantially increase. Because there are uncertainties in the application of the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, there can be no assurance that the Company will not be a PFIC for any future taxable year. In addition, it is possible that the U.S. Internal Revenue Service may challenge the Company’s classification of certain income and assets as non-passive, which may result in the Company being or becoming a PFIC in the current or subsequent years.

 

14
 

 

If the Company is a PFIC for any year during a U.S. holder’s holding period, then such U.S. holder generally will be required to treat any gain realized upon a disposition of Common Shares, or any “excess distribution” received on its Common Shares, as ordinary income, and to pay an interest charge on a portion of such gain or distribution, unless the U.S. holder makes a timely and effective “qualified electing fund” election (“QEF Election”) or a “mark-to-market” election with respect to its Common Shares. A U.S. holder who makes a QEF Election generally must report on a current basis its share of the Company’s net capital gain and ordinary earnings for any year in which the Company is a PFIC, whether or not the Company distributes any amounts to its shareholders. However, U.S. holders should be aware that there can be no assurance that the Company will satisfy the record keeping requirements that apply to a QEF, or that the Company will supply U.S. holders with information that such U.S. holders require to report under the QEF Election rules, in the event that the Company is a PFIC and a U.S. holder wishes to make a QEF Election. Thus, U.S. holders may not be able to make a QEF Election with respect to their Common Shares. A U.S. holder who makes a mark-to-market election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the taxpayer’s basis therein. Each U.S. holder should consult its own tax advisors regarding the PFIC rules and the U.S. federal income tax consequences of the acquisition, ownership, and disposition of Common Shares.‎

 

United States investors may not be able to obtain enforcement of civil liabilities against us.

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this Annual Report reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this Annual Report.

 

We are an emerging growth company and intend to take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make our Common Shares less attractive to ‎investors.‎

 

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.07 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the United States Securities Act of 1933, as amended (the “Securities Act”)); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the ‎market value of our Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).‎

 

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. We cannot predict whether investors will find our Common Shares less attractive if we rely on these ‎exemptions. If some investors find our Common Shares less attractive as a result, there may be a less active ‎trading market for our Common Shares and the price of our Common Shares may be more volatile.

 

15
 

 

We will incur increased costs as a result of operating as a public company in the United States ‎and our management will be required to devote substantial time to new compliance initiatives.‎

 

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as defined ‎under the JOBS Act, we will incur significant legal, accounting and other expenses, in addition to those we ‎currently incur as a Canadian public company, that we did not incur prior to being listed in the United States. In ‎addition, the Sarbanes-Oxley Act, and rules implemented by the SEC and Nasdaq impose various other ‎requirements on public companies, and we will need to spend time and resources to ensure compliance with our ‎reporting obligations in both Canada and the United States.‎

 

For example, pursuant to Section 404, we will be required to furnish a report by our management on our internal ‎control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered public accounting firm. ‎To achieve compliance with Section 404 within the prescribed period, we will document and evaluate our ICFR, ‎which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through testing that ‎controls are functioning as documented and implement a continuous reporting and improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will ‎be able to conclude within the prescribed timeframe that our ICFR is effective as required by Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated ‎financial statements.‎

 

In addition, becoming a public company in the United States will increase legal and financial compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and will make some of our public company obligations ‎more time consuming. We intend to invest resources to comply with evolving laws, regulations and standards in ‎both Canada and the United States, and this investment may result in increased general and administrative ‎expenses and increased diversion of management’s time and attention from revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal proceedings against us and our business ‎may be harmed.‎

 

We also expect that being a public company in the United States and complying with applicable rules and ‎regulations will make it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎coverage. This factor could also make it more difficult for us to attract and retain qualified executive officers and ‎members of our Board of Directors.‎

 

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available to our U.S. shareholders.‎

 

We currently qualify as a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer would file with the SEC, although we will be required to file ‎with or furnish to the SEC the continuous disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, our officers, directors and principal shareholders are exempt from the ‎reporting and “short swing” profit recovery provisions of Section 16 of the Exchange Act. Therefore, our ‎shareholders may not know on as timely a basis when our officers, directors and principal shareholders purchase ‎or sell our securities as the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In addition, as a foreign private issuer, we are exempt from the proxy rules under the Exchange Act. We ‎are also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material non-‎public information. While we expect to comply with the corresponding requirements relating to proxy statements ‎and disclosure of material non-public information under Canadian securities laws, these requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not expect to receive in every case the ‎same information at the same time as such information is provided by U.S. domestic issuers.‎

 

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and describe the Canadian ‎practices we follow instead. We plan to rely on this exemption in part. As a result, our shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that are subject to all U.S. corporate ‎governance requirements.‎

 

16
 

 

At some point in the future, we may cease to qualify as a foreign private issuer. If we cease to ‎qualify, we will be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎domestic issuer, which may increase our costs of being a public company in the ‎United States.‎

 

Item 4. Information on the Company

 

4.A. History and Development of the Company

 

Name, Address and Incorporation

 

The Company was incorporated as Drone Acquisition Corp. (“DAC”) under the Business Corporations Act (British Columbia) (the “BCBCA”) on June 1, 2018 ‎for the purpose of reorganizing and recapitalizing the business of Draganfly Innovations Inc. (“Former Draganfly”). Effective July 17, 2019, the Company amended its articles to ‎remove various classes of ‎authorized but unissued preferred shares and replace them with only one class of preferred ‎shares (the “Preferred Shares”). Effective August 15, 2019, the Company changed its name to “Draganfly Inc.” On ‎August 22, 2019, the Company amended its articles to re-designate its Class A Common Shares as ‎Common ‎Shares‎.‎

 

The Company’s head office is located at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7. The Company’s telephone number is (800) 979-9794. The Company’s registered office is located at Suite 2800, Park Place, 666 Burrard Street, Vancouver, British ‎Columbia V6C 2Z7. ‎ The Company’s registered agent in the United States is C T Corporation System, 1015 15th Street N.W., Suite 1000, Washington, D.C., 20005 and its telephone number is (202) 572-3133.

 

General Development of the Business of the Company

 

Founded in 1998, we believe that Former Draganfly, is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. Zenon Dragan is the founder of Former Draganfly and is a recognized leading expert on UAV.

 

Former Draganfly introduced its first systems in 1999 and since evolved and shaped the UAV industry. The Company’s aircraft are widely used by public safety agencies worldwide and we believe that we were one of the first UAV to receive a FAA (Federal Aviation Administration) Certificate of ‎‎Authorization in the fall of 2009 with the Mesa County Colorado Sheriff’s Office. In 2013, the Royal Canadian Mounted Police flew one of the Company’s drones to locate and save the life of an accident victim.

 

We believe that Draganfly aircraft have achieved many industry firsts, including:

 

  one of the first public safety UAV to shoot aerial photos documenting a manned aircraft accident in an urban area;
     
  one of the first UAV operated by a public safety organization flown at night to locate and save a life;
     
  one of the first UAV helicopter to be granted a county wide U.S. FAA Certificate of ‎‎Authorization;
     
  named as a test platform at one of the U.S. FAA’s certified test sites;
     
  one of the first to have a drone included in the Smithsonian National Air and Space Museum; and
     
  four of the first six compliance certifications for its products issued by Transport ‎Canada.

 

Three Year History

 

A detailed description on the significant developments of the business of the Company over the last three completed financial years is set out below.

 

17
 

 

Financial year ended December 31, 2019

 

On August 15, 2019, DAC, its wholly-owned subsidiary 1187607 B.C. Ltd. (“Subco”) and Former Draganfly completed a business combination transaction (the “Going Public Transaction”) pursuant to a ‎business combination agreement dated January 31, 2019 among the Company, Subco and Former Draganfly (the ‎‎”Combination Agreement”) whereby: (i) Former Draganfly completed settlement of certain overdue debt in the aggregate ‎of $2,779,726; (ii) Former Draganfly continued to British Columbia (being the corporate law ‎jurisdiction of the Company and Subco); (iii) Subco amalgamated (the “Amalgamation”) with Former ‎Draganfly to form the amalgamated wholly-owned subsidiary of the Company, Draganfly Innovations Inc.; and (iv) the Company changed its name to “Draganfly Inc.”‎

 

Under the Amalgamation, holders of common shares of Former Draganfly (“Former Draganfly Shares”) (other than ‎dissenting shareholders) received 1.794 Common Shares for each Former Draganfly share held by such Former ‎Draganfly shareholder. Consequently, the Company owns 100% of Draganfly Innovations Inc. and the Former Draganfly ‎shareholders became shareholders of the Company.

 

‎‎The Company completed a non-brokered private placement offering on May 22, 2019 and August 6, 2019 (the “Subscription Receipt Offering”) of securities raising aggregate gross proceeds of $7,025,749.50 through the issuance of 14,051,499 ‎subscription receipts of the Company (“Subscription Receipts”) at a price of $0.50 per Subscription Receipt. The ‎Subscription Receipt Offering was required in order to satisfy closing conditions of the Going Public Transaction. Each subscription ‎receipt automatically converted, without payment of additional consideration and without any ‎further action on the part of the holder, into one unit of the Company upon the completion of the Going Public Transaction and the listing of the Common Shares on the CSE. Each unit consisted of one Common Share and one transferable Common ‎Share purchase warrant. Each warrant entitled the holder to purchase one Common Share at a ‎price of $0.50 for a period 12 months following the issuance of the warrants.

 

‎The Company completed the listing of its Common Shares for trading on the CSE under ‎the symbol “DFLY” on November 5, 2019.

 

The Board and the ‎Company’s senior management were reconstituted in conjunction with the completion of the ‎Going Public Transaction to consist of four directors, Cameron Chell, Denis Silva, ‎Scott Larson and Olen Aasen, and Cameron Chell as Chairman and CEO and Paul Sun as CFO and Corporate ‎Secretary.

 

On November 7, 2019, the Company announced that Andrew Hill Card Jr. was appointed to the Board.

 

On November 15, 2019, the Company completed the listing of its Common Shares for trading ‎on the Frankfurt Stock Exchange under the trading symbol “3U8”.

 

Financial year ended December 31, 2020

 

On January 9, 2020, the Company completed the listing of its Common Shares for trading ‎on the OTCQB Venture Market of the OTC Markets under the symbol “DFLYF”.

 

On March 26, 2020, the Company announced that it had been selected as the exclusive global systems integrator for a project with Vital Intelligence Inc. (“Vital”), a healthcare data services and deep learning company, in conjunction with the University of South Australia, using technology developed with help from the Australian Department of Defence Science and Technology Group.

 

On April 30, 2020, the Company completed the acquisition of all of the shares of Dronelogics Systems Inc. for a purchase price of $2,000,000 paid by way of a cash payment of $500,000 and 3,225,438 Common Shares at a deemed price of $0.50 per Common Share. In connection with the acquisition, Justin Hannewyk, President of Dronelogics Systems Inc., was appointed to the Board.

 

‎On June 18, 2020, the Company announced that John M. Mitnick was appointed to the Board.

 

On July 3, 2020, the Company announced that Scott Larson, a director of the Company, was appointed President of the Company.

 

18
 

 

On July 6, 2020, Draganfly completed a non-brokered private placement of 961,538 Common Shares at a price of $0.52 per Common Share for gross proceeds of $500,000.

 

On July 16, 2020, Draganfly completed an issuance of shares for a debt transaction for payment of a third-party strategic vendor’s invoices. Draganfly issued an aggregate of 555,409 Common Shares at a deemed price of $0.55 per Common Share to settle $305,475.03 of outstanding debt.

 

On December 2, 2020, the Company announced that it had completed an initial closing of its Regulation A+ offering of units of the Company (the “Regulation A+ Offering”). The Company issued 2,556,496 units at price of US$0.47 per unit for gross proceeds in the amount of US$1,201,553 in the first closing. Each unit is comprised of one Common Share and one Common Share purchase warrant, with each warrant entitling the holder to acquire one Common Share at a price of US$0.71 per Common Share until November 30, 2022. The Common Shares and Warrants issued in connection with the offering were subject to a nine month hold period which expired on August 30, 2021.

 

On December 22, 2020, the Company announced that it had been selected by Coldchain Technology Services, LLC (“Coldchain”) to immediately develop and provide flight services of a robust vaccine delivery payload for use in critical regions for drone delivery of the COVID-19 vaccine.

 

Financial year ended December 31, 2021

 

On January 6, 2021, the Company announced the awarding of a new patent for a vertical take-off and landing cargo delivery drone with variable center of gravity.

 

On January 21, 2021, the Company announced that it had been selected to provide engineering and development services for a drone-based air support defense system for Integrated Launcher Solutions Inc. (“ILS”). The Company entered into a memorandum of understanding with ILS with the objective to create the terms and conditions surrounding a project management and development agreement for the production of ILS’s multi-launching air support defence system.

 

On March 2, 2021, the Company announced that it will be the exclusive supplier of drones to Woz ED’s drone program across its ‎national K-12 curriculum with the expected deployment of approximately 3000 drones in ‎‎2021‎. The Company entered into a memorandum of understanding with Woz ED with the objective to create the terms and conditions surrounding a business agreement. The memorandum of understanding automatically terminated after 60 days.

 

On March 9, 2021, the Company announced that it had completed the final closing of the Regulation A+ Offering. The Company issued 32,443,457 units at price of US$0.47 per unit for gross proceeds in the amount of approximately US$15.3 million in the final closing. Each unit is comprised of one Common Share and one Common Share purchase warrant, with each warrant entitling the holder to acquire one Common Share at a price of US$0.71 per Common Share for a period of two years from the date of issuance. The Common Shares and Warrants issued in connection with the offering were subject to a nine month hold period.

 

On March 9, 2021, the Company also announced that it has entered into an asset purchase agreement with Vital to purchase all the assets of Vital (the “Vital Asset Acquisition”) in consideration for: (a) a cash payment of $500,000 with $50,000 paid upon execution of the asset purchase agreement, $200,000 to be paid at closing and $250,000 to be paid on the six-month anniversary date of closing; and (b) 6,000,000 units of the Company with each unit being comprised of one Common Share and one common share purchase warrant. Each warrant will entitle the holder to acquire one Common Share for a period of 24 months following closing at an exercise price of $2.67 per Common Share and the Company will be able to accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants. The units will be held in escrow following closing with 1,500,000 units being released at closing and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. The Company completed the Vital Asset Acquisition on March 25, 2021.

 

On March 23, 2021, the Company announced that it signed a services deal to deploy EagleEye™ AI flight services with Windfall Geotek Inc. Windfall Geotek Inc. contractually agreed to have Draganfly provide $1,000,000 in flight services over the course of the next year with $500,000 already directly funded and allocated.

 

19
 

 

On May 13, 2021, the Company announced that it entered into a definitive agreement with Coldchain to develop, deploy and operate solutions for the delivery of medical supplies, medicine, and vaccines. The definitive agreement provides for phase one of a planned five-phase roll-out for the comprehensive development, deployment, and operation of a medical drone delivery service as well as the development of a solution for the timely delivery of medical supplies, medicine, and vaccines. Phase one will also include working with various regulatory bodies, including the FAA, to obtain licenses and approvals for initial non-commercial beta test delivery routes. Phase one has a value of US$125,000, to be executed over a maximum of 10 months and the parties have agreed to negotiate an extension to the definitive agreement for phase two prior to the expiry of phase one. Under phase two, Coldchain will commit to purchasing no less than US$625,000 in equipment and services from Draganfly.

 

On May 19, 2021, the Company announced that it signed a contract with ILS for the development, prototyping, and eventual production of a non-lethal 40 mm ‎multi-‎launching systems that can be mounted and deployed from drones, drone systems, robots, ‎robotic systems, and other stationary platforms or similar systems. As part of the contract, Draganfly provided ILS with strategic vendor financing of US$150,000 to assist in the development of the project and in consideration ILS granted Draganfly a worldwide royalty equal to 8% of the gross revenue received from the project for a period of five years from earlier of the repayment date or maturity date of the loan. The loan is secured against the intellectual property related to the project.

 

On July 22, 2021, the Company announced the expected listing of its Common Shares on the Nasdaq, subject to meeting the final listing requirements of the Nasdaq.

 

On July 27, 2021, the Company announced that in connection with the proposed listing of the Common Shares on the Nasdaq, the Company will consolidate its Common Shares effective July 29, 2021 (the “Consolidation”) on a basis of one new Common Share for every five then issued and outstanding Common Shares under a new CSE stock symbol “DPRO”.

 

On July 29, 2021, the Company announced that its application to list its Common Shares on the Nasdaq was approved by The Nasdaq Stock Market LLC and the Common Shares began trading on July 30, 2021 under the ticker “DPRO”.

 

On August 3, 2021, the Company announced that it completed an underwritten public offering in the United States (the “US Offering”) of 5,000,000 post-Consolidation Common Shares at a price of US$4.00 per Common Share, for total gross proceeds of approximately US$20,000,000, before deducting underwriting discounts and expenses of the US Offering. ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the US Offering.

 

On August 12, 2021, the Company announced that it launched its new, North American designed and built, Draganflyer Commander2 drone system. The Draganflyer Commander2 is a small Unmanned Aerial System (sUAS) and replaced the Company’s Commander platform launched in 2015.

 

On September 9, 2021, the Company announced that Julie Myers Wood was appointed to the Board and that Justin Hannewyk resigned from the Board.

 

On September 15, 2021, the Company announced that the over-allotment option granted to the underwriters in connection with the US Offering was exercised in respect of 95,966 post-Consolidation Common Shares. The exercise of the over-allotment at US$4.00 per Common Share produced additional gross proceeds of US$383,864, bringing the aggregate gross proceeds to Draganfly under the US Offering to US$20,383,864, before deducting underwriting discounts and expenses of the US Offering.

 

On September 22, 2021, the Company announced that it entered into an exclusive manufacturing agreement with Valqari LLC (“Valqari”) to produce Valqari’s Drone Delivery Stations. As per the manufacturing agreement, Draganfly will be the exclusive manufacturer of Valqari’s Drone Delivery Stations. Valqari will be ordering at least $400,000 of manufacturing services during the initial phase of the agreement.

 

On October 12, 2021, the Company announced that it signed a minimum $9 million manufacturing agreement with Digital Dream Labs, Inc. (“DDL”) to design and develop an AI consumer companion robot drone. As per the terms of the agreement, Draganfly will be the exclusive manufacturer and assembler of the drone. DDL will order at least 50,000 units annually with delivery starting in 2022. The drone will be integrated into DDL’s existing product family, including support, sales and distribution channels used for its other consumer robots. Draganfly has also been granted a right of first refusal to become the exclusive manufacturer and assembler of subsequent drone or UAV-based robots to be added to DDL’s product portfolio. The parties have entered into a binding letter agreement reflecting the above terms and will use commercially reasonable efforts to enter into a definitive agreement. The binding letter agreement will govern the relationship between DDL and Draganfly and there can be no assurance that a definitive agreement will be completed or entered into amongst the parties.

 

January 1, 2022 to the Effective Date

 

On March 22, 2022, the Company announced that it had received an order for the Company’s Medical Response and Search and Rescue Drones from Coldchain for immediate deployment with Revived Soldiers Ukraine. Draganfly will provide an immediate combined total of 10 North American-made Medical Response and Search and Rescue Drones. In addition, Draganfly will be donating three drone systems to Revived Soldiers Ukraine. The total initial order size (subject to conditions) is up to 200 units.

 

20
 

 

Significant Acquisitions During 2021

 

Draganfly did not complete any significant acquisitions during its most recently completed financial year for which disclosure is required under Part 8 of National Instrument 51-102 — Continuous Disclosure Obligations of the Canadian Securities Administrators.

 

Market for Securities

 

Trading Price and Volume of Common Shares

 

The Common Shares are listed and posted for trading on the CSE under the symbol “DPRO”. The ‎following table sets forth the price range (high and low prices) in Canadian dollars of the Common ‎Shares (on a post-Consolidation basis) and volume traded on the CSE, for the periods indicated ‎(as reported by the CSE)‎‎.

 

Period  High (C$)   Low (C$)   Volume 
2021            
January   20.25    3.85    11,400,861 
February   21.25    10.65    3,947,466 
March   19.10    9.00    2,285,062 
April   12.40    6.85    1,072,256 
May   10.75    7.30    1,010,472 
June   10.40    7.95    763,940 
July(1)    9.45    4.60    1,006,700 
August   5.28    3.35    624,806 
September   5.25    3.80    557,116 
October   4.77    3.42    475,773 
November   4.85    2.94    777,859 
December   3.83    2.05    658,328 
2022               
January   2.22    1.34    556,191 
February   1.75    1.35    184,388 
March 1-25   4.80    1.50    2,041,588 

 

Note:

 

(1)Effective July 29, 2021, the Company completed the Consolidation on a basis of one new Common Share for every five then issued and ‎outstanding Common Shares and changed its stock symbol on the CSE from “DFLY” to “DPRO”.

 

Prior Sales

 

The following table summarizes the issuances of unlisted securities (on a post-Consolidation basis) for the year ended December 31, ‎‎2021: ‎

 

Date of Issuance  Securities   Number of Common
Shares Issued/Issuable
or Aggregate Amount
   Price/Exercise Price per
Security
 
February 2, 2021  Options(1)   30,000   C$           13.20 
February 5, 2021  Warrants(2)   1,323,275   US$3.55 
March 5, 2021  Warrants(2)   5,154,321   US$3.55 
March 8, 2021  Options(1)   10,000   C$13.90 
March 11, 2021  RSUs(1)   98,668    N/A 
March 22, 2021  Warrants(3)   1,200,000   C$13.35 
April 27, 2021  Options(1)   182,000   C$10.15 
April 27, 2021  RSUs(1)   10,000    N/A 
July 29, 2021  Broker Warrants(4)   250,000   US$5.00 
September 3, 2021  RSUs(1)   165,000    N/A 
September 9, 2021  Options(1)   25,826   C$4.84 
September 9, 2021  RSUs(1)   25,826    N/A 
September 14, 2021  Broker Warrants(4)   4,798   US$5.00 

 

Notes:

 

  (1) Issued pursuant to the amended and restated share compensation plan of the Company (the “Share Compensation Plan”).
  (2) Issued pursuant to the Regulation A+ Offering.
  (3) Issued pursuant to the Vital Acquisition.
  (4)

Issued pursuant to the US Offering.

 

21
 

 

Escrowed Securities

 

The following table summarizes the Company’s securities (on a post-Consolidation basis) that remain in escrow or subject to restrictions ‎‎on transfer as of the date hereof:

 

Designation of Class‎ 

Number of securities held in ‎
escrow or that are subject to ‎

contractual restriction on transfer

  

Percentage of Class(4)

 
Common Shares   402,521(1)   1.2%
Common Shares   2,800,000(2)   8.4%
Common Shares   900,000(3)   2.7%
Warrants   900,000(3)   100%

 

Notes:

 

(1) ‎In connection with the listing of the Common Shares for trading on the CSE, an aggregate of 1,341,734 ‎post-Consolidation Common Shares were deposited in escrow with TSX Trust Company (Endeavor Trust Corporation ‎subsequently replaced TSX Trust Company as escrow agent‎). 10% of such Common Shares were released ‎from escrow on the date the Common Shares were listed on the CSE, and 15% will be release from escrow ‎every six months thereafter, subject to acceleration provisions provided for in National Policy 46-201 – ‎Escrow for Initial Public Offerings.‎
(2) Pursuant to the terms of the Combination Agreement, certain shareholders of Former Draganfly and the ‎Company agreed to voluntary trading restrictions on their Common Shares for a period of three years with ‎‎5% of such Common Shares released on the date of listing of the Common Shares on the CSE and then ‎‎15% released every six months thereafter until month 36 when the remaining 20% will be released.‎
(3) In connection with the Vital Asset Acquisition, 900,000 post-Consolidation ‎Common Shares and 900,000 post-Consolidation warrants were deposited in escrow with DLA Piper (Canada) LLP, as escrow agent, to be released upon the Company reaching certain revenue milestones received from the purchased assets‎.
(4) Percentages based on ‎33,197,984‎ Common Shares issued and outstanding as of March 28, 2022.

 

Dividends

 

The Company has not declared or paid a dividend. Other than the requirements of the BCBCA, there are ‎‎no restrictions on the Company that would prevent it from paying a dividend. However, as of April 3, 2022, the Board intends to retain any future earnings (when available) for ‎reinvestment in ‎the Company’s business, and therefore, it has no current intention to declare or pay ‎dividends on the ‎Common Shares in the foreseeable future. Any future determination to pay dividends ‎on the Common ‎Shares will be at the sole discretion of the Board of Directors after considering a variety ‎of factors and ‎conditions existing from time to time including its earnings, financial condition and other ‎relevant factors.

 

Legal Proceedings and Regulatory Actions

 

Draganfly is not, and has not been at any time within the most recently completed financial year, a party ‎to any legal proceedings, nor is or was Draganfly’s property the subject of any legal proceedings, known ‎or contemplated, that involves a claim for damages exclusive of interest and costs that met or exceeded ‎‎10% of the Company’s current assets.‎

 

Further, there have not been any (a) penalties or sanctions imposed against the Company by a court ‎relating to securities legislation or by a securities regulatory authority during the year ended December ‎‎31, 2020, (b) any other penalties or sanctions imposed by a court or regulatory body against the ‎Company that would likely be considered important to a reasonable investor in making an investment ‎decision, or (c) settlement agreements entered into by the Company before a court relating to securities ‎legislation or with a securities regulatory authority during the year ended December 31, 2021‎.

 

22
 

 

Interests of Management and Others in Material Transactions

 

Other than as set forth herein, or as previously disclosed, the Company is not aware of any material ‎interests, ‎direct or indirect, by way of beneficial ownership of securities or otherwise, of any director or ‎executive officer ‎or any shareholder holding more than 10% of the Common Shares or any associate or ‎affiliate of any of the ‎foregoing in any transaction within the three most recently completed financial ‎years or during the current ‎financial year or any proposed or ongoing transaction of the Company which ‎has or will materially affect the ‎Company.

 

Auditor, Transfer Agent and Registrar

 

The auditors of the Company are Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional ‎Accountants, 1500-1700, 1140 W Pender Street, Vancouver, BC V6E 4G1.‎

 

Endeavor Trust Corporation is the transfer agent and registrar for the Common Shares at its principal ‎office in Vancouver, British Columbia‎.

 

Interests of Experts

 

There is no person or company whose profession or business gives authority to a statement made by ‎such person or company and who is named as having prepared or certified a statement, report or ‎valuation described or included in a filing, or referred to in a filing, made under NI 51-102 by the ‎Company during, or related to, the Company’s most recently completed financial year other than Dale ‎Matheson Carr-Hilton Labonte LLP, the Company’s auditors.‎

 

Dale Matheson Carr-Hilton Labonte LLP are the auditors of the Company and have confirmed that they ‎are independent with respect to the Company within the meaning of the relevant rules and related ‎interpretations prescribed by the relevant bodies in Canada and any applicable legislation or regulations.‎

 

Denis Silva, a director of the Company, is a lawyer at DLA Piper (Canada) LLP, which law firm provides ‎legal services to the Company. As of the date hereof, the associates and partners of DLA Piper ‎‎(Canada) LLP, as a group, beneficially own, directly or indirectly, less than 1% of the outstanding ‎Common Shares. ‎

 

Additional Information

 

Additional information about the Company is available on SEDAR at www.sedar.com and on our website at www.draganfly.com. We do not incorporate the contents of our website or of www.sedar.com into this Annual Report. Information on our website does not constitute part of this Annual Report. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC which can be viewed as www.sec.gov.

 

Additional information, including directors’ and officers’ remuneration and indebtedness, principal ‎holders of ‎Draganfly’s securities and securities authorized for issuance under equity compensation ‎plans, where applicable, ‎will be contained in ‎Draganfly’s information circular for the next annual meeting ‎of shareholders that involves the ‎election of directors and additional information as provided in ‎‎Draganfly’s comparative financial statements for its ‎most recently completed financial year. Draganfly ‎will provide this information to any person, upon request made ‎to the Chief Financial Officer of ‎‎Draganfly at 2108 St. George Avenue Saskatoon, Saskatchewan S7M 0K7. The ‎documents will also be ‎located on SEDAR at www.sedar.com.‎

 

Additional financial information is provided in the Company’s comparative financial statements and ‎‎management’s discussion and analysis for the period ended December 31, 2021, which are also ‎available on ‎SEDAR.‎

 

23
 

 

4.B. Business Overview

 

General

 

The Company is a manufacturer, contract engineering, and product development ‎company within the UAV and ‎health space, serving the public safety, agriculture, industrial inspections, monitoring, spraying, and mapping and ‎surveying ‎markets. We provide sustainable, custom and “off-the-shelf” ‎hardware, services, and solutions to ‎companies and government agencies. Our mission is to deliver products that ‎provide vital information to our ‎customers with the hopes of saving time, money and lives‎.

 

Drone Industry Overview

 

Drones or UAV have rapidly evolved from a military origin to commercial and civil government ‎applications from security to farming. The increased automation of drones provides additional value to ‎existing workflows, triggering more widespread adoption. A global shift to sustainable and eco-friendly ‎options has further increased demand for drone usage.

 

Drone applications are being utilized in multiple industries on a global basis. A portion of manned ‎military aircraft (“MMA”) created the drone industry as a safe, inexpensive option. Defense will remain the ‎largest market over the foreseeable future. However, the mobile phone industry created an affordable ‎technology stack for drones. The ability to carry a camera enabled many people to utilize the platforms ‎for media production and beyond. That demand initiated in the consumer market and has migrated along ‎with technological advancements into the growth of commercial drone industry.‎

 

The major segments of the drone market are drone hardware, software and services. Drone hardware are ‎the physical goods, including drone platforms, aerial mobility platforms and components and systems. ‎The software segment includes flight planning, navigation and computer vision, unmanned traffic ‎management (“UTM”), fleet operations, ecosystems, networks and software development kits (“SDKs”). The ‎services aid the drone hardware and software manufacturers. They include drone service providers ‎‎(“DSPs”), system integrators, pilot training providers, retailers and marketplaces, coalitions and ‎organizations, drone test sites, insurance providers and university/educational facilities.‎

 

Drone application methods are being used by a variety of industries today. There are approximately ‎eight methods that are garnering the most attention: mapping, surveying, inspection, ‎filming/photography, dispensing/spraying, warehousing, monitoring/detection, and delivery. These ‎applications are being used today by the civil government, educational facilities, agricultural, ‎construction, health care, real estate, energy, transportation, insurance, security, and scientific industries. ‎According to Drone Industry Insights, the fastest growing drone application method will be delivery and ‎is forecasted at 28.6% CAGR over the next five years1; however, this will not happen without intense ‎industry scrutiny and regulation.‎

 

Products and Services

 

The Company can provide its customers with an entire suite of products and services that include: quadcopters, ‎fixed wing ‎aircrafts, ground based robots, handheld controllers, flight training, and software used for tracking, live ‎streaming, ‎and data collection. In addition, Draganfly has launched a health/telehealth platform. The initial focus of the platform is a COVID-19 screening set of technologies that remotely detects a number of key COVID-19 respiratory symptoms. The Company is also offering sanitary spraying services to indoor and outdoor public gathering spaces such as sport stadiums and fields to provide additional protection against the spread of contagious viruses such as COVID-19. ‎

 

 

1 See Global Drone Market Report 2020-2025

 

24
 

 

The Company generates revenues across the following categories

 

   Revenues 
   Fiscal year ended December 31, 
Category of Activity  2021   2020   2019 
Product Sales  $5,103,399   $3,087,223   $248,939 
Drone Services  $1,304,799   $630,532    - 
Engineering Services  $645,667   $645,756   $1,131,488 

 

The Company did not derive significant revenue from any customers that exceed 10% ‎of total revenues for ‎the year ended December 31, 2021. At December 31, 2020 the Company had one custom engineering customer from which it received revenues in excess of 10% of total revenues for the fiscal year ($474,701).‎

 

Draganfly Products

 

‎‎Quadcopters and Multirotors

 

‎The Company is among the longest-running manufacturers of quadcopters and multirotor drones in the world. Draganfly’s quadcopters and multirotor drones include the following:‎

 

  Draganflyer Commander2 ‎– The Draganflyer Commander2 is a multi-mission, high-endurance, electric sUAS that combines the signature design elements of our past Draganflyer systems with the most advanced features to date. The Commander2 can be used for numerous applications across many industries including agriculture, public safety, and aerial 3D modeling. Paired with powerful MAVLink-based flight planning software, the Draganflyer Commander2 supports both fully- and semi-automated missions, as well as manual flight operations with a pilot in the loop for a high level of system control to handle any operational task.
     
  Draganflyer Commander – a high-endurance, electric, autonomous quadcopter drone built on ‎Draganfly’s patented carbon fiber folding airframe with interchangeable payloads for a variety of ‎missions requiring high resolution imagery, including surveying, 3D mapping, industrial ‎inspection, search and rescue, and high-endurance public safety applications. ‎
     
  Draganflyer X4-P – semi-autonomous quadcopter with 18-minute flight time ideal for medium ‎projects.
   ‎  
  Quantix™ Mapper – exclusive to Draganfly through its partnership with AeroVironment, it is a fully-‎automated drone that is designed for mapping.‎
     
  Tango2 – a high endurance, dual battery, sUAS capable of carrying a wide array of payload systems. ‎The aircraft utilizes the Draganfly intelligent power management system to extend flight time ‎while increasing safety. This sUAS is ideal for agricultural monitoring and research, mapping, ‎surveying, environmental monitoring, and search and rescue.‎

 

Universal Control System

 

The Draganfly Universal Control System is a complete, handheld ground control system that is built to ‎integrate with other software and hardware systems. The Draganfly Universal Control System is designed ‎to provide precise control over sUAS helicopters, fixed-wing, and ground-based robots. Draganfly ‎software provides sophisticated flight planning, automated takeoff, grid following, waypoints, landing, ‎data collection, and video downlink.‎

 

Software

 

The Draganfly Surveyor drone flight planning software is an intuitive, easy to use, application that ‎enables customers to quickly plan, fly, and process meaningful data. Based on the project, camera type, ‎optics, and altitude, the drone software determines the appropriate camera shutter interval, aircraft ‎speed, and flight plan to capture the optimum required photo overlap to generate 2D and 3D maps and ‎models. The Draganfly Surveyor directly integrates with Pix4Dmapper for survey-grade results and can ‎be used alongside other third-party photogrammetry programs.‎

 

Vital Intelligence

 

Draganfly installs standalone and airborne health ‎assessment systems at locations such as universities, hotels, casinos, family entertainment complexes, ‎shopping centers, and other high-traffic locations. These systems effectively measure social distancing ‎and visitors’ vital signs like temperature, cough, and respiratory rate to identify high-risk visitors. Vital ‎Intelligence is a data platform that turns an existing camera into a touchless symptom detection system, ‎measuring vital signs and social distancing. Draganfly integrates this technology into a variety of ‎platforms and camera systems – both on the ground and in the air – to assess people coming into and ‎traveling throughout a facility.‎

 

25
 

 

Draganfly Services

 

Custom Engineering

 

Draganfly is a contract engineering partner for government agencies, enterprise organizations, academic ‎institutions, and businesses of all sizes. The Draganfly team’s truest capabilities are actualized during the ‎engineering process as hardware designers, software designers, engineers, project managers, and ‎vertical-specific experts come together to build custom drone solutions for its partners. Draganfly’s end-‎to-end engineering services include:‎

 

  Hardware design: Component, product, and system design.‎
     
  Software design: Custom software and interface design.‎
     
  Development: Including integration with third party platforms, PixX4D, Pixhawk, Ardupilot, DJI ‎and ‎more.‎
     
  Modeling: 3D design and modeling of mechanical components.‎
     
  ITAR (International Traffic in Arms Regulations) equipment management: Approved handling and integration of ITAR, and Controlled Goods ‎technologies.‎
     
  Support: Testing, training, documentation, and repairs.‎

 

Training

 

Draganfly offers custom-designed training packages that are tailored to specific operations and use ‎cases. The Company also offers basic training for new UAV owners, up to advanced classes for users ‎who understand the fundamentals and are looking for new ways to increase flight efficiency or comply ‎with federal regulations.‎

 

Flight Services

 

Draganfly has a team of qualified pilots that conduct flights on behalf of its customers. The team ‎specializes in working with emergency services including police, fire, and search and rescue personnel. ‎Draganfly also supports industrial applications, utility and power companies, environmental and ‎agricultural entities and others.‎

 

Spraying Services

 

Draganfly operates, in partnership with a leader in natural and organic disinfectants, to ‎administer a sanitization spraying service in large public venues by misting a surface spray across the ‎entire venue in four to six hours.‎

 

Principal Markets

 

Draganfly has more than 20 years of experience designing and manufacturing professional drones for ‎military, public safety, energy, agriculture, and insurance. Draganfly has sold products and services to a number of countries but predominantly focuses on the North American market given its geographical ‎location.‎

 

Military and Government

 

Military and government contractors have partnered with Draganfly to improve personnel and infrastructure ‎safety. Draganfly works with partners to design and manufacture custom airframes, design and develop ‎payloads, and manage complex flight operations. Draganfly team members hold advanced pilot ‎certificates and are approved to fly in controlled airspace and at airports. Since the Company’s ‎development team is cleared by Canada’s Controlled Goods Program, the team is permitted to handle ‎ITAR equipment and technologies, and the Company’s facilities are built to protect those technologies ‎and ensure they are only handled by approved personnel.‎

 

26
 

 

Public Safety

 

In 2013, the Royal Canadian Mounted Police flew one of the Company’s drones to locate and save the life of an accident victim, which we believe was one of the first times a public safety organization used a UAV to save a life. Years later, the Company is still a ‎leader in using drone technology to keep the public safe. Draganfly works with its partners to identify ‎unknowns, such as substances, spills, packages, and chemicals while not putting human lives at risk‎. ‎Draganfly builds aerial and ground systems with custom payloads and sensors to scan scenes, survey ‎public events, locate objects, and clear debris faster and more safely than on-the-ground manpower. The ‎Company also empowers its partners to maximize existing infrastructures via custom API integrations ‎that ensure Draganfly’s technology enhances their safety systems.‎

 

Environmental and Energy

 

Draganfly offers a suite of commercial UAV solutions for energy companies and those servicing the ‎energy market, like surveyors and consultants. Draganfly equips energy companies with the hardware ‎and software they need to optimize existing operations, improve safety, and respond after a natural ‎disaster. Partners can use Draganfly hardware and 3D modeling software to remotely inspect sites that ‎would put human lives at risk. They also conduct environmental monitoring with Draganfly’s sample ‎collection solutions, assessing water and ground pollution, gas composition, infrastructure, and other ‎environments.‎

 

Agriculture

 

Draganfly works with its partners to collect high-quality data, using multi- and hyper-spectral imaging, 3D ‎modeling, and a suite of sophisticated sensor technology that assesses environmental factors. Seed ‎companies use Draganfly technology to optimize growth season, measuring seed trial results throughout ‎the research and development process. Farmers can use Draganfly flight and data collection services to ‎monitor hectares of land year-round, assessing factors like fertilizer efficiency, weed production, and ‎more. ‎

 

Operations

 

Canadian Operations

 

Draganfly Innovation Inc.’s products are manufactured at its machine shop within its leased head office ‎based in Saskatoon, Saskatchewan, Canada. Draganfly Innovations Inc. operates the fully operational ‎facility located at 2108 St. George Avenue, Saskatoon, SK S7M 0K7. This facility is to be used only for ‎the purposes of Draganfly Innovations Inc. operating its business of design, development, production, ‎distribution, sale and/or licensing of drones or robots, or such other use as permitted by the landlord ‎from time to time. ‎

 

Dronelogics Systems Inc.’s products and services are provided through its leased space located at Unit 319, 2999 ‎Underhill Avenue, ‎Burnaby, British Columbia‎. ‎

 

‎United States Operations

 

‎The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has an ‎office in ‎Palm Beach ‎Gardens, Florida that currently stores some inventory for operations in the ‎United States‎. ‎

 

The Company has derived its revenues across the following primary geographic market segments for the last three fiscal years:

 

   Revenues 
   Fiscal year ended December 31, 
Region  2021   2020   2019 
Canada  $4,937,935   $2,270,862   $127,118 
United States  $2,071,492   $1,982,404   $1,251,199 
International  $44,438   $110,245   $2,110 

 

27
 

 

Competitive Conditions

 

Although Draganfly is acknowledged as a drone industry pioneer that we believe was the first to develop the commercial multi rotor ‎helicopter, there ‎are now many drone hardware companies in the world. As technology ‎has improved ‎and costs for hardware and software have come down, the line between consumer and commercial ‎‎drones has blurred. Historically, Draganfly has serviced early adopters in the public safety industry. At ‎this stage of ‎the commercial drone adoption curve, the average public safety organization (local, ‎regional, and even federal law ‎enforcement, for example), are quite budget conscious. Hence, these ‎organizations tend to use lower cost drones ‎that have become quite sophisticated that can accomplish ‎most of their use cases. The dominant company in the industry is ‎DJI, the Chinese drone company that ‎is reputed to own over 70% of the consumer and now commercial drone ‎market. The majority of DJI’s ‎drones are geared towards broad applications involving the masses. Draganfly has ‎moved away from ‎competing directly with DJI and in some cases sells DJI products through its subsidiary, Dronelogics Systems Inc., or ‎has chosen to serve niche markets outside of where DJI tends to ‎be. ‎There are also some organizations that tend to be US based that either prefer or are mandated to not use ‎foreign ‎drones such as those produced by DJI. Some of these organizations are sensitive to their work ‎being exposed to that ‎of overseas governments which has at least for the time being, created a niche ‎market for players such as ‎Draganfly. The combined shift away from foreign made drones (national security issues) and regulatory improvements by the FAA in respect of drone usage is driving industry demand. As Draganfly has evolved to move with the industry trends, the ‎Company now uses DJI drones as part ‎of some of its customization and engineering services work. ‎Draganfly has also moved into innovative engineering ‎procurement which is very specialized. As the drone industry matures, this may bring more competitors to this space or ‎the ‎Company’s customers may choose to develop the in-house expertise to do the work that they currently ‎‎outsource to Draganfly. However, it is the Company’s view that there will be a growing customer base ‎that will ‎require very specialized work that only a handful of companies can do.‎

 

The market remains highly competitive. Private equity continues to significantly capitalize drone start-ups at industry high valuations. The publicly-traded companies in the drone segment trade at different valuations, with a steep discount to private-equity backed ventures. Some of the other publicly traded companies we may compete with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, Inc., and Red Cat Holdings, Inc.

 

Regulatory Framework

 

A new regulatory framework relating to the use of drones in Canada was published by Transport ‎Canada ‎in January 2019 and came into effect on June 1, 2019. The changes, published in the ‎Canadian Aviation ‎Regulations (“CARs”), Part IX, introduce new rules based on the weight of the RPA and the intended ‎operation. This framework creates three broad ‎categories of RPAS: (i) small RPAS in limited (low risk) ‎operations (“Small RPAS Basic”); (ii) ‎small RPAS in advanced (complex) operations (“Small RPAS ‎Advanced”); and (iii) all other RPA ‎operations that fall outside (i) and (ii) above. These regulations focus ‎on foundational issues ‎such as aircraft marking and registration, pilot knowledge and certification, ‎airworthiness of the ‎aircraft, and flight rules.‎

 

Small RPAS Basic are defined as RPAS weighing between 250 grams and 25 kilograms and operated in ‎rural ‎and unpopulated areas. These RPAS will require identification markings, including name, address ‎‎and contact information of the owner and pilot of the RPA. Pilots must be at least 14 years of ‎age and ‎must hold a valid Basic RPA licence that is specific to small drones. Additional ‎restrictions are imposed ‎that include that the RPA cannot operate: (i) within approximately 30 meters of ‎people or open-air ‎assemblies of people, (ii) above 400 feet, (iii) within approximately 1.85 kilometers of ‎heliports or (iv) ‎within approximately 5.5 kilometers of airports. These regulations require the RPA to ‎always be operated ‎within visual line-of-sight.‎

 

Small RPAS Advanced are defined as RPAS weighing between 250 grams and 25 kilograms and ‎operated in ‎urban and/or populated areas. These RPAS will require identification, marking and ‎registration ‎with Transport Canada as well as meeting specified design standards acceptable to ‎Transport ‎Canada. The RPA will be assigned a unique identification/registration number issued by ‎Transport ‎Canada. Pilots must be at least 16 years of age and must hold a valid Advanced RPAS licence ‎‎that is specific to small drones. Approval for operation must be granted by Air Traffic Control ‎when ‎operating in controlled airspace or near controlled aerodromes. A set of flight rules must be ‎followed at ‎all times for these more complex operations. Restrictions, including distances from ‎people, are ‎determined based on the safety certification of the RPA being operated. The RPA ‎must always be ‎operated within visual line-of-sight.‎

 

28
 

 

The current legislation utilizes a similar Special Flight Operations Certificate (“SFOC”) application ‎‎process, as the previous regulations, to approve any operations that do not fit within the ‎regulatory ‎regime set out above, such as operating beyond visual-line-of-sight. For those wishing ‎to operate ‎outside of the regulatory framework set out in CARs, part IX, there will be a variety of ‎SFOC application ‎processes tailored to the nature and use of the RPA. The more complex and ‎riskier the proposed ‎operation, the more thorough and detailed the SFOC application process.‎

 

Those operators requiring an SFOC must apply to the Transport Canada Civil Aviation Regional ‎Office at ‎least 30 working days prior to the date of the proposed RPAS operation. Transport ‎Canada has wide ‎discretion in reviewing and approving SFOC applications; however, to date the ‎Company has never been ‎refused an SFOC for which it has applied. The purpose of the SFOC ‎application review is to ensure that ‎the proposed operation is safe and associated risks have ‎been adequately mitigated by the Company.‎

 

In April 2020, Transport Canada published a Notice of Proposed Amendment (defined herein as “NPA”) as the first ‎step in ‎the publication of new regulations for beyond visual line-of-sight operations. The NPA ‎provided a ‎synopsis of the high-level policies Transport Canada is proposing to support beyond ‎visual line-of-sight ‎operations in lower risk environments such as remote and isolated areas. ‎These new regulations will also ‎provide clear direction and guidance on the use of heavier aircraft ‎‎(up to 650 kilograms), operations at ‎higher altitudes than currently permitted in CARs, Part IX, and will ‎set the foundation for an operator ‎certification program. Once published, these regulations will ‎permit routine beyond visual-line-of-sight ‎operations without the need for the Company to request ‎specific permission for each operation, as is ‎currently required with the current SFOC process. ‎ The first draft of these regulations were expected to be published in Canada Gazette in Spring of 2021; however, as at the date of this Annual Report, the first draft has not been published.‎

 

The Company is currently fully compliant with all current regulatory requirements and has applied ‎for, and ‎received Transport Canada approval for several SFOCs.‎

 

Components

 

The Company obtains hardware components, various subsystems and systems, and raw materials from ‎a limited group of suppliers. The Company does not have long-term agreements with any of these ‎suppliers that obligate such suppliers to continue to sell components, subsystems, systems or products ‎to the Company. The Company’s reliance on these suppliers involves significant risks and uncertainties, ‎including whether suppliers will provide an adequate supply of required raw materials, components, ‎subsystems, or systems of sufficient quality, will increase prices for the raw materials, components, ‎subsystems or systems, and will perform their obligations on a timely basis. See “‎Item 3.D.‎ Risk Factors”.‎

 

Intangible Properties

 

Intangibles such as patents, software, specific technology know-how, and applications expertise all have ‎a significant effect on the Company’s business. The Company has been focused on developing ‎proprietary technology which meets or exceeds anticipated Canadian government requirements relating to drone delivery. By virtue ‎of being one of the first commercial ‎UAV companies in the industry, the Company’s subsidiary, Draganfly ‎Innovations Inc., holds commercial patents. ‎

 

The Company has the following patents and patents pending in the application ‎stage in its portfolio and intends to continue to expand and grow its intellectual property portfolio:‎

 

Title  Country  Application No.  Issue Date  Patent No.   Status 
Multi Rotor UAV With Compact Folding Rotor Arms  Canada   2,917,434  4/23/2019   2,917,434   Issued 
Vehicle with Aerial and Ground Mobility  Canada   2,787,279  10/22/2013   2,787,279   Issued 
Vertical Takeoff and Landing Unmanned Aircraft System  Canada   2,935,793  1/15/2021   2,935,793   Issued 
Wheel with Folding Segments  Canada   2,787,075  10/29/2013   2,787,075   Issued 
Action Camera System for Unmanned Aerial Vehicle  United States   15/707,752  1/22/2019   10,187,580   Issued 
Action Camera System for Unmanned Aerial Vehicle  United States   14/533,995  9/19/2017   9,769,387   Issued 

 

29
 

 

Title  Country  Application No.  Issue Date  Patent No.  Status 
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   14/642,370  7/18/2017   9,710,709   Issued 
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   15/651,672  2/13/2018   9,892,322   Issued 
Cascade Recognition for Personal Tracking via Unmanned Aerial Vehicle (UAV)  United States   15/894,292  10/8/2019   10,438,062   Issued 
Dual Rotor Helicopter with Tilted Rotational Axes  United States   12/458,608  11/8/2011   8,052,081   Issued 
Helicopter with Folding Rotor Arms  United States   13/200,825  10/23/2012   8,292,215   Issued 
Multi Rotor UAV With Compact Folding Rotor Arms  United States   14/994,080  7/31/2018   10,035,581   Issued 
Pixel Based Image Tracking System For Unmanned Aerial Vehicle (UAV) Action Camera System  United States   15/256,193  10/10/2017   9,785,147   Issued 
Pixel Based Image Tracking System for Unmanned Aerial Vehicle (UAV) Action Camera System  United States   14/825,956  9/13/2016   9,442,485   Issued 
Real Time Noise Reduction System for Dynamic Motor Frequencies Aboard an Unmanned Aerial Vehicle (UAV)  United States   14/642,496  11/8/2016   9,489,937   Issued 
System and Method for Adaptive Y Axis Power Usage and Non Linear Battery Usage for Unmanned Aerial Vehicle Equipped with Action Camera System  United States   14/825,914  12/6/2016   9,511,878   Issued 
Tandem Wing Aircraft System with Shrouded Propeller  United States   15/584,815  8/13/2019   10,377,488   Issued 
Vehicle with Aerial and Ground Mobility  United States   14/641,468  3/21/2017   9,598,171   Issued 
Vehicle with Aerial and Ground Mobility  United States   13/846,074  3/31/2015   8,991,740   Issued 
Vertical Take Off And Landing (VTOL) Aircraft Having Variable Center Of Gravity  United States   15/706,158  10/20/2020   10,807,707   Issued 
Vertical Takeoff and Landing Unmanned Aircraft System  United States   15/164,718  8/28/2018   10,059,442   Issued 
Visually Intelligent Camera Device with Peripheral Control Outputs  United States   14/939,369  8/6/2019   10,375,359   Issued 
Wheel with Folding Segments  United States   13/739,419  6/17/2014   8,753,155   Issued 

 

30
 

 

The Company also has the following registered trademarks and pending ‎applications‎:‎

 

Description  Name/Title  Official No.   Governmental Entity
Trademark Application (Status: Filed)  DRAGANFLY   1,972,336   CIPO
Registered Trademark  DRAGANFLYER EXPLORE   TMA1,025,742   CIPO
Registered Trademark  DRAGANFLYER APEX   TMA1,025,624   CIPO
Registered Trademark  DRAGANFLYER COMMANDER   TMA1,008,809   CIPO
Registered Trademark  DRAGANFUEL   TMA997,118   CIPO
Registered Trademark  DRAGANFLY INNOVATIONS   TMA908,564   CIPO
Registered Trademark  DRAGANFLYER   TMA906,939   CIPO
Registered Trademark  DRAGANFLY & DESIGN   TMA905,935   CIPO
Registered Trademark  DRAGANFLY   TMA1,071,582   CIPO
Registered Trademark  DRAGANFLY   TMA1,069,670   CIPO
Registered Trademark  DRAGANFLYER GUARDIAN   TMA904,883   CIPO
Registered Trademark  DRAGANVIEW   TMA886,217   CIPO
Registered Trademark  DRAGANFLYER APEX   6248237   USPTO
Registered Trademark  DRAGANFLY   6373176   USPTO
Registered Trademark  DRAGANFLYER COMMANDER   5760146   USPTO
Registered Trademark  DRAGANFUEL   5563360   USPTO
Registered Trademark  DRAGANFLY INNOVATIONS   5130969   USPTO
Registered Trademark  DRAGANFLYER   4920316   USPTO
Registered Trademark  DRAGANFLY & Design   5130970   USPTO
Registered Trademark  DRAGANFLYER GUARDIAN   4995725   USPTO
Registered Trademark  DRAGANVIEW   4920317   USPTO
Trademark Application2  DRAGANFLY   88488410   USPTO

 

Market Opportunity

 

Drones have rapidly evolved from their military origin to commercial and civil government applications from ‎security to farming. The increased automation of drones provides additional value to existing workflows, triggering ‎more widespread adoption. A global shift to sustainable and eco-friendly options has further increased demand for ‎drone usage. Lastly, regulatory amendments are anticipated to have an ongoing impact on the drone industry. ‎According to Drone Industry Insights, the commercial and private drone market could grow from $22.5 billion in ‎‎2020 to $42.8 billion in 2025, representing compound annual growth rate (“CAGR”) of 13.8%.3

 

Drone application methods are being used by a variety of industries today. The most active segments are Mapping, ‎Surveying, Inspection, Filming/photography, dispensing/spraying, warehousing, monitoring/detection, and delivery. ‎These applications are being used today by the civil government, educational facilities, agricultural, construction, ‎health care, real estate, energy, transportation, insurance, security, and scientific industries for public safety, data ‎collection and profit. According to the Drone Industry Insights, the fastest growing drone application method will be ‎delivery and is forecasted at 28.6% CAGR over the next five years and it is widely believed over 100,000 new jobs will ‎be created in the drone market by 2025.4 However, regulatory hurdles and intense industry scrutiny need to be ‎addressed.‎

 

 

2 The US application is suspended pending registration of the Canadian mark

3 See Global Drone Market Report 2020-2025

4 See Global Drone Market Report 2020-2025

 

31
 

 

Our existing products are configured to meet the needs of multiple industries. We continue to add new customers in ‎different market verticals. We are actively designing and developing new products and services to meet increased ‎customer demands.‎

 

Growth Strategy

 

Draganfly markets its products and services as a drone solution platform that enables customer to do things not ‎easily done before and to collect data not easily available before. Draganfly provides solutions to our customers ‎utilizing drones and adjunct technologies. Sensors, software, AI and more all make up this ability to provide ‎solutions that only a company with end-to-end capabilities can provide. Draganfly grows by dealing with the ‎decision makers in organizations who generally have budget control and/or profit and loss responsibility. Draganfly will ‎continue to develop specific solutions and IP for industry verticals by working directly with customers. Draganfly ‎will also pursue an acquisition strategy focused on adding additional capabilities to its platform that strengthen its ‎value proposition of being able to provide new and total solutions that other drone companies cannot. Draganfly is focused on growth through developing new products, expanding its customer base, and pursuing accretive acquisition opportunities, both within and outside North America, in new markets that complement its existing portfolio.

 

Sales and Marketing

 

Draganfly plans to expand it sales and market capabilities in three key areas. First, Draganfly intends to implement a sales force that has the ability ‎to build relationships and sell specifically designed solutions into industry verticals. This sales force will be ‎specialized into segments that sell either direct or into a channel dependent on the specific product or service ‎solution being provided. Draganfly plans to expand business development personnel that can work with specific industries to envision ‎and develop new product lines and services not yet contemplated by our customers. Second, Draganfly plans to drive greater market ‎awareness of the Draganfly brand via public relations as well as an expanded marketing pushing via specific ‎sponsorships of events that complement and highlight the Draganfly technology. i.e., sporting events where ‎Draganfly’s Vital Intelligence Technology is used to provide health screening for spectators and/or staff; or, where ‎Draganfly’s 20hr + spraying solution via drones is used to disinfect and coat the stadium from pathogens. ‎Third, Draganfly plans targeted marketing and advertising via tradeshows/conferences which are virtual or physical (post ‎COVID restrictions) as well as target digital advertising campaigns used to generate inbound inquires for specific products, services or ‎solution opportunities.

 

Customers

 

Key customers are customers looking to gain strategic advantage in particular markets via the use of drones and ‎drone technology. These are often large organization with a specific problem that they are currently solving in an ‎expensive manner which usually means the use of teams of people or expensive personnel. By designing solution ‎and providing everything from design to manufacturing to sensor development and even giving recognition on ‎patents of IP development (not with commercial interest) to providing the services and housing the data we develop ‎customer relationships that are very “sticky”. ‎

 

Specialized Skill and Knowledge

 

There is a specialized skill required for the development, operations, maintenance, sales and marketing ‎of the Company’s technology. The Company’s current staff possesses the necessary skills and ‎knowledge required for the Company’s business; however, additional employees may be added to staff ‎as needed. All operational staff hold the appropriate licenses and certificate as mandated by Transport ‎Canada.‎

 

Changes to Contracts

 

No aspect of Draganfly’s business is anticipated to ‎be affected in the current financial year by renegotiation or termination of any contract. ‎

 

Capital Expenditures

 

During the years ended December 31, 2021, 2020 and 2019, we did not undertake any capital expenditures.

 

32
 

 

4.C. Organizational Structure

 

We have three wholly-owned subsidiaries. The following chart shows the Company’s subsidiaries:‎

 

 

4.D. Property, Plant and Equipment

 

Draganfly Innovation Inc.’s products are manufactured at its machine shop within its leased head office ‎located at ‎‎‎2108 St. George Avenue, Saskatoon, SK S7M 0K7 (approximately 3,800 square feet in size).‎

 

Dronelogics Services Inc.’s services are provided through its leased space located at Unit 319, 2999 Underhill ‎‎Avenue, ‎Burnaby, British Columbia (approximately 2,752 square feet in size). ‎‎

 

The Company, through its wholly-owned subsidiary, Draganfly Innovations USA Inc., has a leased ‎office at 3910 ‎RCA Boulevard, Suite 1015, Palm Beach Gardens, Florida where inventory is stored (approximately 1,600 square ‎feet in size).‎

 

See also “‎Item 4.B.‎ Business Overview Operations – Operations”.

 

Item 4A. Unresolved Staff Comments

 

Not applicable.

 

Item 5. Operating and Financial Review and Prospects

 

The management’s discussion and analysis of the Company for the year ended December 31, 2021 is included in this Annual Report in Exhibit 15.1.

 

Item 6. Directors, Senior Management and Employees

 

6.A Directors and Senior Management

 

The following table sets forth the name, office held, age, and functions and areas of experience in the Company of each of our directors and senior management:

 

Name and Municipality
of Residence

 

Age

 

Position Held
and Date
Appointed

 

Principal Occupation within the past five years

Cameron Chell
Bowen Island, British Columbia, Canada
  53   Chief Executive Officer, Chairman and a Director
(August 14, 2019)
  Chairman and Chief Executive Officer of the Company since ‎August ‎‎2019; President, Chairman and co-founder of ‎CurrencyWorks Inc. from ‎November 2017 to present; Chief ‎Executive Officer and co-founder of ‎Business Instincts Group ‎Inc‎., a Calgary-based Venture Creation Firm, ‎from 2009 to ‎‎2021; co-founder of BitRail, LLC from May 2019 to May ‎‎‎2020; co-creator and Chairman of KODAKOne from May ‎‎2017 to May ‎‎2020; director of Health Outcomes Worldwide ‎from June 2017 to ‎February 2021; and Chairman of TruTrace ‎Technologies Inc. from April ‎‎2017 to September 2020‎.

 

33
 

 

 

Name and Municipality
of Residence
  Age  

Position Held
and Date
Appointed

 

Principal Occupation within the past five years

Scott Larson(3)
Burnaby, British Columbia, Canada
  49   President (July 3, 2020) and a Director
(August 14, 2019)
  President of the Company since July 2020; former Chief ‎Executive ‎Officer of Kater Technologies, a Vancouver-based ‎mobility as a service ‎‎(MaaS) company building out an ‎integrated intermodal transportation ‎‎platform incorporating ‎public transportation, buses, taxis and ride hailing ‎vehicles into ‎a single service, from January 2019 to March 2020; former ‎‎Chief Executive Officer of ‎Helios Wire, a satellite company ‎building out a ‎space-enabled IoT/M2M network‎, from 2016 to ‎‎2019; and former Chief ‎Executive Officer and founder of ‎UrtheCast ‎Corp. from 2010 to 2015‎.
             
Olen Aasen(1)(2)(3)
Vancouver, British Columbia, Canada
  39  

Director
(August 14, 2019)

 

 

Practicing lawyer since 2007.‎

             
Andrew Hill Card Jr. (2)
Jaffrey, New Hampshire, United States
  74  

Director
(November 7, 2019)

 

  Chairman of the National Endowment for Democracy (NED), ‎a non-‎profit organization ‎dedicated to the growth and ‎strengthening of ‎democratic institutions around the world, ‎from January 2018 to January ‎‎2021; Interim Chief Executive ‎Officer of the George & Barbara Bush ‎Foundation from June ‎‎2020 to December 2020; and President of ‎Franklin Pierce ‎University in New Hampshire from January 2015 to ‎August ‎‎2016‎.
             
John M. Mitnick(1)(2)
McLean, Virginia, United States
  59  

Director
(June 18, 2020)

 

  Member of Board of Directors of Valaurum, Inc., March 2016 ‎to February ‎‎2018 and since October 2019; Advisor to Carbon ‎Neutral Royalty Ltd. ‎from February 2022 to present; General ‎Counsel of the U.S. Department ‎of Homeland Security from ‎February 2018 to September 2019; and ‎Senior Vice President, ‎General Counsel, and Secretary of The Heritage ‎Foundation ‎from March 2014 to February 2018‎.
             
Denis Silva(3)
Vancouver, British Columbia, Canada
  42  

Director
(August 14, 2019)

 

  Corporate and securities partner with the law firm DLA Piper (Canada) ‎LLP since July 2020; and ‎partner at the law firm Gowling WLG (Canada) LLP from 2015 to 2020.
             

Julie Myers Wood(1)

McLean, Virginia, United States

  52  

Director

(September 9, 2021)

  Chief Executive Officer of Guidepost Solutions LLC since ‎May 2014; ‎Chief Executive Officer of ICS Consulting LLC; ‎and has held several ‎high level positions within the U.S. ‎government including at the ‎Departments of Justice, Homeland ‎Security, Treasury, and Commerce, ‎as well as at the White ‎House.
             
Paul Sun
Oakville, Ontario, Canada
  50   Chief Financial Officer and Corporate Secretary
(August 14, 2019)
  Chief Financial Officer of the Company since August 2019; Chief Financial Officer of Former ‎Draganfly since July 2015; and Managing Director, ‎Institutional Equity Sales at Beacon Securities Limited‎ from January 2013 to December 2014.
             
Justin Hannewyk
Vancouver, British Columbia, Canada
  37   President of Dronelogics Systems Inc‎.
(April 30, 2020)
  President of Dronelogics ‎Systems Inc‎.‎, a ‎wholly-owned subsidiary of the Company, ‎‎since ‎‎2009; and ‎an ‎independent ‎consultant to enterprise clients with respect to ‎the ‎integration of ‎drones for over 10 years.

 

Notes:‎

 

(1)Member of the Audit Committee.
(2)Member of the Nominating and Corporate Governance Committee.
(3)Member of the Compensation Committee.

 

34
 

 

The directors listed above will hold office until the next annual meeting of the Company or until their ‎successors are elected or appointed. ‎There are no family relationships among our directors and executive officers. There are no arrangements or understandings with major shareholders, customers, suppliers or others, pursuant to which any of our directors or executive officers was selected.

 

As at March 28, 2022, the directors and senior officers of Draganfly, as a group, beneficially own or ‎control, directly or indirectly, 738,389 Common Shares or 2.2% of the issued and outstanding Common ‎Shares.‎

 

Corporate Cease Trade Orders, Bankruptcies, Penalties or Sanctions

 

To the knowledge of management, no director or executive officer as at the date hereof, is or was within ‎‎10 years before the date hereof, a director, chief executive officer or chief financial officer of any ‎company (including Draganfly), that (a) was subject to an order that was issued while the director or ‎executive officer was acting in the capacity as director, chief executive officer or chief financial officer, ‎or (b) was subject to an order that was issued after the director or executive officer ceased to be a ‎director, chief executive officer or chief financial officer and which resulted from an event that occurred ‎while that person was acting in the capacity as director, chief executive officer or chief financial officer. ‎For the purposes hereof, “order” means (a) a cease trade order, (b) an order similar to a cease trade ‎order, or (c) an order that denied the relevant company access to any exemption under securities ‎legislation, that was in effect for a period of more than 30 consecutive days.‎

 

To the knowledge of management, other than as disclosed herein, no director or executive officer of ‎Draganfly, or a shareholder holding a sufficient number of securities of Draganfly to affect materially the ‎control of the company (a) is, as at the date hereof, or has been within the 10 years before the date ‎hereof, a director or executive officer of any company (including Draganfly) that, while that person was ‎acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, ‎made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted ‎any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or ‎trustee appointed to hold its assets, or (b) has, within the 10 years before the date hereof, become ‎bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject ‎to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver ‎manager or trustee appointed to hold the assets of the director, executive officer or shareholder.‎

 

By Order of the Supreme Court of Newfoundland and Labrador dated June 17, 2020, Deloitte ‎Restructuring Inc. ‎was appointed as the receiver and manager of all current and future assets, ‎undertakings, and properties of the ‎Kami Mine Limited Partnership, Kami General Partner Limited, and ‎Alderon Iron Ore Corp. The receivership was ‎initiated by a secured creditor of the Kami Mine Limited ‎Partnership after its failure to refinance the secured debt ‎due to the COVID-19 pandemic. Mr. Aasen was ‎Corporate Secretary of Alderon Iron Ore Corp. and Secretary and ‎Director of Kami General Partner ‎Limited until April 28, 2020.‎

 

Penalties or Sanctions

 

Other than as disclosed herein‎, no director, executive officer or shareholder holding a sufficient number ‎of securities of Draganfly to materially affect the control of the Company has been subject to: (i) any ‎penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory ‎authority or has entered into a settlement agreement with a securities regulatory authority; or (ii) any other ‎penalties or sanctions imposed by a court or regulatory body that would likely be considered important ‎to a reasonable investor in making an investment decision.‎

 

Pursuant to a settlement agreement (the “Settlement Agreement”) dated November 6, 1998 that Cameron ‎Chell, Chief Executive Officer, Chairman and a director of the Company, signed with the Alberta Stock ‎Exchange (the “ASE”), Mr. Chell agreed to the following sanctions: ‎

 

  prohibition against ASE Approval (as defined in the General By-law of the ASE) in any capacity for a ‎period of five years commencing November 6, 1998; ‎
     
  a fine in the sum of $25,000; ‎
     
  strict supervision for a period of two years following re-registration in any capacity; and ‎
     
  close supervision for a period of one year following the period of strict supervision described ‎above.‎

 

35
 

 

The matters respecting the Settlement Agreement are as set forth in an ASE Notice to Members dated ‎November 12, 1998, which provides that: ‎

 

  representations were made by the promoter of a company to one of Mr. Chell’s clients that he would ‎only be permitted to purchase securities in the initial public offering of that company if he would ‎agree to purchase additional securities in the secondary market following the listing on the ASE ‎and, in or around March or April, 1996, Mr. Chell disclosed confidential information to the ‎promoter of that company concerning a client’s account with respect to a cheque returned NSF ‎to Mr. Chell’s employer;‎
     
  the investment objectives for two of Mr. Chell’s clients were amended without prior knowledge or ‎consent of such clients and purchases and sales of securities were subsequently executed in the ‎accounts of such clients which were unsuitable for the clients given the stated investment ‎objectives for the accounts prior to the amendment of such investment objectives; ‎
     
  Mr. Chell executed a total of 21 transactions in the accounts of two of Mr. Chell’s clients without prior ‎knowledge or authorization of such clients;‎
     
  the signature on the new client account form for one of Mr. Chell’s clients, which purported to be that ‎of the client was not in fact the signature of the client nor did such client have any knowledge of ‎any changes made to the investment objectives for his account(s); ‎
     
  on or about June 10, 1996, the address for the account of one of Mr. Chell’s clients was changed to ‎Mr. Chell’s local post office box address without such client’s knowledge and while the client ‎was resident in Ontario. As a result, during the period of June 10 to and including September, ‎‎1996, the client did not receive any trade confirmations or accounts statements with respect to ‎her accounts with Mr. Chell;‎
     
  on or about March 19, 1996, Mr. Chell permitted one of his clients to acquire approximately 4% of ‎the total initial public offering by a company, contrary to the rules of the ASE; ‎
     
  on or about October 19, 1996, Mr. Chell purchased securities of a company in the account of one of ‎his clients without disclosing the involvement of his brother as president of that company; ‎
     
  on or about June 23, 1996, the private placement questionnaire and undertaking completed in ‎connection with the purchase by one of Mr. Chell’s clients and filed with the ASE disclosed that ‎Mr. Chell’s client was a resident of Alberta when in fact such client was a resident of Ontario. Mr. ‎Chell knew or ought to have known that it contained a misstatement of fact in that regard; ‎
     
  during the period of the summer, 1996 to and including May 1997, Mr. Chell’s day to day involvement ‎as the president and chairman of Coffee.Com Interactive Café Corp. (“Coffee.Com”) as well as ‎being a shareholder was not disclosed to Mr. Chell’s employer;‎
     
  further, Mr. Chell purchased securities offerings via private placement by Coffee.Com for certain of ‎his clients without fully disclosing his involvement with that company to such clients; ‎
     
  on or about March 18 and June 19, 1996, Mr. Chell executed purchase of securities for Ontario ‎residents. At the time of such purchases, Mr. Chell knew or ought to have known that he was not ‎registered in the province of Ontario; ‎
     
  during the summer of 1996, Mr. Chell represented to the ASE that certain purchasers of securities ‎offered via private placement were close friends and business associates when he knew or ‎ought to have known that such representations were untrue; and ‎
     
  during the period of June 19, 1996 and to and including May 1, 1997, Mr. Chell failed to obtain the ‎prior approval of his employer for advertisements and sales literature distributed by Mr. Chell ‎regarding Coffee.Com.‎

 

36
 

 

Conflicts of Interest

 

There are potential conflicts of interest to which the directors and officers of Draganfly will be subject to ‎in connection with the operations of Draganfly. In particular, certain of the directors and officers of ‎Draganfly are involved in managerial or director positions with other companies whose operations may, ‎from time to time, be in direct competition with those of Draganfly or with entities which may, from time ‎to time, provide financing to, or make equity investments in, competitors of Draganfly. ‎

 

In accordance with the applicable corporate and securities legislation, directors who have a material ‎interest or any person who is a party to a material contract or a proposed material contract with ‎Draganfly are required, subject to certain exceptions, to disclose that interest and generally abstain from ‎voting on any resolution to approve the contract. In addition, the directors are required to act honestly ‎and in good faith with a view to the best interests of Draganfly. Certain of the directors and each of the ‎executive officers of Draganfly have either other employment or other business or time restrictions ‎placed on them and accordingly, these directors of Draganfly will only be able to devote part of their ‎time to the affairs of Draganfly. To the extent that conflicts of interest arise, such conflicts will be ‎resolved in accordance with the provisions of the applicable corporate law.‎

 

6.B. Compensation

 

Summary Compensation Table

 

For the year ended December 31, 2021, our directors and executive officers received compensation for services, as follows:

 

                   Non-Equity Incentive Plan Compensation
(C$)
            
Name and
Principal Position
  Year   Salary
($)
  

Share-
Based Awards
($)(1)(2)

  

Option-
Based Awards
($)(3)(4)

  

Annual
Incentive
Plans(5)

  Long-
Term
Incentive
Plans
  Pension
Value
($)
  

All Other
Compen-
sation
($)(6)

   Total
Compen-
sation
($)
 

Cameron Chell(7)

Chairman, CEO and Director

  2021    290,225    570,300    Nil   Nil  Nil   Nil    Nil    860,525 

Paul Sun

CFO

  2021    208,118    365,400    Nil   Nil  Nil   Nil    Nil    573,318 

Scott Larson(7)

President and Director

  2021    205,690    270,900    Nil   Nil  Nil   Nil    Nil    476,590 

Olen Aasen

Director

  2021    Nil    346,250    Nil   Nil  Nil   Nil    100,141(7)   446,391 

Denis Silva

Director

  2021    Nil    346,250    Nil   Nil  Nil   Nil    88,497(7)   434,747 

Andrew Hill Card, Jr

Director

  2021    Nil    346,250    Nil   Nil  Nil   Nil    77,719(7)   423,969 

John M. Mitnick

Director

  2021    Nil    346,250    Nil   Nil  Nil   Nil    80,341(7)   426,591 

Julie Myers Wood

Director

  2021    Nil    124,997    96,305   Nil  Nil   Nil    23,426(7)   148,423 

Justin Hannewyk(7)

President of Dronelogics Systems Inc‎. and former Director‎

  2021    150,776    96,750    Nil   Nil  Nil   Nil    Nil    247,526 

 

37
 

 

Notes:‎

 

(1) ‎“Share-Based Award” means an award under an equity incentive plan of equity-based instruments that do not ‎have option-like features, including, for greater certainty, common shares, restricted shares, restricted share ‎units, deferred share units, phantom shares, phantom share units, common share equivalent units and stock.‎
(2) Based on the number of restricted share units (“RSUs”) granted multiplied by the market price of the underlying Common Shares on the ‎grant date. This methodology was chosen in order to be consistent with industry.
(3) ‎“Option-Based Award” means an award under an equity incentive plan of options, including, for greater certainty, ‎share options, share appreciation rights and similar instruments that have option-like features.‎ See also “Item ‎6.E. Share Ownership”.
(4) This does not represent cash paid to the individual. This figure is based on the grant date fair value of such stock options of the Company (“Options”). The grant date fair value was determined in accordance with IFRS. This methodology was chosen in order to be consistent with the accounting fair value used by the Company in its financial statements and since the Black-Scholes option pricing model is a commonly used methodology for valuing options which provides an objective and reasonable estimate of fair value. The key assumptions of this valuation include current market price of the stock, exercise price of the option, option term, risk-free interest rate, dividend yield of stock and volatility of stock return. Calculating the value of stock options using the Black-Scholes option pricing model is very different from a simple “in-the-money” value calculation. In fact, stock options that are well out-of-the-money can still have a significant “grant date fair value” based on a Black-Scholes option pricing model, especially where, as in the case of the Company, the price of the share underlying the option is highly volatile. Accordingly, caution must be exercised in comparing grant date fair value amounts with cash compensation or an in-the-money option value calculation.‎
(5) ‎Represents annual cash bonus awards that are declared and paid annually. The Company does not have a formal ‎bonus plan and the amount of bonuses paid is not set in relation to any formula or specific criteria but is ‎a result of a subjective determination by the Compensation Committee and the Board. As of March ‎‎‎‎29, 2022, the annual cash bonus awards for the executive officers of the Company for the year ended December ‎‎31, 2021 have not been determined or approved by the Board.‎
(6) This amount represents the aggregate amount of perquisites paid to the ‎individual.
(7) This amount represents director’s fees paid to such director.
(8) Mr. Chell, Mr. Larson and Mr. Hannewyk did not receive any additional compensation for serving as directors of the Corporation.

 

6.C. Board Practices

 

All of our directors are elected at the annual general meeting of our shareholders and each holds such office until his or her successor is elected or appointed, unless his or her office is earlier vacated by way of the director’s resignation or death or under any of the relevant provisions of our Articles or the BCBCA.

 

Employment, Consulting and Directors’ Service Contracts

 

The Company is not a party to any contract, agreement, plan or arrangement that provides for ‎‎payments to a director or executive officer at, following or in connection with any termination (whether ‎‎voluntary, involuntary or constructive), resignation, retirement, a change in control of the Company, its ‎‎subsidiaries or affiliates or a change in a director or executive officer responsibilities, other than as ‎‎described below.‎

 

The Company’s consulting agreement, as amended, (the “Chell Consulting Agreement”) with 1502372 Alberta Ltd. (the “Consultant”) requires the Company to pay monthly fees of C$33,333.33 (amounting to C$400,000 annually) for the provision by of executive services by the Consultant to the Company, and in this regard, has Cameron Chell hold the position of Chairman and Chief Executive Officer of the Company and contains the following provisions: (a) where termination notice is given by the Company, other than for certain specified reasons as set out in the Chell Consulting Agreement, the Company shall give the Consultant at least 60 days’ advance notice in writing; and (b) where termination is given by the Consultant, the Consultant shall give the Company 60 days’ advance notice in writing. If the Chell Consulting Agreement is terminated pursuant to either (a) or (b) above, then the Consultant will be entitled to the fees earned to the effective date of termination and any expenses incurred on behalf of the Company prior to the effective date of termination which are otherwise reimbursable by the Company pursuant to the terms of the Chell Consulting Agreement. The Consultant is also entitled a bonus as determined by the Compensation Committee equal to 100% of the Consultant annual fees. The Consultant is a private company controlled by Cameron Chell. During the year ended December 31, 2021, the Company and the Consultant entered into an amending agreement to the Chell Consulting Agreement to increase the monthly fees from US$14,166.67 (amounting to US$170,000 annually) to C$33,333.33 (amounting to C$400,000 annually).

 

38
 

 

The Company’s consulting agreement, as amended, (the “Larson Consulting Agreement”) with Scott Larson requires the Company pay (a) an annual base salary of C$250,000 and (b) as determined by the Compensation Committee, an annual bonus of up to the base salary, for the provision by of executive services as President to the Company. If the Larson Consulting Agreement is terminated by the Company without just cause, Mr. Larson will be entitled to remuneration in the amount equal the base salary for a period of four months. During the year ended December 31, 2021, the Company and Mr. Larson entered into an amending agreement to the Larson Consulting Agreement to increase the annual base salary from US$140,000 to C$250,000.

 

The Company’s employment agreement, as amended, (the “Sun Agreement”) with Paul Sun requires the Company pay (a) an annual base salary of C$220,000 and (b) as determined by the Company’s Compensation Committee, an annual bonus of up to the base salary, for the provision of executive services as Chief Financial Officer to the Company. If the Sun Agreement is terminated by the Company without just cause, Mr. Sun will be entitled to remuneration in the amount equal the base salary and Mr. Sun’s last bonus earned divided by 12 and multiplied by six. Mr. Sun is also entitled to receive a lump sum payment equal to 18 months of his base salary and average bonus upon a change of control of the Company. During the year ended December 31, 2021, the Company and Mr. Sun entered into an amending agreement to the Sun Agreement to increase the annual base salary from C$150,000 to C$220,000.

 

The Company’s employment agreement, as amended, (the “Hannewyk Agreement”) with Justin ‎Hannewyk requires the Company pay (a) an annual base salary of C$180,000 and (b) as determined by the Company’s Compensation Committee, an annual bonus of up to the base salary, for the provision of executive services as President of ‎Dronelogics ‎Systems Inc‎. ‎If the Hannewyk Agreement is terminated by the Company without just cause, Mr. Hannewyk will be entitled to 12 months’ notice less the minimum amount of notice required under the British Columbia Employment Standards Act, or, in the Company’s sole discretion, payment of the base salary plus the cost of Mr. Hannewyk’s group benefits. The Company may terminate the Hannewyk Agreement at any time without cause during the six months following a change of control of the Company, and Mr. Hannewyk will be entitled to terminate the Hannewyk Agreement for good reason during the six months following a change of control of the Company, and Mr. Hannewyk would be entitled to receive a lump sum payment equal to the base salary plus the cost of Mr. Hannewyk’s group benefits. During the year ended December 31, 2021, the Company and Mr. Hannewyk entered into an amending agreement to the Hannewyk Agreement to increase the annual base salary from C$120,000 to C$180,000.

 

Audit Committee

 

The Audit Committee is a committee of the Board to which the Board delegates its responsibility for oversight of the financial reporting process. The Audit Committee is also responsible for managing, on behalf of our shareholders, the relationship between the Company and the external auditor.

 

Pursuant to National Instrument 52-110 – Audit Committees of the Canadian Securities Administrators‎ (“NI 52-110”), the Company is required to disclose certain information with respect to its Audit Committee, as summarized below.

 

Audit Committee Terms of Reference

 

The Company must, pursuant to NI 52-110, have a written charter which sets out the duties and ‎responsibilities of its Audit Committee. The terms of reference of the Audit Committee are attached ‎hereto as Exhibit 15.2.‎

 

Audit Committee Composition

 

The following are the members of the Audit Committee:‎

 

Olen Aasen(1)   Independent(2)   Financially Literate(2)
Julie Myers Wood   Independent(2)   Financially Literate(2)
John M. ‎Mitnick   Independent(2)   Financially Literate(2)

 

Notes:

 

  (1) Chairman of the Audit Committee.
  (2) As defined by NI 52-110.

 

39
 

 

Relevant Education and Experience

 

All members of the Audit Committee have been either directly involved in the preparation of the financial statements, filing of quarterly and annual financial statements, dealing with auditors, or as a member of the Audit Committee. All members have the ability to read, analyze and understand the complexities surrounding the issuance of financial statements.

 

Olen Aasen

 

Mr. Aasen is a corporate and securities lawyer with more than 15 years of experience in corporate, ‎securities ‎and regulatory matters. He has been the Corporate Secretary, General Counsel or Vice ‎President, Legal at ‎various Canadian and U.S. listed companies. Mr. Aasen obtained a J.D. from the ‎University of British ‎Columbia in 2006 and was called to the British Columbia Bar in 2007. Mr. Aasen was ‎also appointed to the ‎‎2016 Legal 500 GC Powerlist for Canada‎.‎

 

Julie Myers Wood

 

Ms. Myers was appointed by President Bush to serve as Assistant Secretary of Homeland Security for Immigration and Customs Enforcement (ICE). Previously, Ms. Myers worked for the Office of Independent Counsel under Kenneth Starr and was appointed Assistant Secretary for Export Enforcement at the Department of Commerce. She currently is CEO for Guidepost Solutions, LLC, a leading investigative and compliance consulting firm where she leads a global team of investigators, experienced security and technology consultants, and compliance and monitoring experts across a multitude of industries including government and public service agencies.

 

John M. ‎Mitnick

 

Mr. Mitnick is an American attorney with 32 years of experience serving at the highest levels of government and the private sector. From February 2018 until September 2019, he served as the General Counsel of the U.S. Department of Homeland Security (DHS), having been confirmed for that position unanimously by the U.S. Senate. From March 2014 to February 2018, he served as Senior Vice President, General Counsel, and Secretary of The Heritage Foundation, an influential think tank, and from November 2007 to April 2013, he served as Vice President, General Counsel, and Secretary of a Raytheon division with more than US$3 billion in annual sales, more than 9,000 employees, and business operations in more than 40 countries and on all continents. Mr. Mitnick has also served on the Board of Directors of Valaurum, Inc., a private mint, from March 2016 to February 2018 and since October 2019. He received his Juris Doctor degree from the University of Virginia School of Law and a Bachelor of Arts degree in Jurisprudence from the University of Oxford. He also holds a Bachelor of Arts degree in History and Political Science (summa cum laude) from Emory University.

 

Reliance on Certain Exemptions

 

At no time since the commencement of the Company’s financial year ended December 31, 2021, has the ‎Company relied on any exemption from NI 52-110, including Section 2.4 of NI 52-110 (De Minimis Non-‎Audit Services), or an exemption granted under Part 8 of NI 52-110.‎

 

The Company has relied upon the exemption provided by section 6.1 of NI 52-110 which exempts ‎venture issuers from the requirement to comply with the restrictions on the composition of its Audit ‎Committee‎.

 

Audit Committee Oversight

 

At no time since the commencement of the Company’s most recently completed financial year was a recommendation of the Audit Committee to nominate or compensate an external auditor not adopted by the Board.

 

Pre-Approval Policies and Procedures

 

The Audit Committee is authorized by the Board to review the performance of the Company’s external ‎auditors and approve in advance provision of services other than auditing and to consider the ‎independence of the external auditors, including reviewing the range of services provided in the context ‎of all consulting services bought by the Company. The Audit Committee is authorized to approve any ‎non-audit services or additional work which the Chairman of the Audit Committee deems as necessary ‎who will notify the other members of the Audit Committee of such non-audit or additional work‎.

 

40
 

 

External Auditor Service Fees

 

See “Item 16C. Principal Accountant Fees and Services”‎.

 

Compensation Committee

 

The Compensation Committee has the responsibility for reviewing matters relating to the ‎‎compensation of the directors, officers and employees of ‎‎the Company and its subsidiaries in the context of the budget and business plan of ‎‎the Company. As part of the mandate and responsibility of the Compensation ‎‎Committee, it is responsible for formulating and making recommendations to the Board ‎‎in respect of compensation issues relating to directors, officers and employees of the ‎‎Company. Without limiting the generality of the foregoing, the Compensation ‎‎Committee has the following responsibilities:‎

 

  (a) reviewing and making recommendations to the Board with respect to the overall compensation ‎strategy and policies for directors, officers and employees of the Company, including ‎executive officer and management compensation criteria, corporate and personal goals ‎and objectives;
     
  (b) reviewing and making recommendations to the Board with respect to the corporate goals and ‎objectives relevant to the compensation of the Chief Executive Officer, evaluating the ‎performance of the Chief Executive Officer in light of those goals and objectives, and ‎recommending to the Board the compensation level of the Chief Executive Officer based ‎on this evaluation;
   
  (c) reviewing and making recommendations to the Board with respect to the compensation of the ‎Chairman of the Board;‎
     
  (d) reviewing and making recommendations to the Board with respect to the annual compensation ‎of all other executive officers and directors of the Company;‎
     
  (e) reviewing and making recommendations to the Board, as appropriate, in connection with the ‎Company’s succession planning with respect to the Chief Executive Officer and other ‎senior executive officers;‎
     
  (f) administering the Share Compensation Plan, and any other stock option plan, ‎restricted share unit plan or deferred share unit plan that may be in effect from time to ‎time, in accordance with the terms of such plans;‎
     
  (g) making recommendations to the Board with respect to the Company’s incentive compensation ‎and equity-based plans that are subject to Board approval;‎
     
  (h) reviewing and approving the annual public disclosure in the information circular relating to ‎executive compensation of the Company;‎
     
  (i) reviewing the results of the annual CEO evaluation prior to submission to the Nominating and ‎Corporate Governance Committee and the Board; ‎
     
  (j) reviewing and making recommendations regarding the form of annual CEO evaluation ‎questionnaire; and
     
  (k) reviewing and reassessing the adequacy of the charter of the Audit Committee on an annual basis.‎

 

The Compensation Committee is composed of a majority of independent directors‎, being Scott Larson, Olen Aasen and Denis Silva. The Chairman of the ‎Compensation Committee is Scott Larson. ‎The Compensation Committee meets at least once per year and at such other times ‎‎as the Chairman of the Compensation Committee determines.‎

 

41
 

 

6.D. Employees

 

As at December 31, 2021, the Company had 41 employees (37 employees located in Canada and three employees located in the U.S.) and three full-‎time and three part-time consultants whose ‎services were, and continue to be, used on a regular basis for day-‎to-day operations.

 

6.E. Share Ownership

 

The following table sets out the number of Common Shares, Options and RSUs (on a post-Consolidation basis) owned or over which control or direction is exercised by each our directors and executive officers and, where known after reasonable enquiry, by their respective associates or affiliates as at April 3, 2022.

 

Name and position 

Number
and
Percentage
of
Common
Shares(1)

  Type of
‎compensation
security
  Number of‎
compensation‎
securities‎
   Date of issue or ‎
grant
  Issue,
‎conversion
or exercise
price
($)
   Expiry Date

Cameron Chell

Chairman, CEO and Director

  Nil  Options
RSUs
RSUs
RSUs
   

50,000

16,666

20,000

40,000

   October 30, 2019
October 30, 2019
March 8, 2021
September 3, 2021
   

2.50

2.50

13.90

3.87

   October 30, 2029
October 30, 2022
March 8, 2024
September 3, 2024

Paul Sun

CFO

  131,226
(0.4%)
  Options
RSUs
RSUs
RSUs
   

33,333

33,334

12,000

30,000

   October 30, 2019
October 30, 2019
March 8, 2021
September 3, 2021
   

2.50

2.50

13.90

3.87

   October 30, 2029
October 30, 2022
March 8, 2024
September 3, 2024

Scott Larson

President and Director

  Nil  Options
Options
RSUs
RSUs
   

50,000

100,000

16,666

70,000

   October 30, 2019
July 3, 2020
October 30, 2019
September 3, 2021
   

2.50

3.20

2.50

3.87

   October 30, 2029
July 3, 2025
October 30, 2022
September 3, 2024

Olen Aasen

Director

  17,353
(0.05%)
  Options
RSUs
RSUs
   

16,667

16,666

16,667

   October 30, 2019
October 30, 2019
March 8, 2021
   

2.50

2.50

13.90

   October 30, 2029
October 30, 2022
March 8, 2024

Denis Silva

Director

  31,665
(0.1%)
  Options
RSUs
RSUs
   

16,667

16,666

16,667

   October 30, 2019
October 30, 2019
March 8, 2021
   

2.50

2.50

13.90

   October 30, 2029
October 30, 2022
March 8, 2024

Andrew Hill Card, Jr

Director

  34,190
(0.1%)
  Options
RSUs
RSUs
   

50,000

16,667

16,667

   October 30, 2019
October 30, 2019
March 8, 2021
   

2.50

2.50

13.90

   October 30, 2029
October 30, 2022
March 8, 2024

Justin Hannewyk

President of Dronelogics Systems Inc‎.‎ and former Director

  461,354
(1.4%)
  RSUs   25,000   September 3, 2021
   3.87   September 3, 2024

John M. Mitnick

Director

  62,601
(0.2%)
  Options
RSUs
RSUs
   

50,000

8,334

16,667

   November 19, 2019
November 19, 2019
March 8, 2021
   

2.50

2.50

13.90

   November 19, 2029
November 19, 2022
March 8, 2024

Julie Myers Wood

Director

  Nil  Options
Options
RSUs
   

30,000

25,826

25,826

   April 30, 2020
September 9, 2021
September 9, 2021
   

3.85

4.84

4.84

   April 30, 2030
September 9, 2026
September 9, 2024

 

Note:

 

(1)‎Percentages based on ‎33,197,984 Common Shares issued and outstanding as of March 28, 2022.

 

42
 

 

Share Compensation Plan

 

The Board has previously adopted the Share Compensation Plan that provides for the granting of Options and RSUs on such terms and conditions as prescribed by the Share Compensation Plan. The Share Compensation Plan is a “rolling” plan, pursuant to which the maximum number of Common Shares issuable under the Share Compensation Plan and any other share compensation arrangement of the Company including the RSUs that may be awarded under the Share Compensation Plan, is 20% of the Common Shares then issued and outstanding. The Share Compensation Plan was adopted effective August 19, 2019 and amended effective April 14, 2021.

 

The Share Compensation Plan provides participants (each, a “Participant”), who may include participants who are citizens or residents of the United States (each, a “US Participant”), with the opportunity, through RSUs and Options, to acquire an ownership interest in the Company. The RSUs will rise and fall in value based on the value of the Common Shares. Unlike the Options, the RSUs will not require the payment of any monetary consideration to the Company. Instead, each RSU represents a right to receive one Common Share following the attainment of vesting criteria determined at the time of the award. See “Restricted Share Units – Vesting Provisions” below. The Options, on the other hand, are rights to acquire Common Shares upon payment of monetary consideration (i.e., the exercise price), subject also to vesting criteria determined at the time of the grant. See “Options – Vesting Provisions” below.

 

Purpose of the Share Compensation Plan

 

The stated purpose of the Share Compensation Plan is to advance the interests of the Company and its subsidiaries, and its shareholders by: (a) ensuring that the interests of Participants are aligned with the success of the Company and its subsidiaries; (b) encouraging stock ownership by such persons; and (c) providing compensation opportunities to attract, retain and motivate such persons.

 

Eligible Persons

 

The following people are eligible to participate in the Share Compensation Plan: any officer or employee of the Company or any officer or employee of any subsidiary of the Company and, solely for purposes of the grant of Options, any director of the Company or any director of any subsidiary of the Company, and any Consultant (defined under the Share Compensation Plan as an individual (other than an employee or a director of the Company) or a corporation that is not a U.S. Person that: (a) is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Company or to an affiliate of the Company, other than services provided in relation to an offer or sale of securities of the Company in a capital raising transaction, or services that promote or maintain a market for the Company’s securities; (b) provides the services under a written contract between the Company or the affiliate and the individual or the Company, as the case may be; (c) in the reasonable opinion of the Company, spends or will spend a significant amount of time and attention on the affairs and business of the Company or an affiliate of the Company; and (d) has a relationship with the Company or an affiliate of the Company that enables the individual to be knowledgeable about the business and affairs of the Company.

 

Administration of the Share Compensation Plan

 

The Share Compensation Plan is administered by the Board or such other persons as may be designated by the Board (the “Administrators”) based on the recommendation of the Board or the compensation committee of the Board, if applicable. The Administrators determine the eligibility of persons to participate in the Share Compensation Plan, when RSUs and Options will be awarded or granted, the number of RSUs and Options to be awarded or granted, the vesting criteria for each award of RSUs and grant of Options and all other terms and conditions of each award and grant, in each case in accordance with applicable securities laws and the requirements of the CSE and the Nasdaq.

 

Restrictions on the Award of RSUs and Grant of Options

 

The awards of RSUs and grants of Options under the Share Compensation Plan is subject to a number of restrictions:

 

  (a) the total number of Common Shares issuable to insiders under the Share Compensation Plan and any other share compensation arrangements of the Company cannot exceed 20% of the Common Shares then outstanding; and
     
  (b) the aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Company for the sale of the securities) or amount of Common Shares issued during any consecutive 12 month period will not exceed the greatest of the following: (i) US$1,000,000; (ii) 15% of the total assets of the Company, measured at the Company’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the Common Shares, measured at the Company’s most recent balance sheet date.

 

43
 

 

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of the Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may in their sole discretion make such changes or adjustments, if any, as the Administrators consider fair or equitable to reflect such change or event including, without limitation, adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

Restricted Share Units

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for RSUs

 

RSUs awarded to Participants under the Share Compensation Plan are credited to an account that is established on their behalf and maintained in accordance with the Share Compensation Plan. After the relevant date of vesting of any RSUs awarded under the Share Compensation Plan, a Participant shall be entitled to receive and the Company shall issue or pay (at its discretion): (i) a lump sum payment in cash equal to the number of vested RSUs recorded in the Participant’s account multiplied by the volume weighted average price of the Common Shares traded on the CSE for the five (5) consecutive trading days prior to the payout date; (ii) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s RSUs in the Participant’s account will be, duly issued as fully paid and non assessable shares and such Participant shall be registered on the books of the Company as the holder of the appropriate number of Common Shares; or (iii) any combination of thereof.

 

Vesting Provisions

 

The Share Compensation Plan provides that: (i) at the time of the award of RSUs, the Administrators will determine the vesting criteria applicable to the awarded RSUs; (ii) vesting of RSUs may include criteria such as performance vesting; (iii) each RSU shall be subject to vesting in accordance with the terms set out in an agreement evidencing the award of the RSU attached as Exhibit A to the Share Compensation Plan (or in such form as the Administrators may approve from time to time) (each an “RSU Agreement”); and (iv) all vesting and issuances or payments in respect of an RSU shall be completed no later than December 15 of the third calendar year commencing after the award date for such RSU.

 

It is the current intention that RSUs may be awarded with both time-based vesting provisions as a component of the Company’s annual incentive compensation program, and performance based vesting provisions as a component of the Company’s long term incentive compensation program.

 

Under the Share Compensation Plan, should the date of vesting of an RSU fall within a blackout period or within nine business days following the expiration of a blackout period, the date of vesting will be automatically extended to the tenth business day after the end of the blackout period.

 

44
 

 

Termination, Retirement and Other Cessation of Employment in connection with RSUs

 

A person participating in the Share Compensation Plan will cease to be eligible to participate in the following circumstances: (i) receipt of any notice of termination of employment or service (whether voluntary or involuntary and whether with or without cause); (ii) retirement; and (iii) any cessation of employment or service for any reason whatsoever, including disability and death (an “Event of Termination”). In such circumstances, any vested RSUs will be issued (and with respect to each RSU of a US Participant, such RSU will be settled and shares issued as soon as practicable following the date of vesting of such RSU as set forth in the applicable RSU Agreement, but in all cases within 60 days following such date of vesting; and unless otherwise determined by the Administrators in their discretion, any unvested RSUs will be automatically forfeited and cancelled (and with respect to any RSU of a US Participant, if the Administrators determine, in their discretion, to waive vesting conditions applicable to an RSU that is unvested at the time of an Event of Termination, such RSU shall not be forfeited or cancelled, but instead will be deemed to be vested and settled and shares delivered following the date of vesting date of such RSU as set forth in the applicable RSU Agreement). Notwithstanding the above, if a person retires in accordance with the Company’s retirement policy at such time, the pro rata portion of any unvested performance based RSUs will not be forfeited or cancelled and instead shall be eligible to become vested in accordance with the vesting conditions set forth in the applicable RSU Agreement after such retirement (as if retirement had not occurred), but only if the performance vesting criteria, if any, have been met on the applicable date. For greater certainty, if a person is terminated for just cause, all unvested RSUs will be forfeited and cancelled.

 

Options

 

The total number of Common Shares that may be issued on exercise of Options and RSUs, together with any other share compensation arrangements of the Company, shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

Mechanics for Options

 

Each Option granted pursuant to the Share Compensation Plan will entitle the holder thereof to the issuance of one Common Share upon achievement of the vesting criteria and payment of the applicable exercise price. Options granted under the Share Compensation Plan will be exercisable for Common Shares issued from treasury once the vesting criteria established by the Administrators at the time of the grant have been satisfied. However, the Company will continue to retain the flexibility through the amendment provisions in the Share Compensation Plan to satisfy its obligation to issue Common Shares by making a lump sum cash payment of equivalent value (i.e., pursuant to a cashless exercise), provided there is a full deduction of the number of underlying Common Shares from the Share Compensation Plan’s reserve.

 

Vesting Provisions

 

The Share Compensation Plan provides that the Administrators may determine when any Option will become exercisable and may determine that Options shall be exercisable in instalments or pursuant to a vesting schedule. The Option agreement will disclose any vesting conditions prescribed by the Administrators.

 

Termination, Retirement and Other Cessation of Employment in connection with Options

 

A person participating in the Share Compensation Plan will cease to be eligible to participate where there is an Event of Termination. In such circumstances, unless otherwise determined by the Administrators in their discretion, any unvested Options will be automatically cancelled, terminated and not available for exercise and any vested Options may be exercised only before the earlier of: (i) the termination of the Option; and (ii) six months after the date of the Event of Termination. If a person is terminated for just cause, all Options (whether or not then exercisable) will be automatically cancelled.

 

Other Terms

 

The Administrators will determine the exercise price and term/expiration date of each Option, provided that the exercise price in respect of that Option shall not be less than the Market Price on the date of grant. “Market Price” is defined in the Share Compensation Plan, as of any date, the closing price of the Common Shares on the CSE for the last market trading day prior to the date of grant of the Option or if the Common Shares are not listed on a stock exchange, the Market Price shall be determined in good faith by the Administrators.

 

45
 

 

No Option shall be exercisable after ten years from the date the Option is granted. Under the Share Compensation Plan, should the term of an Option expire on a date that falls within a blackout period or within nine business days following the expiration of a blackout period, such expiration date will be automatically extended to the tenth business day after the end of the blackout period.

 

Unless otherwise determined by the Board, in the event of a change of control, any surviving or acquiring corporation shall assume any Option outstanding under the Share Compensation Plan on substantially the same economic terms and conditions or substitute or replace similar options for those Options outstanding under the Share Compensation Plan on substantially the same economic terms and conditions.

 

Transferability

 

RSUs awarded and Options granted under the Share Compensation Plan or any rights of a Participant cannot be transferred, assigned, charged, pledged or hypothecated, or otherwise alienated, whether by operation of law or otherwise.

 

Reorganization and Change of Control Adjustments

 

In the event of any declaration by the Company of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of Common Shares, reclassification or conversion of the Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Company, distribution (other than normal course cash dividends) of Company assets to holders of Common Shares, or any other corporate transaction or event involving the Company or the Common Shares, the Administrators may make such changes or adjustments, if any, as they consider fair or equitable, to reflect such change or event including adjusting the number of Options and RSUs outstanding under the Share Compensation Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under the Share Compensation Plan, provided that the value of any Option or RSU immediately after such an adjustment shall not exceed the value of such Option or RSU prior thereto.

 

Amendment Provisions in the Share Compensation Plan

 

The Board may amend the Share Compensation Plan or any RSU or Option at any time without the consent of any Participant provided that such amendment shall:

 

  (a) not adversely alter or impair any RSU previously awarded or any Option previously granted, except as permitted by the adjustment provisions of the Share Compensation Plan and with respect to RSUs and Options of US Participants;
     
  (b) be subject to any regulatory approvals including, where required, the approval of the CSE or the Nasdaq; and
     
  (c) be subject to shareholder approval, where required, by the requirements of the CSE or the Nasdaq, provided that shareholder approval shall not be required for the following amendments:

 

  (i) amendments of a “housekeeping nature”, including any amendment to the Share Compensation Plan or ‎a RSU or Option that is necessary to comply with ‎applicable laws, tax or accounting provisions or the requirements of any ‎regulatory authority or Exchange and any amendment to the Share Compensation Plan or a ‎RSU or Option to correct or rectify any ambiguity, ‎defective provision, error or omission therein, including any amendment to ‎any definitions therein;‎
     
  (ii) amendments that are necessary or desirable for RUS or ‎Options to qualify for favourable treatment under any applicable tax law;‎
     
  (iii) a change to the vesting provisions of any RSU or any Option ‎‎(including any alteration, extension or acceleration thereof);‎
     
  (iv) a change to the termination provisions of any Option or RSU ‎‎(for example, relating to termination of employment, resignation, ‎retirement or death) that does not entail an extension beyond the original ‎expiration date;‎

 

46
 

 

  (v) the introduction of features to the Share Compensation Plan that would permit the Company to, ‎instead of issuing Common Shares from treasury upon the vesting of the ‎RSUs, retain a broker and make payments for the benefit ‎of Participants to such broker who would purchase Common Shares in ‎the open market for such Participants; ‎
     
  (vi) the amendment of the Share Compensation Plan as it relates to making lump sum payments to ‎Participants upon the vesting of the RSUs;‎ and
     
  (vii) the amendment of the cashless exercise feature set out in the Share Compensation Plan.

 

  (d) ‎be subject to disinterested shareholder approval in the event of any reduction in ‎the exercise price of any Option granted under the Share Compensation Plan to an insider Participant‎.

 

For greater certainty, shareholder approval will be required in circumstances where an amendment to the Share Compensation Plan would:

 

  (a) increase the fixed maximum percentage of issued and outstanding Common Shares issuable under the Share Compensation Plan, other than by virtue of the adjustment provisions in the Share Compensation Plan, or change from a fixed maximum percentage of issued and outstanding Common Shares to a fixed maximum number of Common Shares;
     
  (b) increase the limits referred to above under “Restrictions on the Award of RSUs and Grant of Options”;
     
  (c) reduce the exercise price of any Option (including any cancellation of an Option for the purpose of reissuance of a new Option at a lower exercise price to the same person);
     
  (d) extend the term of any Option beyond the original term (except if such period is being extend by virtue of a blackout period); or
     
  (e) amend the amendment provisions in Section 6.4 of the Share Compensation Plan.

 

Item 7. Major Shareholders and Related Party Transactions

 

7.A. Major Shareholders

 

To the knowledge of the Board and executive officers of the Company, as at April 3, 2022, no persons or ‎companies beneficially own, directly or indirectly or exercise control or direction over shares carrying 5% or ‎more of the voting rights attached to all outstanding shares of the Company‎.

 

7.B. Related Party Transactions

 

Key management personnel include those persons having authority and responsibility for planning, directing and ‎controlling the activities of the Company as a whole. The Company has determined that key management personnel ‎consist of members of the Company’s Board of Directors and corporate officers.‎

 

Trade payables and accrued liabilities

 

On August 1, 2019, the Company entered in a business services agreement with Business Instincts ‎Group Inc. (“BIG”), a company in which Cameron Chell, CEO, Chairman and a director of the Company, has a material interest and that he previously ‎controlled, to provide: corporate development and governance, strategic facilitation and management, general ‎business services, office space, corporate business development video content, website redesign and management, ‎and online visibility management. The services are provided by a team of up to six consultants and the costs of all ‎charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these ‎charges under Professional Fees. For the year ended December 31, 2021, the company incurred fees of $315,643 ‎compared to $177,000 in 2020 and $80,000 in 2019. As at December 31, 2021, the Company was indebted to this ‎company in the amount of $nil (December 31, 2020 - $nil and December 31, 2019 - $nil).‎

 

47
 

 

On October 1, 2019, the Company entered into an independent consultant agreement ‎with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO, Chairman and a director of the Company, to provide executive ‎consulting services to the Company. The costs of all charges are based on the fees set in the consultant agreement ‎and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ‎ended December 31, 2021, the Company incurred fees of $290,225 compared to $525,164 in 2020 and compared ‎to $9,000 in 2019. As at December 31, 2021, the Company was indebted to this company in the amount of $nil ‎‎(December 31, 2020 - $321,741 and December 31, 2019 - $9,450).‎

 

On July 3, 2020, the Company entered into an executive consultant agreement with Scott ‎Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The ‎costs of all charges are based on the fees set in the executive agreement and are settled on a monthly basis. The ‎Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company ‎incurred fees of $205,191 (December 31, 2020 – 227,524). As at December 31, 2021, the Company was indebted ‎to this company in the amount of $nil (December 31, 2020 - $153,887).‎

 

As at December 31, 2021, the Company had $nil (December 31, 2020 - $475,628 and December 31, 2019 - $9,681) ‎payable to related parties outstanding that were included in accounts payable. The balances outstanding are ‎unsecured, non-interest bearing and due on demand. ‎

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. ‎Compensation awarded to key management for the years ended December 31, 2021, 2020, and 2019 included:‎

 

For the year ended December 31  2021
($)
   2020
($)
   2019
($)
 
Director fees   370,094    -    - 
Management fees paid to a company ‎controlled by CEO and director   290,225    737,164    186,000 
Management fees paid to a company ‎controlled by the President and ‎director   205,691    227,524    - 
Management fees paid to a company ‎controlled by a former director   500,074    165,000    195,000 
Salaries   722,068    655,799    179,429 
Salaries paid to the former owner of the ‎Company   -    86,097    149,060 
Share-based payments   2,475,949    1,614,158    480,158 
Totals   4,564,102    3,485,742    1,189,647 

 

7.C. Interests of Experts and Counsel

 

Not applicable.

 

Item 8. Financial Information

 

The audited consolidated financial statements for the years ended December 31, 2021 and 2020 can be found under “Item 17. Financial Statements”.

 

8.B. Significant Changes

 

We are not aware of any significant change that has occurred since December 31, 2021, the date of the audited consolidated financial statements included in this Annual Report, and that has not been disclosed elsewhere in this Annual Report.

 

Item 9. The Offer and Listing.

 

9.A. Offer and Listing Details

 

The Common Shares are listed and posted for trading on the CSE under the trading symbol “DPRO”, on ‎the Nasdaq under the symbol “DPRO”, and on the Frankfurt Stock Exchange under the trading symbol “3U8”.

 

9.B. Plan of Distribution

 

Not applicable.

 

9.C. Markets

 

A discussion of all stock exchanges and other regulated markets on which our securities are listed is provided under “Item 9.A. Offer and Listing Details.”

 

9.D. Selling Shareholders

 

Not applicable.

 

9.E. Dilution

 

Not applicable.

 

9.F. Expenses of the Issue

 

Not applicable.

 

Item 10. Additional Information

 

10.A. Share Capital

 

Not applicable.

 

10.B. Memorandum and Articles of Association

 

The Company was incorporated under the laws of the Province of British Columbia, Canada and was assigned the number BC1166724. The Company is governed by the BCBCA.

 

Our Articles do not contain a description of our objects and purposes.

 

Our Articles do not restrict a director’s power to vote on a proposal, arrangement or contract in which the director is materially interested, vote compensation to themselves or any other members of their body in the absence of an independent quorum or exercise borrowing powers. There is no mandatory retirement age for our directors and our directors are not required to own securities of the Company in order to serve as directors.

 

Our authorized share capital consists of an unlimited number of Common Shares of which ‎33,197,984‎ were ‎issued and ‎outstanding as of March 28, 2022 and an unlimited number of Preferred Shares, issuable in ‎series, none of which were issued and ‎outstanding as of March 28, 2022.

 

Each Common Share entitles the holder ‎to receive notice of and attend all meetings of the shareholders. ‎Each Common Share carries ‎the right to one vote. The ‎holders of Common Shares are entitled to receive ‎any dividends declared by the Company in respect of the ‎Common ‎Shares at such time and in such ‎amount as may be determined by the Board, in its discretion. In the event of the ‎‎liquidation, dissolution, or ‎winding up of the Company, whether voluntary or involuntary, holders of Common Shares ‎are also ‎entitled ‎to participate, rateably, in the distribution of the assets of the Company, subject to the rights of the ‎holders ‎of any other class ‎of shares ranking in priority to the Common Shares. ‎‎

 

The Preferred Shares may be issuable in series ‎and the directors may, from time to time before the issue of ‎any Preferred Shares of ‎any particular series, define and ‎attach special rights, privileges, restrictions, and ‎conditions to the Preferred Shares of any series, ‎including voting rights, ‎entitlement to dividends, and ‎redemption, conversion, and exchange rights. In the event of the liquidation, ‎dissolution, or ‎winding up of ‎the Company, whether voluntary or involuntary, holders of Preferred Shares will rank on a parity with ‎‎‎holders of the Preferred Shares of every other series and be entitled to preference over the Common ‎Shares and over ‎any other ‎shares of the Company ranking junior to the Preferred Shares.‎

 

48
 

 

The provisions in our Articles attaching to the Common Shares may be altered, amended, repealed, suspended or changed by the affirmative vote of the holders of not less than two-thirds of the Common Shares present in person or by proxy at any such meeting of holders.

 

Our Articles provide for our directors to hold office until the expiry of his or her term (which is stipulated to be immediately before the next election or appointment of directors at an annual general meeting of our shareholders) or until his or her successor is elected or appointed, unless their respective office is earlier vacated in accordance with our Articles or with the provisions of the BCBCA. A director appointed or elected to fill a vacancy on the Board holds office for the unexpired term of their predecessor.

 

An annual meeting of shareholders must be held at such time in each year that is not later than 15 months after the last preceding annual meeting and at such place as the Board may from time to time determine. The holders of not less than five percent of the issued Common Shares that carry the right to vote at a meeting may requisition our Board to call a meeting of shareholders for the purposes stated in the requisition. The quorum for the transaction of business at any meeting of shareholders is two persons who are, or represented by proxy, shareholders who, in the aggregate, hold at least 5% of the issued shares entitled to vote at the meeting. In addition to those persons who are entitled to vote at a meeting of shareholders, the only other persons entitled to be present at the meeting are the directors, the president (if any), the secretary (if any), the assistant secretary (if any), any lawyer for the Company, the auditor of the Company and any other persons invited to be present at the meeting by the directors or by the chair of the meeting and any persons entitled or required under the BCBCA or our Articles to be present at the meeting; but if any of those persons does attend the meeting, that person is not to be counted in the quorum and is not entitled to vote at the meeting unless that person is a shareholder or proxy holder entitled to vote at the meeting.

 

Except as provided in the Investment Canada Act, there are no limitations specific to the rights of non-Canadians to hold or vote the Common Shares under the laws of Canada or the Province of British Columbia, or in our charter documents.

 

Our Articles do not contain provisions that would have an effect of delaying, deferring or preventing a change in control of the Company. Our Articles do not contain any provisions that would operate only with respect to a merger, acquisition or corporate restructuring of our company.

 

Our Articles do not contain any provisions governing the ownership threshold above which shareholder ownership must be disclosed.

 

Our Articles are not significantly different from the requirements of the BCBCA and the conditions imposed by our Articles governing changes in capital are not more stringent than what is required by the BCBCA.

 

10.C. Material Contracts

 

Other than as described below, there are no material contracts entered into by Draganfly within the two most recently completed financial ‎years, or ‎before the two most recently completed financial years but which are still in effect, other than ‎contracts entered into ‎in the ordinary course of business.

 

On August 1, 2019, the Company entered in a business services agreement (the “BIG Agreement”) with BIG, ‎a company that Cameron Chell, the Chairman, CEO and ‎director of the Company, has a material interest in, to provide: corporate development and ‎governance, strategic facilitation and management, general business services, office space, corporate ‎business development video content, website redesign and management, and online visibility management. ‎The services are provided by a team of up to six consultants and the costs of all charges are based on the ‎fees set forth in the BIG Agreement and are settled on a monthly basis. The Company records these ‎charges under Office and Miscellaneous. For the year ended December 31, 2021, the Company incurred ‎fees of $315,643 compared to $177,000 in 2020. As at December 31, 2021, the Company was indebted to ‎BIG in the amount of $nil (December 31, 2020 - $nil). ‎

 

10.D. Exchange Controls

 

There are currently no government laws, decrees, regulations or other legislation of Canada or the United States that restrict the export or import of capital (including the availability of cash and cash equivalents) or that affect the remittance of dividends, distributions, interest or other payments to non-residents of Canada or the United States holding our Common Shares. Any remittances of dividends to United States residents and to other non-residents are, however, subject to withholding tax. See “Taxation” below.

 

49
 

 

10.E. Taxation

 

Certain U.S. Federal Income Tax Considerations

 

The following discussion describes the material U.S. federal income tax consequences relating to the ownership and disposition of Common Shares by U.S. Holders (as defined below). This discussion applies to U.S. Holders that hold Common Shares as capital assets (generally, property held for investment). This discussion is based on the Code, U.S. Treasury regulations promulgated thereunder and administrative and judicial interpretations thereof, all as in effect on the date hereof and all of which are subject to change, possibly with retroactive effect. This discussion does not address all of the U.S. federal income tax consequences that may be relevant to specific U.S. Holders in light of their particular circumstances or to U.S. Holders subject to special treatment under U.S. federal income tax law (such as certain financial institutions, banks, insurance companies, broker-dealers and traders in securities or other persons that generally mark their securities to market for U.S. federal income tax purposes, tax-exempt entities or government organizations, retirement plans, regulated investment companies, real estate investment trusts, certain former citizens or residents of the United States, persons who hold Common Shares as part of a “straddle,” “hedge,” “conversion transaction,” “synthetic security” or integrated investment, persons required to accelerate the recognition of any item of gross income with respect to the Common Shares as a result of such income being recognized on an applicable financial statement, persons that have a “functional currency” other than the U.S. dollar, persons that own directly, indirectly or through attribution 10% or more of the voting power or value of our shares, corporations that accumulate earnings to avoid U.S. federal income tax, partnerships and other pass-through entities (or arrangements treated as a partnership for U.S. federal income tax purposes), and investors in such pass-through entities). This discussion does not address any U.S. state or local or non-U.S. tax consequences or any U.S. federal estate, gift or alternative minimum tax consequences.

 

As used in this discussion, the term “U.S. Holder” means a beneficial owner of Common Shares that is, for U.S. federal income tax purposes, (1) an individual who is a citizen or resident of the United States, (2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia, (3) an estate the income of which is subject to U.S. federal income tax regardless of its source or (4) a trust (x) with respect to which a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or (y) that has elected under applicable U.S. Treasury regulations to be treated as a domestic trust for U.S. federal income tax purposes.

 

If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Common Shares, the U.S. federal income tax consequences relating to an investment in the Common Shares will depend in part upon the status and activities of such entity or arrangement and the particular partner. Any such entity or arrangement should consult its own tax advisor regarding the U.S. federal income tax consequences applicable to it and its partners of the purchase, ownership and disposition of Common Shares.

 

U.S. Holders should consult their own tax advisors as to the particular tax consequences applicable to them relating to the purchase, ownership and disposition of Common Shares, including the applicability of U.S. federal, state and local tax laws and non-U.S. tax laws.

 

Passive Foreign Investment Company Consequences

 

In general, a corporation organized outside the United States will be treated as a PFIC, for any taxable year in which either (1) at least 75% of its gross income is “passive income”, or (2) on average at least 50% of its assets, determined on a quarterly basis, are assets that produce passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things, dividends, interest, royalties, rents, and gains from the sale or exchange of property that gives rise to passive income. Assets that produce or are held for the production of passive income generally include cash, even if held as working capital or raised in a public offering, marketable securities, and other assets that may produce passive income. Generally, in determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account.

 

50
 

 

Based upon the current and expected composition of our income and assets, we believe that we were not a PFIC for the taxable year ended December 31, 2021 and expect that we will not be a PFIC for the current taxable year. Nevertheless, because our PFIC status must be determined annually with respect to each taxable year and will depend on the composition and character of our assets and income, including our use of proceeds from the Common Shares, and the value of our assets (which may be determined, in part, by reference to the market value of Common Shares, which may be volatile) over the course of such taxable year, we may be a PFIC in any taxable year. The determination of whether we will be or become a PFIC may also depend, in part, on how, and how quickly, we use our liquid assets and the cash raised in an offering of Common Shares. If we determine not to deploy significant amounts of cash for active purposes, our risk of being a PFIC may substantially increase. Because there are uncertainties in the application of the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, there can be no assurance that we will not be a PFIC for any future taxable year. In addition, it is possible that the U.S. Internal Revenue Service may challenge our classification of certain income and assets as non-passive, which may result in us being or becoming a PFIC in the current or subsequent years.

 

If we are a PFIC in any taxable year during which a U.S. Holder owns Common Shares, the U.S. Holder could be liable for additional taxes and interest charges under the “PFIC excess distribution regime” upon (1) a distribution paid during a taxable year that is greater than 125% of the average annual distributions paid in the three preceding taxable years, or, if shorter, the U.S. Holder’s holding period for the Common Shares, and (2) any gain recognized on a sale, exchange or other disposition, including a pledge, of the Common Shares, whether or not we continue to be a PFIC. Under the PFIC excess distribution regime, the tax on such distribution or gain would be determined by allocating the distribution or gain ratably over the U.S. Holder’s holding period for Common Shares. The amount allocated to the current taxable year (i.e., the year in which the distribution occurs or the gain is recognized) and any year prior to the first taxable year in which we are a PFIC will be taxed as ordinary income earned in the current taxable year. The amount allocated to other taxable years will be taxed at the highest marginal rates in effect for individuals or corporations, as applicable, to ordinary income for each such taxable year, and an interest charge, generally applicable to underpayments of tax, will be added to the tax.

 

If we are a PFIC for any year during which a U.S. Holder holds Common Shares, we must generally continue to be treated as a PFIC by that holder for all succeeding years during which the U.S. Holder holds the Common Shares, unless (i) we cease to meet the requirements for PFIC status and the U.S. Holder makes a “deemed sale” election with respect to the Common Shares or for the period immediately preceding our cessation in meeting the tests described above the Common Shares were subject to a mark-to-market election or (ii) the U.S. Holder makes a timely and effective “qualified electing fund” election (“QEF Election”) with respect to all taxable years during such U.S. Holder’s holding period in which the we are a PFIC. If the election is made, the U.S. Holder will be deemed to sell the Common Shares it holds at their fair market value on the last day of the last taxable year in which we qualified as a PFIC, and any gain recognized from such deemed sale would be taxed under the PFIC excess distribution regime. After the deemed sale election, the U.S. Holder’s Common Shares would not be treated as shares of a PFIC unless we subsequently become a PFIC.

 

If we are a PFIC for any taxable year during which a U.S. Holder holds Common Shares and one of our non-U.S. corporate subsidiaries is also a PFIC (i.e., a lower-tier PFIC), such U.S. Holder would be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC and would be taxed under the PFIC excess distribution regime on distributions by the lower-tier PFIC and on gain from the disposition of shares of the lower-tier PFIC even though such U.S. Holder would not receive the proceeds of those distributions or dispositions. Each U.S. Holder is advised to consult its tax advisors regarding the application of the PFIC rules to our non-U.S. subsidiaries.

 

If we are a PFIC, a U.S. Holder will not be subject to tax under the PFIC excess distribution regime on distributions or gain recognized on Common Shares if such U.S. Holder makes a valid “mark-to-market” election for our Common Shares. A mark-to-market election is available to a U.S. Holder only for “marketable stock”. Our Common Shares will be marketable stock as long as they remain listed on Nasdaq and are regularly traded, other than in de minimis quantities, on at least 15 days during each calendar quarter. If a mark-to-market election is in effect, a U.S. Holder generally would take into account, as ordinary income each year, the excess of the fair market value of Common Shares held at the end of such taxable year over the adjusted tax basis of such Common Shares. The U.S. Holder would also take into account, as an ordinary loss each year, the excess of the adjusted tax basis of such Common Shares over their fair market value at the end of the taxable year, but only to the extent of the excess of amounts previously included in income over ordinary losses deducted as a result of the mark-to-market election. The U.S. Holder’s tax basis in Common Shares would be adjusted to reflect any income or loss recognized as a result of the mark-to-market election. Any gain from a sale, exchange or other disposition of Common Shares in any taxable year in which we are a PFIC would be treated as ordinary income and any loss from such sale, exchange or other disposition would be treated first as ordinary loss (to the extent of any net mark-to-market gains previously included in income) and thereafter as capital loss.

 

51
 

 

A mark-to-market election will not apply to Common Shares for any taxable year during which we are not a PFIC, but will remain in effect with respect to any subsequent taxable year in which we become a PFIC. Such election will not apply to any non-U.S. subsidiaries that we may organize or acquire in the future. Accordingly, a U.S. Holder may continue to be subject to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs that we may organize or acquire in the future notwithstanding the U.S. Holder’s mark-to-market election for the Common Shares.

 

A U.S. Holder who makes a QEF Election generally must report on a current basis its share of our net capital gain and ordinary earnings for any year in which were are a PFIC, whether or not we distribute any amounts to our shareholders. However, U.S. holders should be aware that there can be no assurance that we will satisfy the record keeping requirements that apply to a QEF, or that we will supply U.S. holders with information that such U.S. holders require to report under the QEF election rules, in the event that the Company is a PFIC and a U.S. holder wishes to make a QEF election.

 

Each U.S. person that is an investor of a PFIC is generally required to file an annual information return on IRS Form 8621 containing such information as the U.S. Treasury Department may require. The failure to file IRS Form 8621 could result in the imposition of penalties and the extension of the statute of limitations with respect to U.S. federal income tax.

 

The U.S. federal income tax rules relating to PFICs are very complex. U.S. Holders are strongly urged to consult their own tax advisors with respect to the impact of PFIC status on the purchase, ownership and disposition of Common Shares, the consequences to them of an investment in a PFIC, any elections available with respect to the Common Shares and the IRS information reporting obligations with respect to the purchase, ownership and disposition of Common Shares of a PFIC.

 

Subject to the discussion above under “— Passive Foreign Investment Company Consequences,” a U.S. Holder that receives a distribution with respect to Common Shares generally will be required to include the gross amount of such distribution (before reduction for any Canadian withholding taxes withheld therefrom) in gross income as a dividend when actually or constructively received to the extent of the U.S. Holder’s pro rata share of our current and/or accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder’s pro rata share of our current and accumulated earnings and profits, it will be treated first as a tax-free return of capital and reduce (but not below zero) the adjusted tax basis of the U.S. Holder’s Common Shares. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder’s Common Shares, the remainder will be taxed as capital gain. Because we may not account for our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should expect all distributions to be reported to them as dividends. Distributions on Common Shares that are treated as dividends generally will constitute income from sources outside the United States for foreign tax credit purposes and generally will constitute passive category income. Such dividends will not be eligible for the “dividends received” deduction generally allowed to corporate shareholders with respect to dividends received from U.S. corporations.

 

Dividends paid by a “qualified foreign corporation” are eligible for taxation in the case of non-corporate U.S. Holders at a reduced long-term capital gains rate rather than the marginal tax rates generally applicable to ordinary income provided that certain requirements are met. Each non-corporate U.S. Holder is advised to consult its tax advisors regarding the availability of the reduced tax rate on dividends with regard to its particular circumstances.

 

A non-U.S. corporation (other than a corporation that is classified as a PFIC for the taxable year in which the dividend is paid or the preceding taxable year) generally will be considered to be a qualified foreign corporation (a) if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which includes an exchange of information provision, or (b) with respect to any dividend it pays on Common Shares that are readily tradable on an established securities market in the United States. We believe that we qualify as a resident of Canada for purposes of, and are eligible for the benefits of, the U.S.-Canada Treaty, which the IRS has determined is satisfactory for purposes of the qualified dividend rules and that it includes an exchange of information provision, although there can be no assurance in this regard. Further, our Common Shares will generally be considered to be readily tradable on an established securities market in the United States if they remain listed on Nasdaq. Therefore, subject to the discussion above under “ Passive Foreign Investment Company Consequences”, if the U.S. Treaty is applicable, or if the Common Shares are readily tradable on an established securities market in the United States, dividends paid on Common Shares will generally be “qualified dividend income” in the hands of non-corporate U.S. Holders, provided that certain conditions are met, including conditions relating to holding period and the absence of certain risk reduction transactions.

 

52
 

 

Sale, Exchange or Other Disposition of Common Shares

 

Subject to the discussion above under “— Passive Foreign Investment Company Consequences,” a U.S. Holder generally will recognize capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition of Common Shares in an amount equal to the difference, if any, between the amount realized (i.e., the amount of cash plus the fair market value of any property received) on the sale, exchange or other disposition and such U.S. Holder’s adjusted tax basis in the Common Shares. Such capital gain or loss generally will be long-term capital gain taxable at a reduced rate for non-corporate U.S. Holders or long-term capital loss if, on the date of sale, exchange or other disposition, the Common Shares were held by the U.S. Holder for more than one year. Any capital gain of a non-corporate U.S. Holder that is not long-term capital gain is taxed at ordinary income rates. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by a U.S. Holder from the sale or other disposition of Common Shares will generally be gain or loss from sources within the United States for U.S. foreign tax credit purposes.

 

Medicare Tax

 

Certain U.S. Holders that are individuals, estates or trusts and whose income exceeds certain thresholds generally are subject to a 3.8% Medicare tax on all or a portion of their net investment income, which may include their gross dividend income and net gains from the disposition of Common Shares. If you are a U.S. person that is an individual, estate or trust, you are encouraged to consult your tax advisors regarding the applicability of this Medicare tax to your income and gains in respect of your investment in Common Shares.

 

Information Reporting and Backup Withholding

 

U.S. Holders may be required to file certain U.S. information reporting returns with the IRS with respect to an investment in Common Shares, including, among others, IRS Form 8938 (Statement of Specified Foreign Financial Assets). As described above under “Passive Foreign Investment Company Consequences”, each U.S. Holder who is a shareholder of a PFIC must file an annual report containing certain information. U.S. Holders paying more than US$100,000 for Common Shares may be required to file IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) reporting this payment. Substantial penalties may be imposed upon a U.S. Holder that fails to comply with the required information reporting.

 

Dividends on and proceeds from the sale or other disposition of Common Shares may be reported to the IRS unless the U.S. Holder establishes a basis for exemption. Backup withholding may apply to amounts subject to reporting if the holder (1) fails to provide an accurate U.S. taxpayer identification number or otherwise establish a basis for exemption, or (2) is described in certain other categories of persons. However, U.S. Holders that are corporations generally are excluded from these information reporting and backup withholding tax rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder’s U.S. federal income tax liability if the required information is furnished by the U.S. Holder on a timely basis to the IRS.

 

U.S. Holders should consult their own tax advisors regarding the backup withholding tax and information reporting rules.

 

EACH U.S. HOLDER IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES TO IT OF AN INVESTMENT IN COMMON SHARES IN LIGHT OF THE U.S. HOLDER’S OWN CIRCUMSTANCES.

 

53
 

 

Certain Canadian Federal Income Tax Considerations for United States Residents

 

The following is, at the date of this Annual Report, a summary of certain Canadian federal income tax considerations generally applicable to the holding and disposition of Common Shares acquired by a holder who, at all relevant times, (a) for the purposes of the Tax Act (i) is not resident, or deemed to be resident, in Canada, (ii) deals at “arm’s length” with the Company, and is not “affiliated” with the Company (each as defined in the Tax Act), (iii) holds Common Shares as capital property, (iv) does not use or hold Common Shares in the course of carrying on, or otherwise in connection with, a business carried on or deemed to be carried on in Canada, and (v) is not an insurer that carries on an insurance business in Canada and elsewhere or “authorized foreign bank” (as defined in the Tax Act), or other holder of special status, and (b) for the purposes of the Canada-U.S. Tax Convention (1980) (the “Tax Treaty”), is a resident of the United States, has never been a resident of Canada, does not have and has not had, at any time, a “permanent establishment” (as defined in the Tax Treaty) of any kind in Canada, and otherwise qualifies for the full benefits of the Tax Treaty. Holders who meet all the criteria in clauses (a) and (b) above are referred to herein as “United States Holders”, and this summary only addresses such United States Holders.

 

This summary does not deal with special situations, such as the particular circumstances of traders or dealers, tax exempt entities, insurers or financial institutions, or other holders of special status or in special circumstances. Such holders, and all other holders who do not meet the criteria in clauses (a) and (b) above, should consult their own tax advisors.

 

This summary is based on the current provisions of the Tax Act, the regulations thereunder (the “Regulations”), the current provisions of the Tax Treaty (each as in force as of the date of this Annual Report) and the Company’s understanding of the administrative policies and assessing practices of the Canada Revenue Agency (the “CRA”) published in writing prior to the date hereof. This summary takes into account all specific proposals to amend the Tax Act and Regulations publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof  (the “Proposed Amendments”) and assumes that such Proposed Amendments will be enacted in the form proposed. However, such Proposed Amendments might not be enacted in the form proposed, or at all. This summary does not otherwise take into account or anticipate any changes in law or administrative policies or assessing practices, whether by legislative, governmental or judicial decision or action, nor does it take into account tax laws of any province or territory of Canada or of any other jurisdiction outside Canada, which may differ significantly from those discussed in this summary.

 

For the purposes of the Tax Act, all amounts relating to the acquisition, holding or disposition of Common Shares must generally be expressed in Canadian dollars. Amounts denominated in United States currency generally must be converted into Canadian dollars using a rate of exchange that is acceptable to the CRA.

 

This summary is of a general nature only and is not intended to be, nor should it be construed to be, legal or tax advice to any particular United States Holder, and no representation with respect to the Canadian federal income tax consequences to any particular United States Holder or prospective United States Holder is made. This summary is not exhaustive of all Canadian federal income tax considerations. Accordingly, all United States Holders should consult with their own tax advisors for advice with respect to their own particular circumstances.

 

Withholding Tax on Dividends

 

Amounts paid or credited or deemed to be paid or credited as, on account or in lieu of payment of, or in satisfaction of, dividends on Common Shares to a United States Holder will be subject to Canadian withholding tax. Under the Tax Act, the rate of withholding is 25% of the gross amount of the dividend.

 

Under the Tax Treaty, the rate of withholding on any such dividend beneficially owned by a United States Holder is generally reduced to 15%, or 5% if the United States Holder is a company that owns, directly or indirectly, at least 10% of the voting stock of the Company.

 

Dispositions of Common Shares

 

A United States Holder generally will not be subject to tax under the Tax Act in respect of a capital gain realized on the disposition or deemed disposition of a Common Share, nor will a capital loss arising therefrom be recognized under the Tax Act, unless such Common Share constitutes “taxable Canadian property” (as defined in the Tax Act) of the United States Holder and the gain is not exempt from tax pursuant to the terms of the Tax Treaty.

 

54
 

 

Provided the Common Shares are listed on a “designated stock exchange” (as defined in the Tax Act) (which currently includes the Nasdaq and CSE) and are so listed at the time of disposition, the Common Shares generally will not constitute “taxable Canadian property” of a United States Holder at that time unless, at any time during the 60-month period immediately preceding the disposition, the following two conditions are met concurrently: (i) 25% or more of the issued shares of any class or series of shares of the Company were owned by or belonged to one or any combination of (a) the United States Holder, (b) persons with whom the United States Holder did not deal at “arm’s length” (within the meaning of the Tax Act), or (c) partnerships in which the United States Holder or a person described in (b) holds a membership interest directly or indirectly through one or more partnerships; and (ii) more than 50% of the fair market value of the Common Shares was derived directly or indirectly from one or any combination of (a) real or immovable property situated in Canada, (b) “Canadian resource properties” (as defined in the Tax Act), (c) “timber resource properties” (as defined in the Tax Act), or (d) options in respect of, interests in, or, for civil law purposes, a right in, the foregoing property, whether or not such property exists. Notwithstanding the foregoing, a Common Share may be deemed to be “taxable Canadian property” in certain other circumstances. United States Holders should consult their own tax advisors as to whether their Common Shares will constitute “taxable Canadian property”.

 

United States Holders who may hold Common Shares as “taxable Canadian property” should consult their own tax advisors with respect to the application of Canadian capital gains taxation, any potential relief under the Tax Treaty, and special compliance procedures under the Tax Act, none of which is described in this summary.

 

SHAREHOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS AS TO THE CANADIAN OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON SHARES, INCLUDING, IN PARTICULAR, THE EFFECT OF ANY NON-U.S., STATE OR LOCAL TAXES.

 

10.F. Dividends and Paying Agents

 

Not applicable.

 

10.G. Statement by Experts

 

Not applicable.

 

10.H. Documents on Display

 

Documents concerning our company referred to in this Annual Report may be viewed by appointment during normal business hours at our registered and records office at Suite 2800, Park Place, 666 Burrard Street, Vancouver, British ‎Columbia V6C 2Z7‎.

 

10.I. Subsidiary Information

 

Not applicable.

 

Item 11. Quantitative and Qualitative Disclosures About Market Risk

 

We are exposed in varying degrees to a variety of financial instrument related risks. The Board approves and monitors the risk management processes, inclusive of controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit Risk

 

Credit and liquidity risk associated with cash and the marketable security is managed by ensuring assets are placed with major financial institutions with strong investment grade ratings.

 

Credit risk on trade and other receivables reflects the risk that the Company may be unable to recover them. The Company manages its credit risk by closely monitoring the granting of credit. Trade and other receivables that are greater than 30 days are considered past due. Based on the status of trade and other receivables, no allowance for doubtful accounts has been recorded as at December 31, 2021 (December 31, 2010 - $nil).

 

55
 

 

Interest Rate Risk

 

Interest rate risk is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities. The Company is exposed to minimal interest rate risk on its cash balances as they carry a floating rate of interest. We do not currently hedge our interest rate risk.

 

Foreign Currency Risk

 

We are also exposed to market risk related to change in foreign currency exchange rates. Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does engage in significant transactions and activities in currencies other than its functional currency, the Canadian dollar. Such transactions are primarily denominated in the U.S. dollar. Transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company. We do not currently hedge our foreign exchange rate risk.

 

Item 12. Description of Securities Other than Equity Securities

 

12.A. Debt Securities

 

Not applicable.

 

12.B. Warrants and Rights

 

Not applicable.

 

12.C. Other Securities

 

Not applicable.

 

12.D. American Depositary Shares

 

Not applicable.

 

PART II

 

Item 13. Defaults, Dividend Arrearages and Delinquencies

 

Not applicable.

 

ITEM 14.Material Modifications to the Rights of Security Holders and Use of Proceeds

 

Not applicable.

 

14.E. Use of Proceeds

 

The effective date of the registration statement on Form F-10 (File No. 333-258074) for the Company’s initial underwritten public offering of securities in the United States was July 29, 2021 (defined herein as the “US Offering”). The offering of 5,000,000 Common Shares at a price of U.S.$4.00 per share closed on August 3, 2021 for gross proceeds of U.S.$20,000,000, before deducting underwriting discounts and offering expenses of approximately U.S.$2,400,000 for total net proceeds to the Company from the offering of U.S.$17,600,000. ThinkEquity, a division of Fordham Financial Management, Inc. (“ThinkEquity”), was the sole book-running manager for the offering.

 

In addition, ThinkEquity was granted a 45-day over-allotment option following the closing date to purchase up to an additional 750,000 shares. On September 15, 2021, the Company announced the exercise of 95,966 of the over-allotment shares at a price of U.S.$4.00 per share for additional gross proceeds of U.S.$383,864, bringing the aggregate gross proceeds of the US Offering to U.S.$20,383,864 before deducting underwriting discounts and offering expenses. After deducting underwriting discounts and offering expenses of U.S.$2,400,000, the total net proceeds to the Company from the US Offering were approximately U.S.$17,983,864. None of the net proceeds of the US Offering were paid directly or indirectly to any director or officer of ours or to their associates, persons owning 10% or more of any class of our equity securities, or to any of our affiliates.

 

56
 

 

The Company has not fully used the net proceeds of the US Offering. The proceeds that the Company has used (approximately U.S.$9,500,000 as of December 31, 2021) have been used for general corporate purposes, including funding ongoing operations, growth initiatives, and working capital. There has been no material change in the planned use of proceeds from our initial public offering from that described in our prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act on July 30, 2021 (the “Supplement”). The Company intends to continue to use the remaining net proceeds of the offering, together with existing cash, for general corporate purposes, including to fund ongoing operations, to fund growth initiatives and/or for working capital requirements including the continuing development and marketing of the Company’s core products, potential acquisitions and research and development, as set out in the Supplement.

 

Item 15. Controls and Procedures

 

Disclosure Controls and Procedures

 

At the end of the period covered by this Annual Report, an evaluation of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as such term is defined in Rules 13a-15(e) under the Exchange Act) was carried out by the Company’s principal executive officer (the “CEO”) and principal financial officer (the “CFO”). Based upon that evaluation, the Company’s CEO and CFO have concluded that, as of the end of the period covered by this report, the design and operation of the Company’s disclosure controls and procedures are effective to ensure that (i) information required to be disclosed in reports that the Company files or submits to regulatory authorities is recorded, processed, summarized and reported within the time periods specified by regulation, and (ii) is accumulated and communicated to management, including the Company’s CEO and CFO, to allow timely decisions regarding required disclosure.

 

It should be noted that while the Company’s CEO and CFO believe that the Company’s disclosure controls and procedures provide a reasonable level of assurance that they are effective, they do not expect that the Company’s disclosure controls and procedures will prevent all errors and fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

 

Management Report on Internal Control Over Financial Reporting & Auditor Attestation

 

This Annual Report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the Company’s registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.

 

Changes in Internal Control over Financial Reporting

 

During the year ended December 31, 2021, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Item 16. [Reserved]

 

Item 16A. Audit Committee Financial Expert

 

The Company’s Audit Committee, which consists exclusively of independent directors within the meaning of NI 52-110 and the Nasdaq listing requirements, is comprised of Olen Aasen, Julie Myers Wood and John M. ‎Mitnick. Olen Aasen is the Chair of the Audit Committee. The Board of Directors has determined that Julie Myers Wood, Olen Aasen, and John M. ‎Mitnick each meet the independence requirements for directors, including the heightened independence standards for members of the audit committee under Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and NI 52-110. The Board has determined that Olen Aasen is “financially literate” within the meaning of NI 52-110 and the Nasdaq listing requirements and an “audit committee financial expert” as defined by Rule 10A-3 under the Exchange Act. For a description of the education and experience of each member of the Audit Committee, see “Item 6A. Directors, Senior Management and Employees.”

 

57
 

 

Item 16B. Code of Ethics

 

The Company has adopted a Code of Business Conduct and Ethics applicable to all of its directors, officers and employees, including its CEO and CFO, which is a “code of ethics” as defined in section 406(c) of the Sarbanes-Oxley Act. The Code of Business Conduct and Ethics sets out the fundamental values and standards of behavior that the Company expects from our directors, officers and employees with respect to all aspects of its business.

 

If the Company grants any waiver of the Code of Business Conduct and Ethics, whether explicit or implicit, to a director or executive officer, it will disclose the nature of such waiver on its website to the extent required by, and in accordance with, the rules and regulations of the SEC.

 

The full text of the Code of Business Conduct and Ethics is posted on the Company’s website at www.draganfly.com and the System for Electronic Document Analysis and Retrieval (SEDAR) profile at www.sedar.com. The information on or accessible through the website is not part of and is not incorporated by reference into this Annual Report, and the inclusion of the website address in this Annual Report is only for reference.

 

The Audit Committee is responsible for reviewing and evaluating the Code of Business Conduct and Ethics periodically and will recommend any necessary or appropriate changes thereto to the Board for consideration. The Audit Committee will also assist the Board of Directors with the monitoring of compliance with the Code of Business Conduct and Ethics.

 

Item 16C. Principal Accountant FeeS and Services

 

The following table sets forth information regarding the amount billed and accrued to the Company by Dale Matheson Carr-Hilton Labonte LLP, for the fiscal years ended December 31, 2021 and 2020:

 

   Year Ended December 31, 
Services  2021   2020 
Audit Fees(1)  $280,000   $94,000 
Audit-Related Fees(2)   -   $8,925 
Tax Fees(3)  $11,000   $4,000 
Other Fees(4)   -    - 

 

Notes:

 

  (1) “Audit fees” means the aggregate fees billed for professional services rendered by our principal accounting firm for the audit of the Company’s annual financial statements and the review of its comparative interim financial statements.
  (2) “Audit-related fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for the assurance and related services, which mainly included the audit and review of financial statements and are not reported under “Audit fees” above.
  (3) “Tax fees” means the aggregate fees billed for professional services rendered by the Company’s principal accounting firm for tax compliance, tax advice and tax planning.
  (4) “Other fees” means the aggregate fees incurred in each of the fiscal years listed for the professional tax services rendered by the Company’s principal accounting firm other than services reported under “Audit fees,” “Audit-related fees” and “Tax fees.”

 

The policy of the Company’s Audit Committee is to pre-approve all audit and non-audit services provided by Dale Matheson Carr-Hilton Labonte LLP, its independent registered public accounting firm, including audit services, audit-related services, tax services, and other services as described above.

 

Item 16D. Exemptions from the Listing Standards for Audit Committees

 

Not Applicable.

 

ITEM 16E.PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

Not Applicable.

 

58
 

 

Item 16F. Change in Registrant’s Certifying Accountant

 

Not applicable.

 

Item 16G. Corporate Governance

 

The Company is a foreign private issuer and its Common Shares are listed on the Nasdaq Capital Market. Rule 5615(a)(3) of the rules of the Nasdaq Stock Market LLC Rules (the “Nasdaq Rules”) permits a foreign private issuer to follow its home country practices in lieu of certain requirements of the 5600 Series of the Nasdaq Rules, which set forth corporate governance requirements. In order to claim such an exemption, the Company must disclose the significant differences between its corporate governance practices and those required to be followed by U.S. domestic issuers under the Nasdaq Rules. Set forth below is a brief summary of such differences.

 

Quorum Requirement

 

Nasdaq Rule 5620(c) requires that each company that is not a limited partnership shall provide for a quorum as specified in its by-laws for any meeting of holders of common stock; provided, however, that in no case shall such quorum be less than 33 1/3% of the outstanding shares of the company’s common voting stock. The Company does not presently follow this Nasdaq Rule. Instead, and in accordance with the Nasdaq exemption, the Company complies with the BCBCA which does not require a quorum of no less than 33 1/3% of the outstanding shares of the Company’s common voting shares and provides that the quorum for the transaction of business at a meeting of shareholders is the quorum established by the Company’s Articles, which is two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least 5% of the issued shares entitled to be voted at the meeting.

 

Independent Compensation Committee

 

Nasdaq Rule 5605(d)(2) requires that listed companies have a compensation committee comprised entirely of independent directors. The Company does not have a compensation committee comprised entirely of independent directors. Under Canadian securities laws, National Policy 58-201 only recommends that a compensation committee be composed entirely of independent directors. The rules of the CSE likewise do not require an entirely independent compensation committee.

 

Item 16H. Mine Safety Disclosure

 

Not applicable.

 

Item 16I.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable.

 

PART III

 

Item 17: Financial Statements

 

Financial Statements Filed as Part of this Annual Report:

 

Audited Annual Financial Statements as at December 31, 2021 and 2020:

 

Independent Auditor’s Report of Dale Matheson Carr-Hilton Labonte LLP‎, dated April 3, 2022; F-2
   
Consolidated Statements of Financial Position for the years ended December 31, 2021 and 2020; F-3
   
Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2021 and 2020; F-4
   
Consolidated Statements of Changes in Shareholder Equity (Deficiency) for the years ended December 31, 2021 and 2020; F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020; F-7
   
Notes to the Consolidated Financial Statements. F-9

 

59
 

 

Item 18: Financial Statements

 

Refer to Item 17. Financial Statements.

 

Item 19. Exhibits

 

The following Exhibits are being filed as part of this Annual Report, or are incorporated by reference where indicated:

 

Exhibit Number   Description
1.1*   Certificate of Incorporation dated June 1, 2018.
1.2   Articles dated June 1, 2018 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021).
1.3*   Certificate of Change of Name dated August 15, 2019.
1.4   Notice of Articles dated June 1, 2018 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021).
2.1*   Specimen Option Agreement of the Company
2.2*   Specimen Restricted Share Unit Agreement of the Company
2.3*   Specimen Warrant Certificate of the Company
2.4*   Specimen Warrant Certificate of the Company
2.5*   Specimen Warrant Certificate of the Company
4.1*   Business Services Agreement between the Company and Business Instincts ‎Group Inc. dated August 1, 2019.
4.2*   Share Compensation Plan dated August 9, 2019, as amended April 14, 2021 (incorporated herein by reference to the Company’s Registration Statement on Form S-8 (Registration Number 333-259459) filed with the SEC on September 10, 2021)
4.3*   Consultant Agreement ‎with 1502372 Alberta Ltd., dated October 1, 2019
4.4*   Amending Agreement with 1502372 Alberta Ltd., dated September 3, 2021
4.5*   Consultant Agreement with Scott Larson dated July 3, 2020
4.6*   Amending Agreement with Scott Larson, dated September 3, 2021
4.7*   Employment Agreement with Paul Sun dated November, 2020
4.8*   Amending Agreement with Paul Sun, dated September 3, 2021
4.9*   Employment Agreement with Justin Hannewyk dated April 30, 2020
4.10*   Amending Agreement with Justin Hannewyk, dated September 3, 2021
8.1*   Subsidiaries of the Company
11.1*   Code of Business Conduct and Ethics
12.1*   Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer
12.2*   Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
13.1*   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
13.2*   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
15.1*   Management Discussion and Analysis of the Company for the year ended December 31, 2021.
15.2*   Audit Committee Charter
15.3*   Consent of independent registered public accounting firm (Dale Matheson Carr-Hilton Labonte LLP)
101*   The following materials from the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2021, formatted in eXtensible Business Reporting Language (XBRL):

    (i) Consolidated Balance Sheets as of December 31, 2021 and 2020;
    (ii) Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019;
    (iii) Consolidated Statements of Comprehensive Loss for the years ended December 31, 2021, 2020 and 2019;
    (iv) Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2021, 2020 and 2019;
    (v) Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2019; and
    (vi) Notes to Consolidated Financial Statements

104*   Cover Page Interactive Data File (formatted as Inline eXtensible Business Reporting Language (iXBRL) and contained in Exhibit 101)

 

* Filed herewith.

 

60
 

 

Signatures

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

  DRAGANFLY INC.
     
    /s/ Paul Sun
  By: Paul Sun
  Title: Chief Financial Officer

 

Date: April 3, 2022

 

61
 

 

 

Draganfly Inc.

Consolidated Financial Statements

Years Ended December 31, 2021 and 2020

(Expressed in Canadian Dollars)

 

F-1

 

 

INDEPENDENT AUDITOR’S REPORT (PCAOB ID1173)

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of Draganfly Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Draganfly Inc. (the “Company”) as of December 31, 2021 and 2020, the related consolidated statements of comprehensive loss, changes in shareholders’ equity, and cash flows for the years ended December 31, 2021, 2020, and 2019, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and its financial performance and its cash flows for the years ended December 31, 2021, 2020 and 2019, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting in accordance with the standards of the PCAOB. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion in accordance with the standards of the PCAOB.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

DALE MATHESON CARR-HILTON LABONTE LLP

CHARTERED PROFESSIONAL ACCOUNTANTS

 

/s/ DMCL

 

We have served as the Company’s auditor since 2019.

Vancouver, Canada

April 3, 2022

 

F-2

 

 

Draganfly Inc.

Consolidated Statements of Financial Position

Expressed in Canadian Dollars

 

       December 31,   December 31, 
As at  Notes   2021   2020 
             
ASSETS              
Current Assets              
Cash and cash equivalents  6   $23,075,713   $1,982,416 
Receivables  7    1,407,127    810,791 
Inventory  8    3,390,822    1,233,619 
Notes receivable  9    

190,170

    - 
Prepaids  10    5,494,877    335,022 
 Total current assets       33,558,709    4,361,848 
               
Non-current Assets            
Goodwill  13    5,940,409    2,166,563 
Equipment  12    297,043    153,870 
Intangible assets  13    593,901    273,867 
Investments  11    291,066    - 
Notes receivable  9    964,006    - 
Right of use asset  14    468,106    144,419 
TOTAL ASSETS      $42,113,240   $7,100,567 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY              
Current Liabilities              
Trade payables and accrued liabilities  16   $799,139   $1,857,177 
Customer deposits  17    172,134    385,449 
Deferred income  18    73,286    - 
Loans payable  19    6,745    62,978 
Derivative liability  20    5,560,002    748,634 
Lease liability  15    110,481    93,239 
 Total current liabilities       6,721,787    3,147,477 
               
Non-current Liabilities              
Deferred income  18    -    5,062 
Loans payable  19    86,572    34,938 
Lease liability  15    378,642    64,885 
TOTAL LIABILITIES       7,187,001    3,252,362 
               
SHAREHOLDERS’ EQUITY              
Share capital  20    81,038,365    36,943,304 
Reserves – share-based payments  20    6,406,117   3,024,007 
Accumulated deficit       (52,322,182)   (36,119,210)
Accumulated other comprehensive income (loss)       (196,061)    104 
TOTAL SHAREHOLDERS’ EQUITY       34,926,239    3,848,205 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY      $42,113,240   $7,100,567 

 

Nature and Continuance of Operations (Note 1)

 

Approved and authorized for issuance by the Board of Directors on April 3, 2022.

 

“Scott Larson”   “Cameron Chell”
Director   Director

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-3

 

 

Draganfly Inc.

Consolidated Statements of Comprehensive Loss

Expressed in Canadian Dollars

 

   Note   2021   2020   2019 
       For the years ended December 31, 
   Note   2021   2020   2019 
REVENUE                
Revenue from sales of goods  21   $5,103,399   $3,087,223   $248,939 
Revenue from provision of services  21    1,950,466    1,276,288    1,131,488 
TOTAL REVENUE       7,053,865    4,363,511    1,380,427 
                    
COST OF SALES  8    (4,410,777)   (2,603,911)   (218,800)
                    
GROSS PROFIT       2,643,088    1,759,600    1,161,627 
                    
OPERATING EXPENSES                   
Amortization  13   $135,966   $43,518   $8,386 
Depreciation  12,14    175,098    109,108    41,250 
Director fees  23    370,094    -    - 
Insurance       2,962,767    39,988    23,900 
Office and miscellaneous  22    6,455,998    3,387,865    2,103,732 
Professional fees  23    4,445,949    1,762,594    524,101 
Research and development       510,895    567,999    16,883 
Share-based payments  20,23    3,952,595    2,668,464    761,559 
Travel       143,904    25,617    30,896 
Wages and salaries  23    2,768,010    1,649,329    989,083 
 Total operating expenses       (21,921,276)   (10,254,482)   (4,499,790)

OTHER INCOME (EXPENSE)

                   
Change in fair value of derivative liability  4,20    8,149,812   (748,634)   - 
Finance and other costs      5,074    (23,117)   (171,905)
Foreign exchange gain (loss)       362,448    (87,104)   5,803 
Gain on disposal of assets       -    -    28,651 
Gain (loss) on settlement of debt      -    (38,879)   198,976 
Gain on forgiveness of debt       -    127,711    - 
Government income  26    24,148    51,627    - 
Listing expense  5     -    -    (7,804,859)
Loss on write-off of loan receivable       -    -    (13,560)
Loss on write-off of notes receivable  9    

(891,471

)   -    - 
Loss on impairment of goodwill  13    (4,579,763)          
Other income (loss)  26    4,968    1,197,465    - 
NET LOSS       (16,202,972)  (8,015,813)  (11,095,057)
                    
OTHER COMPREHENSIVE INCOME (LOSS)                   

Items that may be reclassified to profit or loss

                   
Foreign exchange translation       136,475    104    - 
Items that will not be reclassified to profit or loss                   

Change in fair value of equity investments at FVOCI

 

11

    

(332,640

)   -    - 
COMPREHENSIVE LOSS      $(16,399,137)  $(8,015,709)  $(11,095,057)
                    
Net loss per share                   
Basic & diluted      $(0.59)  $(0.48)  $(1.16)
Weighted average number of common shares outstanding - basic & diluted       27,647,293    16,558,184    9,529,595 

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-4

 

 

Draganfly Inc.

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

 

  

Number of

Shares

                   
                  

Accumulated Other Comprehensive Income (Loss)

     
  

Number of

Shares

  

Share

Capital

  

Reserves - Share-Based

Payments

  

Accumulated

Deficit

  

Change in Fair

Value of

Investments

at FVTOCI

  

Exchange

Differences on

Translation of Foreign

Operations

  

Total

Shareholders’

Equity

 
Balance at December 31, 2018   7,869,384   $12,561,342   $882,180   $(17,576,131)  $-   $-   $    (4,132,609)
Shares issued for settlement of notes payable   258,310    645,775    -    -    -    -    645,775 
Shares issued as transactions fees   400,000    1,000,000    -    -    -    -    1,000,000 
Recapitalization of Draganfly Inc.   2,100,000    5,250,001    1,645,193    -    -    -    6,895,194 
Shares issued of settlement of trades payable   9,065    22,662    -    -    -    -    22,662 
Shares issued for settlement of convertible debentures and accrued interest   423,698    1,059,246    -    -    -    -    1,059,246 
Shares issued for exercise of warrants   63,388    221,741    (212,908)   -    -    -    8,833 
Reclassification of unexercised conversion feature   -    -    (567,791)   567,791    -    -    - 
Shares and warrants issued on private placement   2,810,300    7,025,750    -    -    -    -    7,025,750 
Stock-based compensation   -    -    761,559    -    -    -    761,559 
Net loss   -    -    -    (11,095,057)   -    -    (11,095,057)
                                    
Balance at December 31, 2019   13,934,145   $27,786,517   $2,508,233   $(28,103,397)  $-   $-   $2,191,353 
Shares issued for exercise of warrants   1,584,775    4,007,130    (1,645,193)   -    -    -    2,361,937 
Shares issued for acquisition   645,088    2,178,961    -    -    -    -    2,178,961 
Shares issued as finder’s fees   40,000    100,000    -    -    -    -    100,000 
Shares issued for debt settlement   111,082    344,354    -    -    -    -    344,354 
Shares issued for financing   703,607    2,018,845    -    -    -    -    2,018,845 
Shares issued for exercise of RSU’s   199,998    507,497    (507,497)   -    -    -    - 
Share-based payments   -    -    2,668,464    -    -    -    2,668,464 
Net loss   -    -    -    (8,015,813)   -    -    (8,015,813)
Translation of foreign operations   -    -    -    -    -    104    104 
                                    
Balance at December 31, 2020   17,218,695   $  36,943,304   $  3,024,007   $  (36,119,210)  $              -   $             104   $3,848,205 

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-5

 

 

Draganfly Inc.

Consolidated Statements of Changes in Shareholders’ Equity

Expressed in Canadian Dollars

 

                  

Accumulated Other Comprehensive Loss

     
  

Number of

Shares

  

Share

Capital

  

Reserves -

Share-Based Payments

  

Accumulated

Deficit

  

Change in Fair

Value of

Investments

at FVOCI

  

Exchange Differences on Translation of Foreign Operations

  

Total

Shareholders’

Equity

 
Balance at December 31, 2020   17,218,695   $36,943,304   $  3,024,007   $  (36,119,210)  $-   $104   $      3,848,205 
Shares issued for acquisition   1,200,000    2,303,999    1,241,250    -    -    -    3,545,249 
Shares issued for financing   11,584,657    36,092,187    -    -    -    -    36,092,187 
Share issue costs   -    (4,678,821)   

864,060

    -    -    -    (3,814,761)
Shares issued for exercise of RSUs   448,660    1,752,052    (1,752,052)   -    -    -    - 
Shares issued for exercise of warrants   1,939,534    4,929,790    -    -    -    -    4,929,790 
Shares issued for exercise of stock options   405,499    1,937,866    (923,743)   -    -    -    1,014,123 
Shares issued in lieu of cash   371,901    1,757,988    -    -    -    -    1,757,988 
Share-based payments   -    -    3,952,595    -    -    -    3,952,595 
Net loss   -    -    -    (16,202,972)   -    -    (16,202,972)
Change in fair value of equity investments at FVOCI   -    -    -    -    (332,640)   -    (332,640)
Translation of foreign operations   -    -    -    -    -    136,475    136,475 
                                    
Balance at December 31, 2021   33,168,946   $81,038,365   $6,406,117   $(52,322,182)  $(332,640)  $136,579   $34,926,239 

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-6

 

 

Draganfly Inc.

Consolidated Statements of Cash Flows

Expressed in Canadian Dollars

 

             
   For the year ended December 31, 
   2021   2020   2019 
             
OPERATING ACTIVITIES               
Net loss  $(16,202,972)  $(8,015,813)  $(11,095,057)
Adjustments for:               
Amortization   135,966    43,518    8,386 
Depreciation   175,098    109,108    41,250 
Change in fair value of derivative liability   (8,149,812)   748,634    - 
Impairment of notes receivable   

891,471

    

-

    

-

 
Impairment of goodwill   4,579,763    -    - 
Finance and other costs   (926)   23,117    171,905 
Gain on settlement of debt   -    38,879   (198,976)
Gain on forgiveness of debt   -    

(127,711

)   - 
Gain on disposal of assets   -    -    (28,651)
Income from government assistance   (24,148)   (21,090)   - 
Expense of non-financial asset   -    -    15,389 
Listing expense   -    -    7,804,859 
Shares Issued as acquisition cost   -    100,000    - 
Share-based payments   3,952,595    2,568,464    761,559 
 Adjustment for profit loss   (14,642,965)   (4,532,894)   (2,519,336)
                
Net changes in non-cash working capital items:               
Receivables   (596,336)   (1,481,944)   (126,799)
Inventory   (2,157,203)   (555,371)   12,622 
Prepaids    (3,401,868)   31,605    (249,325)
Trade payables and accrued liabilities   (1,044,133)   1,261,066    (1,005,121)
Customer deposits   (213,315)   139,490    - 
Deferred income   51,186    5,062    - 
Funds used in operating activities   (22,004,634)   (5,132,986)   (3,887,959)
                
INVESTING ACTIVITIES               
Cash paid for acquisition, net of cash received   (466,643)   (457,407)   28,538 
Purchase of equipment   (212,579)   (23,888)   (87,785)
Disposal of equipment   -    -    31,500 
Purchase of investments   (623,706)   -    - 
Issuance of notes receivable   (2,002,678)   -    - 
Proceeds from sales of investments   -    997,714    - 
Funds provided by (used in) investing activities   (3,305,606)   516,419    (27,747) 

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-7

 

 

Draganfly Inc.

Consolidated Statements of Cash Flows

Expressed in Canadian Dollars

 

   For the year ended December 31, 
   2021   2020   2019 
             
FINANCING ACTIVITIES               
Proceeds from issuance of common shares for financing   44,255,651    2,018,845    6,534,583 
Share issue costs   (3,814,762)   -    - 
Proceeds from issuance of common shares for warrants exercised   4,929,790    2,361,937    - 
Proceeds from issuance of common shares for stock options exercised   1,014,123    -    - 
Proceeds from issuance of loans   60,000    129,310    - 
Loans repayments   (4,319)   (5,062)   - 
Proceeds from issuance of notes payable   -    123,000   1,137,978 
Repayment of convertible debentures   -    -    

(486,131

)
Repayment of notes payable   -    (183,000)   (882,770)
Repayment of loans   (44,428)   (192,084)   - 
Repayment of lease liability   (128,996)   (83,442)   (38,000)
Funds provided by financing activities   46,267,059    4,169,504    6,265,660 
                
Effects of exchange rate changes on cash   136,478    104    (22,366)
Change in cash   20,956,819    (447,063)   2,349,954 
Cash, beginning of year   1,982,416    2,429,375    101,787 
Cash, end of year  $23,075,713   $1,982,416   $2,429,375 
                
Cash and cash equivalents consist of the following:               
Cash held in banks  $22,729,212   $1,839,871   $2,429,375 
Guaranteed investment certificate   346,501    142,545    - 
 Cash and cash equivalents  $23,075,713   $1,982,416   $2,429,375 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-8

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company’s shares trade on the Canadian Securities Exchange (the “CSE”),” on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

COVID-19

 

The outbreak of the coronavirus, also known as “COVID-19,” spread across the globe and is ‎impacting worldwide economic activity. Government authorities have implemented emergency ‎measures to mitigate the spread of the virus. These measures, which include the ‎implementation of travel bans, self-imposed quarantine periods, and social distancing, have ‎caused material disruption to business globally. ‎Governments and central banks reacted with significant monetary and fiscal interventions ‎designed to stabilize economic conditions.‎

‎ ‎

The Company will continue to monitor the impact of the COVID-19 pandemic, the duration and ‎impact of which is unknown at this time which may include further disruptions to global supply chains and the manufacturing and delivery of parts that the Company relies on for its products. Although it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the ‎Company and its operations in future periods, such impacts are not expected to be ‎significant going forward. Aside from the acquisition of Dronelogics and being opportunistic ‎on ‎other partnerships or acquisitions, the Company has expanded its products and services offered ‎to include ‎health and telehealth applications relating to COVID-19, as a way to mitigate the ‎effects of COVID-19.

 

Share consolidation

 

During the year ended December 31, 2021 in conjunction with its Regulation A financing, the Company underwent a share consolidation at a 5-1 ratio. All reference to share, per share amounts, warrants, RSU’s and stock options in these financial statements have been retroactively restated to reflect the consolidation.

 

F-9

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

 

These consolidated financial statements were authorized for issue by the Board of Directors on April 3, 2022.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary 

Place of Incorporation

 

Ownership Interest

 
Draganfly Innovations Inc.  Canada  100% 
Draganfly Innovations USA, Inc.  US  100% 
Dronelogics Systems Inc.  Canada  100% 

 

All intercompany balances and transactions were eliminated on consolidation.

 

Significant estimates and assumptions

 

The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

Impairment of Non-financial assets

 

The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell calculations. In calculating the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the calculation of the recoverable amount.

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

 

F-10

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices.

 

Contingencies

 

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

 

Business combinations

 

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

 

F-11

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Business combination versus asset acquisition

 

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to the Acquisitions (Notes 3, 4, and 5). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

 

Other significant judgments

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
the classification of financial instruments;
the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;
the determination of whether a set of assets acquired and liabilities assumed constitute a business; and
the determination of the functional currency of the company.

 

Foreign currency translation

 

Transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.

 

The functional currencies for the parent company and each subsidiary are as follows:

 

Draganfly Inc. Canadian Dollar
Draganfly Innovations Inc. Canadian Dollar
Draganfly Innovations USA, Inc. US Dollar
Dronelogics Systems Inc. Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in other comprehensive income.

 

Share-based payments

 

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

 

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

 

Restricted Share Units

 

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. RSUs are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

F-12

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income.

 

There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.

 

F-13

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

 

F-14

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Impairment of non-financial assets

 

The carrying amounts of the Company’s non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life;
an intangible asset not yet available for use; and
goodwill recognized in a business combination.

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in the statement of comprehensive loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax:

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax:

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

F-15

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Inventory

 

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

 

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

 

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

F-16

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

F-17

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Class of equipment  Depreciation rate 
Computer equipment  30% 
Furniture and equipment  20% 
Leasehold improvements  Over expected life of lease 
Software  30% 
Vehicles  30% 

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

SR&ED Investment tax credits

 

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

 

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

 

F-18

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

3. DRONELOGICS ACQUISITION

 

On April 30, 2020, the Company acquired all of the issued and outstanding shares of Dronelogics Systems Inc. (“Dronelogics”), excluding the cinematography division, a leading drone reseller and services company based in Burnaby, BC. The purpose of the acquisition was to increase the Company’s scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work while adding immediate revenue to the business, for consideration of $500,000 cash and 645,088 common shares (the “Transaction”).

 

In connection with the Transaction, the Company paid fees of $160,000 to certain advisors consisting of $100,000 by way of 40,000 in shares at a price of $2.50 per share and $60,000 in cash. At closing, the Company (i) granted 89,000 incentive stock options to certain employees of Dronelogics pursuant to the Company’s share compensation plan, exercisable at a price equal to closing price of the shares on the CSE on January 31, 2020. The options have a term of 10 years and 14,000 vest in three equal tranches, on the grant date and first and second anniversaries of the date of grant while 70,000 vest on the first anniversary of the grant date, and (ii) awarded 75,000 RSUs to certain directors and officers of Dronelogics. RSUs were awarded to certain directors and officers of Dronelogics pursuant to the Company’s share compensation plan. The RSUs vest in three equal tranches, on the first, second and third anniversaries of the date of award.

 

The purchase price allocation (“PPA”) is as follows:

 

      
Number of shares of Draganfly Inc.   645,088 
Fair value of common shares  $4.15 
Fair value of shares of Draganfly Inc.  $2,178,960 
Cash portion of purchase price   500,000 
Total  $2,678,960 

 

F-19

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

3. DRONELOGICS ACQUISITION (CONT’D)

 

Tangible assets acquired    
Cash  $42,593 
Accounts receivable   98,852 
Inventory   629,684 
Prepaids and deposits   93,997 
Other current assets   3,014 
Capital assets   54,946 
Right-of-use assets   83,428 
Accounts payable and accrued liabilities   (222,766)
Customer deposits   (245,959)
Loans   (245,752)
Other current liabilities   (8,437)
Lease liabilities   (87,203)
Total tangible assets acquired   196,397 
Identifiable intangible assets     
Customer relationships   197,000 
Website   119,000 
 Total identifiable intangible assets   316,000 
Goodwill   2,166,563 
Total consideration  $2,678,960 

 

The Company estimated the fair value as follows:

 

Customer relationships based on an income approach, specifically multi-period excess earnings method, by identifying key customers, applying attribution rate of 15% per annum and discount rate of 18% per annum; and
Website based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.5% and discount rate of 17% per annum.

 

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of the assembled workforce.

 

From the date of the acquisition to December 31, 2020, the acquired business contributed $4,086,350 of revenue and a net income of $434,528.

 

F-20

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

4. VITAL INTELLIGENCE ACQUISITION

 

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it to diversify its existing product line as well as recognized opportunities that an initial focus on COVID-19 screening set of technologies would most likely lead to other facets within the healthcare field creating revenue growth from a new vertical, for consideration of: (a) a cash payment of $500,000 and (b) ‎1,200,000 units of the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital.

 

The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:

 

a)300,000 units shall be released on the closing date;
b)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

 

Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:

 

A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and
Discounted due to the lack of liquidity.

 

On acquisition, the fair value of the derivative liability (note 20) was $4,797,717. At December 31, 2021, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $694,230, with the difference flowing through the consolidated statement of loss.

 

Contingent consideration     
Fair value of contingent consideration  $4,797,717 
Change in fair value of contingent consideration   (4,103,487)
Contingent consideration at December 31, 2021 (note 20)  $694,230 

 

The PPA is as follows:

 

Number of units of Draganfly Inc.   578,248 
Fair value of units  $14.43 
Fair value of units of Draganfly Inc.  $8,342,966 
Cash portion of purchase price   466,643 
Total  $8,809,609 

 

Identifiable intangible assets    
Brand  $23,000 
Software   433,000 
    456,000 
      
Goodwill   8,353,609 
Total consideration  $8,809,609 

 

F-21

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

4.VITAL INTELLIGENCE ACQUISITION (CONT’D)

 

Significant estimates are as follows:

 

 Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.
Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.
Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.

 

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments.

 

From the date of the acquisition to December 31, 2021, Vital contributed $115,369 of revenue and a net loss of $203,231.

 

5. AMALGAMATION

 

On January 31, 2019, the Company and Draganfly Innovations entered into the BCA providing for a three-cornered amalgamation among the Company, Draganfly Innovations, and Merger Co. As of August 15, 2019, the Amalgamation closed and the Company acquired, on a one for 1.794 basis, all of the issued and outstanding Draganfly Innovations shares (the “Draganfly Innovations Shares”) in exchange for 8,527,671 common shares of the Company.

 

This resulted in a reverse take-over, of the Company, by the shareholders of Draganfly Innovations. At the time of the Amalgamation, the Company did not constitute a business as defined under IFRS 3; therefore, the Amalgamation is accounted under IFRS 2, where the difference between the consideration given to acquire the Company and the net asset value of the Company is recorded as a listing expense to net loss. As Draganfly Innovations is deemed to be the accounting acquirer for accounting purposes, these consolidated financial statements present the historical financial information of Draganfly Innovations up to the date of the Amalgamation.

 

      
Number of shares of Draganfly Inc.   2,100,000 
Fair value of common shares in concurrent financing  $2.50 
Fair value of shares of Draganfly Inc.  $5,250,001 
Fair value of warrants   1,645,193 
Fair value of shares issued for transaction fees   1,000,000 
Net assets acquired  $(90,335)
Listing expense  $7,804,859 

 

Fair value of the Company acquired, net of liabilities    
Cash  $28,538 
Accounts receivable   4,991 
Loans receivable   963,269 
Accounts payable and accrued liabilities   (406,463)
Subscription receipts   (500,000)
Net of liabilities  $90,335 

 

The fair value of 10,500,001 issued common shares of the Company was estimated to be $2.50 per share using the price of a subscription receipts financing that was completed concurrently.

 

F-22

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

5. AMALGAMATION (CONT’D)

 

Prior to the closing of the Amalgamation, Draganfly Innovations issued 222,965 common shares with a value of $1,000,000 as transaction fees for the Amalgamation to related parties.

 

The Company assumed 800,000 share purchase warrants exercisable at a price of $0.50 per share expiring on February 4, 2021. The fair value of share-purchase warrants was $1,645,193, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

Risk-free interest rate   0.86%
Estimate life   1.48 years 
Expected volatility   100%
Expected dividend yield   0%

 

As at August 15, 2019, the Company received $7,025,750 in proceeds to issue subscription receipts (the “Subscription Receipts”) at a price of $2.50 per Subscription Receipt. Each Subscription Receipt was automatically converted, without payment of additional consideration and without any further action on the part of the holder, into one unit of the Company (a “Unit”) on completion of the Amalgamation and the Company becoming reporting issuer in the Province of Saskatchewan and obtaining conditional approval of a listing of the common shares on the CSE (the “Transaction”). Each Unit consists of one common share and one warrant. Each warrant will entitle the holder to purchase one common share at a price of $2.50 for a period of 12 months following the issuance of warrants. The proceeds of the private placement were released to the Company on November 5, 2019.

 

6. CASH AND CASH EQUIVALENTS

 

   December 31, 2021   December 31, 2020 
Cash held in banks  $22,729,212   $1,839,871 
Guaranteed investment certificates   346,501    142,545 
Cash and Cash Equivalents  $23,075,713   $1,982,416 

 

On March 27, 2020, the Company purchased a $142,000 guaranteed investment certificate (“GIC”) to secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.50% per annum. On March 27, 2021 the company renewed the GIC for $142,710 for 1 year at a rate of 0.10% per annum.

 

On May 28, 2021, the Company purchased an additional $140,000 GIC to further secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.35% per annum.

 

On December 21, 2021, the Company purchased an additional $50,000 USD GIC to further secure its credit cards. The terms of the GIC are for 1 year at 0.05% per annum.

 

All GIC’s must be maintained and renewed upon maturity until such time as the associated credit cards are cancelled.

 

7. RECEIVABLES

 

   December 31, 2021   December 31, 2020 
Trade accounts receivable  $951,314   $780,254 
Corporate taxes receivable   

182,820

    

-

 
GST receivable   272,993   $- 
SR&ED receivable   -    30,537 
Trade and other receivables  $1,407,127   $810,791 

 

8. INVENTORY

 

   December 31, 2021   December 31, 2020    December 31, 2019  
Finished goods  $3,017,363   $1,155,871    $ -  
Parts   373,459    77,748      48,653  
Inventories   $3,390,822   $1,233,619    $ 48,653  

 

During the year ended December 31, 2021, $3,420,713 (2020: $2,257,797 2019: $118,826) of inventory was sold and recognized in cost of sales. During the year ended December 31, 2021, the Company recorded an allowance to value its inventory for obsolete and slow-moving inventory, recognizing an expense in cost of sales of $nil (2020: $23,955, 2019: $nil).

 

  December 31, 2021   December 31, 2020    December 31, 2019  
Inventory  $3,420,713   $2,257,797    $ 118,626  
Consulting and services   679,345    164,119      86,280  
Other   310,719    181,995     

13,894

 
Cost of sales   $4,410,777   $2,603,911    $ 218,800  

 

F-23

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

9. NOTES RECEIVABLE

 

   Start Date  Maturity Date  Rate   Principal   Interest   Accretion 

Impairment

  Total  
Note 1(1)  2021-04-21  2022-10-21   0%  $180,597   $-   $9,573  $- $ 190,170  
Note 2(1)  2021-06-01  2023-06-01   8%   114,833    5,378    -   (120,211)    -  
Note 3(1)  2021-09-22  2024-09-22   5%   943,385    13,156    7,465   -    964,006  
Note 4  2021-11-17  2022-04-26   8%   750,000    21,260    -   (771,260   -  
Total             $1,988,815   $39,794   $17,038  $(891,471 $ 1,154,176  

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

 

Note 1 is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this loan which was the investee’s most recent financing.

 

Note 2 bears interest at 8% and is secured by a general security agreement. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

 

Note 3 bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this convertible loan which was the investee’s most recent financing.

 

Note 4 was issued pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at 8% and is due April 26, 2022. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

 

10. PREPAIDS

 

   December 31, 2021   December 31, 2020 
Insurance  $2,938,246   $992 
Prepaid director fees   107,763    - 
Prepaid interest   6,969    - 
Prepaid marketing services   1,638,179    187,826 
Prepaid rent   -    3,583 
Prepaid subscriptions   35,687    5,953 
Deposits   768,033    136,668 
 Prepaid expenses and deposits  $5,494,877   $335,022 

 

F-24

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

11. INVESTMENTS

 

         
Balance at December 31, 2020   $ -  
Investments     623,706  
Change in fair value     (332,640 )
Balance at December 31, 2021   $ 291,066  

 

Fair value of investments is comprised of:

  .  
      
Public company shares  $

142,857

 
Public company warrants   21,429 
Private company shares   126,780
Balance at December 31, 2021  $291,066 

 

On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $500,000. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023.

 

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

   December 31, 2021   March 10, 2021 
Risk free interest rate   0.91%   0.28%
Expected volatility   124.09%   150.88%
Expected life   2 years    2 years 
Expected dividend yield   0%   0%

 

Volatility is calculated using the historical volatility method

 

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. These assets have been recorded at the price of the company’s most recent private placement, and converted to Canadian dollars at the reporting date.

 

12. EQUIPMENT

 

 

  

Computer

Equipment

  

Furniture

and

Equipment

  

Leasehold

Improvements

   Software   Vehicles   Total 
Cost                              
Balance at January 1, 2020  $7,000   $142,173   $-   $29,967   $-   $179,140 
Additions   2,028    21,860    -    -    -    23,888 
Net assets acquired in the
Transaction
   15,369    7,573    4,352    -    27,652    54,946 
Balance at December 31, 2020  $24,397   $171,606   $4,352   $29,967   $27,652   $257,974 
Additions   29,713    170,866    -    -    12,000    212,579 
Revaluation   -    -    -    -    (3,619)   (3,619)
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
                               
Accumulated depreciation                              
Balance at January 1, 2020  $6,761   $37,944   $-   $19,294   $-   $63,999 
Charge for the year   5,631    22,019    3,220    3,202    6,033    40,105 
Balance at December 31, 2020  $12,392   $59,963   $3,220   $22,496   $6,033   $104,104 
Charge for the year   12,899    42,314    1,132    2,241    7,201    65,787 
Balance at December 31, 2021  $25,291   $

102,277

   $4,352   $24,737   $13,234   $169,891 
                               
Net book value:                              
December 31, 2020  $12,005   $111,643   $1,132   $7,471   $21,619   $153,870 
December 31, 2021  $28,819   $

240,195

   $-   $5,230   $22,799   $

297,043

 

 

F-25

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

13. INTANGIBLE ASSETS AND GOODWILL

 

   Patents  

Customer

Relationships

   Brand    

Software

   Goodwill   Total 
Cost                                 
Balance at December 31, 2019  $41,931   $-   $            -     $-   $-   $41,931 
Intangible assets acquired in the Transaction   -    197,000     -      119,000    2,166,563    2,482,563 
Balance at December 31, 2020  $41,931   $197,000   $ -     $119,000   $2,166,563   $2,524,494 

Intangible assets acquired in the

Acquisition

   -    -     23,000      433,000    8,353,609    8,809,609 
Impairment of goodwill   -    -     -      -    (4,579,763)   (4,579,763)
Balance at December 31, 2021  $41,931   $197,000   $ 23,000     $552,000   $

5,940,409

   $6,754,340 
                                  
Accumulated amortization                                 
Balance at December 31, 2019  $40,546   $-   $ -     $-   $-   $40,546 
Change for the year   1,385    26,267     -      15,866    -    43,518 
Balance at December 31, 2020   41,931    26,267   -     15,866    -    84,064 
Change for the year   -    34,147     3,450      98,369    -    135,966 
Balance at December 31, 2021  $41,931   $60,414   $ 3,450     $114,235   $-   $220,030 
                                  
Net book value:                                 
December 31, 2020  $-   $170,733   $ -     $103,134   $2,166,563   $2,440,430 
December 31, 2021  $-   $136,586   $ 19,550     $437,765   $5,940,409   $6,534,310 

 

Customer relationships

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics (note 3) and assigned $197,000 to the fair value of customer relationships.

 

Brand

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics and assigned $119,000 to the fair value of the website/domain name.

 

On March 25, 2021, the Company acquired the assets of Vital (note 4) and assigned $23,000 to the fair value of the brand.

 

Software

 

On March 25, 2021, the Company acquired the assets of Vital and assigned $433,000 to the fair value of the software.

 

Goodwill

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics, which included goodwill. Goodwill was valued at $2,166,563.

 

On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $8,353,609.

 

F-26

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

13. INTELLECTUAL PROPERTIES AND GOODWILL (CONT’D)

 

On December 31, 2021 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

 

5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2%
Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 14% for Drone and 42% for Vital respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.
Cash flows were discounted at the weighted average cost of capital of 17% for Dronelogics and 24% for Vital based on peer group averages and adjusted for the Company’s risk factors.

 

Based on the annual goodwill impairment test, the Company deemed that the goodwill for Vital required impairment, as such the Company recorded an impairment of $4,579,763.

 

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

 

 A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $597,100 for Dronelogics and $570,133 for Vital.

 

Changing the above assumption would result in an impairment for Dronelogics, and would result in additional impairment for Vital.

 

The key assumptions used in the calculations of the recoverable amounts include sales growth per year, changes in cost of sales and capital expenditures based on internal forecasts.

 

14. RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2019  $159,539 
Leases acquired in the Acquisition   83,428 
Balance at December 31, 2020  $242,967 
Additions   447,242 
Lease removal   (7,092)
Balance at December 31, 2021  $683,117 
      
Accumulated depreciation     
Balance at December 31, 2019  $29,545 
Charge for the year   69,003 
Balance at December 31, 2020  $98,548 
Historical correction   7,152 
Charge for the year   109,311 
Balance at December 31, 2021  $215,011 
      
Net book value:     
December 31, 2020  $144,419 
December 31, 2021  $468,106 

 

F-27

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

15. LEASE LIABILITY

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

 

   Total 
Balance at December 31, 2019  $136,073 
Leases acquired in the Acquisition   87,203 
Interest expense   18,290 
Lease Payments   (83,442)
Balance at December 31, 2020  $158,124 
Addition   440,675 
Interest expenses   26,964 
Lease payments   (128,995)
Lease removal   (7,645)
Balance at December 31, 2021  $489,123 
      
Which consists of:     
Current lease liability  $110,481 
Non-current lease liability   378,642 
Balance at December 31, 2021  $489,123 

 

Maturity analysis  Total 
Less than one year  $150,276 
One to three years   251,765 
Four to five years   183,473 
Greater than five years   5,030 
Total undiscounted lease liabilities   

590,544

 
Amount representing implicit interest   

(101,421

)
Lease liability  $489,123 

 

 

16. TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2021   December 31, 2020 
Trade accounts payable  $362,890   $813,881 
Accrued liabilities   402,540    512,205 
Due to related parties (Note 23)   -    475,628 
Government grant payable   33,709    33,709 
GST/PST Payable   -    21,754 
Trade payables and accrued liabilities  $799,139   $1,857,177 

 

 

17. CUSTOMER DEPOSITS

 

   December 31, 2021   December 31, 2020 
Customer deposits  $172,134   $385,449 

 

F-28

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

 18. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   December 31, 2021   December 31, 2020 
Deferred income from customers  $80,000   $- 
Deferred income from government   5,233    5,062 
Deferred income from note receivable accretion   (11,947)   - 
Deferred Income   73,286    5,062 

 

19. LOANS PAYABLE

   December 31, 2021   December 31, 2020 
Opening balance  $97,916   $- 
Acquisition of loans   -    120,851 
Issuance of loans payable   60,000    60,000 
Fair value adjustment   (24,576)   (26,152)
Repayment of loans payable   (44,428)   (57,873)
Accretion expense   4,405    1,090 
Ending balance  $93,317   $97,916 

 

 

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2021   Carrying Value December 31, 2020 
CEBA  2020-05-19  2022-12-31   0%  $37,384   $34,938 
CEBA  2021-04-23  2022-12-31   0%   37,383    - 
Vehicle loan  2019-08-30  2024-09-11   6.99%   18,550    25,295 
Shopify loan 

2020-08-05

      7.00%   -    

37,683

 
Total             $93,317   $97,916 

 

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

 

On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the loan is repaid on or before December 31, 2022.

 

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

 

The CEBA loans are unsecured and the vehicle loan is secured by the vehicle and the Shopify loan is secured by the Company’s accounts receivable.

 

F-29

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2021,

 

-The Company issued 1,580,525 common shares for the exercise of warrants for $3,951,312.
-The Company issued 149,999 common shares for the vesting of Restricted Share Units.
-The Company issued 392,999 common shares for the exercise of stock options for $987,248.
-The Company issued 15,000 common shares in lieu of cash.
-The Company issued 6,488,691 units for the Regulation A+ financing in the United States for proceeds of $18,815,485. Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to the warrant derivative liability.
-The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
-The Company issued 5,095,966 common shares in a private placement for $25,538,213.
-The Company issued 359,009 common shares for the exercise of warrants for $978,478.
-The Company issued 298,661 common shares for the vesting of Restricted Share Units.
-The Company issued 12,500 common shares for the exercise of stock options for $26,875.
-The Company issued 356,901 common shares in lieu of cash.

 

For the year ended December 31, 2020,

 

-The Company issued 24,000 common shares for the exercise of warrants for $60,000.
-The Company issued 20,000 common shares for the exercise of warrants for $50,000.
-The Company issued 210,320 common shares for the exercise of warrants for $105,160.
-The Company issued 73,000 common shares for the exercise of warrants for $36,500.
-The Company issued 294,840 common shares for the exercise of warrants for $147,420.
-The Company issued 121,840 common shares for the exercise of warrants for $60,920.
-The Company issued 126,000 common shares for the exercise of warrants for $115,000.
-The Company issued 645,088 common shares for the acquisition of Dronelogics and an additional 40,000 common shares as finder’s fees.
-The Company issued 12,000 common shares for the exercise of warrants for $30,000.
-The Company issued 45,600 common shares for the exercise of warrants for $114,000.
-The Company issued 192,308 common shares for cash proceeds of $500,000.
-The Company issued 111,082 common shares for debt settlement of $344,354 and recognized a loss of $38,879 in the statement of comprehensive loss.
-The Company issued 2,000 common shares for the exercise of warrants for $5,000.
-The Company issued 2,200 common shares for the exercise of warrants for $5,500.
-The Company issued 637,975 common shares for the exercise of warrants for $1,594,938.
-The Company issued 7,117 common shares for the vesting of Restricted Share Units.
-The Company issued 511,299 units for the Regulation A+ financing in the United States for proceeds of $1,518,845. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.
-The Company issued 2,040 common shares for the vesting of Restricted Share Units.
-The Company issued 2,647 common shares for the vesting of Restricted Share Units.
-The Company issued 188,194 common shares for the vesting of Restricted Share Units.
-The Company issued 15,000 common shares for the exercise of warrants for $37,500.

 

F-30

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

For the year ended December 31, 2019,

 

-The Company issued 143,985 common shares to a company controlled by a former director of the Company for settlement of $799,341 in accounts payable and application of $153,566 in subscription receivable.
-The Company issued 222,965 common shares with a value of $1,000,000 as transaction fees for the Draganfly Innovations amalgamation to related parties.
-The Company issued 8,517,671 common shares for the amalgamation with Draganfly Innovations.
-The Company issued 9,065 common shares for settlement of $22,662 in trades payables at a value of $2.50 per share.
-The Company issued 423,698 common shares for settlement of $740,000 in convertible debentures and interest. As a result of the settlement, the Company recognized loss on settlement of debt of $319,246 in the statement of loss and comprehensive loss.
-The Company issued 63,388 common shares for exercise of share purchase warrants of the Company for proceeds of $8,833. As a result of the exercise, $212,908 from reserve was reclassification to share capital.
-The Company issued 2,810,300 units in a private placement. Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

As at December 31, 2021, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date 

Exercise

Price

  

Remaining

Contractual

Life (years)

  

Number of

Options

Outstanding

  

Number of

Options

Exercisable

 
October 30, 2019  October 30, 2029  $2.50    7.84    296,665    296,665 
November 19, 2019  November 19, 2029  $2.50    7.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    8.33    87,000    78,666 
April 30, 2020  April 30, 2030  $3.85    8.33    110,000    70,000 
July 3, 2020  July 3, 2025  $3.20    3.51    200,000    166,666 
November 24, 2020  November 24, 2030  $2.50    8.90    32,000    21,000 
December 11, 2020  December 11, 2030  $2.15    8.95    12,500    12,500 
February 2, 2021  February 2, 2031  $13.20    9.09    30,000    10,000 
March 8, 2021  March 8, 2026  $13.90    4.19    10,000    5,000 
April 27, 2021  April 27, 2031  $10.15    9.23    182,000    - 
September 9, 2021  September 9, 2026  $4.84    4.69    25,826    - 
                1,035,991    710,497 

 

 

  

Number of

Options

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   744,993   $2.50 
Forfeited   (43,334)   2.50 
Granted   492,000    3.08 
Outstanding, December 31, 2020   1,193,659   $2.75 
Exercised   (405,494)   2.50 
Granted   247,826    10.12 
Outstanding, December 31, 2021   1,035,991   $4.60 

 

During the year ended December 31, 2021,

 

-The Company granted 30,000 options to an employee. Each option is exercisable at $13.20 per share for 10 years.
-The Company granted 10,000 options to a consultant. Each option is exercisable at $13.90 per share for 5 years.
-The Company granted 182,000 options to employees and a consultant. Each option is exercisable at $10.15 per share for 10 years.
-The Company granted 25,826 options to an employee. Each option is exercisable at $4.84 per share for 5 years.

 

F-31

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Stock Options (cont’d)

 

During the year ended December 31, 2020,

 

-The Company granted 89,000 options to employees. Each option is exercisable at $2.50 per share for a period of 10 years from the grant date.
  - The Company granted 120,000 options to consultants. Each option is exercisable at $3.85 per share for a period of 10 years from the grant date.
-The Company granted 200,000 options to employees. Each option is exercisable at $3.20 per share for a period of 5 years from the grant date.
-The Company granted 33,000 options to employees. Each option is exercisable at $2.50 per share for a period of 10 years from the grant date.
-The Company granted 50,000 options to a consultant. Each option is exercisable at $2.15 per share for a period of 10 years from the grant date.

 

During the year ended December 31, 2021, the Company recorded $1,660,894 (2020 - $1,724,853 and 2019 – $599,701) in stock-based compensation for stock options, based on the fair values of stock options granted which were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Year ended December 31,  2021   2020    2019  
Risk free interest rate   0.69%-1.40%    0.43%-0.66%    1.45%-1.46 %
Expected volatility   62.84%-113.16%    113.53%-119.03%    100 %
Expected life   5 years    5-10 years    7.5 years  
Expected dividend yield   0%   0%   0 %
Exercise price  $4.84-13.90   $2.15-3.85  $ 2.50

 

Volatility is calculated using the historical volatility method based on a comparative company’s stock price.

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at December 31, 2021, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2019   634,997 
Vested   (199,998)
Forfeited   (68,333)
Issued   248,000 
Outstanding, December 31, 2020   614,666 
Vested   (448,660)
Issued   348,826 
Outstanding, December 31, 2021   514,832 

 

F-32

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Restricted Share Units (cont’d)

 

During the year ended December 31, 2021, 323,661 RSUs fully vested according to the terms and the Company accelerated the vesting of 124,999 RSUs. The Company issued 348,826 RSUs to employees of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

 

During the year ended December 31, 2020, the Company committed to grant 248,000 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

 

During the year ended December 31, 2021, the Company recorded share-based payment expense of $2,291,701 (2020: $943,611, 2019: $161,858) in stock-based compensation for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

 

Warrant Derivative Liability

 

Balance at January 1, 2020  $- 
Warrant issuance   

281,732

 
Change in fair value of warrants outstanding   466,902 
Balance at December 31, 2020  $748,634 
Warrant issuance   

8,261,511

 
Exercised   

(98,048

)
Change in fair value of warrants outstanding   (4,046,325
Warrant Balance at December 31, 2021  4,865,772 
Derivative liability     
Warrants  $4,865,772 
Contingent consideration (note 4)   694,230
Contingent consideration at December 31, 2021  $5,560,002 

 

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price 

Number of

Warrants

Outstanding at

December 31,

2021

  

Fair Value at

December 31,

2021

  

Number of

Warrants

Outstanding at

December 31,

2020

  

Fair Value at

December 31,

2020

 
November 30, 2020  US$ 3.55   482,425   $182,262    511,299   $748,634 
February 5, 2021  US$ 3.55   1,323,275    951,226    -    - 
March 5, 2021  US$ 3.55   5,154,321    3,731,285    -    - 
July 29, 2021  US$ 5.00   250,000    84,625    -    - 
September 14, 2021  US$ 5.00   4,798    1,685    -    - 
       7,214,819   $4,865,772    511,299   $748,634 

 

F-33

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Warrants (cont’d)

 

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Year ended December 31,  2021   2020 
Risk free interest rate   0.23%-0.95%    0.20%-0.24% 
Expected volatility   70.95%-144.59%    72.76%-74.10% 
Expected life   2-3 years    2 years 
Expected dividend yield   0%   0%

 

Volatility is calculated using the historical volatility method.

 

During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021.

 

  

Number of

Warrants

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   3,610,340   $2.05 
Exercised   (1,584,775)   1.50 
Forfeited   (120,000)   2.50 
Issued   511,299    3.55 
Outstanding, December 31, 2020   2,416,864   $2.95 
Exercised   (1,939,534)   2.54 
Forfeited   (6,000)   2.50 
Issued   7,943,489    5.10 
Outstanding, December 31, 2021   8,414,819   $4.99 

 

As at December 31, 2021, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price 

Number of warrants

outstanding

 
November 30, 2020  November 30, 2022  US$ 3.55   482,425 
February 5, 2021  February 5, 2023  US$ 3.55   1,323,275 
March 5, 2021  March 5, 2023  US$ 3.55   5,154,321 
March 22, 2021  March 22, 2023  CDN$13.35   1,200,000 
July 29, 2021  July 29, 2024  US$ 5.00   250,000 
September 14, 2021  September 14, 2024  US$ 5.00   4,798 
          8,414,819 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2021, was 1.20 years (December 31, 2020 – 1.07 years).

 

Of 1,200,000 warrants issued on March 22, 2021 to acquire Vital, 900,000 of the warrants are currently held in escrow, to be released upon completion of the milestones (note 4).

 

F-34

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

21. REVENUE

 

The Company sub-classifies revenue within the following components: product revenue and services revenue. Product revenue comprises of sales of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Services revenue consists of fees charged for custom engineering, drone as a service work, and training and simulation consulting.

 

             
   For the years ended December 31, 
   2021   2020   2019 
Product sales  $5,103,399   $3,087,223   $248,939 
Drone service   1,304,799    630,532    - 
Services   645,667    645,756    1,131,488 
Revenue   $7,053,865   $4,363,511   $1,380,427 

 

The Company does not derive significant revenue from any (2020 – 1) customers that exceeds 10% of total revenues for the year ended December 31, 2021 (2020 – $474,701 of custom engineering services revenue).

 

Consulting revenue:

 

On May 22, 2017, the Company executed a standard consulting agreement, whereby the Company would provide consulting, custom engineering and investigating and solving on a project-by-project basis. The Company shall be responsible for the development, design, procurement, fabrication, assembly, integration, checkout, integration and test of hardware, software, and firmware necessary to produce a complete system per each project. The consideration for the services performed are based on the labor cost incurred on an hourly basis and minimal preapproved expenditures.

 

Geographic revenue segmentation is as follows:

 

             
   For the years ended December 31, 
   2021   2020   2019 
Canada  $4,937,935   $2,270,862   $127,118 
United States   2,071,492    1,982,404    1,251,199 
International   44,438    110,245    2,110 
Revenue   $7,053,865   $4,363,511   $1,380,427 

 

F-35

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

21. REVENUE (CONT’D)

 

Non current assets for each geographic segment are as follows:

 

 

   Canada   United States   International 
   For the years ended December 31, 
   Canada   United States   International 
Goodwill  $2,166,564   $3,773,845   $- 
Property and equipment   297,043    -    - 
Intangible assets   219,093    374,808    - 
Investments   291,066    -    - 
Notes receivable   -    964,006    - 
Right of use assets   468,106    -    - 
TOTAL ASSETS  $3,441,872   $5,112,659   $- 

 

F-36

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

22. OFFICE AND MISCELLANEOUS

   2021   2020   2019 
   For the years ended December 31, 
   2021   2020   2019 
Advertising, Marketing, and Investor Relations  $5,165,791   $2,610,930   $1,356,174 
Compliance fees   432,874    122,916    80,525 
Contract Work   300,975    399,546    438,601 
Other   556,358    254,473    228,432 
Office and Miscellaneous Expenses   $6,455,998   $3,387,865   $2,103,732 

 

F-37

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

23. RELATED PARTY TRANSACTIONS

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers.

 

Trade payables and accrued liabilities:

 

On Aug 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the company incurred fees of $315,643 compared to $177,000 in 2020, and $80,000 in 2019.

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $290,225 compared to $525,164 in 2020, and $9,000 in 2019. As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $321,741, December 31, 2019 $9,450).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $205,191 (December 31, 2020 – 227,524). As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $153,887).

 

As at December 31, 2021, the Company had $nil (December 31, 2020 - $475,628, December 31, 2019 $9,681) payable to related parties outstanding that were included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

F-38

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

23. RELATED PARTY TRANSACTIONS (CONT’D)

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:

 

For the years ended December 31,  2021   2020   2019 
Director fees  $370,094   $-   $- 
Management fees paid to a company controlled by CEO and director   290,225    737,164    186,000 
Management fees paid to a company controlled by the President and director   205,691    227,524    - 
Management fees paid to a company controlled by a former director   500,074    165,000    195,000 
Salaries   722,068    655,799    179,429 
Salaries paid to the former owner of the Company   -    86,097    149,060 
Share-based payments   2,475,949    1,614,158    480,158 
Total  $4,564,102   $3,485,742    1,189,647 

 

24. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does not have any past due outstanding receivables and the expected loss rate for undue balance is estimated to be nominal.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

F-39

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

24. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net income upon consolidation as follows:

 

   December 31, 2021   December 31, 2020 
Foreign exchange rate  $150,715   $27,018 

 

Interest rate risk

 

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2021  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $164,286   $126,780   $-   $291,066 
Notes receivable   -    1,154,176    -    1,154,176 
Derivative liability   -     -    5,560,002    5,560,002 
Total  $164,286   $1,280,956   $5,560,002   $7,005,244 

 

December 31, 2021  Level 1   Level 2   Level 3   Total 
Derivative liability   -    -    748,634    748,634 
Total  $-   $-   $748,634   $748,634 

 

Capital Management

 

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of cash, debt, and equity comprised of issued share capital, and share-based payment reserve.

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2020.

 

The breakdown of the Company’s capital is as follows:

 

   December 31, 2021   December 31, 2020 
Cash  $23,075,713   $1,982,416 
Debt   93,317    97,916 
Equity  $34,926,239   $3,848,205 

 

25. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2021, 2020 and 2019:

 

   December 31, 2021   December 31, 2020      December 31, 2019  
Loss before income taxes  $16,202,972   $8,015,813    $ 11,095,507  
Canadian statutory rates        27%     27 %
Expected income tax recovery   4,196,600    2,164,000      2,996,000  
Impact of different foreign statutory tax rates   34,900    -      -  
Non-deductible items   116,400    (687,000)     (2,043,000 )
Share issue costs   887,600    -      -  
Adjustments to prior years provision versus statutory tax returns   376,500    189,000      (388,000 )
Differences between prior year provision and final tax return   (206,000)    (535,000)     (18,000 )
Change in deferred tax asset not recognized   (5,406,000)   (1,131,000)     (547,000 )
Income tax  $-   $-    $ -  

 

F-40

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

25. INCOME TAXES (CONT’D)

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

  December 31, 2021   December 31, 2020      December 31, 2019  
Deferred income tax assets (liabilities):                  
Share issuance costs  $728,000   $30,000    $ -  
Non-capital losses   7,043,000    3,656,000      2,439,000  
Property and equipment   449,000    457,000      581,000  
Capital gain reserve   74,000    -      -  
Scientific Research and Experimental Development   291,000    57,000     

49,000

 
Total deferred income tax assets  $8,585,000   $4,200,000    $ 3,069,000  
Deferred income tax not recognized   (8,585,000)   (4,200,000)     (3,069,000 )
Net deferred tax assets  $-   $-    $ -  

 

The Company has non-capital loss carry forward of approximately $25,487,000 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2040.

 

26. OTHER INCOME

 

The Company had previously written off an investment in a UK-based company. On April 27, 2020, this company was sold and the Company received $1,179,513 (US$854,838).

 

27. SUPPLEMENTAL CASH FLOW DISCLOSURES

 

During the year ended December 31, 2021:

 

-The Company issued 15,000 common shares in lieu of cash.
-The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
-The Company issued 356,901 common shares in lieu of cash.
- The Company recorded a change in fair value of investments of $332,640 to other comprehensive loss.

 

During the year ended December 31, 2020, the Company settled debt of $344,354 with the issuance of 111,082 common shares and recognized a gain on settlement of debt of $28,614.

 

During the year ended December 31, 2019:

 

-Settlement of $822,003 in accounts payable and application of $153,566 in subscription receivable through issuance of shares;
-Issuance of 400,000 common shares at $2.50 per shares as finders’ fees, and;
-Settlement of $740,000 of convertible debentures.

 

F-41

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

28. GOVERNMENT ASSISTANCE

 

In response to COVID-19, the Government of Canada announced the Canada Emergency Wage Subsidy (“CEWS”) program in April 2020. CEWS provides a wage subsidy on eligible remuneration, subject to a maximum per employee, to eligible employers based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. Included in the statement of comprehensive loss for the year ended December 31, 2021 is - $250,756 (2020 - $490,748) relating to the CEWS program of which was recorded as a reduction of wages and salaries included in operating expenses.

 

In September 2020, the Government of Canada announced the Canada Emergency Rent Subsidy (“CERS”) to provide a rent subsidy to eligible businesses based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy as well. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $22,668 (2020 - $nil) relating to the CERS program of which was recorded as a reduction of rent included in operating expenses. As at December 31, 2021, the Company had - $nil (2020 - $nil) included in amounts receivables for CERS subsidies receivable.

 

In October 2021 the Government of Canada announced the Hardest Hit Business Recovery Program (“HHBRP”) to provide continued wage and rent subsidies to business’ severely affected by COVID-19, based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government grant as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $50,756 in wage subsidies and $3,791 in rent subsidies (2020 - $nil, and - $nil respectively) relating to the HHBRP program of which were recorded as a reduction wages and salaries and rent expense respectively. As at December 31, 2021, the Company had - $54,548 (2020 - $nil) included in amounts receivables for HHBRP subsidies receivable.

 

F-42

EX-1.1 2 ex1-1.htm

 

Exhibit 1.1

 

Number: BC1166724

    BRITISH

 COLUMBIA

 

 

CERTIFICATE
OF

INCORPORATION

 

BUSINESS CORPORATIONS ACT

 

I Hereby Certify that DRONE ACQUISITION CORP. was incorporated under the Business Corporations Act on June 1, 2018 at 03:50 PM Pacific Time.

 

Issued under my hand at Victoria, British Columbia

On June 1, 2018

 

 

CAROL PREST

Registrar of Companies

Province of British Columbia
Canada

      ELECTRONIC CERTIFICATE  

 

 

 

 

EX-1.3 3 ex1-3.htm

 

Exhibit 1.3

 

Number: BC1166724

    BRITISH

 COLUMBIA

 

 

CERTIFICATE
OF

CHANGE OF NAME

 

BUSINESS CORPORATIONS ACT

 

I Hereby Certify that DRONE ACQUISITION CORP. changed its name to DRAGANFLY INC. on August 15, 2019 at 12:01 AM Pacific Time.

 

Issued under my hand at Victoria, British Columbia

On August 15, 2019

 

 

CAROL PREST

Registrar of Companies

Province of British Columbia
Canada

      ELECTRONIC CERTIFICATE  

 

 

 

 

EX-2.1 4 ex2-1.htm

 

Exhibit 2.1

 

THE options AND THE optioned shares HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR ANY U.S. STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS SUCH SECURITIES ARE REGISTERED UNDER THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS ARE AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE 1933 ACT.

 

Option Agreement

 

Notice is hereby given that, effective this [●] day of [●] (the “Effective Date”) Draganfly Inc. (the “Corporation”) has granted to [●] (the “Participant”), Options to acquire [●] Common Shares (the “Optioned Shares”) up to 4:30 p.m. Pacific Time on the [●] day of [●] (the “Option Expiry Date”) at an exercise price of Cdn$[●] per Optioned Share pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which is attached hereto.

 

Optioned Shares may be acquired as follows:

 

(a)[●]; and

 

(b)[●].

 

The grant of the Options evidenced hereby and the Option Expiry Date thereof, is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Options, the exercise of the Options and the disposition of Optioned Shares. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

The Participant represents and warrants that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Options, and (ii) either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Options or any Optioned Shares for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Participant understands that the Options may not be exercised in the United States or by or on behalf of a U.S. Person unless the Options and the Option Shares have been registered under the 1933 Act or are exempt from registration thereunder. The Corporation may condition the exercise of the Options upon receiving from the Participant such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

 

In the event of any inconsistency between the terms of this Option Agreement and the Plan, the terms of the Plan shall prevail.

 

 
- 2 -

 

Draganfly Inc.    
     
     
Authorized Signatory   Signature of Participant
     
     
    Name of Participant

 

 

 

EX-2.2 5 ex2-2.htm

 

Exhibit 2.2

 

RESTRICTED SHARE UNIT AGREEMENT

 

Notice is hereby given that, effective this [●] day of [●] (the “Restricted Share Grant Date”) Draganfly Inc. (the “Corporation”) has granted to [●] (the “Participant”), [●] Restricted Share Units pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which has been provided to the Participant.

 

Restricted Share Units are subject to the following terms:

 

  (a) Pursuant to the Plan and as compensation to the Participant, the Corporation hereby grants to the Participant, as of the Restricted Share Grant Date, the number of Restricted Share Units set forth above.
     
  (b) The granting and vesting of the Restricted Share Units and the payment by the Corporation of any payout in respect of any Vested Restricted Share Units (as defined below) are subject to the terms and conditions of the Plan, all of which are incorporated into and form an integral part of this Restricted Share Unit Agreement.
     
  (c) The Restricted Share Units shall become vested restricted share units (the “Vested Restricted Share Units”) in accordance with the following schedule:
     
    (i) [●] on [●]; and
       
    (ii) [●] on [●] (each a “Vesting Date”).
       
  (d) As soon as reasonably practicable and no later than 60 days following the Vesting Date, or, if the Participant is not a U.S. Participant (as defined in the Plan), such later date mutually agreed to by the Corporation and the Participant, the Participant shall be entitled to receive, and the Corporation shall issue or provide, a payout with respect to those Vested Restricted Share Units in the Participant’s Account to which the Vesting Date relates (each a “Payout Date”):
     
    (i) a lump sum payment in cash equal to the number of vested Restricted Share Units recorded in the Participant’s Account multiplied by the Market Value of a Common Share on the Payout Date;
       
    (ii) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s Restricted Share Units in the Participant’s Account, duly issued as fully paid and non-assessable shares and such Participant shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares; or
     
    (iii) any combination of the foregoing,
       
    subject to any applicable Withholding Obligations.
     
  (e) The Participant acknowledges that:
       
    (i) he or she has received and reviewed a copy of the Plan; and
       
    (ii) the Restricted Share Units have been granted to the Participant under the Plan and are subject to all of the terms and conditions of the Plan to the same effect as if all of such terms and conditions were set forth in this Restricted Share Unit Agreement, including with respect to termination and forfeiture as set out in Section 4.7 of the Plan.

 

 
- 2 -

 

Notwithstanding anything to the contrary in this Restricted Share Unit Agreement all vesting and issuances or payments, as applicable, in respect of a Restricted Share Unit evidenced hereby shall be completed no later than December 15 of the third calendar year commencing after the Restricted Share Grant Date;

 

The grant of the Restricted Share Units evidenced hereby is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Restricted Share Units and the vesting of the Restricted Share Units. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

The Participant represents and warrants to the Corporation that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Restricted Share Units, and (ii) either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Restricted Share Units for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Corporation may condition awards and elections under the Plan upon receiving from the undersigned such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable U.S. state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

 

 
- 3 -

 

In the event of any inconsistency between the terms of this Restricted Share Unit Agreement and the Plan, the terms of the Plan shall prevail unless otherwise determined in the Plan.

 

Draganfly Inc.  
   
   

Authorized Signatory

 

 

 

 

EX-2.3 6 ex2-3.htm

 

Exhibit 2.3

 

THE WARRANTS REPRESENTED HEREBY AND THE UNDERLYING SECURITIES ISSUABLE ‎UPON EXERCISE HEREUNDER HAVE BEEN QUALIFIED BY THE U.S. SECURITIES AND ‎EXCHANGE COMMISSION PURSUANT TO A REGULATION A. TIER 2, OFFERING STATEMENT IN ‎AN EXEMPT OFFERING UNDER THE SECURITIES ACT OF 1933, AS AMENDED. RESALES OF ‎THE SECURITIES HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER ANY STATE ‎SECURITIES LEGISLATION AND THEREFORE RESALES OF THE WARRANTS MAY, IN SOME ‎STATES BE LIMITED BY STATE SECURITIES LEGISLATION UNLESS AN EXEMPTION FROM ‎REGISTRATION OR QUALIFICATION IS AVAILABLE UNDER THAT STATES’ SECURITIES LAWS.‎

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT ‎TRADE THE SECURITY BEFORE THE DATE THAT IS 9 MONTHS AFTER

 

THE WARRANTS REPRESENTED HEREBY WILL BE VOID AND OF NO VALUE AFTER 5:00 PM ‎‎(VANCOUVER TIME) ON THE DATE THAT IS THE TWENTY-FOUR (24) MONTH ANNIVERSARY OF ‎ISSUANCE OF A RESPECTIVE PURCHASER’S UNITS IN THE OFFERING (THE “CLOSING ‎DATE”).‎

 

WARRANT CERTIFICATE

 

DRAGANFLY INC.‎

‎(a British Columbia Company)‎

 

Certificate Number: [●] ‎[●] Warrants to Purchase
  ‎[●] Shares

COMMON SHARE PURCHASE WARRANTS

 

THIS IS TO CERTIFY THAT, for value received, [●] of or his lawful assignee (the “Holder”) is the ‎registered holder of warrants (the “Warrants”) of Draganfly Inc. (the “Company”). Each Warrant shall entitle the ‎Holder to subscribe for and purchase one fully paid and non-assessable common shares without par value ‎‎(collectively the “Shares” and individually, a “Share”) in the authorized capital of the Company at any time on or ‎before 5:00 p.m. Vancouver time on the date that is the twenty-four (24) month anniversary of issuance of a ‎respective purchaser’s Units in the Offering, (the “Expiry Date”), at a price of US$0.71 per Share, subject, however, ‎to the provisions and upon the Terms and Conditions attached hereto as Schedule “A.” The Warrants are ‎exercisable immediately and terminating on the date that is the twenty-four (24) month anniversary of issuance of ‎a respective purchaser’s Units (defined below) in the offering of the securities described in the Offering Circular that ‎is available through the online website platform located at www.draganfly.com, which is owned and operated by ‎the Company, as well as on the SEC EDGAR website and the SEDAR website. Each “Unit” of securities is comprised ‎of one Share, and one Warrant to purchase one additional Share.‎

 

The rights represented by this Warrant Certificate may be exercised by the Holder, in whole or in part (but not as ‎to a fraction of a Share) by surrender of this Warrant Certificate (properly endorsed as required), together with a ‎Warrant Exercise Form in the form attached hereto as Appendix “B”, duly completed and executed, to the ‎Company at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 (Attention: Chief Financial Officer), or such other address as the Company may from time to time in writing direct, together with a certified cheque or ‎bank draft payable to or to the order of the Company in payment of the purchase price of the number of Shares ‎subscribed for. The Holder is advised to read “Instruction to Holders” attached hereto as Appendix “A” for details ‎on how to complete the Warrant Exercise Form (as such term is defined in Schedule “A”).‎

 

IN WITNESS WHEREOF the Company has caused this Warrant Certificate to be executed by its duly authorized ‎officer, this

 

DRAGANFLY INC.

 

Per:‎

 

Authorized Signatory

 

 
 

 

SCHEDULE “A”‎

 

TERMS AND CONDITIONS

ATTACHED TO COMMON SHARE PURCHASE WARRANTS

ISSUED BY DRAGANFLY INC.

‎(the “Company”)

 

Each Warrant of the Company, whether single or part of a series, is subject to these Terms and Conditions as they ‎were at the date of issue of the Warrant.‎

 

 

PART 1.
DEFINITIONS AND INTERPRETATION

 

Definitions

 

1.1‎In these Terms and Conditions, except as otherwise expressly provided herein, the following words and phrases ‎will have the following meanings:‎

 

(a)‎“Company” means Draganfly Inc. and includes any successor corporations;‎

 

(b)‎“Company’s auditor” means the accountant duly appointed as auditor of the Company;‎

 

(c)‎“Exchange” has the meaning ascribed thereto in §3.3;‎

 

(d)‎“Exercise Price” means US$0.71 per Share or as may be adjusted as per Part 5;‎

 

(e)‎“Expiry Date” means the date defined as such on the face page of the Warrant Certificate;‎

 

(f)‎“Expiry Time” means 5:00 p.m. Vancouver time on the Expiry Date;‎

 

(g)‎“Holder” means the registered holder of a Warrant;‎

 

(h)‎“Joint Actors” has the meaning ascribed thereto in §7.1;‎

 

(i)‎“person” means an individual, corporation, partnership, trustee or any unincorporated organization, and ‎words importing persons have a similar meaning;‎

 

(j)‎“Shares” or “shares” means the common shares in the capital of the Company as constituted at the date of ‎issue of a Warrant and any shares resulting from any event referred to in §4.7;‎

 

(k)‎“U.S. Securities Act” has the meaning ascribed thereto in §2.6;‎

 

(l)‎“Warrant” means a warrant as evidenced by the certificate, one Warrant entitles the holder to purchase one ‎‎(1) Share of the Company (subject to adjustment) on or before the Expiry Date at the Exercise Price set ‎forth on the Warrant Certificate;‎

 

(m)‎“Warrant Certificate” means the certificate evidencing the Warrant;‎

 

(n)‎“Warrant Exercise Form” means Appendix “B” hereof; and‎

 

(o)Warrant Transfer Form” means Appendix “C” hereof.‎

 

 
- 2 -

 

General

 

1.2‎In these Terms and Conditions, except as otherwise expressly provided herein:‎

 

(a)the words “herein”, “hereof”, and “hereunder” and other words of similar import refer to this Agreement ‎as a whole and not to any particular Part, clause, subclause or other subdivision;‎

 

(b)a reference to a Part means a Part of these Terms and Conditions and the symbol § followed by a number ‎or some combination of numbers and letters refers to the section, paragraph or subparagraph of these ‎Terms and Conditions so designated;‎

 

(c)the headings are for convenience only, do not form a part of these Terms and Conditions and are not ‎intended to interpret, define or limit the scope, extent or intent of these Terms and Conditions or any of its ‎provisions;‎

 

(d)all dollar amounts referred to herein are expressed in United States funds;‎

 

(e)time will be of the essence hereof; and

 

(f)words importing the singular number include the plural and vice versa, and words importing the masculine ‎gender include feminine and neuter genders.‎

 

(g)this Warrant Certificate shall enure to the benefit of and be binding upon the parties hereto and their ‎respective successors and assigns.‎

 

Applicable Law

 

1.3‎This Warrant shall be governed by and construed in accordance with the laws of the Province of British ‎Columbia and the federal laws of Canada applicable therein, without reference to its principles governing the choice ‎or conflict of laws.‎

 

PART 2.
ISSUE OF WARRANTS

 

Additional Warrants

 

2.1‎The Company may at any time and from time to time issue Warrants or grant options or similar rights to ‎purchase shares of in its capital.‎

 

Issue in Substitution for Lost Warrants

 

2.2‎In case a Warrant Certificate will become mutilated, lost, destroyed or stolen, the Company in its discretion may ‎issue and deliver a new Warrant Certificate of like date and tenor as the one mutilated, lost, destroyed or stolen in ‎exchange for, and in place of, and upon cancellation of such mutilated Warrant Certificate, or in lieu of and in ‎substitution for such lost, destroyed or stolen Warrant Certificate, and the Warrants represented by such substituted ‎Warrant Certificate will be entitled to the benefit hereof and rank equally in accordance with its terms with all other Warrants of the same issue. The Company may charge a reasonable fee for the issuance and delivery of a new ‎Warrant Certificate.‎

 

2.3‎The applicant for the issue of a new Warrant Certificate pursuant hereto will bear the cost of the issue thereof ‎and in the case of loss, destruction or theft furnish to the Company such evidence of ownership, and of loss, ‎destruction or theft of the Warrant Certificate so lost, destroyed or stolen as will be satisfactory to the Company in ‎its discretion; and such applicant may also be required to furnish indemnity in amount and form satisfactory to the ‎Company in its discretion and will pay the reasonable charges of the Company in connection therewith.‎

 

 
- 3 -

 

Holder not a Shareholder

 

2.4‎The holding of a Warrant will not constitute the Holder a shareholder of the Company, nor entitle the Holder to ‎any right or interest in respect thereof, except as expressly provided in the Warrant Certificate.‎

 

Canadian Securities Law Exemption

 

2.5‎The Holder acknowledges and agrees that the Warrants and any Shares issued pursuant to the exercise of any ‎Warrants have been or will be issued pursuant to an exemption from the registration and prospectus requirements of ‎applicable Canadian securities law and that the Company has no obligation to, and does not intend to, file any ‎prospectus or registration statement in any jurisdiction in order to qualify any of such Warrants and/or Shares for ‎resale.‎

 

U.S. Securities Law Matters

 

2.6‎Neither the Warrants nor the Shares issuable upon exercise hereof have been or will be registered under the ‎United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or U.S. state securities laws. The ‎Warrants and the Shares issuable upon exercise hereof have been qualified in an exempt Regulation A. Tier 2 ‎offering pursuant to Section 3(b) of the U.S. Securities Act. The Warrants and Shares issuable hereunder are not ‎‎“restricted securities” as defined in Rule 144 of the U.S. Securities Act. Notwithstanding the foregoing the Warrants ‎and the Shares issuable thereunder may not be transferred or resold in the United States without an exemption under ‎applicable state securities legislation and regulations thereunder.‎

 

PART 3.
OWNERSHIP AND TRANSFER OF WARRANT

 

Exchange of Warrants

 

3.1‎A Warrant Certificate in any authorized denomination, upon compliance with the reasonable requirements of ‎the Company, may be exchanged for a Warrant Certificate(s) in any other authorized denomination of the same ‎issue entitling the Holder to purchase an equal aggregate number of Shares at the same Exercise Price and on the ‎same terms as the Warrant Certificate so exchanged.‎

 

3.2‎Warrants may be exchanged only with the Company. Any Warrants tendered for exchange will be surrendered ‎to the Company and cancelled.‎

 

3.3‎Subject to applicable securities legislation and the rules, policies, notices and orders issued by applicable ‎securities regulatory authorities, including the Canadian Securities Exchange, or such other stock exchange as the ‎Shares may then be listed and posted for trading on (the “Exchange”), the Warrants are transferable on the terms ‎and conditions contained herein and by the Holder completing and submitting to the Company a completed and ‎duly executed Warrant Transfer Form and provision of such additional documents as may be reasonably requested by the Company. ‎Subject to the foregoing, the Company shall issue and mail as soon as practicable, and in any event within 5 ‎business days of receipt of this Warrant certificate, together with a duly completed and executed Warrant Transfer ‎Form attached hereto, a new Warrant certificate (with or without legends as may be appropriate) registered in the ‎name of the transferee or as the transferee may direct and shall take all other necessary actions to effect the ‎transfer as directed.‎

 

 
- 4 -

 

Charges for Exchange

 

3.4‎On exchange of Warrants, the Company, except as otherwise herein provided, may charge a reasonable fee for ‎each new Warrant Certificate issued, and payment of any transfer taxes or governmental or other charges required ‎to be paid will be made by the party requesting such exchange.‎

 

Ownership of Warrants

 

3.5‎The Company may deem and treat the Holder of a Warrant as the absolute owner of such Warrant for all ‎purposes and will not be affected by any notice or knowledge to the contrary.‎

 

Notice to Holder

 

3.6‎Unless herein otherwise expressly provided, any notice to be given hereunder to a Holder will be deemed to be ‎validly given, if mailed to the address of the Holder as set out on the Warrant Certificate. Any notice so given will be ‎deemed to have been received 5 days from the date of mailing to the Holder or any market intermediary then ‎holding the Warrants of the Holder in any trust account.‎

 

PART 4.
EXERCISE OF WARRANTS

 

Method of Exercise of Warrants

 

4.1‎The right to purchase Shares conferred by a Warrant may be exercised by the Holder surrendering the Warrant ‎Certificate, together with a duly completed and executed Warrant Exercise Form and a certified cheque or bank ‎draft payable to, or to the order of Company at the address as set out on the Warrant Certificate, for the purchase ‎price applicable at the time of surrender in respect of the shares subscribed for in lawful money of the United States ‎to the Company at the address as set out on the Warrant Exercise Form.‎

 

Effect of Exercise of Warrants

 

4.2‎Upon surrender and payment as aforesaid, the shares so subscribed for will be deemed to have been issued, and ‎the Holder will be deemed to have become the holder of such shares on the date of such surrender and payment, ‎and such shares will be issued at the Exercise Price as may be adjusted in the events and in the manner described ‎herein.‎

 

4.3‎Within 10 business days after surrender and payment as aforesaid, the Company will forthwith cause to be ‎delivered to the person in whose name the shares are directed to be registered as specified in such Warrant Exercise ‎Form, or if no such direction is given, the Holder, a certificate for the appropriate number of shares not exceeding ‎those which the Holder is entitled to purchase pursuant to the Warrant Certificate surrendered.‎

 

Subscription for Less than Entitlement

 

4.4‎A Holder may purchase a number of Shares less than the number which the Holder is entitled to purchase ‎pursuant to the surrendered Warrant Certificate. In the event of any purchase of a number of Shares less than the ‎number which can be purchased pursuant to a Warrant Certificate, the Holder, upon exercise thereof, will, in ‎addition to certificates representing Shares issued on such exercise, and be entitled to receive a new Warrant ‎Certificate in respect of the balance of the Shares which the Holder was entitled to purchase pursuant to the ‎surrendered Warrant Certificate but which were not then purchased.‎

 

 
- 5 -

 

4.5‎The Company shall not be required to issue fractional Shares upon the exercise of the Warrants evidenced ‎hereby and the Holder shall not be entitled to any cash payment or compensation in lieu of a fractional Share.‎

 

Expiration of Warrants

 

4.6‎After the Expiry Date, all rights under the Warrants will wholly cease and terminate, and the Warrants will ‎thereupon be void and of no effect.‎

 

Exercise Price

 

4.7‎The price per share which must be paid to exercise a Warrant is the Exercise Price, as may be adjusted in the ‎events and in the manner described herein.‎

 

Legends on Shares

 

4.8‎In addition to the other legends that may be required by applicable law, the certificates representing ‎Shares issued upon exercise of Warrants will bear the following legend:‎

“UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE         ‎, 202__ [INSERT DATE THAT IS 4 MONTHS AND A DAY AFTER THE DISTRIBUTION DATE];‎

 

provided that at any time subsequent to [INSERT DATE THAT IS FOUR MONTHS AND A DAY AFTER THE ‎DISTRIBUTION DATE], any certificate representing such Shares may be exchanged for a certificate bearing no ‎such legends.‎

U.S. Legends: The certificates representing Shares underlying the Warrants shall bear such legend, if any, as may ‎be required under applicable U.S. state securities laws until such time as is no longer required under the applicable ‎requirements of such state securities laws, with such determination based upon the opinion of United States counsel ‎acceptable to the Company.‎

 

PART 5.
ADJUSTMENTS

 

Adjustments

 

5.1‎If and whenever the Shares will be subdivided into a greater or consolidated into a lesser number of shares, or in ‎the event of any payment by the Company of a stock dividend (other than a dividend paid in the ordinary course), ‎or in the event that the Company conducts a rights offering to its shareholders, the exercise price will be decreased or ‎increased proportionately as the case may be. Upon any such subdivision, consolidation, payment of a stock ‎dividend or rights offering, subject to the consent of the Exchange (if required), the number of shares deliverable ‎upon the exercise of a Warrant and the exercise price of the Warrant will be increased or decreased proportionately as the ‎case may be.‎

 

5.2‎In case of any reclassification of the capital of the Company, or in the case of the merger, reorganization or ‎amalgamation of the Company with, or into any other company or of the sale of substantially all of the property ‎and assets of the Company to any other company, each Warrant will, after such reclassification of capital, merger, ‎amalgamation or sale, confer the right to purchase that number of shares or other securities or property of the ‎Company or of the company resulting from such reclassification, merger, amalgamation, or to which such sale will ‎be made, as the case may be, which the Holder would then hold if the Holder had exercised the Holder’s rights under ‎the Warrant before reclassification of capital, merger, amalgamation or sale; and in any such case, if necessary, ‎appropriate adjustments will be made in the application of the provisions set forth in this Part 5 with respect to the ‎rights and interest thereafter of the Holders to the end that the provisions set forth in this Part 5 will thereafter ‎correspondingly be made applicable as nearly as may reasonably be in relation to any Shares or other securities or ‎property thereafter deliverable on the exercise of a Warrant, subject to any approvals required by the Exchange.‎

 

 
- 6 -

 

5.3‎The adjustments provided for in this Part 5 are ‎cumulative. Determination of Adjustments

 

5.4‎If any question will at any time arise with respect to any adjustments to be made under §5.1 and §5.2, such ‎question will be conclusively determined by the Company’s auditor, or, if the Company’s auditor declines to so act, ‎any other chartered accountant in the Province of British Columbia that the Company may designate (acting ‎reasonably) and who will have access to all appropriate records, and such determination will be binding upon the ‎Company and the Holder.‎

 

Hold Period

 

5.5‎The Shares received by the Holder upon the exercise of the Warrants is subject to a hold period as determined by ‎the Securities Act (British Columbia). There may be further restrictions on resale in accordance with the ‎requirements of any exchange, including the Canadian Securities Exchange, and/or other applicable securities laws.‎

 

PART 6.
COVENANTS BY THE COMPANY

 

Reservation of Shares

 

6.1‎The Company will reserve, and there will remain unissued out of its authorized capital, a sufficient number of ‎shares to satisfy the rights of purchase provided for in all Warrants from time to time outstanding.‎

 

Securities Qualification Requirements

 

6.2‎If, in the opinion of counsel for the Company, any filing is required to be filed with or any permission is required ‎to be obtained from any securities regulatory body or any other step is required under any Federal or Provincial law ‎before any shares which the Holder is entitled to purchase pursuant to the Holder’s Warrant may properly and ‎legally be issued upon exercise thereof, the Company covenants that it will take such action.‎

 

PART 7.
RESTRICTION ON EXERCISE

 

Blocking Language

 

7.1‎Notwithstanding anything contained herein to the contrary, the rights represented by this Warrant Certificate will ‎not be exercisable by the Holder, in whole or in part, and the Company will not give effect to any such exercise, if, ‎after giving effect to such exercise, the Holder, together with any person or company acting jointly or in concert with ‎the Holder (the “Joint Actors”) would in the aggregate beneficially own, or exercise control or direction over that ‎number of voting securities of the Company which is twenty percent (20%) or greater of the total issued and ‎outstanding voting securities of the Company, immediately after giving effect to such exercise. For greater certainty, ‎the rights represented by this Warrant Certificate will not be exercisable by the Holder, in whole or in part, and the ‎Company will not give effect to any such exercise, if, after giving effect to such exercise, the Holder, together with its ‎Joint Actors, would be deemed to hold a number of voting securities sufficient to materially affect the control of the ‎Company.‎

 

 
- 7 -

 

7.2‎Notwithstanding any provision to the contrary contained herein, no Shares will be issued pursuant to the exercise ‎of any Warrant if the issuance of such securities would constitute a violation of the securities laws of any applicable ‎jurisdiction, and the certificates evidencing the Shares thereby issued may bear such legend as may, in the opinion of ‎legal counsel to the Company, be necessary in order to avoid a violation of any securities laws of any applicable ‎jurisdiction or to comply with the requirements of any stock exchange on which the Shares of the Company are ‎listed, provided that, at any time, in the opinion of legal counsel to the Company, such legends are no longer ‎necessary in order to avoid a violation of any such laws, or the holder of any such legended certificate, at that ‎holder’s expense, provides the Company with evidence satisfactory in form and substance to the Company (which ‎may include an opinion of legal counsel satisfactory to the Company) to the effect that such holder is entitled to sell ‎or otherwise transfer such Shares in a transaction in which such legends are not required, such legended certificate ‎may thereafter be surrendered to the Company in exchange for a certificate which does not bear such legend.‎

 

PART 8.
MODIFICATION OF TERMS, SUCCESSORS

 

Modification of Terms and Conditions for Certain Purposes

 

8.1‎From time to time the Company may, subject to the provisions of the Warrant Certificate and approval of the ‎Exchange, when so directed by the Holders, modify the terms and conditions hereof, for any one or more or all of ‎the following purposes:‎

 

(a)adding to the provisions hereof such additional covenants and enforcement provisions as, in the opinion of ‎counsel for the Company, are necessary or advisable in the circumstances;‎

 

(b)making such provisions not inconsistent herewith as may be necessary or desirable with respect to matters ‎or questions arising hereunder or for the purpose of obtaining a listing or quotation of Warrants on any ‎stock exchange or house;‎

 

(c)adding to or altering the provisions hereof in respect of the registration of Warrants making provision for the ‎exchange of Warrant Certificates of different denominations; and making any modification in the form of ‎Warrant Certificates which does not affect the substance thereof;‎

 

(d)for any other purpose not inconsistent with the terms hereof, including the correction or rectification of any ‎ambiguities, defective provisions, errors or omissions herein; and

 

(e)to evidence any succession of any corporation and the assumption by any successor of the covenants of ‎the Company herein and in the Warrants contained as provided hereafter in this Part 8.‎

 

Company may Amalgamate on Certain Terms

 

8.2‎Nothing herein contained will prevent any amalgamation or merger of the Company with or into any other ‎company, or the sale of the property or assets of the Company to any company lawfully entitled to acquire the ‎same; provided however that the company formed by such merger or amalgamation or which acquires by ‎conveyance or transfer all or substantially all the properties and assets of the Company will be a company ‎organized and existing under the laws of Canada or of the United States of America or any Province, State, District ‎or Territory thereof, which will, simultaneously with such amalgamation, merger, conveyance or transfer, assume the ‎due and punctual performance and observance of all the covenants and conditions hereof to be performed or ‎observed by the Company and will succeed to and be substituted for the Company, and such changes in ‎phraseology and form (but not in substance) may be made in the Warrant Certificate as may be appropriate in view ‎of such amalgamation, merger or transfer.‎

 

 
- 8 -

 

Additional Financings

 

8.3‎Nothing herein contained will prevent the Company from issuing any other securities or rights with respect ‎thereto during the period within which a Warrant is exercisable, upon such terms as the Company may deem ‎appropriate.‎

[End of Schedule “A”]‎

 
 

 

APPENDIX “A”‎

 

INSTRUCTIONS TO HOLDERS

 

TO EXERCISE:‎

 

To exercise Warrants, the Holder must complete, sign and deliver the Warrant Exercise Form, attached as Appendix and deliver the Warrant Certificate(s) to the Company, indicating the number of common shares to be acquired.‎

 

TO TRANSFER:‎

 

To transfer Warrants, the Holder must complete, sign and deliver the Warrant Transfer Form, attached as Appendix and deliver the Warrant Certificate(s) to the Company. The Company may require such other certificates or ‎opinions to evidence compliance with applicable securities legislation in Canada.‎

 

To transfer Warrants, the Warrant Holder’s signature on the Warrant Transfer Form must be guaranteed by an ‎authorized officer of a chartered bank, trust company or an investment dealer who is a member of a recognized ‎stock exchange.‎

 

GENERAL:‎

 

If forwarding any documents by mail, registered mail must be employed.‎

 

If the Warrant Exercise Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a ‎corporation or any person acting in a fiduciary or representative capacity, the Warrant Certificate must also be ‎accompanied by evidence of authority to sign satisfactory to the Company.‎

 

The address of the Company is:

 

Draganfly Inc.‎

‎2108 St. George Avenue‎

Saskatoon, Saskatchewan, S7M 0K7

Attention: Chief Financial Officer

Telephone: +1 (306)-955-9907‎

[End of Appendix “A”]‎

 

 
 

 

APPENDIX “B”

 

WARRANT EXERCISE FORM

 

TO: Draganfly Inc.‎
  ‎2108 St. George Avenue‎
  Saskatoon, Saskatchewan, S7M 0K7
  Attention: Chief Financial Officer
  Telephone: +1 (306)-955-9907‎

 

The undersigned Holder of the within Warrants hereby subscribes for __________ common shares (the “Shares”)‎ of DRAGANFLY INC. (the “Company”) pursuant to the within Warrants on the terms and price specified in the ‎Warrants. This subscription is accompanied by a certified cheque or bank draft payable to or to the order of the ‎Company for the whole amount of the purchase price of the Shares.‎

 

The undersigned hereby directs that the Shares be registered as follows:‎

 

NAME(S) IN FULL   ADDRESS(ES)   NO. OF SHARES
         
         

 

The undersigned Holder represents and warrants that he or she is an “accredited investor”, as defined in Rule 501(a) ‎of Regulation D under the U.S. Securities Act (a “U.S. Accredited Investor”), and has completed the U.S. Accredited ‎Investor Status Certificate in the form attached to this exercise form; OR Holder is a “qualified investor” meaning ‎the aggregate exercise price you pay is not more than ten percent (10%) of the greater of your annual income or ‎your net worth. DIFFERENT RULES MAY APPLY TO NON-NATURAL PERSONS. BEFORE MAKING ANY ‎REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ‎ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A+.‎

 

STOP:

 

COMPLETE THE FOLLOWING ONLY IF THE WARRANTS AND/OR THE UNDERLYING SHARES ARE ‎NOT QUALIFIED UNDER REGULATION A, TIER 2.‎

 

Unless the Shares have been registered or qualified under Regulation A under the U.S. Securities Act, and the ‎applicable state securities legislation, as at the time of exercise hereunder, the undersigned Warrantholder represents, ‎warrants and certifies as follows (check one):

 

  (A) ☐‎ the undersigned Warrantholder at the time of exercise of the Warrant is not in the United States, is not a ‎‎“U.S. person” as defined in Regulation S under the United States Securities Act of 1933, as amended (the ‎‎“U.S. Securities Act”), and is not exercising the Warrant for the account or benefit of a U.S. person or a ‎person in the United States (as defined in Regulation S), and did not execute or deliver this exercise form ‎in the United States; OR
     
  (B) ☐ the undersigned Warrantholder is resident in the United States, is a U.S. person, or is exercising the Warrant for ‎the account or benefit of a U.S. person or a person in the United States (a “U.S. Holder”), and is an ‎‎“accredited investor”, as defined in Rule 501(a) of Regulation D under the U.S. Securities Act (a “U.S. ‎Accredited Investor”), and has completed the U.S. Accredited Investor Status Certificate in the form ‎attached to this exercise form; OR

 
- 2 -

 

  (C) ☐ if the undersigned Warrantholder is a U.S. Holder, the undersigned Warrantholder has delivered to the ‎Company and the Company’s transfer agent an opinion of counsel (which will not be sufficient unless it ‎is in form and substance satisfactory to the Company) or such other evidence satisfactory to the ‎Company to the effect that with respect to the common shares to be delivered upon exercise of the ‎Warrant, the issuance of such securities has been registered under the U.S. Securities Act and applicable ‎state securities laws, or an exemption from the registration requirements of the U.S. Securities Act and ‎applicable state securities laws is available.

 

Note: Unless the Shares have been registered or qualified under Regulation A under the U.S. Securities Act and ‎the applicable state securities legislation certificates representing Shares will not be registered or delivered to ‎an address in the United States unless box (B) or (C) immediately above is checked.‎

 

If the undersigned Warrantholder has indicated that the undersigned Warrantholder is a U.S. ‎Accredited Investor by marking box (B) above, the undersigned Warrantholder additionally represents and warrants ‎to the Company that:

 

1‎the undersigned Warrantholder has such knowledge and experience in financial and business matters ‎as to be capable of evaluating the merits and risks of an investment in the Common Shares, and the ‎undersigned is able to bear the economic risk of loss of his or her entire investment;‎
  
2.the undersigned is: (i) purchasing the Shares for his or her own account or for the account of one or ‎more U.S. Accredited Investors with respect to which the undersigned is exercising sole investment ‎discretion, and not on behalf of any other person; (ii) is purchasing the Shares for investment purposes ‎only and not with a view to resale, distribution or other disposition in violation of United States federal ‎or state securities laws; and (iii) in the case of the purchase by the undersigned of the Shares as agent or ‎trustee for any other person or persons (each a “Beneficial Owner”), the undersigned Warrantholder ‎has due and proper authority to act as agent or trustee for and on behalf of each such Beneficial ‎Owner in connection with the transactions contemplated hereby; provided that: (x) if the undersigned ‎Warrantholder, or any Beneficial Owner, is a corporation or a partnership, syndicate, trust or other ‎form of unincorporated organization, the undersigned Warrantholder or each such Beneficial Owner ‎was not incorporated or created solely, nor is it being used primarily to permit purchases without a prospectus ‎or registration statement under applicable law; and (y) each Beneficial Owner, if any, is a U.S. ‎Accredited Investor; and
  
3.the undersigned has not exercised the Warrants as a result of any form of general solicitation or general advertising (as such terms are used in Rule 502 of Regulation D under the U.S. Securities Act), ‎including advertisements, articles, notices or other communications published in any newspaper, ‎magazine or similar media, or broadcast over radio, television, the Internet or other form of ‎telecommunications, or any seminar or meeting whose attendees have been invited by general ‎solicitation or general advertising.

 

If the undersigned has indicated that the undersigned is a U.S. Accredited Investor by marking box ‎‎(B) above, the undersigned also acknowledges and agrees that:‎

 

1.‎the Company has provided to the undersigned the opportunity to ask questions and receive answers concerning the terms and conditions of the offering, and the undersigned has had access to such ‎information concerning the Company as the undersigned has considered necessary or appropriate in ‎connection with the undersigned’s investment decision to acquire the Shares;‎

 

 
- 3 -

 

2.‎if the undersigned decides to offer, sell or otherwise transfer any of the Shares, the undersigned must not, and will not, offer, sell or otherwise transfer any of such Shares directly or indirectly, unless:‎

 

a)the sale is to the Company;‎

 

b)the sale is made outside the United States in a transaction meeting the requirements of Rule 904 of ‎Regulation S under the U.S. Securities Act and in compliance with applicable local laws and ‎regulations;‎

 

c)the sale is made pursuant to the exemption from the registration requirements under the U.S. Securities Act ‎provided by Rule 144 thereunder, if available, and in accordance with any applicable state securities ‎or “blue sky” laws; or

 

d)the Shares are sold in a transaction that does not require registration under the U.S. Securities Act or any ‎applicable state laws and regulations governing the offer and sale of securities,‎

 

and in the case of (c) or (d) above, it has prior to such sale furnished to the Company an opinion of ‎counsel reasonably satisfactory to the Company;‎

 

3.‎the Shares are “restricted securities” under applicable federal securities laws and that the U.S. Securities Act and the rules of the United States Securities and Exchange Commission provide in substance that ‎the undersigned may dispose of the Shares only pursuant to an effective registration statement under ‎the U.S. Securities Act or an exemption therefrom;‎

 

4.‎the Company has no obligation to register any of the Shares or to take action so as to permit sales pursuant to the U.S. Securities Act (including Rule 144 thereunder);‎

 

5.‎the certificates representing the Shares (and any certificates issued in exchange or substitution for the Shares) will bear a legend stating that such securities have not been registered under the U.S. Securities Act or the securities laws of any state of the United States, and may not be offered for sale or sold ‎unless registered under the U.S. Securities Act and the securities laws of all applicable states of the ‎United States, or unless an exemption from such registration requirements is available;‎

 

6.‎‎the legend may be removed by delivery to the registrar and transfer agent and the Company of an opinion of counsel, reasonably satisfactory to the Company, that such legend is no longer required under ‎applicable requirements of the U.S. Securities Act or state securities laws;‎

 

7.there may be material tax consequences to the undersigned of an acquisition or disposition of the Shares;‎

 

8.the Company gives no opinion and makes no representation with respect to the tax consequences to the ‎undersigned under United States, state, local or foreign tax law of the undersigned’s acquisition or ‎disposition of any Shares; in particular, no determination has been made whether the Company will ‎be a “passive foreign investment company” (commonly known as a “PFIC”) within the meaning of ‎Section 1297 of the United States Internal Revenue Code;‎

 

9.funds representing the subscription price for the Shares which will be advanced by the undersigned to the ‎Company upon exercise of the Warrants will not represent proceeds of crime for the purposes of the ‎United States Uniting and Strengthening America by Providing Appropriate Tools Required to ‎Intercept and Obstruct Terrorism Act (the “PATRIOT Act”), and the undersigned acknowledges that ‎the Company may in the future be required by law to disclose the undersigned’s name and other ‎information relating to this exercise form and the undersigned’s subscription hereunder, on a ‎confidential basis, pursuant to the PATRIOT Act. No portion of the subscription price to be provided ‎by the undersigned (i) has been or will be derived from or related to any activity that is deemed ‎criminal under the laws of the United States of America, or any other jurisdiction, or (ii) is being ‎tendered on behalf of a person or entity who has not been identified to or by the undersigned, and it ‎shall promptly notify the Company if the undersigned discovers that any of such representations ‎ceases to be true and provide the Company with appropriate information in connection therewith; ‎and

 

 
- 4 -

 

10.the undersigned consents to the Company making a notation on its records or giving instructions to any ‎transfer agent of the Company in order to implement the restrictions on transfer set forth and ‎described in this subscription form.‎

 

In the absence of instructions to the contrary, the securities or other property will be issued in the ‎name of or to the Warrantholder hereof and will be sent by first class mail to the last address of the Warrantholder ‎appearing on the register maintained for the Warrants.‎

 

DATED this _____ day of _______________

 

     
Signature of witness   Signature of Holder
     
     
Witness’s Name  

Name and Title of Authorized

Signatory for the Holder

 

Please print below your name and address in full.‎

 

Legal Name:    
     
Address:    
     
     

 

 
 

 

INSTRUCTIONS FOR SUBSCRIPTION

 

The signature to the subscription must correspond in every particular with the name written upon the face of the ‎Warrant Certificate without alteration. If the registration in respect of the certificates representing the Shares to be ‎issued upon exercise of the Warrants differs from the registration of the Warrant Certificates the signature of the ‎registered holder must be guaranteed by an authorized officer of a Canadian chartered bank, or of a major ‎Canadian trust company, or by a medallion signature guarantee from a member recognized under the Signature ‎Medallion Guarantee Program, or from a similar entity in the United States, if this transfer is executed in the United ‎States, or in accordance with industry standards.‎

 

In the case of persons signing by agent or attorney or by personal representative(s), the authority of such agent, ‎attorney or representative(s) to sign must be proven to the satisfaction of the Company.‎

 

If the Warrant Certificate and the form of subscription are being forwarded by mail, registered mail must be ‎employed.‎

 

U.S. ACCREDITED INVESTOR STATUS CERTIFICATE

 

In connection with the exercise of certain outstanding warrants of DRAGANFLY INC. (the ‎‎“Company”) by the Warrantholder, the Warrantholder hereby represents and warrants to the Company that the ‎Warrantholder, and each beneficial owner (each a “Beneficial Owner”), if any, on whose behalf the Warrantholder ‎is exercising such warrants, satisfies one or more of the following categories of Accredited Investor (please write ‎‎“W/H” for the undersigned Warrantholder, and “B/O” for each beneficial owner, if any, on each line that ‎applies):‎

 

_______ (1)‎Any bank as defined in Section 3(a)(2) of the United States Securities Act of 1933, as amended (the ‎‎“U.S. Securities Act”), or any savings and loan association or other institution as defined in Section ‎‎3(a)(5)(A) of the U.S. Securities Act whether acting in its individual or fiduciary capacity; any ‎broker or dealer registered pursuant to Section 15 of the U.S. Securities Exchange Act of 1934; any ‎insurance company as defined in Section 2(a)(13) of the U.S. Securities Act; any investment ‎company registered under the U.S. Investment Company Act of 1940 or a business development ‎company as defined in Section 2(a)(48) of that Act; any Small Business Investment Company ‎licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the U.S. Small ‎Business Investment Act of 1958; any plan established and maintained by a state, its political ‎subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit ‎of its employees, if such plan has total assets in excess of US$5,000,000; any employee benefit ‎plan within the meaning of the U.S. Employee Retirement Income Security Act of 1974 if the ‎investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is ‎either a bank, savings and loan association, insurance company, or registered investment adviser, ‎or if the employee benefit plan has total assets in excess of US$5,000,000, or, if a self-directed ‎plan, with investment decisions made solely by persons that are “accredited investors” (as such ‎term is defined in Rule 501 of Regulation D of the U.S. Securities Act);‎
  
_______ (2)Any private business development company as defined in Section 202(a)(22) of the U.S. ‎Investment Advisers Act of 1940;
  
_______ (3)Any organization described in Section 501(c)(3) of the U.S. Internal Revenue Code, corporation, ‎Massachusetts or similar business trust, or partnership, not formed for the specific purpose of ‎acquiring the securities offered, with total assets in excess of US$5,000,000;

 

 
- 2 -

 

_______ (4)Any trust with total assets in excess of US$5,000,000, not formed for the specific purpose of ‎acquiring the securities offered, whose purchase is directed by a sophisticated person (being defined as a person who has such knowledge and experience in financial and business matters that he or ‎she is capable of evaluating the merits and risks of the prospective investment);
  
_______ (5)A natural person whose individual net worth, or joint net worth with that person’s spouse, at the ‎time of purchase, exceeds US$1,000,000 (for the purposes of calculating net worth, (i) the person’s ‎primary residence shall not be included as an asset; (ii) indebtedness that is secured by the person’s ‎primary residence, up to the estimated fair market value of the primary residence at the time of this ‎certification, shall not be included as a liability (except that if the amount of such indebtedness ‎outstanding at the time of this certification exceeds the amount outstanding 60 days before such ‎time, other than as a result of the acquisition of the primary residence, the amount of such excess ‎shall be included as a liability); and (iii) indebtedness that is secured by the person’s primary ‎residence in excess of the estimated fair market value of the primary residence shall be included as ‎a liability);
  
_______ (6)A natural person who had annual gross income during each of the last two full calendar years in ‎excess of US$200,000 (or together with his or her spouse in excess of US$300,000) and reasonably ‎expects to have annual gross income in excess of US$200,000 (or together with his or her spouse in ‎excess of US$300,000) during the current calendar year, and no reason to believe that his or her ‎annual gross income will not remain in excess of US$200,000 (or that together with his or her ‎spouse will not remain in excess of US$300,000) for the foreseeable future;
  
_______ (7)Any director or executive officer of the Company; or
  
_______ (8)Any entity in which all of the equity owners meet the requirements of at least one of the above ‎categories (if this alternative is selected you must identify each equity owner and provide ‎statements for each demonstrating how they qualify as an accredited investor).

 

‎[End of Appendix “B”]‎

 

 
 

 

APPENDIX “C”‎

 

WARRANT TRANSFER FORM

 

TO: Draganfly Inc.‎
  ‎2108 St. George Avenue‎
  Saskatoon, Saskatchewan, S7M 0K7
  Attention: Chief Financial Officer
  Telephone: +1 (306)-955-9907‎

 

FOR VALUE RECEIVED, the undersigned holder of the within Warrants hereby sells, assigns and transfers to ____________________________, _____________________, Warrants of Draganfly Inc. (the “Company”) registered ‎in the name of the undersigned on the records of the Company and irrevocably appoints ‎_______________________ the attorney of the undersigned to transfer the said securities on the books or register with full power of substitution.‎

 

The undersigned hereby directs that the Warrants hereby transferred be issued and delivered as follows:‎

 

NAME(S) IN FULL   ADDRESS(ES)   NO. OF SHARES
         
         

 

DATED this _____ day of ________________‎, 20____.‎

 

     
Signature of Warrant Holder   Signature Guaranteed

 

INSTRUCTIONS FOR TRANSFER

 

Signature of the Warrant Holder must be the signature of the person appearing on the face of this Warrant ‎Certificate.‎

 

If the Transfer Form is signed by a trustee, executor, administrator, curator, guardian, attorney, officer of a ‎corporation or any person acting in a fiduciary or representative capacity, the certificate must be accompanied by ‎evidence of authority to sign satisfactory to the Company.‎

 

The signature on the Transfer Form must be guaranteed by a chartered bank or trust company, or a member firm of ‎an approved signature guarantee medallion program. The guarantor must affix a stamp bearing the actual words: ‎‎“SIGNATURE GUARANTEED”.‎

 

The Warrants will only be transferable in accordance with applicable laws. The Warrants and the common shares ‎issuable upon exercise thereof not been and will not be registered under the United States Securities Act of 1933, as ‎amended (the “U.S. Securities Act”), or under the securities laws of any state of the United States, and may not be ‎transferred to or for the account or benefit of a U.S. person or any person in the United States without registration ‎under the U.S. Securities Act and applicable state securities laws, or compliance with the requirements of an ‎exemption from registration. “United States” and “U.S. person” are as defined in Regulation S under the U.S. ‎Securities Act.‎

[End of Appendix “C”]

 

 

EX-2.4 7 ex2-4.htm

 

Exhibit 2.4

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT ‎TRADE THE SECURITY BEFORE JULY 23, 2021.

 

Number of Warrants: ●   Issue Date: March 22, 2021 (the “Issue Date”)
Certificate No: ●   Expiry Date: March 22, 2023 (the “Expiry Date”, subject to the Accelerated Expiry (as defined herein))

 

WARRANT CERTIFICATE

 

DRAGANFLY INC.

 

For value received, ‎ (the “Holder”) is the registered holder of that number of warrants (the “Warrants”) of Draganfly Inc. (the “Corporation”) as set forth above.

 

1. Warrants. Each Warrant shall entitle the holder to purchase one common share of the Corporation (a “Share”) as constituted on the Issue Date, at a price of $2.67 per Share until 4:00 pm (Vancouver time) on the earlier to occur of: (a) the Expiry Date; and (b) the Accelerated Expiry. If, at any time after March 22, 2022 and before the Expiry Date, the Shares have a closing price at or above $3.47 per Share on the Canadian Securities Exchange‎, the Corporation may give notice (an “Acceleration Notice”) to the Holder that the Warrants shall expire on a date that is not less than 90 days from the date of the Acceleration Notice (the “Accelerated Expiry”).

 

2. Transferable. Subject to the provisions hereof, applicable securities legislation and the rules, policies, notices and orders issued by applicable securities regulatory authorities, including the Canadian Securities Exchange, or such other stock exchange as the Shares may then be listed and posted for trading on (the “Exchange”), the Warrants evidenced hereby (or any portion thereof) may be assigned or transferred by the holder by provision of a Transfer Form in the form attached as Schedule “B” hereto duly completed and executed and such additional documents as may be reasonably requested by the Corporation. Subject to the foregoing, the Corporation shall issue and mail as soon as practicable, and in any event within five (5) business days of receipt of this Warrant certificate, together with a duly completed and executed Transfer Form attached hereto, a new Warrant certificate (with or without legends as may be appropriate) registered in the name of the transferee or as the transferee may direct and shall take all other necessary actions to effect the transfer as directed.

 

3. Warrants Exercise Procedure. The Warrants represented by this Warrant certificate may be exercised in whole or in part at any time prior to the Expiry Date or the Accelerated Expiry, as applicable, by surrendering the original of this Warrant certificate at the offices of the Corporation set out in subsection 17(g) hereof together with a subscription form in the form attached as Schedule “A” hereto duly completed and executed, such additional documents as may be contemplated thereby, and a certified cheque, bank draft or money order in lawful money of Canada payable to or to the order of the Corporation.

 

4. Register of Warrantholders. The Corporation shall cause a register (the “Register”) to be kept in which shall be entered the names and addresses of all holders of the Warrants and the number of Warrants held by each of them. The Corporation may treat the registered holder of any certificate representing Warrants as the absolute owner of the Warrants represented thereby for all purposes, and the Corporation shall not be affected by any notice or knowledge to the contrary except where the Corporation is required to take notice by statute or by order of a court of competent jurisdiction.

 

5. Partial Exercise. The Holder may subscribe for and purchase less than the full number of Shares entitled to be subscribed for and purchased hereunder. In the event that the Holder subscribes for and purchases less than the full number of Shares entitled to be subscribed for and purchased under this Warrant certificate prior to the Expiry Date, the Corporation shall issue a new Warrant certificate to the Holder in substantially the same form as this Warrant certificate with appropriate changes to reflect the unexercised balance of the Warrants.

 

 
- 2 -

 

6. Delivery of Shares. Within five business days of receipt by the Corporation of this Warrant certificate in accordance with, and the documents and payment noted in, Section 3, the Corporation will deliver a certificate(s) representing the Shares subscribed for and purchased by the Holder hereunder, and a replacement Warrant certificate, if any.

 

7. No Rights of Shareholders. Nothing contained in this Warrant certificate shall be construed as conferring upon the Holder any right or interest whatsoever as a holder of Shares of the Corporation or any other right or interest except as herein expressly provided.

 

8. Adjustment of Subscription and Purchase Rights. The rights evidenced by this Warrant certificate are to purchase Shares. If there shall, prior to the exercise of any of the rights evidenced hereby, be any (i) reorganization of the authorized capital of the Corporation by way of consolidation, merger, sub-division, amalgamation, arrangement, reclassification or otherwise; (ii) transfer, sale, lease or exchange of the undertaking or assets of the Corporation as an entirety or substantially as an entirety to another person; (iii) the payment of any stock dividends (other than in the ordinary course of business); (iv) a special distribution or rights offering; (v) the change or exchange of the Shares into or with another security; or (vi) any similar event or transaction not specifically contemplated by this Section 8 as determined by the Corporation in its sole discretion (collectively, a “Reorganization”), then there shall automatically be an adjustment, as applicable, in (A) the number of Shares of the Corporation which may be issued pursuant hereto and/or the exercise price for the Shares, by corresponding amounts if applicable, and/or (B) the kind and aggregate number of shares or other securities or property resulting from the Reorganization, so that the rights evidenced hereby shall thereafter be as reasonably as possible equivalent to the rights originally granted hereby and such that the Holder, upon exercise of this Warrant following the effective date of the Reorganization, shall receive the kind and type of shares, securities or property the Holder would have been entitled to receive if, on the effective date thereof, the Holder had been the registered holder of the number of Shares which the Holder was theretofore entitled to purchase or receive upon the exercise of this Warrant certificate. In accordance with this certificate, the Corporation will make adjustments as it considers necessary and equitable acting in good faith. If at any time a dispute arises with respect to adjustments provide for herein, such dispute will be conclusively determined by the Canadian auditors of the Corporation or if they are unable or unwilling to act, by such other firm of Canadian independent chartered accountants as may be selected by the directors of the Corporation and any such determination, absent manifest error, will be binding upon the Corporation, the Holder and shareholders of the Corporation. The Corporation will provide such auditors or accountants with access to all necessary records of the Corporation and fees payable to such accountants or auditors will be paid by the Corporation.

 

9. Consolidation and Amalgamation. In the case of the Corporation entering into a transaction whereby all or substantially all of its undertaking, property and assets would become the property of any other corporation (herein called a “successor corporation”) whether by way of reorganization, reconstruction, consolidation, amalgamation, arrangement, merger, transfer, sale, disposition or otherwise, the successor corporation shall be bound by all of the provisions hereof including the due and punctual performance of all covenants of the Corporation and forthwith following the occurrence of such event, the successor corporation resulting from such reorganization, reconstruction, consolidation, amalgamation, arrangement, merger, transfer, sale, disposition or otherwise (if not the Corporation), shall expressly assume, by supplemental certificate satisfactory in form to the Holder, acting reasonably, and executed and delivered to the Holder, the due and punctual performance and observance of this Warrant certificate to be performed and observed by the Corporation and these securities and the terms set forth in this Warrant certificate will be a valid and binding obligation of the successor corporation entitling the Holder, as against the successor corporation, to all the rights of the Holder under this Warrant certificate.

 

10. No Fractional Shares. Upon the exercise of the Warrants evidenced hereby, the Corporation shall not be required to issue an aggregate number of Shares that results in any fractional Shares being issued and the Holder shall not be entitled to any cash payment or compensation in lieu of a fractional Share.

 

11. Legending of Shares. The Warrants have been, and the Shares will be, issued pursuant to an exemption (an “Exemption”) from the registration and prospectus requirements of applicable securities law. To the extent that the Corporation relies on such Exemption, the Shares may be subject to restrictions on resale and transferability contained in applicable securities laws.

 

 
- 3 -

 

The Holder hereby agrees and consents by acceptance hereof that the certificate or certificates representing the Shares issued before the date that is four months and one day from the Issue Date upon exercise of the Warrant, shall be impressed with a legend in the following form:

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST ‎NOT ‎TRADE THE SECURITY BEFORE JULY 23, 2021.‎

 

12. Change; Waiver. The provisions of these Warrants may from time to time be amended, modified or waived, if such amendment, modification or waiver is in writing and consented to in writing by the Corporation and the Holder.

 

13. No Obligation to Purchase. Nothing herein contained or done pursuant hereto shall obligate the Holder to purchase or pay for or the Corporation to issue any Shares except those Shares in respect of which the Holder shall have exercised its right to purchase in the manner provided hereunder.

 

14. Covenants.

 

  (a) The Corporation covenants that (i) so long as any Shares evidenced hereby remain outstanding, it shall reserve and there shall remain unissued out of its authorized capital a sufficient number of Shares to satisfy the right of purchase provided for herein should the Holder determine to exercise its rights in respect of all the Shares available for purchase and issuance under outstanding Warrants, and (ii) all Shares which shall be issued upon the due exercise of the right to purchase provided for herein, upon payment therefor of the amount at which such Shares may at the time be purchased pursuant to the provisions hereof, shall be issued as fully paid and non-assessable common shares in the capital of the Corporation and free of all liens, charges and encumbrances;
     
  (b) The Corporation shall preserve and maintain its corporate existence; and
     
  (c) ‎The Corporation will maintain the listing of its Shares on the Exchange and its status as a ‎reporting issuer not in default or the equivalent under the securities legislation of each of the ‎jurisdictions in which it is a reporting issuer or the equivalent as of the date hereof (the “Reporting ‎Jurisdictions”) up to and including the Expiry Date, provided the foregoing shall not, in any ‎manner, preclude the Corporation from pursuing or completing a transaction that would result in ‎the delisting of the Shares from the Exchange or ceasing to be a reporting issuer or the equivalent ‎in each of the Reporting Jurisdictions where the board of directors of the Corporation, acting in ‎good faith and in accordance with applicable laws, determines that such a transaction is in the ‎best interests of the Corporation‎.

 

15. Representations and Warranties. The Corporation hereby represents and warrants with and to the Holder that the Corporation is duly authorized and has the corporate and lawful power and authority to create and issue this Warrant certificate and the Shares issuable upon the exercise hereof and perform its obligations hereunder and that this Warrant certificate represents a valid, legal and binding obligation of the Corporation enforceable in accordance with its terms.

 

16. Lost Certificate. If this Warrant certificate becomes stolen, lost, mutilated or destroyed, the Corporation may, on such terms as it may in its discretion impose, respectively issue and countersign a new Warrant certificate of like denomination, tenor and date as the Warrant certificate so stolen, lost, mutilated or destroyed.

 

17. General.

 

  (a) The headings in this certificate are for reference only and do not constitute terms of the Warrant certificate.
     
  (b) Whenever the singular or masculine is used in this Warrant certificate the same shall be deemed to include the plural or the feminine or the body corporate as the context may require.

 

 
- 4 -

 

  (c) This Warrant certificate shall enure to the benefit of and be binding upon the parties hereto and their respective successors and assigns.
     
  (d) Time shall be of the essence of this Warrant certificate.
     
  (e) This Warrant shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, without reference to its principles governing the choice or conflict of laws. The Corporation and the Holder hereby irrevocably attorn and submit to the exclusive jurisdiction of the courts of the Province of British Columbia, sitting in the City of Vancouver, with respect to any dispute related to or arising from this Warrant certificate.
     
  (f) All references herein to monetary amounts are references to lawful money of Canada.
     
  (g) All notices or other communications to be given to the Holder by the Corporation under this Warrant certificate shall be delivered by hand, courier, ordinary prepaid mail, facsimile or electronic mail; and, if delivered by hand, shall be deemed to have been given on the delivery date, if delivered by ordinary prepaid mail shall be deemed to have been given on the fifth day following the delivery date and, if sent by facsimile or electronic mail, on the date of transmission if sent before 5:00 p.m. (local time where the notice is received) on a business day or, if such day is not a business day, on the first business day following the date of transmission.
     
    Notices to the Holder shall be addressed to the address of the Holder set out in the Register.
     
    Notices to the Corporation shall be addressed to:

 

Draganfly Inc.

2108 St. George Avenue

Saskatoon, Saskatchewan

S7M 0K7

 

Attention:     Chief Financial Officer

Email:           paul.sun@draganfly.com

 

Each of the Corporation and the Holder may change its address for service by notice in writing to the other of them specifying its new address for service under this Warrant certificate.

 

[THE REMAINDER OF THIS PAGE IS LEFT INTENTIONALLY BLANK.]

 

 
- 5 -

 

IN WITNESS WHEREOF the Corporation has caused this Warrant certificate to be signed by its duly authorized officer on March 22, 2021.

 

DRAGANFLY INC.  
   
By:    
  Authorized Signatory  

 

The digital signature above shall be deemed to constitute an original signature to this Warrant certificate.

 

 
 

 

SCHEDULE “A”

 

WARRANT CERTIFICATE SUBSCRIPTION FORM

 

Draganfly Inc.
‎2108 St. George Avenue‎

Saskatoon, Saskatchewan

S7M 0K7 ‎

Dear Sirs:

 

The undersigned hereby exercises the right to purchase and hereby subscribes for ___________ common shares (the “Shares”) of Draganfly Inc. (the “Corporation”) referred to in the Warrant certificate attached hereto according to the conditions thereof, and herewith makes payment of the purchase price in full for the Shares.

 

In connection with the exercise of the Warrant certificate, the undersigned represents as follows: (Please check the ONE box applicable):

 

1. The undersigned (i) at the time of exercise is not a U.S. person, (ii) at the time of exercise is not within the United States, (iii) is not exercising any of the Warrants represented by this Warrant certificate for the account or benefit of any U.S. person or person within the United States, and (iv) did not execute or deliver this Subscription Form in the United States.
     
2. The undersigned has delivered to the Corporation a written opinion of U.S. counsel reasonably satisfactory to the Corporation to the effect that the Shares to be delivered upon exercise hereof are exempt from registration under the 1933 Act and the securities laws of all applicable states of the United States.

 

1933 Act” means the United States Securities Act of 1933, as amended. “U.S. person” and “United States” are as defined by Regulation S under the 1933 Act.

 

Certificates representing Shares will not be registered or delivered to an address in the United States unless Box 2 above is checked and the requirements in connection therewith have been satisfied.

 

Certificates representing Shares issued upon exercise of Warrants pursuant to Box 2 above will bear a U.S. restrictive legend.

 

If any Shares represented by this Warrant certificate are not being exercised, a new Warrant certificate will be issued and delivered with the Share certificate(s).

 

Please issue and deliver a certificate for the Shares being purchased as follows:

 

  NAME:    
    (please print)  
       
  ADDRESS:    
       
  DELIVERY    
       

 

 
- 2 -

 

INSTRUCTIONS:

 

1. The registered holder of a Warrant may exercise its right to acquire Shares by completing and surrendering this Subscription Form and the ORIGINAL Warrant certificate representing the Warrants being converted to the Corporation, together with the aggregate amount of the exercise price for the Shares as provided for in the Warrant certificate. Certificates representing the Shares to be acquired on exercise will be sent by prepaid first class mail to the address(es) above within five business days after the receipt of all required documentation, subject to the terms of the Warrant certificate.
   
2. If this Subscription Form indicates that the Shares are to be issued to a person or persons other than the registered holder of the Warrants to be converted: (i) the signature of the registered holder on this Subscription Form must be medallion guaranteed by an authorized officer of a chartered bank, trust Corporation or an investment dealer who is a member of a recognized stock exchange, and (ii) the registered holder must pay to the Corporation all applicable taxes and other duties.
   
3. If this Subscription Form is signed by a trustee, executor, administrator, custodian, guardian, attorney, officer of a corporation or any other person acting in a fiduciary or representative capacity, this Subscription Form must be accompanied by evidence of authority to sign satisfactory to the Corporation.

 

DATED this _______ day of __________________________________, ___________________.

 

     
    (Signature)
     
  )  
Signature of Witness ) Signature of registered holder or Signatory thereof
[Please Note Instruction 2] )  
  )  
  ) If applicable, print Name and Office of Signatory
Print name of Witness )  

 

)  
  ) Print Name of registered holder as on certificate
  )  
  )  
  ) Street Address
  )  
  )  
  ) City, Province/State and Postal/ZIP Code
  )  

 

 
 

 

SCHEDULE “B”

 

TRANSFER FORM

 

FOR VALUE RECEIVED, the undersigned transferor hereby sells, assigns and transfers unto

 

 
 
(Transferee)
 
 
 
(Address)

 

_________________of the Warrants registered in the name of the undersigned transferor represented by the attached Warrant Certificate.

 

THE UNDERSIGNED TRANSFEROR HEREBY CERTIFIES AND DECLARES that the Warrants are not being offered, sold or transferred to, or for the account or benefit of, a “U.S. person” (as defined in Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”)) or a person within the United States unless registered under the U.S. Securities Act and any applicable state securities laws or unless an exemption from such registration is available.

 

  DATED this ________________day of __________________, ______.  
         
         
  Signature of Registered Holder   Signature Guarantee  
  (Transferor)      
         
         
  Print name of Registered Holder      
         
         
         
         
  Address      

 

NOTE: The signature on this Transfer Form must correspond with the name as recorded on the face of the Warrant Certificate in every particular without alteration or enlargement or any change whatsoever or this Transfer Form must be signed by a duly authorized trustee, executor, administrator, or attorney of the Holder or a duly authorized signing officer in the case of a corporation. If this Transfer Form is signed by any of the foregoing, or any person acting in a fiduciary or representative capacity, the Warrant Certificate must be accompanied by evidence of authority to sign.
   
  All endorsements or assignments of these Warrants must be signature guaranteed by a bank or trust company or by a member of a stock exchange in Canada.

 

 

 

EX-2.5 8 ex2-5.htm

 

Exhibit 2.5

 

THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR AN UNDERWRITER OR A SELLING FIRM IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR OF ANY SUCH UNDERWRITER OR SELLING FIRM.

 

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO JANUARY 29, 2022. VOID AFTER 5:00 P.M., EASTERN TIME, JULY 29, 2024.

 

WARRANT TO PURCHASE COMMON SHARES

 

DRAGANFLY INC.

 

Warrant Shares: [●] Initial Exercise Date: January 29, 2022

 

THIS WARRANT TO PURCHASE COMMON SHARES (the “Warrant”) certifies that, for value received, [] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 29, 2022 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00 p.m. (New York time) on the date that is three (3) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Draganfly Inc., a British Columbia corporation (the “Company”), up to [] Common Shares, with no par value per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1 . Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated in this Section 1:

 

Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed, or a legal holiday in the United States or day in which banking institutions in the State of New York are required by law or other governmental action to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day

 

 
 

 

Commission” means the United States Securities and Exchange Commission.

 

Common Shares” means the common shares of the Company, with no par value per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Share Equivalents” means any securities of the Company or its subsidiaries which would entitle the holder thereof to acquire at any time Common Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.

 

Effective Date” means the effective date of the registration statement on Form F-10 (File No. 333-258074), including any related prospectus or prospectuses, for the registration of the Warrant and the Warrant Shares under the Securities Act, that the Company has filed with the Commission.

 

Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Offering” means the offering of securities pursuant to which this Warrant was issued.

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.

 

Trading Day” means a day on which the Common Shares are traded on a Trading Market, provided however, that if a Trading Day is not a Business Day, then “Trading Day” shall mean the next following Business Day.

 

Trading Market” means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question: the Canadian Securities Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then listed or quoted for trading on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Shares are then quoted for trading on the OTCQB or OTCQX operated by OTC Markets Group, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if the Common Shares are then quoted for trading on the Pink Open Market operated by OTC Markets Group (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share reported on the Pink Open Market, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

 
 

 

Section 2. Exercise.

 

(a) Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and at or prior to 5:00 p.m. (New York City time) on the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise form annexed hereto. Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Days of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

(b) Exercise Price. The exercise price per Common Share under this Warrant shall be $5.00, subject to adjustment hereunder (the “Exercise Price”).

 

(c) Cashless Exercise. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier’s check, at the election of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

  (A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

 

  (B) = the Exercise Price of this Warrant, as adjusted hereunder; and

 

 
 

 

  (X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If Warrant Shares are issued in such a “cashless exercise,” the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this Section 2(c). The Company shall not take any action that would prevent the exercise of this Warrant by means of a “cashless exercise” (as contemplated under Section 2(c) hereof) or make Rule 144 unavailable to the Holder for resale of the Warrant Shares without volume or manner-of-sale restrictions or current public information requirements unless the Warrant Shares are registered for resale pursuant to an effective registration statement under the Securities Act.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

Mechanics of Exercise.

 

(i) Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by its transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (the “DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as defined below), and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). If the Warrant Shares can be delivered via DWAC, the transfer agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation required by it to deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(c)(vi) prior to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.

 

 
 

 

(ii) Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

(iii) Rescission Rights. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section 2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however, that the Holder shall be required to return any Warrant Shares or Common Shares subject to any such rescinded exercise notice concurrently with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder’s right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

(iv) Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue by (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.

 

(v) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

 
 

 

(vi) Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

(vii) Closing of Books. The Company shall not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

(viii) Signature. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder in order to exercise this Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise this Warrant. No additional legal opinion, other information or instructions shall be required of the Holder to exercise this Warrant. The Company shall honor exercises of this Warrant and shall deliver Shares underlying this Warrant in accordance with the terms, conditions and time periods set forth herein.

 

(d) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(d), in determining the number of outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s transfer agent setting forth the number of Common Shares outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding Common Shares was reported. The “Beneficial Ownership Limitation” shall be 9.99% of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

 
 

 

Section 3. Certain Adjustments.

 

(a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on Common Shares or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse share split or consolidation) outstanding Common Shares into a smaller number of shares, or (iv) issues by reclassification of Common Shares any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells or grants any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Shares or Common Share Equivalents, at an effective price per share less than the Exercise Price then in effect.

 

(b) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to all or substantially all of the record holders of Common Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

 
 

 

(c) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.

 

(d) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger, amalgamation, arrangement or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(d) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation or is otherwise the continuing corporation, and any additional consideration (the “Alternate Consideration”) receivable by holders of Common Shares as a result of such Fundamental Transaction for each Common Share for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(d) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares or other securities of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares or other securities (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such shares or other securities, such number of shares or other securities and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

 
 

 

(e) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.

 

(f) Notice to Holder.

 

(i) Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

(ii) Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of the Company or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Common Shares, any consolidation, merger, amalgamation or arrangement to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, amalgamation, arrangement, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, amalgamation, arrangement, sale, transfer or share exchange; provided that the failure to provide such notice or any defect therein shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of its subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K or a Report of Foreign Private Issuer on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

 
 

 

Section 4. Transfer of Warrant.

 

(a) Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of the Offering, except the transfer of any security:

 

(i) by operation of law or by reason of reorganization of the Company;

 

(ii) to any FINRA member firm participating in the Offering and the officers or partners thereof, if all securities so transferred remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;

 

(iii) if the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;

 

(iv) that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the fund; or

 

(v) the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a) for the remainder of the time period.

 

Subject to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

 
 

 

(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

(d) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 5. Registration Rights.

 

5.1 Demand Registration.

 

5.1.1 Grant of Right. The Company, upon written demand (a “Demand Notice”) of the Holder(s) of at least 51% of the Warrants and/or the underlying Warrant Shares (the “Majority Holders”), agrees to register, on one occasion, all or any portion of the Warrant Shares underlying the Warrants (collectively, the “Registrable Securities”). On such occasion, the Company shall file a registration statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice and use its reasonable best efforts to have the registration statement declared effective promptly thereafter, subject to compliance with review by the Commission; provided, however, that the Company shall not be required to comply with a Demand Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggyback registration rights pursuant to 5.2 hereof and either: (i) the Holder has elected to participate in the offering covered by such registration statement or (ii) if such registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration statement has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration may be made at any time beginning on the Initial Exercise Date and expiring on the fifth anniversary of the Effective Date. The Company covenants and agrees to give written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders of the Warrants and/or the Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.

 

 
 

 

5.1.2 Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to 5.1.1, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities. The Company agrees to use its commercially reasonable efforts to cause the filing required herein to become effective promptly and to qualify or register the Registrable Securities in such States as are reasonably requested by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a State in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit to general service of process in such State, or (ii) the principal shareholders of the Company to be obligated to escrow their shares of capital stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date that the Holders of the Registrable Securities covered by such registration statement are first given the opportunity to sell all of such securities. The Holders shall only use the prospectuses provided by the Company to sell the Warrant Shares covered by such registration statement, and will immediately cease to use any prospectus furnished by the Company if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding the provisions of this Section 5.1.2, the Holder shall be entitled to a demand registration under this Section 5.1.2 on only one (1) occasion and such demand registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement (as defined below) in accordance with FINRA Rule 5110(f)(2)(G)(iv).

 

5.1.3 Notwithstanding the foregoing, Section 5.1.1 shall not apply if the Holder can exercise this Warrant by means of a “cashless exercise” (as contemplated under Section 2(c) hereof) and the Warrant Shares issued upon such cashless exercise are eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144.

 

5.2 “Piggy-Back” Registration.

 

5.2.1 Grant of Right. In addition to the demand right of registration described in Section 5(a) hereof, the Holder shall have the right, for a period of no more than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(f)(2)(G)(v), to include the Registrable Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however, that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of Registrable Securities which may be included in the Registration Statement because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.

 

5.2.2 Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement filed by the Company during the two (2) year period following the Initial Exercise Date until such time as all of the Registrable Securities have been sold by the Holder. The holders of the Registrable Securities shall exercise the “piggy-back” rights provided for herein by giving written notice within ten (10) days of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration under this Section 5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise Date.

 

 
 

 

5.2.3 Notwithstanding the foregoing, Section 5.2.1 shall not apply if the Holder can exercise this Warrant by means of a “cashless exercise” (as contemplated under Section 2(c) hereof) and the Warrant Shares issued upon such cashless exercise are eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144.

 

5.3 General Terms

 

5.3.1 Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the Underwriting Agreement between the Underwriters and the Company, dated as of July 29, 2021. The Holder(s) of the Registrable Securities to be sold pursuant to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns, in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions contained in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.

 

5.3.2 Exercise of Warrants. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

5.3.3 Documents Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a “cold comfort” letter dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has issued a report on the Company’s financial statements included in such registration statement, in each case covering substantially the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants’ letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s counsel and in accountants’ letters delivered to underwriters in underwritten public offerings of securities. The Company shall also deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.

 

 
 

 

5.3.4 Underwriting Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except as they may relate to such Holders, their Warrant Shares and their intended methods of distribution.

 

5.3.5 Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.

 

5.3.6 Damages. Should the registration or the effectiveness thereof required by Sections 5.1 and 5.2 hereof be delayed by the Company or the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity of posting bond or other security.

 

Section 6. Miscellaneous.

 

(a) No Rights as Shareholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i).

 

(b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which shall in no event include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company shall make and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.

 

(c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.

 

 
 

 

(d) Authorized Shares.

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company shall take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, amalgamation, arrangement, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company shall (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

(e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the underwriting agreement, dated July 29, 2021, by and between the Company and ThinkEquity, a division of Fordham Financial Management, Inc., as representatives of the underwriters set forth therein (the “Underwriting Agreement”).

 

(f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

(g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

(h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Underwriting Agreement.

 

(i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

 
 

 

(j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

(k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

(l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

(n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

 
 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

  DRAGANFLY INC.
     
  By:                     
  Name:   
  Title:  

 

 
 

 

NOTICE OF EXERCISE

 

TO: DRAGANFLY INC.

 

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2) Payment shall take the form of (check applicable box):

 

  in lawful money of the United States; or

 

  if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3) Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

(4) Accredited Investor. If the Warrant is being exercised via cash exercise, the undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: _______________________________________________________________

 

Signature of Authorized Signatory of Investing Entity: _________________________________________

 

Name of Authorized Signatory: ___________________________________________________________

 

Title of Authorized Signatory: ____________________________________________________________

 

Date: ________________________________________________________________________________

 

Ex. F-1
 

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute this form and supply required information.
Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address is

 

_______________________________________________________________.

 

_______________________________________________________________

 

Dated: ______________, _______

 

  Holder’s Signature:                                                               
       
  Holder’s Address:  
       
       

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

 

EX-4.1 9 ex4-1.htm

 

Exhibit 4.1

 

 

THIS BUSINESS SERVICES AGREEMENT is entered into effective on August 1, 2019.

 

BETWEEN:

 

Business Instincts Group Inc.

a corporation having its office located

at L120, 2303 4th Street SW., Calgary, Alberta T2S 2S7

 

(hereinafter referred to as “BIG”)

 

AND

 

Draganfly Innovations Inc.

a corporation having its office located

at 2108 St. George Ave, Saskatoon, SK, S7M0K7

 

(hereinafter referred to as the “Client”)

 

WHEREAS in order to help achieve its corporate and business objectives, the Client desires and has agreed to retain the services of BIG to provide the services and complete the duties described in Schedule “A” attached hereto and BIG agrees to provide such services to the Client, in accordance with the terms and conditions contained herein;

 

WHEREAS the parties desire that the Services (as defined below) shall be provided by BIG directly to each of the senior executive officers and management team employed by the Client (collectively, “Senior Management” and each a “Senior Manager”) of the Client;

 

WHEREAS the Canadian Dollar is the accepted currency for the purposes of this Agreement;

 

NOW THEREFORE in consideration and mutual covenants herein contained and such good and other consideration, the receipt and sufficiency of which is acknowledged by each of the parties, the parties hereto agree as follows:

 

1.Services, Term, and Compensation. The term of this Agreement (the “Term”), the services to be provided by BIG under this Agreement (the “Services”) and the amounts to be paid to BIG as full and complete consideration for BIG providing the Services under this Agreement (the “Fees”), are set out in the attached Schedule “A”, which forms part of this Agreement.

 

This Agreement shall come into force and effect as of the date set out first above, and shall continue as prescribed in Schedule “A”. In the event of the expiration or termination of this Agreement, the Client agrees to pay to BIG any and all unpaid Fees and expenses (as set forth herein) in full.

 

2.Independent Contractor. Subject to the terms and conditions of this Agreement, the Client hereby engages BIG as an independent contractor to perform the Services, and BIG hereby accepts such engagement. It is expressly agreed that BIG is acting as an independent contractor in performing the Services hereunder.

 

Page 1 of 11
 

 

 

3.Nature of Engagement. BIG shall perform the Services as an independent contractor, and nothing contained in this Agreement shall be construed to create or imply a joint venture, partnership, principal-agent, or employment relationship between the Client and BIG. Unless the Client specifically

 

authorizes BIG in writing to do so, BIG shall neither act or purport to be acting as the agent of the Client, nor enter into any agreement on behalf of the Client or otherwise bind, nor purport to bind the Client or cause the Client to incur liability in any manner whatsoever. All final decisions with respect to services provided by BIG hereunder shall be entirely the Client’s to make, and BIG shall have no liability relating to or arising from the Client’s decisions. It is understood that BIG’s responsibility to the Client is solely contractual in nature and that BIG does not act in a fiduciary capacity in relation to the Client as a result of this Agreement.

 

With the prior written consent of BIG, not to be unreasonably withheld, nothing in this Agreement shall prohibit the Client, or any entity chosen by the Client, from performing some or all of the functions of BIG herein. It is recognized that BIG will expend significant time and commit considerable resources to the Client. The Services are not exclusive to the Client however, and BIG may render similar services to other parties both during and after the Term.

 

4.Third-Party Expenses. The Client is responsible for paying specific disbursements charged by third parties to BIG relating to this Agreement, including graphic design, creative, legal and other advisory fees. The Client further agrees to reimburse BIG for any out-of-pocket expenses incurred by BIG in connection with this Agreement and carrying out the Services within thirty (30) days of presentation of reasonably itemized invoices to the Client as set forth in clause 5 below.

 

5.Billing. Accounts, including out-of-pocket expenses, will be rendered by BIG as prescribed in Schedule “A”. Interest on overdue accounts attracts interest which is calculated at the rate of 12% per annum commencing thirty (30) days following the date of the invoice until the account is paid in full. Any out-of-pocket expenses and disbursements to be charged by third parties shall be pre-approved by the Client.

 

6.Information Provided to BIG. The Client agrees BIG is entitled to rely (without independent verification) upon any information by the Client in relation to this agreement, including information with respect to the assets, liabilities, earnings, earning potential, financial condition, historical performance, future prospects and financial projections, and any assumptions used in the development of such projections furnished by the Client or any individual on behalf of the Client, and BIG is entitled to assume that all such information is true, correct and complete in all material respects and does not contain any untrue statements of material fact or omit to state a material fact necessary to ensure the information supplied is not misleading. BIG is not liable or responsible for any loss or damage suffered by the Client or others if any misstatement, error or omission in any material, information, document or representation supplied or approved by the Client. If at any time during the effectiveness of this Agreement, the Client or any of the Client’s agents or advisors becomes aware of any material change in any of the information previously furnished to BIG, the Client will promptly advise BIG of the change.

 

Page 2 of 11
 

 

 

7.Confidentiality.

 

a)For the purpose of this section, the term “Confidential Information” includes, but is not limited to, all business and financial information, marketing and strategic plans, equipment details, software

 

programs, manuals, maps, customer and client lists, employee information, supplier information, analyses, reports, technologies, processes and operations, compilations, forecasts, studies. lists, summaries, notes, designs, formulae, innovations, techniques, data, patents and trade secrets of the Client, as well as the present and contemplated products, techniques and other services evolved or to be used by the Client. Confidential Information does not include such portions of the Confidential Information which: (i) are, or prior to the time of disclosure or utilization become, generally available to the public; (ii) are received by BIG from an independent third party who had obtained the Confidential. Information lawfully and was, to the best of BIG’s knowledge, under

 

No obligation of secrecy or duty of confidentiality owed to the Client; (iii) BIG can show was in BIG’s lawful possession before BIG received such Confidential Information from the Client, or (iv) BIG can show that such Confidential Information was independently developed by BIG having no access to the Confidential Information at the time of its independent development.

 

b)In the course of performing the Services, BIG acknowledges and understands that it will have access to and will be entrusted with Confidential Information which is not public, but is proprietary and confidential to the Client. BIG shall keep the Confidential Information strictly confidential and shall take all necessary precautions against unauthorized disclosure of the Confidential Information during the Term of this Agreement and thereafter. BIG shall not use or reproduce any Confidential Information, in any manner, except as reasonably required to perform the Services and/or fulfill the purposes of this Agreement. BIG shall ensure that any copies of Confidential Information it takes or makes are clearly marked, or otherwise identified as confidential and proprietary to the Client and that all Confidential Information and copies thereof are stored in a secure location while in BIG’s possession, control, charge or custody.

 

c)BIG hereby agrees and acknowledges that the disclosure of any of the Confidential Information to competitors of the Client or to the general public would be highly detrimental to the best interests of the Client. Accordingly, BIG covenants and agrees with the Client that, save with the written consent of the Client, it will not, either during the Term of this Agreement, or at any time thereafter, directly or indirectly, disclose, allow access to, transmit or transfer any of such Confidential Information to any person other than its directors, officers, employees, consultants, agents and advisers or to similar representatives of the Client, nor shall it use the same for any purpose other than the purposes of performing the Services to be performed by BIG under this Agreement.

 

d)BIG acknowledges that it shall not acquire any right, title or interest in or to any Confidential Information by virtue of it having access to the same during the Term of this Agreement.

 

e)In the event BIG is requested or required pursuant to any Court order, or other legal or regulatory demand, to disclose any Confidential Information to a third party, BIG agrees that it will provide the Client with prompt notice of such request or requirement so that the Client, at its option, may seek an appropriate protective order or other remedies to ensure that Confidential Information will be accorded confidential treatment.

 

f)Upon termination or expiry of this Agreement, for whatever reason, BIG agrees to:

 

  (i) deliver to the Client, or destroy, all Confidential Information and copies thereof which are in its power or possession which relate in any way to the business of the Client, or its customers; and

 

  (ii) remove any Confidential Information from BIG’s computers, or computer databases that may have been created in the course of performing BIG’s Services under this Agreement (other than

 

information stored on back-up servers pursuant to the retention of files laws and policies) and certify the return or destruction of all documents containing Confidential Information.

 

Page 3 of 11
 

 

 

8.Ownership of Work Product. Any and all Work Product conceived, developed, reduced to practice or a definite and practical shape, invented, authored, wrote, created, produced or otherwise generated on behalf of BIG or by any employee, agent, contractor, representative or other individual acting on behalf of BIG (“BIG Personnel”) in connection with the performance of the Services will be the exclusive property of the Client. BIG shall assign and waive, and shall cause to be assigned or waived at BIG’s

 

expense, any right, title and interest in and to the Work Product to or in favor of the Client. In this Agreement, “Work Product” includes, without limitation any and all of the following: (a) any invention,

 

process, formula, algorithm, specification, technique, concept, idea, method, diagnostic, compound, development, composition, apparatus, machine, test, design, trade secret, know how or any improvement, modification, thereto or any issued patent, industrial design or application therefor applied for, issued or granted in any jurisdiction anywhere in the world, including but not limited to reissues, divisions, continuations, continuations-in-part, re-examinations, renewals and substitutes thereof, foreign counterparts of the foregoing, including, without limitation, the right to apply for Letters Patent in the United States, Canada and all other countries throughout the world and all rights to claim priority based on said applications under the terms of any international convention, and all rights in the United States, Canada and all other countries throughout the world to sue and recover for past or future infringement of such rights; (b) trade names, trademarks, trade secrets, service names, service marks, business names, product names, brands, logos and other distinctive identifications used in commerce, whether in connection with products or services, and the goodwill associated with any of the foregoing; (c) original works of authorship, derivative works and other copyrightable works of any nature, and fixations of any of the foregoing; (d) computer software or code of any type (whether source code or object code) in any programming or markup language, underlying any type of computer programming (whether application software, middleware, firm ware or system software) including, but not limited to, applets, assemblers, compilers, design tools, and user interfaces, databases and fixations thereof; (e) uniform resource locators, website addresses, domain names, website content and all fixations thereof; and (f) any other intellectual and industrial property in and to the foregoing, which is recognized under the law of any jurisdiction anywhere in the world, whether under common law, by statute or otherwise.

 

9.Moral Rights. BIG acknowledges and agrees that the Client may use, alter, vary, adapt and exploit any Work Product as the Client sees fit, in its sole and unfettered discretion. At its own expense, BIG shall cause to be assigned, waived or released any and all rights including, but not limited to, all moral rights (as defined under the Copyright Act (Canada)), in or otherwise relating to any Work Product in favor of the Client, its successor and assigns.

 

10.Further Assurances. At the requested of the Client, BIG will promptly do all acts and execute and deliver to the Client all instruments that may be required to effect, register, record, or otherwise perfect the interest of the Client in or relating to Work Product, and BIG will cause the BIG Personnel to do the same.

 

Page 4 of 11
 

 

 

11.Conflicts. BIG assists other companies and individuals, some of whom may, on occasion, be competitors or adverse in interest to the Client. BIG will not disclose to others any sensitive, proprietary or

 

otherwise confidential information of a non-public nature concerning or affecting the Client’s affairs, unless such disclosure is authorized by the client or required to defend BIG against any claim, action, suit, or proceeding, or to the extent such disclosure is required by any applicable law or regulation.

 

12.Announcements. Provided the Client has provided its prior written consent, not to be unreasonably withheld, BIG may, subject to compliance with paragraph 7 hereof, disclose the existence of this Agreement to certain persons and entities selected by BIG and in certain electronic and print publications, including BIG’s website. In accordance with all applicable laws, including the Client’s disclosure obligations under applicable securities laws, the Client is expressly permitted to make any required disclosures of this Agreement, including the material terms hereof.

 

13.Legal and Tax Advice. BIG will not provide or be responsible for obtaining legal or tax advice with respect to the Client, nor any other legal and regulatory requirements and issues which may arise pursuant to this Agreement. The Client is responsible for ensuring compliance with all of the Client’s legal and regulatory requirements in connection with all aspects of this Agreement.

 

14.Best Efforts/Timely Performance. BIG will use all reasonable efforts to perform the Services described in Schedule “A” to this Agreement within the time-frame agreed upon by the parties. Neither the execution and/or delivery of this Agreement, nor the provision of Services hereunder constitutes a guarantee or commitment, express or implied, on the part of BIG, as to the timeliness of BIG’s performance of the Services. Further, BIG shall not be liable for failures or delays in performance that arise from causes beyond our control.

 

15.Indemnification.

 

a)The Client shall indemnify BIG, its shareholders, directors, officers and employees (in each case, a “BIG Indemnitee”) from and against all losses, damages, costs and expenses, and hold such BIG Indemnitee harmless from and against any and all claims, liabilities, demands, actions, causes of action, lawsuits and proceedings which may be made or brought against or suffered by a BIG Indemnitee, or which it may suffer or incur as a result of, in respect of or arising out of, the performance of the Services. Notwithstanding the foregoing, no BIG Indemnitee shall be entitled to any indemnification by the Client for or in respect of any act, matter or omission caused by (i) fraud, wilful misconduct, bad faith or gross negligence; (ii) violation of applicable laws; or (iii) a breach of this Agreement.

 

b)BIG shall indemnify and hold harmless the Client, its shareholders, directors, officers and employees (in each case, an “Client Indemnitee”) from and against all losses, damages, costs and expenses, and hold such Client Indemnitee harmless from and against any and all claims, liabilities, demands, actions, causes of action, lawsuits and proceedings which may be made or brought against or suffered by a Client Indemnitee, which it may suffer or incur as a result of, in respect of or arising out of any act, matter or omission caused by BIG or any representative thereof: i) fraud, wilful misconduct, bad faith or gross negligence; (ii) violation of applicable laws; or (iii) a breach of this Agreement.

 

Page 5 of 11
 

 

 

16.Non-Solicitation. During the Term and for a period of one (1) year thereafter, the Client will not directly or indirectly recruit, solicit or hire any employee of BIG, or induce or attempt to induce any employee of BIG to terminate his/her employment with, or otherwise cease his/her relationship with BIG. During the

 

Term and for a period of one (1) year thereafter, BIG will not directly or indirectly recruit, solicit or hire any employee of the Client, or induce or attempt to induce any employee of the Client to terminate his/her employment with, or otherwise cease his/her relationship with the Client.

 

17.Successors and Assigns. This Agreement and all obligations and benefits of the Client and BIG shall bind the Client and BIG and any of the respective successors and assigns of either.

 

18.Termination on Notice.

 

a)Either party may terminate this Agreement at any time upon the provision of sixty (60) days written notice to the other party.

 

b)Upon termination of the Agreement BIG will be entitled to no further compensation except the following lump-sum payments (if applicable):

 

i)any fees and commissions earned to the effective date of termination;

 

ii)out of pocket expenses incurred prior to the effective date of termination which is otherwise reimbursable by the Client pursuant to the terms of this Agreement.

 

iii)a lump sum payment of $29,000 CAD (such amount reflecting 2 months of the pro-rata fees set forth in Schedule “A” attached hereto.

 

19.Arbitration of Disputes. The Client and BIG agree that all claims or controversies, whether such claims or controversies arose prior to, on, or subsequent to the date hereof, between the Client and BIG or any of the present or former members, managers, officers, employees, agents and representatives of either party concerning or arising from, without limitation, the construction, performance or breach of this Agreement, or any duty arising therefrom, shall be determined by arbitration. Any arbitration under this Agreement shall be conducted pursuant to the laws of the Province of Alberta before a single arbitrator and shall be binding upon the Client and BIG. The costs of the arbitrator shall be borne equally by the Client and BIG, and each of the Client and BIG shall bear their respective legal and other fees unless the arbitrator decides to allocate a greater burden of said costs and fees to the unsuccessful party.

 

20.Notices. Any and all notices, demands, or other communications required or desired to be given hereunder by any party shall be in:

 

a)writing and shall be validly given or made to another party if personally served, or if deposited in the Canadian mail, certified or registered, postage prepaid, return receipt requested, but not required; or

 

b)via electronic mail.

 

Page 6 of 11
 

 

 

If such notice or demand is served personally, notice shall be deemed constructively made at the time of such personal service. If such notice, demand or other communication is given by mail, such notice shall be conclusively deemed given five days after deposit thereof in the Canadian mail addressed to the party to whom such notice, demand or other communication is to be given as follows:

 

If to BIG:

 

Business Instincts Group Inc.,

L120, 2303 4 Street SW

Calgary, Alberta T2S 2S7

 

Attention: Erika Racicot

(403)992-7295

erika@businessinstincts.com

 

If to the Client:

Dragonfly Innovations Inc.

Attention: Paul Sun, CFO

416-569-5070

Paul.Sun@draganflyinnovations.com

 

Any party hereto may change its office or email addresses for purposes of this paragraph by written notice given in the manner provided above.

 

21.Waiver. Failure of either party hereto to insist upon strict compliance with any of the terms, covenants, and conditions hereof shall not be deemed a waiver or relinquishment of any similar right or power hereunder at any subsequent time or of any other provision hereof.

 

22.Modification or Amendment. No amendment, change or modification of this Agreement shall be valid unless in writing signed by the parties hereto,

 

23.Survival. Any provision of this Agreement which expressly states that it is to continue in effect after termination or expiration of this Agreement, or which by its nature would survive the termination or expiration of this Agreement, shall do so.

 

24.Severability. If anyone or more of the provisions of this Agreement shall for any reason be held to be invalid, illegal, or unenforceable in any respect, any such provision shall be severable from this Agreement, in which event this Agreement shall be construed as if such provision had never been contained herein and the remainder of this Agreement shall nevertheless remain in full force and effect.

 

25.Entire Understanding. This document, and Schedule “A” hereto, constitute the entire understanding and agreement of the parties, and any and all prior agreements, understandings, and representations are hereby terminated and canceled in their entirety and are of no further force and effect.

 

26.Jurisdiction. The laws of the Province of Alberta shall govern the validity of this Agreement, the construction of its terms and the interpretation of the rights and duties of the parties hereto. The parties hereto irrevocably submit to the jurisdiction of Alberta for the purpose of any legal suit, action or other proceeding arising out of the Agreement.

 

27.Counterparts. Each party hereto may sign this Agreement in counterparts and deliver such counterparts by facsimile or other electronic delivery, which parts will be read together and construed as if all signing parties had signed one copy of this Agreement.

 

Page 7 of 11
 

 

 

IN WITNESS WHEREOF the undersigned have executed this Agreement as of the day and year first written above.

 

 

Page 8 of 11
 

 

 

SCHEDULE A

 

BUSINESS SERVICES, MONTHLY RATE, SCOPE OF WORK, and TERM

 

Business Instincts Group Inc., (“BIG”) will provide staffing, business functions, and other business services in the following areas to Draganfly Innovations Inc. (“the Client”) on an on-going basis during the term of the Agreement.

 

All figures in Canadian Dollars, applicable taxes are in addition.

 

Service   Deliverables   Fee

Corporate Development and

 

BIG has been engaged to create and deliver:

 
Governance        

(Monthly)   Provide Executive Management Support;   $7,500.00
         
  Liaison with Management and the Board of Directors and Advisors to provide clarity on the best path forward for Draganfly and partners;    
           
    Ongoing business development work, including prospecting, sales, and pipeline management;    
           
    Ongoing corporate development and mergers and acquisitions work;    
           
    Create and manage investor presentations and investor material;    
           
    Recruitment efforts surrounding Executives, Board of Directors, Board of Advisors, and Management level employees    
           
    Manage shareholder communication process;    
           
    Provide assistance in developing Capital structures;    
           
    Partner integrations where applicable;    
           
    Assist and provide guidance on product/service development; and    
           
    Assist with financing efforts;    

 

Page 9 of 11
 

 

 

Strategic Facilitation & Management

(Monthly)

 

RIPKIT implementation, including quarterly and monthly strategy sessions and weekly meetings;

 
  Access to the RIPKIT platform for monitoring and goal tracking; and   $2,500.00
           
    Weekly Tracking of RIPs, and Strategic goals, including Offsite sessions, RIP resets and team alignment meetings.    
           
    Project facilitator to assist in project growth and support.    
           
    Coordination of efforts between all areas of the business to ensure projects and timelines stay on track.    

 

Business Services

(Monthly)

 

Provide personnel to directly support Draganfly Innovations Senior Management with respect to:

 

HR Support & recruiting support;

 

Administration and project coordination of basic marketing initiatives.

  $2,500.00
         
Shared Office Space LA Office   Office/Shop space including up to 2desks   $2000.00

 

Total Fee (Monthly): $14,500 (plus tax)

 

Term:

 

March 1, 2020— July 31, 2020

 

Performance:

 

Our performance will be reviewed quarterly, measured against the RIPKIT by the Client and the BIG team.

 

Fees:

 

As compensation for the services rendered pursuant to this agreement, and as compensation for the past services provided by BIG to the client prior to the effective date of the agreement, the client shall pay to BIG any amounts due within 30 days of the invoice plus any applicable tax. All expenses incurred will be billed directly to BIG and allocated to the Client appropriately.

 

The Client understands that based on workloads surrounding financing efforts, capital structure, shareholder engagement/communications, business development, and marketing initiatives there may be an increase in billing within select months. This increase will only occur with previous management approval of the request.

 

 

Page 10 of 11
 

 

 

SCHEDULE B

 

SHAREHOLDER MARKETING VIDEO CONTENT SCOPE OF WORK

 

Business Instincts Group Inc., (“BIG”) will provide video marketing services in the following areas to Draganfly Innovations Inc. (“the Client”) on an on-going basis during the term of the 3-month engagement, budget to be in part allocated through Draganfly’s marketing initiatives.

 

All figures in Canadian Dollars, applicable taxes are in addition.

 

Service   Deliverables   Fee
Corporate Business Development Video Content  

BIG has been engaged to create and deliver:

 

BIG implementation of the awareness to advocacy video series;

  $47,000
         

    Video Production of 15 Corporate videos reflecting the Draganfly story, their ability to execute, service and solutions set.    

 

*Total Fee: $47,000 (plus tax)

 

*BIG acknowledges that payment has already been made for this service. Videos will be delivered during the term of this agreement.

 

Term:

 

March 1, 2020—July 31, 2020

 

Fees:

 

As compensation for the services rendered pursuant to this agreement, and as compensation for the past services provided by BIG to the client prior to the effective date of the agreement, the client shall pay to BIG any amounts due within 30 days of the invoice plus any applicable tax. All expenses incurred with be billed directly to BIG and allocated to the Client appropriately. The Client understands that based on workloads surrounding financing efforts, capital structure, shareholder engagement/communications, business development, and marketing initiatives there may be an increase in billing within select months. This increase will only occur with previous management approval of the request.

 

 

Page 11 of 11

EX-4.2 10 ex4-2.htm

 

Exhibit 4.2

 

DRAGANFLY INC.

 

sHARE COMPENSATION PLAN

 

1. DEFINITIONS AND INTERPRETATION

 

1.1 Definitions: For purposes of the Plan, unless the context requires otherwise, the following words and terms shall have the following meanings:

 

  (a) 1933 Act” means the United States Securities Act of 1933, as amended;
     
  (b) Account” has the meaning attributed to that term in section 4.8;
     
  (c) Administrators” means the Board or such other persons as may be designated by the Board from time to time;
     
  (d) Affiliate” has the meaning attributed to that term in the Securities Act (British Columbia);
     
  (e) Associate” has the meaning attributed to that term in the Securities Act (British Columbia);
     
  (f) Award Date” means the date or dates on which an award of Restricted Share Units is made to a Participant in accordance with section 4.1;
     
  (g) Blackout Period” means the period during which designated directors, officers and employees of the Corporation cannot trade the Common Shares pursuant to the Corporation’s policy respecting restrictions on directors’, officers’ and employee trading which is in effect at that time (which, for greater certainty, does not include the period during which a cease trade order is in effect to which the Corporation or in respect of an insider, that insider is subject);
     
  (h) Board” means the board of directors of the Corporation from time to time;
     
  (i) Business Day” means each day other than a Saturday, Sunday or statutory holiday in Vancouver, British Columbia, Canada;
     
  (j) Change of Control” means:

 

  (i) the acceptance of an Offer by a sufficient number of holders of voting shares in the capital of the Corporation to constitute the offeror, together with persons acting jointly or in concert with the offeror, a shareholder of the Corporation being entitled to exercise more than 50% of the voting rights attaching to the outstanding voting shares in the capital of the Corporation (provided that prior to the Offer, the offeror was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting shares in the capital of the Corporation),
     
  (ii) the completion of a consolidation, merger or amalgamation of the Corporation with or into any other corporation whereby the voting shareholders of the Corporation immediately prior to the consolidation, merger or amalgamation receive less than 50% of the voting rights attaching to the outstanding voting shares of the consolidated, merged or amalgamated corporation or any parent entity, or  

 

 
- 2 -

 

  (iii) the completion of a sale whereby all or substantially all of the Corporation’s undertakings and assets become the property of any other entity and the voting shareholders of the Corporation immediately prior to that sale hold less than 50% of the voting rights attaching to the outstanding voting securities of that other entity immediately following that sale;

 

Notwithstanding the foregoing, if it is determined that an award hereunder with respect to a U.S. Participant is subject to the requirements of Section 409A of the Code and payable upon a Change of Control, the Corporation will not be deemed to have undergone a Change of Control unless the Corporation is deemed to have undergone a “change in control event” pursuant to the definition of such term in Section 409A of the Code to the extent required for the award to comply with Section 409A of the Code;

 

  (k) “Code” means the U.S. Internal Revenue Code of 1986, as amended, and includes the valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder;
     
  (l) Common Shares” means the common shares of the Corporation;
     
  (m) Consultant” means an individual (other than an employee or a director of the Corporation) or company that:

 

    (A) is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Corporation or to an Affiliate of the Corporation, other than services provided in relation to an offer or sale of securities of the Corporation in a capital-raising transaction, or services that promote or maintain a market for the Corporation’s securities;
       
    (B) provides the services under a written contract between the Corporation or the Affiliate and the individual or the company, as the case may be;
       
    (C) in the reasonable opinion of the Corporation, spends or will spend a significant amount of time and attention on the affairs and business of the Corporation or an Affiliate of the Corporation; and
       
    (D) has a relationship with the Corporation or an Affiliate of the Corporation that enables the individual to be knowledgeable about the business and affairs of the Corporation;

 

  (n) Corporation” means Draganfly Inc., a corporation existing under the Business Corporations Act (British Columbia) and the successors thereof;
     
  (o) Effective Date” means August 19, 2019;

 

 
- 3 -

 

  (p) Eligible Person” means:

 

  (i) any officer or employee of the Corporation and/or any officer or employee of any Subsidiary of the Corporation and any director of the Corporation and/or any director of any Subsidiary of the Corporation; and
     
  (ii) a Consultant;

 

  (q) Event of Termination” means an event whereby a Participant ceases to be an Eligible Person and shall be deemed to have occurred by the giving of any notice of termination of employment or service (whether voluntary or involuntary and whether with or without cause), retirement, or any cessation of employment or service for any reason whatsoever, including disability or death;
     
  (r) Exchange” means the Canadian Stock Exchange or any other stock exchange or quotation system where the Common Shares are listed on or through which the Common Shares are listed or quoted;
     
  (s) Grant Date” means the date on which a grant of Options is made to a Participant in accordance with section 5.1;
     
  (t) insider” has the meaning attributed to that term in the Securities Act (British Columbia);
     
  (u) Insider Participant” means a Participant who is (i) an insider of the Corporation or any of its Subsidiaries, and (ii) an associate of any person who is an insider by virtue of (i);
     
  (v) Investor Relations Activities” means any activities, by or on behalf of the Corporation or shareholder of the Corporation, that promote or reasonably could be expected to promote the purchase or sale of securities of the Corporation, but does not include:

 

  (i) the dissemination of information provided, or records prepared, in the ordinary course of business of the Corporation:

 

    (A) to promote the sale of products or services of the Corporation, or
       
    (B) to raise public awareness of the Corporation, that cannot reasonably be considered to promote the purchase or sale of securities of the Corporation;

 

  (ii) activities or communications necessary to comply with the requirements of:

 

    (A) applicable securities laws;
       
    (B) the by-laws, rules or other regulatory instruments of the Exchange or any other self-regulatory body or exchange having jurisdiction over the Corporation;

 

 
- 4 -

 

  (iii) communications by a publisher of, or writer for, a newspaper, magazine or business or financial publication, that is of general and regular paid circulation, distributed only to subscribers to it for value or to purchasers of it, if:

 

    (A) the communication is only through the newspaper, magazine or publication, and
       
    (B) the publisher or writer receives no commission or other consideration other than for acting in the capacity of publisher or writer; or

 

  (iv) activities or communications that may be otherwise specified by the Exchange.

 

  (w) Market Price” means, as of any date, the closing price of the Common Shares on the Exchange for the last market trading day prior to the date of grant of the Option or if the Common Shares are not listed on a stock exchange, the Market Price shall be determined in good faith by the Administrators;
     
  (x) Market Value” means, on any date, the volume weighted average price of the Common Shares traded on the Exchange for the five (5) consecutive trading days prior to such date;
     
  (y) Offer” means a bona fide arm’s length offer made to all holders of voting shares in the capital of the Corporation to purchase, directly or indirectly, voting shares in the capital of the Corporation;
     
  (z) Option” means an option granted to an Eligible Person under the Plan to purchase Common Shares;
     
  (aa) Option Agreement” has the meaning ascribed to that term in section 3.2;
     
  (bb) Participant” means an Eligible Person selected by the Administrators to participate in the Plan in accordance with section 3.1 hereof;
     
  (cc) Payout Date” means the day on which the Corporation pays to a Participant the Market Value of the RSUs that have become vested and payable;
     
  (dd) Plan” means this share compensation plan, as amended, replaced or restated from time to time;
     
  (ee) reserved for issuance” refers to Common Shares that may be issued in the future upon the vesting of Restricted Share Units which have been awarded and upon the exercise of Options which have been granted;
     
  (ff) Restricted Share Unit” means a right granted in accordance with section 4.1 hereof to receive one Common Share that becomes vested in accordance with section 4.3;
     
  (gg) Restricted Share Unit Agreement” has the meaning ascribed to that term in section 3.2;
     
  (hh) Share Compensation Arrangement” means a stock option, stock option plan, employee stock purchase plan or any other compensation or incentive mechanism involving the issuance or potential issuance of Common Shares to directors, officers and employees of the Corporation and any of its Subsidiaries or to Consultants;

 

 
- 5 -

 

  (ii) Subsidiary” has the meaning ascribed thereto in the Securities Act (British Columbia) and “Subsidiaries” shall have a corresponding meaning;

 

  (jj) United States” means the United States of America, its territories and possessions, any state of the United States and the District of Columbia;
     
  (kk) U.S. Participant” means a Participant who is a citizen of the United States or a resident of the United States, as defined in section 7701(a)(30)(A) and section 7701(b)(1) of the Code and any other Participant who is subject to tax under the Code with respect to compensatory awards granted pursuant to the Plan;
     
  (ll) U.S. Person” means a “U.S. person”, as such term is defined in Rule 902 of Regulation S under the 1933 Act; and
     
  (mm) Withholding Obligations” has the meaning ascribed to that term in section 4.6.

 

1.2 Headings: The headings of all articles, sections, and paragraphs in the Plan are inserted for convenience of reference only and shall not affect the construction or interpretation of the Plan.
   
1.3 Context, Construction: Whenever the singular or masculine are used in the Plan, the same shall be construed as being the plural or feminine or neuter or vice versa where the context so requires.
   
1.4 References to this Plan: The words “hereto”, “herein”, “hereby”, “hereunder”, “hereof” and similar expressions mean or refer to the Plan as a whole and not to any particular article, section, paragraph or other part hereof.
   
1.5 Currency: All references in this Plan or in any agreement entered into under this Plan to “dollars”, “$” or lawful currency shall be references to Canadian dollars, unless the context otherwise requires.

 

2. PURPOSE AND ADMINISTRATION OF THE PLAN

 

2.1 Purpose: The purpose of the Plan is to advance the interests of the Corporation and its Subsidiaries, and its shareholders by: (i) ensuring that the interests of Eligible Persons are aligned with the success of the Corporation and its Subsidiaries; (ii) encouraging stock ownership by Eligible Persons; and (iii) providing compensation opportunities to attract, retain and motivate Eligible Persons.

 

2.2 Common Shares Subject to the Plan:

 

  (a) The total number of Common Shares reserved and available for grant and issuance pursuant to this Plan, and the total number of Restricted Share Units that may be awarded pursuant to this Plan, shall not exceed 20% (in the aggregate) of the issued and outstanding Common Shares from time to time;

 

 
- 6 -

 

  (b) The aggregate sales price (meaning the sum of all cash, property, notes, cancellation of debt, or other consideration received or to be received by the Corporation for the sale of the securities) or amount of Common Shares issued during any consecutive 12-month period will not exceed the greatest of the following: (i) U.S.$1,000,000; (ii) 15% of the total assets of the Corporation, measured at the Corporation’s most recent balance sheet date; or (iii) 15% of the outstanding amount of the Common Shares of the Corporation, measured at the Corporation’s most recent balance sheet date; and
     
  (c) The number of Common Shares issuable pursuant to the exercise of Options under the Plan within a 12 month period to all Eligible Persons retained to provide Investor Relations Activities (together with those Common Shares that are issued pursuant to any other Share Compensation Arrangement) shall not, at any time, exceed 1% of the issued and outstanding Common Shares.

 

2.3 Administration of the Plan: The Plan shall be administered by the Administrators, through the recommendation of the Compensation Committee of the Board. Subject to any limitations of the Plan, the Administrators shall have the power and authority to:

 

  (a) adopt rules and regulations for implementing the Plan;
     
  (b) determine the eligibility of persons to participate in the Plan, when Restricted Share Units and Options to Eligible Persons shall be awarded or granted, the number of Restricted Share Units and Options to be awarded or granted, the vesting criteria for each award of Restricted Share Units and the vesting period for each grant of Options;
     
  (c) interpret and construe the provisions of the Plan and any agreement or instrument under the Plan;
     
  (d) subject to regulatory requirements, make exceptions to the Plan in circumstances which they determine to be exceptional;
     
  (e) require that any Participant provide certain representations, warranties and certifications to the Corporation to satisfy the requirements of applicable laws, including without limitation, the registration requirements of the 1933 Act and applicable state securities laws, or exemptions therefrom; and
     
  (f) make all other determinations and take all other actions as they determine to be necessary or desirable to implement, administer and give effect to the Plan.

 

3. ELIGIBILITY AND PARTICIPATION IN PLAN

 

3.1 The Plan and Participation: The Plan is hereby established for Eligible Persons. Restricted Share Units may be awarded and Options may be granted to any Eligible Person as determined by the Administrators in accordance with the provisions hereof. The Corporation and each Participant acknowledge that they are responsible for ensuring and confirming that such Participant is a bona fide Eligible Person entitled to receive Options or Restricted Share Units, as the case may be.
   
3.2 Agreements: All Restricted Share Units awarded hereunder shall be evidenced by a restricted share unit agreement (“Restricted Share Unit Agreement”) between the Corporation and the Participant, substantially in the form set out in Exhibit A or in such other form as the Administrators may approve from time to time. All Options granted hereunder shall be evidenced by an option agreement (“Option Agreement”) between the Corporation and the Participant, substantially in the form as set out in Exhibit B or in such other form as the Administrators may approve from time to time.

 

 
- 7 -

 

4. AWARD OF RESTRICTED SHARE UNITS

 

4.1 Award of Restricted Share Units: The Administrators may, at any time and from time to time, award Restricted Share Units to Eligible Persons. In awarding any Restricted Share Units, the Administrators shall determine:

 

  (a) to whom Restricted Share Units pursuant to the Plan will be awarded;
     
  (b) the number of Restricted Share Units to be awarded and credited to each Participant’s Account;
     
  (c) the Award Date; and
     
  (d) subject to section 4.3 hereof, the applicable vesting criteria.

 

Upon the award of Restricted Share Units, the number of Restricted Share Units awarded to a Participant shall be credited to the Participant’s Account effective as of the Award Date.

 

4.2 Restricted Share Unit Agreement: Upon the award of each Restricted Share Unit to a Participant, a Restricted Share Unit Agreement shall be delivered by the Administrators to the Participant.

 

4.3 Vesting:

 

  (a) Subject to subsections (c) and (d) below, at the time of the award of Restricted Share Units, the Administrators shall determine in their sole discretion the vesting criteria applicable to such Restricted Share Units.
     
  (b) For greater certainty, the vesting of Restricted Share Units may be determined by the Administrators to include criteria such as performance vesting, in which the number of Common Shares to be delivered to a Participant for each Restricted Share Unit that vests may fluctuate based upon the Corporation’s performance and/or the Market Price of the Common Shares, in such manner as determined by the Administrators in their sole discretion.
     
  (c) Each Restricted Share Unit shall be subject to vesting in accordance with the terms set out in the Restricted Share Unit Agreement.
     
  (d) Notwithstanding anything to the contrary in this Plan, all vesting and issuances or payments, as applicable, in respect of a Restricted Share Unit shall be completed no later than December 15 of the third calendar year commencing after the Award Date for such Restricted Share Unit.

 

 
- 8 -

 

4.4 Blackout Periods: Should the date of vesting of a Restricted Share Unit fall within a Blackout Period or within nine Business Days following the expiration of a Blackout Period, such date of vesting shall be automatically extended without any further act or formality to that date which is the tenth Business Day after the end of the Blackout Period, such tenth Business Day to be considered the date of vesting for such Restricted Share Unit for all purposes under the Plan. Notwithstanding section 6.4 hereof, the ten Business Day period referred to in this section 4.4 may not be extended by the Board.
   
4.5 Vesting and Settlement: As soon as practicable after the relevant date of vesting of any Restricted Share Units awarded under the Plan and with respect to a U.S. Participant, no later than 60 days thereafter, but subject to subsection 4.3(d), a Participant shall be entitled to receive and the Corporation shall issue or pay (at its discretion):

 

  (a) a lump sum payment in cash equal to the number of vested Restricted Share Units recorded in the Participant’s Account multiplied by the Market Value of a Common Share on the Payout Date;
     
  (b) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s Restricted Share Units in the Participant’s Account, duly issued as fully paid and non-assessable shares and such Participant shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares; or
     
  (c) any combination of the foregoing.

 

4.6 Taxes and Source Deductions: the Corporation or an affiliate of the Corporation may take such reasonable steps for the deduction and withholding of any taxes and other required source deductions which the Corporation or the affiliate, as the case may be, is required by any law or regulation of any governmental authority whatsoever to remit in connection with this Plan, any Restricted Share Units or any issuance of Common Shares (“Withholding Obligations”). Without limiting the generality of the foregoing, the Corporation may, at its discretion: (i) deduct and withhold those amounts it is required to remit pursuant to the Withholding Obligations from any cash remuneration or other amount payable to the Participant, whether or not related to the Plan, the vesting of any Restricted Share Units or the issue of any Common Shares; (ii) allow the Participant to make a cash payment to the Corporation equal to the amount required to be remitted, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant; or (iii) settle a portion of vested Restricted Share Units of a Participant in cash equal to the amount the Corporation is required to remit, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant. Where the Corporation considers that the steps undertaken in connection with the foregoing result in inadequate withholding or a late remittance of taxes, the delivery of any Common Shares to be issued to a Participant on vesting of any Restricted Share Units may be made conditional upon the Participant (or other person) reimbursing or compensating the Corporation or making arrangements satisfactory to the Corporation for the payment to it in a timely manner of all taxes required to be remitted, pursuant to the Withholding Obligations, for the account of the Participant.

 

 
- 9 -

 

4.7 Rights Upon an Event of Termination:

 

  (a) If an Event of Termination has occurred in respect of any Participant, any and all Common Shares corresponding to any vested Restricted Share Units in the Participant’s Account shall be issued as soon as practicable after the Event of Termination to the former Participant in accordance with section 4.5 hereof. With respect to each Restricted Share Unit of a U.S. Participant, such Restricted Share Unit will be settled and shares issued as soon as practicable following the date of vesting of such Restricted Share Unit as set forth in the applicable Restricted Share Unit Agreement, but in all cases within 60 days following such date of vesting.
     
  (b) If an Event of Termination has occurred in respect of any Participant, any unvested Restricted Share Units in the Participant’s Account shall, unless otherwise determined by the Administrators in their discretion, forthwith and automatically be forfeited by the Participant and cancelled. With respect to any Restricted Share Unit of a U.S. Participant, if the Administrators determine, in their discretion, to waive vesting conditions applicable to a Restricted Share Unit that is unvested at the time of an Event of Termination, such Restricted Share Unit shall not be forfeited or cancelled, but instead will be deemed to be vested and settled and shares delivered following the date of vesting of such Restricted Share Unit as set forth in the applicable Restricted Share Unit Agreement.
     
  (c) Notwithstanding the foregoing subsection 4.7(b) and subject to the requirements of the Exchange, if a Participant retires in accordance with the Corporation’s retirement policy, at such time, any unvested performance-based Restricted Share Units in the Participant’s Account shall not be forfeited by the Participant or cancelled and instead shall be eligible to become vested in accordance with the vesting conditions set forth in the applicable Restricted Share Unit Agreement after such retirement (as if retirement had not occurred), but only if the performance vesting criteria, if any, are met on the applicable date.
     
  (d) For greater certainty, if a Participant’s employment is terminated for just cause, each unvested Restricted Share Unit in the Participant’s Account shall forthwith and automatically be forfeited by the Participant and cancelled.
     
  (e) For the purposes of this Plan and all matters relating to the Restricted Share Units, the date of the Event of Termination shall be determined without regard to any applicable severance or termination pay, damages, or any claim thereto (whether express, implied, contractual, statutory, or at common law).

 

4.8 Restricted Share Unit Accounts: A separate notional account for Restricted Share Units shall be maintained for each Participant (an “Account”). Each Account will be credited with Restricted Share Units awarded to the Participant from time to time pursuant to section 4.1 hereof by way of a bookkeeping entry in the books of the Corporation. On the vesting of the Restricted Share Units pursuant to section 4.3 hereof and the corresponding issuance of Common Shares to the Participant pursuant to section 4.5 hereof, or on the forfeiture and cancellation of the Restricted Share Units pursuant to section 4.7 hereof, the applicable Restricted Share Units credited to the Participant’s Account will be cancelled.

 

 
- 10 -

 

4.9 Record Keeping: the Corporation shall maintain records in which shall be recorded:

 

  (a) the name and address of each Participant;
     
  (b) the number of Restricted Share Units credited to each Participant’s Account;
     
  (c) any and all adjustments made to Restricted Share Units recorded in each Participant’s Account; and
     
  (d) any other information which the Corporation considers appropriate to record in such records.

 

5. GRANT OF OPTIONS

 

5.1 Grant of Options: Subject to section 2.2, the total number of Common Shares reserved and available for grant pursuant to this section on exercise of Options (together with those Common Shares issuable pursuant to any other Share Compensation Arrangement, including Restricted Share Units) shall not exceed 20% of the number of issued and outstanding Common Shares from time to time.

 

The Administrators may at any time and from time to time grant Options to Eligible Persons. In granting any Options, the Administrators shall determine:

 

  (a) to whom Options pursuant to the Plan will be granted;
     
  (b) the number of Options to be granted, the Grant Date and the exercise price of each Option;
     
  (c) the expiration date of each Option; and
     
  (d) subject to section 5.3 hereof, the applicable vesting criteria,

 

provided, however that the exercise price for a Common Share pursuant to any Option shall not be less than the Market Price on the Grant Date in respect of that Option.

 

5.2 Option Agreement: Upon each grant of Options to a Participant, an Option Agreement shall be delivered by the Administrators to the Participant.
   
5.3 Vesting:

 

  (a) Subject to subsection 2.2(c) above with respect to grants to Eligible Persons providing Investor Relations Activities, at the time of the grant of any Options, the Administrators shall determine, in accordance with minimum vesting requirements of the Exchange, the vesting criteria applicable to such Options.
     
  (b) The Administrators may determine when any Option will become exercisable and may determine that Options shall be exercisable in instalments or pursuant to a vesting schedule. The Option Agreement will disclose any vesting conditions prescribed by the Administrators.

 

 
- 11 -

 

5.4 Term of Option/Blackout Periods: The term of each Option shall be determined by the Administrators; provided that no Option shall be exercisable after ten years from the Grant Date. Should the term of an Option expire on a date that falls within a Blackout Period or within nine Business Days following the expiration of a Blackout Period, such expiration date shall be automatically extended without any further act or formality to that date which is the tenth Business Day after the end of the Blackout Period, such tenth Business Day to be considered the expiration date for such Option for all purposes under the Plan. Notwithstanding section 6.4 hereof, the ten Business Day period referred to in this section 5.4 may not be extended by the Board.

 

5.5 Exercise of Option:

 

Options that have vested in accordance with the provisions of this Plan and the applicable Option Agreement may be exercised at any time, or from time to time, during their term and subject to the provisions of Section 5.9 hereof as to any number of whole Common Shares that are then available for purchase thereunder; provided that no partial exercise may be for less than 100 whole Common Shares. Options may be exercised by delivery of a written notice of exercise to the Administrators, substantially in the form attached to this Plan as Exhibit C, with respect to the Options, or by any other form or method of exercise acceptable to the Administrators.

 

5.6 Payment and Issuance:

 

  (a) Upon actual receipt by the Corporation or its agent of the materials required by subsection 5.5 and receipt by the Corporation of cash, a cheque, bank draft or other form of acceptable payment for the aggregate exercise price, the number of Common Shares in respect of which the Options are exercised will be issued as fully paid and non-assessable shares and the Participant exercising the Options shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares. No person or entity shall enjoy any part of the rights or privileges of a holder of Common Shares which are subject to Options until that person or entity becomes the holder of record of those Common Shares. No Common Shares will be issued by the Corporation prior to the receipt of payment by the Corporation for the aggregate exercise price for the Options being exercised.
     
  (b) Without limiting the foregoing, unless otherwise determined by the Administrators or not compliant with any applicable laws or rules of the Exchange, a Participant may elect a cashless exercise in a notice of exercise in accordance with the following: (i) cashless exercise of Options shall only be available to a Participant who intends to immediately sell the Common Shares issuable upon exercise of such Options and the proceeds of sale will be sufficient to satisfy the exercise price of the Options, and (ii) if an eligible Participant elects to exercise the Options through cashless exercise and complies with any relevant protocols approved by the Administrators, a sufficient number of the Common Shares issued upon exercise of the Options will be sold by a designated broker on behalf of the Participant to satisfy the exercise price of the Options, the exercise price of the Options will be delivered to the Corporation and the Participant will receive only the remaining unsold Common Shares from the exercise of the Options and the net proceeds of the sale after deducting the exercise price of the Options, applicable taxes and any applicable fees and commissions, all as determined by the Administrators from time to time. The Corporation shall not deliver the Common Shares issuable upon a cashless exercise of Options until receipt of the exercise price therefor, whether by a designated broker selling the Common Shares issuable upon exercise of such Options through a short position or such other method determined by the Administrators in compliance with applicable laws.

 

 
- 12 -

 

5.7 Cashless Exercise: Provided that the Common Shares are listed and posted for trading on a stock exchange or market that permits cashless exercise, a Participant may elect a cashless exercise in a notice of exercise, which election will result in all of the Common Shares issuable on the exercise being sold. In such case, the Participant will not be required to deliver to the Administrators a cheque or other form of payment for the aggregate exercise price referred to above. Instead the following provisions will apply:

 

  (a) The Participant will instruct a broker selected by the Participant to sell through the stock exchange or market on which the Common Shares are listed or quoted, the Common Shares issuable on the exercise of Options, as soon as possible upon the issue of such Common Shares to the Participant at the then applicable bid price of the Common Shares.
     
  (b) Before the relevant trade date, the Participant will deliver the exercise notice including details of the trades to the Corporation electing the cashless exercise and the Corporation will direct its registrar and transfer agent to issue a certificate for such Participant’s Common Shares in the name of the broker (or as the broker may otherwise direct) for the number of Common Shares issued on the exercise of the Options, against payment by the broker to the Corporation of (i) the exercise price for such Common Shares; and (ii) the amount the Corporation determines, in its discretion, is required to satisfy the Corporation withholding tax and source deduction remittance obligations in respect of the exercise of the Options and issuance of Common Shares.
     
  (c) The broker will deliver to the Participant the remaining proceeds of sale, net of any brokerage commission or other expenses.

 

5.8 Taxes and Source Deductions: The Corporation or an affiliate of the Corporation may take such reasonable steps for the deduction and withholding of any taxes and other required source deductions which the Corporation or the affiliate, as the case may be, is required by any law or regulation of any governmental authority whatsoever to remit pursuant to the Withholding Obligations in connection with this Plan, any Options or any issuance of Common Shares. Without limiting the generality of the foregoing, the Corporation may, at its discretion: (i) deduct and withhold those amounts it is required to remit, pursuant to the Withholding Obligations, from any cash remuneration or other amount payable to the Participant, whether or not related to the Plan, the exercise of any Options or the issue of any Common Shares; or (ii) allow the Participant to make a cash payment to the Corporation equal to the amount required to be remitted, pursuant to the Withholding Obligations, which amount shall be remitted by the Corporation to the appropriate governmental authority for the account of the Participant. Where the Corporation considers that the steps undertaken in connection with the foregoing result in inadequate withholding or a late remittance of taxes, the delivery of any Common Shares to be issued to a Participant on the exercise of Options may be made conditional upon the Participant (or other person) reimbursing or compensating the Corporation or making arrangements satisfactory to the Corporation for the payment in a timely manner of all taxes required to be remitted, pursuant to the Withholding Obligations, for the account of the Participant.

 

 
- 13 -

 

5.9 Rights Upon an Event of Termination:

 

  (a) If an Event of Termination has occurred in respect of a Participant, any unvested Options, to the extent not available for exercise as of the date of the Event of Termination, shall, unless otherwise determined by the Administrators in their discretion, forthwith and automatically be cancelled, terminated and not available for exercise without further consideration or payment to the Participant.
     
  (b) Except as otherwise stated herein or otherwise determined by the Administrators in their discretion (provided such determination does not exceed a maximum of one year), upon the occurrence of an Event of Termination in respect of a Participant, any vested Options granted to the Participant that are available for exercise may be exercised only before the earlier of:

 

  (i) the expiry of the Option; and
     
  (ii) six months after the date of the Event of Termination.

 

  (c) Notwithstanding the foregoing subsections 5.9(a) and (b), if a Participant’s employment is terminated for just cause, each Option held by the Participant, whether or not then exercisable, shall forthwith and automatically be cancelled and may not be exercised by the Participant.
     
  (d) For the purposes of this Plan and all matters relating to the Options, the date of the Event of Termination shall be determined without regard to any applicable severance or termination pay, damages, or any claim thereto (whether express, implied, contractual, statutory, or at common law).

 

5.10 Record Keeping: The Corporation shall maintain an Option register in which shall be recorded:

 

  (a) the name and address of each holder of Options;
     
  (b) the number of Common Shares subject to Options granted to each holder of Options;
     
  (c) the term of the Option and exercise price, including adjustments for each Option granted; and
     
  (d) any other information which the Corporation considers appropriate to record in such register.

 

6. GENERAL

 

6.1 Effective Date of Plan: The Plan shall be effective as of the Effective Date.

 

 
- 14 -

 

6.2 Change of Control: If there is a Change of Control transaction then, notwithstanding any other provision of this Plan except subsection 4.3(d) which will continue to apply in all circumstances, the Administrators may, in their sole discretion, determine that any or all unvested Restricted Share Units and any or all Options (whether or not currently exercisable) shall vest or become exercisable, as applicable, at such time and in such manner as may be determined by the Administrators in their sole discretion such that Participants under the Plan shall be able to participate in the Change of Control transaction, including, at the election of the holder thereof, by surrendering such Restricted Share Units and Options to the Corporation or a third party or exchanging such Restricted Share Units or Options, for consideration in the form of cash and/or securities, to be determined by the Administrators in their sole discretion. Notwithstanding the foregoing, with respect to Options of U.S. Participants, any exchange, substitution or amendment of such Options will occur only to the extent and in a manner that will not result in the imposition of taxes under Section 409A of the Code, and with respect to Restricted Share Units of U.S. Participants, any surrender or other modification of Restricted Share Units will occur only to the extent such surrender or other modification will not result in the imposition of taxes under Section 409A of the Code.

 

6.3 Reorganization Adjustments:

 

  (a) In the event of any declaration by the Corporation of any stock dividend payable in securities (other than a dividend which may be paid in cash or in securities at the option of the holder of Common Shares), or any subdivision or consolidation of Common Shares, reclassification or conversion of Common Shares, or any combination or exchange of securities, merger, consolidation, recapitalization, amalgamation, plan of arrangement, reorganization, spin off involving the Corporation, distribution (other than normal course cash dividends) of company assets to holders of Common Shares, or any other corporate transaction or event involving the Corporation or the Common Shares, the Administrators, in the Administrators’ sole discretion, may, subject to any relevant resolutions of the Board, and without liability to any person, make such changes or adjustments, if any, as the Administrators consider fair or equitable, in such manner as the Administrators may determine, to reflect such change or event including, without limitation, adjusting the number of Options and Restricted Share Units outstanding under this Plan, the type and number of securities or other property to be received upon exercise or redemption thereof, and the exercise price of Options outstanding under this Plan, provided that the value of any Option or Restricted Share Unit immediately after such an adjustment, as determined by the Administrators, shall not exceed the value of such Option or Restricted Share Unit prior thereto, as determined by the Administrators.
     
  (b) Notwithstanding the foregoing, with respect to Options and Restricted Share Units of U.S. Participants, such changes or adjustments will be made in a manner so as to not result in the imposition of taxes under Section 409A of the Code and will comply with the requirements in subsection 4.3(d).
     
  (c) The Corporation shall give notice to each Participant in the manner determined, specified or approved by the Administrators of any change or adjustment made pursuant to this section and, upon such notice, such adjustment shall be conclusive and binding for all purposes.
     
  (d) The Administrators may from time to time adopt rules, regulations, policies, guidelines or conditions with respect to the exercise of the power or authority to make changes or adjustments pursuant to section 6.2 or section 6.3(a). The Administrators, in making any determination with respect to changes or adjustments pursuant to section 6.2 or section 6.3(a) shall be entitled to impose such conditions as the Administrators consider or determine necessary in the circumstances, including conditions with respect to satisfaction or payment of all applicable taxes (including, but not limited to, withholding taxes).

 

 
- 15 -

 

6.4 Amendment or Termination of Plan:

 

The Board may amend this Plan or any Restricted Share Unit or any Option at any time without the consent of Participants provided that such amendment shall:

 

  (a) not adversely alter or impair any Restricted Share Unit previously awarded or any Option previously granted except as permitted by the provisions of section 6.3 hereof, and, with respect to Restricted Share Units and Options of U.S. Participants, such amendment will not result in the imposition of taxes under Section 409A;
     
  (b) be subject to any regulatory approvals including, where required, the approval of the Exchange; and
     
  (c) be subject to shareholder approval, where required by the requirements of the Exchange, provided that shareholder approval shall not be required for the following amendments:

 

  (i) amendments of a “housekeeping nature”, including any amendment to the Plan or a Restricted Share Unit or Option that is necessary to comply with applicable laws, tax or accounting provisions or the requirements of any regulatory authority or Exchange and any amendment to the Plan or a Restricted Share Unit or Option to correct or rectify any ambiguity, defective provision, error or omission therein, including any amendment to any definitions therein;
     
  (ii) amendments that are necessary or desirable for Restricted Share Units or Options to qualify for favourable treatment under any applicable tax law;
     
  (iii) a change to the vesting provisions of any Restricted Share Unit or any Option (including any alteration, extension or acceleration thereof);
     
  (iv) a change to the termination provisions of any Option or Restricted Share Units (for example, relating to termination of employment, resignation, retirement or death) that does not entail an extension beyond the original expiration date (as such date may be extended by virtue of section 5.4);
     
  (v) the introduction of features to the Plan that would permit the Corporation to, instead of issuing Common Shares from treasury upon the vesting of the Restricted Share Units, retain a broker and make payments for the benefit of Participants to such broker who would purchase Common Shares in the open market for such Participants;
     
  (vi) the amendment of this Plan as it relates to making lump sum payments to Participants upon the vesting of the Restricted Share Units;
     
  (vii) the amendment of the cashless exercise feature set out in this Plan; and

 

 
- 16 -

 

  (d) be subject to disinterested shareholder approval in the event of any reduction in the exercise price of any Option granted under the Plan to an Insider Participant.

 

For greater certainty and subject to approval by the Exchange (if applicable), shareholder approval shall be required in circumstances where an amendment to the Plan would:

 

  (a) change from a fixed maximum percentage of issued and outstanding Common Shares to a fixed maximum number of Common Shares;
     
  (b) increase the limits in section 2.2;
     
  (c) reduce the exercise price of any Option (including any cancellation of an Option for the purpose of reissuance of a new Option at a lower exercise price to the same person);
     
  (d) extend the term of any Option beyond the original term (except if such period is being extended by virtue of section 5.4 hereof); or
     
  (e) amend this section 6.4.

 

6.5 Termination: The Administrators may terminate this Plan at any time in their absolute discretion. If the Plan is so terminated, no further Restricted Share Units shall be awarded and no further Options shall be granted, but the Restricted Shares Units then outstanding and credited to Participants’ Accounts and the Options then outstanding shall continue in full force and effect in accordance with the provisions of this Plan. Any termination of this Plan shall occur in a manner that will not result in the imposition of taxes on a U.S. Participant under Section 409A.
   
6.6 Transferability: A Participant shall not be entitled to transfer, assign, charge, pledge or hypothecate, or otherwise alienate, whether by operation of law or otherwise, the Participant’s Restricted Share Units or Options or any rights the Participant has under the Plan.
   
6.7 Rights as a Shareholder: Under no circumstances shall the Restricted Share Units or Options be considered Common Shares nor shall they entitle any Participant to exercise voting rights or any other rights attaching to the ownership of Common Shares (including, but not limited to, the right to dividend equivalent payments).
   
6.8 Credits for Dividends: Unless otherwise determined by the Administrators, whenever cash or other dividends are paid on Common Shares, additional Restricted Share Units will be automatically granted to each Participant who holds Restricted Share Units on the record date for such dividends. The number of such Restricted Share Units (rounded to the nearest whole Restricted Share Units) to be credited to such Participant as of the date on which the dividend is paid on the Common Shares shall be an amount equal to the quotient obtained when (i) the aggregate value of the cash or other dividends that would have been paid to such Participant if the Participant’s Restricted Share Units as of the record date for the dividend had been Common Shares, is divided by (ii) the Market Value of the Common Shares as of the date on which the dividend is paid on the Common Shares. Restricted Share Units granted to a Participant shall be subject to the same vesting conditions (time and performance (as applicable)) as the Restricted Share Units to which they relate.

 

 
- 17 -

 

6.9 No Effect on Employment, Rights or Benefits:

 

  (a) The terms of employment shall not be affected by participation in the Plan.
     
  (b) Nothing contained in the Plan shall confer or be deemed to confer upon any Participant the right to continue as a director, officer, employee or Consultant nor interfere or be deemed to interfere in any way with any right of the Corporation, the Board or the shareholders of the Corporation to remove any Participant from the Board or of the Corporation or any Subsidiary to terminate any Participant’s employment or agreement with a Consultant at any time for any reason whatsoever.
     
  (c) Under no circumstances shall any person who is or has at any time been a Participant be able to claim from the Corporation or any Subsidiary any sum or other benefit to compensate for the loss of any rights or benefits under or in connection with this Plan or by reason of participation in this Plan.

 

6.10 Market Value of Common Shares: The Corporation makes no representation or warranty as to the future market value of any Common Shares. No Participant shall be entitled, either immediately or in the future, either absolutely or contingently, to receive or obtain any amount or benefit granted to or to be granted for the purpose of reducing the impact, in whole or in part, of any reduction in the market value of the shares of the Corporation or a corporation related thereto.

 

6.11 Compliance with Applicable Law:

 

  (a) If any provision of the Plan contravenes any law or any order, policy, by-law or regulation of any regulatory body having jurisdiction, then such provision shall be deemed to be amended to the extent necessary to bring such provision into compliance therewith. Notwithstanding the foregoing, the Corporation shall have no obligation to register any securities provided for in this Plan under the 1933 Act.
     
  (b) The award of Restricted Share Units, the grant of Options and the issuance of Common Shares under this Plan shall be carried out in compliance with applicable statutes and with the regulations of governmental authorities and the Exchange. If the Administrators determine in their discretion that, in order to comply with any such statutes or regulations, certain action is necessary or desirable as a condition of or in connection with the award of a Restricted Share Unit, the grant of an Option or the issue of a Common Share upon the vesting of a Restricted Share Unit or exercise of an Option, as applicable, that Restricted Share Unit may not vest in whole or in part and that Option may not be exercised in whole or in part, as applicable, unless that action shall have been completed in a manner satisfactory to the Administrators. Without limiting the foregoing, any Common Shares issued upon the vesting of Restricted Share Units or exercise of Options granted pursuant to this Plan must be registered under the 1933 Act, and all applicable state securities laws, or must comply with the requirements of an exemption or exclusion therefrom. If the Common Shares issued upon the vesting of Restricted Share Units or exercise of Options are issued in the United States or to a U.S. Person in reliance upon an exemption from the registration requirements of the 1933 Act and applicable state securities laws, such Common Shares will be “restricted securities” (as such term is defined in Rule 144 under the 1933 Act) and the certificate representing such Common Shares will bear a legend restricting the transfer of such securities under the 1933 Act and applicable state securities laws. The Board may require that a Participant provide certain representations, warranties and certifications to the Corporation to satisfy the requirements of applicable securities laws, including without limitation, the registration requirements of the 1933 Act and applicable state securities laws or exemptions or exclusions therefrom.

 

 
- 18 -

 

6.12 Governing Law: This Plan shall be governed by and construed in accordance with the laws of the Province of British Columbia and the laws of Canada applicable therein, and with respect to U.S. Participants, the Code.
   
6.13 Subject to Approval: The Plan is adopted subject to the approval of the Exchange and any other required regulatory approval. To the extent a provision of the Plan requires regulatory approval which is not received, such provision shall be severed from the remainder of the Plan until the approval is received and the remainder of the Plan shall remain in effect.
   
6.14 Special Terms and Conditions Applicable to U.S. Participants: Options issued to U.S. Participants are intended to be exempt from Section 409A of the Code pursuant to Treas. Reg. Section 1.409A-1(b)(5)(i)(A) and the Plan and such Options will be construed and administered accordingly. Options may be issued to U.S. Participants under the Plan only if the shares with respect to the Options qualify as “service recipient stock” as defined in Treas. Reg. Section 1.409A-1(b)(5)(E)(iii). Restricted Share Units awarded to U.S. Participants are intended to be either exempt from (e.g., as short-term deferrals) or compliant with Section 409A of the Code and such Restricted Share Units will be construed and administered accordingly. Any waiver or acceleration of vesting under the Plan or any Restricted Share Unit Agreement for a U.S. Participant may occur only to the extent that such acceleration or waiver will not result in the imposition of taxes under Section 409A of the Code. Any payments made under this Plan or any Restricted Share Unit Agreement to a U.S. Participant as a result of a termination of employment that are deemed to be subject to Section 409A of the Code shall occur only if such termination constitutes a “separation from service” as defined in Treas. Reg. 1.409A-1(h). Additionally, any payments resulting from a separation from service made to a U.S. Participant who is a “specified employee” as defined in Treas. Reg. 1.409A-1(i) shall be subject to the six month delay in payments required by Treas. Reg. 1.409A-1(3)(v) if such payments are deemed to be subject to Section 409A of the Code. Although the Corporation intends Options and Restricted Share Units granted to U.S. Participants to be exempt from or compliant with Section 409A, the Corporation makes no representation or guaranty as to the tax treatment of such Options and Restricted Share Units. Each U.S. Participant (and any beneficiary or the estate of the Participant, as applicable) is solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or for the account of such U.S. Participant in connection with this Plan. Neither the Corporation nor any affiliate, nor any employee or director of the Corporation or an affiliate, shall have any obligation to indemnify or otherwise hold such U.S. Participant, beneficiary or estate harmless from any or all such taxes or penalties.

 

ADOPTED the 19th day of August, 2019 and Amended on April 14, 2021.

 

 
 

 

Exhibit A

 

[Insert of the underlying Common Shares have not been registered under the 1933 Act:

 

THE RESTRICTED SHARE UNITS AND THE UNDERLYING COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR ANY U.S. STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS SUCH SECURITIES ARE REGISTERED UNDER THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS ARE AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE 1933 ACT.]

 

RESTRICTED SHARE UNIT AGREEMENT

 

Notice is hereby given that, effective this ________ day of ________________, __________ (the “Restricted Share Grant Date”) Draganfly Inc. (the “Corporation”) has granted to ___________________________________________ (the “Participant”), ______________ Restricted Share Units pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which has been provided to the Participant.

 

Restricted Share Units are subject to the following terms:

 

  (a) Pursuant to the Plan and as compensation to the Participant, the Corporation hereby grants to the Participant, as of the Restricted Share Grant Date, the number of Restricted Share Units set forth above.
     
  (b) The granting and vesting of the Restricted Share Units and the payment by the Corporation of any payout in respect of any Vested Restricted Share Units (as defined below) are subject to the terms and conditions of the Plan, all of which are incorporated into and form an integral part of this Restricted Share Unit Agreement.
     
  (c) The Restricted Share Units shall become vested restricted share units (the “Vested Restricted Share Units”) in accordance with the following schedule:

 

  (i) ● on the 6 month anniversary of the Restricted Share Grant Date;
     
  (ii) ● on the 12 month anniversary of the Restricted Share Grant Date;
     
  (iii) ● on the 18 month anniversary of the Restricted Share Grant Date; and
     
  (iv) ● on the 24 month anniversary of the Restricted Share Grant Date (each a “Vesting Date”).

 

  (d) As soon as reasonably practicable and no later than 60 days following the Vesting Date, or, if the Participant is not a U.S. Participant (as defined in the Plan), such later date mutually agreed to by the Corporation and the Participant, the Participant shall be entitled to receive, and the Corporation shall issue or provide, a payout with respect to those Vested Restricted Share Units in the Participant’s Account to which the Vesting Date relates (each a “Payout Date”):

 

 
- 2 -

 

  (i) a lump sum payment in cash equal to the number of vested Restricted Share Units recorded in the Participant’s Account multiplied by the Market Value of a Common Share on the Payout Date;
     
  (ii) the number of Common Shares required to be issued to a Participant upon the vesting of such Participant’s Restricted Share Units in the Participant’s Account, duly issued as fully paid and non-assessable shares and such Participant shall be registered on the books of the Corporation as the holder of the appropriate number of Common Shares; or
     
  (iii) any combination of the foregoing.

 

subject to any applicable Withholding Obligations.

 

  (e) The Participant acknowledges that:

 

  (i) he or she has received and reviewed a copy of the Plan; and
     
  (ii) the Restricted Share Units have been granted to the Participant under the Plan and are subject to all of the terms and conditions of the Plan to the same effect as if all of such terms and conditions were set forth in this Restricted Share Unit Agreement, including with respect to termination and forfeiture as set out in Section 4.7 of the Plan.

 

Notwithstanding anything to the contrary in this Restricted Share Unit Agreement all vesting and issuances or payments, as applicable, in respect of a Restricted Share Unit evidenced hereby shall be completed no later than December 15 of the third calendar year commencing after the Restricted Share Grant Date;

 

The grant of the Restricted Share Units evidenced hereby is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Restricted Share Units and the vesting of the Restricted Share Units. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

The Participant represents and warrants to the Corporation that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Restricted Share Units, and (ii) if the Common Shares issuable pursuant to the Restricted Share Units have not been registered under the 1933 Act, either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Restricted Share Units for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Corporation may condition awards and elections under the Plan upon receiving from the undersigned such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable U.S. state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

 

In the event of any inconsistency between the terms of this Restricted Share Unit Agreement and the Plan, the terms of the Plan shall prevail unless otherwise determined in the Plan.

 

Draganfly Inc.    
     
     
Authorized Signatory   Signature of Participant
     
     
    Name of Participant

 

 
 

 

Exhibit B

 

[Insert if the underlying Common Shares have not been registered under the 1933 Act:

 

THE options AND THE optioned shares HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR ANY U.S. STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS SUCH SECURITIES ARE REGISTERED UNDER THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND ALL APPLICABLE U.S. STATE SECURITIES LAWS ARE AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE 1933 ACT.]

 

Option Agreement

 

Notice is hereby given that, effective this ________ day of ________________, __________ (the “Effective Date”) Draganfly Inc. (the “Corporation”) has granted to ___________________________________________ (the “Participant”), Options to acquire ______________ Common Shares (the “Optioned Shares”) up to 4:30 p.m. Pacific Time on the __________ day of ____________________, __________ (the “Option Expiry Date”) at an exercise price of Cdn$____________ per Optioned Share pursuant to the Corporation’s Share Compensation Plan (the “Plan”), a copy of which is attached hereto.

 

Optioned Shares may be acquired as follows:

 

  (f) [insert vesting provisions, if applicable]; and

 

  (g) [insert hold period when required].

 

The grant of the Options evidenced hereby and the Option Expiry Date thereof, is made subject to the terms and conditions of the Plan. The Participant agrees that he/she may suffer tax consequences as a result of the grant of these Options, the exercise of the Options and the disposition of Optioned Shares. The Participant acknowledges that he/she is not relying on the Corporation for any tax advice and has had an adequate opportunity to obtain advice of independent tax counsel.

 

The Participant represents and warrants to the Corporation that (i) under the terms and conditions of the Plan the Participant is a bona fide Eligible Person (as defined in the Plan) entitled to receive Options, and (ii) if the Common Shares issuable pursuant to the Restricted Share Units have not been registered under the 1933 Act, either (A) the Participant is not in the United States or a U.S. Person, nor is the Participant acquiring the Options or any Optioned Shares for the benefit of a person in the United States or a U.S. Person, or (B) an exemption from the registration requirements of the 1933 Act and all applicable state securities laws is available and the Participant has provided evidence satisfactory to the Corporation to such effect. The Participant understands that the Options may not be exercised in the United States or by or on behalf of a U.S. Person unless the Options and the Option Shares have been registered under the 1933 Act or are exempt from registration thereunder. The Corporation may condition the exercise of the Options upon receiving from the Participant such representations and warranties and such evidence of registration or exemption under the 1933 Act and all applicable state securities laws as is satisfactory to the Corporation, acting in its sole discretion.

 

In the event of any inconsistency between the terms of this Option Agreement and the Plan, the terms of the Plan shall prevail.

 

Draganfly Inc.    
     
     
Authorized Signatory   Signature of Participant
     
     
    Name of Participant

 

 
 

 

Exhibit C

 
Notice of OPTION EXERCISE

 

TO: Draganfly Inc. (the “Corporation”)  
     
FROM:    
     
DATE:    

 

The undersigned hereby irrevocably gives notice, pursuant to the Corporation’s Share Compensation Plan (the “Plan”), of the exercise of the Options to acquire and hereby subscribes for:

 

[check one]

 

(a) all of the Optioned Shares; or
     
(b) _______________ of the Optioned Shares,

 

which are the subject of the Option Agreement attached hereto.

 

Calculation of total Exercise Price:

 

  (i) number of Optioned Shares to be acquired on exercise __________ Optioned Shares
     
  (ii) multiplied by the Exercise Price per Optioned Share: $ __________
       
  TOTAL EXERCISE PRICE, enclosed herewith (unless this is a cashless exercise):
$ __________

 

A. The undersigned (i) at the time of exercise of these Options is not in the “United States” or a “U.S. Person” (as such terms are defined in Regulation S under the United States Securities Act of 1933, as amended (the “1933 Act”) and is not exercising these Options on behalf of a person in the United States or U.S. Person and (ii) did not execute or deliver this Notice of Option Exercise in the United States.
     
B. The undersigned has delivered an opinion of counsel of recognized standing or other evidence in form and substance satisfactory to the Corporation to the effect that an exemption from the registration requirements of the 1933 Act, and applicable state securities laws is available for the issuance of the Optioned Shares.
     
C. The Optioned Shares have been registered under the 1933 Act.
     
  Note: The undersigned understands that unless Box A or C is checked, the certificates representing the Optioned Shares will bear a legend restricting transfer without registration under the 1933 Act and applicable state securities laws unless an exemption from registration is available.
     
  Note: Certificates representing Optioned Shares will not be registered or delivered to an address in the United States unless Box B or C above is checked.
     
  Note: If Box B is checked, any opinion or other evidence tendered must be in form and substance satisfactory to the Corporation. Holders planning to deliver an opinion of counsel or other evidence in connection with the exercise of Options should contact the Corporation in advance to determine whether any opinions to be tendered or other evidence will be acceptable to the Corporation.

 

 
- 2 -

 

I hereby:

 

☐  (a) unless this is a cashless exercise, enclose a cheque payable to “[●]” for the aggregate Exercise Price plus the amount of the estimated Withholding Obligations and agree that I will reimburse the Corporation for any amount by which the actual Withholding Obligations exceed the estimated Withholding Obligations; or

 

(b) advise the Corporation that I am exercising the above Options on a cashless exercise basis, in compliance with the procedures established from time to time by the Administrators for cashless exercises of Options under the Plan. I will consult with the Corporation to determine what additional documentation, if any, is required in connection with my cashless exercise of the above Options. I agree to comply with the procedures established by the Corporation for cashless exercises and all terms and conditions of the Plan. Please prepare the Optioned Shares certificates, if any, issuable in connection with this exercise in the following name(s):

 

_____________________________________________________

 

______________________________________________________

 

   
Signature of Participant  
   
   
Name of Participant  

 

Letter and consideration/direction received on ________________, 20 _____.

 

[●]

 

By:    
  [Name]  
  [Title]  

 

 

 

EX-4.3 11 ex4-3.htm

 

Exhibit 4.3

 

INDEPENDENT CONSULTANT AGREEMENT

 

This Independent Consultant Agreement (“Agreement”) is dated effective as of the 1st day of October, 2019 (the “Effective Date”).

 

BETWEEN:

 

DRAGANFLY INC., a company duly incorporated under the laws

of the Province of British Columbia with a business address at 2108

St. George Avenue, Saskatoon, Saskatchewan S7M 0K7

 

(“Company”)

 

AND:

 

1502372 ALBERTA LTD., a corporation having an address at

L120, 2303 – 4 Street SW, Calgary, AB T2S 2S7

 

(“Consultant”)

 

AND:

 

CAMERON CHELL, the principal of the Consultant

 

(“Principal”)

 

WHEREAS:

 

A. The Consultant has considerable expertise in the general management of start-ups, financial and business matters; and

 

B. The Company wishes to obtain, and the Consultant wishes to provide, certain services to the Company on the terms and conditions set out in this Agreement;

 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration (including but not limited to a signing bonus paid by the Company to the Consultant for this Agreement in the amount of CAD $50.00), the receipt and sufficiency of which are hereby acknowledged, the Company, the Consultant and the Principal covenant and agree as follows:

 

1. SERVICES TO BE PROVIDED

 

1.1 Commencing on the Effective Date, the Consultant shall provide executive services to the Company and, in this regard, the Consultant shall have the Principal hold the position of Chairman and Chief Executive Officer at the Company. Furthermore, commencing on the Effective Date the Consultant shall provide such services to the Company as are described in Schedule A to this Agreement (the “Services”). The Consultant shall also provide any other services not specifically mentioned in Schedule A, but which, by reason of the Consultant’s capability, the Consultant knows or ought to know are necessary to ensure that the best interests of the Company are maintained.

 

 
- 2 -

 

1.2 The Consultant shall provide all of the Services through the Principal, unless otherwise agreed in writing by the Company. The Consultant and the Principal undertake to make the Principal available to perform the Services required under this Agreement.
   
1.3 The Consultant shall perform the Services to the level of competence and skill one would reasonably expect from a company with the skills and experience similar to that of the Consultant. The Consultant shall devote sufficient working time, attention and ability in a timely manner to the Business of the Company (as defined herein), and to any associated company, as is reasonably necessary for the proper performance of the Services pursuant to this Agreement.
   
1.4 The Consultant will faithfully, honestly and diligently serve the Company, use its best efforts to promote the best interests of the Company and co-operate with the Company, and utilize maximum professional skill and care to ensure that the Services are rendered to the satisfaction of the Company.
   
1.5 The Consultant will comply with all applicable rules, laws and regulations, and all applicable Company policies (to the extent they have been provided to the Consultant by the Company), having application to the carrying out and performance of its obligations under this Agreement.
   
1.6 At all times while on the Company’s premises or representing the Company in any other location in connection with the provision of the Services, the Consultant will observe the Company’s rules and regulations with respect to conduct, health, safety and protection of persons and property.
   
2. INDEPENDENT CONSULTANT RELATIONSHIP
   
2.1 It is expressly agreed that the Consultant’s relationship with the Company is that of an independent contractor in performing the Services under this Agreement, and nothing in this Agreement is intended to, or shall be construed to, create a partnership, agency, joint venture, employment or similar relationship either between the Consultant and the Company, or the Principal and the Company.
   
2.2 The Consultant and, where applicable, the Principal, shall file on a timely basis, all tax returns and payments required to be filed with or made to any federal or provincial tax authority with respect to the performance of the Services and the consideration therefor under this Agreement.
   
2.3 The Consultant is solely responsible for, and must maintain adequate records of, expenses incurred in the course of performing the Services.
   
2.4 The Consultant represents and warrants that the Consultant has the right to provide the Services to the Company without violation of obligations to others and that any advice, information and documents given by the Consultant to the Company under this Agreement may be used fully and freely by the Company, unless otherwise so designated orally or in writing by the Consultant at the time of communication of such information.

 

 
- 3 -

 

2.5 The Consultant and the Principal agree to indemnify and save harmless the Company and its directors, officers, employees, administrators and agents from:

 

  (a) any and all liability for any premium, contribution, remittance, tax, assessment, penalty, interest, wages or any other amount of any kind whatsoever, arising under one or more statutes relating to income tax, Employment Insurance, Canada Pension Plan, workers’ compensation, employment standards, human rights or any other similar statute of Canada or the Province of British Columbia that may arise in connection with the performance of the Services under this Agreement; and
     
  (b) any and all costs, charges, legal fees and expenses reasonably incurred by the Company or such persons identified in this section in connection with defending any civil, criminal, statutory or administrative action, proceeding or other remedy with respect to any such alleged liability.

 

2.6 The Company will not be liable to the Consultant for any damages, liabilities, penalties, interest or costs suffered by the Consultant’s failure to make the statutorily required deductions or payments.
   
3. CONSIDERATION FOR SERVICES
   
3.1 As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay to the Consultant a consulting fee in the amount of CAD $3,000 per month for the first four months, and then CAD $10,000 per month for the remainder of this Agreement or until any change is mutually agreed upon. All fees will be paid on a monthly basis upon submission of an invoice.
   
4. TERM AND TERMINATION
   
4.1 This Agreement will commence on the Effective Date and will continue for twelve (12) months (“Term”), unless terminated in accordance with Section 4.3 or renewed in accordance with Section 4.2.
   
4.2 Notwithstanding Section 4.1, this Agreement will automatically be renewed for subsequent terms of twelve (12) months unless the Company provides written notice to the Consultant by no later than sixty (60) days prior to the last day of the applicable Term of its intention to not renew this Agreement. If this Agreement is renewed, the Company’s board of directors (“Board”) shall perform an annual review of compensation paid to the Consultant, at around the time of any renewal.

 

 
- 4 -

 

4.3 Notwithstanding Section 4.1, and notwithstanding any renewal under Section 4.2, this Agreement may be terminated at any time by:

 

  (a) the Consultant giving at least sixty (60) days’ advance notice in writing to the Company;
     
  (b) the Company by giving at least sixty (60) days advance notice in writing to the Consultant; or
     
  (c) the Company without notice in the event that the Consultant: (i) breaches any term of this Agreement, (ii) neglects the Services or any other duty to be performed by the Consultant under this Agreement, (iii) engages in any conduct which is dishonest, or damages the reputation or standing of the Company, (iv) is convicted of any criminal act, (v) engages in any act of moral turpitude, (vi) files a voluntary petition in bankruptcy, or (vii) is adjudicated as bankrupt or insolvent.

 

4.4 Upon termination of this Agreement for any reason, the Consultant shall promptly deliver the following in accordance with the directions of the Company:

 

  (a) a final accounting, reflecting the balance of expenses incurred on behalf of the Company as of the date of termination;
     
  (b) all documents pertaining to the Company or this Agreement, including, but not limited to, all Confidential Information, books of account, correspondence and contracts; and
     
  (c) all equipment and any other property belonging to the Company.

 

4.5 If this Agreement is terminated for any reason set forth in Section 4, then the Consultant will be entitled to the fees earned to the effective date of termination and any expenses incurred on behalf of the Company prior to the effective date of termination which are otherwise reimbursable by the Consultant pursuant to the terms of this Agreement.
   
4.6 The definitions contained in this Agreement and the rights and obligations contained in this Section 4 and in Sections 5, 6, 7 and 8 will survive any termination or expiration of this Agreement.
   
4.7 Upon the termination of this Agreement for whatever reason, upon the request of the Company, the Consultant shall cause the Principal to immediately resign, and the Principal shall so resign, without claim for compensation or severance of any kind whatsoever, from all offices and directorships held by the Principal in the Company or any affiliated company and in the event of their respective failure to do so the Company is hereby irrevocably authorized to appoint its designated person in their respective names and on their behalf to execute any documents and to do all things requisite to give effect thereto.
   
4.8 The Consultant shall not, at any time after the termination of this Agreement, represent itself as being in any way connected with or interested in the business of the Company.

 

 
- 5 -

 

5. CONFIDENTIALITY

 

5.1 For the purposes of this Agreement, “Confidential Information” means information, whether or not originated by the Consultant, that relates to the business or affairs of the Company, its affiliates, clients, sales personnel or suppliers and is confidential or proprietary to, about or created by the Company, its affiliates, clients or suppliers (whether or not reduced to writing or designated or marked as confidential), including, but not limited to, the following:

 

  (a) any technical and non-technical information related to the Company’s business and current, future and proposed products and services of the Company, including, without limitation, Company Innovations (as defined herein), Company Property (as defined herein) and the Company’s information concerning research, development, design and product details and specifications, financial information, procurement requirements, engineering and manufacturing information, and business plans;
     
  (b) information relating to strategies, research, communications, business plans and financial data of the Company;
     
  (c) any information of or regarding the Company and its business which is not readily publicly available;
     
  (d) work product resulting from or related to work or projects performed, or to be performed, for the Company or its affiliates, including, but not limited to, the methods, processes, procedures, analysis, techniques and audits used in connection therewith;
     
  (e) any intellectual property contributed to the Company, and any other technical and business information of the Company and its affiliates which is of a confidential, trade secret and/or proprietary character;
     
  (f) marketing and development plans, price and cost data, price and fee amounts, pricing and billing policies, quoting procedures, marketing techniques, methods of obtaining business, forecasts and forecast assumptions and volumes, current and prospective client lists, and future plans and potential strategies of the Company that have been or are being discussed;
     
  (g) information belonging to third parties or which is claimed by third parties to be confidential or proprietary and which the Company has agreed to keep confidential; and
     
  (h) any other information that becomes known to the Consultant as a result of this Agreement or the services performed hereunder, including information received by the Company from others, that the Consultant, acting reasonably, believes is confidential information or that the Company takes measures to protect.

 

 
- 6 -

 

5.2 The Consultant’s obligations under this Section 5 do not apply to any Confidential Information that the Consultant can demonstrate: (a) was in the public domain at or subsequent to the time the Confidential Information was communicated to the Consultant by the Company through no fault of the Consultant; (b) was rightfully in the Consultant’s possession free of any obligation of confidence at or subsequent to the time the Confidential Information was communicated to the Consultant by the Company; or (c) was independently developed by the Consultant without use of, or reference to, any Confidential Information communicated to the Consultant by the Company. A disclosure of any Confidential Information by Consultant in response to a valid order by a court or other governmental body or as otherwise required by law will not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes, provided, however, that the Consultant provides prompt prior written notice thereof to the Company to enable the Company to seek a protective order or otherwise prevent the disclosure
   
5.3 The Consultant acknowledges that the Confidential Information is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company. The Consultant agrees to maintain securely and hold in strict confidence all Confidential Information received, acquired or developed by the Consultant or disclosed to the Consultant as a result of or in connection with the Services. The Consultant and the Principal agree that, both during and after the termination of this Agreement, the Consultant and the Principal will not, directly or indirectly, divulge, communicate, use, copy or disclose or permit others to use, copy or disclose, any Confidential Information to any person, except as such disclosure may be consented to by prior written authorization of the board of directors of the Company.
   
5.4 The Consultant may use the Confidential Information solely to perform the Services for the benefit of Company. The Consultant shall treat all Confidential Information with the same degree of care as the Consultant accords to the Consultant’s own confidential information, but in no case shall the Consultant use less than reasonable care. The Consultant shall immediately give notice to the Company of any unauthorized use or disclosure of the Confidential Information. The Consultant shall assist the Company in remedying any unauthorized use or disclosure of the Confidential Information.
   
5.5 All Confidential Information and any materials and items (including, without limitation, software, equipment, tools, artwork, documents, drawings, papers, diskettes, tapes, models, apparatus, sketches, designs and lists) that the Company furnishes to the Consultant, whether delivered to the Consultant by the Company or made by the Consultant in the performance of the Services, and whether or not they contain or disclose Confidential Information (collectively, the “Company Property”), are the sole and exclusive property of the Company or the Company’s affiliates, suppliers or customers. The Consultant agrees to treat the Company Property with the same degree of care as the Consultant treats its own property, but in no case shall the Consultant use less than reasonable care. Within five (5) days after any request by the Company, the Consultant shall destroy or deliver to the Company, at the Company’s option: (a) all Company Property and (b) all materials and items in the Consultant’s possession or control that contain or disclose any Confidential Information. The Consultant will provide the Company a written certification of the Consultant’s compliance with the Consultant’s obligations under this Section 5.5.

 

 
- 7 -

 

5.6 During the term of this Agreement, the Consultant will not accept work, enter into a contract or accept an obligation in breach of the Consultant’s obligations under Section 7 of this Agreement, or the scope of the Services to be rendered for the Company under this Agreement. The Consultant warrants that, to the best of the Consultant’s knowledge, there is no other existing contract or duty on the Consultant’s part that conflicts with or is inconsistent with this Agreement.
   
5.7 The Consultant represents and warrants that the Consultant has not used and will not use, while performing the Services, any materials or documents of another company which the Consultant is under a duty not to disclose. The Consultant understands that, while performing the Services, the Consultant shall not breach any obligation or confidence or duty the Consultant may have to any current or former client or employer. The Consultant represents and warrants that it will not, to the best of its knowledge and belief, use or cause to be incorporated in any of the Consultant’s work product, any data software, information, designs, techniques or know-how which the Consultant or the Company does not have the right to use.
   
5.8 The Consultant will indemnify and hold harmless the Company from and against any and all third party claims, suits, actions, demands and proceedings against the Company and all losses, costs, damages, expenses, fees and liabilities related thereto arising out of or related to: (a) an allegation that any item, material or other deliverable delivered by the Consultant under this Agreement infringes any intellectual property rights or publicity rights of a third party; (b) an alleged breach by the Consultant of any agreement between the Consultant and any third party; or (c) any negligence by the Consultant or any other act or omission of the Consultant, including, without limitation, any breach of this Agreement by the Consultant.
   
6. DISCLOSURE AND ASSIGNMENT OF WORK RESULTING FROM PROVISION OF SERVICES.
   
6.1 In this Agreement, “Innovations” means all discoveries, designs, developments, improvements, inventions (whether or not protectable under patent laws), works of authorship, information fixed in any tangible medium of expression (whether or not protectable under copyright laws), trade secrets, know-how, ideas (whether or not protectable under trade secret laws), mask works, trademarks, service marks, trade names and trade dress. “Company Innovations” means Innovations that: (a) result or derive from the provision of the Services or from the Consultant’s knowledge or use of Confidential Information; (b) are conceived or made by the Consultant (individually or in collaboration with others) in the course of provision of the Services; (c) result from or derive from the use or application of the resources of the Company, its affiliates or suppliers; (d) relate to the Business of the Company or to actual or demonstrably anticipated research and development by the Company or its affiliates; or (e) the Consultant, solely or jointly with others, creates, derives, conceives, develops, makes or reduces to practice during the Term.

 

 
- 8 -

 

6.2 All Company Innovations shall be the exclusive property of the Company and the Company shall have sole discretion to deal with Company Innovations. The Consultant agrees that no intellectual property rights in the Company Innovations are or shall be retained by the Consultant. For greater certainty, all work done during the Term by the Consultant for the Company or its affiliates is the sole property of the Company or its affiliates, as the case may be, as the first author for copyright purposes and in respect of which all copyright shall vest in the Company or the relevant affiliate, as the case may be.
   
6.3 The Consultant agrees to maintain adequate and current records of all Company Innovations, which records shall be and remain the property of the Company. The Consultant agrees to promptly disclose and describe to the Company all Company Innovations. The Consultant hereby does and will irrevocably assign to the Company or the Company’s designee all of the Consultant’s right, title and interest in and to any and all Company Innovations and all associated records.
   
6.4 In consideration of the benefits to be received by the Consultant under the terms of this Agreement, the Consultant hereby irrevocably sells, assigns and transfers, and agrees in the future to sell, assign and transfer all right, title and interest in and to the Company Innovations and intellectual property rights therein, including, without limitation, all patents, copyright, industrial design, circuit topography and trademarks, and any goodwill associated therewith in Canada, the United States and worldwide to the Company and the Consultant shall hold all the benefits of the rights, title and interest mentioned above in trust for the Company prior to the assignment to the Company, save and except for any moral rights which the Consultant shall waive. To the extent any of the rights, title and interest in and to Company Innovations cannot be assigned by the Consultant to the Company, the Consultant hereby grants to the Company an exclusive, royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit those non-assignable rights, title and interest, including, but not limited to, the right to make, use, sell, offer for sale, import, have made, and have sold, the Company Innovations. To the extent any of the rights, title and interest in and to the Company Innovations can neither be assigned nor licensed by the Consultant to the Company, the Consultant hereby irrevocably waives and agrees never to assert the non-assignable and non-licensable rights, title and interest against the Company, any of the Company’s successors in interest, or any of the Company’s customers.
   
6.5 The Consultant agrees to perform, during and after the Term, all acts that the Company deems necessary or desirable to permit and assist the Company, at its expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Company Innovations as provided to the Company under this Agreement. If the Company is unable for any reason to secure the Consultant’s signature to any document required to file, prosecute, register or memorialize the assignment of any rights under any Company Innovations as provided under this Agreement, the Consultant hereby irrevocably designates and appoints the Company and the Company’s duly authorized officers and agents as the Consultant’s agents and attorneys-in-fact to act for and on the Consultant’s behalf and instead of the Consultant to take all lawfully permitted acts to further the filing, prosecution, registration, memorialization of assignment, issuance and enforcement of rights in, to and under the Company Innovations, all with the same legal force and effect as if executed by the Consultant. The foregoing is deemed a power coupled with an interest and is irrevocable.

 

 
- 9 -

 

6.6 If the Consultant incorporates or permits to be incorporated any Innovations relating in any way, at the time of conception, reduction to practice, creation, derivation, development or making of the Innovation, to the Company’s business or actual or demonstrably anticipated research or development but which were conceived, reduced to practice, created, derived, developed or made by the Consultant (solely or jointly) either unrelated to the Consultant’s work for Company under this Agreement or prior to the Effective Date (collectively, the “Out-of-Scope Innovations”) into any of the Company Innovations, then the Consultant hereby grants to the Company and the Company’s designees a royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit all patent, copyright, moral right, mask work, trade secret and other intellectual property rights relating to the Out-of-Scope Innovations. Notwithstanding the foregoing, the Consultant agrees that the Consultant shall not incorporate, or permit to be incorporated, any Innovations conceived, reduced to practice, created, derived, developed or made by others or any Out-of-Scope Innovations into any Company Innovations without the Company’s prior written consent.
   
7. NON-INTERFERENCE WITH BUSINESS
   
7.1 In this Agreement, “Business of the Company” means the business of manufacturing search and navigation equipment within the commercial UAV space.
   
7.2 The Consultant agrees that, during the Term, the Consultant will not, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, including, without limitation, as an employer, employee, principal, agent, director, officer, joint venturer, partner, shareholder or other equity holder, lender or other debt holder, independent contractor, licensor, licensee, franchisor, franchisee, distributor, consultant, financier, supplier or trustee, or by or through any company, cooperative, partnership, trust, unincorporated association or otherwise, anywhere in North America:

 

  (a) carry on, be engaged in, have any financial or other interest in or be otherwise commercially involved in any endeavour, activity or business which is in competition with the Business of the Company;
     
  (b) canvass or solicit the business of (or procure or assist the canvassing or soliciting of the business of) any customer, prospective customer or supplier of the Company to supply or purchase any goods or services that are substantially the same as or in competition with goods or services supplied in the Business of the Company;
     
  (c) accept (or procure or assist the acceptance of) any business from any customer, prospective customer, sales personnel or supplier that is substantially the same as or in competition with the Business of the Company; or
     
  (d) supply (or procure or assist the supply of) any goods or services to any customer, prospective customer, sales personnel or supplier that are substantially the same as or in competition with the goods or services supplied in the Business of the Company.

 

 
- 10 -

 

7.3 During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Consultant agrees not to solicit or induce any customer, prospective customer, supplier, sales personnel, employee or independent contractor involved with the Company to terminate or breach any employment, contractual or other relationship with Company, or to otherwise discontinue or alter such third party’s relationship with the Company.
   
7.4 During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Consultant agrees not to, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including without limitation the repetition or distribution of derogatory rumours, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity, reputation or goodwill of the Company or any of its affiliates, officers, directors, employees, consultants or advisors.
   
8. GENERAL
   
8.1 This Agreement contains the entire Agreement and obligation between the parties with respect to its subject matter. No amendment to this Agreement will be valid or effective unless in writing and signed by all of the parties.
   
8.2 The Principal undertakes to ensure the Consultant fulfills all of its obligations under this Agreement, and not to do anything which would impair or prejudice the Consultant’s ability to do so. The Principal shall be jointly and severally liable with the Consultant for any breach by the Consultant of this Agreement. The Principal agrees that he is bound, along with the Consultant, in respect of the Consultant’s obligations in Sections 5, 6 and 7 of this Agreement.
   
8.3 The Consultant’s obligations under this Agreement are of a unique character that gives them particular value, and that the breach of any of these obligations will cause irreparable and continuing damage to the Company for which money damages are insufficient. The Company is entitled to injunctive relief, a decree for specific performance, and all other relief as may be proper (including money damages if appropriate), without the need to post a bond.
   
8.4 The Consultant and the Principal acknowledge that the restrictions contained in Sections 5, 6 and 7 are, in view of the nature of the Business of the Company, reasonable and necessary to protect the legitimate interests of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions and that any violation of any provision of those Sections could result in irreparable injury to the Company. The Consultant agrees that, in the event it violates any of the restrictions referred to in Section 5, 6 and 7, the Company shall be entitled to such injunctive relief or other remedies at law or in equity which the Court deems fit.

 

 
- 11 -

 

8.5 The Consultant expressly acknowledges that this Agreement is reasonable and valid in all respects and irrevocably waives (and irrevocably agrees not to raise) as a defence any issue of reasonableness in any proceeding to enforce any provision of this Agreement, the intention of the parties being to provide for the legitimate and reasonable protection of the interests of the Company by providing, without limitation, for the broadest scope, the longest duration and the widest territory allowable by law.
   
8.6 The Consultant agrees to indemnify the Company from all losses, claims, actions, damages, assessments or demands (including reasonable legal fees and expenses) which result from negligent acts or omissions of the Consultant in providing the Services. Notwithstanding the foregoing, the Company agrees that the Consultant will be covered by the Company’s Directors & Officers and Employment Practices Liability Insurance, once such insurance is obtained by the Company.
   
8.7 Any notice, request, demand or other communication hereunder shall be in writing and shall be delivered as follows, with notice deemed given as indicated: (a) by personal delivery, when actually delivered; (b) by overnight courier, upon written verification of receipt; (c) by facsimile or email, when sent, if sent during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day; or (e) by certified or registered mail, return receipt requested, upon verification of receipt. Notice to the Principal may be given at the same address as shown for the Consultant. Notice shall be sent to the addresses set forth on the first page of this Agreement or to such other address as the parties may advise each other in writing from time to time in accordance with this Section 8.7.
   
8.8 The Company and the Consultant will be responsible for all of their own expenses, legal and other professional fees, disbursements, and all other costs incurred in connection with the negotiation, preparation, execution and delivery of this Agreement and all documents and instruments relating hereto. The parties agree that they have had adequate opportunity to seek independent legal advice with respect to the subject matter of this Agreement, and have either obtained such advice or consciously chosen not to do so with full knowledge of the risks associated with not obtaining such legal advice.
   
8.9 If any provision of this Agreement, including as to term or geographical area, is held to be illegal, invalid or unenforceable under present or future laws by any court of competent jurisdiction, such illegality, invalidity or unenforceability shall not affect the legality, enforceability or validity of any other provisions of this Agreement or of the same provision as applied to any other fact or circumstance, and such illegal, unenforceable or invalid provision shall be modified to the minimum extent necessary to make such provision legal, valid or enforceable.
   
8.10 Time shall be of the essence of this Agreement.

 

 
- 12 -

 

8.11 Except as specifically permitted herein, the Consultant will not sell, assign or transfer any rights or interests created under this Agreement or delegate any of the Consultant’s duties without the prior written consent of the Company.
   
8.12 The headings in this Agreement are inserted for convenience of reference only and shall not affect the construction or interpretation of this Agreement. Wherever the singular or masculine or neuter is used in this Agreement, the same shall be construed as meaning the plural or feminine or a body politic or corporate and vice versa where the context so requires.
   
8.13 The parties agree that this Agreement is effective as of the Effective Date, and the parties agree that there is fresh, sufficient consideration for this Agreement. The parties waive the ability to claim that: (i) this Agreement is void for lack of fresh, sufficient consideration, and (ii) this Agreement is not effective as of the Effective Date.
   
8.14 This Agreement will be governed by and construed in accordance with the laws of the Province of British Columbia, and the federal laws of Canada applicable therein, and each of the parties irrevocably submit to the exclusive jurisdiction of courts of competent jurisdiction in the Province of British Columbia, without reference to its conflicts of law jurisprudence, in respect of any dispute or claim arising out of this Agreement or any legal obligation between the parties. Notwithstanding the foregoing, the Company may enforce any obligation of the Consultant or the Principal which continues after the Consultant ceases providing the Services under this Agreement in any court of competent jurisdiction.
   
8.15 This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which taken together shall be deemed to constitute one and the same instrument. Counterparts may be executed either in original or electronic form and each of the parties to this Agreement agree that any signature delivered by electronic transmission will be deemed to be the original signature of the delivering party.
   
8.16 Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful money of Canadian.

 

(Signature page follows)

 

 
- 13 -

 

IN WITNESS WHEREOF, the parties have signed this Agreement as of the day and year first written above.

 

DRAGANFLY INC.   1502372 ALBERTA LTD.
by its authorized signatory   by its authorized signatory
     
  /s/ Paul Sun     /s/ Cameron Chell
Name: Paul Sun   Name: Cameron Chell
Title: Chief Financial Officer   Title:
         
      /s/ Cameron Chell
      CAMERON CHELL
      Principal of 1502372 ALBERTA LTD.

 

 

 

 

SCHEDULE A

 

SERVICES

 

Defined terms used but not otherwise defined in this Schedule A have the meaning ascribed thereto in the Independent Consultant Agreement dated effective October 1, 2019 (the “Agreement”) between Cameron Chell (“Consultant”) and Draganfly Innovations Inc. (the “Company”) of which this Schedule A forms part.

 

The Services to be provided by the Consultant under the Agreement are as follows:

 

  1. Communicating, on behalf of the Company, with shareholders, government entities, and the public
  2. Leading the development of the Company’s short- and long-term strategy
  3. Creating and implementing the Company or organization’s vision and mission
  4. Maintaining awareness of the competitive market landscape, expansion opportunities, industry developments, etc.
  5. Ensuring that the Company maintains high social responsibility wherever it does business
  6. Assessing risks to the Company and ensuring they are monitored and minimized
  7. Setting strategic goals and making sure they are measurable and describable

 

 

EX-4.4 12 ex4-4.htm

 

Exhibit 4.4

 

INDEPENDENT CONSULTANT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of ___________, 2021 (the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

1502372 ALBERTA LTD.,

a corporation having an address at L120, 2303 – 4 Street SW, Calgary, AB T2S 2S7

 

‎(Hereinafter referred to as the “Consultant”)

 

-and-

 

CAMERON CHELL,

 

the principal of the Consultant

 

‎(Hereinafter referred to as the “Principal”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Parties entered into an Independent Consultant Agreement dated October 1, 2019 (the “Independent Consultant Agreement”) setting out the terms and conditions of the Consultant’s engagement;
   
B.The Company wishes to continue to engage the services of the Consultant and the Principal, and the Consultant and Principal desire to continue to be engaged by the Company upon the terms and subject to the conditions of the Independent Consultant Agreement as amended by the terms of this Independent Consultant Agreement Amending Agreement hereinafter set forth;

 

 
- 2 -

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Independent Consultant Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Consultant’s consulting fees and the grant of restricted share units, and in exchange for the Consultant and Principal’s continued engagement, the Parties agree to amend the Independent Consultant Agreement as follows:

 

1.Provision 3.1 entitled “Consideration for Services” in the Independent Consultant Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay to the Consultant a consulting fee in the amount of CAD $400,000 per year for the remainder of this Agreement or until any change is mutually agreed upon. All fees will be paid on a monthly basis upon submission of an invoice.

 

2.Provision 3.2 entitled “Consideration for Services” will be added into the Independent Consultant Agreement as follows:

 

As further compensation for carrying out the Services during the term of this Agreement, the Consultant will be eligible to receive an annual success fee (the “Success Fee”) ‎as determined by the Company in its sole ‎discretion. The Success Fee, if any, for a given year: (i) will be determined following the completion of the Company’s financial year ‎each year, based on performance metrics to be determined by the Company’s ‎compensation committee in its sole discretion; (ii) will be paid following the completion of such year; and (iii) is not ‎earned or accrued until and unless the Consultant is engaged on the last day of the period for ‎which the Success Fee is payable. ‎ The Consultant understands and agrees that payment of a Success Fee should not be considered to be expected compensation and the payment of a Success Fee in any one or successive years shall not create an entitlement to a Success Fee in any subsequent year.

 

Beginning in the calendar year of 2021, the Consultant’s target annual Success Fee is CDN$300,000.00, pro-rated to the date of this Amending Agreement for 2021.

 

3.Provision 3.3 entitled “Consideration for Services” will be added into the Independent Consultant Agreement as follows:

 

Subject to the receipt of all necessary regulatory approvals, the Company shall grant to the Consultant 40,000 restricted share units (“RSU”) in Draganfly Inc., which shall vest and be governed in accordance with the Company’s RSU plan.

 

4.All other terms and conditions of engagement set out in the Independent Consultant Agreement will remain unchanged and in effect.

 

 
- 3 -

 

5.The Consultant hereby releases the Company from any and all claims it has or may have arising in any way out of the terms of this Amending Agreement or the changes to its engagement as set out herein, specifically includes any claims under any applicable human rights, workers’ compensation, employment standards, employment or labour legislation.
  
6.This Amending Agreement amends the Independent Consultant Agreement. This Amending Agreement and the Independent Consultant Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.
  
7.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.
  
8.If there is a conflict between any provision of this Amending Agreement and any provision of the Independent Consultant Agreement, the relevant provision(s) of this Amending Agreement are to prevail.
  
9.This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of British Columbia. The Parties irrevocably attorn to the jurisdiction to the Courts of the Province of British Columbia.

 

[signature page follows]

 

 
- 4 -

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this _______ day of _____________ 2021:

 

     

DRAGANFLY INC.

 

Authorized Signatory

I have authority to bind the Corporation

 

1502372 ALBERTA LTD.

 

by its authorized signatory,

Cameron Chell

 

 
    CAMERON CHELL
     
    Principal of 1502372 Alberta Ltd.

 

 

EX-4.5 13 ex4-5.htm

 

Exhibit 4.5

 

EXECUTIVE CONSULTING AGREEMENT

 

THIS INDEPENDENT CONSULTING AGREEMENT AGREEMENT” is entered into on this 3rd day of July, 2020 (the “Effective Date”)

 

BETWEEN:

 

DRAGANFLY INC.

(the “Company”)

 

and -

 

SCOTT LARSON

(“Executive”)

 

WHEREAS The Company is builder and supplier of quality, cutting-edge unmanned aerial vehicles and geoinformation software that serves the public safety, agriculture, industrial inspections, security, and mapping and surveying markets.

 

AND WHEREAS The Consultant is an Executive with relevant operational, financial and corporate development experience in the technology sector and whose skills are a material inducement for the Company to enter into this Agreement;

 

AND WHEREAS The Company desires to retain the Executive as an Independent Contractor on a limited basis to provide corporate development, operational, financial assistance and to generally assist the company in its strategic plan (the “Services”); and

 

NOW THEREFORE The Executive agrees to provide the Services as an Independent Contractor to the Company, subject to the terms of this Agreement.

 

ARTICLE I

COMMENCEMENT AND TERM

 

1.01 Term

 

The Company will employ Executive for a term commencing on the effective date of this Agreement and Executive’s engagement with the Company shall be terminable in accordance with the applicable provision in Article VI of this Agreement.

 

ARTICLE II

ASSIGNMENT

 

2.01 Position

 

Executive shall be employed by the Company as a member of the senior executive team in the position of President (“President”).

 

 
- 2 -

 

2.02 Duties

 

As set out below, Executive shall perform the duties and exercise the powers that are normally performed or exercised by President (the “Duties”). In addition, Executive shall perform such Duties and exercise such powers as prescribed or specified by the Board of Directors. Executive acknowledges that the nature of Executive’s position and Duties make him a fiduciary to the Company. Executive further acknowledges that such Duties and responsibilities may require frequent travel and frequent performance of work at irregular times acting reasonably.

 

Executive shall be responsible for leading the development and execution of the Company’s long-term strategy with a view to creating shareholder value. Executive shall, under direction of the CEO and Board of Directors, among other things:

 

(a)be responsible for all day-to-day management decisions;
   
(b)implement the Company’s short and long-term plans;
   
(c)act as a direct liaison between the Board of Directors and management of the Company;
   
(d)communicate on behalf of the Company to shareholders, employees, Government authorities, other stakeholders, and the public.

 

ARTICLE III

REMUNERATION

 

3.01 Salary Compensation

 

Commencing on the Effective Date, the Company shall pay Executive:

 

a)An annual base salary of US$140,000 (the “Base Salary”) per annum, payable monthly.
   
b)The Executive will also be eligible for an “Annual Bonus” of 100% of the Base Salary, for a total potential Annual Bonus of US$140,000. The annual Bonus will be determined following the completion of the Company’s financial year each year based on performance metrics to be negotiated by the end of August 31, 2020, as determined by the Company’s compensation committee. The Annual Bonus shall be prorated for 2020.

 

The Base Salary and Annual Bonus shall be reviewed by the Company’s compensation committee following the completion of the Company’s financial year each year. The Annual Bonus, if deemed to be payable, will be due to the Executive regardless of whether the term has ended.

 

3.02 Equity Awards

 

Concurrent with the execution hereof and by virtue of Executive’s position, the Company will grant the Executive 500,000 stock options to acquire common shares of the Company (the “Stock Options”) will vest after nine months from the Effective Date and any common shares resulting from the exercise of such Stock Options shall be pooled over a period of six months.

 

 
- 3 -

 

3.03 Expense Reimbursement

 

The Company shall reimburse Executive on a monthly basis for all bona-fide business expenses (including travel, accommodation, entertainment/business expenses) incurred by Executive on behalf of the Company upon submission of written receipts or other written evidence. Any single or series of related expenses exceeding US$5,000 and any expenses exceeding US$5,000 in the aggregate in any month shall be subject to pre-approval by the CEO.

 

ARTICLE IV

DUTIES OF EXECUTIVE

 

4.01 Rules and Regulations

 

Executive shall be bound by and shall faithfully observe and abide by all applicable laws and all the rules and regulations to which the Company may be subject from time to time, which are brought to Executive’s notice or of which Executive should reasonably be aware.

 

4.02 Conflict of Interest

 

As a fiduciary to the Company, Executive shall refrain from any situation in which Executive’s personal interests’ conflict, or may appear to conflict, with Executive’s Duties with the Company. Executive shall not participate in the ownership of, have any financial involvement with or work for, any competing business or for any client or potential client of the Company or otherwise take steps that would benefit him personally while causing loss or damage to the Company, including reputational and/or financial loss or damage. Executive acknowledges that if there is any doubt in this respect, Executive shall inform the Board of Directors and obtain prior written authorization.

 

ARTICLE V

CONFIDENTIAL INFORMATION, INTELLECTUAL PROPERTY, NON-

COMPETITION AND NON-SOLICITATION

 

5.01 Definitions

 

(a)In this Agreement, unless something in the subject-matter or context is inconsistent therewith:

 

Confidential Information” means all confidential information of the Company, including but not limited to trade secrets, customer lists and other confidential information concerning the business and affairs of the Company.

 

 
- 4 -

 

Intellectual Property” means, without limitation, any domestic and foreign:

 

(i) patents, inventions, applications for patents and reissues, divisions, continuations, renewals, extensions and continuations-in-part of patents or patent applications; (ii) proprietary and non-public business information, including inventions, developments, trade secrets, know-how, methods, processes, designs, technology, technical data, schematics, formulae and client lists, and documentation relating to any of the foregoing; (iii) works of authorship, copyrights, copyright registrations and applications for copyright registration; (iv) designs, design registrations, design registration applications and integrated circuit topographies; (v) trade names, business names, corporate names, domain names, website names and world wide web addresses, common law trade-marks, trade-mark registrations, trade mark applications, trade dress and logos, and the goodwill associated with any of the foregoing; (vi) computer software and programs (both source code and object code form), all proprietary rights in the computer software and programs and all documentation and other materials related to the computer software and programs; (vii) any other intellectual property and industrial property and moral rights, title and interest therein, anywhere in the world and whether registered or unregistered, registrable or unregistrable, or protected or protectable under intellectual property laws, or (viii) any derivatives of or improvements on any of the foregoing,

 

which Executive may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the period of time Executive is in the employ of the Company, including the copyright thereon.

 

In the context of any action taken by Executive, the words “directly or indirectly” include any action taken by Executive for Executive’s own benefit or the benefit of any person competing with the Company, whether taken individually or in partnership or jointly or in conjunction with any person as principal, agent, trustee, employee or shareholder (other than holding of shares listed on a Canadian or United States stock exchange that does not exceed 5% of the outstanding shares so listed).

 

5.02 Confidential Information

 

(a)Executive acknowledges that, by reason of Executive’s employment with the Company, Executive will have access to Confidential Information. Executive agrees that, during and after Executive’s employment with the Company, Executive will not disclose to any person, except in the proper course of Executive’s employment with the Company, or use for Executive’s own purposes or for any purposes other than those of the Company, any Confidential Information acquired, created or contributed to by Executive.
   
(b)Any breach of Section 5.02(a) by Executive will result in material and irreparable harm to the Company although it may be difficult for the Company to establish the monetary value flowing from such harm. Executive therefore agrees that the Company, in addition to being entitled to the monetary damages which flow from the breach, will be entitled to injunctive relief in a court of appropriate jurisdiction in the event of any breach by Executive of Section 5.02(a).

 

 
- 5 -

 

5.03 Intellectual Property

 

Executive hereby irrevocably and unconditionally waives all moral rights arising under the Copyright Act (Canada) as amended (or any successor legislation of similar effect), or similar legislation in any applicable jurisdiction, or at common law, that Executive may have now or in the future with respect to Intellectual Property, including, without limitation, any right Executive may have to have Executive’s name associated with the Intellectual Property or to have Executive’s name not associated with the Intellectual Property, any right Executive may have to prevent the alteration, translation or destruction of the Intellectual Property, and any rights Executive may have to control the use of the Intellectual Property in association with any product, service, cause, or institution. Executive agrees that this waiver may be invoked by the Company, and by any of its authorized agents or assignees, in respect of any or all of the Intellectual Property. Executive agrees that all Intellectual Property is and shall be owned by the Company and not Executive and hereby assigns all such Intellectual Property to the extent not already owned by the Company by operation of law. Executive further agrees to, promptly, at the request of the Company, take all such steps and execute all such assignments and other documents as the Company may reasonably require or consider helpful to effect or evidence the assignment and transfer of the Intellectual Property and to protect, obtain or maintain any patents, copyrights, trade-marks or other proprietary rights in the Intellectual Property.

 

5.04 Non-Solicitation

 

(a)During the Restricted Period, Executive shall not, directly or indirectly:

 

(i)other than for the benefit of the Company or any of its affiliates solicit any customer of the Company who was a customer in the twelve (12) months preceding Executive’s last day of active employment for the purpose of selling or providing any products or services similar to those sold or provided by the Company;
   
(ii)refer any customer of the Company who was a customer in the twelve (12) months preceding Executive’s last day of active employment to a competitor of the Company;
   
(iii)solicit for business of any person or entity who is, or was at any time within the previous 12 months, a customer of the Business conducted by the Company (or a potential customer with whom Executive had Business-related dealings in the prior 12 month period prior to termination); or
   
(iv)otherwise attempt to interfere with or damage the business relationship between the Company, on the one hand, and any customer of the Company who was a customer in the twelve (12) months preceding Executive’s last day of employment.

 

 
- 6 -

 

(b)For a period of 12 months following cessation of Executive’s active employment, Executive shall not, directly or indirectly:

 

(i)solicit the employment of (whether as an employee, independent contractor or otherwise) any personnel of the Company (other than any personnel who at the time of the solicitation has not worked for the Company or any of its affiliates for a period of at least six (6) months); or
   
(ii)otherwise attempt to interfere with or damage the business relationship between the Company, on the one hand, and any personnel of the Company, on the other hand. Notwithstanding the foregoing, the restrictions set forth in this Subsection 5.05(b)(ii) shall not prohibit Executive from conducting general solicitations of employment or engagement that are not targeted to personnel of the Company.

 

5.05 Acknowledgements

 

Executive acknowledges that:

 

(a)the business of the Company is carried on throughout Canada and that the Company is interested in and solicits or canvasses opportunities throughout Canada;
   
(b)the reputation of the Company in the industry and its relationships with its customers is the result of hard work, diligence and perseverance on behalf of the Company over an extended period of time;
   
(c)the nature of the business of the Company is such that the on-going relationship between the Company and its customers is material and has a significant effect on the ability of the Company to continue to obtain business from its customers with respect to both long term and new contracts; and
   
(d)in light of the foregoing, the restrictions in this Article 5 are reasonable and valid and Executive hereby waives all defences to the strict enforcement thereof.

 

5.06 Equitable Remedies

 

Executive further acknowledges and agrees that: (i) the Company would suffer irreparable and ongoing damages (including a significant loss of the value and goodwill of the Business) in the event that any provision of this Article 5 (or Section 6.04) were not performed in accordance with its terms or otherwise were breached; and (ii) monetary damages, even if available, alone would not be an adequate remedy for any such non-performance or breach. Accordingly, such Executive agrees that in the event of any breach or threatened breach of any provision of this Article 5, or Section 6.04, the Company shall be entitled, in addition to all other rights and remedies that it may have existing in its favor at law, in equity or otherwise to seek injunctive or other equitable relief (including a temporary restraining order, a preliminary injunction and a final injunction) to prevent any such breach or threatened breach and to enforce such provisions specifically, without the necessity of posting a bond or other security or of proving actual damages. The prevailing party in any action commenced under this Section 5.07 (whether through a monetary judgment, injunctive relief or otherwise) also shall be entitled to recover reasonable legal fees and court costs incurred in connection with such action.

 

 
- 7 -

 

ARTICLE VI

TERMINATION OF CONSULTING AGREEMENT

 

6.01 Termination by the Company For Cause

 

The Company may immediately terminate this Consulting Agreement with the Executive, at any time, for Cause (without notice or payment of compensation in lieu of notice or damages of any kind) by notifying Executive in writing of such termination. For greater certainty, “Cause” means: (i) Executive’s conviction of or admission to the commission of an indictable offence or Executive’s conviction of or admission to a violation of another criminal law involving the affairs of the Company; (ii) any intentional act of fraud, theft, embezzlement or other illegal conduct by Executive involving the Company; (iii) a material breach (which breach is not promptly cured within five (5) business days after receiving written notice of same) of Executive’s obligations under any agreement entered into between Executive and the Company or any of its affiliates; willful or substantial neglect by Executive of Executive’s Duties and responsibilities under this Agreement for a period of ten (10) business days after receiving written notice of the same; Executive’s material breach of the Company’s policies or procedures that is not reasonably curable in the Company’s sole discretion (acting reasonably) or any other willful misconduct which causes material harm to the Company or its business reputation, including due to any adverse publicity; and/or (vi) any conduct that constitutes cause at common law.

 

6.02 Termination by the Company Without Cause

 

In the event that Executive’s Consulting Agreement is terminated by the Company without Cause or Executive resigns his engagement for Good Reason, as defined below, then, subject to Executive’s execution and non-revocation of a release in a form satisfactory to the Company as set out in Section 6.05 below, the Company shall pay Executive severance in an amount equal to the Base Salary for a period of four (4) months. This Severance shall only be applicable if this Agreement is not terminated, or any reason, prior to the four (4) month anniversary of the Effective Date. For clarity:

 

(a)Executive shall not be entitled to any severance in the event that Executive’s Independent Consulting Agreement with the Company is terminated for Cause or Executive resigns without Good Reason;
   
(b)Executive shall not be entitled to any severance in the event that this Agreement is terminated prior to the four month anniversary of the Effective Date;
   
(c)Executive agrees that such payments and other benefits set out in this Section 6.02 shall be his complete and full entitlements to notice or pay in lieu as set out under the Employment Standards Act of Canada, contract or common law.

 

6.03 Voluntary Resignation for Good Reason

 

Good Reason will be established where Executive voluntarily resigns after any of the following actions are taken by the Company or any of its subsidiaries without Executive’s consent (any of the following being “Good Reason”): (i) a reduction in the Base Salary or any target bonus agreed from time to time (but not including any diminution related to a broader compensation reduction that is not limited to any particular employee or executive); or (ii) a material diminution in Executive’s title, Duties, or responsibilities from those in effect on the date hereof (it being understood that Executive’s obligation to report to the Board of Directors and the Board of Director’s exercise of its final authority over Company matters shall not give rise to any such claim of diminution); provided, however, that no event shall constitute Good Reason unless Executive has notified the Company in writing describing the event which constitutes Good Reason and then only if the Company fails to cure such event within thirty (30) days after the Company’s receipt of such written notice.

 

 
- 8 -

 

6.04 Return of Property

 

Upon any cessation of Executive’s employment under this Agreement, or for any reason at any time, and as a condition of the Company paying Executive any termination payments or benefits required hereunder, Executive shall at once deliver or caused to be delivered to the Company all books, documents, effects, money, securities or other property belonging to the Company or for which the Company is liable to others, which are in the possession, charge, control or custody of Executive.

 

6.05 Expense Reimbursement

 

Upon termination for any reason, any expenses properly and legally incurred under this Agreement shall be promptly repaid to Executive.

 

6.06 Release

 

Executive acknowledges and agrees that the payments, benefits and entitlements pursuant to this Article that are in excess of his statutory minimums shall be in full satisfaction of all terms of the cessation of Executive’s employment, including termination pay pursuant to the ESA. Except as otherwise provided in this Article or as may be required by the ESA, Executive shall not be entitled to any further termination payments, damages, compensation or entitlements whatsoever. As a condition precedent to any payment or entitlement pursuant to this Article that exceeds Executive’s statutory minimum entitlements, Executive agrees to deliver to the Company prior to any such payment or receipt of such entitlement, a full and final release from all actions or claims in connection therewith in favour of the Company, its affiliates, subsidiaries, directors, officers, employees and agents, in a form reasonably satisfactory to the Company.

 

ARTICLE VII

DIRECTORS AND OFFICERS

 

7.01 Indemnity

 

Subject to the provisions of the Canada Business Corporations Act, the Company agrees to indemnify and save Executive harmless from and against all demands, claims, costs, charges and expenses, including any amount paid to settle an action or satisfy a judgment, reasonably incurred by Executive in respect of any civil, criminal or administrative action or proceeding to which Executive is made a party by reason of being or having been a director or officer of the Company or of any affiliated Company whether before or after any cessation of employment if:

 

(a)Executive acted honestly and in good faith with a view to the best interests of the Company; and

 

 
- 9 -

 

(b)in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, Executive had reasonable grounds for believing that Executive’s conduct was lawful.

 

7.02 Insurance

 

If Executive is a director or officer at the relevant time, Executive shall be covered by comprehensive directors’ and officers’ liability insurance, which shall be established and maintained by the Company at its expense. The insurance policies to be maintained by the Company hereunder may contain exclusions from coverage in respect of negligence or mala fides acts on the part of Executive.

 

ARTICLE VIII

CONTRACT PROVISIONS

 

8.01 No Breach of Obligations to Others

 

Executive acknowledges and represents to the Company that in carrying out Executive’s Duties and functions for the Company, Executive will not disclose to the Company any confidential information of any third party. Executive acknowledges and represents to the Company that Executive has not brought to the Company nor will Executive use in the performance of Executive’s Duties and functions with the Company any confidential materials or property of any third party. Executive further acknowledges and represents that Executive is not a party to any agreement with or under any legal obligation to any third party that conflicts with any of Executive’s obligations to the Company under this Agreement.

 

8.02 Headings

 

The headings of the Articles and paragraphs herein are inserted for convenience of reference only and shall not affect the meaning or construction hereof.

 

8.03 Independent Advice

 

Executive confirms having had the reasonable opportunity to obtain independent legal advice regarding this Agreement that Executive is signing this Agreement freely and voluntarily with full understanding of its contents.

 

8.04 Governing Law

 

This Agreement shall be governed by the laws in force in the Province of British Columbia and the laws of Canada applicable therein.

 

 
- 10 -

 

8.05 Entire Agreement

 

This Agreement constitutes and expresses the whole agreement of the parties hereto with reference to any of the matters or things herein provided for or herein before discussed or mentioned with reference to Executive’s employment, and it cancels and replaces any and all prior understandings and agreements between Executive and the Company. All promises, representations, collateral agreements and understandings not expressly incorporated in this Agreement are hereby superseded by the within Agreement.

 

8.06 Severability

 

If any provision contained herein is determined to be void or unenforceable in whole or in part, it shall not be deemed to affect or impair the validity of any other provision herein and each such provision is deemed to be separate and distinct.

 

8.07 Survival

 

This Agreement shall continue in full force and effect during the term of this Agreement and, upon the termination of this Agreement pursuant to Sections 6.01, 6.02 or 6.03, Sections 5.02, 5.03, 5.04, 5.05 and 6.05 shall survive such termination.

 

8.08 Notice

 

Any notice required or permitted to be given under this Agreement shall be in writing and shall be properly given if personally delivered, delivered by facsimile transmission (with confirmation of receipt) or mailed by prepaid registered mail addressed as follows:

 

(a)

in the case of the Company:

 

XXXXX

 

(b)in the case of Executive:

 

Scott Larson

Suite 3907 – 1788 Gilmore Ave.

Burnaby, BC

V5C 0L5

 

8.09 Amendments and Waiver

 

No modification of or amendment to this Agreement shall be valid or binding unless set forth in writing and duly executed by both of the parties hereto and no waiver of any breach of any term or provision of this Agreement shall be effective or binding unless made in writing and signed by the party purporting to give the same and, unless otherwise provided, shall be limited to the specific breach waived.

 

 
- 11 -

 

8.10 Successors

 

This Agreement and all rights of Executive hereunder shall enure to the benefit of and be enforceable by Executive and Executive’s personal or legal representatives, heirs, executors, administrators and successors and shall enure to the benefit of and be binding upon the Company, its successors and assigns.

 

8.11 Taxes and Deductions

 

All payments under this Agreement shall be subject to withholding of such amounts, if any, relating to tax or other payroll deductions as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation.

 

8.12 Currency

 

All dollar amounts set forth or referred to in this Agreement refer to the currency of the United States of America.

 

8.13 Counterparts

 

This Agreement may be executed in counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument.

 

8.14 Copy of Agreement

 

Executive hereby acknowledges receipt of a copy of this Agreement duly executed by the Company.

 

 
- 12 -

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

Draganfly Corporation

 

 
 Name:Cameron Chell
 Title:CEO

 

  Scott Larson
 

 

 

 

EX-4.6 14 ex4-6.htm

 

Exhibit 4.6

 

INDEPENDENT CONSULTING AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of ___________, 2021 (the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

-and-

 

SCOTT LARSON

 

‎(Hereinafter referred to as the “Consultant”)‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Parties entered into an Independent Consulting Agreement dated July 3, 2020 (the “Independent Consultant Agreement”) setting out the terms and conditions of the Consultant’s engagement;
   
B.The Company wishes to continue to engage the services of the Consultant, and the Consultant desires to continue to be engaged by the Company upon the terms and subject to the conditions of the Independent Consultant Agreement as amended by the terms of this Independent Consulting Agreement Amending Agreement hereinafter set forth;

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Independent Consulting Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Consultant’s consulting fees and the grant of restricted share units, and in exchange for the Consultant’s continued engagement, the Parties agree to amend the Independent Consultant Agreement as follows:

 

1.Provision 3.01 entitled “Salary Compensation” in the Independent Consultant Agreement will be replaced with the following:

 

Commencing on the Effective Date of the Amending Agreement, the Company shall pay Executive an annual base salary of CDN$250,000.00 (the “Base Salary”) per annum, payable monthly.

 

 
- 2 -

 

The Executive will also be eligible for an “Annual Bonus” of 100% of the Base Salary, for a total potential Annual Bonus of CDN$250,000.00. The Annual Bonus will be determined following the completion of the Company’s financial year each year, based on performance metrics to be determined by the Company’s compensation committee in its sole discretion. The Annual Bonus for 2021 shall be pro-rated to the date of the Amending Agreement.

 

The Base Salary and Annual Bonus shall be reviewed by the Company’s compensation committee following the completion of the Company’s financial year each year. The Annual Bonus, if deemed to be payable, will be due to the Executive regardless of whether the term has ended.

 

2.Provision 3.02 entitled “Equity Awards” in the Independent Consultant Agreement will be replaced with the following:

 

Concurrent with the execution hereof and by virtue of Executive’s position, the Company will grant the Executive 500,000 stock options to acquire common shares of the Company (the “Stock Options”) which will vest after nine months from the Effective Date and any common shares resulting from the exercise of such Stock Options shall be pooled over a period of six months.

 

In addition to the Stock Options, subject to the receipt of all necessary regulatory approvals, the Company shall grant to the Executive 70,000 restricted share units (“RSU”) in Draganfly Inc., which shall vest and be governed in accordance with the Company’s RSU plan.

 

3.All other terms and conditions of engagement set out in the Independent Consultant Agreement will remain unchanged and in effect.

 

4.The Consultant hereby releases the Company from any and all claims it has or may have arising in any way out of the terms of this Amending Agreement or the changes to its engagement as set out herein, specifically includes any claims under any applicable human rights, workers’ compensation, employment standards, employment or labour legislation.

 

5.This Amending Agreement amends the Independent Consultant Agreement. This Amending Agreement and the Independent Consultant Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.

 

6.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

7.If there is a conflict between any provision of this Amending Agreement and any provision of the Independent Consultant Agreement, the relevant provision(s) of this Amending Agreement are to prevail.

 

8.This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of British Columbia. The Parties irrevocably attorn to the jurisdiction to the Courts of the Province of British Columbia.

 

 
- 3 -

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this _______ day of _____________ 2021:

 

     
DRAGANFLY INC.   SCOTT LARSON
     
Authorized Signatory   (Consultant Signature)
I have authority to bind the Corporation    

 

 

EX-4.7 15 ex4-7.htm

 

Exhibit 4.7

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (“Agreement”) is dated as of the November _________, 2020 the “Effective Date”).

 

BETWEEN:

 

DRAGANFLY INC., a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7

 

(“Company”)

 

AND:

 

PAUL SUN, 1179 Fairmeadow Trail, Oakville , Ontario L6M 2M8

 

(the “Employee”)

 

WHEREAS:

 

A.The Company carries on the worldwide business of manufacturing search and navigation equipment within the commercial UAV space;
  
B.The Company has employed the Employee since June 1, 2015; and
  
C.The Company and the Employee wish to amend and restate the employment relationship on the terms set out in this Agreement.

 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth in this Agreement, and for other good and valuable consideration (including but not limited to the $15,000 annual incentive payment at clause 3.2, the Pixology bonus at clause 3.4, and a signing bonus paid by the Company to the Employee for this Agreement in the amount of CAD $50.00), the receipt and sufficiency of which are hereby acknowledged, the Company and the Employee covenant and agree as follows:

 

1.SERVICES TO BE PROVIDED

 

1.1Commencing on the Effective Date, the Employee shall provide executive services to the Company and, in this regard, the Employee shall hold the position of Chief Financial Officer at the Company. Furthermore, commencing on the Effective Date the Employee shall provide such services to the Company as are described in Schedule “A” to this Agreement (the “Services”). The Employee shall also provide any other services not specifically mentioned in Schedule “A”, but which, by reason of the Employee’s capability, the Employee knows or ought to know are necessary to ensure that the best interests of the Company are maintained.

 

 
- 2 -

 

1.2The Employee shall perform the Services to the level of competence and skill one would reasonably expect from an Employee with the skills and experience similar to that of the Employee. The Employee shall devote sufficient working time, attention and ability in a timely manner to the Business of the Company (as hereinafter defined), and to any associated company, as is reasonably necessary for the proper performance of the Services pursuant to this Agreement.
  
1.3The Employee will faithfully, honestly and diligently serve the Employee, use its best efforts to promote the best interests of the Company and co-operate with the Company, and utilize maximum professional skill and care to ensure that the Services are rendered to the satisfaction of the Company.
  
1.4The Employee will comply with all applicable rules, laws and regulations, and all applicable Company policies (to the extent they have been provided to the Employee by the Company), having application to the carrying out and performance of its obligations under this Agreement.
  
1.5At all times while on the Company’s premises or representing the Company in any other location in connection with the provision of the Services, the Employee will observe the Company’s rules and regulations with respect to conduct, health, safety and protection of persons and property.

 

2.location and performance of work

 

2.1The Employee shall work primarily from Oakville, Ontario. The Employee shall also be expected to regularly travel to, and perform the duties at, such other locations as may be determined by Company from time to time. The Employee warrants and represents that the Employee shall maintain a valid passport and that the Employee is not disqualified, to the Employee’s knowledge, from receiving permission to enter the U.S., the European Union, China or any other country or region of the world as a business visitor.

 

3.COnsideration for services

 

3.1As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay the Employee a salary in the amount of CDN$150,000 (the “Annual Salary”) payable by semi-monthly instalments. The Company will review the Annual Salary annually during the term of this Agreement and may, in its sole discretion, adjust the Annual Salary.
  
3.2As of September 1, 2020, the Employee will also receive an annual retention payment amount of CDN$15,000, in addition to the Annual Salary (“Annual retention Payment”). This amount will accrue pro rata and will be paid at a time proposed by management, acting reasonably, and accepted by the Board.

 

 
- 3 -

 

3.3In addition to the above Annual Salary and Annual Retention Payment, the Employee shall be eligible to earn a discretionary annual performance bonus (“Performance Bonus”), pursuant to the terms and conditions that are set out in Schedule “B” of this Agreement and as determined and approved by the Board. The Company shall pay the Employee the Performance Bonus within the thirty (30) days following the Employee’s completion of each Term (as hereinafter defined), beginning from the Effective Date. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year. Further, the Employee shall be eligible to earn a Performance Bonus on a pro-rated basis, and the Employee shall be entitled to receive a pro rata portion of the Performance Bonus for any period of employment predating the payment of the Performance Bonus. In order for the Employee to be entitled to receive a Performance Bonus payment, the Employee must be employed on the date that the payment is made, not including any period of notice or pay in lieu of notice or severance, if applicable. This is because a Performance Bonus is not earned until the payment date. Without limiting the generality of the foregoing, a Performance Bonus shall only continue to vest, accrue or be payable up to the date designated by the Company as the effective date on which the period of employment ends.
  
3.4In addition to the above Annual Salary and Performance Bonus, the Employee will be entitled to a one-time bonus (“Pixology Bonus”), which will be paid as set out as described in Schedule “C” of this Agreement. The Employee agrees that the Pixology Bonus is a one time bonus, does not form part of the Employee’s regular compensation package, and does not create an entitlement to additional future compensation or incentives. The Employee also understands and agrees that the Pixology Bonus will not be included in any termination payment or severance calculations, either pursuant to this Agreement or common law.
  

If the Employee gives notice of resignation or the Company terminates the Employee’s employment for just cause ‎before the applicable Pixology Bonus payment dates as outline in Schedule “C” of this Agreement, the Employee will not be entitled to any remaining amounts of the Pixology Bonus after the date of notice of resignation or date of termination for just cause. For greater ‎certainty, even if all or part of the Pixology Bonus would have become payable during a ‎notice period, if the Employee has ‎provided notice of resignation, or the Employee’s employment was terminated for cause before the all or part of the Pixology Bonus was paid pursuant to Schedule “C”, the Employee will not be entitled to any remaining Pixology Bonus amount(s).

 

‎The Employee agrees that this clause and Schedule “C” contains all of the understandings and representations between ‎‎the ‎Company and the Employee relating to the Employee’s efforts with Pixology, ‎compensation related to Pixology, and the Pixology Bonus. This clause and Schedule “C” supersedes all prior and ‎‎contemporaneous understandings, discussions, agreements, representations and warranties, ‎both ‎written and oral, with respect to compensation for the Employee’s efforts with respect to ‎Pixology and the Pixology Bonus.

 

3.5The Employee shall be entitled to participate in the Company’s benefit programs as may be amended from time to time (the “Benefits”). All Benefits are subject to the terms and conditions of the applicable policies. The Employee agrees that the Company may substitute or modify the Benefits or their terms and conditions without notice.

 

 
- 4 -

 

4.vacation

 

4.1The Employee shall be entitled to take vacation during each calendar year at such time or times as shall be agreed between the Employee and the Company, in the amount of four (4) weeks, pro-rated for part years. The Employee shall be entitled to carry over vacation entitlement from one (1) year to the next without written approval of the Company, without any excess being forfeited subject to any applicable statutory minimums being honoured.

 

5.expenses

 

5.1The Employee shall be reimbursed by the Company for all out-of-pocket expenses actually, necessarily and properly incurred by the Employee in the discharge of duties for the Company. The Employee agrees that such reimbursements shall be due only after the Employee has rendered an itemized expense account, together with receipts where applicable, showing all monies actually expended on behalf of the Company and such other information as may be required and requested by the Company.

 

6.statutory deductions and taxes

 

6.1The Company shall be entitled to withhold from any compensation, benefits or amounts payable under this Agreement all applicable federal or provincial taxes and other statutory deductions as may be required from time to time pursuant to any law or governmental regulation or ruling.

 

7.term and TERMINATION

 

7.1This Agreement will commence on the Effective Date and will continue until terminated in accordance with the provisions of this Agreement (“Term”).

 

7.2The Employee may resign employment by giving the Company sixty (60) days’ written notice, in which event the Employee shall not be entitled to any severance payment but shall be entitled to receive all Annual Salary earned to the date of cessation of employment, all earned but unpaid bonus payment, any outstanding earned but untaken vacation pay and reimbursement of any final expenses (collectively, “Final Wages”). The Company may, at its option, terminate the Employee’s employment prior to the end of such resignation notice period, in which case, the Company shall only be liable to pay the Employee his Annual Salary on regular paydays through to the end of the resignation period, to pay all earned but unpaid bonus payment, to pay out any outstanding earned but untaken vacation pay, to reimburse any final expenses and to continue Benefits other than disability and other coverages which cannot be extended to former employees over such period.

 

 
- 5 -

 

7.3At any time, the Company may terminate the employment of the Employee without just cause by notice in writing stating the last day of employment (the “Termination Date”), in which case the Company shall be obligated to provide the Employee with the compensation set out below (the “Severance”). The unconditional lump sum portions of the Severance shall be payable within fourteen (14) business days following the Termination Date. The Severance shall consist of the following:

 

(a)the Final Wages;
   
(b)an additional lump sum payment equal to the Annual Salary plus last Performance Bonus earned divided by 12 and then multiplied by six (6) (the “Severance Period”); and
   
(c)the Company shall continue at its cost the Benefits then in effect for the Employee, other than disability insurance and other coverages which cannot be extended to former employees, until the earlier of the end of the Severance Period or the Employee obtaining alternate coverage (of which prompt written notice must be given to the Company).

 

It is intended that the Severance exceeds the minimum requirements of the Employment Standards Act (Ontario), as amended. To the extent that the Severance falls below a minimum requirement of this statute, or its regulations, as may be amended from time to time, then the Company shall be required to pay an amount to the Employee that meets, but does not exceed, such minimum requirement, in lieu of the Severance.

 

7.4At any time, the Company may terminate the engagement of the Employee and this Agreement for cause. In such event, the Employee shall not be entitled to any compensation or advance notice, but shall be entitled to receive Final Wages. For purposes of this Agreement, “cause” includes but is not limited to: (i) the Employee commits a crime involving dishonesty, breach of trust, or physical harm to any person; (ii) the Employee willfully engages in conduct that is in bad faith and injurious to the Company, including but not limited to, misappropriation or disclosure of trade secrets or any other kind of Company assets including intellectual property or Confidential Information, dishonesty, fraud, embezzlement, diverting or misusing Company resources for Employee’s own or a third party’s benefit; (iii) the Employee commits a material breach of this Agreement or known Company policy, including policy against bullying, sexual harassment or racial discrimination, which breach is not cured within twenty (20) days after written notice to Employee from the Company; (iv) the Employee willfully refuses to implement or follow a lawful policy or directive of the Company, which breach is not cured within twenty (20) days after written notice to Employee from the Company; (v) the Employee has demonstrated a clear inability to satisfactorily perform the duties of the position despite an opportunity to improve his performance; or (vi) any other conduct that constitutes cause for termination of employment under the common law.

 

8.CHANGE OF CONTROL

 

8.1Change of Control” means:

 

(a)the acquisition, beneficially, directly or indirectly, by any person or group of persons acting jointly or in concert, within the meaning of National Instrument 62-104, Takeover Bids and Issuer Bids, or any successor instrument thereto, of common shares of the Company which, when added to all other common shares of the Company at the time held directly or indirectly by such person or persons acting jointly or in concert, totals for the first time more than 50% of the outstanding common shares of the Company;

 

 
- 6 -

 

(b)during any period of not more than six (6) consecutive months, the removal, by extraordinary resolution of the shareholders of the Company, of more than fifty-one (51%) percent of the incumbent directors on the Company’s Board at the beginning of the period;
   
(c)the consummation of a sale of all or substantially all of the assets of the Company; or
   
(d)the consummation of a reorganization, plan of arrangement, merger or other transaction which has substantially the same effect as to (a) to (c) above.

 

If at any time during the term of this Agreement there is a Change of Control, and within twelve (12) months of such Change of Control there is a termination by the Company without cause or termination by the Employee due to the following (“Good Reason”):

 

(a)the failure of the Company to pay any amount due to the Employee hereunder, which failure persists for fifteen (15) days after the Company receives the Employee’s notice of failure;
   
(b)any unilateral material reduction in the Employee’s title or a material reduction in his duties or responsibilities;
   
(c)any unilateral material adverse change in the Employee’s Annual Salary, or
   
(d)the Company’s material breach of this Agreement, which breach has not been cured by the Company within fifteen (15) days after receipt of notice from the Employee specifying, in reasonable detail, the nature of the breach or failure,

 

the Employee shall then be entitled to receive from the Company only a lump sum payment equal to eighteen (18) months of Annual Salary and average Performance Bonus. The Employee acknowledges and agrees that the terms of this clause set out the entire obligation of the Company to ‎‎give the Employee notice or pay in lieu of notice in the event that the Employee’s employment is terminated for a reason as described in this clause.

 

 
- 7 -

 

9.confidentiality

 

9.1For the purposes of this Agreement, “Confidential Information” means information, whether or not originated by the Employee, that relates to the business or affairs of the Company, its affiliates, clients, sales personnel or suppliers and is confidential or proprietary to, about or created by the Company, its affiliates, clients or suppliers (whether or not reduced to writing or designated or marked as confidential), including, but not limited to, the following:

 

(a)any technical and non-technical information related to the Company’s business and current, future and proposed products and services of the Company, including, without limitation, Company Innovations (as defined herein), Company Property (as defined herein) and the Company’s information concerning research, development, design and product details and specifications, financial information, procurement requirements, engineering and manufacturing information, and business plans;
   
(b)information relating to strategies, research, communications, business plans and financial data of the Company;
   
(c)any information of or regarding the Company and its business which is not readily publicly available;
   
(d)work product resulting from or related to work or projects performed, or to be performed, for the Company or its affiliates, including, but not limited to, the methods, processes, procedures, analysis, techniques and audits used in connection therewith;
   
(e)any intellectual property contributed to the Company, and any other technical and business information of the Company and its affiliates which is of a confidential, trade secret and/or proprietary character;
   
(f)marketing and development plans, price and cost data, price and fee amounts, pricing and billing policies, quoting procedures, marketing techniques, methods of obtaining business, forecasts and forecast assumptions and volumes, current and prospective client lists, and future plans and potential strategies of the Company that have been or are being discussed;
   
(g)information belonging to third parties or which is claimed by third parties to be confidential or proprietary and which the Company has agreed to keep confidential; and
   
(h)any other information that becomes known to the Employee as a result of this Agreement or the services performed hereunder, including information received by the Company from others, that the Employee, acting reasonably, believes is confidential information or that the Company takes measures to protect.

 

9.2The Employee’s obligations under this Section 9 do not apply to any Confidential Information that the Employee can demonstrate: (a) was in the public domain at or subsequent to the time the Confidential Information was communicated to the Employee by the Company through no fault of the Employee; (b) was rightfully in the Employee’s possession free of any obligation of confidence at or subsequent to the time the Confidential Information was communicated to the Employee by the Company; or (c) was independently developed by the Employee without use of, or reference to, any Confidential Information communicated to the Employee by the Company. A disclosure of any Confidential Information by Employee in response to a valid order by a court or other governmental body or as otherwise required by law will not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes, provided, however, that the Employee provides prompt prior written notice thereof to the Company to enable the Company to seek a protective order or otherwise prevent the disclosure.

 

 
- 8 -

 

9.3The Employee acknowledges that the Confidential Information is a valuable and unique asset of the Company and that the Confidential Information is and will remain the exclusive property of the Company. The Employee agrees to maintain securely and hold in strict confidence all Confidential Information received, acquired or developed by the Employee or disclosed to the Employee as a result of or in connection with the Services. The Employee agrees that, both during and after the termination of this Agreement, the Employee will not, directly or indirectly, divulge, communicate, use, copy or disclose or permit others to use, copy or disclose, any Confidential Information to any person, except as such disclosure may be consented to by prior written authorization of the Board.
  
9.4The Employee may use the Confidential Information solely to perform the Services for the benefit of Company. The Employee shall treat all Confidential Information with the same degree of care as the Employee accords to the Employee’s own confidential information, but in no case shall the Employee use less than reasonable care. The Employee shall immediately give notice to the Company of any unauthorized use or disclosure of the Confidential Information. The Employee shall assist the Company in remedying any unauthorized use or disclosure of the Confidential Information.
  
9.5All Confidential Information and any materials and items (including, without limitation, software, equipment, tools, artwork, documents, drawings, papers, diskettes, tapes, models, apparatus, sketches, designs and lists) that the Company furnishes to the Employee, whether delivered to the Employee by the Company or made by the Employee in the performance of the Services, and whether or not they contain or disclose Confidential Information (collectively, the “Company Property”), are the sole and exclusive property of the Company or the Company’s affiliates, suppliers or customers. The Employee agrees to treat the Company Property with the same degree of care as the Employee treats its own property, but in no case shall the Employee use less than reasonable care. Within five (5) days after any request by the Company, the Employee shall destroy or deliver to the Company, at the Company’s option: (a) all Company Property and (b) all materials and items in the Employee’s possession or control that contain or disclose any Confidential Information. The Employee will provide the Company a written certification of the Employee’s compliance with the Employee’s obligations under this Section 9.5.
  
9.6During the term of this Agreement, the Employee will not accept work, enter into a contract or accept an obligation in breach of the Employee’s obligations under Section 11 of this Agreement, or the scope of the Services to be rendered for the Company under this Agreement. The Employee warrants that, to the best of the Employee’s knowledge, there is no other existing contract or duty on the Employee’s part that conflicts with or is inconsistent with this Agreement.

 

 
- 9 -

 

9.7The Employee represents and warrants that the Employee has not used and will not use, while performing the Services, any materials or documents of another company which the Employee is under a duty not to disclose. The Employee understands that, while performing the Services, the Employee shall not breach any obligation or confidence or duty the Employee may have to any current or former client or employer. The Employee represents and warrants that it will not, to the best of its knowledge and belief, use or cause to be incorporated in any of the Employee’s work product, any data software, information, designs, techniques or know-how which the Employee or the Company does not have the right to use.
  
9.8The Employee will indemnify and hold harmless the Company from and against any and all third party claims, suits, actions, demands and proceedings against the Company and all losses, costs, damages, expenses, fees and liabilities related thereto arising out of or related to: (a) an allegation that any item, material or other deliverable delivered by the Employee under this Agreement infringes any intellectual property rights or publicity rights of a third party; (b) an alleged breach by the Employee of any agreement between the Employee and any third party; or (c) any negligence by the Employee or any other act or omission of the Employee, including, without limitation, any breach of this Agreement by the Employee.

 

10.DISCLOSURE AND ASSIGNMENT OF WORK RESULTING FROM PROVISION OF SERVICES

 

10.1In this Agreement, “Innovations” means all discoveries, designs, developments, improvements, inventions (whether or not protectable under patent laws), works of authorship, information fixed in any tangible medium of expression (whether or not protectable under copyright laws), trade secrets, know-how, ideas (whether or not protectable under trade secret laws), mask works, trademarks, service marks, trade names and trade dress. “Company Innovations” means Innovations that: (a) result or derive from the provision of the Services or from the Employee’s knowledge or use of Confidential Information; (b) are conceived or made by the Employee (individually or in collaboration with others) in the course of provision of the Services; (c) result from or derive from the use or application of the resources of the Company, its affiliates or suppliers; (d) relate to the Business of the Company or to actual or demonstrably anticipated research and development by the Company or its affiliates; or (e) the Employee, solely or jointly with others, creates, derives, conceives, develops, makes or reduces to practice during the Term.
  
10.2All Company Innovations shall be the exclusive property of the Company and the Company shall have sole discretion to deal with Company Innovations. The Employee agrees that no intellectual property rights in the Company Innovations are or shall be retained by the Employee. For greater certainty, all work done during the Term by the Employee for the Company or its affiliates is the sole property of the Company or its affiliates, as the case may be, as the first author for copyright purposes and in respect of which all copyright shall vest in the Company or the relevant affiliate, as the case may be.

 

 
- 10 -

 

10.3The Employee agrees to maintain adequate and current records of all Company Innovations, which records shall be and remain the property of the Company. The Employee agrees to promptly disclose and describe to the Company all Company Innovations. The Employee hereby does and will irrevocably assign to the Company or the Company’s designee all of the Employee’s right, title and interest in and to any and all Company Innovations and all associated records.
  
10.4In consideration of the benefits to be received by the Employee under the terms of this Agreement, the Employee hereby irrevocably sells, assigns and transfers, and agrees in the future to sell, assign and transfer all right, title and interest in and to the Company Innovations and intellectual property rights therein, including, without limitation, all patents, copyright, industrial design, circuit topography and trademarks, and any goodwill associated therewith in Canada, the United States and worldwide to the Company and the Employee shall hold all the benefits of the rights, title and interest mentioned above in trust for the Company prior to the assignment to the Company, save and except for any moral rights which the Employee shall waive. To the extent any of the rights, title and interest in and to Company Innovations cannot be assigned by the Employee to the Company, the Employee hereby grants to the Company an exclusive, royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit those non-assignable rights, title and interest, including, but not limited to, the right to make, use, sell, offer for sale, import, have made, and have sold, the Company Innovations. To the extent any of the rights, title and interest in and to the Company Innovations can neither be assigned nor licensed by the Employee to the Company, the Employee hereby irrevocably waives and agrees never to assert the non-assignable and non-licensable rights, title and interest against the Company, any of the Company’s successors in interest, or any of the Company’s customers.
  
10.5The Employee agrees to perform, during and after the Term, all acts that the Company deems necessary or desirable to permit and assist the Company, at its expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Company Innovations as provided to the Company under this Agreement. If the Company is unable for any reason to secure the Employee’s signature to any document required to file, prosecute, register or memorialize the assignment of any rights under any Company Innovations as provided under this Agreement, the Employee hereby irrevocably designates and appoints the Company and the Company’s duly authorized officers and agents as the Employee’s agents and attorneys-in-fact to act for and on the Employee’s behalf and instead of the Employee to take all lawfully permitted acts to further the filing, prosecution, registration, memorialization of assignment, issuance and enforcement of rights in, to and under the Company Innovations, all with the same legal force and effect as if executed by the Employee. The foregoing is deemed a power coupled with an interest and is irrevocable.

 

 
- 11 -

 

10.6If the Employee incorporates or permits to be incorporated any Innovations relating in any way, at the time of conception, reduction to practice, creation, derivation, development or making of the Innovation, to the Company’s business or actual or demonstrably anticipated research or development but which were conceived, reduced to practice, created, derived, developed or made by the Employee (solely or jointly) either unrelated to the Employee’s work for Company under this Agreement or prior to the Effective Date (collectively, the “Out-of-Scope Innovations”) into any of the Company Innovations, then the Employee hereby grants to the Company and the Company’s designees a royalty-free, transferable, irrevocable, worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to fully use, practice and exploit all patent, copyright, moral right, mask work, trade secret and other intellectual property rights relating to the Out-of-Scope Innovations. Notwithstanding the foregoing, the Employee agrees that the Employee shall not incorporate, or permit to be incorporated, any Innovations conceived, reduced to practice, created, derived, developed or made by others or any Out-of-Scope Innovations into any Company Innovations without the Company’s prior written consent.

 

11.NON-INTERFERENCE WITH BUSINESS

 

11.1In this Agreement, “Business of the Company” means the business of manufacturing search and navigation equipment within the commercial UAV space.
  
11.2The Employee agrees that, during the Term, the Employee will not, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, including, without limitation, as an employer, employee, principal, agent, director, officer, joint venturer, partner, shareholder or other equity holder, lender or other debt holder, independent contractor, licensor, licensee, franchisor, franchisee, distributor, consultant, financier, supplier or trustee, or by or through any company, cooperative, partnership, trust, unincorporated association or otherwise, anywhere in North America:

 

(a)carry on, be engaged in, have any financial or other interest in or be otherwise commercially involved in any endeavour, activity or business which is in competition with the Business of the Company;
   
(b)canvass or solicit the business of (or procure or assist the canvassing or soliciting of the business of) any customer, prospective customer or supplier of the Company to supply or purchase any goods or services that are substantially the same as or in competition with goods or services supplied in the Business of the Company;
   
(c)accept (or procure or assist the acceptance of) any business from any customer, prospective customer, sales personnel or supplier that is substantially the same as or in competition with the Business of the Company; or
   
(d)supply (or procure or assist the supply of) any goods or services to any customer, prospective customer, sales personnel or supplier that are substantially the same as or in competition with the goods or services supplied in the Business of the Company.

 

 
- 12 -

 

11.3During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Employee agrees not to solicit or induce any customer, prospective customer, supplier, sales personnel, employee or independent contractor involved with the Company to terminate or breach any employment, contractual or other relationship with the Company, or to otherwise discontinue or alter such third party’s relationship with the Company.
  
11.4During the Term, and for a period of twelve (12) months immediately following the termination or expiration of this Agreement, the Employee agrees not to, on its own behalf or on behalf of or in connection with any third party, directly or indirectly, in any capacity whatsoever, engage in any pattern of conduct that involves the making or publishing of written or oral statements or remarks (including without limitation the repetition or distribution of derogatory rumours, allegations, negative reports or comments) which are disparaging, deleterious or damaging to the integrity, reputation or goodwill of the Company or any of its affiliates, officers, directors, employees, consultants or advisors.

 

12.full satisfation and release

 

12.1The Employee agrees to accept the Severance, as applicable, in full satisfaction of any and all claims the Employee has or may have against the Company arising out of such termination, including: under applicable employment standards legislation and entitlement to reasonable notice under common law. The Employee agrees to sign and deliver a full and final release of the Company of all such claims arising upon such termination in return for payment of the lump sum components of the Severance in excess of employment standards minimum payments.

 

13.right to deduct

 

13.1The Company shall have the right to offset any money properly due by the Employee to the Company against any amounts payable by the Company to the Employee under this Agreement.

 

14.general

 

14.1This Agreement contains the entire Agreement and obligation between the parties with respect to its subject matter. No amendment to this Agreement will be valid or effective unless in writing and signed by all of the parties.
  
14.2The Employee undertakes to fulfill all of its obligations under this Agreement, and not to do anything which would impair or prejudice the Employee’s ability to do so. The Employee agrees that he is bound under his obligations in Sections 9, 10 and 11 of this Agreement.

 

 
- 13 -

 

14.3The Employee’s obligations under this Agreement are of a unique character that gives them particular value, and that the breach of any of these obligations will cause irreparable and continuing damage to the Company for which money damages are insufficient. The Company is entitled to injunctive relief, a decree for specific performance, and all other relief as may be proper (including money damages if appropriate), without the need to post a bond.
  
14.4It is intended that this Agreement shall be in compliance with the minimum requirements of Ontario’s Employment Standards Act, as may be amended from time to time. To the extent that a term or condition of this Agreement falls below a minimum requirement of this statute or its regulations, as may be amended from time to time, such minimum requirement, and no greater requirement, shall replace the term or condition of this Agreement, and shall be incorporated into the Agreement.
  
14.5The Employee acknowledges that the restrictions contained in Section s 9, 10 and 11 are, in view of the nature of the Business of the Company, reasonable and necessary to protect the legitimate interests of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions and that any violation of any provision of those Sections could result in irreparable injury to the Company. The Employee agrees that, in the event it violates any of the restrictions referred to in Section 9, 10 and 11, the Company shall be entitled to such injunctive relief or other remedies at law or in equity which the Court deems fit.
  
14.6The Employee expressly acknowledges that this Agreement is reasonable and valid in all respects and irrevocably waives (and irrevocably agrees not to raise) as a defence any issue of reasonableness in any proceeding to enforce any provision of this Agreement, the intention of the parties being to provide for the legitimate and reasonable protection of the interests of the Company by providing, without limitation, for the broadest scope, the longest duration and the widest territory allowable by law.
  
14.7The Employee agrees to indemnify the Company from all losses, claims, actions, damages, assessments or demands (including reasonable legal fees and expenses) which result from negligent acts or omissions of the Employee in providing the Services. Notwithstanding the foregoing, the Company agrees that the Employee will be covered by the Company’s Directors & Officers and Employment Practices Liability Insurance, once such insurance is obtained by the Company.
  
14.8Any notice, request, demand or other communication hereunder shall be in writing and shall be delivered as follows, with notice deemed given as indicated: (a) by personal delivery, when actually delivered; (b) by overnight courier, upon written verification of receipt; (c) by facsimile or email, when sent, if sent during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day; or (d) by certified or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to the addresses set forth on the first page of this Agreement or to such other address as the parties may advise each other in writing from time to time in accordance with this Section 14.8.

 

 
- 14 -

 

14.9The Company and the Employee will be responsible for all of their own expenses, legal and other professional fees, disbursements, and all other costs incurred in connection with the negotiation, preparation, execution and delivery of this Agreement and all documents and instruments relating hereto. The parties agree that they have had adequate opportunity to seek independent legal advice with respect to the subject matter of this Agreement, and have either obtained such advice or consciously chosen not to do so with full knowledge of the risks associated with not obtaining such legal advice.
  
14.10If any provision of this Agreement, including as to term or geographical area, is held to be illegal, invalid or unenforceable under present or future laws by any court of competent jurisdiction, such illegality, invalidity or unenforceability shall not affect the legality, enforceability or validity of any other provisions of this Agreement or of the same provision as applied to any other fact or circumstance, and such illegal, unenforceable or invalid provision shall be modified to the minimum extent necessary to make such provision legal, valid or enforceable.
  
14.11Time shall be of the essence of this Agreement.
  
14.12Except as specifically permitted herein, the Employee will not sell, assign or transfer any rights or interests created under this Agreement or delegate any of the Employee’s duties without the prior written consent of the Company.
  
14.13The headings in this Agreement are inserted for convenience of reference only and shall not affect the construction or interpretation of this Agreement. Wherever the singular or masculine or neuter is used in this Agreement, the same shall be construed as meaning the plural or feminine or a body politic or corporate and vice versa where the context so requires.
  
14.14The parties agree that this Agreement is effective as of the Effective Date, and the parties agree that there is fresh, sufficient consideration for this Agreement. The parties waive the ability to claim that: (i) this Agreement is void for lack of fresh, sufficient consideration, and (ii) this Agreement is not effective as of the Effective Date.
  
14.15This Agreement will be governed by and construed in accordance with the laws of the Province of Ontario, and the federal laws of Canada applicable therein, and each of the parties irrevocably submit to the exclusive jurisdiction of courts of competent jurisdiction in the Province of Ontario, without reference to its conflicts of law jurisprudence, in respect of any dispute or claim arising out of this Agreement or any legal obligation between the parties. Notwithstanding the foregoing, the Company may enforce any post-employment obligation of the Employee under this Agreement in any court of competent jurisdiction anywhere in the world.
  
14.16This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which taken together shall be deemed to constitute one and the same instrument. Counterparts may be executed either in original or electronic form and each of the parties to this Agreement agree that any signature delivered by electronic transmission will be deemed to be the original signature of the delivering party.
  
14.17Unless otherwise provided, all dollar amounts referred to in this Agreement are in lawful money of Canadian.

 

 
- 15 -

 

IN WITNESS WHEREOF, the parties have signed this Agreement as of the day and year first written above.

 

DRAGANFLY INC.    
by its authorized signatory    
     
     
Name: Cameron Chell   Name: Paul Sun
Title: Chief Executive Officer    

 

 

 

 

SCHEDULE “A”

 

SERVICES

 

Defined terms used but not otherwise defined in this Schedule “A” have the meaning ascribed thereto in the Employment Agreement dated November ______, 2020 (the “Agreement”) between Paul Sun (“Employee”) and Draganfly Inc. (the “Company”) of which this Schedule “A” forms part.

 

The Services to be provided by the Employee under the Agreement are as follows:

 

Providing leadership, direction and management of the finance and accounting team.
   
Providing strategic recommendations to the CEO/president and members of the executive management team.
   
Managing the processes for financial forecasting and budgets, and overseeing the preparation of all financial reporting.
   
Advising on long-term business and financial planning.
   
Establishing and developing relations with senior management and external partners and stakeholders.
   
Reviewing all formal finance, HR and IT related procedures.
   
Other tasks and mandates as set by the Board and President.

 

 

 

 

SCHEDULE “B”

 

ANNUAL PERFORMANCE BONUS

 

Defined terms used but not otherwise defined in this Schedule “B” have the meaning ascribed thereto in the Employment Agreement dated November _______, 2020 (the “Agreement”) between Paul Sun (“Employee”) and Draganfly Inc. (the “Company”) of which this Schedule “B” forms part.

 

The Employee shall be eligible to receive, at the sole discretion of the Company, an annual Performance Bonus, equivalent to an amount not exceeding the Employee’s Annual Salary as referenced in the Agreement. The following bonus target percentages will guide the Company’s Compensation Committee in determining an appropriate bonus:

 

Financing / capital raise of at least CDN$7 million   30%
Actual vs Projected Budget Management   25%
Monthly Reporting at 95% accuracy within 21 days   10%
Company-wide HR / Equity / Compensation alignment   10%
12 months burn rate in cash in bank   15%
Signed revenue / contracts of CDN$7 million   10%

 

 
- 2 -

 

SCHEDULE “C”

 

ONE TIME LEGACY PIXOLOGY BONUS

 

1.A one time payment of CDN$40,000 will be paid on following schedule:

 

a.CDN$20,000 as at Effective Date or as soon as practical thereafter based on management’s proposal, Board acceptance, and the Company’s cash flow situation;
   
b.CDN$10,000 at time of the Employee’s next annual Performance Bonus (this payment is in addition to annual Performance Bonus calculations); and
   
c.CDN$10,000 at time of Pixology escrow release (estimated October 2021).

 

 

EX-4.8 16 ex4-8.htm

 

Exhibit 4.8

 

EMPLOYMENT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of _____________, 2021 (the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

‎(Hereinafter referred to as the “Company”)

 

OF THE FIRST PART.‎

 

-and-

 

PAUL SUN,

 

an individual residing at 1179 Fairmeadow Trail, Oakville , Ontario L6M 2M8

 

‎(Hereinafter referred to as the “Employee” or “you”)‎

 

OF THE SECOND PART.‎

 

(collectively, the “Parties”)

 

WHEREAS:

 

A.The Company ‎and the Employee entered into an Employment Agreement dated November, 2020 (the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;
   
B.The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Employment Agreement Amending Agreement hereinafter set forth;

 

 
- 2 -

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Employment Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Employee’s base salary and the grant of restricted share units, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1.Provision 3.1 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

As compensation for carrying out the Services during the term of this Agreement, the Company agrees to pay the Employee a salary in the amount of CDN$220,000.00 (the “Annual Salary”) payable by semi-monthly instalments. The Company will review the Annual Salary annually during the term of this Agreement and may, in its sole discretion, adjust the Annual Salary.

 

2.Provision 3.2 entitled “Consideration for Services” in the Employment Agreement will be removed.

 

3.Provision 3.3 entitled “Consideration for Services” in the Employment Agreement will be replaced with the following:

 

In addition to the above Annual Salary, the Employee shall be eligible to earn a discretionary annual performance bonus (“Performance Bonus”). The Performance Bonus will be determined following the completion of the ‎Company’s financial year each year, based on performance metrics to be ‎determined by the Company’s compensation committee in its sole discretion‎. The Company shall pay the Employee the Performance Bonus, if any, within the thirty (30) days following the Employee’s completion of each Term (as hereinafter defined), beginning from the Effective Date. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year. Further, the Employee shall be eligible to earn a Performance Bonus on a pro-rated basis, and the Employee shall be entitled to receive a pro rata portion of the Performance Bonus for any period of employment predating the payment of the Performance Bonus. To be eligible for a Performance Bonus, the Employee must also be Actively Employed on the date of payment of any such ‎bonus. For purposes of this Agreement, the last day that the Employee is “Actively Employed” ‎shall be the later of:‎ (i) the ‎last day that‎ the Employee actually performs their ‎duties prior to the termination ‎of the Employee’s employment with the ‎Company for ‎any reason; or (ii) the ‎end of ‎the minimum ‎period of statutory notice of termination prescribed by the Ontario Employment Standards Act, 2000 (the “ESA”)‎. This is because a Performance Bonus is not earned until the payment date. For clarity, ‎except to the extent required by the ESA: ‎‎‎(i) the last day that the Employee is Actively ‎Employed ‎shall not be extended by any ‎‎‎‎contractual or ‎‎common law notice of ‎‎termination period in ‎respect ‎of which the Employee ‎receives ‎‎or may ‎‎receive pay ‎in ‎lieu of notice ‎of termination or damages ‎in ‎lieu of such ‎notice ‎of ‎‎termination; and ‎(ii) entitlement to any ‎Performance Bonus‎ shall not ‎be included ‎in any ‎entitlement which the Employee ‎may ‎have to pay in lieu or damages in lieu ‎‎of ‎notice ‎‎of ‎termination. ‎

 

 
- 3 -

 

Beginning in the calendar year of 2021, the Employee’s annual target Performance Bonus is CDN$220,000.00, pro-rated to the date of this Amending Agreement for 2021. To clarify, the Performance Bonus remains discretionary as solely determined and approved by the Board. The Employee understands and agrees that payment of a Performance Bonus should not be considered to be expected compensation and the payment of a Performance Bonus in any one or successive years shall not create an entitlement to a Performance Bonus in any subsequent year.

 

4.Provision 3.6 entitled “Consideration for Services” will be added into the Employment Agreement as follows:

 

Subject to the receipt of all necessary regulatory approvals, the Company shall grant to you 30,000 restricted share units (“RSU”) in Draganfly Inc., which shall vest and be governed in accordance with the Company’s RSU plan.

 

5.All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.

 

6.The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Amending Agreement or the changes to his employment as set out herein, specifically includes any claims under any applicable human rights, workers’ compensation, employment standards, employment or labour legislation including but not limited to the Employment Standards Act, 2000, the Human Rights Code, the Workplace Safety and Insurance Act, 1997 and the Pay Equity Act.

 

7.This Amending Agreement amends the Employment Agreement. This Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.

 

8.This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.

 

9.If there is a conflict between any provision of this Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Amending Agreement are to prevail.

 

10.This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of Ontario. The Parties irrevocably attorn to the jurisdiction to the Ontario Superior Court of Justice in Toronto.

 

‎[signature page follows]‎

 

 
- 4 -

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this _______ day of _____________ 2021:

 

     
DRAGANFLY INC.   PAUL SUN
     
Authorized Signatory   (Consultant Signature)
I have authority to bind the Corporation    

 

 

EX-4.9 17 ex4-9.htm

 

Exhibit 4.9

 

April 30, 2020

 

Personal & Confidential

Delivered by E-mail

 

Justin Hannewyk

304—1126 Barclay Street

 

Dear Mr. Hannewyk,

 

RE: Employment Agreement

 

Further to our recent discussions, Dronelogics Systems Inc. (“Dronelogics”) is pleased to offer you this new employment contract (“Agreement”), which will supersede your existing employment agreement with Dronelogics.

 

1. Effective Date; Location This Agreement is contingent and conditional upon Draganfly Inc. (“Draganfly”) completing its share purchase acquisition of Dronelogics (the “Transaction”) by April 30, 2020, or such other date as may be subsequently agreed to by the parties in writing (“Deadline”). If Draganfly does not complete the Transaction by the Deadline, this Agreement (and any schedules, attachments and enclosures thereto) is null and void. If Dronelogics completes the Transaction by the Deadline, this Agreement (and any schedules, attachments and enclosures thereto) will take effect on the date of such completion.
   
2. Existing Employee; Fresh Consideration The parties acknowledge that you have been employed with Dronelogics since January 13, 2009. Dronelogics wishes to continue your employment subject to the terms and conditions of this Agreement, and you wish to continue your employment with Dronelogics on such terms and conditions. Subject to the terms and conditions of this Agreement, your seniority of employment with Dronelogics will be recognized for all purposes. The parties acknowledge and agree that you will be provided with sufficient consideration in exchange for your execution of this Agreement, including but not necessarily limited to compensation, benefits, Options and RSUs set out herein.
   
3. Duration Your employment under this Agreement will be indefinite, subject to the termination provisions set out herein. As you will be living and working primarily in British Columbia in respect of this employment, the British Columbia Employment Standards Act and the regulations thereunder, as may be amended from time to time, (“ESA”) will apply to this employment.
   
4. Conditions You may be required to undertake occasional business travel (both domestic and international). Accordingly, you will be required to maintain an up-to-date passport and remain legally able to travel for business internationally.

 

1 | Page
 

 

5. Position and Responsibilities You will continue to be employed in the position of President of Dronelogics. You will be expected to faithfully perform the duties and functions which are consistent with the duties of this position and such other duties as may be prescribed or specified from time to time by Dronelogics. You will also act as a director on Draganfly’s board of directors (the “Draganfly Board”). You will resign from this position as director immediately upon cessation of your employment with Dronelogics, except as may be agreed otherwise by the parties in writing.
   
  In addition to the compensation and benefits that you are eligible for as a President of Dronelogics, which is set out in Section 6 of this Agreement, your compensation as a director on the Draganfly Board is set out in Schedule “A” of this Agreement. Dronelogics represents that it has authority from the Draganfly Board and Draganfly to offer the compensation in Schedule “A” to you.
   
  You will be employed on a full-time basis for Dronelogics and you understand and agree that you will work a minimum of 40 hours per week. You acknowledge and agree that you will be required to work such other hours as may reasonably be necessary for the proper performance of the duties of your position, subject to compliance with the minimum requirements of the ESA.
   
  Due to the managerial nature position of your position as President of Dronelogics, you will not be entitled to any form of overtime compensation.
   
  You agree to carry out all lawful instructions given to you by Dronelogics. You also acknowledge and hereby agree to observe all rules and policies of Dronelogics. Dronelogics reserves the right to revise, revoke, or introduce new rules and policies, as Dronelogics may deem necessary from time to time, and you will also be required to abide by any new or revised rules and policies, once you are advised of them and they come into effect.
   
  You are expected to devote your full time and attention during your working hours to promoting the business and interests of Dronelogics. While working for Dronelogics, you may participate in charitable organizations or other similar organizations, subject to the reasonable objection of Dronelogics and provided that such participation does not interfere with the proper discharge of your duties to Dronelogics. However, you must not carry out any other work or be involved in any other business for yourself or any other person, firm or company (whether for compensation or not) without first obtaining written permission from the Draganfly Board. You acknowledge that you do not currently have any involvements for which such permission must be sought. Notwithstanding the foregoing, nothing in this paragraph shall prohibit you from having an interest in, being employed by, or working in the business of: (i) providing cinematography, scanning services related to cinematography and virtual reality and game design related solely to cinematography in Canada, including by using drones, and (ii) development and sale of associated hardware world-wide (including the VersaArm and other camera arms) and accessories, other than drones; and in each case, related services carried on by Dronelogics prior to completion of the Transaction, and which, for greater certainty, has not been acquired by Draganfly under the Transaction. Additionally, you shall not be in default under this paragraph by virtue of your holding, strictly for portfolio purposes and as a passive investor, no more than five percent (5%) of the issued and outstanding shares of, or any other interest in, any body corporate which is listed on any recognized stock exchange, the business of which body corporate is in competition, in whole or in part, with Dronelogics.

 

2 | Page
 

 

6. Compensation and Benefits

 

  (a) Base Salary Your annual base salary under this Agreement will be $120,000, payable in accordance with our regular payroll schedule, as may be increased by Dronelogics from time to time in its sole discretion (“Base Salary”).
     
  (b) Stock Options As President of Dronelogics, you will be eligible for the stock options as set out in Schedule “B”.
     
  (c) Incentive In addition to your Base Salary, you will be eligible to participate in any incentive plans Dronelogics’ board of directors (“Dronelogics Board”) may implement, or amend, from time to time in consultation with Draganfly Board (“Incentive Plan”). For emphasis, the Dronelogics Board has full discretion in respect of any Incentive Plan, including but not limited to, targets, amending the plan from year-to-year, assessing performance and payouts. Such discretion will be exercised in good faith. Subject to the Dronelogics Board, confirming that the following Incentive Plan targets have been met and subsequent verification by the Draganfly Board, you will be eligible to receive the following:

 

  (i) $20,000 Milestones bonus if the annual Dronelogics budget is achieved; and
     
  (ii) 2% of revenues exceeding the annual Dronelogics budget, subject to the revenues having a minimum 25% margin.

 

Except as expressly stated otherwise elsewhere in this Agreement, if you resign from your employment with Dronelogics or Dronelogics terminates your employment for cause, any Incentive Plan payment for the calendar year in which the date of termination of employment occurs shall be cancelled, and you will not be entitled to any Incentive Plan payment for any period following the termination date, but any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of your termination of employment will be paid to you.

 

Except as expressly stated otherwise elsewhere in this Agreement, if your employment with Dronelogics ends for any reason other than your resignation or for cause, any Incentive Plan payment payable to you for the calendar year in which the date of termination of employment occurs shall be prorated based on the number of days of your employment with Dronelogics in the calendar year in which the date of termination occurs, and any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of termination of your employment will be paid to you, but you will not be entitled to any Incentive Plan payment for any period following the termination date.

 

3 | Page
 

 

  (d) Health Benefits You will be eligible to participate in any group benefits Dronelogics may implement from time to time in its sole discretion (“Group Benefits”). Your participation in any Group Benefit plan is subject to the terms and conditions of any applicable benefit carriers. Furthermore, Dronelogics reserves the right to amend benefits and/or to switch to a different carrier or plan, and you will not have any right to compensation as a consequence.
     
  (e) Vacation Subject to future increases based on existing practices for Dronelogics’ senior executives, during each year of employment you will be entitled to four (4) weeks of paid vacation per calendar year, pro rata for any part calendar years. The vacation year is a calendar year and you will immediately become entitled to your full vacation entitlement commencing on January 1 of each calendar year. You are required to use all paid vacation within one (1) year following the calendar year of accrual. Failure to do so will result in you forfeiting the paid vacation time in question, subject to any minimum requirements of the ESA being honoured.
     
    During any statutory leave provided for by the ESA or any other leave that is more extensive than casual sick leave of short duration, vacation entitlement and/or vacation pay shall only accrue in accordance with the minimum requirements of the ESA.
     
    At the cessation of your employment with Dronelogics, any paid vacation time not taken by you, and which has not been forfeited, will be paid out to you as part of final wages.
     
  (f) Expenses You will be reimbursed for reasonable and customary business expenses incurred in the course of performing your duties hereunder, in accordance with Dronelogics’ policies and practices (as amended from time to time) and conditional upon submission of receipts and details satisfactory to Dronelogics.
     
  (g) Equipment During the course of your employment, Dronelogics may supply you with equipment, devices or other property to carry out your responsibilities hereunder. You agree that during the term of your employment and thereafter any and all equipment, devices or other property provided to you by Dronelogics shall remain the property of Dronelogics (“Dronelogics Property”). The foregoing shall include all property (whether in electronic or hard copy form), including without limitation computers, peripherals, software, cellular phones, keys, door passes and any other equipment. You understand and agree that you will not be entitled to use any Dronelogics Property for any period after the last day of your active employment, and you will not be entitled to compensation for the loss of use of Dronelogics Property.
     
  (h) Mileage Allowance Dronelogics will reimburse you for all mileage accumulated on your personal vehicle that was incurred solely for completing Dronelogics business and only for travel to and from Dronelogics’ premises and its customers. Such reimbursement will be paid monthly and conditional upon submission of receipts and details satisfactory to Dronelogics.

 

4 | Page
 

 

  (i) Cell Phone Reimbursement Dronelogics will reimburse you for 50% of your monthly cellular telephone bill.
     
  (j) Directors and Officers Liability Insurance Dronelogics will maintain directors and officers’ insurance for your benefit in your capacity as a director or officer of Dronelogics and any of its subsidiaries or affiliates.

 

7. Cessation of Employment

 

  (a) Resignation You must give thirty (30) days’ prior written notice if you wish to resign (“Resignation Notice Period”). Once you give Dronelogics notice of resignation, Dronelogics reserves the right to waive all or part of any resignation notice exceeding the Resignation Notice Period, in which case your resignation will take effect and your employment will cease at the end of the reduced period, with no further obligation to you, except as otherwise necessary to comply with the minimum requirements of the ESA. Dronelogics also reserves the right to, at any point during the Resignation Notice Period, (i) require you to immediately return all Dronelogics Property; and/or (ii) require you to refrain from being present at any Dronelogics worksites. You acknowledge and agree that if Dronelogics exercises the foregoing right, it shall not constitute a termination of your employment, a breach of this Agreement or constructive dismissal.
     
  (b) Termination for Cause Subject to strict compliance with the minimum requirements of the ESA, Dronelogics may terminate your employment at any time for cause, upon providing written notification to you. For these purposes, “cause” means any grounds at law for which an employer is entitled to dismiss an employee summarily without notice or compensation in lieu of notice.
     
  (c) Termination without Cause in the Absence of a Change of Control Other than during the six (6) month period following a Change of Control, Dronelogics may terminate your employment at any time without cause, and you will be entitled to terminate your employment with Dronelogics at any time for Good Reason. Upon either of the immediately foregoing events, Dronelogics will provide you with the following:

 

  (i) such notice, or in Dronelogics’ sole discretion, payment in lieu of all or any part thereof, as is necessary to meet the minimum requirements under the ESA, together with any other minimum statutorily prescribed payments, entitlements and benefits, and
     
  (ii) twelve (12) months’ notice less the minimum amount of notice to which you are entitled under the ESA, or in Dronelogics’ sole discretion payment of Base Salary plus Dronelogic’s cost of paying your Group Benefits in lieu of all or any part of the notice set out in this subsection,
     
    (the “Severance Amount”).

 

5 | Page
 

 

In addition to the Severance Amount, if your employment with Dronelogics ends under section 7(c) of this Agreement, any Incentive Plan payment payable to you for the calendar year in which the date of termination of employment occurs shall be prorated based on the number of days of your employment with Dronelogics in the calendar year in which the date of termination occurs, and any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of termination of your employment will be paid to you, but you will not be entitled to any Incentive Plan payment for any period following your termination date. Furthermore, any paid vacation time not taken by you, and which has not been forfeited, will be paid out to you as part of final wages. There is no duty to mitigate in respect of Section 7(c) of this Agreement. If you are entitled to the amounts set out in Section 7(c) of this Agreement, you will not be entitled to any payment under Section 7(d) of this Agreement.

 

In consideration of and as a condition precedent to receiving any entitlement under Section 7(c)(ii) of this Agreement, within fifteen (15) days after receiving notice of termination from Dronelogics, you must sign and deliver to Dronelogics a release in favour of Dronelogics and affiliates, based on the standard form employment release then in use by Dronelogics.

 

  (d) Change of Control Termination Dronelogics may terminate your employment at any time without cause during the six (6) months following a Change of Control, and you will be entitled to terminate your employment with Dronelogics for Good Reason during the six (6) months following a Change of Control (and you must provide written notice to Dronelogics of the Good Reason within this six (6) month period). Upon either of the immediately foregoing events, Dronelogics will provide you with the following:

 

  (i) payment in lieu as is necessary to meet the minimum requirements under the ESA, together with any other statutory prescribed minimum payments, entitlements and benefits; and
     
  (ii) payment of Base Salary plus Dronelogic’s cost of paying for your Group Benefits, for the following period: twelve (12) months less the minimum amount of notice to which you are entitled under the ESA for the cessation of employment,
     
    (the “Change of Control Severance”).

 

In addition to the Change of Control Severance, if your employment with Dronelogics ends under section 7(d) of this Agreement, any Incentive Plan payment payable to you for the calendar year in which the date of termination of employment occurs shall be prorated based on the number of days of your employment with Dronelogics in the calendar year in which the date of termination occurs, and any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of termination of your employment will be paid to you, but you will not be entitled to any Incentive Plan payment for any period following your termination date. Furthermore, any paid vacation time not taken by you, and which has not been forfeited, will be paid out to you as part of final wages. There is no duty to mitigate in respect of Section 7(d) of this Agreement. If you are entitled to the amounts set out in Section 7(d) of this Agreement, you will not be entitled to any payment under Section 7(c) of this Agreement.

 

6 | Page
 

 

In consideration of and as a condition precedent to receiving any entitlement under Section 7(d)(ii) of this Agreement, within fifteen (15) days after receiving notice of termination from Dronelogics, you must sign and deliver to Dronelogics a release in favour of Dronelogics and affiliates, based on the standard form employment release then in use by Dronelogics.

 

  (e) Change of Control “Change of Control” means:

 

  (i) the occurrence of:
     
    (A) an amalgamation, arrangement, merger or other consolidation of Dronelogics or its parent with another issuer entity pursuant to which the shareholders of Dronelogics or its parent immediately prior thereto do not immediately thereafter own shares (or other securities) of the successor continuing corporation (or other issuer entity) which entitle them to cast more than 50% of the votes attaching to all shares in the capital of the successor or continuing corporation (or other issuer entity) which may be cast to elect directors of that corporation (or the equivalent of such other issuer entity) (unless such transaction relates to an issuer with tax attributes and the shareholders of Dronelogics or its parent retain more than 50% of the equity of the successor continuing entity);
     
    (B) a liquidation, dissolution or winding-up of Dronelogics or its parent; or
     
    (C) a sale, lease or other disposition of all or substantially all of the assets of Dronelogics or its parent;

 

provided that, a Change of Control does not include: (i) an initial public offering of Dronelogics or its parent; (ii) a reverse takeover following which the shareholders of Dronelogics or its parent immediately prior thereto own shares of the successor or continuing corporation which would entitle them to cast more than 50% of the votes attaching to all shares in the capital of the successor or continuing corporation which may be cast to elect directors of such corporation; (iii) any other internal reorganization where beneficial ownership of the issued and outstanding shares of Dronelogics or its parent remains unchanged; or (iv) Draganfly’s acquisition of Dronelogics by the Deadline.

 

  (f) For the purposes of this Agreement, “Good Reason” means the occurrence of any of the following, unless consented to in writing by you:

 

  (i) a material decrease in your title, position, or responsibilities;

 

7 | Page
 

 

  (ii) a reduction of more than fifteen percent (15%) in your then current base salary;
     
  (iii) any material breach of this Agreement by Dronelogics;
     
  (iv) the relocation of your principal place of employment to a location more than one hundred (100) kilometers from Dronelogics office at which you are located as at the Deadline, or
     
  (v) anything else that would constitute a constructive dismissal of your employment with Dronelogics at common law.

 

  (g) Termination by Death This Agreement and your employment hereunder shall be automatically terminated by death. All compensation to you shall cease at your death, subject to compliance with the minimum requirements of the ESA.
     
  (h) General If your employment with Dronelogics ceases for any reason whatsoever, then:

 

  (i) Group Benefit coverage will end on the earliest day strictly permitted under the ESA. No further Group Benefit coverage will be provided. However, notwithstanding the cancellation of Group Benefit coverage, you will be entitled to be compensated for the costs of your Group Benefits in accordance with sections 7(c) and 7(d) as outlined above.
     
  (ii) Any paid vacation time not taken by you, and which has not been forfeited, will be paid out to you as part of final wages
     
  (iii) Where applicable, if a court of competent jurisdiction finds that you have been constructively dismissed by Dronelogics or that Dronelogics did not have cause to terminate your employment, and such termination occurred at any time other than in the period of six (6) months following a Change of Control, your entitlements will still be limited to those detailed in Section 7(c) of this Agreement.
     
  (iv) Where applicable, if a court of competent jurisdiction finds that you have been constructively dismissed by Dronelogics or that Dronelogics did not have cause to terminate your employment, and such termination occurred in the period of six (6) months following a Change of Control, your entitlements will still be limited to those detailed in Section 7(d) of this Agreement.
     
  (v) It is intended that the provisions set out above in this Section 7 of this Agreement are in satisfaction of and substitution for any and all statutory rights and common law rights, including without limitation, any right to reasonable notice of termination. To be clear, in no case will the total payments and entitlements provided to you in respect of the termination of your employment be less than your minimum entitlements pursuant to the ESA. In the event that your minimum entitlement under the ESA exceeds these contractual provisions, then those entitlements shall replace these provisions and no further entitlements or payments are due to you pursuant to the ESA or at common law.

 

8 | Page
 

 

  (vi) Except as otherwise set out above in this Agreement, or as otherwise may be strictly required under the ESA, you will not be entitled to notice or severance or compensation in lieu of notice or any other compensation or benefits or entitlements of any nature whatsoever upon cessation of your employment with Dronelogics.

 

8. Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation In order to accept this Agreement, you must also sign and abide by the Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation Agreement attached to this offer.
   
9. General Terms

 

  (a) Governing Law This Agreement shall be governed and construed in accordance with the laws of British Columbia and the laws of Canada applicable therein. You and Dronelogics hereby irrevocably submit and attorn to the exclusive jurisdiction of the courts of British Columbia. Notwithstanding the foregoing, Dronelogics may enforce this Agreement anywhere in the world, should there be a breach of the Agreement that occurs outside of British Columbia.
     
  (b) ESA Notwithstanding anything to the contrary in this Agreement, Dronelogics intends to fully comply with the strict requirements of the ESA. Therefore, where the minimum requirements of the ESA provide you with any greater entitlements than those set out in this Agreement, Dronelogics will provide you with such minimum entitlements in substitution for any relevant entitlements set out in this Agreement, and no further entitlements or payments are due to you pursuant to the ESA, or at common law.
     
  (c) Severability Each of the covenants and obligations set out in this Agreement will be construed as constituting obligations independent of each other and of any other obligations in the Agreement. If any provision of this Agreement is held by a court of competent jurisdiction to be overly broad, that provision is to be construed to afford Dronelogics the maximum protection permitted by law. If any provision of this Agreement is held by a court of competent jurisdiction to be invalid or unenforceable, that provision is to be deleted in such jurisdiction only, and the other provisions remain in effect and are valid and enforceable to the fullest extent permitted by law.

 

9 | Page
 

 

  (d) Survival and Enforceability If your employment with Dronelogics ceases for any reason whatsoever, the provisions set out in Section 8 of this Agreement, the Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation Agreement and Section 9 of this Agreement will each survive and remain enforceable by Dronelogics in a court of competent jurisdiction, notwithstanding the existence of any claim or cause of action you may assert against Dronelogics, whether predicated on this Agreement or otherwise. You also acknowledge that it would be difficult to compute the monetary loss to Dronelogics arising from your breach or threatened breach of your obligations under Section 8 of this Agreement and the Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation Agreement and accordingly, Dronelogics will be entitled, in addition to any other rights and remedies that it may have at law or equity, to a temporary or permanent injunction restraining you from engaging in or continuing any such breach.
     
  (e) Entire Agreement This Agreement (and any references to other agreements or obligations under this Agreement) constitutes the entire agreement between Dronelogics and yourself with respect to the subject matter herein, and supersedes any prior agreements between the parties regarding the subject matter herein. No other representations, negotiations or conditions, either verbal or written, shall be of any force or effect except as expressly agreed upon in writing by us. Both you and Dronelogics hereby release and forever discharge the other of and from all manner of actions, causes of action, claims and demands whatsoever under or in respect of any prior agreements and representations.
     
  (f) Amendment No amendment to this Agreement shall be valid or binding unless set forth in writing and duly executed by both of the parties hereto. No waiver of any breach of any provision of this Agreement shall be effective or binding unless made in writing and signed by the party purporting to give the same and unless otherwise provided in the written waiver, shall be limited to the specific breach waived.
     
  (g) Assignment You may not assign, pledge or encumber any interest in this Agreement without the prior written consent of Dronelogics. Dronelogics may assign this Agreement to another entity controlled by Dronelogics, to any affiliate of Dronelogics or to any entity with which Dronelogics may merge or consolidate or to which it may transfer substantially all of its assets.
     
  (h) Authority to Work in Canada You verify that you are legally authorized to work in Canada for Dronelogics.
     
  (i) Currency/Withholdings All dollar amounts herein are expressed in Canadian dollars, unless otherwise stated. All payments and other remuneration made by Dronelogics to you will be subject to statutory deductions and withholdings required by any applicable law or regulation.
     
  (j) Acknowledgment/Waiver You acknowledge that you will receive actual and valuable consideration including but not limited to the compensation and benefits set out in Section 6 herein, in exchange for signing this Agreement and the attached Confidentiality, Ownership of Property, Non-Compete, and Non-Solicitation Agreement. You further acknowledge that it is our mutual intention that your obligations under Section 8 and the Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation Agreement shall be deemed to have been in effect since your commencement of employment with Dronelogics and you acknowledge that, to date, you have fully complied with those obligations.

 

10 | Page
 

 

  (k) Execution in Counterparts This Agreement and any attachments may be executed by the parties in separate counterparts each of which, when executed, will be considered to be an original and all of which will constitute the same agreement. Delivery, acceptance and execution of this Agreement or counterparts of it, by facsimile, e-mail or other functionally equivalent electronic means of signature and transmission, constitutes valid and effective delivery, acceptance and execution and shall be legally effective to create a valid and binding agreement between the parties.

 

Please review this letter carefully and indicate your acceptance of this Agreement and the terms and conditions contained herein, by signing your name where indicated below and returning a signed copy of the letter to me on or before April 30, 2020. You must also sign and return, at the same time, the enclosed Confidentiality, Ownership of Property, Non-Compete and Non-Solicitation Agreement.

 

Sincerely,

 

Dronelogics Systems Inc.  
     
Per: /s/ Cameron Chell  
Name: Cameron Chell  
Title: Director  

 

11 | Page
 

 

Confirmation, Acceptance and Consent. I am not relying on any representation other than those set out in this offer. I have had the opportunity to confer with an independent legal advisor, if I so wished, in advance of signing below and I have either obtained such advice or declined to do so.

 

I understand that from time to time, Dronelogics will collect, use and disclose my personal information to establish, manage, terminate and administer the employment relationship. For these purposes, “personal information” means any information about me as an identifiable individual, but does not include my name, title, business address or telephone number at Dronelogics. I also understand that Dronelogics will disclose my personal information to third parties where required (1) for payroll/direct deposit; (2) to manage and promote Dronelogics’ business; (3) to sell, acquire, finance and transfer businesses; (4) for any other purposes that a reasonable person would consider appropriate in the circumstances of an employment relationship, and (5) where required or permitted by law to do so. For these purposes I acknowledge that some of my personal information may be retained or used in countries, including the United States, where privacy laws may offer different levels of protection from those in Canada and while Dronelogics takes all reasonable measures to protect personal information, it may be subject to access by and disclosure to law enforcement agencies in those foreign jurisdictions. I hereby consent to Dronelogics’ collection, use, disclosure, and retention of my personal information for these purposes.

 

I have read and understood this offer, and I accept and agree to be bound by its terms.

 

Signed: /s/ Justin Hannewyk   Date: April 30, 2020

 

12 | Page
 

 

SCHEDULE “A”

 

This is Schedule “A” to an Employment Agreement dated April 30, 2020 between Dronelogics Systems Inc. (“Dronelogics”) and Justin Hannewyk

 

Subject to the receipt of all necessary regulatory approvals, Draganfly Inc. (“Draganfly”) shall grant to you, the following as compensation for you serving as a director on the board of directors of Draganfly (“Draganfly Board”):

 

  (i) 125,000 stock options in Draganfly, which shall vest (and be governed) in accordance with Draganfly’s stock option plan; and
     
  (ii) 125,000 restricted share units in Draganfly (“RSU”), which shall vest (and be governed) in accordance with Draganfly’s RSU plan.

 

13 | Page
 

 

SCHEDULE “B”

 

This is Schedule “B” to an Employment Agreement dated April 30, 2020 between Dronelogics Systems Inc. (“Dronelogics”) and Justin Hannewyk

 

Subject to the receipt of all necessary regulatory approvals, you shall be granted the following as compensation for you serving as President of Dronelogics:

 

  (iii) 125,000 stock options in Draganfly Inc.(“Draganfly”), which shall vest (and be governed) in accordance with Draganfly’s stock option plan; and
     
  (iv) 125,000 restricted share units in Draganfly (“RSU”), which shall vest (and be governed) in accordance with Draganfly’s RSU plan.

 

14 | Page

 

EX-4.10 18 ex4-10.htm

 

Exhibit 4.10

 

EMPLOYMENT AGREEMENT AMENDING AGREEMENT

 

THIS AGREEMENT, effective as of ______________, 2021 (the “Effective Date”) is between:

 

DRAGANFLY INC.,

 

a company duly incorporated under the laws of the Province of British Columbia with a

business address at 2108 St. George Avenue, Saskatoon, Saskatchewan S7M 0K7,

 

(Hereinafter referred to as the “Company”)

 

OF THE FIRST PART.

 

-and-

 

JUSTIN HANNEWYK,

 

(Hereinafter referred to as the “Employee” or “you”)

 

OF THE SECOND PART.

 

(collectively, the “Parties”)

 

WHEREAS:

 

  A. The Company and the Employee entered into an Employment Agreement dated April 30, 2020 (the “Employment Agreement”) setting out the terms and conditions of the Employee’s employment;
     
  B. The Company wishes to continue to engage the services of the Employee and the Employee desires to continue to be employed by the Company upon the terms and subject to the conditions of the Employment Agreement as amended by the terms of this Employment Agreement Amending Agreement hereinafter set forth;

 

NOW THEREFORE in consideration of the promises and the mutual covenants and agreements contained in this Employment Agreement Amending Agreement (this “Amending Agreement”), including the increase to the Employee’s base salary and the grant of restricted share units, and in exchange for the Employee’s continued employment, the Parties agree to amend the Employment Agreement as follows:

 

1. Provision 6.(a) entitled “Base Salary” in the Employment Agreement will be replaced with the following:
   
  Your annual base salary under this Agreement will be CDN$180,000, payable in accordance with our regular payroll schedule, as may be increased by the Company from time to time in its sole discretion (“Base Salary”).

 

 
- 2 -

 

2. Provision 6.(b) entitled “Stock Options” in the Employment Agreement will be replaced with the following:
   
  As President of Dronelogics, you will be eligible for the stock options as set out in Schedule “B”. In addition, as of the Effective Date the Company will grant to you 25,000 restricted share units (“RSU”) in Draganfly Inc., which shall vest and be governed in accordance with the Company’s RSU plan.
   
3. Provision 6.(c) entitled “Incentive” in the Employment Agreement will be replaced with the following:
   
  In addition to your Base Salary, you will be eligible to participate in any incentive plans the Company may implement, or amend, from time to time in consultation with Dronelogics’ board of directors (“Incentive Plan”). Your compensation under the Incentive Plan, if any, will be determined following the completion of the Company’s financial year each year, based on performance metrics to be determined by the Company’s compensation committee in consultation with Dronelogics’ board of directors at their sole discretion.
   
  Subject to your attainment of the Incentive Plan targets, as determined by the Company’s compensation committee and the Dronelogics’ board of directors, your annual target compensation under the Incentive Plan will be CDN$180,000, pro-rated to the date of this Amending Agreement for 2021.
   
  Except as expressly stated otherwise elsewhere in this Agreement, if you resign from your employment with Dronelogics or Dronelogics terminates your employment for cause, any Incentive Plan payment for the calendar year in which the date of termination of employment occurs shall be cancelled, and you will not be entitled to any Incentive Plan payment for any period following the termination date, but any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of your termination of employment will be paid to you.
   
  Except as expressly stated otherwise elsewhere in this Agreement, if your employment with Dronelogics ends for any reason other than your resignation or for cause, any Incentive Plan payment payable to you for the calendar year in which the date of termination of employment occurs shall be prorated based on the number of days of your employment with Dronelogics in the calendar year in which the date of termination occurs, and any unpaid Incentive Plan payment payable to you in respect of a calendar year that has ended prior to the date of termination of your employment will be paid to you, but you will not be entitled to any Incentive Plan payment for any period following the termination date.
   
4. All other terms and conditions of employment set out in the Employment Agreement will remain unchanged and in effect.
   
5. The Employee hereby releases the Company from any and all claims he has or may have arising in any way out of the terms of this Amending Agreement or the changes to his employment as set out herein, specifically includes any claims under any applicable human rights, workers’ compensation, employment standards, employment or labour legislation including but not limited to the Employment Standards Act, the Human Rights Code, the Workers Compensation Act, and the Personal Information Protection Act.
   
6. This Amending Agreement amends the Employment Agreement. This Amending Agreement and the Employment Agreement shall be read together and constitute one agreement. The Parties agree that the terms of the Amending Agreement will be effective on the Effective Date.
   
7. This Amending Agreement enures to the benefit of and binds the parties hereto and their respective heirs, executors, legal personal representatives, successors and permitted assigns.
   
8. If there is a conflict between any provision of this Amending Agreement and any provision of the Employment Agreement, the relevant provision(s) of this Amending Agreement are to prevail.
   
9. This Amending Agreement is governed by, and is to be construed and interpreted in accordance with the laws of British Columbia. The Parties irrevocably attorn to the jurisdiction of the Courts in the Province of British Columbia.

 

[signature page follows]

 

 
- 3 -

 

TO EVIDENCE THEIR AGREEMENT the parties have executed the Amending Agreement this ______ day of _______________________2021:

 

/s/ Scott Larson   /s/ Justin Hannewyk
DRAGANFLY INC.   JUSTIN HANNEWYK
     
Authorized Signatory   (Consultant Signature)
I have authority to bind the Corporation    

 

 

 

EX-8.1 19 ex8-1.htm

 

Exhibit 8.1

 

List of Significant Subsidiaries

 

Innovations Inc., a company incorporated under the laws of the Province of British Columbia, all of the shares of which are beneficially owned by the Company.

 

Systems Inc., a company incorporated under the laws of the Province of British Columbia, all of the shares of which are beneficially owned by the Company.

 

Draganfly Innovations USA Inc., a company incorporated under the laws of Delaware, all of the shares of which are beneficially owned by the Company.

 

 

EX-11.1 20 ex11-1.htm

 

Exhibit 11.1

 

DRAGANFLY INC.

 

CODE OF BUSINESS CONDUCT AND ETHICS

 

PURPOSE OF THIS CODE

 

Draganfly Inc. (the “Company”) has adopted this Code of Business Conduct and Ethics (the “Code”) in order to document the principles of conduct and ethics to be adhered to by the Company’s directors, officers and employees, and to establish mechanisms for the reporting of unethical conduct.

 

The Company is committed to:

 

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
operating in a responsible manner that complies with applicable laws, rules and regulations;
promoting the avoidance of conflicts of interest;
promoting the prompt internal reporting of violations of this Code and other policies applicable to the Company;
providing a safe and healthy workplace
providing accountability for adherence to the Code; and
providing full, fair, accurate, timely and understandable disclosure in reports and documents filed with any governing body or which are publicly disclosed;

 

and the Company requires its directors and officers to provide leadership and direction with respect to these principles and standards.

 

When used herein, the “Company” shall refer to the Company and to its subsidiaries.

 

1.COMPLIANCE WITH THE CODE

 

This Code is a reflection of the Company’s commitment to the highest standards of governance and ethics. As such, all directors, officers and employees of the Company are required to:

 

  (a) Comply with the Code.
     
  (b) Assist and co-operate with audits and investigations related to the Code and other policies of the Company.
     
  (c) Promptly report violations of the Code.

 

Directors, officers or employees of the Company who are found to have violated the Code will be subject to disciplinary measures. Such measures may include but are not limited to, taking corrective actions with respect to the violation, suspension, demotion and possible termination of their employment or relationship with the Company. In addition, the Company may, where appropriate, refer the matter to relevant government authorities.

 

 
- 2 -

 

2.COMPLIANCE WITH LAWS

 

The Company expects everyone to comply with all applicable laws, rules and regulations in performing work for the Company, including without limitation, those dealing with public disclosure, insider trading, discrimination and harassment, and health and safety. Violations of laws, rules or regulations can lead to disciplinary measures under the Code and may result in civil or criminal liability for the Company and the person or persons involved.

 

As such, directors, officers and employees will:

 

  (a) Comply with all laws, rules and regulations in connection with their work for the Company.
     
  (b) Seek clarification and advice if they are unsure about any law, rule or regulation or if they have questions related to any law, rule or regulation.
     
  (c) Never commit or condone an illegal act in any way related to or during the course of their work for the Company, nor authorize or encourage others to act in an illegal manner.
     
  (d) Avoid conduct that could bring the reputation and integrity of the Company into question.

 

The Company is committed to ensuring that its business operations are not used by others to facilitate illegal activity. In particular, the Company will strive to prevent its operations from being used in any manner to launder money or further the interests of terrorism.

 

3.RECORD KEEPING AND CONTROL SYSTEMS

 

The Company’s record keeping and control systems are critical components of its business and the integrity of such systems must be maintained at all times. As such, directors, officers and employees will:

 

  (a) Strive to ensure that the Company’s records (including financial and bookkeeping records, public disclosure documents, reports, presentations, safety documents, monitoring data and correspondence) are complete, true, accurate and understandable, and provide assistance and information necessary to maintain them as such.
     
  (b) Never use, authorize or encourage improper or deceptive accounting practices, such as falsification of books and records, that could, among other things, result in the Company’s operating results or performance being fallacious or misleading, or be intended to hide violations of this Code or any applicable law.
     
  (c) Never destroy, alter, or render unreadable Company records for an improper or illicit purpose and comply with the Company’s records management processes, with special care being given to financial, bookkeeping and other accounting records.
     
  (d) Retain the Company records as required by law and as otherwise notified by the Company’s legal personnel.
     
  (e) Return the Company records to the Company and notify the appropriate management member as to the location of such records upon changing roles or ceasing employment with the Company.

 

 
- 3 -

 

Information, data, records, documents and communications (in any format) created or received in the ordinary course of business or in connection with a director’s, officer’s or employee’s job function, are the property of the Company.

 

4.EMPLOYEE RELATIONS

 

The Company believes that a strong, enthusiastic workforce is critical to its success. The Company strives to ensure that all employees and contractors are treated fairly and recognizes that the work conditions of its employees, their wages and their job satisfaction have deep impacts not only on the employees themselves, but also on their families, the communities in which they live and on the environment. As such, the Company believes that it is in the best interest of all parties to work together in a respectful and understanding manner and is committed to providing an environment that is frank and open and provides equal opportunities to its employees.

 

Directors, officers and employees will:

 

  (a) Treat each other and members of the community in which the Company operates with respect and courtesy.
     
  (b) Strive to keep the workplace free from harassment.

 

The Company does not condone the use of factors such as race, religion, colour, sex, sexual orientation or ethnicity as the basis for decisions related to hiring, promotions, pay or terminations, nor should directors, officers or employees allow physical disabilities to form the basis of work-related decisions, unless the disability interferes with a person’s ability to perform a job in a safe and effective manner and the disability cannot reasonably be accommodated.

 

5.USE OF COMPANY ASSETS AND PROPERTY

 

Directors, officers and employees must safeguard and not use corporate property to pursue private interests or the interests of a spouse, family members or a private corporation controlled by any of these individuals. Company property includes real and tangible items such as land, buildings, furniture, fixtures, equipment, supplies, and vehicles and also includes intangible items such as data, computer systems, reports, information, patents, trademarks, copyrights, logos, name and reputation.

 

Directors, officers and employees will:

 

  (a) Except for the limited exception provided in (b) below, always use the Company’s assets and resources only for Company related business purposes unless the Company provides its prior written approval for the director, officer or employee to use Company property for their personal interest in circumstances where doing so would:

 

    (i) not result in additional cost to the Company;

 

 
- 4 -

 

 

    (ii) not interfere with the performance of the person’s duties to the Company; and
       
    (iii) not result in material personal gain to the person or to their spouse, family member or private corporation.

 

  (b) Limit personal use of the Company’s computers and software, e-mail, telephones, mobile devices, internet and other electronic systems to incidental, reasonable amounts (i.e. personal use must not interfere with the proper performance of job duties), and follow other provisions of this Code and other Company policies as they relate to use of Company assets and resources.
     
  (c) Exercise prudence and good judgment when incurring and approving business expenses and ensure that such expenses are reasonable, bona fide and appropriate and serve the Company’s business interests.
     
  (d) Never steal, damage, misuse or waste the Company assets.
     
  (e) Never use the Company assets in an illegal or improper manner or for an illegal or improper purpose.

 

6.CONFLICTS OF INTEREST

 

Directors, officers and employees shall avoid situations where their individual personal interests could conflict with, or appear to conflict with, the interests of the Company and its stakeholders, and shall perform the responsibilities of their positions on the basis of what is in the best interests of the Company, free from the influence of personal considerations and relationships.

 

A conflict of interest may be real or apparent:

 

  (a) A “real conflict of interest” occurs when directors, officers or employees exercise their corporate duties, official powers or perform official duties or functions and at the same time know that in doing so there is the opportunity for personal gain.
     
  (b) An “apparent conflict of interest” occurs when a reasonably well-informed person could have a perception that a director’s, officer’s or employee’s ability to exercise their corporate duty, an official power or perform an official duty or function was or will be affected by that individual’s private interest.

 

Directors and officers have a duty to act honestly, in good faith, and in the best interests of the Company and must exercise the degree of skill and diligence reasonably expected from an ordinary person of his or her knowledge and experience.

 

Conflicts of interest can include the following:

 

  (a) Furthering Private Interests

 

    (i) Directors, officers and employees should avoid outside financial interests that might influence their corporate decisions or actions, and should not engage in such activities or transactions where the activity or transaction may be detrimental to the Company or where the activity may be in conflict with the proper discharge of their duties to the Company.

 

 
- 5 -

 

    (ii) If a director, officer or employee is directly or indirectly personally interested in a proposed activity or transaction which involves the Company, or if the director or officer has discretionary decision-making power which could bring about direct or indirect financial benefit to the director, officer or employee due to his or her financial holdings, business and property interests or other relationships, there is potential for a conflict of interest. In these instances, at a minimum, these circumstances and these holdings should be fully disclosed in advance to the Chief Financial Officer of the Company. If it is determined there is a conflict of interest, the conflict must be fully disclosed in advance to the Audit Committee.

 

  (b) Corporate Opportunities

 

    (i) Directors, officers and employees cannot divert to a third party, themselves, their spouses, their children or a private corporation controlled by any of these individuals, a business opportunity that the Company is pursuing.
       
    (ii) A director, officer or employee of the Company whose corporate duties bring them into business dealings with a business in which they or a member of their family has a financial interest or to which they or a member of their family has an indebtedness, or a business employing a relative or close friend, must immediately:

 

      (A) in respect of a director or officer, notify the Audit Committee; and
         
      (B) in respect of an employee, notify his or her immediate supervisor, who will then notify the Audit Committee;
         
      and such business dealings may not be pursued unless properly authorized by the Audit Committee.

 

  (c) Preferential Treatment
     
    Directors, officers and employees must not assist others in their dealings with the Company if this may result in preferential treatment. A director, officer or employee who exercises regulatory, inspection or other discretionary authority over others, must disqualify themselves from dealing with individuals where the director’s, officer’s or employee’s relationship with the individual could bring their impartiality into question.
     
  (d) Workplace Relationships
     
    Directors, officers, employees and individuals who are direct relatives or who permanently reside together may not be employed or hold office in situations where:

 

    (i) A reporting relationship exists where a director, officer or employee has influence, input or decision-making power over the relative or cohabitant’s performance evaluation, salary, special permissions, conditions of work or similar matters; and

 

 
- 6 -

 

    (ii) The working relationship affords an opportunity for collusion between the individuals that could have a detrimental effect on the Company’s interest.

 

This restriction may be waived if the Audit Committee is satisfied that sufficient safeguards are in place to ensure that the interests of the Company are not compromised.

 

7.ACCEPTING GIFTS, BENEFITS AND ENTERTAINMENT

 

Directors, officers and employees:

 

  (a) May generally accept gifts, hospitality or other similar benefits (other than cash or cash equivalents which must never be accepted) associated with their official duties and responsibilities if such gifts, hospitality or other benefits:

 

    (i) are within the bounds of propriety, a normal expression of courtesy or within reasonable standards of hospitality;
       
    (ii) are advertising and promotional materials, clearly marked with the company or brand name;
       
    (iii) would not bring suspicion on the director’s, officer’s or employee’s objectivity and impartiality; or
       
    (iv) would not compromise the integrity and reputation of the Company.

 

  (b) Notwithstanding (a) above, will never solicit or accept gifts, benefits or entertainment in exchange for, or as a condition of, the exercise of duties or as an inducement for performing an act associated with the director’s, officer’s or employee’s duties or responsibilities to the Company and will never solicit or accept a gift of cash or cash equivalent from a business partner or anyone else with whom the Company does business in connection with that director’s, officer’s or employee’s position, duties or responsibilities within the Company.
     
  (c) Will return any improper gift or benefit to the person offering it as soon as practicable or, if there is no opportunity to return an improper gift or benefit, or where the return may be perceived as offensive or inappropriate for cultural or other reasons, immediately disclose and turn over the gift or benefit to the Chief Financial Officer who will attend to a suitable disposition of the item.

 

8.FRAUD OR BRIBERY

 

The Company is committed to the highest level of honesty and integrity and therefore does not tolerate fraud or bribery. Fraud can include a wide range of activities, such as falsifying books, records or timesheets, embezzlement, skimming and misappropriating Company assets (including such things as proprietary information and corporate opportunities) for personal gain.

 

 
- 7 -

 

Bribery of government officials, government entities and commercial customers is illegal in most countries. It can take different forms, such as cash payments, gifts, employment opportunities, quid pro quo transactions, directing business to a particular individual or business, excessive hospitality or providing services or other benefits or things of value to a person, organization, or company or to those related to a particular person, organization, or company.

 

There are serious criminal and civil consequences for fraud and bribery, including fines and imprisonment, and the Company considers fraud and the payment of bribes or other corrupt activity serious misconduct and grounds for dismissal.

 

9.POLITICAL AND CHARITABLE DONATIONS

 

Laws in many jurisdictions prohibit or regulate corporate donations to governments, political parties, politicians, and candidates for public office. The Company’s policy is that all corporate contributions to governments, political parties, politicians, or candidates for public office are prohibited unless they are approved in advance by the Chief Executive Officer of the Company. The Company may also donate to certain charities.

 

10.COMMUNICATING WITH THE MEDIA AND OTHER MEMBERS OF THE PUBLIC

 

The Company is committed to ensuring that disclosure made by the Company to its shareholders and to the public in general, and in reports and documents it files with appropriate securities commissions is made in a timely manner, is full, fair, accurate and understandable, and is broadly disseminated in accordance with all applicable legal and regulatory requirements.

 

Directors, officers and employees will:

 

  (a) Always comply with the Company’s Disclosure Policy and Stock Transaction Policy which set out the Company’s policies regarding public disclosure, identify spokespersons for the Company, and establish rules for directors, officers and employees relating to trading securities of the Company.
     
  (b) Not respond under any circumstances to inquiries from external parties unless they are a designated spokesperson for the Company, or are specifically asked to respond by such a Company spokesperson or are otherwise expressly authorized to do so by the Chief Executive Officer.

 

11.CONFIDENTIALITY AND MISUSE OF UNDISCLOSED MATERIAL INFORMATION

 

Directors, officers and employees of the Company are required to maintain and protect the confidentiality of all information and materials relating to the Company which are entrusted to them, or which they receive by virtue of their position or employment with the Company. Such information may only be divulged to persons authorized to receive the information. For greater certainty, confidential information should not be divulged to spouses, associates, immediate family, friends, or persons with whom the director, officer or employee is connected by frequent or close association.

 

In addition, directors, officers and employees must not engage in any transactions for personal benefit which results or may result from confidential or non-public information which the director, officer or employee gains by reason of their position or authority. In addition to the foregoing prohibition under the Code, directors, officers and employees should be aware that securities laws make it illegal to use material non-public information when buying, selling or otherwise trading shares (“insider trading”) and passing on this information to others for their use when buying, selling or otherwise trading shares (“tipping”).

 

 
- 8 -

 

12.AGENTS, CONSULTANTS AND SERVICE PROVIDERS

 

The Company requires its agents, consultants and service providers to act in a manner consistent with this Code in providing services to the Company. As such, persons retaining or hiring such service providers must consider and be satisfied that the reputations and business practices of such agents, consultants and contractors are in alignment with this Code. Where appropriate, background and reference checks on service providers should be performed.

 

If reasonable and appropriate, efforts should be made to draft agreements with agents, consultants and service providers that include terms requiring compliance with this Code and providing for remedies, including termination, for failure to comply. Where such provisions exist and there is a breach of the Code, the appropriate remedies should be enforced against the agent, consultant or service provider.

 

13.DUTIES WITH RESPECT TO REPORTING

 

Directors, officers and employees have a duty to immediately report to management any activity that:

 

  (a) he or she believes contravenes the law;
     
  (b) represents a breach of this Code or a real or apparent conflict of interest;
     
  (c) represents a misuse of the Company’s funds or assets; or
     
  (d) represents a danger to the health and safety of our employees, contractors or public, or to the environment; and
     
  (e) are also responsible for helping to identify and raise potential issues before they lead to Code violations.

 

If a director, officer or employee finds him or herself in a conflict or potential conflict of interest, or in violation of the Code, their duties are as follows:

 

  (a) If the individual involved is an officer or an employee:

 

    (i) The individual must immediately notify his or her immediate superior.
       
    (ii) If the conflict or violation cannot be avoided or resolved by the individual and his or her respective superior, the individual must advise the Audit Committee.

 

  (b) If the individual involved is a director:

 

    (i) The individual must immediately notify the Chairman of the Board of Directors.

 

 
- 9 -

 

    (ii) If the conflict or potential conflict cannot be avoided or resolved, the director must disclose the conflict or potential conflict to all of the directors of the Company and abstain or recuse themselves, as the case may be, from any vote or meeting in connection with the subject of the conflict.

 

Directors, officers and employees shall act in good faith in reporting a suspected Code violation or a situation that may create a potential for a Code violation and shall not take or tolerate any act of reprisal or retaliation against:

 

    (i) a person who in good faith reports a suspected Code violation or a situation that may create a potential for a Code violation; or
       
    (ii) a person who cooperates with the investigation of a suspected Code violation or a situation that may create a potential for a Code violation.

 

14.REPORTING

 

The Company promotes an open and honest environment and encourages directors, officers and employees to address any questions they may have regarding a particular situation or concerns about a possible violation of a law, regulation or the Code promptly with management. Except with respect to self-reporting referred to in Article 13 above, if for some reason an individual is not comfortable doing so or if management does not resolve the matter, reports of potential or actual violations of law or this Code may be made in confidence using the following methods:

 

  (a) By e-mail to the Audit Committee Chair
     
  (b) By mail, addressed to the Audit Committee Chair at address of the Company

 

While we encourage all individuals to identify themselves to facilitate a proper investigation, it is not required to do so and an individual may make a report anonymously.

 

15.INTERNAL AUDITS AND INVESTIGATING REPORTS OF SUSPECTED CODE VIOLATIONS

 

All suspected Code violations, or potential Code violations, will be investigated. The Audit Committee Chairperson and the Chief Executive Officer will decide on the most appropriate method of investigation in each instance and may seek the assistance of external legal advisors, accountants, or other advisors. To the extent possible, investigators will keep information and reports related to investigations confidential, subject to the need to conduct a full and impartial investigation, to comply with law and to remedy Code violations and monitor compliance.

 

Directors, officers and employees have a duty to cooperate with these investigations.

 

16.WAIVER OF THE CODE

 

Any waiver of this Code for the benefit of a director or executive officer may be granted only by the Board of Directors of the Company, or a committee of the Board duly authorized to do so. For non-executive officers, the Chief Executive Officer may, in appropriate circumstances as he or she determines using best judgment, waive a conflict or violation of the Code, however any such waivers must be reported to the Audit Committee at its next meeting.

 

 
- 10 -

 

Any waivers granted to a member of the Board of Directors or to an executive officer that relates to any element of the “code of ethics” set forth in Section 406(c) of the Sarbanes-Oxley Act of 2002, will be disclosed as required by law or stock exchange regulations applicable to the Company. Those who fail to cooperate with investigations will be subject to discipline, which may include termination of employment.

 

17.VERIFICATION OF THE CODE

 

The Company will make the most current version of the Code available to new directors, officers and employees at or about their time of hire and require such persons to verify they have read and understand the Code. In addition, the Company may require directors, officers and employees to periodically review the current version of the Code and verify their compliance with and understanding of the Code. Any director, officer or employee who fails or refuses to review the Code and to respond to a verification request by the Company may be subject to disciplinary measures up to and including termination.

 

The Code will be publicly available on the Company’s website at www.draganfly.com.

 

Adopted by the Board on October 30, 2019, and amended on April 14, 2021.

 

 

 

EX-12.1 21 ex12-1.htm

 

Exhibit 12.1

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Cameron Chell, certify that:

 

1.I have reviewed this annual report on Form 20-F of Draganfly Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

 

4.The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(c)Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting.

 

5.The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

 

Date: April 3, 2022  
     
  /s/ Cameron Chell  
Name: Cameron Chell  
Title: Chief Executive Officer  
  (principal executive officer)  

 

 

 

EX-12.2 22 ex12-2.htm

 

Exhibit 12.2

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Paul Sun, certify that:

 

1.I have reviewed this annual report on Form 20-F of Draganfly Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the issuer as of, and for, the periods presented in this report;

 

4.The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(c)Evaluated the effectiveness of the issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the issuer’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting.

 

5.The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer’s auditors and the audit committee of the issuer’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer’s internal control over financial reporting.

 

Date: April 3, 2022  
     
  /s/ Paul Sun  
Name: Paul Sun  
Title: Chief Financial Officer  
  (principal financial officer)  

 

 

 

EX-13.1 23 ex13-1.htm

 

Exhibit 13.1

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, as the Chief Executive Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 20-F for the fiscal year ended December 31, 2021, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 20-F for the fiscal year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

 

Date: April 3, 2022  
   
/s/ Cameron Chell  
Cameron Chell  
Chief Executive Officer  
(principal executive officer)  

 

 

 

EX-13.2 24 ex13-2.htm

 

Exhibit 13.2

 

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, as the Chief Financial Officer of Draganfly Inc. certifies that, to the best of his knowledge and belief, the annual report on Form 20-F for the fiscal year ended December 31, 2021, which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and the information contained in the annual report on Form 20-F for the fiscal year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of Draganfly Inc. at the dates and for the periods indicated. The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350) and shall not be relied upon for any other purpose. The undersigned expressly disclaims any obligation to update the foregoing certification except as required by law.

 

Date: April 3, 2022  
   
/s/ Paul Sun  
Paul Sun  
Chief Financial Officer  
(principal executive officer)  

 

 

 

EX-15.1 25 ex15-1.htm

 

Exhibit 15.1

 

 

 

Management Discussion and Analysis

For the year ended December 31, 2021

 

 
 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

This Management’s Discussion and Analysis (“MD&A) is presented and dated as of April 3, 2022 and should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2021. The Company’s audited consolidated financial statements have been prepared on a “going concern” basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

 

The operations of the Company have been primarily funded through internally generated cashflow and private placements of equity and convertible debentures. The continued operations of the Company are dependent on the Company’s ability to generate profitable operations in the future, develop and execute a sufficient financing plan for future operations and receive continued financial support from shareholders and other providers of finance.

 

The consolidated financial statements do not reflect the adjustments, if any, or changes in presentation that may be necessary should the Company not be able to continue on a going concern basis.

 

All currency amounts in the accompanying financial statements and this management discussion and analysis are in Canadian dollars unless otherwise noted.

 

The outbreak of the coronavirus, also known as “COVID-19,” spread across the globe and is ‎impacting worldwide economic activity. Government authorities have implemented emergency ‎measures to mitigate the spread of the virus. These measures, which include the ‎implementation of travel bans, self-imposed quarantine periods, and social distancing, have ‎caused material disruption to business globally. ‎Governments and central banks reacted with significant monetary and fiscal interventions ‎designed to stabilize economic conditions.‎

 

The Company will continue to monitor the impact of the COVID-19 pandemic, the duration and ‎impact of which is unknown at this time which may include further disruptions to global supply chains and the manufacturing and delivery of parts that the Company relies on for its products. Although it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the ‎Company and its operations in future periods, such impacts are not expected to be ‎significant going forward. Aside from the acquisition of Dronelogics and being opportunistic ‎on ‎other partnerships or acquisitions, the Company has expanded its products and services offered ‎to include ‎health and telehealth applications relating to COVID-19, as a way to mitigate the ‎effects of COVID-19. ‎

 

Special Note Regarding Forward Looking Information

 

This Management Discussion & Analysis (“MD&A”) is intended to provide readers with the information that management believes is required to gain an understanding of the current results of Draganfly Inc. (the “Company” or “Draganfly”) and to assess the Company’s future prospects. Accordingly, certain sections of this report, other than statements of historical fact, may contain forward-looking statements that are based on current plans and expectations and are subject to certain risks and uncertainties. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions.

 

The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions noted below:

 

the intentions, plans and future actions of the Company;
statements relating to the business and future activities of the ‎Company;
anticipated developments in operations of the Company;
market position, ability to compete and future ‎financial or operating performance of the Company;
the timing and amount of funding required to execute the ‎Company’s business plans;
capital expenditures;
the effect on the Company of any changes to existing or new ‎legislation or policy or government regulation;

 

1

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

‎the availability of labor;
requirements for additional capital;
goals, strategies and future ‎growth;
the adequacy of financial resources;
expectations regarding revenues, ‎expenses and anticipated cash needs‎;
the impact of the COVID-19 pandemic on the business and operations of the Company; and
general market conditions and macroeconomic trends driven by the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors.

 

The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. Furthermore, unless otherwise stated, the forward-looking statements contained in this MD&A are made as of the date hereof, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes or otherwise, except as required by law.

 

These statements are only predictions based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. These include, without limitation, the Company’s current and planned operations and the expected results of new operations and new clients. These risks and uncertainties include, but are not restricted to:

 

The Company’s history of losses;
The dilution of holdings in the Company’s securities;
Research and development costs;
The failure of new business models to produce financial returns;
Operational risks for which the Company may not be adequately insured;
The Company operates in an evolving market that makes it difficult to evaluate business and future prospects;
Competitive market conditions and challenges from competitors;
The pace of technological change and the Company’s ability to stay on top of market and technology changes;
The failure to obtain necessary regulatory approvals and permits or limitations placed on the development, operation, and sale of unmanned aerial vehicles (“UAVs”) by governments;
Risks associated with any particular future acquisitions that would allow the company to provide additional product or service offerings;
The Company’s ability to retain key employees and personnel and the Company’s ability to manage growth;
Adverse economic changes;
The impact of the COVID-19 pandemic on the Company’s business, operations, and future financial performance;
Negative macroeconomic and geopolitical trends that could restrict the Company’s ability to access capital;
Uncertainties associated with operations in foreign countries;
Adverse tax policies;
An inability to access critical components or raw materials used to manufacture the Company’s products and supply chain disruptions;
Weather and other natural outdoor conditions that can imperil the use of UAVs;
The Company’s products may be subject to recalls or returns or defective products or services that could negatively effect the Company’s operating results;
An inability to secure adequate funding for research and development;
Export controls or restrictions on the Company’s ability to deliver its product outside of Canada;
Consumer perception regarding the use and safety of UAVs;
A failure to successfully market the Company’s products;
Security risks associated with electronic communications and IT infrastructure;
Inadequate consumer protection and data privacy practices;

 

2

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

An inability of our business partners to fulfill their obligations to us or to secure company information;
A failure to protect the Company’s intellectual property, proprietary rights, and trade secrets, including through a failure to adequately apply for or seek such protections;
Failure to adhere to financial reporting obligations and mandates associated with being a public company;
The Company’s limited experience operating as publicly traded corporation;
Changes in accounting standards and subjective assumptions, estimates and judgments by management related to ‎complex accounting matters;
Write-downs of goodwill or other intangible assets;
Legal proceedings in which the Company may become involved;
Conflicts of interests among our directors and officers;
Volatility related to our share price;
A failure to maintain an active trading market for our common shares;
The Company may never pay dividends and a return on an investment in the Company will depend upon an appreciation in the price of our shares after purchase;
The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes;
United States investors may not be able to obtain an enforcement of civil liabilities against the Company
The Company’s status as an “emerging growth company”;
Increased costs and compliance matters related to our status as a public company in the United States; and
The Company’s status as a “foreign private issuer.”

 

Readers are cautioned to read more about the potential risks the Company faces under the heading “Business Risks” beginning on page 29 of this MD&A.

 

Non-GAAP Measures and Additional GAAP Measures

 

In this MD&A we describe certain income and expense items that are unusual or non-recurring. There are terms not defined by International Financial Reporting Standards (IFRS). Our usage of these terms may vary from the usage adopted by other companies. Specifically, Gross profit, Gross margin and Cash flow from operations are undefined terms by IFRS that may be referenced herein. We provide this detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results.

 

Throughout this document, reference is made to “gross profit,” “gross margin,” and “working capital”, which are non-IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Management believes that working capital, defined as current assets less current liabilities, is an indicator of the Corporation’s liquidity and its ability to meet its current obligations. Readers are cautioned that these non-IFRS measures may not be comparable to similar measures used by other companies. Readers are also cautioned not to view these non-IFRS financial measures as an alternative to financial measures calculated in accordance with International Financial Reporting Standards (“IFRS”).

 

Core Business and Strategy

 

Draganfly creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company is incorporated under the British Columbia Business Corporations Act and has its registered office located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z75 with a head office at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7.

 

Recognized as being at the forefront of UAV (unmanned aerial vehicles) technology for two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, agriculture, industrial inspections, and mapping and surveying markets. More recently, the Company’s offering expanded to include the health/telehealth field providing illness detection, social monitoring solutions, and sanitary spraying services relating to the ongoing COVID-19 pandemic. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

 

3

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Founded in 1998, Draganfly is recognized as one of the first commercial multi-rotor manufacturers and has a legacy for its innovation and superior customer service. The company has sold products and services to over 50 countries.

 

Draganfly can provide its customers with an entire suite of products and services that include quad-copters, fixed-wing aircrafts, ground based robots, handheld controllers, flight training, and software used for tracking, live streaming, and data collection. The integrated UAV system is equipped for automated take-offs and landings with altitude and return to home functions as well as in-house created survey software. Draganfly’s standard features combined with custom fit camera payloads ranging from multi-spectral, hyper-spectral, LIDAR, thermal, and infrared allows Draganfly to offer a truly unique solution to clients.

 

With 23 issued and one pending fundamental UAV patents in the portfolio, Draganfly will continue to expand and grow its intellectual property portfolio.

 

In addition, Draganfly has launched a health/telehealth platform. The initial focus is a COVID-19 screening set of technologies that remotely detect a number of key underlying respiratory symptoms. Further, Draganfly offers sanitary spraying services to any indoor or outdoor public gathering space such as sports auditoriums and fields to provide an additional level of protection against the spread of contagious viruses such as COVID-19.

 

Historically, the main business of the Company was as a manufacturing company offering commercial UAVs directly to its customer base across various industry verticals. The Company has evolved to offer engineering procurement for certain customers in a vertical that it did not previously serve, such as military applications. The rationale is three-fold: engage in long term contracts that tend to be recurring in nature, gain exposure to an industry that the Company otherwise did not have access to, and leverage our innovation learnings into other products that can be sold in other industries.

 

Draganfly works with its customers to customize a product or platform from idea to research and development (R&D) to completion and testing. A work plan is created with timelines and budgets which includes materials, travel, testing, and engineering time. The work plan is approved by the customer before work begins. To date, the majority of this work is considered proprietary in nature and is protected by trade secrets and other intellectual property protections.

 

With its acquisition of Dronelogics in April 2020, the Company has further broadened its scope to provide custom built parts, accessories, drone services, and the ability to sell third-party manufactured UAVs along with support services that it did not typically offer before.

 

On March 9, 2021, the Company announced that it completed the final closing of its Regulation A+ Offering of units sold pursuant to the Company’s Regulation A+ offering circular (the “Offering Document”) filed with the U.S. Securities and Exchange Commission. The Company issued 5,154,293 units for gross proceeds in the ‎amount of $15,504,135 (US$12,112,606) in the final closing. Each unit is comprised of one common share of the Company ‎‎and one common share purchase warrant, with each warrant entitling the ‎holder to acquire one common share at a price of US$3.55 per common share for period of two years from the date of issuance. ‎The common shares and warrants issued in connection with the offering are subject to a nine month ‎hold period.‎ In total, the Company issued 7,000,000 units under its Offering Document for aggregate gross proceeds of US$16,450,000.

 

On July 30, 2021, the Company’s shares began trading on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO”. The Company’s shares continue to trade on the Canadian Stock Exchange (the “CSE”), however, as of July 30, 2021 they now trade under the symbol “DPRO” on that exchange as well. The Company’s shares also trade on the Frankfurt Stock Exchange under the Symbol “3UB”.

 

In order to become compliant with Nasdaq regulations, the company also underwent a stock consolidation. Effective July 29, 2021, the Company consolidated its issued and outstanding common shares on a 5 to 1 basis, which resulted in 27,045,909 common shares outstanding post-consolidation.

 

4

 

  

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Additional information relating to the Company may be found at the Company’s website, www.draganfly.com.

 

2021 Highlights

 

2021 Total Revenues of $7,053,865 with Product Sales of $5,103,399

 

Although, the Company’s products are still well regarded in the industry, the commercial UAV space as a whole has been impacted by lower priced consumer drones that can now offer similar functionality. The Company recognized an opportunity to address this market by acquiring Dronelogics, a company that among other things, resells lower priced, third party drones as well as other third party products such as LiDAR sensors. 2021 revenues increased by $2,690,354 from $4,363,511 in 2020 to $7,053,865 with the bulk of this revenue coming from product sales. Engineering services revenue of $645,667 was down slightly over 2020 while drone services sales of $1,304,799 was up 107% over the same period in 2020 due to the gradual shift towards providing more services revenue.

 

Gross Profit was up 50.2% with Gross Margins down 6.9% in 2021 Compared to 2020

 

In 2021, the Company’s total gross margin was 37.5% vs 40.3% in 2020. This is due to higher revenues from product sales which have lower profit margins compared to the Company’s services.

 

Company Diversified its Product and Services Offering with Acquisition

 

Given the Company’s deep engineering talent, a natural evolution was to outsource in-house capabilities to customers. Doing this leverages the Company’s core skill set of innovation that tends to lead to future projects, bringing in more consistent revenue. With its recent acquisition of Dronelogics, the Company has increased its scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work. This has proved beneficial during the current pandemic as not all services are impacted the same way so having a larger breadth of products and services, in part mitigates some risk for the Company.

 

Company Broadens its Services to Include Health Vertical in the Face of Global Pandemic

 

Through its recently purchased Vital Intelligence assets and Varigard partnership, the Company recently added health monitoring and prevention to its product and service offering. Securing some key clients in this business line was key to proving out this new vertical. These clients were important for validation of this relatively new technology, but more importantly demonstrates the Company’s ability to evolve and offer products and services that have global applicability.

 

Risks Related to Operations

 

The Company’s UAVs are sold in rapidly evolving markets. The commercial UAV market is in early stages of customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could impact the Company’s ability to do the following:

 

generate sufficient revenue to maintain profitability;
acquire and maintain market share;
achieve or manage growth in operations;
develop and renew contracts;
attract and retain additional engineers and other highly qualified personnel;
successfully develop and commercially market new products;
adapt to new or changing policies and spending priorities of governments and government agencies; and
access additional capital when required and on reasonable terms.

 

For further and more detailed risk disclosure, please reference “Business Risks” at the end of this MD&A.

 

5

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Outlook and Guidance

 

General

 

The Company believes that drone regulations are gradually loosening which should lead to more revenue opportunities from a greater pool of customers. With the Company more capitalized and having easier access to funds in the public markets on both sides of the border, the Company will increasingly focus on some of its growth initiatives in the US, Canada, and abroad. Operationally, having more capital will help the Company expand and diversify its engineering, drone, and health services businesses. This will require more human resources from an oversight, sales, and engineering perspective and the Company anticipates adding additional staff to accommodate these plans. Further, the Company will continue to focus on innovation, product development, and expanding its hardware offerings opportunistically into niche segments of the UAV and related sectors. Finally, the Company has considered providing various other non-engineering services and it may make more sense to buy an existing industry player than to build out this offering. With the Company now also listed on the Nasdaq, it will open up further opportunities to use its Common Shares as a currency for potential acquisitions. The Company expects to be active in this regard reviewing partnerships, investments, and acquisitions in the current fiscal year and the near future.

 

Selected Financial Information

 

The following selected financial data has been extracted from the audited condensed consolidated financial statements, prepared in accordance with International Financial Reporting Standards, for the fiscal years indicated and should be read in conjunction with the audited condensed consolidated financial statements. All earnings per share calculations are shown post-consolidation.

 

For the year ended December 31,  2021   2020   2019 
Total revenues  $7,053,865   $4,363,511   $1,380,427 
Gross Profit (as a % of revenues)   37.5%   40.3%   84.1%
Net income (loss)   (16,202,972)   (8,015,813)   (11,095,057)
Net income (loss) per share ($)               
- Basic   (0.59)   (0.48)   (0.23)
- Diluted   (0.59)   (0.48)   (0.23)
Comprehensive income (loss)   (16,399,137)   (8,015,709)   (11,095,057)
Comprehensive income (loss) per share ($)               
- Basic (post-consolidation)   (0.59)   (0.48)   (0.23)
- Diluted (post-consolidation)   (0.59)   (0.48)   (0.23)
Change in cash and cash equivalents  $20,956,819   $(447,063)  $2,349,954 

 

The net loss and comprehensive loss for the year ended December 31, 2021, include a change in fair value of derivative liability of $8,149,812 and an expense for goodwill impairment of $4,579,763, and would otherwise been a loss of $19,773,021 for the net loss, and $19,969,186 for the comprehensive loss, respectively.

 

As at 

December 31,

2021

   December 31, 2020 
Total assets  $42,113,240   $7,100,567 
Working capital   26,836,922    1,214,371 
Total non-current liabilities   465,214    104,885 
Shareholders’ equity  $34,926,239   $3,848,205 
           
Number of shares outstanding   33,168,946    17,218,694 

 

6

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Shareholders’ equity and working capital as at December 31, 2021 includes a fair value of derivative liability of $5,560,002 and would otherwise be $40,486,241 and working capital of $32,396,924 respectively.

 

Results of Operations

 

Revenue

 

For the year ended December 31,  2021   2020 
Product sales  $5,103,399   $3,087,223 
Drone services   1,304,799    630,532 
Custom engineering services   645,667    645,756 
Total revenue  $7,053,865   $4,363,511 

 

Total revenue for the year ended December 31, 2021 increased by $2,690,354 or 61.7% as compared to 2020. The increase in revenue is largely due to the Company’s acquisition of Dronelogics and the retail sales and services business that it brought to the Company’s offering. Product sales increased $2,016,176 or 65.3% in 2021 as compared to 2020 primarily due to third party product sales generated from Dronelogics.

 

Draganfly ‎Innovations Inc.’s (“Draganfly Innovations”) primary custom engineering customer was domiciled in the US and was shut down and ‎reduced a number of its projects due to the COVID-19 pandemic in 2020. Although, there was no contribution from this customer after ‎March 2020, there was an increase in other engineering services work for 2021.

 

As at April 30, 2020, the Issuer completed its acquisition of Dronelogics. Therefore, the December 31, 2020 results only include eight months of contributions from Dronelogics.

 

Cost of Goods Sold / Gross Margin

 

For the year ended December 31,  2021   2020 
Cost of goods sold  $(4,410,777)  $(2,603,911)
Gross profit  $2,643,088   $1,759,600 
Gross margin (%)   37.5%   40.3%

 

Gross profit is the difference between the revenue received and the direct cost of that revenue. Gross margin is gross profit divided by revenue and is often presented as a percent.

 

For the year ended December 31, 2021, the Company’s Gross Profit increased by $883,488 or 50.2%. As a percentage of sales, gross margin decreased from 40.3% in 2020 to 37.5% in 2021.

 

Engineering service work consists of the design and customization of various UAV type products for the Company’s clients. Further, this service work tends to have higher gross margins than straight product sales. With this business line currently impacted by the pandemic, gross profit margins were down as this shift in gross margin is due to the lower margin product sales that the Company acquired with Dronelogics.

 

7

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Selling, General, and Administrative (SG&A)

 

For the year ended December 31,  2021   2020 
Insurance  $2,962,767   $39,988 
Office and Miscellaneous   6,455,998    3,387,865 
Professional Fees   4,445,949    1,762,594 
Research and development   510,895    567,999 
Share-based payments   3,952,595    2,668,464 
Travel   143,904    25,617 
Wages and salaries   2,768,010    1,649,329 
Total  $21,240,118   $10,101,856 

 

For the year ended December 31, 2021, SG&A expenses in 2021 increased by 110.3%, from $10,101,856 in 2020 to $21,240,118 in 2021. The largest contributor to the increase is marketing and investor relations costs in the office and miscellaneous line as well as Directors and Officers insurance cost and share-based payments. Some of the other SG&A expenses such as professional fees increased due to increased accounting and legal work around preparation for the Nasdaq listing along with increases in wages and salaries due to the Company’s growth.

 

Net and Comprehensive Income (Loss)

 

For the year ended December 31,  2021   2020 
Loss from operations  $(19,278,188)  $(8,494,882)
Change in fair value of derivative liability   8,149,812   (748,634)
Finance and other costs   5,074    (23,117)
Foreign exchange gain (loss)   362,448    (87,104)
Gain (loss) on settlement of debt   -    (38,879)
Impairment of notes receivable   (891,471)   - 
Impairment of goodwill   

(4,579,763

)   - 
Income from government assistance   24,148    51,627 
Other income (loss)   4,968    1,197,465 
Net income (loss)   (16,202,972)   (8,015,813)
Cumulative translation differences   136,475    104 
Unrealized gain on investments available for sale   (332,640)   - 
Comprehensive income (loss)  $(16,399,137)  $(8,015,709)

 

For the year ended December 31, 2021, the Company recorded a comprehensive loss of $16,399,137 compared to $8,015,709 in 2020. The net loss and comprehensive loss for the year ended December 31, 2021, include a gain in fair value of derivative liability of $8,149,812 and an expense for goodwill impairment of $4,579,763 and would otherwise be $19,773,021 and $19,969,186, respectively. The other largest contributors to the year over year increase is the increased insurance, marketing and investor relations costs, share-based payments, and professional fees relating to the Regulation A+ and Nasdaq financings partially offset by increased revenues.

 

8

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2021:

 

The Company issued 1,580,525 common shares for the exercise of warrants for $3,951,312.
The Company issued 149,999 common shares for the vesting of Restricted Share Units.
The Company issued 392,999 common shares for the exercise of stock options for $987,248.
The Company issued 15,000 common shares in lieu of cash.
The Company issued 6,488,691 units for the Regulation A+ financing in the United States. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years.
The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
The Company consolidated shares in a 5:1 share consolidation transaction.
The Company issued 5,095,966 common shares in a private placement for $25,538,213.
The Company issued 359,009 common shares for the exercise of warrants for $978,478.
The Company issued 298,661 common shares for the vesting of Restricted Share Units.
The Company issued 12,500 common shares for the exercise of stock options for $26,875.
The Company issued 356,901 common shares in lieu of cash.

 

For the year ended December 31, 2020:

 

The Company issued 24,000 common shares for the exercise of warrants for $60,000.
The Company issued 20,000 common shares for the exercise of warrants for $50,000.
The Company issued 210,320 common shares for the exercise of warrants for $105,160.
The Company issued 73,000 common shares for the exercise of warrants for $36,500.
The Company issued 294,840 common shares for the exercise of warrants for $147,420.
The Company issued 121,840 common shares for the exercise of warrants for $60,920.
The Company issued 126,000 common shares for the exercise of warrants for $115,000.
The Company issued 645,088 common shares for the acquisition of Dronelogics and an additional 200,000 common shares as finder’s fees.
The Company issued 12,000 common shares for the exercise of warrants for $30,000.
The Company issued 45,600 common shares for the exercise of warrants for $114,000.
The company issued 192,308 common shares for $500,000.
The Company issued 111,082 common shares for debt settlement of $344,354, and recognized a loss of $38,879 in the statement of comprehensive loss
The Company issued 2,000 common shares for the exercise of warrants for $5,000.
The Company issued 637,975 common shares for the exercise of warrants for $1,594,938.
The Company issued 7,117 common shares for the vesting of Restricted Share Units.
The Company issued 511,299 units for the Regulation A+ financing in the United States. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.
The Company issued 2,040 common shares for the vesting of Restricted Share Units.
The Company issued 2,647 common shares for the vesting of Restricted Share Units.
The Company issued 188,194 common shares for the vesting of Restricted Share Units.
The Company issued 15,000 common shares for the exercise of warrants for $37,500.

 

9

 

  

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Dronelogics Acquisition

 

On April 30, 2020, the Company closed the share purchase agreement with the shareholders of Dronelogics, whereby the Company acquired all the issued and outstanding shares in the capital of Dronelogics, excluding the cinematography division, for a consideration of $2,000,000, plus the amount, if any, by which the estimated closing date working capital exceeds the target closing working capital (the “Transaction”). The consideration was paid $500,000 in cash, subject to working capital adjustment and 645,088 common shares in the capital of the Company at a deemed price of $2.50 per share. In addition, the Company welcomed Mr. Hannewyk as a member of the Board.

 

In connection with the Transaction, the Company paid fees of $160,000 to certain advisors; consisting of $100,000 by way of 40,000 in shares at a deemed price of $2.50 per share and as to $60,000 in cash or shares at a deemed price of $2.50 per share. At closing, the Company (i) granted 89,000 incentive stock options to certain employees of Dronelogics pursuant to the Company’s share compensation plan, exercisable at $2.50. The options shall have a term of 10 years with 75,000 vesting in three equal tranches on the grant date and first and second anniversaries of the date of grant while the additional 14,000 vested on the first anniversary of the grant date, and (ii) awarded 75,000 RSUs to certain directors and officers of Dronelogics. RSUs were awarded to certain directors and officers of Dronelogics pursuant to the Company’s share compensation plan. The RSUs shall vest in three equal tranches, on the first, second and third anniversaries of the date of award.

 

The purchase price allocation (“PPA”) is as follows:

 

Number of shares of Draganfly Inc.   645,088 
Fair value of common shares  $4.15 
Fair value of shares of Draganfly Inc.  $2,677,114 
Present value of the fair value of shares of Draganfly Inc.   2,178,960 
Cash portion of purchase price   500,000 
Total  $2,678,960 

 

Tangible assets acquired    
Cash  $42,593 
Accounts receivable   98,852 
Inventory   629,684 
Prepaids and deposits   93,997 
Other current assets   3,014 
Capital assets   54,946 
Right-of-use assets   83,428 
Accounts payable and accrued liabilities   (222,766)
Customer deposits   (245,959)
Loans   (245,752)
Other current liabilities   (8,437)
Lease liabilities   (87,203)
    196,397 
      
Identifiable intangible assets     
Customer relationships   197,000 
Website   119,000 
    316,000 
      
Goodwill   2,166,563 
Total consideration  $2,678,960 

 

10

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Vital Intelligence Acquisition

 

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”) for consideration of: (a) a cash payment of $500,000 with ‎‎$50,000 paid upon execution of the asset purchase agreement, $200,000 to be paid at closing and ‎‎$250,000 to be paid on the six-month anniversary date of ‎closing; and (b) ‎1,200,000 units of the ‎Company with each unit being comprised of one common share of the Company and one common share ‎purchase warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing at an exercise price of $13.35 per common share and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow following closing with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. On August 19, 2021, the parties agreed to reduce the final payment from $250,000 to $227,984 as certain assets listed in the purchase agreement had not been delivered by Vital.

 

The units of the Company are to be released from escrow in accordance with the terms and conditions of the Escrow Agreement, as follows:

 

a)300,000 units shall be released on the closing date;
b)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

 

Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:

 

A weighted average probability of achieving the milestones necessary to release the shares held in escrow
Discounted due to the lack of liquidity.

 

On acquisition, the fair value of the derivative liability was $4,797,900. At December 31, 2021, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $3,470,995, with the difference flowing through the consolidated statement of loss.

 

The 900,000 units will be forfeited and cancelled within two years of the closing if the Company does not meet the revenue milestones.

 

The Vital Intelligence product platform is a combination of proprietary Intellectual Property along with external technology. The base technology is computer vision signal processing that incorporates learning algorithms that can detect heart rate, breathing/respiratory rate, coughs, mask usage, social distancing, temperature, oxygen saturation of blood, and blood pressure. Combined, all these data points provide and deliver an analysis of health and better accuracy in determining infection with various respiratory related issues.

 

Vital Intelligence has developed a suite of products designed to maximize the use of its technology by serving a variety of different market segments and sectors:

 

Drone Vital Sign Detection: Video from a drone is analyzed and can provide an individuals’ heart rate, respiratory rate, and also detect coughing. The data is processed via either a local or cloud storage service in real or near-real time.
Drone Social Distancing Detection: Video cameras attached to drones collect data which is then used to determine social distancing. The data is processed via either a local or cloud storage service in real or near-real time.
Thermography Kiosk: This product, also branded as Safe Set Solution, is a moveable kiosk (consisting of a thermal detection camera, laptop and stand) to provide thermal detection and reporting systems. The Kiosk is able to be placed in entryways or throughways to capture temperature readouts of passers-by.
Thermography Detection Camera System: This group of products is a stationary camera system, or systems of networked cameras aimed at critical entryways or locations designed to capture core-body temperature of individuals entering a space. Algorithms read video feeds and allow for company or facility use decisions to be made. An example would be capturing temperature readouts from individuals and then integrating that data into a company’s employee badge systems for compliance and monitoring as well as door locking systems to grant access to a space.
Social Distancing Camera System: This product is a stationary camera system, or system of networked cameras aimed at high traffic areas in order to capture data on social distancing. Information is provided via overlay on capture footage. The technology can be used on archived or real-time video footage to assist community health workers in predicting outbreaks of infections.

 

11

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The PPA is as follows:

 

Number of units of Draganfly Inc.   578,248 
Fair value of units  $14.43 
Fair value of units of Draganfly Inc.  $8,342,966 
Fair value of cash portion of purchase price   488,659 
Cash discount for inventory not received   (22,016)
Total  $8,809,609 

 

Identifiable intangible assets    
Brand  $23,000 
Software   433,000 
    456,000 
Goodwill   8,375,625 
Goodwill adjustment for inventory not received   (22,016)
Total consideration  $8,809,609 

 

Significant estimates are as follows:

 

Number of units issued based upon a weighted average calculation for the Company achieving revenue targets.
Brand based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 1.0% and discount rate of 40% per annum.
Software based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 40% per annum.

 

Summary of Quarterly Results

 

The following selected quarterly financial data has been extracted from the financial statements, prepared in accordance with International Financial Reporting Standards.

 

Total revenue for the three months ended December 31, 2021 increased by $149,256 or 10.0% as compared to the same period in 2020. The increase in revenue is largely due to the increase in services and custom engineering work due to continued adoption of businesses using drones for commercial purposes. Product sales decreased by $86,409 or 7.1% in the fourth quarter of 2021 as compared to the same period in 2020 primarily due to delayed timing of certain product orders.

 

SG&A expenses increased 88.2% compared to the same period in 2020 due to higher insurance, R&D, marketing, investor relations costs, professional fees, and share-based payments after going public. The other income and comprehensive income for the fourth quarter of 2021 include a recovery in fair value of the derivative liability of $23,428,117, and an expense for goodwill impairment of $4,579,763 and would otherwise be an expense of $1,036,914 and loss of $6,212,888, respectively.

 

Total revenue for the three months ended December 31, 2021 decreased by $261,727 or 13.8% as compared to the three months ended September 30, 2021. The decrease in revenue is due to the decrease in product sales and services partially offset by an increase in custom engineering work. Product sales decreased by $216,925 or 16.1% in the fourth quarter of 2021 as compared to the third quarter of 2021 primarily due to delayed timing of certain product orders.

 

SG&A expenses decreased 11.0% compared to the third quarter of 2021 due to reduced professional fees and share based payments as well as a recovery of amortization expense due to the revaluation of the software and brand acquired in the Vital Intelligence acquisition.

 

12

 

  

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The table below summarizes the quarterly results over the past eight fiscal quarters. All earnings per share calculations are shown post-consolidation.

 

   2021 Q4   2021 Q3   2021 Q2   2021 Q1 
Revenue  $1,635,265   $1,896,992   $1,981,872   $1,539,736 
Cost of goods sold  $(1,008,827)  $(1,123,942)  $(1,253,279)  $(1,024,729)
Gross profit  $626,438   $773,050   $728,593   $515,007 
Gross margin – percentage   38.3%   40.8%   36.8%   33.4%
Operating expenses  $(5,733,767)  $(8,006,957)  $(3,340,952)  $(4,839,600)
Operating income (loss)  $(5,107,329)  $(7,233,907)  $(2,612,359)  $(4,324,593)
Operating loss per share - basic  $(0.16)  $(0.24)  $(0.10)  $(0.23)
Operating loss per share - diluted  $(0.15)  $(0.24)  $(0.10)  $(0.23)
Other income (expense)  $17,811,440   $31,135,835   $(4,955,575)  $(40,599,341)
Other comprehensive income (loss)  $(151,465)  $73,472   $(404,602)  $286,430 
Comprehensive income (loss)  $12,635,466   $23,975,400   $(8,095,356)  $(44,914,647)
Comprehensive income (loss) per share - basic  $0.39   $0.79   $(0.30)  $(2.40)
Comprehensive income (loss) per share - diluted  $0.39   $0.75   $(0.30)  $(2.40)

 

   2020 Q4   2020 Q3   2020 Q2   2020 Q1 
Revenue  $1,486,009   $1,453,905   $926,540   $497,057 
Cost of goods sold  $(1,155,491)  $(893,441)  $(495,193)  $(59,786)
Gross profit  $330,518   $560,464   $431,347   $437,271 
Gross margin – percentage   22.2%   38.5%   46.6%   88.0%
Operating expenses  $(3,109,508)  $(3,102,003)  $(2,387,738)  $(1,655,233)
Operating loss  $(2,778,990)  $(2,541,539)  $(1,956,391)  $(1,217,962)
Operating loss per share - basic  $(0.17)  $(0.15)  $(0.13)  $(0.09)
Operating loss per share - diluted  $(0.17)  $(0.15)  $(0.13)  $(0.09)
Other income (expense)  $(713,885)  $91,228   $987,872   $113,854 
Other comprehensive income (loss)  $1,235   $(1,232)  $(13,713)  $13,814 
Comprehensive loss  $(3,491,640)  $(2,451,453)  $(982,232)  $(1,090,294)
Comprehensive loss per share - basic  $(0.21)  $(0.15)  $(0.06)  $(0.08)
Comprehensive loss per share - diluted  $(0.21)  $(0.15)  $(0.06)  $(0.08)

 

Liquidity and Capital Resources

 

The Company’s liquidity risk is derived from its loans, accounts payable, and accrued liabilities, as it may encounter difficulty discharging those obligations, but the Company endeavors to mitigate that risk through the careful management of its debt holders and the assertive pursuit of capital inflow for its operations. The Company’s working capital of $26,836,922 as at December 31, 2021, would be increased to $32,396,924, if the non-cash derivative liability was excluded. The Company’s working capital as at December 31, 2020 was $1,214,371.

 

The Company considers the items included in capital to include shareholders’ equity. The Company manages its capital structure and makes adjustments to it in light of changes in economic and business conditions, financing environment, and the risk characteristics of the underlying assets. The Company does not have any contracted or committed capital expenditures as of the date of this MD&A. The Company utilizes its credit card facilities from time to time to make various purchases for their operations. Based on the Company’s existing operations, the Company has sufficient funds for the next twelve months. However, the Company may need to raise additional capital during the next twelve months and beyond to support potential acquisitions, new initiatives or a change in business plan.

 

Management intends to finance operating costs over the next twelve months predominantly with cash on hand and with the potential issuance of securities such as the private placement of common shares and convertible debentures. Further, in order to maintain or adjust its capital structure, the Company may issue new shares, new debt, or scale back the size and nature of its operations. The Company is not subject to externally imposed capital requirements. As at December 31, 2021, shareholders’ equity was $34,926,239 and at December 31, 2020, shareholder’s equity was $3,848,205. The Company’s shareholder’s equity would be $40,486,241 if the non-cash derivative liability was excluded.

 

13

 

  

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

On February 5, 2021, the Company closed a second tranche of its Regulation A+ Offering for gross proceeds in the amount of $4,003,195 (US$3,135,838). On March 9, 2021, the Company announced that it completed the final closing of its Regulation A+ offering of units sold pursuant to the Company’s Regulation A+ offering circular (the “Offering Document”) filed with the U.S. Securities and Exchange Commission. The Company issued 5,154,293 units at the offering price set out in the Offering Document for gross proceeds in the ‎amount of $15,504,135 (US$12,112,606) in the final closing. Each unit is comprised of one common share of the Company ‎‎and one common share purchase warrant, with each warrant entitling the ‎holder to acquire one common share at a price of US$3.55 per common share for period of two years from the date of issuance. ‎The common shares and warrants issued in connection with the offering are subject to a nine month ‎hold period.‎ In total, the Company issued 7,000,000 units under its Offering Document for aggregate gross proceeds of US$16,450,000.

 

On August 3, 2021, the Company announced that it closed on gross proceeds of a US$20,000,000 share offering that was filed with the U.S. Securities and Exchange Commission as part of its successful Nasdaq listing. The Company issued 5,000,000 shares at US$4.00.

 

We expect, from time to time, to evaluate the acquisition of businesses, intellectual property, products and technologies for which a portion of the net proceeds may be used. There is always the potential that any acquisition or investment in a company or product has a negative impact on future cash flows of the Company.

 

Our plan of operations for the next year includes the following: (i) hiring engineers to perform more engineering service work, to complete contracts on a timelier basis, and to perform R&D for the Company’s next generation of products; (ii) hiring sales/marketing employees for our product lines and engineering services work; (iii) hiring sales/marketing employees for further expansion into services (e.g. drone as a service); (iv) diversifying and expanding business lines organically and by potential acquisitions; (v) updating machinery used for manufacturing and production; (vi) continuing to patent innovative ideas for new products; and (vii) developing and increasing current product offering to various niche industries that are not currently being served.

 

This expected use of the net proceeds from the Regulation A+ Offering and Nasdaq financing represents our intentions based upon our current financial condition, results of operations, and conditions. As of the date of this MD&A, we cannot predict with certainty all of the particular uses for the net proceeds received from the closing of the Regulation A+ Offering and Nasdaq financing. The amounts and timing of our actual expenditures may vary significantly depending on numerous factors.

 

Off-Balance Sheet Arrangements

 

The Company has no material undisclosed off-balance sheet arrangements that have or are reasonably likely to have, a current or future effect on our results of operations, financial condition, revenues or expenses, liquidity, capital expenditures or capital resources.

 

Contractual Obligations

 

As of December 31, 2021, and as of the date of this MD&A, and in the normal course of business, the following is a summary of the Company’s material obligations to make future payments, representing contracts, and other commitments that are known and committed.

 

On December 1, 2020 and October 6, 2021, the Company entered into 2 separate amendments for the lease agreements, where the leases were amended with a change in annual payments. As a result of IFRS 16, the right of use asset and lease liability were setup and recorded. The total right of use assets and lease liabilities for the Company are as follows:

 

14

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Right of Use Asset

 

   Total 
Cost     
Balance at January 1, 2020  $159,539 
Lease acquired in the Acquisition   83,428 
Balance at December 31, 2020  $242,967 
Additions   447,242 
Lease removal   (7,092)
Balance at December 31, 2021  $683,117 
      
Accumulated depreciation     
Balance at January 1, 2020  $29,545 
 Charge for the period   69,003 
Balance at December 31, 2020  $98,548 
Historical correction   7,152 
Charge for the period   109,311 
Balance at December 31, 2021  $215,011 
      
Net book value:     
December 31, 2020  $144,419 
December 31, 2021  $468,106 

 

Lease Liability

 

   Total 
Balance at January 1, 2020  $136,073 
Leases acquired in the Acquisition   87,203 
Interest expense   18,290 
Lease Payments   (83,442)
Balance at December 31, 2020  $158,124 
Addition   418,632 
Historical correction   22,043 
Interest expense   26,964 
Lease payments   (128,995)
Lease removal   (7,645)
Balance at December 31, 2021   489,123 
      
Which consists of:     
Current lease liability  $110,481 
Non-current lease liability   378,642 
Balance at December 31, 2021  $489,123 

 

Related Party Transactions

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers.

 

Trade payables and accrued liabilities:

 

On Aug 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the company incurred fees of $315,643 compared to $177,000 in 2020. As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $nil).

 

15

 

  

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $290,225 compared to $525,164 in 2020. As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $321,741).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $205,191 (December 31, 2020 – 227,524). As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $153,887).

 

As at December 31, 2021, the Company had $nil (December 31, 2020 - $475,628) payable to related parties outstanding that were included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:

 

For the year ended December 31,  2021   2020 
Director fees  $370,094   $- 
Management fees paid to a company controlled by CEO and director   290,225    737,164 
Management fees paid to a company controlled by the President and director   205,691    227,524 
Management fees paid to a company controlled by a former director   500,074    165,000 
Salaries   722,068    655,799 
Salaries paid to the former owner of the Company   -    86,097 
Share-based payments   2,475,949    1,614,158 
   $4,564,102   $3,485,742 

 

16

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Share Capital

 

Common shares issued

 

   Number of Common Shares   Share Capital 
Balance, December 31, 2019   13,934,145   $27,786,517 
Shares issued for exercise of warrants   1,584,775    4,007,130 
Shares issued for acquisition   645,088    2,178,961 
Shares issued as finder’s fees   40,000    100,000 
Shares issued for debt settlement   111,082    344,354 
Shares issued for financing   703,607    2,018,845 
Shares issued for exercise of RSUs   199,998    507,497 
Balance, December 31, 2020   17,218,695   $36,943,304 
Shares issued for exercise of warrants   1,580,525    3,951,312 
Shares issued for acquisition   1,200,000    2,303,999 
Shares issued for exercise of RSUs   149,999    396,249 
Shares issued for exercise of stock options   392,999    1,910,991 
Shares issued for financing   6,488,691    18,717,438 
Share issue costs   -    (273,169)
Shares issued in lieu of cash   15,000    198,000 
Shares issued for financing   5,095,966    17,374,749 
Share issue costs   -    (4,393,420)
Shares issued for exercise of warrants   359,009    978,478 
Share issue costs   -    (12,232)
Shares issued for exercise of RSUs   298,661    1,355,803 
Shares issued for exercise of stock options   12,500    26,875 
Shares issued in lieu of cash   356,901    1,559,988 
Balance, December 31, 2021   33,168,946   $81,038,365 

 

Stock options

 

The following is the summary of the Company’s stock option activity. Number of options and weighted average exercise prices in the table below are shown as they were outstanding, forfeited, granted, and exercised:

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2019   744,993   $2.50 
Forfeited   (43,334)   2.50 
Granted   492,000    3.08 
Outstanding, December 31, 2020   1,193,659   $2.75 
Exercised   (405,494)   2.50 
Granted   247,826    10.12 
Outstanding, December 31, 2021   1,035,991   $4.60 

 

17

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Restricted Share Units (RSUs)

 

The following is the summary of the Company’s RSU activity. Number of RSUs in the table below are shown as they were outstanding, exercised, forfeited, and granted:

 

   Number of RSUs 
Outstanding, December 31, 2019   634,997 
Exercised   (199,998)
Forfeited   (68,333)
Granted   248,000 
Outstanding, December 31, 2020   614,666 
Exercised   (448,660)
Granted   348,826 
Outstanding, December 31, 2021   514,832 

 

Warrants

 

During the years ended December 31, 2020 and 2021, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded through the Consolidated Statement of Comprehensive Loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the OTCQB. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

 

Warrant Derivative Liability

 

Balance at January 1, 2020  $- 
Change in fair value of warrants outstanding   748,634 
Balance at December 31, 2020  $748,634 
Change in fair value of warrants outstanding   4,202,449 
Balance at December 31, 2021  $4,865,772 

 

The derivative financial liability consists of the fair value of the non-compensatory share purchase warrants that have exercise prices that differ from the functional currency of the Company and are within the scope of IAS 32 “Financial Instruments: Presentation”. Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price  Number of Warrants Outstanding at July 29, 2021   Fair Value at July 29, 2021   Number of Warrants Outstanding at December 31, 2020   Fair Value at December 31, 2020 
November 30, 2020  US$ 0.71   2,556,496   $3,402,992    2,556,496   $748,634 
February 5, 2021  US$ 0.71   6,671,992    8,881,192    -    - 
March 5, 2021  US$ 0.71   25,771,465    34,304,799    -    - 
       34,999,953   $46,588,983    2,556,496   $748,634 

 

18

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

On July 29, 2021, the Company underwent a share consolidation at which time the warrants were consolidated on a 5:1 basis. Results of the consolidation are as follows:

 

Issue Date  Exercise Price (Post-consolidation)  Number of Warrants Outstanding at July 29, 2021 (Post-consolidation)   Number of Warrants Outstanding at December 31, 2020 (Post-consolidation) 
November 30, 2020  US$ 3.55   511,299    511,299 
February 5, 2021  US$ 3.55   1,334,398    - 
March 5, 2021  US$ 3.55   5,154,294    - 
       6,999,991    511,299 

 

Issue Date  Exercise Price  Number of Warrants Outstanding at December 31, 2021   Fair Value at December 31, 2021   Number of Warrants Outstanding at December 31, 2020   Fair Value at December 31, 2020 
November 30, 2020  US$ 3.55   482,425   $182,262    511,299   $748,634 
February 5, 2021  US$ 3.55   1,323,275    951,226    -    - 
March 5, 2021  US$ 3.55   5,154,321    3,731,284    -    - 
July 29, 2021  US$ 5.00   250,000    84,626    -    - 
September 14, 2021  US$ 5.00   4,798    1,685    -    - 
       7,214,819   $4,865,772    511,299   $748,634 

 

During the year ended December 31, 2020, the Company extended the life of the November 5, 2019 warrants from expiring on November 5, 2020 to expiring on November 5, 2021. To do this, it was required that 25% of the remaining November 5, 2019 warrants needed to be exercised by October 21, 2020 and 25% needed to be exercised by May 5, 2021 which was completed.

 

The following is the summary of the Company’s warrant activity. Number of warrants and weighted average exercise prices in the table below are shown as they were outstanding, exercised, forfeited, and granted:

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2019   3,610,340   $2.05 
Expired   (1,584,775)   1.50 
Exercised   (120,000)   2.50 
Issued   511,299    3.55 
Outstanding, December 31, 2020   2,416,864   $2.95 
Exercised   (1,939,534)   2.54 
Granted   7,943,489    5.10 
Forfeited   (6,000)   2.50 
Outstanding, December 31, 2021   8,414,819    4.99 

 

As at December 31, 2021, the Company had the following warrants outstanding:

  

Date issued  Expiry date  Exercise price  Number of warrants outstanding 
November 30, 2020  November 30, 2022  US$ 3.55   482,425 
February 5, 2021  February 5, 2023  US$ 3.55   1,323,275 
March 5, 2021  March 5, 2023  US$ 3.55   5,154,321 
March 22, 2021  March 22, 2023  CDN$ 13.35   1,200,000 
July 29, 2021  July 29, 2024  US$ 5.00   250,000 
September 14, 2021  September 14, 2024  US$ 5.00   4,798 
          8,414,819 

 

19

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2021 was 1.20 years (December 31, 2020 – 1.07 years).

 

Of the 1,200,000 warrants issued on March 22, 2021 with regards to the Vital Intelligence Acquisition, 900,000 of the warrants are currently held in escrow, to be released only upon completion of the milestones.

 

Critical Accounting Policies and Estimates

 

Measurement Uncertainty (Use of Estimates)

 

The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and contingent liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. However, actual outcomes can differ from these estimates.

 

The key sources of estimation uncertainty that have a significant risk of causing material adjustment to the amounts recognized in the consolidated financial statements are:

 

SR&ED tax credits

 

The determination of the amount of the Saskatchewan Scientific Research & Experimental Development (“SR&ED”) tax credit receivable requires management to make calculations based on its interpretation of eligible expenditures in accordance with the terms of the programs. The reimbursement claims submitted by the Company are subject to review by the relevant government agencies. Although the Company has used its best judgment and understanding of the related program agreements in determining the receivable amount, it is possible that the amounts could increase or decrease by a material amount in the near-term dependent on the review and audit by the government agency.

 

Allowance for uncollectible trade and other receivables

 

The Company makes use of estimates when making allowances for uncollectible trade and other receivables. The Company evaluates each receivable at year end using factors such as age of receivable, payment history, and credit risk to estimate when determining if an allowance is required, and the amount of the allowance.

 

Share-based payment transactions

 

The Company measures the cost of share-based payment transactions with employees by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected lives and forfeiture rates of the share options and volatility of the market value of the underlying shares.

 

Significant estimates and assumptions

 

The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

20

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

 

Inventories

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions.

 

Contingencies

 

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the annual financial statements.

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Other Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
the classification of financial instruments;
the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;
the determination of whether a set of assets acquired and liabilities assumed constitute a business; and
the determination of the functional currency of the company.

 

21

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Foreign currency translation

 

The Company’s functional currency is the Canadian dollar and transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.

 

The functional currencies for the parent company and each subsidiary are as follows:

 

Draganfly Inc.   Canadian Dollar
Draganfly Innovations Inc.   Canadian Dollar
Draganfly Innovations USA, Inc.   U.S. Dollar
Dronelogics Systems Inc.   Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in accumulated other comprehensive income (“AOCI”).

 

Transactions and balances:

 

Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the period-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange rate at the date when fair values were determined.

 

Exchange differences arising on the translation of monetary items or on settlement of monetary items are recognized in the statement of comprehensive loss in the period in which they arise, except where deferred in equity as a qualifying cash flow or net investment hedge.

 

Exchange differences arising on the translation of non-monetary items are recognized in other comprehensive income to the extent that gains and losses arising on those non-monetary items are also recognized in other comprehensive income. Where the non-monetary gain or loss is recognized in profit or loss, the exchange component is also recognized in profit or loss.

 

22

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Share-based payments

 

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

 

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

 

Restricted Share Units

 

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. A liability for outstanding RSUs is measured at fair value on the grant date and is subsequently adjusted for changes in fair value at each reporting date until settlement. The liability is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted loss per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period.

 

Financial instruments

 

All financial assets are initially recorded at fair value and classified into one of four categories: fair value through profit or loss (“FVTPL”), fair value through other comprehensive income (“FVTOCI”) and at amortized costs. All financial liabilities are initially recorded at fair value and classified as either FVTPL or other financial liabilities. Financial instruments comprise cash and accounts payable and accrued liabilities.

 

Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

23

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income. There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.

 

Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Accounts payable and accrued liabilities, and convertible debentures, are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

 

24

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged or cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

 

Impairment of assets

 

The carrying amount of the Company’s non-financial assets (which include equipment and intangible assets) is reviewed at each reporting date to determine whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. An impairment loss is recognized whenever the carrying amount of an asset or its cash generating unit exceeds its recoverable amount. Impairment losses are recognized in the statement of comprehensive loss.

 

The recoverable amount of assets is the greater of an asset’s fair value less cost to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects the current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

 

An impairment loss is only reversed if there is an indication that the impairment loss may no longer exist and there has been a change in the estimates used to determine the recoverable amount. Any reversal of impairment cannot increase the carrying value of the asset to an amount higher than the carrying amount that would have been determined had no impairment loss been recognized in previous years. Assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment.

 

INCOME TAXES

 

Current Income tax

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred Income Tax

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and li abilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

25

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Inventory

 

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

 

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

 

Consulting services

 

The Company provides consulting, custom engineering, investigation, and solution services on a project by project basis under fixed-price and variable price contracts. Revenue from services provided is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spent relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

 

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

 

26

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets includes intellectual property, which consists of patent and trademark applications.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized by a declining balance at a 20% rate over their estimated useful lives from the date they are available for use. The amortization period of the Company’s intellectual property is 5 years.

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired. Goodwill is allocated to the cash generating unit to which it relates.

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

 

Class of equipment

  Depreciation rate 
Computer equipment   30%
Furniture and equipment   20%
Leasehold improvements   Over expected life of lease 
Software   30%
Vehicles   30%

 

27

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

SR&ED Investment tax credits

 

The Company claims federal investment tax credits as a result of incurring SR&ED expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

 

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Tax and Revenue Administration.

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

28

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Business Risks

 

The Company does engage in significant transactions and activities in currencies other than its functional currency. Depending on the timing of the transactions and the applicable currency exchange rates such conversions may positively or negatively impact the Company.

 

An investment in the Company’s Common Shares is highly speculative and involves significant risks. In addition to the other ‎information contained in this MD&A and the documents incorporated by ‎reference herein and therein, you should review and carefully consider the risks described herein. The risks described herein are not the only risk factors facing us and should not be ‎considered exhaustive. Additional risks and uncertainties not currently known to us, or that we currently ‎consider immaterial, may also materially and adversely affect our business, operations and condition, financial ‎or otherwise.‎

 

Risks Related to the Company, its Business and Industry

 

The Company has a history of losses.

 

The Company has incurred net losses since its inception. The Company cannot assure that it can become profitable or avoid net losses in the future or that there will be any earnings or revenues in any future quarterly or other periods. The Company expects that its operating expenses will increase as it grows its business, including expending substantial resources for research, development and marketing. As a result, any decrease or delay in generating revenues could result in material operating losses.

 

A shareholder’s holding in the Company may be diluted if the Company issues additional Common ‎Shares or other securities in the future.‎

 

The Company may issue additional Common Shares or other securities in the future, which may dilute a ‎shareholder’s holding in the Company. ‎The Company’s articles permit the issuance of an unlimited ‎number of Common Shares, and shareholders have no pre-emptive rights in connection with further ‎issuances of any securities. The directors of the Company have the discretion to ‎determine if an ‎issuance of Common Shares or other securities is warranted, the price at which any such securities are ‎issued and the other ‎terms of issue of Common Shares or securities. In addition, the Company may ‎issue additional Common Shares upon the exercise of incentive stock options to ‎acquire Common ‎Shares under its share compensation plan or upon the exercise or conversion of other outstanding convertible securities of the Company, which will result in further dilution to shareholders. In addition, ‎the issuance of Common Shares or other securities in any potential ‎future acquisitions, if any, may also ‎result in further dilution to shareholder interests.‎

 

The Company expects to incur substantial research and development costs and devote significant resources to ‎identifying and commercializing new products and services, which could significantly reduce its profitability and ‎may never result in revenue to the Company.‎

 

‎The Company’s future growth depends on penetrating new markets, adapting existing products to new applications, ‎and introducing new products and services that achieve market acceptance. The Company plans to incur ‎substantial research and development costs as part of its efforts to design, develop and commercialize new ‎products and services and enhance its existing products. The Company believes that there are significant opportunities in a number of business areas. Because the Company accounts for research and development costs as ‎operating expenses, these expenditures will adversely affect its earnings in the future. Further, the Company’s ‎research and development programs may not produce successful results, and its new products and services may not ‎achieve market acceptance, create any additional revenue or become profitable, which could materially harm the ‎Company’s business, prospects, financial results and liquidity.‎

 

The Company’s adoption of new business models could fail to produce any financial returns.‎

 

‎Forecasting the Company’s revenues and profitability for new business models is inherently uncertain and ‎volatile. The Company’s actual revenues and profits for its business models may be significantly less ‎than the Company’s forecasts. Additionally, the new business models could fail for one or more of the ‎Company’s products and/or services, resulting in the loss of Company’s investment in the development and ‎infrastructure needed to support the new business models, and the opportunity cost of diverting management and ‎financial resources away from more successful businesses.‎

 

29

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The Company will be affected by operational risks and may not be adequately insured for certain risks.‎

 

‎The Company will be affected by a number of operational risks and the Company may not be adequately insured ‎for certain risks, including: labour disputes; catastrophic accidents; fires; blockades or other acts of social activism; ‎changes in the regulatory environment; impact of non-compliance with laws and regulations; natural phenomena, ‎such as inclement weather conditions, floods, earthquakes and ground movements. There is no assurance that the ‎foregoing risks and hazards will not result in damage to, or destruction of, the Company’s technologies, personal ‎injury or death, environmental damage, adverse impacts on the Company’s operation, costs, monetary losses, ‎potential legal liability and adverse governmental action, any of which could have an adverse impact on the ‎Company’s future cash flows, earnings and financial condition. Also, the Company may be subject to or affected ‎by liability or sustain loss for certain risks and hazards against which the Company cannot insure or which the ‎Company may elect not to insure because of the cost. This lack of insurance coverage could have an adverse ‎impact on the Company’s future cash flows, earnings, results of operations and financial condition.‎

 

The Company operates in evolving markets, which makes it difficult to evaluate the Company’s business and ‎future prospects.‎

 

‎The Company’s unmanned aerial vehicles (“UAVs”) are sold in rapidly evolving markets. The commercial UAV market is in early stages of ‎customer adoption. Accordingly, the Company’s business and future prospects may be difficult to evaluate. The ‎Company cannot accurately predict the extent to which demand for its products and services will increase, if at all. ‎The challenges, risks and uncertainties frequently encountered by companies in rapidly evolving markets could ‎impact the Company’s ability to do the following:‎

 

  generate sufficient revenue to reach and maintain profitability;‎
  acquire and maintain market share;‎
  achieve or manage growth in operations;‎
  develop and renew contracts;‎
  attract and retain additional engineers and other highly qualified personnel;‎
  successfully develop and commercially market new products;‎
  adapt to new or changing policies and spending priorities of governments and government agencies; and
  access additional capital when required and on reasonable terms.‎

 

If the Company fails to address these and other challenges, risks and uncertainties successfully, its business, results ‎of operations and financial condition would be materially harmed.‎

 

The Company operates in a competitive market.

 

The Company faces competition and new competitors will continue to emerge throughout the world. Services offered by the Company’s competitors may take a larger share of consumer spending than anticipated, which could cause revenue generated from the Company’s products and services to fall below expectations. It is expected that competition in these markets will intensify. Some of the other publicly traded companies we may compete with include Alpine 4 Tech, Inc., Aerovironment Inc., EHang Holdings Limited, AgEagle, Drone Delivery Canada, Inc., and Red Cat Holdings, Inc.

 

If competitors of the Company develop and market more successful products or services, offer competitive products or services at lower price points, or if the Company does not produce consistently high-quality and well-received products and services, revenues, margins, and profitability of the Company will decline.

 

The Company’s ability to compete effectively will depend on, among other things, the Company’s pricing of services and equipment, quality of customer service, development of new and enhanced products and services in response to customer demands and changing technology, reach and quality of sales and distribution channels and capital resources. Competition could lead to a reduction in the rate at which the Company adds new customers, a decrease in the size of the Company’s market share and a decline in its customers. Examples include but are not limited to competition from other companies in the UAV industry.

 

In addition, the Company could face increased competition should there be an award of additional licenses in jurisdictions in which the Company operates in.

 

30

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The markets in which the Company competes are characterized by rapid technological change that could render the Company’s existing ‎products obsolete, which requires ‎the Company to continually develop new products and product enhancements.

 

‎Continuing technological changes in the market for the Company’s products could make its products less ‎competitive or obsolete, either generally or for particular applications. The Company’s future success will depend ‎upon its ability to develop and introduce a variety of new capabilities and enhancements to its existing product and ‎service offerings, as well as introduce a variety of new product offerings, to address the changing needs of the ‎markets in which it offers products. Delays in introducing new products and enhancements, the failure to choose ‎correctly among technical alternatives or the failure to offer innovative products or enhancements at competitive ‎prices may cause existing and potential customers to purchase the Company’s competitors’ products.‎

 

If the Company is unable to devote adequate resources to develop new products or cannot otherwise successfully ‎develop new products or enhancements that meet customer requirements on a timely basis, its products could lose ‎market share, its revenue and profits could decline, and the Company could experience operating losses.‎

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental agencies, or ‎limitations put on the use of small UAV in response to public privacy concerns, may prevent the Company from ‎expanding sales of its small UAV to non-military customers in Canada.‎

 

‎Transport Canada is responsible for establishing, managing, and developing safety and security ‎standards and regulations for civil aviation in Canada, and includes unmanned civil aviation ‎‎(drones). Civil operations include law enforcement, scientific research, or use by private sector ‎companies for commercial purposes. The Canadian Aviation Regulations (“CARs”) govern civil ‎aviation safety and security in Canada, and by extension govern operation of drones in Canada ‎to an acceptable level of safety.‎

 

While Transport Canada has been a leader in the development of regulations for the commercial ‎use of remotely piloted aircraft systems (“RPAS”), and continues to move forward rapidly with its regulatory development, it has ‎acknowledged the challenge of regulations keeping pace with the rapid development in ‎technology and the growing demand for commercial RPAS use, particularly in the beyond visual ‎line-of-sight environment. In 2012, the Canadian Aviation Regulation Advisory Council UAS ‎working group released its Phase 2 report which outlined a proposed set of revision to the CARs ‎to permit Beyond Visual Line of Sight (“BVLOS”) operations. This report was the basis for the recently released Notice of Proposed Amendment (“NPA”) by Transport Canada on lower ‎risk beyond visual line-of-sight.‎

 

Failure to obtain necessary regulatory approvals from Transport Canada or other governmental ‎agencies, including the granting of certain Special Flight Operations Certificates (“SFOCs”), or limitations put on the use of RPAS in ‎response to public safety concerns, may prevent the Company from testing or operating its ‎aircraft and/or expanding its sales which could have an adverse impact on the Company’s ‎business, prospects, results of operations and financial condition.‎

 

There are risks associated with the regulatory regime and permitting requirements of the Company’s business.‎

 

‎A significant portion of the Company’s business is based on the operation of RPAS. The operation of ‎RPAS poses a risk or hazard to airspace users as well as personnel on the ground. As ‎the RPAS ‎industry is rapidly developing, the regulatory environment for RPAS is constantly evolving to keep pace. ‎‎As such, whenever a policy change with respect to operating regulations occurs, there is a risk that the ‎Company ‎could find itself to be in non-compliance with these new regulations. While the Company ‎endeavours to take all ‎necessary action to reduce the risks associated with the operations of RPAS and ‎to remain well-informed and up-‎to-date on any addendums and changes to the applicable regulations, ‎there is no assurance that an incident ‎involving an RPAS or the Company’s non-compliance would not ‎create a significant current or future liability for ‎the company.‎

 

31

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The regulation of RPAS operations within the Canadian Domestic Airspace (“CDA”) is still evolving and is expected ‎to continue to change ‎with the proliferation of RPAS, advancements in technology, and standardization within the ‎industry. ‎Changes to the regulatory regime may be disruptive and result in the Company needing to adopt ‎‎significant changes in its operations and policies, which may be costly and time-consuming, and may ‎materially ‎adversely affect the Company’s ability to manufacture and make delivery of its products and ‎services in a timely ‎fashion.‎

 

The Company’s business and research and development activities are subject to oversight by Transport ‎Canada, the federal ‎institution responsible for transportation policies and programs, including the rules in ‎the CARs. Currently, Transport Canada requires that any non-recreational operators of RPAS have a ‎‎SFOC. The Company’s ability to develop, test, demonstrate, and sell products and ‎services depends on ‎its ability to acquire and maintain a valid SFOC.‎

 

‎In addition, there exists public concern regarding the privacy implications of Canadian commercial and ‎law ‎enforcement use of small UAV. This concern has included calls to develop explicit written policies ‎and procedures ‎establishing UAV usage limitations. There is no assurance that the response from ‎regulatory agencies, customers and ‎privacy advocates to these concerns will not delay or restrict the ‎adoption of small UAV by prospective non-military customers‎.‎

 

The Company may be subject to the risks associated with future acquisitions.

 

As part of the Company’s overall business strategy, the Company may pursue select strategic acquisitions that would provide additional product or service offerings, additional industry expertise, and a stronger industry presence in both existing and new jurisdictions. Any such future acquisitions, if completed, may expose the Company to additional potential risks, including risks associated with: (a) the integration of new operations, services and personnel; (b) unforeseen or hidden liabilities; (c) the diversion of resources from the Company’s existing business and technology; (d) potential inability to generate sufficient revenue to offset new costs; (e) the expenses of acquisitions; or (f) the potential loss of or harm to relationships with both employees and existing users resulting from its integration of new businesses. In addition, any proposed acquisitions may be subject to regulatory approval.

 

‎The Company’s inability to retain management and key employees could impair the future success of the Company.

 

The Company’s future success depends substantially on the continued services of its executive officers and its key development personnel. If one or more of its executive officers or key development personnel were unable or unwilling to continue in their present positions, the Company might not be able to replace them easily or at all. In addition, if any of its executive officers or key employees joins a competitor or forms a competing company, the Company may lose experience, know-how, key professionals and staff members as well as business partners. These executive officers and key employees could develop drone technologies that could compete with and take customers and market share away from the Company.

 

A significant growth in the number of personnel would place a strain upon the Company’s management and resources.

 

The Company may experience a period of significant growth in the number of personnel that could place a strain upon its management systems and resources. The Company’s future will depend in part on the ability of its officers and other key employees to implement and improve financial and management controls, reporting systems and procedures on a timely basis and to expand, train, motivate and manage its workforce. The Company’s current and planned personnel, systems, procedures and controls may be inadequate to support its future operations.

 

The Company faces uncertainty and adverse changes in the economy.‎

Adverse changes in the economy could negatively impact the Company’s business. Future economic distress may ‎result in a decrease in demand for the Company’s products, which could have a material adverse impact on the ‎Company’s operating results and financial condition. Uncertainty and adverse changes in the economy could also ‎increase costs associated with developing and publishing products, increase the cost and decrease the availability of ‎sources of financing, and increase the Company’s exposure to material losses from bad debts, any of which could ‎have a material adverse impact on the financial condition and operating results of the Company.‎

 

32

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The Company is subject to certain market-based financial risks associated with its operations.

 

The Company could be subject to interest rate risks, which is the risk that the value of a financial instrument might be adversely affected by a change in the interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities, however market fluctuations could increase the costs at which the Company can access capital and its ability to obtain financing and the Company’s cash balances carry a floating rate of interest. In addition, the Company engages in transactions in currencies other than its functional currency. Depending on the timing of these transactions and the applicable currency exchange rates, conversions to the Company’s functional currency may positively or negatively impact the Company.

 

The COVID-19‎ pandemic could negatively affect our business, operations and future financial performance.

 

In March 2020, the World Health Organization designated the outbreak of a novel strain of coronavirus, specifically identified ‎as COVID-19, as a global pandemic. This resulted in governments, companies, and individuals worldwide enacting emergency measures to combat the spread of ‎the virus, including the implementation of travel bans, mandated and self-imposed quarantine ‎periods and physical distancing, that have caused a material disruption to businesses globally. Throughout the course of the pandemic, the impact of COVID-19 has varied significantly due to both global and localized infection rates, notwithstanding widespread vaccine availability within Canada and the United States beginning in spring 2020.

 

As a result of the pandemic, global equity markets have experienced significant volatility and weakness. ‎Governments and central banks have reacted with significant monetary and fiscal interventions designed ‎to stabilize economic conditions. Such volatility has led to significant challenges to the global supply chain, disrupted labor markets and has recently contributed to rising levels of inflation. The Company has experienced material pandemic related impacts, including the loss of its primary customer engineering customer in 2020 due to mandated stay-at-home orders. The duration and impact of the COVID-19 outbreak is unknown at this ‎time, as is the efficacy of the government and central bank interventions. ‎ As such, the Company cannot predict with any certainty what the future impacts the pandemic may have on its business.

 

Company management has and continues to closely monitor the impact of the COVID-19 global pandemic, with a focus on the health and safety of the Company’s employees, customers, and business continuity. Since the outbreak of the pandemic, the Company has taken various ‎steps to mitigate the impact of COVID-19, ‎including following government or health authority guidelines and restrictions at its facilities to ‎ensure the safety of ‎its staff and product consumers. The Company will continue to follow government or health authority guidelines ‎and restrictions and has experienced minimal disruption to its operations and supply chain‎. However, there is no guarantee that the company’s mitigation efforts will prove successful in combating the spread of the virus or that supply chain disruptions will not occur in the future. As the ‎Company reintegrates its personnel to its workplace, it may incur additional costs to adapt the workplace to ‎meet applicable health and safety requirements. The occurrence of additional waves of the virus or its variants, or insufficient vaccination levels may require the Company to revise or delay such plans. ‎To the extent that it is unable to effectively protect its workforce against the transmission of the virus, the ‎Company may be forced to slow or reverse its reintegration efforts and could face allegations of liability.‎

 

Given the uncertainties associated with the ongoing COVID-19 pandemic, including ‎the uncertainty surrounding the remaining duration and outcome, COVID-19 variants and vaccine efficacy, the Company is unable to estimate the full impact of the COVID-19 pandemic on its business, financial condition, results of operations, and/or cash flows; however, the impact could be material. The Company cannot accurately predict ‎the future impact COVID-19 may have on, among others, the: (i) demand for drone ‎delivery services, (ii) severity and the length of potential measures taken by governments to manage the ‎spread of the virus and their effect on labour availability and supply lines, (iii) availability of essential ‎supplies, (iv) purchasing power of the Canadian dollar, or (v) ability of the Company to obtain necessary ‎financing. Despite global vaccination efforts, it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the Company in ‎the future.‎

 

33

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The conflict between Russia and Ukraine could destabilize global markets and threatens global peace.

 

On February 24, 2022, Russian military forces launched a full-scale military invasion of Ukraine. In response, Ukrainian military personal and civilians are actively resisting the invasion. Many countries throughout the world have provided aid to the Ukraine in the form of financial aid and in some cases military equipment and weapons to assist in their resistance to the Russian invasion. The North Atlantic Treaty Organization (“NATO”) has also mobilized forces to NATO member countries that are close to the conflict as deterrence to further Russian aggression in the region. The outcome of the conflict is uncertain and is likely to have wide ranging consequences on the peace and stability of the region and the world economy. Certain countries including Canada and the United States, have imposed strict financial and trade sanctions against Russia and such sanctions may have far reaching effects on the global economy. The long-term impacts of the conflict and the sanctions imposed on Russia remain uncertain.

 

Negative macroeconomic and geopolitical trends could affect the Company’s ability to access sources of ‎capital.‎

 

The COVID-19 pandemic and the Russian invasion of Ukraine could negatively impact the Company’s ability to obtain financing and access sources of capital. Both events have led to significant market volatility as governments undertake measures to prevent the spread of COVID-19 and discourage political conflict. These events have contributed to significant uncertainty in global markets, increased inflationary pressures, and could lead to a tightening of credit markets and a decline in economic activity. These impacts could have a material adverse effect on the Company’s ‎liquidity and ability to obtain financing in the future.‎ As the Company’s history of losses and present revenues do not allow it to sustain its operations, an inability to access credit or capital markets could undermine the Company’s ability to continue as a going concern.

 

‎‎The Company may be subject to the risks associated with foreign operations in other countries.

 

The Company’s primary revenues are expected to be achieved in Canada and the US. However, the Company may expand to markets outside of North America and become subject to risks normally associated with conducting business in other countries. As a result of such expansion, the Company may be subject to the legal, political, social and regulatory requirements and economic conditions of foreign jurisdictions. The Company cannot predict government positions on such matters as foreign investment, intellectual property rights or taxation. A change in government positions on these issues could adversely affect the Company’s business.

 

If the Company expands its business to foreign markets, it will need to respond to rapid changes in market conditions, including differing legal, regulatory, economic, social and political conditions in these countries. If the Company is not able to develop and implement policies and strategies that are effective in each location in which it does business, then the Company’s business, prospects, results of operations and financial condition could be materially and adversely affected.

 

There are tax risks the Company may be subject to in carrying on business in Canada.

 

The Company is a resident of Canada for purposes of the Income ‎Tax Act (Canada) (the “Tax Act”). Since the ‎Company is operating in a new and developing industry there is a risk that ‎foreign governments may look to ‎increase their tax revenues or levy additional taxes to level the playing ‎field for perceived disadvantages to ‎traditional brick and mortar businesses. There is no guarantee that ‎governments will not impose such additional ‎adverse taxes in the future‎.‎

 

If critical components or raw materials used to manufacture the Company’s products become scarce or ‎unavailable, then the Company may incur delays in manufacturing and delivery of its products, which could ‎damage its business.‎

 

‎The Company obtains hardware components, various subsystems and systems from a limited group of suppliers. ‎The Company does not have long-term agreements with any of these suppliers that obligate it to continue to sell ‎components, subsystems, systems or products to the Company. The Company’s reliance on these suppliers ‎involves significant risks and uncertainties, including whether its suppliers will provide an adequate supply of ‎required components, subsystems, or systems of sufficient quality, will increase prices for the components, ‎subsystems or systems and will perform their obligations on a timely basis.‎

 

34

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Recently, the global supply chain has experienced significant disruptions caused by the COVID-19 pandemic and by geopolitical conflict, including the war in Ukraine. These disruptions have impacted a variety of products and goods and have had various downstream effects, making it more difficult to reliably and timely source and supply goods and has also resulted in shortages of labor and equipment. The macroeconomic impacts of the COVID-19 pandemic and global conflicts have contributed to inflationary pressure and increased market volatility, adding additional pricing uncertainty. These conditions, if not mitigated or remedied in a timely manner, could delay or preclude delivery of raw materials needed to manufacture our products or delivery of the Company’s products to customers, particularly in international markets. If the ‎Company is unable to obtain components from third-party suppliers in the quantities and of the quality that it ‎requires, on a timely basis and at acceptable prices, then it may not be able to deliver its products on a timely or ‎cost-effective basis to its customers, or at all, which could cause customers to terminate their contracts with the Company, ‎increase the Company’s costs and seriously harm its business, results of operations and financial condition. ‎Moreover, if any of the Company’s suppliers become financially unstable, then it may have to find new suppliers. ‎It may take several months to locate alternative suppliers, if required, or to redesign the Company’s products to ‎accommodate components from different suppliers. The Company may experience significant delays in ‎manufacturing and shipping its products to customers and incur additional development, manufacturing, and other ‎costs to establish alternative sources of supply if the Company loses any of these sources or is required to redesign ‎its products. The Company cannot predict if it will be able to obtain replacement components within the time ‎frames that it requires at an affordable cost, if at all.‎

 

Natural outdoor elements such as wind and precipitation may have a material adverse effect on the ‎use and effectiveness of the Company’s products.

 

The Company’s business will involve the operation and flying of UAVs, a technology-based product ‎used outside. As such, the business is subject to various risks inherent in a technology-based ‎businesses operated in outdoor conditions, including faulty parts, breakdowns, and crashes. Although ‎the Company anticipates the use of its UAVs in good climactic conditions and that adequate flying ‎conditions will be monitored by trained personnel, there can be no assurance that unpredictable natural ‎outdoor elements will not have a material adverse effect on the use and effectiveness of its products.‎

 

The Company’s products may be subject to the recall or return.

 

Manufacturers and distributors of products are sometimes subject to the recall or return of their products ‎‎for a variety of reasons, including product defects, safety concerns, packaging issues and inadequate ‎or inaccurate ‎labeling disclosure. If any of the Company’s equipment were to be recalled due to an ‎alleged product ‎defect, safety concern or for any other reason, the Company could be required to incur ‎unexpected expenses of the recall ‎and any legal proceedings that might arise in connection with the ‎recall. The Company may lose a significant ‎amount of sales and may not be able to replace those sales ‎at an acceptable margin or at all. In ‎addition, a product recall may require significant management time ‎and attention. Additionally, product recalls may lead to ‎increased scrutiny of the Company’s operations ‎by Transport Canada or other regulatory agencies, requiring ‎further management time and attention and ‎potential legal fees, costs and other expenses.‎‎

 

‎‎If the Company releases defective products or services, its operating results could suffer.‎

 

‎Products and services designed and released by the Company involve extremely complex software ‎programs and ‎are difficult to develop and distribute. While the Company has quality controls in place to ‎detect and prevent defects in its ‎products and services before they are released, these quality controls ‎are subject to human error, ‎overriding, and reasonable resource constraints. Therefore, these quality ‎controls and preventative measures may ‎not be effective in detecting and preventing defects in the ‎Company’s products and services before they have been released into ‎the marketplace. In such an ‎event, the Company could be required, or decide voluntarily, to suspend the availability of the product or ‎services, which could significantly harm its business and operating results‎.‎

 

‎The Company’s products and services are complex and could have unknown defects or errors, which may give ‎rise to legal claims against the Company, diminish its brand or divert its resources from other purposes.‎

 

The Company’s UAVs rely on complex avionics, sensors, user-friendly interfaces and tightly integrated, ‎electromechanical designs to accomplish their missions. Despite testing, the Company’s products have contained ‎defects and errors and may in the future contain defects, errors or performance problems when first introduced, ‎when new versions or enhancements are released, or even after these products have been used by the Company’s ‎customers for a period of time. These problems could result in expensive and time-consuming design modifications ‎or warranty charges, delays in the introduction of new products or enhancements, significant increases in the ‎Company’s service and maintenance costs, exposure to liability for damages, damaged customer relationships and ‎harm to the Company’s reputation, any of which could materially harm the Company’s results of operations and ‎ability to achieve market acceptance. In addition, increased development and warranty costs could be substantial ‎and could significantly reduce the Company’s operating margins.‎

 ‎

35

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The existence of any defects, errors, or failures in the Company’s products or the misuse of the Company’s ‎products could also lead to product liability claims or lawsuits against it. A defect, error or failure in one of the ‎Company’s UAV could result in injury, death or property damage and significantly damage the Company’s ‎reputation and support for its UAV in general. The Company anticipates this risk will grow as its UAV begins to be ‎used in Canadian domestic airspace and urban areas. The Company’s UAV test systems also have the potential to ‎cause injury, death or property damage in the event that they are misused, malfunction or fail to operate properly ‎due to unknown defects or errors.

‎Although the Company maintains insurance policies, it cannot provide any assurance that this insurance will be ‎adequate to protect the Company from all material judgments and expenses related to potential future claims or ‎that these levels of insurance will be available in the future at economical prices or at all. A successful product ‎liability claim could result in substantial cost to us. Even if the Company is fully insured as it relates to a particular claim, the ‎claim could nevertheless diminish the Company’s brand and divert management’s attention and resources, which ‎could have a negative impact on the Company’s business, financial condition and results of operations.‎

 

Shortfalls in available external research and development funding could adversely affect the Company.‎

 

‎The Company depends on its research and development activities to develop the core technologies used in its UAV ‎products and for the development of the Company’s future products. A portion of the Company’s research and ‎development activities can depend on funding by commercial companies and the Canadian government. Canadian ‎government and commercial spending levels can be impacted by a number of variables, including general ‎economic conditions, specific companies’ financial performance and competition for Canadian government ‎funding with other Canadian government-sponsored programs in the budget formulation and appropriation ‎processes. Moreover, the Canadian, federal and provincial governments provide energy rebates and incentives to ‎commercial companies, which directly impact the amount of research and development that companies ‎appropriate for energy systems. To the extent that these energy rebates and incentives are reduced or eliminated, ‎company funding for research and development could be reduced. Any reductions in available research and ‎development funding could harm the Company’s business, financial condition and operating results.‎

 

The Company could be prohibited from shipping its products to certain countries if it is unable to obtain ‎Canadian government authorization regarding the export of its products, or if current or future export laws limit ‎or otherwise restrict the Company’s business.‎

 

The Company must comply with Canadian federal and provincial laws regulating the export of its products. In ‎some cases, explicit authorization from the Canadian government is needed to export its products. The export ‎regulations and the governing policies applicable to the Company’s business are subject to change. The Company ‎cannot provide assurance that such export authorizations will be available for its products in the future. ‎Compliance with these laws has not significantly limited the Company’s operations or sales in the recent past, but ‎could significantly limit them in the future. Non-compliance with applicable export regulations could potentially ‎expose the Company to fines, penalties and sanctions. If the Company cannot obtain required government ‎approvals under applicable regulations, the Company may not be able to sell its products in certain international ‎jurisdictions, which could adversely affect the Company’s financial condition and results of operations.‎

 

Negative consumer perception regarding the Company’s products‎ could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company.

 

The Company believes the UAV industry is highly dependent upon consumer perception regarding the ‎safety, efficacy, and quality of the UAV used. Consumer perception of these products can be ‎significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, ‎and other publicity regarding the use of UAV. There can be no assurance that future scientific research, ‎findings, regulatory proceedings, litigation, media attention, or other research findings or publicity will be ‎favourable to the UAV market. Future research reports, findings, regulatory proceedings, litigation, media ‎attention or other publicity that are perceived as less favourable than, or that question, earlier research ‎reports, findings or publicity could have a material adverse effect on the demand for the Company’s ‎products and the business, results of operations, financial condition and cash flows of the Company. The ‎dependence upon consumer perceptions means that adverse scientific research reports, findings, ‎regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, ‎could have a material adverse effect on the Company, the demand for the Company’s products, and the ‎business, results of operations, financial condition and cash flows of the Company. Further, adverse ‎publicity reports or other media attention regarding the safety, the efficacy, and quality of UAV based surveys in general, or the Company’s products specifically, ‎could have a material adverse effect.‎

 

36

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

If the Company fails ‎‎to successfully promote its product brand, this could have a material adverse ‎effect on the Company’s business, prospects, ‎‎financial condition and results of operations‎.

 

The Company believes that brand recognition is an important factor to its success. If the Company fails ‎‎to promote its brands successfully, or if the expenses of doing so are disproportionate to any increased ‎‎net sales it achieves, it would have a material adverse effect on the Company’s business, prospects, ‎‎financial condition and results of operations. This will depend largely on the Company’s ability to ‎‎maintain trust, be a technology leader, and continue to provide high-quality and secure technologies, ‎‎products and services. Any negative publicity about the Company or its industry, the quality and reliability of the Company’s technologies, products and services, the Company’s risk management ‎‎processes, changes to the Company’s technologies, products and services, its ability to effectively ‎‎manage and resolve customer complaints, its privacy and security practices, litigation, regulatory activity, and the experience of sellers and buyers with the Company’s products or services, could adversely affect the Company’s reputation and the confidence in and use of the ‎‎Company’s technologies, products and services. Harm to the Company’s brand can arise from ‎‎many sources, including; failure by the Company or its partners to satisfy expectations of service and quality; inadequate protection of sensitive information; compliance failures and claims; litigation and ‎‎other claims; employee misconduct; and misconduct by the Company’s partners, service ‎‎providers, or other counterparties. If the Company does not successfully maintain a strong and trusted brand, its business could be materially and adversely affected.‎ ‎

 

The Company may be subject to electronic communication security risks.

 

A significant potential vulnerability of electronic communications is the security of transmission of confidential information over public networks. Cyberattacks could result in unauthorized access to the Company’s computer systems or its third-party IT service provider’s systems and, if successful, misappropriate personal or confidential information. Anyone who is able to circumvent the Company’s security measures could misappropriate proprietary information or cause interruptions in its operations. The Company may be required to expend capital and other resources to protect against such security breaches or to alleviate problems caused by such breaches.

 

Since the outset of the COVID-19 pandemic, there has been an increase in the volume and sophistication of targeted cyber-attacks. Pandemic-adjusted operations, such as work ‎from home arrangements and remote access to the Company’s systems, may pose heightened risk of ‎cyber security and privacy breaches and may put additional stress on the Company’s IT infrastructure. A failure of such infrastructure could severely limit the Company’s ability ‎to conduct ordinary operations or expose the Company to liability. To date, the Company’s systems have functioned capably, and it has not experienced a material impact to its ‎operations as a result of an IT infrastructure issue.‎ In addition, the outbreak of hostilities between Russia and Ukraine and the response of the global community to such aggression is widely seen as increasing the risk of state-sponsored cyberattacks.

 

Even the most well-protected IT networks, systems and facilities remain potentially vulnerable because the techniques used in attempted security breaches are continually evolving and generally are not recognized until launched against a target or, in some cases, are designed not to be detected and, in fact, may not be detected. Any such compromise of the Company’s or its third party’s IT service providers’ data security and access, public disclosure, or loss of personal or confidential business information, could result in legal claims and proceedings, liability under laws to protect privacy of personal information, and regulatory penalties, and could disrupt our operations, require significant management attention and resources to remedy any damages that result, and damage our reputation and customers willingness to transact business with us, any of which could adversely affect our business.

 

37

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The Company’s business could be adversely affected if its consumer protection and data privacy practices are not ‎perceived as adequate or there are breaches of its security measures or unintended disclosures of its consumer data.‎

 

‎The rate of privacy law-making is accelerating globally and interpretation and application of consumer protection ‎and data privacy laws in Canada, the United States, Europe and elsewhere are often uncertain, contradictory and in ‎flux. As business practices are being challenged by regulators, private litigants, and consumer protection agencies ‎around the world, it is possible that these laws may be interpreted and applied in a manner that is inconsistent with ‎the Company’s data and/or consumer protection practices. If so, this could result in increased litigation government ‎or court-imposed fines, judgments or orders requiring that the Company change its practices, which could have an ‎adverse effect on its business and reputation. Complying with these various laws could cause the Company to incur ‎substantial costs or require it to change its business practices in a manner adverse to its business.‎

 

‎The Company relies on its business partners, and they may be given access to sensitive and proprietary ‎information in order to provide services and support to the Company’s teams.‎

 

‎The Company relies on various business partners, including third-party service providers, vendors, licensing partners, ‎development partners, and licensees, among others, in some areas of the Company’s business. In some cases, these ‎third parties are given access to sensitive and proprietary information in order to provide services and support to the ‎Company’s teams. These third parties may misappropriate the Company’s information and engage in ‎unauthorized use of it. The failure of these third parties to provide adequate services and technologies, or the failure ‎of the third parties to adequately maintain or update their services and technologies, could result in a disruption to ‎the Company’s business operations. Further, disruptions in the financial markets and economic downturns may ‎adversely affect the Company’s business partners and they may not be able to continue honoring their obligations ‎to the Company. Alternative arrangements and services may not be available to the Company on commercially ‎reasonable terms or the Company may experience business interruptions upon a transition to an alternative partner ‎or vendor. If the Company loses one or more significant business partners, the Company’s business could be ‎harmed.‎

 

If the Company fails to protect, or incurs significant costs in defending, its intellectual property and other ‎proprietary rights, the Company’s business, financial condition, and results of operations could be materially ‎harmed.‎

 

‎The Company’s success depends, in large part, on its ability to protect its intellectual property and other proprietary ‎rights. The Company relies primarily on patents, trademarks, copyrights, trade secrets and unfair competition laws, ‎as well as license agreements and other contractual provisions, to protect the Company’s intellectual property and ‎other proprietary rights. However, a portion of the Company’s technology is not patented, and the Company may ‎be unable or may not seek to obtain patent protection for this technology. Moreover, existing Canadian legal ‎standards relating to the validity, enforceability and scope of protection of intellectual property rights offer only ‎limited protection, may not provide the Company with any competitive advantages, and may be challenged by ‎third parties. The laws of countries other than Canada may be even less protective of intellectual property rights. ‎Accordingly, despite its efforts, the Company may be unable to prevent third parties from infringing upon or ‎misappropriating its intellectual property or otherwise gaining access to the Company’s technology. Unauthorized ‎third parties may try to copy or reverse engineer the Company’s products or portions of its products or otherwise ‎obtain and use the Company’s intellectual property. Moreover, many of the Company’s employees have access to ‎the Company’s trade secrets and other intellectual property. If one or more of these employees leave to work for ‎one of the Company’s competitors, then they may disseminate this proprietary information, which may as a result ‎damage the Company’s competitive position. If the Company fails to protect its intellectual property and other ‎proprietary rights, then the Company’s business, results of operations or financial condition could be materially ‎harmed. From time to time, the Company may have to initiate lawsuits to protect its intellectual property and other ‎proprietary rights. Pursuing these claims is time consuming and expensive and could adversely impact the ‎Company’s results of operations.‎

 

‎In addition, affirmatively defending the Company’s intellectual property rights and investigating whether the ‎Company is pursuing a product or service development that may violate the rights of others may entail significant ‎expense. Any of the Company’s intellectual property rights may be challenged by others or invalidated through ‎administrative processes or litigation. If the Company resorts to legal proceedings to enforce its intellectual property ‎rights or to determine the validity and scope of the intellectual property or other proprietary rights of others, then the ‎proceedings could result in significant expense to the Company and divert the attention and efforts of the ‎Company’s management and technical employees, even if the Company prevails.‎

 

38

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

Obtaining and maintaining the Company’s patent protection depends on compliance with various procedural, document ‎submission, fee payment, and other requirements imposed by governmental patent agencies, and its patent ‎protection could be reduced or eliminated for non-compliance with these requirements.‎

 

‎The Canadian Intellectual ‎Property Office (“CIPO”), the United States Patent and ‎Trademark Office (“USPTO”) and various foreign national or international patent agencies ‎require compliance with a number of procedural, documentary, fee payment, and other similar provisions during ‎the patent application process. Periodic maintenance fees on any issued patent are due to be paid to the CIPO, the USPTO and ‎various foreign national or international patent agencies in several stages over the lifetime of the patent. While an ‎inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the ‎applicable rules, there are situations in which non-compliance can result in abandonment or lapse of the patent or ‎patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance ‎events that could result in abandonment or lapse of patent rights include, but are not limited to, failure to timely file ‎national and regional stage patent applications based on the Company’s international patent application, failure to respond to ‎official actions within prescribed time limits, non-payment of fees, and failure to properly legalize and submit ‎formal documents. If the Company fails to maintain the patents and patent applications covering its product candidates, its ‎competitors might be able to enter the market, which would have a material adverse effect on the Company’s business. ‎

 

While a patent may be granted by a national patent office, there is no guarantee that the granted patent is valid. ‎Options exist to challenge the validity of a patent which, depending upon the jurisdiction, may include re-‎examination, opposition proceedings before the patent office, and/or invalidation proceedings before the relevant ‎court. Patent validity may also be the subject of a counterclaim to an allegation of patent infringement.‎

 

Pending patent applications may be challenged by third parties in protest or similar proceedings. Third parties can ‎typically submit prior art material to patentability for review by the patent examiner. Regarding Patent Cooperation ‎Treaty applications, a positive opinion regarding patentability issued by the International Searching Authority does ‎not guarantee allowance of a national application derived from the Patent Cooperation Treaty application. The ‎coverage claimed in a patent application can be significantly reduced before the patent is issued, and the patent’s ‎scope can be modified after issuance. It is also possible that the scope of claims granted may vary from jurisdiction ‎to jurisdiction.‎

 

The grant of a patent does not have any bearing on whether the invention described in the patent application would ‎infringe the rights of earlier filed patents. It is possible to both obtain patent protection for an invention and yet still ‎infringe the rights of an earlier granted patent.‎

 

The Company may be sued by third parties for alleged infringement of their proprietary rights, which could be ‎costly, time-consuming and limit the Company’s ability to use certain technologies in the future.‎

 

‎The Company may become subject to claims that its technologies infringe upon the intellectual property or other ‎proprietary rights of third parties. Any claims, with or without merit, could be time-consuming and expensive, and ‎could divert the Company’s management’s attention away from the execution of its business plan. Moreover, any ‎settlement or adverse judgment resulting from these claims could require the Company to pay substantial amounts ‎or obtain a license to continue to use the disputed technology, or otherwise restrict or prohibit the Company’s use of ‎the technology. The Company cannot assure that it would be able to obtain a license from the third party asserting ‎the claim on commercially reasonable terms, if at all, that the Company would be able to develop alternative ‎technology on a timely basis, if at all, or that the Company would be able to obtain a license to use a suitable ‎alternative technology to permit the Company to continue offering, and the Company’s customers to continue ‎using, the Company’s affected product. An adverse determination also could prevent the Company from offering ‎its products to others. Infringement claims asserted against the Company may have a material adverse effect on its ‎business, results of operations or financial condition.‎

 

39

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

The Company may not be able to protect its intellectual property rights throughout the world.‎

 

‎Filing, prosecuting, and defending patents on all the Company’s product candidates throughout the world would be ‎prohibitively expensive. Therefore, the Company has filed applications and/or obtained patents only in key markets ‎including the United States and Canada. Competitors may use the Company’s technologies in jurisdictions where it has not ‎obtained patent protection to develop their own products and their products may compete with products of the Company.‎‎

 

‎Failure to adhere to the Company’s financial reporting obligations and other public company requirements could adversely ‎affect the market price of the Common Shares.‎

 

‎The Company ‎is subject to ‎reporting and other obligations under applicable securities laws in Canada and the United States, and the rules ‎of the CSE, Nasdaq and the Frankfurt Stock Exchange. These reporting and other obligations ‎place significant demands on the Company’s management, administrative, operational and ‎accounting resources. If the Company is unable to meet such ‎demands in a timely and effective manner, ‎its ability to comply with its financial reporting obligations ‎and other rules applicable to reporting issuers ‎could be impaired. Moreover, any failure to maintain effective ‎internal controls could cause the Company ‎to fail to satisfy its reporting obligations or result in material misstatements in its ‎financial statements. If ‎the Company cannot provide reliable financial reports or prevent fraud, its reputation and operating ‎‎results could be materially adversely affected which could also cause investors to lose confidence in its ‎reported ‎financial information, which could result in a reduction in the trading price of the Common ‎Shares.‎

 

In addition, the Company does not expect that its disclosure controls and procedures and internal ‎controls over financial reporting will ‎prevent all errors or fraud. A control system, no matter how well ‎designed and implemented, can provide only ‎reasonable, not absolute, assurance that the control ‎system’s objectives will be met. Further, the design of a control ‎system must reflect the fact that there ‎are resource constraints, and the benefits of controls must be considered ‎relative to their costs. Due to ‎the inherent limitations in all control systems, no evaluation of controls can provide ‎absolute assurance ‎that all control issues within an organization are detected. The inherent limitations include the ‎realities that ‎judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors ‎or ‎mistakes. Controls can also be circumvented by individual acts of certain persons, by collusion of two ‎or more ‎people or by management override of the controls. Due to the inherent limitations in a control ‎system, ‎misstatements due to errors or fraud may occur and may not be detected in a timely manner or ‎at all‎.‎

 

We have limited operating experience as a publicly traded company in the U.S.

 

We have limited operating experience as a publicly traded company in the U.S. Although our management team have experience managing a publicly-traded company, there is no assurance that the past experience of our management team will be sufficient to operate the Company as a publicly traded company in the United States, including timely compliance with the disclosure requirements of the U.S. Securities and Exchange Commission (the “SEC”). We are required to develop and implement internal control systems and procedures in order to satisfy the periodic and current reporting requirements under applicable SEC regulations and comply with the listing standards of the Nasdaq. These requirements place significant strain on our management team, infrastructure and other resources. In addition, our management team may not be able to successfully or efficiently manage the Company as a U.S. public reporting company that is subject to significant regulatory oversight and reporting obligations.

 

If the Company is required to write down goodwill and other intangible assets, the Company’s financial ‎condition and results could be negatively affected. ‎

 

‎Goodwill impairment arises when there is deterioration in the capabilities of acquired assets to generate cash flows, ‎and the fair value of the goodwill dips below its book value. The Company is required to review its goodwill for ‎impairment at least annually. Events that may trigger goodwill impairment include deterioration in economic ‎conditions, increased competition, loss of key personnel, and regulatory action. Should any of these occur, an impairment of ‎goodwill relating to the acquisition of Dronelogics Systems Inc. could have a negative effect on the assets of the ‎Company.‎

 

40

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

From time to time, the Company may become involved in legal proceedings, which could adversely affect the ‎Company.‎

 

‎The Company may, from time to time in the future, become subject to legal proceedings, claims, litigation and ‎government investigations or inquiries, which could be expensive, lengthy, and disruptive to normal business ‎operations. In addition, the outcome of any legal proceedings, claims, litigation, investigations or inquiries may be ‎difficult to predict and could have a material adverse effect on the Company’s business, operating results, or ‎financial condition.‎

 

The Company’s directors and officers may have conflicts of interest in conducting their duties.

 

Because directors and officers of the Company are or may become directors or officers of other ‎reporting companies or have significant shareholdings in other technology companies, the directors and ‎officers of the Company may have conflicts of interest in conducting their duties. The Company and its ‎directors and officers will attempt to minimize such conflicts. In the event that such a conflict of interest ‎arises at a meeting of the directors of the Company, a director who has such a conflict will abstain from ‎voting for or against a particular matter in which the director has the conflict. In appropriate cases, the ‎Company will establish a special committee of independent directors to review a particular matter in ‎which several directors, or officers, may have a conflict. In determining whether the Company will ‎participate in a particular program and the interest therein to be acquired by it, the directors will primarily ‎consider the potential benefits to the Company, the degree of risk to which the Company may be ‎exposed and its financial position at that time. Other than as indicated, the Company has no other ‎procedures or mechanisms to deal with conflicts of interest.‎

 

Our Articles ‎provide that the Company must indemnify a director or former director against all judgments, penalties ‎‎or fines to which such person is or may be liable by reason of such person being or having been a director of the ‎‎Company and the executive officers and directors may also have rights to indemnification from the Company, ‎‎including ‎pursuant to directors’ and officers’ liability insurance policies, that will survive termination of their ‎‎‎agreements‎.

 

Risks Related to Our Common Shares

 

The market price of the Common Shares may be highly volatile.‎

 

The market price of the Common Shares may be highly volatile and could be subject to wide fluctuations ‎in response to a number of factors that are beyond our control, including but not limited ‎to‎

 

  revenue or results of operations in any quarter failing to meet the expectations, published or otherwise, of ‎the investment community;‎
  actual or anticipated changes or fluctuations in our results of operations;‎
  announcements by us or our competitors of new products or new or terminated significant contracts, ‎commercial relationships or capital commitments;‎
  rumors and market speculation involving us or other companies in our industry;‎
  changes in our executive management team or the composition of the board of directors of the Company (the “Board”);‎
  fluctuations in the share prices of other companies in the technology and emerging growth sectors;‎
  general market conditions and macroeconomic trends driven by factors outside our control, such as the COVID-19 pandemic and/or geopolitical conflicts, including supply chain disruptions, market volatility, inflation, and labor challenges, among other factors;
  actual or anticipated developments in our business or our competitors’ businesses or the competitive ‎landscape generally;‎
  litigation involving us, our industry or both, or investigations by regulators into our operations or those of ‎competitors;‎
  announced or completed acquisitions of businesses or technologies by us or our competitors;‎
  new laws or regulations or new interpretations of existing laws or regulations applicable to our ‎business;‎
  shareholder activism and related publicity;‎
  foreign exchange rates; and
  other risk factors as set out in this MD&A and in the documents incorporated by ‎reference into this MD&A.‎

 

If the market price of our Common Shares drops significantly, shareholders could institute securities class action ‎lawsuits against us, regardless of the merits of such claims. Such a lawsuit could cause us to incur substantial ‎costs and could divert the time and attention of our management and other resources from our business. This ‎could harm our business, results of operations and financial condition.‎

 

41

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

There is no guarantee that an active trading market for our Common Shares will be maintained on ‎the CSE, the Nasdaq, and/or the Frankfurt Stock Exchange. Investors may not be able to sell their Common Shares quickly or at the ‎latest market price if the trading in our Common Shares is not active.‎

 

Our Common Shares are currently listed on the CSE, Nasdaq, and the Frankfurt Stock Exchange, however, our shareholders may be unable to sell significant quantities of Common Shares into the public ‎trading markets without a significant reduction in the price of their Common Shares, or at all and there can be no guarantee that an active trading market for the Common Shares ‎may be maintained. There can be no assurance that ‎there will be sufficient liquidity of our Common Shares on the trading market, and that we will continue to meet ‎the listing requirements of the CSE, the Nasdaq or any other public listing exchange.

 

Future issuances of equity securities by us or sales by our existing shareholders may cause the price ‎of our Common Shares to fall.‎

 

The market price of our Common Shares could decline as a result of issuances of securities or sales by our ‎existing shareholders in the market, including by our directors, executive officers and significant shareholders, or ‎the perception that these sales could occur. Sales of our Common Shares by shareholders might also make it ‎more difficult for us to sell Common Shares at a time and price that we deem appropriate. We also expect to ‎issue Common Shares in the future. Future issuances of Common Shares, or the perception that such issuances ‎are likely to occur, could affect the prevailing trading prices of the Common Shares.‎

 

We may never pay dividends over the foreseeable future.‎

 

Investors should not rely on an investment in our Common Shares to provide dividend ‎income. The Company does not anticipate that it will pay any cash dividends to holders of its Common ‎Shares in the foreseeable future. Instead, the Company plans to retain any earnings to maintain and expand ‎its operations. In addition, any future debt financing arrangement may contain terms prohibiting or limiting ‎the amount of dividends that may be declared or paid on its Common Shares. Accordingly, investors must ‎rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to ‎realize any return on their investment. As a result, investors seeking cash dividends should not purchase the ‎Company’s Common Shares.‎

 

The Company may be classified as a “passive foreign investment company” for U.S. federal income tax purposes, which would subject U.S. investors that hold the Company’s Common Shares to potentially significant adverse U.S. federal income tax consequences.

 

If the Company is classified as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes in any taxable year, U.S. investors holding Common Shares generally will be subject, in that taxable year and all subsequent taxable years (whether or not the Company continued to be a PFIC), to certain adverse US federal income tax consequences. The Company will be classified as a PFIC in respect of any taxable year in which, after taking into account its income and gross assets (including the income and assets of 25% or more owned subsidiaries), either (i) 75% or more of its gross income consists of certain types of  “passive income” or (ii) 50% or more of the average quarterly value of its assets is attributable to “passive assets” (assets that produce or are held for the production of passive income). Based upon the current and expected composition of the Company’s income and assets, the Company believes that it was not a PFIC for the taxable year ended December 31, 2021 and expects that it will not be a PFIC for the current taxable year. Nevertheless, because the Company’s PFIC status must be determined annually with respect to each taxable year and will depend on the composition and character of the Company’s assets and income, and the value of the Company’s assets (which may be determined, in part, by reference to the market value of Common Shares, which may be volatile) over the course of such taxable year, the Company may be a PFIC in any taxable year. The determination of whether the Company will be or become a PFIC may also depend, in part, on how, and how quickly, the Company uses its liquid assets and the cash raised in an offering. If the Company determines not to deploy significant amounts of cash for active purposes, the Company’s risk of being a PFIC may substantially increase. Because there are uncertainties in the application of the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, there can be no assurance that the Company will not be a PFIC for any future taxable year. In addition, it is possible that the U.S. Internal Revenue Service may challenge the Company’s classification of certain income and assets as non-passive, which may result in the Company being or becoming a PFIC in the current or subsequent years.

 

42

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

If the Company is a PFIC for any year during a U.S. holder’s holding period, then such U.S. holder generally will be required to treat any gain realized upon a disposition of Common Shares, or any “excess distribution” received on its Common Shares, as ordinary income, and to pay an interest charge on a portion of such gain or distribution, unless the U.S. holder makes a timely and effective “qualified electing fund” election (“QEF Election”) or a “mark-to-market” election with respect to its Common Shares. A U.S. holder who makes a QEF Election generally must report on a current basis its share of the Company’s net capital gain and ordinary earnings for any year in which the Company is a PFIC, whether or not the Company distributes any amounts to its shareholders. However, U.S. holders should be aware that there can be no assurance that the Company will satisfy the record keeping requirements that apply to a QEF, or that the Company will supply U.S. holders with information that such U.S. holders require to report under the QEF Election rules, in the event that the Company is a PFIC and a U.S. holder wishes to make a QEF Election. Thus, U.S. holders may not be able to make a QEF Election with respect to their Common Shares. A U.S. holder who makes a mark-to-market election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the taxpayer’s basis therein. Each U.S. holder should consult its own tax advisors regarding the PFIC rules and the U.S. federal income tax consequences of the acquisition, ownership, and disposition of Common Shares.‎

 

United States investors may not be able to obtain enforcement of civil liabilities against us.

The Company is incorporated under the laws of British Columbia, Canada, and its principal executive offices are located in Canada. Most of the Company’s directors and officers and most of the experts named in this MD&A or in our annual report for the fiscal year ended December 31, 2021 reside outside of the United States and all or a substantial portion of the Company’s assets and the assets of these persons are located outside the United States. Consequently, it may not be possible for an investor to effect service of process within the United States on the Company or those persons. Furthermore, it may not be possible for an investor to enforce judgments obtained in United States courts based upon the civil liability provisions of United States federal securities laws or other laws of the United States against those persons or the Company. There is doubt as to the enforceability, in original actions in Canadian courts, of liabilities based upon United States federal securities laws and as to the enforceability in Canadian courts of judgments of United States courts obtained in actions based upon the civil liability provisions of the United States federal securities laws. Therefore, it may not be possible to enforce those actions against the Company, certain of the Company’s directors and officers or the experts named in this MD&A or in our annual report for the fiscal year ended December 31, 2021.

 

We are an emerging growth company and intend to take advantage of reduced disclosure requirements ‎applicable to emerging growth companies, which could make our Common Shares less attractive to ‎investors.‎

 

We are an “emerging growth company” as defined in the JOBS Act. We will remain an emerging growth ‎company until the earliest to occur of (i) the last day of the fiscal year in which we have total annual gross ‎revenue of $1.07 billion or more; (ii) December 31, 2026 (the last day of the fiscal year ending after the fifth ‎anniversary of the date of the completion of the first sales of its common equity pursuant to an effective ‎registration statement under the United States Securities Act of 1933, as amended (the “Securities Act”)); (iii) ‎the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-‎year period; or (iv) the date we qualify as a “large accelerated filer” under the rules of the SEC, which means the ‎market value of our Common Shares held by non-affiliates exceeds $700 million as of the last business day of ‎its most recently completed second fiscal quarter after we have been a reporting company in the United States ‎for at least 12 months. For so long as we remain an emerging growth company, we are permitted to and intend to ‎rely upon exemptions from certain disclosure requirements that are applicable to other public companies that ‎are not emerging growth companies. These exemptions include not being required to comply with the auditor ‎attestation requirements of Section 404 (“Section 404”) of the Sarbanes-Oxley Act (2002), as amended (the “Sarbanes-Oxley Act”).‎

 

We may take advantage of some, but not all, of the available exemptions available to emerging growth ‎companies. We cannot predict whether investors will find our Common Shares less attractive if we rely on these ‎exemptions. If some investors find our Common Shares less attractive as a result, there may be a less active ‎trading market for our Common Shares and the price of our Common Shares may be more volatile.

 

43

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

We will incur increased costs as a result of operating as a public company in the United States ‎and our management will be required to devote substantial time to new compliance initiatives.‎

 

As a U.S. public company, particularly if or when we are no longer an “emerging growth company” as defined ‎under the JOBS Act, we will incur significant legal, accounting and other expenses, in addition to those we ‎currently incur as a Canadian public company, that we did not incur prior to being listed in the United States. In ‎addition, the Sarbanes-Oxley Act, and rules implemented by the SEC and Nasdaq impose various other ‎requirements on public companies, and we will need to spend time and resources to ensure compliance with our ‎reporting obligations in both Canada and the United States.‎

 

For example, pursuant to Section 404, we will be required to furnish a report by our management on our internal ‎control over financial reporting (“ICFR”), which, if or when we are no longer an emerging growth company, must ‎be accompanied by an attestation report on ICFR issued by our independent registered public accounting firm. ‎To achieve compliance with Section 404 within the prescribed period, we will document and evaluate our ICFR, ‎which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the ‎adequacy of our ICFR, continue steps to improve control processes as appropriate, validate through testing that ‎controls are functioning as documented and implement a continuous reporting and improvement process for ‎ICFR. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will ‎be able to conclude within the prescribed timeframe that our ICFR is effective as required by Section 404. This ‎could result in a determination that there are one or more material weaknesses in our ICFR, which could cause an ‎adverse reaction in the financial markets due to a loss of confidence in the reliability of our consolidated ‎financial statements.‎

 

In addition, becoming a public company in the United States will increase legal and financial compliance as well ‎as regulatory costs, such as additional Nasdaq fees, and will make some of our public company obligations ‎more time consuming. We intend to invest resources to comply with evolving laws, regulations and standards in ‎both Canada and the United States, and this investment may result in increased general and administrative ‎expenses and increased diversion of management’s time and attention from revenue-generating activities to ‎compliance activities. If our efforts to comply with public company laws, regulations and standards in the ‎United States are insufficient, regulatory authorities may initiate legal proceedings against us and our business ‎may be harmed.‎

 

We also expect that being a public company in the United States and complying with applicable rules and ‎regulations will make it more expensive for us to obtain sufficient levels of director and officer liability insurance ‎coverage. This factor could also make it more difficult for us to attract and retain qualified executive officers and ‎members of our Board of Directors.‎

 

As a foreign private issuer, we are subject to different U.S. securities laws and rules than a domestic U.S. ‎issuer, which may limit the information publicly available to our U.S. shareholders.‎

 

We currently qualify as a “foreign private issuer” under applicable U.S. federal securities laws and, therefore, are ‎not required to comply with all the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. As a result, we do ‎not file the same reports that a U.S. domestic issuer would file with the SEC, although we will be required to file ‎with or furnish to the SEC the continuous disclosure documents that we are required to file in Canada under ‎Canadian securities laws. In addition, our officers, directors and principal shareholders are exempt from the ‎reporting and “short swing” profit recovery provisions of Section 16 of the Exchange Act. Therefore, our ‎shareholders may not know on as timely a basis when our officers, directors and principal shareholders purchase ‎or sell our securities as the reporting periods under the corresponding Canadian insider reporting requirements are ‎longer. In addition, as a foreign private issuer, we are exempt from the proxy rules under the Exchange Act. We ‎are also exempt from Regulation FD, which prohibits issuers from making selective disclosures of material non-‎public information. While we expect to comply with the corresponding requirements relating to proxy statements ‎and disclosure of material non-public information under Canadian securities laws, these requirements differ from ‎those under the Exchange Act and Regulation FD and shareholders should not expect to receive in every case the ‎same information at the same time as such information is provided by U.S. domestic issuers.‎

 

44

 

 

Draganfly Inc.

Management Discussion and Analysis

For the year ended December 31, 2021

 

In addition, as a foreign private issuer, we have the option to follow certain Canadian corporate governance ‎practices, except to the extent that such laws would be contrary to U.S. federal securities laws and Nasdaq ‎listing rules and provided that we disclose the requirements we are not following and describe the Canadian ‎practices we follow instead. We plan to rely on this exemption in part. As a result, our shareholders may not have ‎the same protections afforded to shareholders of U.S. domestic issuers that are subject to all U.S. corporate ‎governance requirements.‎

 

At some point in the future, we may cease to qualify as a foreign private issuer. If we cease to ‎qualify, we will be subject to the same reporting requirements and corporate governance requirements as a U.S. ‎domestic issuer, which may increase our costs of being a public company in the ‎United States.‎

 

REGULATORY POLICIES

 

Disclosure Controls and Procedures

 

Disclosure Controls and Procedures (“DC&P”) are designed to provide reasonable assurance that all material information is gathered and reported on a timely basis to senior management so that appropriate decisions can be made regarding public disclosure and that information required to be disclosed by the issuer under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation. The Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), along with other members of management, have designed, or caused to be designed under the CEO and CFO’s supervision, DC&P and have assessed the design and operating effectiveness of the Company’s DC&P as at December 31, 2021. Based on this assessment, it was concluded that the design and operation of the Company’s DC&P are effective as at December 31, 2021.

 

Internal Controls over Financial Reporting

 

The CEO and CFO, along with participation from other members of management, are responsible for establishing and maintaining adequate Internal Control over Financial Reporting (“ICFR”) to provide reasonable assurance regarding the reliability of financial statements prepared in accordance with IFRS. The Company’s CEO and CFO, with support of management have assessed the design and operating effectiveness of the Company’s ICFR as at December 31, 2021 based on criteria described in “Internal Control - Integrated Framework” issued in 2013 by the Committee of Sponsoring Organization of the Treadway Commission. Based on this assessment, it was concluded that the design and operation of the Company’s ICFR are effective as at December 31, 2021. During the three months ended December 31, 2021, there has been no change in the Company’s ICFR that has materially affected, or is reasonably likely to materially affect, the Company’s ICFR.

 

Limitations of Controls and Procedures

 

The Company’s management, including its CEO and CFO, believe that any DC&P or ICFR, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, they cannot provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been prevented or detected. These inherent limitations include the realities that judgements in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Accordingly, because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Other Information

 

Additional information about the Company is available at www.draganfly.com

 

Approval

 

This MD&A is authorized for issue by the Board on April 3, 2022

 

45

 

EX-15.2 26 ex15-2.htm

 

Exhibit 15.2

 

DRAGANFLY INC.

 

AUDIT COMMITTEE CHARTER

 

PURPOSE

 

Senior management of Draganfly Inc. (the “Company”), as overseen by its Board of Directors (the “Board”), has primary responsibility for the Company’s financial reporting, accounting systems and internal controls. The Audit Committee (the “Committee”) is a standing committee of the Board established for the purposes of overseeing:

 

(a)the quality and integrity of the Company’s financial and accounting reporting processes, audits of the financial statements of the Company, and internal accounting and financial control systems of the Company;

 

(b)the external auditor’s qualifications and independence;

 

(c)management’s responsibility for assessing the effectiveness of internal controls;

 

(d)the Company’s compliance with legal and regulatory requirements in connection with financial and accounting matters; and

 

COMPOSITION AND OPERATION

 

1.The Committee shall be composed of at least three members, each of whom:

 

(a)must be an “Independent Director” (as defined in the Definitions section of this Charter), taking into account the rules and regulations of any securities regulatory authorities and/or stock exchanges that may be applicable to the Company;

 

(b)must not accept any consulting, advisory, or other compensatory fee from the Company (or any subsidiary) other than for board or committee service;

 

(c)must not be an “Affiliated Person” (as defined in the Definitions section of this Charter) of the Company or any of its subsidiaries;

 

(d)must not have participated in the preparation of the financial statements of the Company or any current subsidiary of the Company at any time during the past three years;

 

(e)must be Financially Literate.

 

In addition, at least one member will be a “Committee Financial Expert” (as defined in the Definitions section of this Charter).

 

The foregoing requirements are subject to any exemptions, exceptions, cure periods or phase-in accommodations that may be available to the Company under applicable securities laws and stock exchange rules.

 

2.The members of the Committee shall be appointed by the Board to serve one-year terms and are permitted to serve an unlimited number of consecutive terms.

 

 
- 2 -

 

3.The Committee shall appoint a chair (the “Chair”) from among its members who shall be an independent director. If the Chair is not present at any meeting of the Committee, one of the other Committee members present at the meeting shall be chosen to preside at the meeting.

 

4.The Committee will make every effort to meet at least four times per year and each member is entitled to request that an additional meeting be called, which will be held within two weeks of the request for such meeting. A quorum at meetings of the Committee shall be two members present in person or by telephone. The Committee may also act by unanimous written consent of its members as described under the heading “Authority” in this Charter.

 

5.The external auditor may request the Chair to call a meeting of the Committee to consider any matter that the auditor believes should be brought to the attention of the directors or the shareholders of the Company. In addition to the external auditor, each committee chair, members of board, as well as the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) shall be entitled to request the Chair to call a meeting, which meeting shall be held within two weeks of the request.

 

6.Notice of the time and place of every meeting shall be given in writing or by email communication to each member of the Committee at least 24 hours prior to the time fixed for such meeting.

 

7.The Committee shall fix its own procedure at meetings, keep records of its proceedings and provide a verbal report to the Board routinely at the next regularly scheduled Board meeting and shall provide copies of finalized minutes of meetings to the Corporate Secretary to be kept with the official minute books of the Company.

 

8.The Committee will review and approve its minutes of meetings and copies will be made available to the external auditor or its members as requested.

 

9.In camera sessions will be scheduled for each regularly scheduled quarterly Committee meeting, and as needed from time to time.

 

10.On an ad-hoc basis, the Committee may also meet separately with the Chief Executive Officer and the Chief Financial Officer and such other members of management as they may deem necessary.

 

RESPONSIBILITIES AND DUTIES

 

Overall Committee:

 

To fulfill its responsibilities and duties the Committee will:

 

(a)review this Charter periodically, but at least once per annum, and recommend to the Board any necessary amendments;

 

(b)review and, where necessary, recommend revisions to the Company’s disclosure in the Company’s public disclosures and securities filings (including its Management Information Circular) regarding Committee’s composition and responsibilities and how they are discharged;

 

 
- 3 -

 

(c)assist the Board in the discharge of its responsibilities relating to the quality, acceptability and integrity of the Company’s accounting policies and principles, reporting practices and internal controls;

 

(d)review and recommend approval by the Board of all significant and material financial disclosure documents to be released by the Company, including but not limited to, quarterly and annual financial statements and management discussion and analysis, annual reports, Form 40-F, annual information forms, and prospectuses containing material information of a financial nature; and

 

(e)oversee the relationship and maintain a direct line of communication with the Company’s internal and external auditors and assess their respective performance.

 

Public Filings, Policies and Procedures:

 

The Committee is responsible for:

 

(a)ensuring adequate procedures are in place for the review of the Company’s disclosure of financial information extracted or derived from the Company’s financial statements and periodically assess the Company’s disclosure controls and procedures, and management’s evaluation thereof, to ensure that financial information is recorded, processed, summarized and reported within the time periods required by law;

 

(b)reviewing disclosures made to the Committee by the CEO and the CFO during their certification process for any significant deficiencies in the design or operation of internal controls or material weakness therein and any fraud involving management or other employees who have a significant role in internal controls;

 

(c)reviewing with management and the external auditor any correspondence with securities regulators or other regulatory or government agencies which raise material issues regarding the Company’s financial reporting or accounting policies.

 

External Auditors

 

The responsibilities and duties of the Committee as they relate to the external auditor are to:

 

(a)consider and make recommendations to the Board with respect to the appointment, compensation, and retention of the external auditor to be nominated for appointment by shareholders at each annual general meeting of the Company;

 

(b)review the performance of the external auditor and, where appropriate, recommend to the Board the removal of the external auditor;

 

(c)confirm the independence and effectiveness of the external auditor, which will require receipt from the external auditor of a formal written statement delineating all relationships between the auditor and the Company and any other factors that might affect the independence of the auditor;

 

 
- 4 -

 

(d)oversee the work of the external auditor generally, and review and report to the Board on the planning and results of external audit work, including:

 

(i)the external auditor’s engagement letter or other reports of the auditor;

 

(ii)the reasonableness of the estimated fees and other compensation to be paid to the external auditor;

 

(iii)the form and content of the quarterly and annual audit report, which should include, inter alia:

 

(A)a summary of the Company’s internal controls and procedures;

 

(B)any material issues raised in the most recent meeting of the Committee; and

 

(C)any other related audit, review or attestation services performed for the Company by the external auditors.

 

(e)actively engage in dialogue with the external auditor with respect to any disclosed relationships or services that may affect the independence and objectivity of the external auditor and take, or recommend the Board take, appropriate actions to oversee the independence of the external auditor;

 

(f)monitor the relationship between management and the external auditor and resolve any disagreements between them regarding financial reporting;

 

(g)engage the external auditor in discussions regarding any amendments to critical accounting policies and practices; alternative treatments of financial information within generally accepted accounting principles related to material items that have been discussed with management, including any potential ramifications and the preferred treatment by the independent auditor; and lastly, written communication between management and the independent auditor, including but not limited to, the management letter and schedule of adjusted differences.

 

Internal Controls and Financial Reporting

 

The Committee will:

 

(a)obtain reasonable assurance from discussions with (and/or reports from) management, and reports from the external auditors that the Company’s financial and accounting systems are reliable and that the prescribed internal controls are operating effectively;

 

(b)in consultation with the external auditor, the CEO, the CFO, and where necessary, other members of management, review the integrity of the Company’s financial reporting process and the internal control structure;

 

(c)review the acceptability of the Company’s accounting principles and direct the auditors’ examinations to particular areas of question or concern, as required;

 

 
- 5 -

 

(d)request the auditors to undertake special examinations (e.g., review compliance with conflict of interest policies) when it deems necessary;

 

(e)together with management, review control weaknesses identified by the external and internal auditors;

 

(f)review the appointments of the CFO and other key financial executives;

 

(g)during the annual audit process, consider if any significant matters regarding the Company’s internal controls and procedures over financial reporting, including any significant deficiencies or material weaknesses in their design or operation, need to be discussed with the external auditor, and review whether internal control recommendations made by the auditor have been implemented by management.

 

Ethical and Legal Compliance

 

The responsibilities and duties of the Committee as they relate to compliance and risk management are to:

 

(a)obtain reasonable assurances as to the integrity of the CEO and other senior management and that the CEO and other senior management strive to create a culture of integrity throughout the Company;

 

(b)review the adequacy, appropriateness and effectiveness of the Company’s policies and business practices which impact on the integrity, financial and otherwise, of the Company, including those relating to hedging, insurance, accounting, information services and systems and financial controls, and management reporting;

 

(c)receive a report from management on tax issues and planning, including compliance with the Company’s source deduction obligations and other remittances under applicable tax or other legislation;

 

(d)review annually the adequacy and quality of the Company’s financial and accounting staffing, including the need for and scope of internal audit reviews (if any);

 

(e)establish procedures for a) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal controls, or auditing matters; and b) the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters.

 

(f)review any complaints and concerns received regarding accounting, internal controls, or auditing matters or with respect to the Company’s Code of Ethical Conduct, and the investigation and resolution thereof, and provide all relevant information relating to such complaints and concerns to the Nominating and Governance Committee;

 

(g)review and monitor the Company’s compliance with applicable legal and regulatory requirements related to financial reporting and disclosure;

 

 
- 6 -

 

(h)review all “related party transactions” (as such term is defined under applicable securities laws and stock exchange rules) for any potential conflicts of interest; and

 

(i)carry the responsibility for reviewing reports from management, external auditors with respect to the Company’s compliance with the laws and regulations having a material impact on financial reporting and disclosure, including: tax and financial reporting laws and regulations; legal withholding requirements; environmental; and any other laws and regulations which expose directors to liability.

 

AUTHORITY

 

1.The Committee shall have the authority to:

 

(a)engage independent counsel and other advisors as it determines necessary to carry out its duties;

 

(b)set and pay the compensation for the external auditor engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company;

 

(c)set and pay the compensation for any independent counsel and other advisors employed by the Committee;

 

(d)incur ordinary administrative expenses that are necessary or appropriate in carrying out its duties; and

 

(e)communicate directly with the external auditors.

 

2.The Committee shall have the power, authority and discretion delegated to it by the Board which shall not include the power to change the membership of or fill vacancies in the Committee.

 

3.A resolution approved in writing by the members of the Committee shall be valid and effective as if it had been passed at a duly called meeting. Such resolution shall be filed with the minutes of the proceedings of the Committee and shall be effective on the date stated thereon or on the latest date stated in any counterpart.

 

4.The Board shall have the power at any time to revoke or override the authority given to or acts done by the Committee except as to acts done before such revocation or act of overriding and to terminate the appointment or change the membership of the Committee or fill vacancies in it as it shall see fit.

 

5.The Committee shall have unrestricted and unfettered access to all Company personnel and documents and shall be provided with the resources necessary to carry out its responsibilities.

 

6.At the invitation of the Chair, one or more officers or employees of the Company may, and if required by the Committee, shall attend a meeting of the Committee.

 

7.The Committee shall have the authority to obtain advice and assistance from outside legal, accounting or financials advisors in its sole discretion.

 

 
- 7 -

 

DEFINITIONS

 

Capitalized terms used in this Charter and not otherwise defined have the meaning attributed to them below:

 

Affiliated Person” means an “affiliate” of, or a person “affiliated” with, a specified person, which is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the person specified.

 

Committee Financial Expert” means a person who has the following attributes:

 

(a)past employment experience in finance or accounting;

 

(b)requisite professional certification in accounting; or

 

(c)or any other comparable experience or background which results in the individual’s financial sophistication, including being or having been a chief executive officer, chief financial officer or other senior officer with financial oversight responsibilities.

 

Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or, if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division or function (such as sales, administration or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company.

 

Family Member” means a person’s spouse, parents, children, siblings, mothers and fathers-in-law, sons and daughters-in-law, brothers and sisters-in-law, and anyone (other than domestic employees) who shares such person’s home.

 

Financially Literate” means the ability to read and understand a set of fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement, that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised in the Company’s financial statements.

 

“Independent Director” means a director that is “independent” as the term is defined in both National Instrument 52-110 - Audit Committees (“NI 52-110”) and Nasdaq Rule 5605(a)(2), as each may be amended from time to time, and being a person other than an Executive Officer or employee of the Company or any other individual having a relationship which, in the opinion of the Company’s board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The following persons shall not be considered independent:

 

(a)a director who is, or at any time during the past three years was, employed by the Company;

 

(b)a director who accepted or who has a Family Member who accepted any compensation from the Company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than the following:

 

 
- 8 -

 

(i)compensation for board or board committee service;

 

(ii)compensation paid to a Family Member who is an employee (other than an Executive Officer) of the Company; or

 

(iii)benefits under a tax-qualified retirement plan, or non-discretionary compensation

 

Provided, however, that in addition to the requirements contained in this paragraph (B), audit committee members are also subject to additional, more stringent requirements under Rule 5605(c)(2).

 

(c)a director who is a Family Member of an individual who is, or at any time during the past three years was, employed by the Company as an Executive Officer;

 

(d)a director who is, or has a Family Member who is, a partner in, or a controlling Shareholder or an Executive Officer of, any organization to which the Company made, or from which the Company received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient’s consolidated gross revenues for that year, or $200,000, whichever is more, other than the following:

 

(i)payments arising solely from investments in the Company’s securities; or

 

(ii)payments under non-discretionary charitable contribution matching programs.

 

(e)a director of the Company who is, or has a Family Member who is, employed as an Executive Officer of another entity where at any time during the past three years any of the Executive Officers of the Company serve on the compensation committee of such other entity; or

 

(f)a director who is, or has a Family Member who is, a current partner of the Company’s outside auditor, or was a partner or employee of the Company’s outside auditor who worked on the Company’s audit at any time during any of the past three years.

 

Adopted by the Board on August 19, 2019, and amended April 14, 2021.

 

 

 

EX-15.3 27 ex15-3.htm

 

Exhibit 15.3

 

CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Annual Report on Form 20-F of our report dated April 3, 2022, with respect to the consolidated financial statements of Draganfly Inc. as at and for the years ended December 31, 2021 and 2020 included in this Annual Report on Form 20-F of Draganfly Inc.

 

We also consent to the incorporation by reference in the Registration Statements on Form F-10 (No. 333-258074), as amended, and Form S-8 (No. 333-259459) of Draganfly Inc. of our report dated April 3, 2022 referred to above.

 

/s/ DMCL LLP

 

Chartered Professional Accountants

Vancouver, Canada

 

April 3, 2022

 

 

GRAPHIC 28 ex1-1_001.jpg begin 644 ex1-1_001.jpg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end GRAPHIC 29 ex1-1_002.jpg begin 644 ex1-1_002.jpg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end GRAPHIC 30 ex1-1_003.jpg begin 644 ex1-1_003.jpg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end GRAPHIC 31 ex4-1_001.jpg begin 644 ex4-1_001.jpg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ex4-1_002.jpg begin 644 ex4-1_002.jpg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end GRAPHIC 33 ex4-1_003.jpg begin 644 ex4-1_003.jpg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ex4-1_004.jpg begin 644 ex4-1_004.jpg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

(/'.K:5INO-HUCI,$& M[R[2.62>24%MV9 0% 7' Y.?2KS_ Y\/2^"K?PE)#.VDP2>8J><=Q.\ORW7 MJQJQK7@C2];U3^TVGU&QO6B\F2;3[Q[=I4!R ^T_-CG'U^E '%6'CW7)=#\, M:U>2K';Q:J^DZT$11%(3\BS;F **&P>"!R0?2ICXPU34=)\7Z['XCMM'TB"[ M6RTRXN+=)53R\"610!ND+G.T<^F#7;GPAHA\(OX7%DJZ4\)B,0///.[/7=GY MMW7/-5I_ F@7'@^W\+/:N-,M]IB"R$.C*CZ3X$T;2=1GU!&O[J\N+8VL\U[>R3M+&3G! MW$],8&,NZ0R1%BNU3P 2QR!UX]* M,@7?BGQ?XMU^VTO7UT6RT25;>&..U29KB4IDM(6_A&< #KG/! -5;/QCKGBK M1_ MQIUTNES:S+I3:@\FH6=U<( M([E[&\>#[0H&%\P*<-@#&<=/H,:*^&=*CET=X+80+HY?[''$=J)N0H++ MG5/%5SIMUXJFO'6VW-IFIZ6+2[@D!&>4 4C!Y')^@Y/6W7@G1KR?7IIXIF?7 M%A6\(E(_U2[8RN/ND=<^HJ+0_ FD:'JBZHLM_?ZBD1ACNM1NWN'C0XR%W'"Y MQV'J.A(H P/B5Y'_ E7@#[1MV?VR,;O[^!M_P#'L5B)JWC'4-'\=:S!XJ>T MCT/4K^.WMULH7#I"H8(Q9'K#6K[3+R\60S:;/]HMRCE0' MQCG'4>U5K?PAI-MI6N:;&DOV?6Y[B>\!DY+S+M?:>W'3TH Y;4M:\0>(?&6F M^'=)U<:(CZ(NKRW$=LD[NS2!!'A^ H//J>E=GX=_M$:';C5K^TO[T;EDN+1- ML;X8CID\\<].<\5G:WX$T/75LS-'<6T]G'Y,-Q:3M%*(_P"X7!R5[X/?ZG)% MX$T*W@T6"UAGM8='D\VVCMYVC5FXR9 #\^<<[LYR?4Y .EHHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKQ>VTSP]X MIT?7O'/CA+FY@@O9HX8([B79;0Q-L0*L9!W9SDGUSQR:N:1XNTWPK\+->UKP M[J,^O6&GZ@!;K=))$(TD>(>4&;YF"B0G<1U/3'4 ]L:%I>OQZYIED-7TNQ2^C%I M.S07,;EE!!*AEPRD$'GT]: /0:*X&\\>W]MIG@2XCT^*:7Q');).JEL0B159 MBOTW$\]A5&7QYXLNM5\4VND:!ITL6@R$-+<73IYR[20JC;@O@9.2 ./7- 'I ME%97AK78/$WAO3]:MT,<=Y")-A.2AZ%<]\$$?A7EOAGQ->^%OALUWIVG+J%W M<>(Y+2.W:39O+RD8![$XP"> 3GG&* /9Z*\_3QWK&C^)]0TOQ5IEG!#!I,FJ MQ3Z?*\H9(R=Z?.JY;'/;&.^X8?X9\4^,-=DTG4I?#]BN@ZD&8/#+VT:UOY_M%S9R627*B5C^\D0N3C/7:,#/<<89<_#2YN_A[ MK?AVZU][F_U>[^V7&H/:JH,@:,X$:G &(E'7N3[5Z%10!RGB3P3'KMGI#6]^ M]CJNCNLEC?)"KA#@!@T9P"I ' QT'.,@T['P->7=GK,GBC5AJ&IZK9&P>:"$ M1I!!\^%1>YRY;+9.?U[>B@#S'2_A?K4,GAU-5\6"\M/#]PLEI MBJ[T4?*&; M=D$=.X [\UB:3X5\1:YXJ\=R:;XAN="BN-0,$JOIRRK<1A2,KO((ZGYE/(. M?3'M-% &;H&AV7AK0;/1M.1EM;2/8FX@LW!R37):;\-I++1+?3Y M-51C!X@&LAUM_O!9-PC/S=2!][G&>AQ7?T4 GRAPHIC 35 ex4-5_001.jpg begin 644 ex4-5_001.jpg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end GRAPHIC 36 ex4-5_002.jpg begin 644 ex4-5_002.jpg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mda1_001.jpg begin 644 mda1_001.jpg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end GRAPHIC 38 form20-f_001.jpg begin 644 form20-f_001.jpg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fs_001.jpg begin 644 fs_001.jpg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dpro-20211231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - DRONELOGICS ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - VITAL INTELLIGENCE ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - AMALGAMATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTES RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PREPAIDS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - INTANGIBLE ASSETS AND GOODWILL link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - RIGHT OF USE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - LEASE LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - CUSTOMER DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - DEFERRED INCOME link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SHARE CAPITAL link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - OFFICE AND MISCELLANEOUS link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - OTHER INCOME link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - GOVERNMENT ASSISTANCE link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - BASIS OF PREPARATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - BASIS OF PREPARATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - DRONELOGICS ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - AMALGAMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - NOTES RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - PREPAIDS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - RIGHT OF USE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - LEASE LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - CUSTOMER DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - DEFERRED INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - LOANS PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SHARE CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - OFFICE AND MISCELLANEOUS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF RESULTS OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - DRONELOGICS ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF CONTINGENT CONSIDERATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - AMALGAMATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF COST OF SALES (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - NOTES RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - SCHEDULE OF INVESTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - LEASE LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - SCHEDULE OF CUSTOMER DEPOSITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - SCHEDULE OF LOANS (Details) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - LOANS PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - SUMMARY OF CHANGES IN STOCK OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000099 - Disclosure - SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000100 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000101 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000102 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000103 - Disclosure - SHARE CAPITAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000104 - Disclosure - SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000105 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000106 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000107 - Disclosure - REVENUE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000108 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000109 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000110 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000111 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000112 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 00000113 - Disclosure - SCHEDULE OF BREAKDOWN CAPITAL (Details) link:presentationLink link:calculationLink link:definitionLink 00000114 - Disclosure - SCHEDULE OF INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000115 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000116 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000117 - Disclosure - OTHER INCOME (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000118 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000119 - Disclosure - GOVERNMENT ASSISTANCE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 41 dpro-20211231_cal.xml XBRL CALCULATION FILE EX-101.DEF 42 dpro-20211231_def.xml XBRL DEFINITION FILE EX-101.LAB 43 dpro-20211231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Issued capital [member] Capital reserve [member] Retained earnings [member] Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member] Accumulated other comprehensive income [member] Legal Entity [Axis] Draganfly Innovations Inc [Member] Draganfly Innovations USA Inc [Member] Dronelogics Systems Inc. [Member] Classes of property, plant and equipment [axis] Computer equipment [member] Furniture and Equipment [Member] Leasehold improvements [member] Computer software [member] Vehicles [member] Business combinations [axis] Title of Individual [Axis] Employee [Member] Maturity [axis] First and Second Anniversary [Member] Certain Directors and Officers [Member] Types of share-based payment arrangements [axis] Restricted Stock Units [Member] Vital Intelligence Inc [Member] Types of contracts [axis] Asset Purchase Agreement [Member] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Escrow Agreement One [Member] Escrow Agreement Two [Member] Escrow Agreement Three [Member] Escrow Agreement Four [Member] Intangible assets material to entity [axis] Brand [Member] Software [Member] Consolidated structured entities [axis] Draganfly Innovations Shares [Member] Warrant reserve [member] Guaranteed Investment Certificate [Member] Products and services [axis] Inventory [Member] Note One [Member] Note Two [Member] Note 3 [Member] Note 4 [Member] Types of investment property [axis] Public Company Shares [Member] Public Company Warrants [Member] Private Company Shares [Member] Classes of share capital [axis] Warrants [Member] Classes of intangible assets and goodwill [axis] Patent [Member] Customer Relationship [Member] Goodwill [member] Customer-related intangible assets [member] Counterparties [axis] Dronelogics [Member] Vital [Member] Vital and Dronelogics [Member] Not later than one year [member] Later than one year and not later than three years [member] Later than four years and not later than five years [member] Later than five years [member] Categories of related parties [axis] Customers [Member] Government [Member] Note Receivable Accretion [Member] Borrowings by name [axis] CEBA [Member] CEBA [Member] Vehicle Loan [Member] Shopify Loan [Member] Common Stock 1 [Member] Consolidated Entities [Axis] Common Stock 2 [Member] Common Stock 3 [Member] Common Stock 4 [Member] Common Stock 5 [Member] Common Stock 6 [Member] Common Stock 7 [Member] Dronelogics Inc [Member] Common Stock 8 [Member] Common Stock 9 [Member] Common Stock 10 [Member] Common Stock 11 [Member] Common Stock 12 [Member] Common Stock 13 [Member] Consultant [Member] Employees and Consultant [Member] Employee One [Member] Employee Two [Member] Consultant One [Member] Stock Options [Member] Employee and Consultant [Member] Ranges of exercise prices for outstanding share options [axis] Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Exercise Price Five [Member] Exercise Price Six [Member] Exercise Price Seven [Member] Exercise Price Eight [Member] Exercise Price Nine [Member] Exercise Price Ten [Member] Exercise Price Eleven [Member] Range [axis] Bottom of range [member] Top of range [member] Restricted Stock Units Rsu [Member] Range 1 [member] Range 2 [member] Range 3 [member] Range 4 [member] Range 5 [member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] Warrant Six [Member] Product Sales [member] Drone Service [member] Services [Member] Custom Engineering Services [member] Geographical [Axis] CA Country [member] US Country [member] International [member] Geographical areas [axis] Canada [member] United States [member] Agreement [Axis] Business Service Agreement [Member] Business Instincts Group [Member] Consultant Agreement [Member] Alberta Ltd [Member] Executive Agreement [Member] Scott Larson [Member] CEO and Director [Member] President and Director [Member] Former Director [Member] Former Owner [Member] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Common Shares [Member] Common Shares One [Member] Convertible Debentures [member] Scenario [Axis] Canada Emergency Wage Subsidy [member] Canada Emergency Rent Subsidy [Member] Hardest Hit Business Recovery Program [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Contact Personnel Email Address Auditor Firm ID Auditor Name Auditor Location Statement of financial position [abstract] ASSETS Current Assets Cash and cash equivalents Receivables Inventory Notes receivable Prepaids  Total current assets Non-current Assets Goodwill Equipment Intangible assets Investments Notes receivable Right of use asset TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Trade payables and accrued liabilities Customer deposits Deferred income Loans payable Derivative liability Lease liability  Total current liabilities Non-current Liabilities Deferred income Loans payable Lease liability TOTAL LIABILITIES SHAREHOLDERS’ EQUITY Share capital Reserves – share-based payments Accumulated deficit Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS’ EQUITY TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Profit or loss [abstract] REVENUE Revenue from sales of goods Revenue from provision of services TOTAL REVENUE COST OF SALES GROSS PROFIT OPERATING EXPENSES Amortization Depreciation Director fees Insurance Office and miscellaneous Professional fees Research and development Share-based payments Travel Wages and salaries  Total operating expenses OTHER INCOME (EXPENSE) Change in fair value of derivative liability Finance and other costs Foreign exchange gain (loss) Gain on disposal of assets Gain (loss) on settlement of debt Gain on forgiveness of debt Government income Listing expense Loss on write-off of loan receivable Loss on write-off of notes receivable Loss on impairment of goodwill Other income (loss) NET LOSS OTHER COMPREHENSIVE INCOME (LOSS) Items that may be reclassified to profit or loss Foreign exchange translation Items that will not be reclassified to profit or loss Change in fair value of equity investments at FVOCI COMPREHENSIVE LOSS Net loss per share Basic & diluted Weighted average number of common shares outstanding - basic & diluted Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Balance Beginning balance, shares Shares issued for settlement of notes payable Shares issued for settlement of notes payable, shares Shares issued as transactions fees Shares issued as transactions fees, shares Recapitalization of Draganfly Inc. Recapitalization of Draganfly Inc., shares Shares issued of settlement of trades payable Shares issued of settlement of trades payable, shares Shares issued for settlement of convertible debentures and accrued interest Shares issued for settlement of convertible debentures and accrued interest, shares Shares issued for exercise of warrants Shares issued for exercise of warrants, shares Reclassification of unexercised conversion feature Shares and warrants issued on private placement Shares and warrants issued on private placement, shares Stock-based compensation Net loss Shares issued for acquisition Beginning balance, shares Shares issued as finder’s fees Shares issued as finder's fees, shares Shares issued for debt settlement Shares issued for debt settlement, shares Shares issued for financing Shares issued for financing, shares Shares issued for exercise of RSUs Beginning balance, shares Share-based payments Translation of foreign operations Share issue costs Shares issued for exercise of warrants Shares isued for exercise of warrants, shares Shares issued for exercise of stock options Beginning balance, shares Shares issued in lieu of cash Beginning balance, shares Change in fair value of equity investments at FVOCI Balance Beginning balance, shares Statement of cash flows [abstract] OPERATING ACTIVITIES Net loss Adjustments for: Amortization Depreciation Change in fair value of derivative liability Impairment of notes receivable Impairment of goodwill Finance and other costs Gain on settlement of debt Gain on forgiveness of debt Gain on disposal of assets Income from government assistance Expense of non-financial asset Listing expense Shares Issued as acquisition cost Share-based payments  Adjustment for profit loss Net changes in non-cash working capital items: Receivables Inventory Prepaids Trade payables and accrued liabilities Customer deposits Deferred income Funds used in operating activities INVESTING ACTIVITIES Cash paid for acquisition, net of cash received Purchase of equipment Disposal of equipment Purchase of investments Issuance of notes receivable Proceeds from sales of investments Funds provided by (used in) investing activities FINANCING ACTIVITIES Proceeds from issuance of common shares for financing Share issue costs Proceeds from issuance of common shares for warrants exercised Proceeds from issuance of common shares for stock options exercised Proceeds from issuance of loans Loans repayments Proceeds from issuance of notes payable Repayment of convertible debentures Repayment of notes payable Repayment of loans Repayment of lease liability Funds provided by financing activities Effects of exchange rate changes on cash Change in cash Cash, beginning of year Cash, end of year Cash and cash equivalents consist of the following: Cash held in banks Guaranteed investment certificate  Cash and cash equivalents Nature And Continuance Of Operations NATURE AND CONTINUANCE OF OPERATIONS Disclosure of notes and other explanatory information [text block] BASIS OF PREPARATION DRONELOGICS ACQUISITION Vital Intelligence Acquisition VITAL INTELLIGENCE ACQUISITION Disclosure of interests in other entities [text block] AMALGAMATION CASH AND CASH EQUIVALENTS Receivables RECEIVABLES INVENTORY Notes Receivable NOTES RECEIVABLE PREPAIDS Investments INVESTMENTS Disclosure of detailed information about property, plant and equipment [abstract] EQUIPMENT INTANGIBLE ASSETS AND GOODWILL Right Of Use Assets RIGHT OF USE ASSETS Lease Liability LEASE LIABILITY Trade Payables And Accrued Liabilities TRADE PAYABLES AND ACCRUED LIABILITIES Customer Deposits CUSTOMER DEPOSITS DEFERRED INCOME Loans Payable LOANS PAYABLE Share Capital SHARE CAPITAL Revenue REVENUE Office And Miscellaneous OFFICE AND MISCELLANEOUS RELATED PARTY TRANSACTIONS Financial Instruments And Financial Risk Management FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT INCOME TAXES OTHER INCOME Supplemental Cash Flow Disclosures SUPPLEMENTAL CASH FLOW DISCLOSURES Government Assistance GOVERNMENT ASSISTANCE Inventory Contingencies Useful lives of equipment and intangible assets Significant judgments Business combinations Business combination versus asset acquisition Other significant judgments Foreign currency translation Share-based payments Restricted Share Units Loss per share Impairment of non-financial assets Income taxes Inventory Revenue recognition Cost of Goods Sold Intangible Assets and Goodwill Equipment Research and development expenditures Government Assistance SR&ED Investment tax credits Leases SCHEDULE OF RESULTS OF OPERATIONS SCHEDULE OF CLASS OF EQUIPMENT SCHEDULE OF PURCHASE PRICE ALLOCATION SCHEDULE OF CONTINGENT CONSIDERATION SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE SUMMARY OF HISTORICAL FINANCIAL INFORMATION SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES SCHEDULE OF CASH AND CASH EQUIVALENTS SCHEDULE OF AMOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF COST OF SALES DISCLOSURE OF NOTES RECEIVABLE SCHEDULE OF PREPAID EXPENSES AND DEPOSITS SCHEDULE OF INVESTMENTS SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF INTELLECTUAL PROPERTY SCHEDULE OF RIGHT OF USE ASSETS SCHEDULE OF OPERATING LEASE LIABILITIES SCHEDULE OF OPERATING MATURITY ANALYSIS SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF CUSTOMER DEPOSITS SCHEDULE OF DEFERRED INCOME SCHEDULE OF LOANS PAYABLE SCHEDULE OF LOANS SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SUMMARY OF CHANGES IN STOCK OPTIONS SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS SCHEDULE OF WARRANT DERIVATIVE LIABILITY SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS SUMMARY OF CHANGES IN WARRANTS SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF PRODUCT AND SERVICE REVENUE SCHEDULE OF GEOGRAPHIC REVENUE SCHEDULE OF OPERATING SEGMENTS SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES SCHEDULE OF KEY MANAGEMENT TRANSACTIONS SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS SCHEDULE OF BREAKDOWN CAPITAL SCHEDULE OF INCOME TAX SCHEDULE OF DEFERRED TAXES Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table] Reserve Quantities [Line Items] Name of subsidiary Country of incorporation of subsidiary Proportion of ownership interest in subsidiary Disclosure of detailed information about property, plant and equipment [table] Depreciation rate Depreciation rate, description Disclosure of detailed information about business combination [table] Number of shares of Draganfly Inc. Fair value of common shares Fair value of shares of Draganfly Inc. Cash portion of purchase price Total Cash Accounts receivable Inventory Prepaids and deposits Other current assets Capital assets Right-of-use assets Accounts payable and accrued liabilities Customer deposits Loans Other current liabilities Lease liabilities Total tangible assets acquired Customer relationships Website  Total identifiable intangible assets Goodwill Total consideration Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Acquisition date fair value of total consideration cash transferred Acquisition date shares transferred Advisors fees expenses Advisiors fees paid in value of shares Advisory fees expenses paid in shares Advisory fees expenses value per share Advisors fees paid in cash Number of share options granted in share-based payment arrangement Number of other equity instruments exercised or vested in share-based payment arrangement Attribution rate percentage Discount rate Royalty percentage Royalty discount percentage Revenue Profit (loss) Schedule Of Contingent Consideration Fair value of contingent consideration Change in fair value of contingent consideration Contingent consideration at December 31, 2021 (note 20) Number of units of Draganfly Inc. Fair value of units Fair value of units of Draganfly Inc. Identifiable intangible assets, Brand Identifiable intangible assets, Software Identifiable intangible assets Total consideration Payment to acquire assets Number of shares issued Explanation of nature and amount of significant transactions Warrant exercise price per share Warrant expiration term Escrow deposit units Description for Number of Shares Issued Final payment Stock issued, shares Shares issued, amount Shares held in escrow Derivative financial liabilities Increase (decrease) in credit derivative, fair value Royalty Percentage Number of shares of Draganfly Inc. Fair value of common shares in concurrent financing Fair value of shares of Draganfly Inc. Fair value of warrants Fair value of shares issued for transaction fees Net assets acquired Cash Accounts receivable Loans receivable Accounts payable and accrued liabilities Subscription receipts Net of liabilities Risk-free interest rate Estimated life Expected volatility Expected dividend yield Disclosure of information about consolidated structured entities [table] Exchange of common stocks Common stock, issued Exercisable warrant price Transaction fees Fair value of warrants Proceeds from subscription receipts Cash held in banks Guaranteed investment certificates Cash and Cash Equivalents Disclosure of disaggregation of revenue from contracts with customers [table] Purchase of financial instrument Financial instrument term Average effective Instrument rate Renew of financial instruments Renewed financial instrument term Renewed effective instrument rate Schedule Of Amounts Receivable Trade accounts receivable Corporate taxes receivable GST receivable SR&ED receivable Trade and other receivables Finished goods Parts Inventories  Inventory Consulting and services Other Cost of sales  Cost of sales Inventory write-down Disclosure of terms and conditions of share-based payment arrangement [table] Start Date Maturity Date Interest Rate Principal Interest Accretion Impairment loss Note receivable Note receivable interest rate Loans written down Insurance Prepaid director fees Prepaid interest Prepaid marketing services Prepaid rent Prepaid subscriptions Deposits  Prepaid expenses and deposits Disclosure of detailed information about investment property [table] Balance at December 31, 2020 Investments Change in fair value Balance at December 31, 2021 Risk free interest rate Expected life Number of shares purchased Number of shares purchased, value warrant, exercise price Warrants expiration date Property, plant and equipment, beginning balance Additions Net assets acquired in the Transaction Revaluation Property, plant and equipment, ending balance Accumulated depreciation Property, plant and equipment, beginning balance Charge for the year Accumulated depreciation Property, plant and equipment, ending balance Property, plant and equipment Disclosure of reconciliation of changes in intangible assets and goodwill [table] Intellectual properties and goodwill, beginning balance Intangible assets acquired in the Acquisition Impairment of goodwill Intellectual properties and goodwill, Ending balance Accumulated amortization, beginning balance Change for the year Accumulated amortization, ending balance Intellectual properties and goodwill Percentage of acquired Customer relationships Percentage of cash flow projection [custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0] Percentage of weighted average cost of capital Assumption discount rates Reduction in value Schedule Of Right Of Use Assets Right of use assets, at cost, beginning Leases acquired in the Acquisition Additions Lease removal Right of use assets, at cost, ending Accumulated amortization, Beginning Charge for the year Historical correction Accumulated amortization, ending Right of use assets Schedule Of Operating Lease Liabilities Balance - Beginning of period Leases acquired in the Acquisition Interest expense Lease Payments Additions Lease removal Balance - End of period Current lease liabilities Non-current lease liabilities Lease liabilities Maturity analysis Amount representing implicit interest Lease liability Depreciation Lease Liability Schedule Of Trade Payables And Accrued Liabilities Trade accounts payable Accrued liabilities Due to related parties (Note 23) Government grant payable GST/PST Payable Trade payables and accrued liabilities Schedule Of Customer Deposits Disclosure of transactions between related parties [table] Deferred Income Schedule Of Loans Payable Opening balance Acquisition of loans Issuance of loans payable Fair value adjustment Repayment of loans payable Accretion expense Ending balance Disclosure of detailed information about borrowings [table] Start Date Maturity Date Rate Total Carrying Value Loan received Interest rate Loans forgivable amount Maturity Proceeds from loan Loan forgiveness Unsecured loan received Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Grant date Expiry date Exercise Price Remaining Contractual Life (years) Number of Options Exercisable Summary Of Changes In Stock Options Number of options outstanding, Beginning Balance Weighted average exercise price, Beginning Balance Number of options outstanding, forfeited Weighted average exercise price, forfeited Number of options outstanding, Granted Weighted average exercise price, Granted Number of options outstanding, Exercised Weighted average exercise price, Exercised Number of options outstanding, Ending Balance Weighted average exercise price, Ending Balance Exercise price Number of RSUs outstanding, Beginning of the period Exercised Forfeited Issued Number of RSUs outstanding, Ending of the period Beginning of the period Warrants issuance Change in fair value of warrants outstanding Shares issued for exercise of broker warrants of derivatives End of the period Warrants Contingent consideration Contingent consideration at December 31, 2021 Issue Date Exercise price Number of Warrants Outstanding Fair Value of warrants Weighted Average Exercise Price, Oustanding, Beginning Balance Exercised Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Forfeited Granted Weighted Average Exercise Price, Granted Weighted Average Exercise Price, Oustanding, Ending Balance Date issued Expiry Date Exercise price Number of warrants outstanding Number of stock issued for exercise of warrants Value of stock issued for exercise of warrants Number of stock issued for restrcited share units Number of stock issued for exercise of options Value of stock issued for exercise of options Number of stock units issued for regulation financing Stock units issued during period value regulation financing Share capital issuance, description Warrant derivative liability Number of stock units issued for acquisition Number of stock issued for private placement Value of stock issued for private placement Stock units issued during period shares common shares finder fees Number of stock issued for cash proceeds Value of stock issued for cash proceeds Number of stock issued for debt settlement Recongnized loss Comprehensive loss Subscription receivable Amounts payable, related party transactions Stock issued during period value units, shares Shares issued of settlement trades payable, shares [custom:SharesIssuedOfSettlementTradesPayable] Trades payable per share Shares issued of settlement convertible debentures and accrued interest, shares Shares issued of settlement convertible debentures Gain loss on settlement of debt Purchases of exercise of warrants, shares Purchases of exercise of warrants Capital reserve Stock option exercisable year Adjustments for share-based payments Number of accelerated vesting shares Number of shares vested Number of shares granted post consolidation Share based payment expense Warrants Expiration Date Description Weighted average remaining contractual life of outstanding share options Warrants issued Warrants held in escrow Revenue  Property and equipment TOTAL ASSETS Service Revenue Schedule Of Office And Miscellaneous Expenses Advertising, Marketing, and Investor Relations Compliance fees Contract Work Other Office and Miscellaneous Expenses  Director fees Management fees paid to a company Salaries Share-based payments Total Schedule Of Changes In Foreign Exchange Rates Foreign exchange rate Disclosure of fair value measurement of assets [table] Equity securities in investee companies Notes receivable Derivative liability Total Schedule Of Breakdown Capital Cash Debt Equity Loss before income taxes Canadian statutory rates Expected income tax recovery Impact of different foreign statutory tax rates Non-deductible items Share issue costs Adjustments to prior years provision versus statutory tax returns Differences between prior year provision and final tax return Change in deferred tax asset not recognized Income tax Share issuance costs Non-capital losses Property and equipment Capital gain reserve Scientific Research and Experimental Development Total deferred income tax assets Deferred income tax not recognized Net deferred tax assets Tax effect of tax losses Amount received from sale of investment [custom:WarrantsExercisePrice-0] Fair value of investments other comprehensive loss Debt settlement, amount Debt settlement, shares issued Gai on settlement of debt Accounts payable Price per share IfrsStatementTable [Table] Rental expense Other receivables Notes receivables. Conversion feature on convertible note. Deferred income liabilities current. Current Loans Payable. Deferred income liabilities noncurrent. Non-current Loans Payable. Director Fees. Office and Miscellaneous Expenses. Share-based payments expenses. Finance and other costs. Gain loss on settlement of debt. Disclosure of notes receivable. Note Five [Member] Debt discount rate. Note One [Member] Gain on forgiveness of debt. Description of note receivable. Note Three [Member] Listing expense. Note receivable interest rate. Note Six [Member] Loans payables. Disclosure of notes receivable. Loans payable amount. Loss on write off loan receivable. Acquisition of loans. Other income loss. Unrealized Investment Loss. Issuance of loans payable. Fair value adjustment on loans. Repayment of loans payable. Basic and diluted earnings loss per share. Accretion expenses. Note receivable start date. Note Two [Member] Note receivable maturity date. Disclosure of loans payable explanatory. Note receivable face amount. Note Four [Member] Borrowings maturity start day. CEBA [Member] CEBA [Member] Vehicle Loan [Member] Note receivable interest amount. Note receivable accretion amount. Loan received. Loss on write off of loan receivable. Loan forgiveness. Shares issued for exercise of warrants. Shares issued for settlement of notes payable. Note receivable. Shares issued as finders fees. Number of stock issued for exercise of warrants. Pre-Consolidation [Member] Shares issued as transactions fees. Value of stock issued for exercise of warrants Number of stock issued for restrcited share units. Number of stock issued for exercise of options. Value of stock issued for exercise of options. Share Capital Issuance Description. Recapitalization of equity. Number of stock units issued for regulation financing. Vital Intelligence Inc [Member] Number of stock units issued for acquisition. Shares issued for debt settlement. Shares issued of settlement trades payable. Number of stock issued for private placement Value of stock issued for private placement. Shares issued of settlement convertible debentures and accrued interest. Reclassification of unexercised conversion feature. Common Stock 1 [Member] Common Stock 2 [Member] Disclosure of Prepaid Expenses. Shares and warrants issued on private placement. Disclosure of prepaid expenses and deposits explanatory Share consolidation to equity method. Profit loss exclude investment loss. Current insurance expenses. Current prepaid director fees. Current prepaid interest. Current prepaid marketing services. Current prepaid rent. Current prepaid subscriptions. Current deposits. Shares issued for exercise of warrants, shares. Shares issued for settlement of notes payable, shares Shares issued as transactions fees, shares. Recapitalization of equity, shares Shares issued of settlement trades payable, shares Shares issued of settlement convertible debentures and accrued interest, shares. Number of shares purchased. Common Stock 3 [Member] Number of shares purchased, value. Shares and warrants issued on private placement, shares. Warrant exercise price. Common Stock 4 [Member] Warrants expiration date. Common Stock 5 [Member] Common Stock 6 [Member] Common Stock 7 [Member] Dronelogics Inc [Member] Stock units issued during period shares common shares finder fees. Shares issued for acquisition. Shares issued for financing. Shares issued for exercise of restricted stock units. Common Stock 8 [Member] Common Stock 9 [Member] Shares issued as finders fees, shares. Shares issued for debt settlement, shares. Shares issued for financing, shares Stock issued during period shares cash proceeds. Shares issued for exercise of restricted stock units, shares. Stock issued during period value cash proceeds. Shares issued for acquisition, shares Stock issued during period shares debt settlement. Shares issued for exercise of stock options. Shares issued for financing, share issue costs. Shares issued in lieu of cash. Shares issued for financing one. Shares issued for financing, share issue costs one. Shares issued for exercise of warrants one. Shares issued for exercise of restricted stock units. Shares issued for exercise of stock options. Shares issued in lieu of cash. Unrealized loss on investments available for sale. Shares issued for exercise of stock options, shares. Shares issued in lieu of cash, shares. Shares issued for exercise of warrants, shares one. Shares issued for exercise of restricted stock units, shares Debt settlement comprehensive loss. Shares issued in lieu of cash, shares. Shares issued for financing, shares. Common Stock 10 [Member] Common Stock 11 [Member] Shares issued for financing share issue costs. Common Stock 12 [Member] Common Stock 13 [Member] Furniture and Equipment [Member] Comprehensive loss. Change in fair value of derivative liability. Finance and other costs. Gain on settlement of debt. Gain on disposal of assets. Income from government assistance. Gain loss on disposal of assets. Income expense from government assistance. Expense of non-financial asset. Shares issued as acquisition cost. Accumulated depreciation. Changes in items of working capital [Abstract] Adjustments for increase decrease in trade account receivable. Adjustments for increase decrease in inventories. Adjustments for increase decrease in prepaid expenses. Adjustments for increase decrease in right of use asset. Increase decrease in deferred income. Adjustments for decrease increase in loans. Adjustments for decrease increase in lease liabilities. Adjustments for increase decrease in tax accrual. Payments for acquisition. Proceeds from revaluation of equipment Proceeds from disposal of equipment. Payments for development of intellectual property. Payments for investments. Payments for issuance of notes receivable. Proceeds from issuance of common shares for financing. Proceed from issuance of common stock. Proceeds from issuance of common shares for debt settlement. Proceeds from issuance ofCommon shares in lieu of cash. Proceeds from issuance of common shares for warrants exercised. Proceeds from issuance of common shares for stock options exercised. Proceeds from issuance of loans. Proceeds from issuance of notes payable. Repayment of loans. Repayment of notes payable. Repayment of lease liability. Restricted Stock Units [Member] Cash And Cash Equivalent [Abstract] Cash held in banks. Cash and cash guaranteed investment certificate. Cash and cash equivalents. Disclosure of warrant derivative liability explanatory. Current Investments. Disclosure of investment explanatory Warrants [Member] Cash flow from used in operating activities. Intangible assets other-than goodwill gross. Accumulated Amortization. Disclosure of measurement inputs and validation techniques explanatory. Customer Relationship [Member] Brand and Software [Member] Intangible Assets Including Goodwill. Dronelogics [Member] Brand [Member] Vital [Member] Payments to acquire assets. Adjustments for increase decrease in trade account payables. Patent [Member] Disclosure of nature and continuance of operations explanatory. Post Consolidation [Member] Dragonfly Innovations Inc [Member] Draganfly Innovations USA, Inc. [Member] Dronelogics Systems Inc [Member] Draganfly Innovations Inc [Member] Draganfly Innovations USA Inc [Member] Vital and Dronelogics [Member] Description of accounting policy for statement of compliance explanatory. Description of accounting policy for basis of consolidation explanatory. Description of accounting policy for significant estimates and assumptions explanatory. Description of accounting policy restricted share units explanatory Percentage of weighted average revenue growth rate earnings before interest taxes depreciation and amortization. Description of accounting policy for cost of goods sold explanatory Percentage of weighted average cost of capital. Depreciation Percentage. Depreciation description. Disclosure of detailed information about of right of use assets Right of use assets leases acquired in acquisition. Right of use assets lease removal. Right of use Assets Accumulated Amortization. Accumulated amortization historical correction. Stock Options [Member] Write off asset percent. Disclosure of acquisitions explanatory [Text Block] Disclosure of purchase price allocation explanatory table text block Number of shares of draganfly. Common shares fair value. Common shares fair value amount. Present fair value of shares. Cash portion of purchase price. Total purchase price allocation. Accounts receivable recognised as of acquisition date. Prepaids and deposits recognised as of acquisition date. Other current assets recognised as of acquisition date Capital assets recognised as of acquisition date. Right of use assets recognised as of acquisition date. Accounts payable and accrued liabilities recognised as of acquisition date. Customer deposits recognised as of acquisition date. Loans recognised as of acquisition date. Other current liabilities recognised as of acquisition date. Lease liabilities recognised as of acquisition date. Total tangible assets recognised as of acquisition date. Depreciation Lease Liability. Disclosure of detailed information about operating lease liabilities Acquisition date fair value of total consideration cash transferred. Leases acquired in the acquisition. Acquisition date shares transferred. Additions lease liabilities. Historical correction. Advisors Fees Expense. Advisiors fees paid in value of shares. Advisory Fees Expenses Paid in Shares. Lease removal. Advisry fees expenses value per share. Advisors fees paid in cash. Employee [Member] First Anniversary [Member] Certain Directors and Officers [Member] Attribution rate percentage. Discount rate. Royalty Percentage. Royalty discount percentage. Disclosure of Vital Intelligence Acquisition [Text Block] Schedule of Purchase Price Allocation for Vital Intelligence. Asset Purchase Agreement [Member] Disclosure of trader payables and accrued liabilities explanatory Warrant exercise price per share. Warrant expiration term. Escrow deposit units. Description for Number of Shares Issued. Final payment. Stock issued during period value units, shares. Escrow Agreement One [Member] Escrow Agreement Two [Member] Stock issued during period value units. Escrow Agreement Three [Member] Escrow Agreement Four [Member] Disclosure of customer deposits explanatory. Software [Member] Schedule of deferred income explanatory [Table Text Block] Customers [Member] Government [Member] Note Receivable Accretion [Member] Discount for inventory not received. Identifiable intangible assets brand. Identifiable intangible assets software. Reduction for inventory not received. Disclosure of Cash and Cash Equivalents. Purchase of financial instruments. Guaranteed Investment Certificate [Member] Financial Instrument Term. Average effective instrument rate. Renewed of financial instruments. Renewed financial instrument term. Renewed effective instrument rate. Disclosure Of AmountsReceivable [Text Block] Stock options grant date. Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Disclosure Of Inventories Information Explanatory [Text Block] Goods and services tax receivable. Scientific research and experimental development receivable. Exercise Price Four [Member] Exercise Price Five [Member] Exercise Price Six [Member] Exercise Price Seven [Member] Exercise Price Eight [Member] Exercise Price Nine [Member] Exercise Price Ten [Member] Exercise Price Eleven [Member] Expiry date for stock options. Inventory. Consulting and Services. Other. Inventory [Member] Compensation warrants issued date. Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] Warrant Six [Member] Warrant expiry date. Compensation warrants, exercise price. Compensation warrants number of warrants. Weighted average remaining contractual life of exercisable share options. Consultant [Member] Disclosure of class of equipment explanatory. Common Shares [Member] Warrants Exercise Price Private Placements [Member] Common Shares One [Member] Employees and Consultant [Member] Employee One [Member] Employee Two [Member] Consultant One [Member] Disclosure of detailed information about income tax [text block] Expected life of options. Restricted Stock Units Rsu [Member] Number of instruments other equity instruments exercised. Number of instruments other equity instruments issued. Subscription receivable. Change in fair value of warrants outstanding. Disclosure of canadian emergency wage subsidy disclosure explanatory [text block] Tax effect of differences between prior year provision and final tax return. Tax effect of adjustments to prior years provision versus statutory tax returns. Range 1 [member] Range 2 [member] Range 3 [member] Range 4 [member] Range 5 [member] Disclosure of detailed information about deferred taxes explanatory [text block] Warrants issuance date. Deferred tax assets share issuance costs. Deferred tax assets non-capital losses. Canada Emergency Wage Subsidy [member] Deferred tax assets property and equipment. Deferred tax assets intangible assets. Deferred tax assets scientific research and experimental development. Canada Emergency Rent Subsidy [Member] Deferred tax assets deferred income tax not recognized. Hardest Hit Business Recovery Program [Member] Current warrants fair value. Disclosure of number and weighted average exercise prices of restricted stock units explanatory [member] Disclosure of measurement inputs and validation techniques for warrants explanatory [text block] Disclosure of number and weighted average exercise prices of warrants explanatory [member] Amount of investment sold. Disclosure of sharebased payment arrangements options outstanding and exercisable explanatory [text block] Disclosure of Measurement Inputs and Validation Techniques for Weighted Average Assumptions Explanatory [text block] Disclosure of Number and Weighted Average Exercise Prices of Warrants and Their Fair Values Explanatory [text block] Disclosure of Change in Warrants Explanatory [text block] Disclosure of Sharebased Payment Arrangements for Warrants Outstanding Explanatory [text block] Disclosure of other and miscellaneous explanatory [text block] Compliance fees. Contract work. Number of other equity instruments vesting in share-based payment arrangement. Number of share options granted post consolidation in share-based payment arrangement. Employee and Consultant [Member] Warrants Expiration Date Description Product Sales [member] Drone Service [member] Custom Engineering Services [member] Agreement [Axis] Business Service Agreement [Member] Business Instincts Group [Member] Operating Segment [member] Consultant Agreement [Member] Alberta Ltd [Member] Executive Agreement [Member] Scott Larson [Member] Director fees expense. Service Revenue. Salary and wages. CEO and Director [Member] President and Director [Member] Former Director [Member] Former Owner [Member] Gai on settlement of debt International [member] Canada [member] United States [member] Canada Country [member] United States Country [member] CA Country [member] US Country [member] Disclosure of notes receivables explanatory [text block] Shares issued for exercise of stock options, shares. Description of accounting policy for business combinations versus asset acquisition explanatory. Description of other significant judgments explanatory. First and Second Anniversary [Member] Number of share purchased. Description of accounting policy measuring inventories Accumulated depreciation property, plant and equipment. Accumulated amortization intellectual properties and goodwill. Loans forgivable amount. Regulation A+ financing [Member] Debt settlement amount. Stock issued during period shares debt settlements. Convertible Debentures [member] Deferred income liabilities. Debt Conversion Amount. Second Note [Member] Initial Note [Member] Exercise price of Warrants. Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)] Loss on write-off of notes receivable. Description of other significant judgments explanatory. Stock issued during period at fair value units shares. Dividend Yield, Measurement Input [Member]. Disclosure of structured entities financial information [TableTextBlock]. Disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. Proceeds from issuance of subscription receipts. Price per subscription receipts. subscription receipts. Shopify Loan [Member] Stock units issued during period value regulation financing. Shares issued of settlement trades payable per share. Proceeds from exercise of warrants shares. Gain loss on settlements of debt. Shares issued of settlement convertible debentures. Number of instruments other equity instruments vested. Change in fair value of warrant outstanding. Shares issued for exercise of warrants of derivatives. Change in fair value of warrant of derivatives outstanding. Shares issued for exercise of broker warrants of derivatives. Gains losses on change in fair value of derivative. Services [Member] Change in fair value of equity investments comprehensive income Current financial assets at fair value through profit or loss of equity. Current financial assets at fair value through profit or loss of warrants. Loss for adjustments. Lease implicit interest. Warrants issued. Warrants held in escrow. Notes receivable. shares held in escrow. Public Company Shares [Member] Public Company Warrants [Member] Private Company Shares [Member] Share issue costs. Capital gain reserve. Loans written down. Fair value of contingent consideration. Changes in fair value of contingent consideration. Contingent consideration. Warrants. Fair value, notes receivable. Fair value, derivative liability. Contingent consideration [table text block] CEBA [Member] [Default Label] Current assets NotesReceivableNonCurrent Current liabilities DeferredIncomeLiabilitiesNoncurrent NonCurrentLoansPayable Equity and liabilities Gross profit Operating expense FinanceCost LossOnWriteOffOfLoanReceivable LossOnWriteoffOfNotesReceivable Comprehensive income Equity [Default Label] Number of shares outstanding Shares issued for exercise of RSUs, shares Increase (decrease) through share-based payment transactions, equity Share issue related cost Shares issued for exercise of stock options, shares Shares issued in lieu of cash, shares Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income Loss for adjustments Adjustments for amortisation expense Adjustments for depreciation expense ChangeInFairValueOfDerivativeLiability GainOnSettlementOfDebt GainLossOnDisposalOfAssets IncomeExpenseFromGovernmentAssistance SharesIssuedAsAcquisitionCost SharebasedPayments Adjustments to reconcile profit (loss) Adjustments for increase decrease in trade account receivable Adjustments for increase decrease in inventories Adjustments for increase decrease in prepaid expenses Adjustments for increase (decrease) in trade accounts payable Adjustments for increase (decrease) in deposits from customers IncreaseDecreaseInDeferredIncome CashFlowFromUsedInOperatingActivities PaymentsForAcquisition Purchase of property, plant and equipment, classified as investing activities PaymentsForInvestments PaymentsForIssuanceOfNotesReceivable Cash flows from (used in) investing activities Payments for share issue costs Repayments of non-current borrowings Repayments of bonds, notes and debentures RepaymentOfNotesPayable Repayment of loans RepaymentOfLeaseLiability Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Disclosure of revenue [text block] Description of accounting policy for measuring inventories [text block] Description of accounting policy for share-based payment transactions [text block] DescriptionOfAccountingPolicyMeasuringInventories Description of accounting policy for property, plant and equipment [text block] Description of accounting policy for government grants [text block] Inventory recognised as of acquisition date AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate CustomerDepositsRecognisedAsOfAcquisitionDate LoansRecognisedAsOfAcquisitionDate OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate LeaseLiabilitiesRecognisedAsOfAcquisitionDate Identifiable intangible assets recognised as of acquisition date Goodwill recognised as of acquisition date AcquisitiondateFairValuesOfTotalConsiderationTransferred ChangeInFairValueOfContingentConsideration NumberOfSharesOfStructuredEntity FairValueOfSharesOfStructuredEntity Cash [Default Label] Non-current trade receivables Current accrued expenses and other current liabilities Subscription receivable [Default Label] Balances with banks CashAndCashEquivalentsCarryingValue Trade and other receivables Inventory [Default Label] Impairment loss CurrentInsuranceExpenses CurrentInvestments1 Losses on change in fair value of derivatives PropertyPlantAndEquipmentCost AccumulateddepreciationPropertyPlantAndEquipment IntangibleAssetsOtherThanGoodwillGross AccumulatedAmortizationIntellectualPropertiesAndGoodwill Other intangible assets Right-of-use assets, revalued assets, at cost Additions to right-of-use assets RightofuseAssetsAccumulatedAmortization Depreciation, right-of-use assets LeasesAcquiredInAcquisition Payments of lease liabilities, classified as financing activities AdditionsLeaseLiabilities LeaseRemoval LoansPayableAmount BorrowingsMaturityStartDay Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options forfeited in share-based payment arrangement Number of share options exercised in share-based payment arrangement Number of instruments other equity instruments vested Number of other equity instruments forfeited in share-based payment arrangement Gains losses on change in fair value of derivative Warrants NumberOfInstrumentsOtherEquityInstrumentsExercised CompensationWarrantsExercisePrice Other expense, by function Miscellaneous other operating expense DirectorFeesExpense Key management personnel compensation, share-based payment Key management personnel compensation CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability Current financial assets at fair value through profit or loss Tax effect of expense not deductible in determining taxable profit (tax loss) Deferred tax assets Net deferred tax assets EX-101.PRE 44 dpro-20211231_pre.xml XBRL PRESENTATION FILE XML 45 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
12 Months Ended
Dec. 31, 2021
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2021
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2021
Current Fiscal Year End Date --12-31
Entity File Number 001-40688
Entity Registrant Name Draganfly Inc.
Entity Central Index Key 0001786286
Entity Incorporation, State or Country Code Z4
Entity Address, Address Line One 2108 St. George Avenue
Entity Address, City or Town Saskatoon
Entity Address, State or Province SK
Entity Address, Country CA
Entity Address, Postal Zip Code S7M 0K7
Title of 12(b) Security Common Shares
Trading Symbol DPRO
Security Exchange Name NASDAQ
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Bankruptcy Proceedings, Reporting Current false
Entity Common Stock, Shares Outstanding 33,197,984
Auditor Firm ID 1173
Auditor Name DALE MATHESON CARR-HILTON LABONTE LLP
Auditor Location Vancouver, Canada
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 2108 St. George Avenue
Entity Address, City or Town Saskatoon
Entity Address, State or Province SK
Entity Address, Country CA
Entity Address, Postal Zip Code S7M 0K7
City Area Code 800
Local Phone Number 979.9794
Contact Personnel Name Paul Sun
Contact Personnel Email Address paul.sun@draganfly.com

XML 46 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Financial Position - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 23,075,713 $ 1,982,416
Receivables 1,407,127 810,791
Inventory 3,390,822 1,233,619
Notes receivable 190,170
Prepaids 5,494,877 335,022
 Total current assets 33,558,709 4,361,848
Non-current Assets    
Goodwill 5,940,409 2,166,563
Equipment 297,043 153,870
Intangible assets 593,901 273,867
Investments 291,066
Notes receivable 964,006
Right of use asset 468,106 144,419
TOTAL ASSETS 42,113,240 7,100,567
Current Liabilities    
Trade payables and accrued liabilities 799,139 1,857,177
Customer deposits 172,134 385,449
Deferred income 73,286
Loans payable 6,745 62,978
Derivative liability 5,560,002 748,634
Lease liability 110,481 93,239
 Total current liabilities 6,721,787 3,147,477
Non-current Liabilities    
Deferred income 5,062
Loans payable 86,572 34,938
Lease liability 378,642 64,885
TOTAL LIABILITIES 7,187,001 3,252,362
SHAREHOLDERS’ EQUITY    
Share capital 81,038,365 36,943,304
Reserves – share-based payments 6,406,117 3,024,007
Accumulated deficit (52,322,182) (36,119,210)
Accumulated other comprehensive income (loss) (196,061) 104
TOTAL SHAREHOLDERS’ EQUITY 34,926,239 3,848,205
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 42,113,240 $ 7,100,567
XML 47 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Comprehensive Income (Loss) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
REVENUE      
Revenue from sales of goods $ 5,103,399 $ 3,087,223 $ 248,939
Revenue from provision of services 1,950,466 1,276,288 1,131,488
TOTAL REVENUE 7,053,865 4,363,511 1,380,427
COST OF SALES (4,410,777) (2,603,911) (218,800)
GROSS PROFIT 2,643,088 1,759,600 1,161,627
OPERATING EXPENSES      
Amortization 135,966 43,518 8,386
Depreciation 175,098 109,108 41,250
Director fees 370,094
Insurance 2,962,767 39,988 23,900
Office and miscellaneous 6,455,998 3,387,865 2,103,732
Professional fees 4,445,949 1,762,594 524,101
Research and development 510,895 567,999 16,883
Share-based payments 3,952,595 2,668,464 761,559
Travel 143,904 25,617 30,896
Wages and salaries 2,768,010 1,649,329 989,083
 Total operating expenses (21,921,276) (10,254,482) (4,499,790)
OTHER INCOME (EXPENSE)      
Change in fair value of derivative liability 8,149,812 (748,634)
Finance and other costs 5,074 (23,117) (171,905)
Foreign exchange gain (loss) 362,448 (87,104) 5,803
Gain on disposal of assets 28,651
Gain (loss) on settlement of debt (38,879) 198,976
Gain on forgiveness of debt 127,711
Government income 24,148 51,627
Listing expense (7,804,859)
Loss on write-off of loan receivable (13,560)
Loss on write-off of notes receivable (891,471)
Loss on impairment of goodwill (4,579,763)
Other income (loss) 4,968 1,197,465
NET LOSS (16,202,972) (8,015,813) (11,095,057)
Items that may be reclassified to profit or loss      
Foreign exchange translation 136,475 104
Items that will not be reclassified to profit or loss      
Change in fair value of equity investments at FVOCI (332,640)
COMPREHENSIVE LOSS $ (16,399,137) $ (8,015,709) $ (11,095,057)
Net loss per share      
Basic & diluted $ (0.59) $ (0.48) $ (1.16)
Weighted average number of common shares outstanding - basic & diluted 27,647,293 16,558,184 9,529,595
XML 48 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Shareholders' Equity - CAD ($)
Issued capital [member]
Capital reserve [member]
Retained earnings [member]
Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member]
Accumulated other comprehensive income [member]
Total
Balance at Dec. 31, 2018 $ 12,561,342 $ 882,180 $ (17,576,131) $ (4,132,609)
Beginning balance, shares at Dec. 31, 2018 7,869,384          
IfrsStatementLineItems [Line Items]            
Shares issued for settlement of notes payable $ 645,775 645,775
Shares issued for settlement of notes payable, shares 258,310          
Shares issued as transactions fees $ 1,000,000 1,000,000
Shares issued as transactions fees, shares 400,000          
Recapitalization of Draganfly Inc. $ 5,250,001 1,645,193 6,895,194
Recapitalization of Draganfly Inc., shares 2,100,000          
Shares issued of settlement of trades payable $ 22,662 $ 22,662
Shares issued of settlement of trades payable, shares 9,065         9,065
Shares issued for settlement of convertible debentures and accrued interest $ 1,059,246 $ 1,059,246
Shares issued for settlement of convertible debentures and accrued interest, shares 423,698         423,698
Shares issued for exercise of warrants $ 221,741 (212,908) $ 8,833
Shares issued for exercise of warrants, shares 63,388          
Reclassification of unexercised conversion feature (567,791) 567,791
Shares and warrants issued on private placement $ 7,025,750 7,025,750
Shares and warrants issued on private placement, shares 2,810,300          
Stock-based compensation 761,559 761,559
Net loss (11,095,057) (11,095,057)
Translation of foreign operations          
Balance at Dec. 31, 2019 $ 27,786,517 2,508,233 (28,103,397) 2,191,353
Beginning balance, shares at Dec. 31, 2019 13,934,145          
IfrsStatementLineItems [Line Items]            
Shares issued for exercise of warrants $ 4,007,130 (1,645,193) 2,361,937
Shares issued for exercise of warrants, shares 1,584,775          
Net loss (8,015,813) (8,015,813)
Shares issued for acquisition $ 2,178,961 2,178,961
Beginning balance, shares 645,088          
Shares issued as finder’s fees $ 100,000 100,000
Shares issued as finder's fees, shares 40,000          
Shares issued for debt settlement $ 344,354 344,354
Shares issued for debt settlement, shares 111,082          
Shares issued for financing $ 2,018,845 2,018,845
Shares issued for financing, shares 703,607          
Shares issued for exercise of RSUs $ 507,497 (507,497)
Beginning balance, shares 199,998          
Share-based payments 2,668,464 2,668,464
Translation of foreign operations 104 104
Balance at Dec. 31, 2020 $ 36,943,304 3,024,007 (36,119,210) 104 3,848,205
Beginning balance, shares at Dec. 31, 2020 17,218,695          
IfrsStatementLineItems [Line Items]            
Net loss (16,202,972) (16,202,972)
Shares issued for acquisition $ 2,303,999 1,241,250 3,545,249
Beginning balance, shares 1,200,000          
Shares issued for financing $ 36,092,187 36,092,187
Shares issued for financing, shares 11,584,657          
Shares issued for exercise of RSUs $ 1,752,052 (1,752,052)
Beginning balance, shares 448,660          
Share-based payments 3,952,595 3,952,595
Translation of foreign operations 136,475 136,475
Share issue costs (4,678,821) 864,060 (3,814,761)
Shares issued for exercise of warrants $ 4,929,790 4,929,790
Shares isued for exercise of warrants, shares 1,939,534          
Shares issued for exercise of stock options $ 1,937,866 (923,743) 1,014,123
Beginning balance, shares 405,499          
Shares issued in lieu of cash $ 1,757,988 1,757,988
Beginning balance, shares 371,901          
Change in fair value of equity investments at FVOCI (332,640) (332,640)
Balance at Dec. 31, 2021 $ 81,038,365 $ 6,406,117 $ (52,322,182) $ (332,640) $ 136,579 $ 34,926,239
Beginning balance, shares at Dec. 31, 2021 33,168,946          
XML 49 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
OPERATING ACTIVITIES      
Net loss $ (16,202,972) $ (8,015,813) $ (11,095,057)
Adjustments for:      
Amortization 135,966 43,518 8,386
Depreciation 175,098 109,108 41,250
Change in fair value of derivative liability (8,149,812) 748,634
Impairment of notes receivable 891,471
Impairment of goodwill 4,579,763
Finance and other costs (926) 23,117 171,905
Gain on settlement of debt 38,879 (198,976)
Gain on forgiveness of debt (127,711)
Gain on disposal of assets (28,651)
Income from government assistance (24,148) (21,090)
Expense of non-financial asset 15,389
Listing expense 7,804,859
Shares Issued as acquisition cost 100,000
Share-based payments 3,952,595 2,568,464 761,559
 Adjustment for profit loss (14,642,965) (4,532,894) (2,519,336)
Net changes in non-cash working capital items:      
Receivables (596,336) (1,481,944) (126,799)
Inventory (2,157,203) (555,371) 12,622
Prepaids (3,401,868) 31,605 (249,325)
Trade payables and accrued liabilities (1,044,133) 1,261,066 (1,005,121)
Customer deposits (213,315) 139,490
Deferred income 51,186 5,062
Funds used in operating activities (22,004,634) (5,132,986) (3,887,959)
INVESTING ACTIVITIES      
Cash paid for acquisition, net of cash received (466,643) (457,407) 28,538
Purchase of equipment (212,579) (23,888) (87,785)
Disposal of equipment 31,500
Purchase of investments (623,706)
Issuance of notes receivable (2,002,678)
Proceeds from sales of investments 997,714
Funds provided by (used in) investing activities (3,305,606) 516,419 (27,747)
FINANCING ACTIVITIES      
Proceeds from issuance of common shares for financing 44,255,651 2,018,845 6,534,583
Share issue costs (3,814,762)
Proceeds from issuance of common shares for warrants exercised 4,929,790 2,361,937
Proceeds from issuance of common shares for stock options exercised 1,014,123
Proceeds from issuance of loans 60,000 129,310
Loans repayments (4,319) (5,062)
Proceeds from issuance of notes payable 123,000 1,137,978
Repayment of convertible debentures (486,131)
Repayment of notes payable (183,000) (882,770)
Repayment of loans (44,428) (192,084)
Repayment of lease liability (128,996) (83,442) (38,000)
Funds provided by financing activities 46,267,059 4,169,504 6,265,660
Effects of exchange rate changes on cash 136,478 104 (22,366)
Change in cash 20,956,819 (447,063) 2,349,954
Cash, beginning of year 1,982,416 2,429,375 101,787
Cash, end of year 23,075,713 1,982,416 2,429,375
Cash and cash equivalents consist of the following:      
Cash held in banks 22,729,212 1,839,871 2,429,375
Guaranteed investment certificate 346,501 142,545
 Cash and cash equivalents $ 23,075,713 $ 1,982,416 $ 2,429,375
XML 50 R6.htm IDEA: XBRL DOCUMENT v3.22.1
NATURE AND CONTINUANCE OF OPERATIONS
12 Months Ended
Dec. 31, 2021
Nature And Continuance Of Operations  
NATURE AND CONTINUANCE OF OPERATIONS

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company’s shares trade on the Canadian Securities Exchange (the “CSE”),” on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

COVID-19

 

The outbreak of the coronavirus, also known as “COVID-19,” spread across the globe and is ‎impacting worldwide economic activity. Government authorities have implemented emergency ‎measures to mitigate the spread of the virus. These measures, which include the ‎implementation of travel bans, self-imposed quarantine periods, and social distancing, have ‎caused material disruption to business globally. ‎Governments and central banks reacted with significant monetary and fiscal interventions ‎designed to stabilize economic conditions.‎

‎ ‎

The Company will continue to monitor the impact of the COVID-19 pandemic, the duration and ‎impact of which is unknown at this time which may include further disruptions to global supply chains and the manufacturing and delivery of parts that the Company relies on for its products. Although it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the ‎Company and its operations in future periods, such impacts are not expected to be ‎significant going forward. Aside from the acquisition of Dronelogics and being opportunistic ‎on ‎other partnerships or acquisitions, the Company has expanded its products and services offered ‎to include ‎health and telehealth applications relating to COVID-19, as a way to mitigate the ‎effects of COVID-19.

 

Share consolidation

 

During the year ended December 31, 2021 in conjunction with its Regulation A financing, the Company underwent a share consolidation at a 5-1 ratio. All reference to share, per share amounts, warrants, RSU’s and stock options in these financial statements have been retroactively restated to reflect the consolidation.

XML 51 R7.htm IDEA: XBRL DOCUMENT v3.22.1
BASIS OF PREPARATION
12 Months Ended
Dec. 31, 2021
BASIS OF PREPARATION

2. BASIS OF PREPARATION

 

Statement of Compliance

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

 

These consolidated financial statements were authorized for issue by the Board of Directors on April 3, 2022.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.

 

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary 

Place of Incorporation

 

Ownership Interest

 
Draganfly Innovations Inc.  Canada  100% 
Draganfly Innovations USA, Inc.  US  100% 
Dronelogics Systems Inc.  Canada  100% 

 

All intercompany balances and transactions were eliminated on consolidation.

 

Significant estimates and assumptions

 

The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.

 

Impairment of Non-financial assets

 

The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell calculations. In calculating the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the calculation of the recoverable amount.

 

Share-based payments

 

The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Income taxes

 

Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.

 

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices.

 

Contingencies

 

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

 

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

 

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

 

Business combinations

 

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Business combination versus asset acquisition

 

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to the Acquisitions (Notes 3, 4, and 5). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

 

Other significant judgments

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
the classification of financial instruments;
the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;
the determination of whether a set of assets acquired and liabilities assumed constitute a business; and
the determination of the functional currency of the company.

 

Foreign currency translation

 

Transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.

 

The functional currencies for the parent company and each subsidiary are as follows:

 

Draganfly Inc. Canadian Dollar
Draganfly Innovations Inc. Canadian Dollar
Draganfly Innovations USA, Inc. US Dollar
Dronelogics Systems Inc. Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in other comprehensive income.

 

Share-based payments

 

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

 

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

 

Restricted Share Units

 

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. RSUs are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

 

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income.

 

There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Impairment of non-financial assets

 

The carrying amounts of the Company’s non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life;
an intangible asset not yet available for use; and
goodwill recognized in a business combination.

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in the statement of comprehensive loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

 

Income taxes

 

Current income tax:

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax:

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Inventory

 

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

 

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

 

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

 

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

 

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

 

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Class of equipment  Depreciation rate 
Computer equipment  30% 
Furniture and equipment  20% 
Leasehold improvements  Over expected life of lease 
Software  30% 
Vehicles  30% 

 

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

 

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

 

SR&ED Investment tax credits

 

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

 

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

XML 52 R8.htm IDEA: XBRL DOCUMENT v3.22.1
DRONELOGICS ACQUISITION
12 Months Ended
Dec. 31, 2021
DRONELOGICS ACQUISITION

3. DRONELOGICS ACQUISITION

 

On April 30, 2020, the Company acquired all of the issued and outstanding shares of Dronelogics Systems Inc. (“Dronelogics”), excluding the cinematography division, a leading drone reseller and services company based in Burnaby, BC. The purpose of the acquisition was to increase the Company’s scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work while adding immediate revenue to the business, for consideration of $500,000 cash and 645,088 common shares (the “Transaction”).

 

In connection with the Transaction, the Company paid fees of $160,000 to certain advisors consisting of $100,000 by way of 40,000 in shares at a price of $2.50 per share and $60,000 in cash. At closing, the Company (i) granted 89,000 incentive stock options to certain employees of Dronelogics pursuant to the Company’s share compensation plan, exercisable at a price equal to closing price of the shares on the CSE on January 31, 2020. The options have a term of 10 years and 14,000 vest in three equal tranches, on the grant date and first and second anniversaries of the date of grant while 70,000 vest on the first anniversary of the grant date, and (ii) awarded 75,000 RSUs to certain directors and officers of Dronelogics. RSUs were awarded to certain directors and officers of Dronelogics pursuant to the Company’s share compensation plan. The RSUs vest in three equal tranches, on the first, second and third anniversaries of the date of award.

 

The purchase price allocation (“PPA”) is as follows:

 

      
Number of shares of Draganfly Inc.   645,088 
Fair value of common shares  $4.15 
Fair value of shares of Draganfly Inc.  $2,178,960 
Cash portion of purchase price   500,000 
Total  $2,678,960 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

3. DRONELOGICS ACQUISITION (CONT’D)

 

Tangible assets acquired    
Cash  $42,593 
Accounts receivable   98,852 
Inventory   629,684 
Prepaids and deposits   93,997 
Other current assets   3,014 
Capital assets   54,946 
Right-of-use assets   83,428 
Accounts payable and accrued liabilities   (222,766)
Customer deposits   (245,959)
Loans   (245,752)
Other current liabilities   (8,437)
Lease liabilities   (87,203)
Total tangible assets acquired   196,397 
Identifiable intangible assets     
Customer relationships   197,000 
Website   119,000 
 Total identifiable intangible assets   316,000 
Goodwill   2,166,563 
Total consideration  $2,678,960 

 

The Company estimated the fair value as follows:

 

Customer relationships based on an income approach, specifically multi-period excess earnings method, by identifying key customers, applying attribution rate of 15% per annum and discount rate of 18% per annum; and
Website based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.5% and discount rate of 17% per annum.

 

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of the assembled workforce.

 

From the date of the acquisition to December 31, 2020, the acquired business contributed $4,086,350 of revenue and a net income of $434,528.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 53 R9.htm IDEA: XBRL DOCUMENT v3.22.1
VITAL INTELLIGENCE ACQUISITION
12 Months Ended
Dec. 31, 2021
Vital Intelligence Acquisition  
VITAL INTELLIGENCE ACQUISITION

4. VITAL INTELLIGENCE ACQUISITION

 

On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it to diversify its existing product line as well as recognized opportunities that an initial focus on COVID-19 screening set of technologies would most likely lead to other facets within the healthcare field creating revenue growth from a new vertical, for consideration of: (a) a cash payment of $500,000 and (b) ‎1,200,000 units of the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. The units were issued on March 22, 2021. On August 19, 2021 the parties agreed to reduce the final payment from $250,000 to $227,984 due to certain assets listed in the purchase agreement had not been delivered by Vital.

 

The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:

 

a)300,000 units shall be released on the closing date;
b)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $2,000,000;
c)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $4,000,000; and
d)300,000 units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $6,000,000.

 

Upon acquisition, the 900,000 shares held in escrow were classified as a derivative liability and were valued based upon:

 

A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and
Discounted due to the lack of liquidity.

 

On acquisition, the fair value of the derivative liability (note 20) was $4,797,717. At December 31, 2021, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $694,230, with the difference flowing through the consolidated statement of loss.

 

Contingent consideration     
Fair value of contingent consideration  $4,797,717 
Change in fair value of contingent consideration   (4,103,487)
Contingent consideration at December 31, 2021 (note 20)  $694,230 

 

The PPA is as follows:

 

Number of units of Draganfly Inc.   578,248 
Fair value of units  $14.43 
Fair value of units of Draganfly Inc.  $8,342,966 
Cash portion of purchase price   466,643 
Total  $8,809,609 

 

Identifiable intangible assets    
Brand  $23,000 
Software   433,000 
    456,000 
      
Goodwill   8,353,609 
Total consideration  $8,809,609 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

4.VITAL INTELLIGENCE ACQUISITION (CONT’D)

 

Significant estimates are as follows:

 

 Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.
Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 0.25% and discount rate of 14.4% per annum.
Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of 5.0% and discount rate of 14.4% per annum.

 

Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments.

 

From the date of the acquisition to December 31, 2021, Vital contributed $115,369 of revenue and a net loss of $203,231.

 

XML 54 R10.htm IDEA: XBRL DOCUMENT v3.22.1
AMALGAMATION
12 Months Ended
Dec. 31, 2021
AMALGAMATION

5. AMALGAMATION

 

On January 31, 2019, the Company and Draganfly Innovations entered into the BCA providing for a three-cornered amalgamation among the Company, Draganfly Innovations, and Merger Co. As of August 15, 2019, the Amalgamation closed and the Company acquired, on a one for 1.794 basis, all of the issued and outstanding Draganfly Innovations shares (the “Draganfly Innovations Shares”) in exchange for 8,527,671 common shares of the Company.

 

This resulted in a reverse take-over, of the Company, by the shareholders of Draganfly Innovations. At the time of the Amalgamation, the Company did not constitute a business as defined under IFRS 3; therefore, the Amalgamation is accounted under IFRS 2, where the difference between the consideration given to acquire the Company and the net asset value of the Company is recorded as a listing expense to net loss. As Draganfly Innovations is deemed to be the accounting acquirer for accounting purposes, these consolidated financial statements present the historical financial information of Draganfly Innovations up to the date of the Amalgamation.

 

      
Number of shares of Draganfly Inc.   2,100,000 
Fair value of common shares in concurrent financing  $2.50 
Fair value of shares of Draganfly Inc.  $5,250,001 
Fair value of warrants   1,645,193 
Fair value of shares issued for transaction fees   1,000,000 
Net assets acquired  $(90,335)
Listing expense  $7,804,859 

 

Fair value of the Company acquired, net of liabilities    
Cash  $28,538 
Accounts receivable   4,991 
Loans receivable   963,269 
Accounts payable and accrued liabilities   (406,463)
Subscription receipts   (500,000)
Net of liabilities  $90,335 

 

The fair value of 10,500,001 issued common shares of the Company was estimated to be $2.50 per share using the price of a subscription receipts financing that was completed concurrently.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

5. AMALGAMATION (CONT’D)

 

Prior to the closing of the Amalgamation, Draganfly Innovations issued 222,965 common shares with a value of $1,000,000 as transaction fees for the Amalgamation to related parties.

 

The Company assumed 800,000 share purchase warrants exercisable at a price of $0.50 per share expiring on February 4, 2021. The fair value of share-purchase warrants was $1,645,193, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

Risk-free interest rate   0.86%
Estimate life   1.48 years 
Expected volatility   100%
Expected dividend yield   0%

 

As at August 15, 2019, the Company received $7,025,750 in proceeds to issue subscription receipts (the “Subscription Receipts”) at a price of $2.50 per Subscription Receipt. Each Subscription Receipt was automatically converted, without payment of additional consideration and without any further action on the part of the holder, into one unit of the Company (a “Unit”) on completion of the Amalgamation and the Company becoming reporting issuer in the Province of Saskatchewan and obtaining conditional approval of a listing of the common shares on the CSE (the “Transaction”). Each Unit consists of one common share and one warrant. Each warrant will entitle the holder to purchase one common share at a price of $2.50 for a period of 12 months following the issuance of warrants. The proceeds of the private placement were released to the Company on November 5, 2019.

 

XML 55 R11.htm IDEA: XBRL DOCUMENT v3.22.1
CASH AND CASH EQUIVALENTS
12 Months Ended
Dec. 31, 2021
CASH AND CASH EQUIVALENTS

6. CASH AND CASH EQUIVALENTS

 

   December 31, 2021   December 31, 2020 
Cash held in banks  $22,729,212   $1,839,871 
Guaranteed investment certificates   346,501    142,545 
Cash and Cash Equivalents  $23,075,713   $1,982,416 

 

On March 27, 2020, the Company purchased a $142,000 guaranteed investment certificate (“GIC”) to secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.50% per annum. On March 27, 2021 the company renewed the GIC for $142,710 for 1 year at a rate of 0.10% per annum.

 

On May 28, 2021, the Company purchased an additional $140,000 GIC to further secure its credit cards. The terms of the GIC are for 1 year at a rate of 0.35% per annum.

 

On December 21, 2021, the Company purchased an additional $50,000 USD GIC to further secure its credit cards. The terms of the GIC are for 1 year at 0.05% per annum.

 

All GIC’s must be maintained and renewed upon maturity until such time as the associated credit cards are cancelled.

 

XML 56 R12.htm IDEA: XBRL DOCUMENT v3.22.1
RECEIVABLES
12 Months Ended
Dec. 31, 2021
Schedule Of Amounts Receivable  
RECEIVABLES

7. RECEIVABLES

 

   December 31, 2021   December 31, 2020 
Trade accounts receivable  $951,314   $780,254 
Corporate taxes receivable   

182,820

    

-

 
GST receivable   272,993   $- 
SR&ED receivable   -    30,537 
Trade and other receivables  $1,407,127   $810,791 

 

XML 57 R13.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORY
12 Months Ended
Dec. 31, 2021
INVENTORY

8. INVENTORY

 

   December 31, 2021   December 31, 2020    December 31, 2019  
Finished goods  $3,017,363   $1,155,871    $ -  
Parts   373,459    77,748      48,653  
Inventories   $3,390,822   $1,233,619    $ 48,653  

 

During the year ended December 31, 2021, $3,420,713 (2020: $2,257,797 2019: $118,826) of inventory was sold and recognized in cost of sales. During the year ended December 31, 2021, the Company recorded an allowance to value its inventory for obsolete and slow-moving inventory, recognizing an expense in cost of sales of $nil (2020: $23,955, 2019: $nil).

 

  December 31, 2021   December 31, 2020    December 31, 2019  
Inventory  $3,420,713   $2,257,797    $ 118,626  
Consulting and services   679,345    164,119      86,280  
Other   310,719    181,995     

13,894

 
Cost of sales   $4,410,777   $2,603,911    $ 218,800  

 

XML 58 R14.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES RECEIVABLE
12 Months Ended
Dec. 31, 2021
Notes Receivable  
NOTES RECEIVABLE

9. NOTES RECEIVABLE

 

   Start Date  Maturity Date  Rate   Principal   Interest   Accretion 

Impairment

  Total  
Note 1(1)  2021-04-21  2022-10-21   0%  $180,597   $-   $9,573  $- $ 190,170  
Note 2(1)  2021-06-01  2023-06-01   8%   114,833    5,378    -   (120,211)    -  
Note 3(1)  2021-09-22  2024-09-22   5%   943,385    13,156    7,465   -    964,006  
Note 4  2021-11-17  2022-04-26   8%   750,000    21,260    -   (771,260   -  
Total             $1,988,815   $39,794   $17,038  $(891,471 $ 1,154,176  

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.

 

Note 1 is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this loan which was the investee’s most recent financing.

 

Note 2 bears interest at 8% and is secured by a general security agreement. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

 

Note 3 bears interest at 5%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this convertible loan which was the investee’s most recent financing.

 

Note 4 was issued pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at 8% and is due April 26, 2022. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $Nil.

 

XML 59 R15.htm IDEA: XBRL DOCUMENT v3.22.1
PREPAIDS
12 Months Ended
Dec. 31, 2021
PREPAIDS

10. PREPAIDS

 

   December 31, 2021   December 31, 2020 
Insurance  $2,938,246   $992 
Prepaid director fees   107,763    - 
Prepaid interest   6,969    - 
Prepaid marketing services   1,638,179    187,826 
Prepaid rent   -    3,583 
Prepaid subscriptions   35,687    5,953 
Deposits   768,033    136,668 
 Prepaid expenses and deposits  $5,494,877   $335,022 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 60 R16.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS
12 Months Ended
Dec. 31, 2021
Disclosure Investments Abstract  
INVESTMENTS

11. INVESTMENTS

 

         
Balance at December 31, 2020   $ -  
Investments     623,706  
Change in fair value     (332,640 )
Balance at December 31, 2021   $ 291,066  

 

Fair value of investments is comprised of:

  .  
      
Public company shares  $

142,857

 
Public company warrants   21,429 
Private company shares   126,780
Balance at December 31, 2021  $291,066 

 

On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $500,000. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expire on March 17, 2023.

 

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

   December 31, 2021   March 10, 2021 
Risk free interest rate   0.91%   0.28%
Expected volatility   124.09%   150.88%
Expected life   2 years    2 years 
Expected dividend yield   0%   0%

 

Volatility is calculated using the historical volatility method

 

On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. These assets have been recorded at the price of the company’s most recent private placement, and converted to Canadian dollars at the reporting date.

 

XML 61 R17.htm IDEA: XBRL DOCUMENT v3.22.1
EQUIPMENT
12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [abstract]  
EQUIPMENT

12. EQUIPMENT

 

 

  

Computer

Equipment

  

Furniture

and

Equipment

  

Leasehold

Improvements

   Software   Vehicles   Total 
Cost                              
Balance at January 1, 2020  $7,000   $142,173   $-   $29,967   $-   $179,140 
Additions   2,028    21,860    -    -    -    23,888 
Net assets acquired in the
Transaction
   15,369    7,573    4,352    -    27,652    54,946 
Balance at December 31, 2020  $24,397   $171,606   $4,352   $29,967   $27,652   $257,974 
Additions   29,713    170,866    -    -    12,000    212,579 
Revaluation   -    -    -    -    (3,619)   (3,619)
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
                               
Accumulated depreciation                              
Balance at January 1, 2020  $6,761   $37,944   $-   $19,294   $-   $63,999 
Charge for the year   5,631    22,019    3,220    3,202    6,033    40,105 
Balance at December 31, 2020  $12,392   $59,963   $3,220   $22,496   $6,033   $104,104 
Charge for the year   12,899    42,314    1,132    2,241    7,201    65,787 
Balance at December 31, 2021  $25,291   $

102,277

   $4,352   $24,737   $13,234   $169,891 
                               
Net book value:                              
December 31, 2020  $12,005   $111,643   $1,132   $7,471   $21,619   $153,870 
December 31, 2021  $28,819   $

240,195

   $-   $5,230   $22,799   $

297,043

 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 62 R18.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS AND GOODWILL
12 Months Ended
Dec. 31, 2021
INTANGIBLE ASSETS AND GOODWILL

13. INTANGIBLE ASSETS AND GOODWILL

 

   Patents  

Customer

Relationships

   Brand    

Software

   Goodwill   Total 
Cost                                 
Balance at December 31, 2019  $41,931   $-   $            -     $-   $-   $41,931 
Intangible assets acquired in the Transaction   -    197,000     -      119,000    2,166,563    2,482,563 
Balance at December 31, 2020  $41,931   $197,000   $ -     $119,000   $2,166,563   $2,524,494 

Intangible assets acquired in the

Acquisition

   -    -     23,000      433,000    8,353,609    8,809,609 
Impairment of goodwill   -    -     -      -    (4,579,763)   (4,579,763)
Balance at December 31, 2021  $41,931   $197,000   $ 23,000     $552,000   $

5,940,409

   $6,754,340 
                                  
Accumulated amortization                                 
Balance at December 31, 2019  $40,546   $-   $ -     $-   $-   $40,546 
Change for the year   1,385    26,267     -      15,866    -    43,518 
Balance at December 31, 2020   41,931    26,267   -     15,866    -    84,064 
Change for the year   -    34,147     3,450      98,369    -    135,966 
Balance at December 31, 2021  $41,931   $60,414   $ 3,450     $114,235   $-   $220,030 
                                  
Net book value:                                 
December 31, 2020  $-   $170,733   $ -     $103,134   $2,166,563   $2,440,430 
December 31, 2021  $-   $136,586   $ 19,550     $437,765   $5,940,409   $6,534,310 

 

Customer relationships

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics (note 3) and assigned $197,000 to the fair value of customer relationships.

 

Brand

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics and assigned $119,000 to the fair value of the website/domain name.

 

On March 25, 2021, the Company acquired the assets of Vital (note 4) and assigned $23,000 to the fair value of the brand.

 

Software

 

On March 25, 2021, the Company acquired the assets of Vital and assigned $433,000 to the fair value of the software.

 

Goodwill

 

On April 30, 2020, the Company acquired a 100% interest in Dronelogics, which included goodwill. Goodwill was valued at $2,166,563.

 

On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $8,353,609.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

13. INTELLECTUAL PROPERTIES AND GOODWILL (CONT’D)

 

On December 31, 2021 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:

 

5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of 2%
Budgeted cash flows calculated using a weighted average revenue EBITDA margin of 14% for Drone and 42% for Vital respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.
Cash flows were discounted at the weighted average cost of capital of 17% for Dronelogics and 24% for Vital based on peer group averages and adjusted for the Company’s risk factors.

 

Based on the annual goodwill impairment test, the Company deemed that the goodwill for Vital required impairment, as such the Company recorded an impairment of $4,579,763.

 

The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:

 

 A 10% reduction in the Value in use for the discounted cash flow model would result in a reduction of $597,100 for Dronelogics and $570,133 for Vital.

 

Changing the above assumption would result in an impairment for Dronelogics, and would result in additional impairment for Vital.

 

The key assumptions used in the calculations of the recoverable amounts include sales growth per year, changes in cost of sales and capital expenditures based on internal forecasts.

 

XML 63 R19.htm IDEA: XBRL DOCUMENT v3.22.1
RIGHT OF USE ASSETS
12 Months Ended
Dec. 31, 2021
Right Of Use Assets  
RIGHT OF USE ASSETS

14. RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2019  $159,539 
Leases acquired in the Acquisition   83,428 
Balance at December 31, 2020  $242,967 
Additions   447,242 
Lease removal   (7,092)
Balance at December 31, 2021  $683,117 
      
Accumulated depreciation     
Balance at December 31, 2019  $29,545 
Charge for the year   69,003 
Balance at December 31, 2020  $98,548 
Historical correction   7,152 
Charge for the year   109,311 
Balance at December 31, 2021  $215,011 
      
Net book value:     
December 31, 2020  $144,419 
December 31, 2021  $468,106 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 64 R20.htm IDEA: XBRL DOCUMENT v3.22.1
LEASE LIABILITY
12 Months Ended
Dec. 31, 2021
Lease Liability  
LEASE LIABILITY

15. LEASE LIABILITY

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%

 

   Total 
Balance at December 31, 2019  $136,073 
Leases acquired in the Acquisition   87,203 
Interest expense   18,290 
Lease Payments   (83,442)
Balance at December 31, 2020  $158,124 
Addition   440,675 
Interest expenses   26,964 
Lease payments   (128,995)
Lease removal   (7,645)
Balance at December 31, 2021  $489,123 
      
Which consists of:     
Current lease liability  $110,481 
Non-current lease liability   378,642 
Balance at December 31, 2021  $489,123 

 

Maturity analysis  Total 
Less than one year  $150,276 
One to three years   251,765 
Four to five years   183,473 
Greater than five years   5,030 
Total undiscounted lease liabilities   

590,544

 
Amount representing implicit interest   

(101,421

)
Lease liability  $489,123 

 

 

XML 65 R21.htm IDEA: XBRL DOCUMENT v3.22.1
TRADE PAYABLES AND ACCRUED LIABILITIES
12 Months Ended
Dec. 31, 2021
Trade Payables And Accrued Liabilities  
TRADE PAYABLES AND ACCRUED LIABILITIES

16. TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2021   December 31, 2020 
Trade accounts payable  $362,890   $813,881 
Accrued liabilities   402,540    512,205 
Due to related parties (Note 23)   -    475,628 
Government grant payable   33,709    33,709 
GST/PST Payable   -    21,754 
Trade payables and accrued liabilities  $799,139   $1,857,177 

 

 

XML 66 R22.htm IDEA: XBRL DOCUMENT v3.22.1
CUSTOMER DEPOSITS
12 Months Ended
Dec. 31, 2021
Customer Deposits  
CUSTOMER DEPOSITS

17. CUSTOMER DEPOSITS

 

   December 31, 2021   December 31, 2020 
Customer deposits  $172,134   $385,449 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 67 R23.htm IDEA: XBRL DOCUMENT v3.22.1
DEFERRED INCOME
12 Months Ended
Dec. 31, 2021
DEFERRED INCOME

 18. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   December 31, 2021   December 31, 2020 
Deferred income from customers  $80,000   $- 
Deferred income from government   5,233    5,062 
Deferred income from note receivable accretion   (11,947)   - 
Deferred Income   73,286    5,062 

 

XML 68 R24.htm IDEA: XBRL DOCUMENT v3.22.1
LOANS PAYABLE
12 Months Ended
Dec. 31, 2021
Loans Payable  
LOANS PAYABLE

19. LOANS PAYABLE

   December 31, 2021   December 31, 2020 
Opening balance  $97,916   $- 
Acquisition of loans   -    120,851 
Issuance of loans payable   60,000    60,000 
Fair value adjustment   (24,576)   (26,152)
Repayment of loans payable   (44,428)   (57,873)
Accretion expense   4,405    1,090 
Ending balance  $93,317   $97,916 

 

 

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2021   Carrying Value December 31, 2020 
CEBA  2020-05-19  2022-12-31   0%  $37,384   $34,938 
CEBA  2021-04-23  2022-12-31   0%   37,383    - 
Vehicle loan  2019-08-30  2024-09-11   6.99%   18,550    25,295 
Shopify loan 

2020-08-05

      7.00%   -    

37,683

 
Total             $93,317   $97,916 

 

On May 19, 2020, Dronelogics received a $40,000 CEBA loan. This loan is currently interest-free and 25% of the loan, up to $10,000, is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

 

On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $20,000, of which, an additional $10,000 is forgivable if the loan is repaid on or before December 31, 2022.

 

On April 23, 2021, Draganfly Innovations Inc. received a $60,000 CEBA loan. This loan is currently interest free and up to $20,000 is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of 5%.

 

The CEBA loans are unsecured and the vehicle loan is secured by the vehicle and the Shopify loan is secured by the Company’s accounts receivable.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 69 R25.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE CAPITAL
12 Months Ended
Dec. 31, 2021
Share Capital  
SHARE CAPITAL

20. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the year ended December 31, 2021,

 

-The Company issued 1,580,525 common shares for the exercise of warrants for $3,951,312.
-The Company issued 149,999 common shares for the vesting of Restricted Share Units.
-The Company issued 392,999 common shares for the exercise of stock options for $987,248.
-The Company issued 15,000 common shares in lieu of cash.
-The Company issued 6,488,691 units for the Regulation A+ financing in the United States for proceeds of $18,815,485. Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. The fair value of $8,261,511 was allocated to the warrant derivative liability.
-The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
-The Company issued 5,095,966 common shares in a private placement for $25,538,213.
-The Company issued 359,009 common shares for the exercise of warrants for $978,478.
-The Company issued 298,661 common shares for the vesting of Restricted Share Units.
-The Company issued 12,500 common shares for the exercise of stock options for $26,875.
-The Company issued 356,901 common shares in lieu of cash.

 

For the year ended December 31, 2020,

 

-The Company issued 24,000 common shares for the exercise of warrants for $60,000.
-The Company issued 20,000 common shares for the exercise of warrants for $50,000.
-The Company issued 210,320 common shares for the exercise of warrants for $105,160.
-The Company issued 73,000 common shares for the exercise of warrants for $36,500.
-The Company issued 294,840 common shares for the exercise of warrants for $147,420.
-The Company issued 121,840 common shares for the exercise of warrants for $60,920.
-The Company issued 126,000 common shares for the exercise of warrants for $115,000.
-The Company issued 645,088 common shares for the acquisition of Dronelogics and an additional 40,000 common shares as finder’s fees.
-The Company issued 12,000 common shares for the exercise of warrants for $30,000.
-The Company issued 45,600 common shares for the exercise of warrants for $114,000.
-The Company issued 192,308 common shares for cash proceeds of $500,000.
-The Company issued 111,082 common shares for debt settlement of $344,354 and recognized a loss of $38,879 in the statement of comprehensive loss.
-The Company issued 2,000 common shares for the exercise of warrants for $5,000.
-The Company issued 2,200 common shares for the exercise of warrants for $5,500.
-The Company issued 637,975 common shares for the exercise of warrants for $1,594,938.
-The Company issued 7,117 common shares for the vesting of Restricted Share Units.
-The Company issued 511,299 units for the Regulation A+ financing in the United States for proceeds of $1,518,845. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.
-The Company issued 2,040 common shares for the vesting of Restricted Share Units.
-The Company issued 2,647 common shares for the vesting of Restricted Share Units.
-The Company issued 188,194 common shares for the vesting of Restricted Share Units.
-The Company issued 15,000 common shares for the exercise of warrants for $37,500.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

For the year ended December 31, 2019,

 

-The Company issued 143,985 common shares to a company controlled by a former director of the Company for settlement of $799,341 in accounts payable and application of $153,566 in subscription receivable.
-The Company issued 222,965 common shares with a value of $1,000,000 as transaction fees for the Draganfly Innovations amalgamation to related parties.
-The Company issued 8,517,671 common shares for the amalgamation with Draganfly Innovations.
-The Company issued 9,065 common shares for settlement of $22,662 in trades payables at a value of $2.50 per share.
-The Company issued 423,698 common shares for settlement of $740,000 in convertible debentures and interest. As a result of the settlement, the Company recognized loss on settlement of debt of $319,246 in the statement of loss and comprehensive loss.
-The Company issued 63,388 common shares for exercise of share purchase warrants of the Company for proceeds of $8,833. As a result of the exercise, $212,908 from reserve was reclassification to share capital.
-The Company issued 2,810,300 units in a private placement. Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

As at December 31, 2021, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date 

Exercise

Price

  

Remaining

Contractual

Life (years)

  

Number of

Options

Outstanding

  

Number of

Options

Exercisable

 
October 30, 2019  October 30, 2029  $2.50    7.84    296,665    296,665 
November 19, 2019  November 19, 2029  $2.50    7.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    8.33    87,000    78,666 
April 30, 2020  April 30, 2030  $3.85    8.33    110,000    70,000 
July 3, 2020  July 3, 2025  $3.20    3.51    200,000    166,666 
November 24, 2020  November 24, 2030  $2.50    8.90    32,000    21,000 
December 11, 2020  December 11, 2030  $2.15    8.95    12,500    12,500 
February 2, 2021  February 2, 2031  $13.20    9.09    30,000    10,000 
March 8, 2021  March 8, 2026  $13.90    4.19    10,000    5,000 
April 27, 2021  April 27, 2031  $10.15    9.23    182,000    - 
September 9, 2021  September 9, 2026  $4.84    4.69    25,826    - 
                1,035,991    710,497 

 

 

  

Number of

Options

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   744,993   $2.50 
Forfeited   (43,334)   2.50 
Granted   492,000    3.08 
Outstanding, December 31, 2020   1,193,659   $2.75 
Exercised   (405,494)   2.50 
Granted   247,826    10.12 
Outstanding, December 31, 2021   1,035,991   $4.60 

 

During the year ended December 31, 2021,

 

-The Company granted 30,000 options to an employee. Each option is exercisable at $13.20 per share for 10 years.
-The Company granted 10,000 options to a consultant. Each option is exercisable at $13.90 per share for 5 years.
-The Company granted 182,000 options to employees and a consultant. Each option is exercisable at $10.15 per share for 10 years.
-The Company granted 25,826 options to an employee. Each option is exercisable at $4.84 per share for 5 years.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Stock Options (cont’d)

 

During the year ended December 31, 2020,

 

-The Company granted 89,000 options to employees. Each option is exercisable at $2.50 per share for a period of 10 years from the grant date.
  - The Company granted 120,000 options to consultants. Each option is exercisable at $3.85 per share for a period of 10 years from the grant date.
-The Company granted 200,000 options to employees. Each option is exercisable at $3.20 per share for a period of 5 years from the grant date.
-The Company granted 33,000 options to employees. Each option is exercisable at $2.50 per share for a period of 10 years from the grant date.
-The Company granted 50,000 options to a consultant. Each option is exercisable at $2.15 per share for a period of 10 years from the grant date.

 

During the year ended December 31, 2021, the Company recorded $1,660,894 (2020 - $1,724,853 and 2019 – $599,701) in stock-based compensation for stock options, based on the fair values of stock options granted which were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Year ended December 31,  2021   2020    2019  
Risk free interest rate   0.69%-1.40%    0.43%-0.66%    1.45%-1.46 %
Expected volatility   62.84%-113.16%    113.53%-119.03%    100 %
Expected life   5 years    5-10 years    7.5 years  
Expected dividend yield   0%   0%   0 %
Exercise price  $4.84-13.90   $2.15-3.85  $ 2.50

 

Volatility is calculated using the historical volatility method based on a comparative company’s stock price.

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at December 31, 2021, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2019   634,997 
Vested   (199,998)
Forfeited   (68,333)
Issued   248,000 
Outstanding, December 31, 2020   614,666 
Vested   (448,660)
Issued   348,826 
Outstanding, December 31, 2021   514,832 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Restricted Share Units (cont’d)

 

During the year ended December 31, 2021, 323,661 RSUs fully vested according to the terms and the Company accelerated the vesting of 124,999 RSUs. The Company issued 348,826 RSUs to employees of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

 

During the year ended December 31, 2020, the Company committed to grant 248,000 RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.

 

During the year ended December 31, 2021, the Company recorded share-based payment expense of $2,291,701 (2020: $943,611, 2019: $161,858) in stock-based compensation for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.

 

To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.

 

Warrant Derivative Liability

 

Balance at January 1, 2020  $- 
Warrant issuance   

281,732

 
Change in fair value of warrants outstanding   466,902 
Balance at December 31, 2020  $748,634 
Warrant issuance   

8,261,511

 
Exercised   

(98,048

)
Change in fair value of warrants outstanding   (4,046,325
Warrant Balance at December 31, 2021  4,865,772 
Derivative liability     
Warrants  $4,865,772 
Contingent consideration (note 4)   694,230
Contingent consideration at December 31, 2021  $5,560,002 

 

Details of these warrants and their fair values are as follows:

 

Issue Date  Exercise Price 

Number of

Warrants

Outstanding at

December 31,

2021

  

Fair Value at

December 31,

2021

  

Number of

Warrants

Outstanding at

December 31,

2020

  

Fair Value at

December 31,

2020

 
November 30, 2020  US$ 3.55   482,425   $182,262    511,299   $748,634 
February 5, 2021  US$ 3.55   1,323,275    951,226    -    - 
March 5, 2021  US$ 3.55   5,154,321    3,731,285    -    - 
July 29, 2021  US$ 5.00   250,000    84,625    -    - 
September 14, 2021  US$ 5.00   4,798    1,685    -    - 
       7,214,819   $4,865,772    511,299   $748,634 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

20. SHARE CAPITAL (CONT’D)

 

Warrants (cont’d)

 

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Year ended December 31,  2021   2020 
Risk free interest rate   0.23%-0.95%    0.20%-0.24% 
Expected volatility   70.95%-144.59%    72.76%-74.10% 
Expected life   2-3 years    2 years 
Expected dividend yield   0%   0%

 

Volatility is calculated using the historical volatility method.

 

During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021.

 

  

Number of

Warrants

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   3,610,340   $2.05 
Exercised   (1,584,775)   1.50 
Forfeited   (120,000)   2.50 
Issued   511,299    3.55 
Outstanding, December 31, 2020   2,416,864   $2.95 
Exercised   (1,939,534)   2.54 
Forfeited   (6,000)   2.50 
Issued   7,943,489    5.10 
Outstanding, December 31, 2021   8,414,819   $4.99 

 

As at December 31, 2021, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price 

Number of warrants

outstanding

 
November 30, 2020  November 30, 2022  US$ 3.55   482,425 
February 5, 2021  February 5, 2023  US$ 3.55   1,323,275 
March 5, 2021  March 5, 2023  US$ 3.55   5,154,321 
March 22, 2021  March 22, 2023  CDN$13.35   1,200,000 
July 29, 2021  July 29, 2024  US$ 5.00   250,000 
September 14, 2021  September 14, 2024  US$ 5.00   4,798 
          8,414,819 

 

The weighted average remaining contractual life of warrants outstanding as of December 31, 2021, was 1.20 years (December 31, 2020 – 1.07 years).

 

Of 1,200,000 warrants issued on March 22, 2021 to acquire Vital, 900,000 of the warrants are currently held in escrow, to be released upon completion of the milestones (note 4).

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 70 R26.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE
12 Months Ended
Dec. 31, 2021
Revenue  
REVENUE

21. REVENUE

 

The Company sub-classifies revenue within the following components: product revenue and services revenue. Product revenue comprises of sales of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Services revenue consists of fees charged for custom engineering, drone as a service work, and training and simulation consulting.

 

             
   For the years ended December 31, 
   2021   2020   2019 
Product sales  $5,103,399   $3,087,223   $248,939 
Drone service   1,304,799    630,532    - 
Services   645,667    645,756    1,131,488 
Revenue   $7,053,865   $4,363,511   $1,380,427 

 

The Company does not derive significant revenue from any (2020 – 1) customers that exceeds 10% of total revenues for the year ended December 31, 2021 (2020 – $474,701 of custom engineering services revenue).

 

Consulting revenue:

 

On May 22, 2017, the Company executed a standard consulting agreement, whereby the Company would provide consulting, custom engineering and investigating and solving on a project-by-project basis. The Company shall be responsible for the development, design, procurement, fabrication, assembly, integration, checkout, integration and test of hardware, software, and firmware necessary to produce a complete system per each project. The consideration for the services performed are based on the labor cost incurred on an hourly basis and minimal preapproved expenditures.

 

Geographic revenue segmentation is as follows:

 

             
   For the years ended December 31, 
   2021   2020   2019 
Canada  $4,937,935   $2,270,862   $127,118 
United States   2,071,492    1,982,404    1,251,199 
International   44,438    110,245    2,110 
Revenue   $7,053,865   $4,363,511   $1,380,427 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

21. REVENUE (CONT’D)

 

Non current assets for each geographic segment are as follows:

 

 

   Canada   United States   International 
   For the years ended December 31, 
   Canada   United States   International 
Goodwill  $2,166,564   $3,773,845   $- 
Property and equipment   297,043    -    - 
Intangible assets   219,093    374,808    - 
Investments   291,066    -    - 
Notes receivable   -    964,006    - 
Right of use assets   468,106    -    - 
TOTAL ASSETS  $3,441,872   $5,112,659   $- 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 71 R27.htm IDEA: XBRL DOCUMENT v3.22.1
OFFICE AND MISCELLANEOUS
12 Months Ended
Dec. 31, 2021
Office And Miscellaneous  
OFFICE AND MISCELLANEOUS

22. OFFICE AND MISCELLANEOUS

   2021   2020   2019 
   For the years ended December 31, 
   2021   2020   2019 
Advertising, Marketing, and Investor Relations  $5,165,791   $2,610,930   $1,356,174 
Compliance fees   432,874    122,916    80,525 
Contract Work   300,975    399,546    438,601 
Other   556,358    254,473    228,432 
Office and Miscellaneous Expenses   $6,455,998   $3,387,865   $2,103,732 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 72 R28.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2021
RELATED PARTY TRANSACTIONS

23. RELATED PARTY TRANSACTIONS

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers.

 

Trade payables and accrued liabilities:

 

On Aug 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the company incurred fees of $315,643 compared to $177,000 in 2020, and $80,000 in 2019.

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $290,225 compared to $525,164 in 2020, and $9,000 in 2019. As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $321,741, December 31, 2019 $9,450).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $205,191 (December 31, 2020 – 227,524). As at December 31, 2021, the Company was indebted to this company in the amount of $nil (December 31, 2020 - $153,887).

 

As at December 31, 2021, the Company had $nil (December 31, 2020 - $475,628, December 31, 2019 $9,681) payable to related parties outstanding that were included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

23. RELATED PARTY TRANSACTIONS (CONT’D)

 

Key management compensation

 

Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:

 

For the years ended December 31,  2021   2020   2019 
Director fees  $370,094   $-   $- 
Management fees paid to a company controlled by CEO and director   290,225    737,164    186,000 
Management fees paid to a company controlled by the President and director   205,691    227,524    - 
Management fees paid to a company controlled by a former director   500,074    165,000    195,000 
Salaries   722,068    655,799    179,429 
Salaries paid to the former owner of the Company   -    86,097    149,060 
Share-based payments   2,475,949    1,614,158    480,158 
Total  $4,564,102   $3,485,742    1,189,647 

 

XML 73 R29.htm IDEA: XBRL DOCUMENT v3.22.1
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
12 Months Ended
Dec. 31, 2021
Financial Instruments And Financial Risk Management  
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

24. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does not have any past due outstanding receivables and the expected loss rate for undue balance is estimated to be nominal.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

24. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net income upon consolidation as follows:

 

   December 31, 2021   December 31, 2020 
Foreign exchange rate  $150,715   $27,018 

 

Interest rate risk

 

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2021  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $164,286   $126,780   $-   $291,066 
Notes receivable   -    1,154,176    -    1,154,176 
Derivative liability   -     -    5,560,002    5,560,002 
Total  $164,286   $1,280,956   $5,560,002   $7,005,244 

 

December 31, 2021  Level 1   Level 2   Level 3   Total 
Derivative liability   -    -    748,634    748,634 
Total  $-   $-   $748,634   $748,634 

 

Capital Management

 

The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of cash, debt, and equity comprised of issued share capital, and share-based payment reserve.

 

The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2020.

 

The breakdown of the Company’s capital is as follows:

 

   December 31, 2021   December 31, 2020 
Cash  $23,075,713   $1,982,416 
Debt   93,317    97,916 
Equity  $34,926,239   $3,848,205 

 

XML 74 R30.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
12 Months Ended
Dec. 31, 2021
INCOME TAXES

25. INCOME TAXES

 

The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2021, 2020 and 2019:

 

   December 31, 2021   December 31, 2020      December 31, 2019  
Loss before income taxes  $16,202,972   $8,015,813    $ 11,095,507  
Canadian statutory rates        27%     27 %
Expected income tax recovery   4,196,600    2,164,000      2,996,000  
Impact of different foreign statutory tax rates   34,900    -      -  
Non-deductible items   116,400    (687,000)     (2,043,000 )
Share issue costs   887,600    -      -  
Adjustments to prior years provision versus statutory tax returns   376,500    189,000      (388,000 )
Differences between prior year provision and final tax return   (206,000)    (535,000)     (18,000 )
Change in deferred tax asset not recognized   (5,406,000)   (1,131,000)     (547,000 )
Income tax  $-   $-    $ -  

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

25. INCOME TAXES (CONT’D)

 

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

  December 31, 2021   December 31, 2020      December 31, 2019  
Deferred income tax assets (liabilities):                  
Share issuance costs  $728,000   $30,000    $ -  
Non-capital losses   7,043,000    3,656,000      2,439,000  
Property and equipment   449,000    457,000      581,000  
Capital gain reserve   74,000    -      -  
Scientific Research and Experimental Development   291,000    57,000     

49,000

 
Total deferred income tax assets  $8,585,000   $4,200,000    $ 3,069,000  
Deferred income tax not recognized   (8,585,000)   (4,200,000)     (3,069,000 )
Net deferred tax assets  $-   $-    $ -  

 

The Company has non-capital loss carry forward of approximately $25,487,000 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2040.

 

XML 75 R31.htm IDEA: XBRL DOCUMENT v3.22.1
OTHER INCOME
12 Months Ended
Dec. 31, 2021
OTHER INCOME

26. OTHER INCOME

 

The Company had previously written off an investment in a UK-based company. On April 27, 2020, this company was sold and the Company received $1,179,513 (US$854,838).

 

XML 76 R32.htm IDEA: XBRL DOCUMENT v3.22.1
SUPPLEMENTAL CASH FLOW DISCLOSURES
12 Months Ended
Dec. 31, 2021
Supplemental Cash Flow Disclosures  
SUPPLEMENTAL CASH FLOW DISCLOSURES

27. SUPPLEMENTAL CASH FLOW DISCLOSURES

 

During the year ended December 31, 2021:

 

-The Company issued 15,000 common shares in lieu of cash.
-The Company issued 1,200,000 units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.
-The Company issued 356,901 common shares in lieu of cash.
- The Company recorded a change in fair value of investments of $332,640 to other comprehensive loss.

 

During the year ended December 31, 2020, the Company settled debt of $344,354 with the issuance of 111,082 common shares and recognized a gain on settlement of debt of $28,614.

 

During the year ended December 31, 2019:

 

-Settlement of $822,003 in accounts payable and application of $153,566 in subscription receivable through issuance of shares;
-Issuance of 400,000 common shares at $2.50 per shares as finders’ fees, and;
-Settlement of $740,000 of convertible debentures.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 77 R33.htm IDEA: XBRL DOCUMENT v3.22.1
GOVERNMENT ASSISTANCE
12 Months Ended
Dec. 31, 2021
Government Assistance  
GOVERNMENT ASSISTANCE

28. GOVERNMENT ASSISTANCE

 

In response to COVID-19, the Government of Canada announced the Canada Emergency Wage Subsidy (“CEWS”) program in April 2020. CEWS provides a wage subsidy on eligible remuneration, subject to a maximum per employee, to eligible employers based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. Included in the statement of comprehensive loss for the year ended December 31, 2021 is - $250,756 (2020 - $490,748) relating to the CEWS program of which was recorded as a reduction of wages and salaries included in operating expenses.

 

In September 2020, the Government of Canada announced the Canada Emergency Rent Subsidy (“CERS”) to provide a rent subsidy to eligible businesses based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy as well. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $22,668 (2020 - $nil) relating to the CERS program of which was recorded as a reduction of rent included in operating expenses. As at December 31, 2021, the Company had - $nil (2020 - $nil) included in amounts receivables for CERS subsidies receivable.

 

In October 2021 the Government of Canada announced the Hardest Hit Business Recovery Program (“HHBRP”) to provide continued wage and rent subsidies to business’ severely affected by COVID-19, based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government grant as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $50,756 in wage subsidies and $3,791 in rent subsidies (2020 - $nil, and - $nil respectively) relating to the HHBRP program of which were recorded as a reduction wages and salaries and rent expense respectively. As at December 31, 2021, the Company had - $54,548 (2020 - $nil) included in amounts receivables for HHBRP subsidies receivable.

XML 78 R34.htm IDEA: XBRL DOCUMENT v3.22.1
BASIS OF PREPARATION (Policies)
12 Months Ended
Dec. 31, 2021
Inventory

Inventory

 

Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices.

Contingencies

Contingencies

 

The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.

Useful lives of equipment and intangible assets

Useful lives of equipment and intangible assets

 

Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.

Significant judgments

Significant judgments

 

The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:

Business combinations

Business combinations

 

The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.

Business combination versus asset acquisition

Business combination versus asset acquisition

 

The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to the Acquisitions (Notes 3, 4, and 5). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.

 

Other significant judgments

Other significant judgments

 

The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;
the classification of financial instruments;
the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;
the determination of whether a set of assets acquired and liabilities assumed constitute a business; and
the determination of the functional currency of the company.

Foreign currency translation

Foreign currency translation

 

Transactions in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.

 

The functional currencies for the parent company and each subsidiary are as follows:

 

Draganfly Inc. Canadian Dollar
Draganfly Innovations Inc. Canadian Dollar
Draganfly Innovations USA, Inc. US Dollar
Dronelogics Systems Inc. Canadian Dollar

 

Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in other comprehensive income.

 

Share-based payments

Share-based payments

 

The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.

 

Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.

Restricted Share Units

Restricted Share Units

 

The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. RSUs are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.

Loss per share

Loss per share

 

Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.

 

a)Financial assets

 

Classification and measurement

 

The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.

 

Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.

 

Financial assets at FVTPL

 

Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.

 

Financial assets at FVTOCI

 

Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income.

 

There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.

 

Financial assets at amortized cost

 

Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.

 

Impairment of financial assets at amortized cost

 

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.

 

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.

 

Derecognition of financial assets

 

Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

b)Financial liabilities

 

The Company classifies its financial liabilities into one of two categories as follows:

 

Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.

 

Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.

 

Derecognition of financial liabilities

 

Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.

Impairment of non-financial assets

Impairment of non-financial assets

 

The carrying amounts of the Company’s non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:

 

an intangible asset with an indefinite useful life;
an intangible asset not yet available for use; and
goodwill recognized in a business combination.

 

The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in the statement of comprehensive loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.

 

In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.

Income taxes

Income taxes

 

Current income tax:

 

Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.

 

Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.

 

Deferred income tax:

 

Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.

Inventory

Inventory

 

Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.

 

Revenue recognition

Revenue recognition

 

Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.

 

Sales of goods

 

The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.

 

Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.

 

Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.

 

A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.

 

Services

 

The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.

 

Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.

Cost of Goods Sold

Cost of Goods Sold

 

Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.

Intangible Assets and Goodwill

Intangible Assets and Goodwill

 

An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications.

 

Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.

 

Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.

 

Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.

Equipment

Equipment

 

Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.

 

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.

 

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.

 

Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

2. SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)

 

Class of equipment  Depreciation rate 
Computer equipment  30% 
Furniture and equipment  20% 
Leasehold improvements  Over expected life of lease 
Software  30% 
Vehicles  30% 

 

Research and development expenditures

Research and development expenditures

 

Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.

Government Assistance

Government Assistance

 

Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.

SR&ED Investment tax credits

SR&ED Investment tax credits

 

The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.

 

The Company claims provincial investment tax credits as a result of incurring SR&ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.

Leases

Leases

 

A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.

 

The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.

 

A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.

 

XML 79 R35.htm IDEA: XBRL DOCUMENT v3.22.1
BASIS OF PREPARATION (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF RESULTS OF OPERATIONS

The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary 

Place of Incorporation

 

Ownership Interest

 
Draganfly Innovations Inc.  Canada  100% 
Draganfly Innovations USA, Inc.  US  100% 
Dronelogics Systems Inc.  Canada  100% 
SCHEDULE OF CLASS OF EQUIPMENT

 

Class of equipment  Depreciation rate 
Computer equipment  30% 
Furniture and equipment  20% 
Leasehold improvements  Over expected life of lease 
Software  30% 
Vehicles  30% 
XML 80 R36.htm IDEA: XBRL DOCUMENT v3.22.1
DRONELOGICS ACQUISITION (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF PURCHASE PRICE ALLOCATION

The purchase price allocation (“PPA”) is as follows:

 

      
Number of shares of Draganfly Inc.   645,088 
Fair value of common shares  $4.15 
Fair value of shares of Draganfly Inc.  $2,178,960 
Cash portion of purchase price   500,000 
Total  $2,678,960 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

3. DRONELOGICS ACQUISITION (CONT’D)

 

Tangible assets acquired    
Cash  $42,593 
Accounts receivable   98,852 
Inventory   629,684 
Prepaids and deposits   93,997 
Other current assets   3,014 
Capital assets   54,946 
Right-of-use assets   83,428 
Accounts payable and accrued liabilities   (222,766)
Customer deposits   (245,959)
Loans   (245,752)
Other current liabilities   (8,437)
Lease liabilities   (87,203)
Total tangible assets acquired   196,397 
Identifiable intangible assets     
Customer relationships   197,000 
Website   119,000 
 Total identifiable intangible assets   316,000 
Goodwill   2,166,563 
Total consideration  $2,678,960 
XML 81 R37.htm IDEA: XBRL DOCUMENT v3.22.1
VITAL INTELLIGENCE ACQUISITION (Tables)
12 Months Ended
Dec. 31, 2021
Vital Intelligence Acquisition  
SCHEDULE OF CONTINGENT CONSIDERATION

 

Contingent consideration     
Fair value of contingent consideration  $4,797,717 
Change in fair value of contingent consideration   (4,103,487)
Contingent consideration at December 31, 2021 (note 20)  $694,230 
SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE

The PPA is as follows:

 

Number of units of Draganfly Inc.   578,248 
Fair value of units  $14.43 
Fair value of units of Draganfly Inc.  $8,342,966 
Cash portion of purchase price   466,643 
Total  $8,809,609 

 

Identifiable intangible assets    
Brand  $23,000 
Software   433,000 
    456,000 
      
Goodwill   8,353,609 
Total consideration  $8,809,609 
XML 82 R38.htm IDEA: XBRL DOCUMENT v3.22.1
AMALGAMATION (Tables)
12 Months Ended
Dec. 31, 2021
SUMMARY OF HISTORICAL FINANCIAL INFORMATION

 

      
Number of shares of Draganfly Inc.   2,100,000 
Fair value of common shares in concurrent financing  $2.50 
Fair value of shares of Draganfly Inc.  $5,250,001 
Fair value of warrants   1,645,193 
Fair value of shares issued for transaction fees   1,000,000 
Net assets acquired  $(90,335)
Listing expense  $7,804,859 

 

Fair value of the Company acquired, net of liabilities    
Cash  $28,538 
Accounts receivable   4,991 
Loans receivable   963,269 
Accounts payable and accrued liabilities   (406,463)
Subscription receipts   (500,000)
Net of liabilities  $90,335 
SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES

 

Risk-free interest rate   0.86%
Estimate life   1.48 years 
Expected volatility   100%
Expected dividend yield   0%
XML 83 R39.htm IDEA: XBRL DOCUMENT v3.22.1
CASH AND CASH EQUIVALENTS (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF CASH AND CASH EQUIVALENTS

   December 31, 2021   December 31, 2020 
Cash held in banks  $22,729,212   $1,839,871 
Guaranteed investment certificates   346,501    142,545 
Cash and Cash Equivalents  $23,075,713   $1,982,416 
XML 84 R40.htm IDEA: XBRL DOCUMENT v3.22.1
RECEIVABLES (Tables)
12 Months Ended
Dec. 31, 2021
Schedule Of Amounts Receivable  
SCHEDULE OF AMOUNTS RECEIVABLE

   December 31, 2021   December 31, 2020 
Trade accounts receivable  $951,314   $780,254 
Corporate taxes receivable   

182,820

    

-

 
GST receivable   272,993   $- 
SR&ED receivable   -    30,537 
Trade and other receivables  $1,407,127   $810,791 
XML 85 R41.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORY (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF INVENTORIES

   December 31, 2021   December 31, 2020    December 31, 2019  
Finished goods  $3,017,363   $1,155,871    $ -  
Parts   373,459    77,748      48,653  
Inventories   $3,390,822   $1,233,619    $ 48,653  
SCHEDULE OF COST OF SALES

 

  December 31, 2021   December 31, 2020    December 31, 2019  
Inventory  $3,420,713   $2,257,797    $ 118,626  
Consulting and services   679,345    164,119      86,280  
Other   310,719    181,995     

13,894

 
Cost of sales   $4,410,777   $2,603,911    $ 218,800  
XML 86 R42.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES RECEIVABLE (Tables)
12 Months Ended
Dec. 31, 2021
Notes Receivable  
DISCLOSURE OF NOTES RECEIVABLE

 

   Start Date  Maturity Date  Rate   Principal   Interest   Accretion 

Impairment

  Total  
Note 1(1)  2021-04-21  2022-10-21   0%  $180,597   $-   $9,573  $- $ 190,170  
Note 2(1)  2021-06-01  2023-06-01   8%   114,833    5,378    -   (120,211)    -  
Note 3(1)  2021-09-22  2024-09-22   5%   943,385    13,156    7,465   -    964,006  
Note 4  2021-11-17  2022-04-26   8%   750,000    21,260    -   (771,260   -  
Total             $1,988,815   $39,794   $17,038  $(891,471 $ 1,154,176  

 

(1)These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 87 R43.htm IDEA: XBRL DOCUMENT v3.22.1
PREPAIDS (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS

 

   December 31, 2021   December 31, 2020 
Insurance  $2,938,246   $992 
Prepaid director fees   107,763    - 
Prepaid interest   6,969    - 
Prepaid marketing services   1,638,179    187,826 
Prepaid rent   -    3,583 
Prepaid subscriptions   35,687    5,953 
Deposits   768,033    136,668 
 Prepaid expenses and deposits  $5,494,877   $335,022 
XML 88 R44.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Investments Abstract  
SCHEDULE OF INVESTMENTS

         
Balance at December 31, 2020   $ -  
Investments     623,706  
Change in fair value     (332,640 )
Balance at December 31, 2021   $ 291,066  

 

Fair value of investments is comprised of:

  .  
      
Public company shares  $

142,857

 
Public company warrants   21,429 
Private company shares   126,780
Balance at December 31, 2021  $291,066 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:

 

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS

   December 31, 2021   March 10, 2021 
Risk free interest rate   0.91%   0.28%
Expected volatility   124.09%   150.88%
Expected life   2 years    2 years 
Expected dividend yield   0%   0%
XML 89 R45.htm IDEA: XBRL DOCUMENT v3.22.1
EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [abstract]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 

  

Computer

Equipment

  

Furniture

and

Equipment

  

Leasehold

Improvements

   Software   Vehicles   Total 
Cost                              
Balance at January 1, 2020  $7,000   $142,173   $-   $29,967   $-   $179,140 
Additions   2,028    21,860    -    -    -    23,888 
Net assets acquired in the
Transaction
   15,369    7,573    4,352    -    27,652    54,946 
Balance at December 31, 2020  $24,397   $171,606   $4,352   $29,967   $27,652   $257,974 
Additions   29,713    170,866    -    -    12,000    212,579 
Revaluation   -    -    -    -    (3,619)   (3,619)
Balance at December 31, 2021  $54,110   $342,472   $4,352   $29,967   $36,033   $466,934 
                               
Accumulated depreciation                              
Balance at January 1, 2020  $6,761   $37,944   $-   $19,294   $-   $63,999 
Charge for the year   5,631    22,019    3,220    3,202    6,033    40,105 
Balance at December 31, 2020  $12,392   $59,963   $3,220   $22,496   $6,033   $104,104 
Charge for the year   12,899    42,314    1,132    2,241    7,201    65,787 
Balance at December 31, 2021  $25,291   $

102,277

   $4,352   $24,737   $13,234   $169,891 
                               
Net book value:                              
December 31, 2020  $12,005   $111,643   $1,132   $7,471   $21,619   $153,870 
December 31, 2021  $28,819   $

240,195

   $-   $5,230   $22,799   $

297,043

 
XML 90 R46.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS AND GOODWILL (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF INTELLECTUAL PROPERTY

 

   Patents  

Customer

Relationships

   Brand    

Software

   Goodwill   Total 
Cost                                 
Balance at December 31, 2019  $41,931   $-   $            -     $-   $-   $41,931 
Intangible assets acquired in the Transaction   -    197,000     -      119,000    2,166,563    2,482,563 
Balance at December 31, 2020  $41,931   $197,000   $ -     $119,000   $2,166,563   $2,524,494 

Intangible assets acquired in the

Acquisition

   -    -     23,000      433,000    8,353,609    8,809,609 
Impairment of goodwill   -    -     -      -    (4,579,763)   (4,579,763)
Balance at December 31, 2021  $41,931   $197,000   $ 23,000     $552,000   $

5,940,409

   $6,754,340 
                                  
Accumulated amortization                                 
Balance at December 31, 2019  $40,546   $-   $ -     $-   $-   $40,546 
Change for the year   1,385    26,267     -      15,866    -    43,518 
Balance at December 31, 2020   41,931    26,267   -     15,866    -    84,064 
Change for the year   -    34,147     3,450      98,369    -    135,966 
Balance at December 31, 2021  $41,931   $60,414   $ 3,450     $114,235   $-   $220,030 
                                  
Net book value:                                 
December 31, 2020  $-   $170,733   $ -     $103,134   $2,166,563   $2,440,430 
December 31, 2021  $-   $136,586   $ 19,550     $437,765   $5,940,409   $6,534,310 
XML 91 R47.htm IDEA: XBRL DOCUMENT v3.22.1
RIGHT OF USE ASSETS (Tables)
12 Months Ended
Dec. 31, 2021
Right Of Use Assets  
SCHEDULE OF RIGHT OF USE ASSETS

 

   Total 
Cost     
Balance at December 31, 2019  $159,539 
Leases acquired in the Acquisition   83,428 
Balance at December 31, 2020  $242,967 
Additions   447,242 
Lease removal   (7,092)
Balance at December 31, 2021  $683,117 
      
Accumulated depreciation     
Balance at December 31, 2019  $29,545 
Charge for the year   69,003 
Balance at December 31, 2020  $98,548 
Historical correction   7,152 
Charge for the year   109,311 
Balance at December 31, 2021  $215,011 
      
Net book value:     
December 31, 2020  $144,419 
December 31, 2021  $468,106 
XML 92 R48.htm IDEA: XBRL DOCUMENT v3.22.1
LEASE LIABILITY (Tables)
12 Months Ended
Dec. 31, 2021
Lease Liability  
SCHEDULE OF OPERATING LEASE LIABILITIES

 

   Total 
Balance at December 31, 2019  $136,073 
Leases acquired in the Acquisition   87,203 
Interest expense   18,290 
Lease Payments   (83,442)
Balance at December 31, 2020  $158,124 
Addition   440,675 
Interest expenses   26,964 
Lease payments   (128,995)
Lease removal   (7,645)
Balance at December 31, 2021  $489,123 
      
Which consists of:     
Current lease liability  $110,481 
Non-current lease liability   378,642 
Balance at December 31, 2021  $489,123 
SCHEDULE OF OPERATING MATURITY ANALYSIS

Maturity analysis  Total 
Less than one year  $150,276 
One to three years   251,765 
Four to five years   183,473 
Greater than five years   5,030 
Total undiscounted lease liabilities   

590,544

 
Amount representing implicit interest   

(101,421

)
Lease liability  $489,123 
XML 93 R49.htm IDEA: XBRL DOCUMENT v3.22.1
TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2021
Trade Payables And Accrued Liabilities  
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES

 

   December 31, 2021   December 31, 2020 
Trade accounts payable  $362,890   $813,881 
Accrued liabilities   402,540    512,205 
Due to related parties (Note 23)   -    475,628 
Government grant payable   33,709    33,709 
GST/PST Payable   -    21,754 
Trade payables and accrued liabilities  $799,139   $1,857,177 
XML 94 R50.htm IDEA: XBRL DOCUMENT v3.22.1
CUSTOMER DEPOSITS (Tables)
12 Months Ended
Dec. 31, 2021
Customer Deposits  
SCHEDULE OF CUSTOMER DEPOSITS

 

   December 31, 2021   December 31, 2020 
Customer deposits  $172,134   $385,449 
XML 95 R51.htm IDEA: XBRL DOCUMENT v3.22.1
DEFERRED INCOME (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF DEFERRED INCOME

 

   December 31, 2021   December 31, 2020 
Deferred income from customers  $80,000   $- 
Deferred income from government   5,233    5,062 
Deferred income from note receivable accretion   (11,947)   - 
Deferred Income   73,286    5,062 
XML 96 R52.htm IDEA: XBRL DOCUMENT v3.22.1
LOANS PAYABLE (Tables)
12 Months Ended
Dec. 31, 2021
Loans Payable  
SCHEDULE OF LOANS PAYABLE

   December 31, 2021   December 31, 2020 
Opening balance  $97,916   $- 
Acquisition of loans   -    120,851 
Issuance of loans payable   60,000    60,000 
Fair value adjustment   (24,576)   (26,152)
Repayment of loans payable   (44,428)   (57,873)
Accretion expense   4,405    1,090 
Ending balance  $93,317   $97,916 

SCHEDULE OF LOANS

 

   Start Date  Maturity Date  Rate   Carrying Value December 31, 2021   Carrying Value December 31, 2020 
CEBA  2020-05-19  2022-12-31   0%  $37,384   $34,938 
CEBA  2021-04-23  2022-12-31   0%   37,383    - 
Vehicle loan  2019-08-30  2024-09-11   6.99%   18,550    25,295 
Shopify loan 

2020-08-05

      7.00%   -    

37,683

 
Total             $93,317   $97,916 
XML 97 R53.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE CAPITAL (Tables)
12 Months Ended
Dec. 31, 2021
Share Capital  
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

As at December 31, 2021, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date 

Exercise

Price

  

Remaining

Contractual

Life (years)

  

Number of

Options

Outstanding

  

Number of

Options

Exercisable

 
October 30, 2019  October 30, 2029  $2.50    7.84    296,665    296,665 
November 19, 2019  November 19, 2029  $2.50    7.89    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    8.33    87,000    78,666 
April 30, 2020  April 30, 2030  $3.85    8.33    110,000    70,000 
July 3, 2020  July 3, 2025  $3.20    3.51    200,000    166,666 
November 24, 2020  November 24, 2030  $2.50    8.90    32,000    21,000 
December 11, 2020  December 11, 2030  $2.15    8.95    12,500    12,500 
February 2, 2021  February 2, 2031  $13.20    9.09    30,000    10,000 
March 8, 2021  March 8, 2026  $13.90    4.19    10,000    5,000 
April 27, 2021  April 27, 2031  $10.15    9.23    182,000    - 
September 9, 2021  September 9, 2026  $4.84    4.69    25,826    - 
                1,035,991    710,497 
SUMMARY OF CHANGES IN STOCK OPTIONS

 

  

Number of

Options

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   744,993   $2.50 
Forfeited   (43,334)   2.50 
Granted   492,000    3.08 
Outstanding, December 31, 2020   1,193,659   $2.75 
Exercised   (405,494)   2.50 
Granted   247,826    10.12 
Outstanding, December 31, 2021   1,035,991   $4.60 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS

 

Year ended December 31,  2021   2020    2019  
Risk free interest rate   0.69%-1.40%    0.43%-0.66%    1.45%-1.46 %
Expected volatility   62.84%-113.16%    113.53%-119.03%    100 %
Expected life   5 years    5-10 years    7.5 years  
Expected dividend yield   0%   0%   0 %
Exercise price  $4.84-13.90   $2.15-3.85  $ 2.50
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS

As at December 31, 2021, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2019   634,997 
Vested   (199,998)
Forfeited   (68,333)
Issued   248,000 
Outstanding, December 31, 2020   614,666 
Vested   (448,660)
Issued   348,826 
Outstanding, December 31, 2021   514,832 
SCHEDULE OF WARRANT DERIVATIVE LIABILITY

Warrant Derivative Liability

 

Balance at January 1, 2020  $- 
Warrant issuance   

281,732

 
Change in fair value of warrants outstanding   466,902 
Balance at December 31, 2020  $748,634 
Warrant issuance   

8,261,511

 
Exercised   

(98,048

)
Change in fair value of warrants outstanding   (4,046,325
Warrant Balance at December 31, 2021  4,865,772 
Derivative liability     
Warrants  $4,865,772 
Contingent consideration (note 4)   694,230
Contingent consideration at December 31, 2021  $5,560,002 
SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING

 

Issue Date  Exercise Price 

Number of

Warrants

Outstanding at

December 31,

2021

  

Fair Value at

December 31,

2021

  

Number of

Warrants

Outstanding at

December 31,

2020

  

Fair Value at

December 31,

2020

 
November 30, 2020  US$ 3.55   482,425   $182,262    511,299   $748,634 
February 5, 2021  US$ 3.55   1,323,275    951,226    -    - 
March 5, 2021  US$ 3.55   5,154,321    3,731,285    -    - 
July 29, 2021  US$ 5.00   250,000    84,625    -    - 
September 14, 2021  US$ 5.00   4,798    1,685    -    - 
       7,214,819   $4,865,772    511,299   $748,634 
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS

Year ended December 31,  2021   2020 
Risk free interest rate   0.23%-0.95%    0.20%-0.24% 
Expected volatility   70.95%-144.59%    72.76%-74.10% 
Expected life   2-3 years    2 years 
Expected dividend yield   0%   0%
SUMMARY OF CHANGES IN WARRANTS

 

  

Number of

Warrants

  

Weighted Average

Exercise Price

 
Outstanding, December 31, 2019   3,610,340   $2.05 
Exercised   (1,584,775)   1.50 
Forfeited   (120,000)   2.50 
Issued   511,299    3.55 
Outstanding, December 31, 2020   2,416,864   $2.95 
Exercised   (1,939,534)   2.54 
Forfeited   (6,000)   2.50 
Issued   7,943,489    5.10 
Outstanding, December 31, 2021   8,414,819   $4.99 
SCHEDULE OF WARRANTS OUTSTANDING

As at December 31, 2021, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price 

Number of warrants

outstanding

 
November 30, 2020  November 30, 2022  US$ 3.55   482,425 
February 5, 2021  February 5, 2023  US$ 3.55   1,323,275 
March 5, 2021  March 5, 2023  US$ 3.55   5,154,321 
March 22, 2021  March 22, 2023  CDN$13.35   1,200,000 
July 29, 2021  July 29, 2024  US$ 5.00   250,000 
September 14, 2021  September 14, 2024  US$ 5.00   4,798 
          8,414,819 
XML 98 R54.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE (Tables)
12 Months Ended
Dec. 31, 2021
Revenue  
SCHEDULE OF PRODUCT AND SERVICE REVENUE

 

             
   For the years ended December 31, 
   2021   2020   2019 
Product sales  $5,103,399   $3,087,223   $248,939 
Drone service   1,304,799    630,532    - 
Services   645,667    645,756    1,131,488 
Revenue   $7,053,865   $4,363,511   $1,380,427 
SCHEDULE OF GEOGRAPHIC REVENUE

Geographic revenue segmentation is as follows:

 

             
   For the years ended December 31, 
   2021   2020   2019 
Canada  $4,937,935   $2,270,862   $127,118 
United States   2,071,492    1,982,404    1,251,199 
International   44,438    110,245    2,110 
Revenue   $7,053,865   $4,363,511   $1,380,427 
SCHEDULE OF OPERATING SEGMENTS

Non current assets for each geographic segment are as follows:

 

 

   Canada   United States   International 
   For the years ended December 31, 
   Canada   United States   International 
Goodwill  $2,166,564   $3,773,845   $- 
Property and equipment   297,043    -    - 
Intangible assets   219,093    374,808    - 
Investments   291,066    -    - 
Notes receivable   -    964,006    - 
Right of use assets   468,106    -    - 
TOTAL ASSETS  $3,441,872   $5,112,659   $- 

 

 

Draganfly Inc.

Notes to the Consolidated Financial Statements

For The Year Ended December 31, 2021

Expressed in Canadian Dollars

 

XML 99 R55.htm IDEA: XBRL DOCUMENT v3.22.1
OFFICE AND MISCELLANEOUS (Tables)
12 Months Ended
Dec. 31, 2021
Office And Miscellaneous  
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES

   2021   2020   2019 
   For the years ended December 31, 
   2021   2020   2019 
Advertising, Marketing, and Investor Relations  $5,165,791   $2,610,930   $1,356,174 
Compliance fees   432,874    122,916    80,525 
Contract Work   300,975    399,546    438,601 
Other   556,358    254,473    228,432 
Office and Miscellaneous Expenses   $6,455,998   $3,387,865   $2,103,732 
XML 100 R56.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS

Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:

 

For the years ended December 31,  2021   2020   2019 
Director fees  $370,094   $-   $- 
Management fees paid to a company controlled by CEO and director   290,225    737,164    186,000 
Management fees paid to a company controlled by the President and director   205,691    227,524    - 
Management fees paid to a company controlled by a former director   500,074    165,000    195,000 
Salaries   722,068    655,799    179,429 
Salaries paid to the former owner of the Company   -    86,097    149,060 
Share-based payments   2,475,949    1,614,158    480,158 
Total  $4,564,102   $3,485,742    1,189,647 
XML 101 R57.htm IDEA: XBRL DOCUMENT v3.22.1
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2021
Financial Instruments And Financial Risk Management  
SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net income upon consolidation as follows:

 

   December 31, 2021   December 31, 2020 
Foreign exchange rate  $150,715   $27,018 
SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS

December 31, 2021  Level 1   Level 2   Level 3   Total 
Equity securities in investee companies  $164,286   $126,780   $-   $291,066 
Notes receivable   -    1,154,176    -    1,154,176 
Derivative liability   -     -    5,560,002    5,560,002 
Total  $164,286   $1,280,956   $5,560,002   $7,005,244 

 

December 31, 2021  Level 1   Level 2   Level 3   Total 
Derivative liability   -    -    748,634    748,634 
Total  $-   $-   $748,634   $748,634 
SCHEDULE OF BREAKDOWN CAPITAL

The breakdown of the Company’s capital is as follows:

 

   December 31, 2021   December 31, 2020 
Cash  $23,075,713   $1,982,416 
Debt   93,317    97,916 
Equity  $34,926,239   $3,848,205 
XML 102 R58.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2021
SCHEDULE OF INCOME TAX

 

   December 31, 2021   December 31, 2020      December 31, 2019  
Loss before income taxes  $16,202,972   $8,015,813    $ 11,095,507  
Canadian statutory rates        27%     27 %
Expected income tax recovery   4,196,600    2,164,000      2,996,000  
Impact of different foreign statutory tax rates   34,900    -      -  
Non-deductible items   116,400    (687,000)     (2,043,000 )
Share issue costs   887,600    -      -  
Adjustments to prior years provision versus statutory tax returns   376,500    189,000      (388,000 )
Differences between prior year provision and final tax return   (206,000)    (535,000)     (18,000 )
Change in deferred tax asset not recognized   (5,406,000)   (1,131,000)     (547,000 )
Income tax  $-   $-    $ -  
SCHEDULE OF DEFERRED TAXES

The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:

 

  December 31, 2021   December 31, 2020      December 31, 2019  
Deferred income tax assets (liabilities):                  
Share issuance costs  $728,000   $30,000    $ -  
Non-capital losses   7,043,000    3,656,000      2,439,000  
Property and equipment   449,000    457,000      581,000  
Capital gain reserve   74,000    -      -  
Scientific Research and Experimental Development   291,000    57,000     

49,000

 
Total deferred income tax assets  $8,585,000   $4,200,000    $ 3,069,000  
Deferred income tax not recognized   (8,585,000)   (4,200,000)     (3,069,000 )
Net deferred tax assets  $-   $-    $ -  
XML 103 R59.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF RESULTS OF OPERATIONS (Details)
12 Months Ended
Dec. 31, 2021
Draganfly Innovations Inc [Member]  
Reserve Quantities [Line Items]  
Name of subsidiary Draganfly Innovations Inc.
Country of incorporation of subsidiary Canada
Proportion of ownership interest in subsidiary 100.00%
Draganfly Innovations USA Inc [Member]  
Reserve Quantities [Line Items]  
Name of subsidiary Draganfly Innovations USA, Inc.
Country of incorporation of subsidiary US
Proportion of ownership interest in subsidiary 100.00%
Dronelogics Systems Inc. [Member]  
Reserve Quantities [Line Items]  
Name of subsidiary Dronelogics Systems Inc.
Country of incorporation of subsidiary Canada
Proportion of ownership interest in subsidiary 100.00%
XML 104 R60.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CLASS OF EQUIPMENT (Details)
12 Months Ended
Dec. 31, 2021
Computer equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 30.00%
Furniture and Equipment [Member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 20.00%
Leasehold improvements [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, description Over expected life of lease
Computer software [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 30.00%
Vehicles [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate 30.00%
XML 105 R61.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) - Dronelogics Systems Inc. [Member]
Apr. 30, 2020
CAD ($)
$ / shares
shares
IfrsStatementLineItems [Line Items]  
Number of shares of Draganfly Inc. | shares 645,088
Fair value of common shares | $ / shares $ 4.15
Fair value of shares of Draganfly Inc. $ 2,178,960
Cash portion of purchase price 500,000
Total 2,678,960
Cash 42,593
Accounts receivable 98,852
Inventory 629,684
Prepaids and deposits 93,997
Other current assets 3,014
Capital assets 54,946
Right-of-use assets 83,428
Accounts payable and accrued liabilities (222,766)
Customer deposits (245,959)
Loans (245,752)
Other current liabilities (8,437)
Lease liabilities (87,203)
Total tangible assets acquired 196,397
Customer relationships 197,000
Website 119,000
 Total identifiable intangible assets 316,000
Goodwill 2,166,563
Total consideration $ 2,678,960
XML 106 R62.htm IDEA: XBRL DOCUMENT v3.22.1
DRONELOGICS ACQUISITION (Details Narrative)
8 Months Ended 12 Months Ended
Apr. 30, 2020
CAD ($)
shares
Apr. 30, 2020
CAD ($)
shares
$ / shares
Dec. 31, 2020
CAD ($)
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2020
CAD ($)
shares
Dec. 31, 2019
CAD ($)
IfrsStatementLineItems [Line Items]            
Number of share options granted in share-based payment arrangement       247,826 492,000  
Revenue | $       $ 7,053,865 $ 4,363,511 $ 1,380,427
Profit (loss) | $       $ (16,202,972) $ (8,015,813) $ (11,095,057)
Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of other equity instruments exercised or vested in share-based payment arrangement       124,999    
Employee [Member]            
IfrsStatementLineItems [Line Items]            
Number of share options granted in share-based payment arrangement       30,000 89,000  
Dronelogics Systems Inc. [Member]            
IfrsStatementLineItems [Line Items]            
Acquisition date fair value of total consideration cash transferred | $ $ 500,000 $ 500,000        
Acquisition date shares transferred 645,088          
Advisors fees expenses | $   160,000        
Advisiors fees paid in value of shares | $   $ 100,000        
Advisory fees expenses paid in shares   40,000        
Advisory fees expenses value per share | $ / shares   $ 2.50        
Advisors fees paid in cash | $   $ 60,000        
Number of other equity instruments exercised or vested in share-based payment arrangement   14,000        
Attribution rate percentage   0.15        
Discount rate   0.18        
Royalty percentage   0.005        
Royalty discount percentage   0.17        
Revenue | $     $ 4,086,350      
Profit (loss) | $     $ 434,528      
Dronelogics Systems Inc. [Member] | First and Second Anniversary [Member]            
IfrsStatementLineItems [Line Items]            
Number of other equity instruments exercised or vested in share-based payment arrangement   70,000        
Dronelogics Systems Inc. [Member] | Employee [Member]            
IfrsStatementLineItems [Line Items]            
Number of share options granted in share-based payment arrangement   89,000        
Dronelogics Systems Inc. [Member] | Certain Directors and Officers [Member] | Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of other equity instruments exercised or vested in share-based payment arrangement   75,000        
XML 107 R63.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CONTINGENT CONSIDERATION (Details)
12 Months Ended
Dec. 31, 2021
CAD ($)
Vital Intelligence Acquisition  
Fair value of contingent consideration $ 4,797,717
Change in fair value of contingent consideration (4,103,487)
Contingent consideration at December 31, 2021 (note 20) $ 694,230
XML 108 R64.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details) - CAD ($)
Mar. 25, 2021
Dec. 31, 2021
Dec. 31, 2020
Reserve Quantities [Line Items]      
Goodwill   $ 5,940,409 $ 2,166,563
Vital Intelligence Inc [Member]      
Reserve Quantities [Line Items]      
Number of units of Draganfly Inc. 578,248    
Fair value of units $ 14.43    
Fair value of units of Draganfly Inc. $ 8,342,966    
Cash portion of purchase price 466,643    
Total 8,809,609    
Identifiable intangible assets, Brand 23,000    
Identifiable intangible assets, Software 433,000    
Identifiable intangible assets 456,000    
Goodwill 8,353,609    
Total consideration $ 8,809,609    
XML 109 R65.htm IDEA: XBRL DOCUMENT v3.22.1
VITAL INTELLIGENCE ACQUISITION (Details Narrative)
9 Months Ended 12 Months Ended
Aug. 19, 2021
CAD ($)
shares
Mar. 25, 2021
CAD ($)
$ / shares
shares
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2021
CAD ($)
shares
Dec. 31, 2020
CAD ($)
Dec. 31, 2019
CAD ($)
Reserve Quantities [Line Items]            
Shares held in escrow | shares 900,000          
Derivative financial liabilities $ 4,797,717          
Increase (decrease) in credit derivative, fair value       $ 694,230    
Revenue       7,053,865 $ 4,363,511 $ 1,380,427
Profit (loss)       $ (16,202,972) $ (8,015,813) $ (11,095,057)
Vital Intelligence Inc [Member]            
Reserve Quantities [Line Items]            
Revenue     $ 115,369      
Profit (loss)     $ 203,231      
Escrow Agreement One [Member]            
Reserve Quantities [Line Items]            
Stock issued, shares | shares 300,000          
Escrow Agreement Two [Member]            
Reserve Quantities [Line Items]            
Stock issued, shares | shares 300,000          
Shares issued, amount $ 2,000,000          
Escrow Agreement Three [Member]            
Reserve Quantities [Line Items]            
Stock issued, shares | shares 300,000          
Shares issued, amount $ 4,000,000          
Escrow Agreement Four [Member]            
Reserve Quantities [Line Items]            
Stock issued, shares | shares 300,000          
Shares issued, amount $ 6,000,000          
Vital Intelligence Inc [Member]            
Reserve Quantities [Line Items]            
Number of shares issued | shares     1,200,000 1,200,000    
Vital Intelligence Inc [Member] | Brand [Member]            
Reserve Quantities [Line Items]            
Royalty Percentage   0.0025        
Royalty discount percentage   0.144        
Vital Intelligence Inc [Member] | Software [Member]            
Reserve Quantities [Line Items]            
Royalty Percentage   0.050        
Royalty discount percentage   0.144        
Vital Intelligence Inc [Member] | Asset Purchase Agreement [Member]            
Reserve Quantities [Line Items]            
Payment to acquire assets   $ 500,000        
Number of shares issued | shares   1,200,000        
Explanation of nature and amount of significant transactions   the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets.        
Warrant exercise price per share | $ / shares   $ 13.35        
Warrant expiration term   1 year        
Escrow deposit units | shares   300,000        
Description for Number of Shares Issued   The units were issued on March 22, 2021        
Vital Intelligence Inc [Member] | Asset Purchase Agreement [Member] | Maximum [Member]            
Reserve Quantities [Line Items]            
Final payment 250,000          
Vital Intelligence Inc [Member] | Asset Purchase Agreement [Member] | Minimum [Member]            
Reserve Quantities [Line Items]            
Final payment $ 227,984          
XML 110 R66.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details) - CAD ($)
12 Months Ended
Aug. 15, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of shares of Draganfly Inc. 2,100,000      
Fair value of common shares in concurrent financing $ 2.50      
Fair value of shares of Draganfly Inc. $ 5,250,001      
Fair value of warrants 1,645,193      
Fair value of shares issued for transaction fees 1,000,000      
Net assets acquired (90,335)      
Listing expense 7,804,859 $ 7,804,859
Cash 28,538      
Accounts receivable 4,991      
Loans receivable 963,269      
Accounts payable and accrued liabilities (406,463)      
Subscription receipts (500,000)      
Net of liabilities $ 90,335 $ 7,187,001 $ 3,252,362  
XML 111 R67.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)
12 Months Ended
Feb. 04, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Expected volatility       100.00%
Expected dividend yield   0.00% 0.00% 0.00%
Warrant reserve [member]        
IfrsStatementLineItems [Line Items]        
Risk-free interest rate 0.86%      
Estimated life 1.48      
Expected volatility 100.00%      
Expected dividend yield 0.00%      
XML 112 R68.htm IDEA: XBRL DOCUMENT v3.22.1
AMALGAMATION (Details Narrative) - CAD ($)
1 Months Ended 12 Months Ended
Feb. 04, 2021
Aug. 15, 2019
Jan. 31, 2019
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Transaction fees   $ 1,000,000    
Fair value of warrants       $ 8,833
Draganfly Innovations Shares [Member]        
IfrsStatementLineItems [Line Items]        
Exchange of common stocks   8,527,671   8,517,671
Common stock, issued   10,500,001 222,965  
Exercisable warrant price $ 0.50 $ 2.50    
Transaction fees     $ 1,000,000  
Fair value of warrants $ 1,645,193      
Proceeds from subscription receipts   $ 7,025,750    
Draganfly Innovations Shares [Member] | Warrant reserve [member]        
IfrsStatementLineItems [Line Items]        
Common stock, issued 800,000      
XML 113 R69.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Cash held in banks $ 22,729,212 $ 1,839,871
Guaranteed investment certificates 346,501 142,545
Cash and Cash Equivalents $ 23,075,713 $ 1,982,416
XML 114 R70.htm IDEA: XBRL DOCUMENT v3.22.1
CASH AND CASH EQUIVALENTS (Details Narrative) - Guaranteed Investment Certificate [Member] - CAD ($)
Dec. 21, 2021
May 28, 2021
Mar. 27, 2021
Mar. 27, 2020
IfrsStatementLineItems [Line Items]        
Purchase of financial instrument $ 50,000 $ 140,000   $ 142,000
Financial instrument term 1 year 1 year   1 year
Average effective Instrument rate 0.05% 0.35%   0.50%
Renew of financial instruments     $ 142,710  
Renewed financial instrument term     1 year  
Renewed effective instrument rate     0.10%  
XML 115 R71.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF AMOUNTS RECEIVABLE (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Amounts Receivable    
Trade accounts receivable $ 951,314 $ 780,254
Corporate taxes receivable 182,820
GST receivable 272,993
SR&ED receivable 30,537
Trade and other receivables $ 1,407,127 $ 810,791
XML 116 R72.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INVENTORIES (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Finished goods $ 3,017,363 $ 1,155,871
Parts 373,459 77,748 48,653
Inventories  $ 3,390,822 $ 1,233,619 $ 48,653
XML 117 R73.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF COST OF SALES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Inventory $ 3,420,713 $ 2,257,797 $ 118,626
Consulting and services 679,345 164,119 86,280
Other 310,719 181,995 13,894
Cost of sales  $ 4,410,777 $ 2,603,911 $ 218,800
XML 118 R74.htm IDEA: XBRL DOCUMENT v3.22.1
INVENTORY (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Cost of sales $ 4,410,777 $ 2,603,911 $ 218,800
Inventory write-down 23,955
Inventory [Member]      
IfrsStatementLineItems [Line Items]      
Cost of sales $ 3,420,713 $ 2,257,797 $ 118,826
XML 119 R75.htm IDEA: XBRL DOCUMENT v3.22.1
DISCLOSURE OF NOTES RECEIVABLE (Details)
12 Months Ended
Dec. 31, 2021
CAD ($)
IfrsStatementLineItems [Line Items]  
Principal $ 1,988,815
Interest 39,794
Accretion 17,038
Impairment loss (891,471)
Note receivable $ 1,154,176
Note One [Member]  
IfrsStatementLineItems [Line Items]  
Start Date Apr. 21, 2021 [1]
Maturity Date Oct. 21, 2022 [1]
Interest Rate 0.00% [1]
Principal $ 180,597 [1]
Interest [1]
Accretion 9,573 [1]
Impairment loss [1]
Note receivable $ 190,170 [1]
Note Two [Member]  
IfrsStatementLineItems [Line Items]  
Start Date Jun. 01, 2021 [1]
Maturity Date Jun. 01, 2023 [1]
Interest Rate 8.00% [1]
Principal $ 114,833 [1]
Interest 5,378 [1]
Accretion [1]
Impairment loss (120,211) [1]
Note receivable [1]
Note 3 [Member]  
IfrsStatementLineItems [Line Items]  
Start Date Sep. 22, 2021 [1]
Maturity Date Sep. 22, 2024 [1]
Interest Rate 5.00% [1]
Principal $ 943,385 [1]
Interest 13,156 [1]
Accretion 7,465 [1]
Impairment loss [1]
Note receivable $ 964,006 [1]
Note 4 [Member]  
IfrsStatementLineItems [Line Items]  
Start Date Nov. 17, 2021
Maturity Date Apr. 26, 2022 [1]
Interest Rate 8.00%
Principal $ 750,000
Interest 21,260
Accretion
Impairment loss (771,260)
Note receivable
[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 120 R76.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES RECEIVABLE (Details Narrative)
12 Months Ended
Dec. 31, 2021
CAD ($)
Note Two [Member]  
IfrsStatementLineItems [Line Items]  
Note receivable interest rate 8.00% [1]
Loans written down
Note 3 [Member]  
IfrsStatementLineItems [Line Items]  
Note receivable interest rate 5.00% [1]
Note 4 [Member]  
IfrsStatementLineItems [Line Items]  
Note receivable interest rate 8.00%
Loans written down
[1] These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.
XML 121 R77.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Insurance $ 2,938,246 $ 992
Prepaid director fees 107,763
Prepaid interest 6,969
Prepaid marketing services 1,638,179 187,826
Prepaid rent 3,583
Prepaid subscriptions 35,687 5,953
Deposits 768,033 136,668
 Prepaid expenses and deposits $ 5,494,877 $ 335,022
XML 122 R78.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INVESTMENTS (Details)
12 Months Ended
Dec. 31, 2021
CAD ($)
IfrsStatementLineItems [Line Items]  
Balance at December 31, 2020
Investments 623,706
Change in fair value (332,640)
Balance at December 31, 2021 291,066
Public Company Shares [Member]  
IfrsStatementLineItems [Line Items]  
Balance at December 31, 2021 142,857
Public Company Warrants [Member]  
IfrsStatementLineItems [Line Items]  
Balance at December 31, 2021 21,429
Private Company Shares [Member]  
IfrsStatementLineItems [Line Items]  
Balance at December 31, 2021 $ 126,780
XML 123 R79.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)
12 Months Ended
Mar. 10, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Expected volatility       100.00%
Expected life   5 years   7 years 6 months
Expected dividend yield   0.00% 0.00% 0.00%
Warrants [Member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate 0.28% 0.91%    
Expected volatility 150.88% 124.09%    
Expected life 2 years 2 years 2 years  
Expected dividend yield 0.00% 0.00% 0.00%  
XML 124 R80.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENTS (Details Narrative) - CAD ($)
Oct. 27, 2021
Mar. 10, 2021
Disclosure Investments Abstract    
Number of shares purchased 50,000 1,428,571
Number of shares purchased, value $ 100,000 $ 500,000
warrant, exercise price   $ 0.50
Warrants expiration date   Mar. 17, 2023
XML 125 R81.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance $ 257,974 $ 179,140
Additions 212,579 23,888
Net assets acquired in the Transaction   54,946
Revaluation (3,619)  
Property, plant and equipment, ending balance 466,934 257,974
Accumulated depreciation Property, plant and equipment, beginning balance 104,104 63,999
Charge for the year 65,787 40,105
Accumulated depreciation Property, plant and equipment, ending balance 169,891 104,104
Property, plant and equipment 297,043 153,870
Computer equipment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 24,397 7,000
Additions 29,713 2,028
Net assets acquired in the Transaction   15,369
Revaluation  
Property, plant and equipment, ending balance 54,110 24,397
Accumulated depreciation Property, plant and equipment, beginning balance 12,392 6,761
Charge for the year 12,899 5,631
Accumulated depreciation Property, plant and equipment, ending balance 25,291 12,392
Property, plant and equipment 28,819 12,005
Furniture and Equipment [Member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 171,606 142,173
Additions 170,866 21,860
Net assets acquired in the Transaction   7,573
Revaluation  
Property, plant and equipment, ending balance 342,472 171,606
Accumulated depreciation Property, plant and equipment, beginning balance 59,963 37,944
Charge for the year 42,314 22,019
Accumulated depreciation Property, plant and equipment, ending balance 102,277 59,963
Property, plant and equipment 240,195 111,643
Leasehold improvements [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 4,352
Additions
Net assets acquired in the Transaction   4,352
Revaluation  
Property, plant and equipment, ending balance 4,352 4,352
Accumulated depreciation Property, plant and equipment, beginning balance 3,220
Charge for the year 1,132 3,220
Accumulated depreciation Property, plant and equipment, ending balance 4,352 3,220
Property, plant and equipment 1,132
Computer software [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 29,967 29,967
Additions
Net assets acquired in the Transaction  
Revaluation  
Property, plant and equipment, ending balance 29,967 29,967
Accumulated depreciation Property, plant and equipment, beginning balance 22,496 19,294
Charge for the year 2,241 3,202
Accumulated depreciation Property, plant and equipment, ending balance 24,737 22,496
Property, plant and equipment 5,230 7,471
Vehicles [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment, beginning balance 27,652
Additions 12,000
Net assets acquired in the Transaction   27,652
Revaluation (3,619)  
Property, plant and equipment, ending balance 36,033 27,652
Accumulated depreciation Property, plant and equipment, beginning balance 6,033
Charge for the year 7,201 6,033
Accumulated depreciation Property, plant and equipment, ending balance 13,234 6,033
Property, plant and equipment $ 22,799 $ 21,619
XML 126 R82.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INTELLECTUAL PROPERTY (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance $ 2,524,494 $ 41,931  
Intangible assets acquired in the Acquisition 8,809,609 2,482,563  
Impairment of goodwill (4,579,763)
Intellectual properties and goodwill, Ending balance 6,754,340 2,524,494 41,931
Accumulated amortization, beginning balance 84,064 40,546  
Change for the year 135,966 43,518  
Accumulated amortization, ending balance 220,030 84,064 40,546
Intellectual properties and goodwill 6,534,310 2,440,430  
Patent [Member]      
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance 41,931 41,931  
Intangible assets acquired in the Acquisition  
Impairment of goodwill    
Intellectual properties and goodwill, Ending balance 41,931 41,931 41,931
Accumulated amortization, beginning balance 41,931 40,546  
Change for the year 1,385  
Accumulated amortization, ending balance 41,931 41,931 40,546
Intellectual properties and goodwill  
Customer Relationship [Member]      
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance 197,000  
Intangible assets acquired in the Acquisition 197,000  
Impairment of goodwill    
Intellectual properties and goodwill, Ending balance 197,000 197,000
Accumulated amortization, beginning balance 26,267  
Change for the year 34,147 26,267  
Accumulated amortization, ending balance 60,414 26,267
Intellectual properties and goodwill 136,586 170,733  
Brand [Member]      
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance  
Intangible assets acquired in the Acquisition 23,000  
Impairment of goodwill    
Intellectual properties and goodwill, Ending balance 23,000
Accumulated amortization, beginning balance  
Change for the year 3,450  
Accumulated amortization, ending balance 3,450
Intellectual properties and goodwill 19,550  
Software [Member]      
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance 119,000  
Intangible assets acquired in the Acquisition 433,000 119,000  
Impairment of goodwill    
Intellectual properties and goodwill, Ending balance 552,000 119,000
Accumulated amortization, beginning balance 15,866  
Change for the year 98,369 15,866  
Accumulated amortization, ending balance 114,235 15,866
Intellectual properties and goodwill 437,765 103,134  
Goodwill [member]      
IfrsStatementLineItems [Line Items]      
Intellectual properties and goodwill, beginning balance 2,166,563  
Intangible assets acquired in the Acquisition 8,353,609 2,166,563  
Impairment of goodwill (4,579,763)    
Intellectual properties and goodwill, Ending balance 5,940,409 2,166,563
Accumulated amortization, beginning balance  
Change for the year  
Accumulated amortization, ending balance
Intellectual properties and goodwill $ 5,940,409 $ 2,166,563  
XML 127 R83.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Mar. 25, 2021
Apr. 30, 2020
IfrsStatementLineItems [Line Items]          
Goodwill $ 5,940,409 $ 2,166,563      
Impairment of goodwill $ 4,579,763    
Assumption discount rates 10.00%        
Dronelogics [Member]          
IfrsStatementLineItems [Line Items]          
[custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0] 14.00%        
Percentage of weighted average cost of capital 17.00%        
Reduction in value $ 597,100        
Vital [Member]          
IfrsStatementLineItems [Line Items]          
[custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0] 42.00%        
Percentage of weighted average cost of capital 24.00%        
Reduction in value $ 570,133        
Vital and Dronelogics [Member]          
IfrsStatementLineItems [Line Items]          
Percentage of cash flow projection 2.00%        
Customer-related intangible assets [member] | Dronelogics [Member]          
IfrsStatementLineItems [Line Items]          
Percentage of acquired         100.00%
Customer relationships         $ 197,000
Brand [Member]          
IfrsStatementLineItems [Line Items]          
Impairment of goodwill        
Brand [Member] | Dronelogics [Member]          
IfrsStatementLineItems [Line Items]          
Percentage of acquired         100.00%
Customer relationships         $ 119,000
Brand [Member] | Vital [Member]          
IfrsStatementLineItems [Line Items]          
Customer relationships       $ 23,000  
Computer software [member] | Vital [Member]          
IfrsStatementLineItems [Line Items]          
Customer relationships       433,000  
Goodwill [member]          
IfrsStatementLineItems [Line Items]          
Impairment of goodwill $ 4,579,763        
Goodwill [member] | Dronelogics [Member]          
IfrsStatementLineItems [Line Items]          
Percentage of acquired         100.00%
Goodwill       $ 8,353,609 $ 2,166,563
XML 128 R84.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF RIGHT OF USE ASSETS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Right Of Use Assets    
Right of use assets, at cost, beginning $ 242,967 $ 159,539
Leases acquired in the Acquisition   83,428
Additions 447,242  
Lease removal (7,092)  
Right of use assets, at cost, ending 683,117 242,967
Accumulated amortization, Beginning 98,548 29,545
Charge for the year 109,311 69,003
Historical correction 7,152  
Accumulated amortization, ending 215,011 98,548
Right of use assets $ 468,106 $ 144,419
XML 129 R85.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF OPERATING LEASE LIABILITIES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Lease Liability    
Balance - Beginning of period $ 158,124 $ 136,073
Leases acquired in the Acquisition   87,203
Interest expense 26,964 18,290
Lease Payments (128,995) (83,442)
Additions 440,675  
Lease removal (7,645)  
Balance - End of period 489,123 158,124
Current lease liabilities 110,481 93,239
Non-current lease liabilities 378,642 64,885
Lease liabilities $ 489,123 $ 158,124
XML 130 R86.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Maturity analysis $ 590,544    
Amount representing implicit interest (101,421)    
Lease liability 489,123 $ 158,124 $ 136,073
Not later than one year [member]      
IfrsStatementLineItems [Line Items]      
Maturity analysis 150,276    
Later than one year and not later than three years [member]      
IfrsStatementLineItems [Line Items]      
Maturity analysis 251,765    
Later than four years and not later than five years [member]      
IfrsStatementLineItems [Line Items]      
Maturity analysis 183,473    
Later than five years [member]      
IfrsStatementLineItems [Line Items]      
Maturity analysis $ 5,030    
XML 131 R87.htm IDEA: XBRL DOCUMENT v3.22.1
LEASE LIABILITY (Details Narrative)
12 Months Ended
Dec. 31, 2021
Lease Liability  
Depreciation Lease Liability The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%
XML 132 R88.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Trade Payables And Accrued Liabilities    
Trade accounts payable $ 362,890 $ 813,881
Accrued liabilities 402,540 512,205
Due to related parties (Note 23) 475,628
Government grant payable 33,709 33,709
GST/PST Payable 21,754
Trade payables and accrued liabilities $ 799,139 $ 1,857,177
XML 133 R89.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CUSTOMER DEPOSITS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Customer Deposits    
Customer deposits $ 172,134 $ 385,449
XML 134 R90.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF DEFERRED INCOME (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Deferred Income $ 73,286 $ 5,062
Customers [Member]    
IfrsStatementLineItems [Line Items]    
Deferred Income 80,000
Government [Member]    
IfrsStatementLineItems [Line Items]    
Deferred Income 5,233 5,062
Note Receivable Accretion [Member]    
IfrsStatementLineItems [Line Items]    
Deferred Income $ (11,947)
XML 135 R91.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF LOANS PAYABLE (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Loans Payable    
Opening balance $ 97,916
Acquisition of loans 120,851
Issuance of loans payable 60,000 60,000
Fair value adjustment (24,576) (26,152)
Repayment of loans payable (44,428) (57,873)
Accretion expense 4,405 1,090
Ending balance $ 93,317 $ 97,916
XML 136 R92.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF LOANS (Details) - CAD ($)
12 Months Ended
May 19, 2020
Dec. 31, 2021
Apr. 23, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]        
Rate 25.00%      
Total Carrying Value   $ 93,317   $ 97,916
CEBA [Member]        
IfrsStatementLineItems [Line Items]        
Start Date   May 19, 2020    
Maturity Date three-year term Dec. 31, 2022    
Rate 5.00% 0.00% 5.00%  
Total Carrying Value   $ 37,384   34,938
CEBA [Member]        
IfrsStatementLineItems [Line Items]        
Start Date   Apr. 23, 2021    
Maturity Date   Dec. 31, 2022    
Rate   0.00%    
Total Carrying Value   $ 37,383  
Vehicle Loan [Member]        
IfrsStatementLineItems [Line Items]        
Start Date   Aug. 30, 2019    
Maturity Date   Sep. 11, 2024    
Rate   6.99%    
Total Carrying Value   $ 18,550   25,295
Shopify Loan [Member]        
IfrsStatementLineItems [Line Items]        
Start Date   Aug. 05, 2020    
Rate   7.00%    
Total Carrying Value     $ 37,683
XML 137 R93.htm IDEA: XBRL DOCUMENT v3.22.1
LOANS PAYABLE (Details Narrative) - CAD ($)
12 Months Ended
Apr. 23, 2021
Dec. 04, 2020
May 19, 2020
Dec. 31, 2021
IfrsStatementLineItems [Line Items]        
Interest rate     25.00%  
CEBA [Member]        
IfrsStatementLineItems [Line Items]        
Loan received     $ 40,000  
Interest rate 5.00%   5.00% 0.00%
Loans forgivable amount $ 20,000   $ 10,000  
Maturity     three-year term Dec. 31, 2022
Proceeds from loan   $ 20,000    
Loan forgiveness   $ 10,000    
Unsecured loan received $ 60,000      
XML 138 R94.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)
12 Months Ended
Dec. 31, 2021
shares
$ / shares
Dec. 31, 2020
shares
Dec. 31, 2019
shares
IfrsStatementLineItems [Line Items]      
Remaining Contractual Life (years) 1 year 2 months 12 days 1 year 25 days  
Number of Options 1,035,991 1,193,659 744,993
Exercisable 710,497    
Exercise Price One [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Oct. 30, 2019    
Expiry date Oct. 30, 2029    
Exercise Price | $ / shares $ 2.50    
Remaining Contractual Life (years) 7 years 10 months 2 days    
Number of Options 296,665    
Exercisable 296,665    
Exercise Price Two [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Nov. 19, 2019    
Expiry date Nov. 19, 2029    
Exercise Price | $ / shares $ 2.50    
Remaining Contractual Life (years) 7 years 10 months 20 days    
Number of Options 50,000    
Exercisable 50,000    
Exercise Price Three [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Apr. 30, 2020    
Expiry date Apr. 30, 2030    
Exercise Price | $ / shares $ 2.50    
Remaining Contractual Life (years) 8 years 3 months 29 days    
Number of Options 87,000    
Exercisable 78,666    
Exercise Price Four [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Apr. 30, 2020    
Expiry date Apr. 30, 2030    
Exercise Price | $ / shares $ 3.85    
Remaining Contractual Life (years) 8 years 3 months 29 days    
Number of Options 110,000    
Exercisable 70,000    
Exercise Price Five [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Jul. 03, 2020    
Expiry date Jul. 03, 2025    
Exercise Price | $ / shares $ 3.20    
Remaining Contractual Life (years) 3 years 6 months 3 days    
Number of Options 200,000    
Exercisable 166,666    
Exercise Price Six [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Nov. 24, 2020    
Expiry date Nov. 24, 2030    
Exercise Price | $ / shares $ 2.50    
Remaining Contractual Life (years) 8 years 10 months 24 days    
Number of Options 32,000    
Exercisable 21,000    
Exercise Price Seven [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Dec. 11, 2020    
Expiry date Dec. 11, 2030    
Exercise Price | $ / shares $ 2.15    
Remaining Contractual Life (years) 8 years 11 months 12 days    
Number of Options 12,500    
Exercisable 12,500    
Exercise Price Eight [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Feb. 02, 2021    
Expiry date Feb. 02, 2031    
Exercise Price | $ / shares $ 13.20    
Remaining Contractual Life (years) 9 years 1 month 2 days    
Number of Options 30,000    
Exercisable 10,000    
Exercise Price Nine [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Mar. 08, 2021    
Expiry date Mar. 08, 2026    
Exercise Price | $ / shares $ 13.90    
Remaining Contractual Life (years) 4 years 2 months 8 days    
Number of Options 10,000    
Exercisable 5,000    
Exercise Price Ten [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Apr. 27, 2021    
Expiry date Apr. 27, 2031    
Exercise Price | $ / shares $ 10.15    
Remaining Contractual Life (years) 9 years 2 months 23 days    
Number of Options 182,000    
Exercisable    
Exercise Price Eleven [Member]      
IfrsStatementLineItems [Line Items]      
Grant date Sep. 09, 2021    
Expiry date Sep. 09, 2026    
Exercise Price | $ / shares $ 4.84    
Remaining Contractual Life (years) 4 years 8 months 8 days    
Number of Options 25,826    
Exercisable    
XML 139 R95.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF CHANGES IN STOCK OPTIONS (Details)
12 Months Ended
Dec. 31, 2021
shares
$ / shares
Dec. 31, 2020
shares
$ / shares
Share Capital    
Number of options outstanding, Beginning Balance | shares 1,193,659 744,993
Weighted average exercise price, Beginning Balance | $ / shares $ 2.75 $ 2.50
Number of options outstanding, forfeited | shares   (43,334)
Weighted average exercise price, forfeited | $ / shares   $ 2.50
Number of options outstanding, Granted | shares 247,826 492,000
Weighted average exercise price, Granted | $ / shares $ 10.12 $ 3.08
Number of options outstanding, Exercised | shares (405,494)  
Weighted average exercise price, Exercised | $ / shares $ 2.50  
Number of options outstanding, Ending Balance | shares 1,035,991 1,193,659
Weighted average exercise price, Ending Balance | $ / shares $ 4.60 $ 2.75
XML 140 R96.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Expected volatility     100.00%
Expected life 5 years   7 years 6 months
Expected dividend yield 0.00% 0.00% 0.00%
Exercise price     $ 2.50
Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Risk free interest rate 0.69% 0.43% 1.45%
Expected volatility 62.84% 113.53%  
Expected life   5 years  
Exercise price $ 4.84 $ 2.15  
Top of range [member]      
IfrsStatementLineItems [Line Items]      
Risk free interest rate 1.40% 0.66% 146.00%
Expected volatility 113.16% 119.03%  
Expected life   10 years  
Exercise price $ 13.90 $ 3.85  
XML 141 R97.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) - shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 511,299  
Number of RSUs outstanding, Ending of the period 7,214,819 511,299
Restricted Stock Units Rsu [Member]    
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 614,666 634,997
Exercised (448,660) (199,998)
Forfeited   (68,333)
Issued 348,826 248,000
Number of RSUs outstanding, Ending of the period 514,832 614,666
XML 142 R98.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2020
USD ($)
IfrsStatementLineItems [Line Items]      
Contingent consideration at December 31, 2021   $ 694,230  
Warrants [Member]      
IfrsStatementLineItems [Line Items]      
Beginning of the period $ 748,634  
Warrants issuance 8,261,511   281,732
Change in fair value of warrants outstanding (4,046,325)   466,902
Shares issued for exercise of broker warrants of derivatives (98,048)    
End of the period 4,865,772   $ 748,634
Warrants 4,865,772    
Contingent consideration 694,230    
Contingent consideration at December 31, 2021 $ 5,560,002    
XML 143 R99.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2021
USD ($)
shares
$ / shares
Dec. 31, 2020
USD ($)
shares
IfrsStatementLineItems [Line Items]    
Number of Warrants Outstanding | shares 7,214,819 511,299
Fair Value of warrants | $ $ 4,865,772 $ 748,634
Range 1 [member]    
IfrsStatementLineItems [Line Items]    
Issue Date Nov. 30, 2020  
Exercise price | $ / shares $ 3.55  
Number of Warrants Outstanding | shares 482,425 511,299
Fair Value of warrants | $ $ 182,262 $ 748,634
Range 2 [member]    
IfrsStatementLineItems [Line Items]    
Issue Date Feb. 05, 2021  
Exercise price | $ / shares $ 3.55  
Number of Warrants Outstanding | shares 1,323,275
Fair Value of warrants | $ $ 951,226
Range 3 [member]    
IfrsStatementLineItems [Line Items]    
Issue Date Mar. 05, 2021  
Exercise price | $ / shares $ 3.55  
Number of Warrants Outstanding | shares 5,154,321
Fair Value of warrants | $ $ 3,731,285
Range 4 [member]    
IfrsStatementLineItems [Line Items]    
Issue Date Jul. 29, 2021  
Exercise price | $ / shares $ 5.00  
Number of Warrants Outstanding | shares 250,000
Fair Value of warrants | $ $ 84,625
Range 5 [member]    
IfrsStatementLineItems [Line Items]    
Issue Date Sep. 14, 2021  
Exercise price | $ / shares $ 5.00  
Number of Warrants Outstanding | shares 4,798
Fair Value of warrants | $ $ 1,685
XML 144 R100.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)
12 Months Ended
Mar. 10, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]        
Expected volatility       100.00%
Expected life   5 years   7 years 6 months
Expected dividend yield   0.00% 0.00% 0.00%
Bottom of range [member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate   0.69% 0.43% 1.45%
Expected volatility   62.84% 113.53%  
Expected life     5 years  
Top of range [member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate   1.40% 0.66% 146.00%
Expected volatility   113.16% 119.03%  
Expected life     10 years  
Warrants [Member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate 0.28% 0.91%    
Expected volatility 150.88% 124.09%    
Expected life 2 years 2 years 2 years  
Expected dividend yield 0.00% 0.00% 0.00%  
Warrants [Member] | Bottom of range [member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate   0.23% 0.20%  
Expected volatility   70.95% 72.76%  
Expected life   2 years    
Warrants [Member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Risk free interest rate   0.95% 0.24%  
Expected volatility   144.59% 74.10%  
Expected life   3 years    
XML 145 R101.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF CHANGES IN WARRANTS (Details)
12 Months Ended
Dec. 31, 2021
shares
$ / shares
Dec. 31, 2020
shares
$ / shares
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period | shares 511,299  
Weighted Average Exercise Price, Oustanding, Beginning Balance   $ 2.50
Number of RSUs outstanding, Ending of the period | shares 7,214,819 511,299
Warrants [Member]    
IfrsStatementLineItems [Line Items]    
Number of RSUs outstanding, Beginning of the period 2,416,864 3,610,340
Weighted Average Exercise Price, Oustanding, Beginning Balance $ 2.95 $ 2.05
Exercised (1,939,534) (1,584,775)
Weighted Average Exercise Price, Exercised $ 2.54 $ 1.50
Forfeited (6,000) (120,000)
Weighted Average Exercise Price, Forfeited $ 2.50 $ 2.50
Granted 7,943,489 511,299
Weighted Average Exercise Price, Granted $ 5.10 $ 3.55
Number of RSUs outstanding, Ending of the period 8,414,819 2,416,864
Weighted Average Exercise Price, Oustanding, Ending Balance $ 4.99 $ 2.95
XML 146 R102.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF WARRANTS OUTSTANDING (Details)
12 Months Ended
Dec. 31, 2021
$ / shares
shares
Warrant One [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Nov. 30, 2020
Expiry Date Nov. 30, 2022
Exercise price | $ / shares $ 3.55
Number of warrants outstanding 482,425
Warrant Two [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Feb. 05, 2021
Expiry Date Feb. 05, 2023
Exercise price | $ / shares $ 3.55
Number of warrants outstanding 1,323,275
Warrant Three [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Mar. 05, 2021
Expiry Date Mar. 05, 2023
Exercise price | $ / shares $ 3.55
Number of warrants outstanding 5,154,321
Warrant Four [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Mar. 22, 2021
Expiry Date Mar. 22, 2023
Exercise price | $ / shares $ 13.35
Number of warrants outstanding 1,200,000
Warrant Five [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Jul. 29, 2021
Expiry Date Jul. 29, 2024
Exercise price | $ / shares $ 5.00
Number of warrants outstanding 250,000
Warrant Six [Member]  
IfrsStatementLineItems [Line Items]  
Date issued Sep. 14, 2021
Expiry Date Sep. 14, 2024
Exercise price | $ / shares $ 5.00
Number of warrants outstanding 4,798
Warrants [Member]  
IfrsStatementLineItems [Line Items]  
Number of warrants outstanding 8,414,819
XML 147 R103.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE CAPITAL (Details Narrative) - CAD ($)
12 Months Ended
Mar. 22, 2021
Feb. 04, 2021
Aug. 15, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]            
Value of stock issued for exercise of warrants       $ 4,929,790    
Number of stock units issued for regulation financing       6,488,691 511,299  
Stock units issued during period value regulation financing       $ 18,815,485 $ 1,518,845  
Share capital issuance, description       Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.  
Warrant derivative liability       $ 8,261,511    
Number of stock issued for private placement       5,095,966   2,810,300
Value of stock issued for private placement       $ 25,538,213    
Number of stock issued for cash proceeds         192,308  
Value of stock issued for cash proceeds         $ 500,000  
Number of stock issued for debt settlement         111,082  
Recongnized loss         $ 344,354  
Comprehensive loss         38,879  
Proceeds from issuance of notes payable       123,000 $ 1,137,978
Subscription receivable           153,566
Amounts payable, related party transactions       475,628 $ 9,681
Shares issued of settlement trades payable, shares           9,065
[custom:SharesIssuedOfSettlementTradesPayable]           $ 22,662
Trades payable per share           $ 2.50
Shares issued of settlement convertible debentures and accrued interest, shares           423,698
Shares issued of settlement convertible debentures           $ 740,000
Gain loss on settlement of debt           $ 319,246
Purchases of exercise of warrants, shares           63,388
Purchases of exercise of warrants           $ 8,833
Capital reserve       $ 6,406,117 $ 3,024,007 212,908
Number of options outstanding, Granted       247,826 492,000  
Weighted average exercise price, Granted       $ 10.12 $ 3.08  
Adjustments for share-based payments       $ 3,952,595 $ 2,668,464 761,559
Weighted average remaining contractual life of outstanding share options       1 year 2 months 12 days 1 year 25 days  
Warrants issued 1,200,000          
Warrants held in escrow 900,000          
Warrants [Member]            
IfrsStatementLineItems [Line Items]            
Warrants Expiration Date Description       During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021.    
Stock Options [Member]            
IfrsStatementLineItems [Line Items]            
Adjustments for share-based payments       $ 1,660,894 $ 1,724,853 599,701
Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of accelerated vesting shares       323,661    
Number of shares vested       124,999    
Number of shares granted post consolidation       348,826    
Share based payment expense       $ 2,291,701 $ 943,611 $ 161,858
Employee [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       30,000 89,000  
Weighted average exercise price, Granted       $ 13.20 $ 2.50  
Stock option exercisable year       10 years 10 years  
Consultant [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       10,000 120,000  
Weighted average exercise price, Granted       $ 13.90 $ 3.85  
Stock option exercisable year       5 years 10 years  
Employees and Consultant [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       182,000    
Weighted average exercise price, Granted       $ 10.15    
Stock option exercisable year       10 years    
Employee One [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted       25,826 200,000  
Weighted average exercise price, Granted       $ 4.84 $ 3.20  
Stock option exercisable year       5 years 5 years  
Employee Two [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         33,000  
Weighted average exercise price, Granted         $ 2.50  
Stock option exercisable year         10 years  
Consultant One [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         50,000  
Weighted average exercise price, Granted         $ 2.15  
Stock option exercisable year         10 years  
Employee and Consultant [Member] | Restricted Stock Units [Member]            
IfrsStatementLineItems [Line Items]            
Number of options outstanding, Granted         248,000  
Draganfly Innovations Shares [Member]            
IfrsStatementLineItems [Line Items]            
Stock issued during period value units, shares     8,527,671     8,517,671
Purchases of exercise of warrants   $ 1,645,193        
Vital Intelligence Inc [Member]            
IfrsStatementLineItems [Line Items]            
Share capital issuance, description       Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.   Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020
Number of stock units issued for acquisition       1,200,000    
Dronelogics Inc [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock units issued for acquisition         645,088  
Stock units issued during period shares common shares finder fees         40,000  
Common Stock 1 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants       1,580,525 24,000  
Value of stock issued for exercise of warrants       $ 3,951,312 $ 60,000  
Number of stock issued for restrcited share units       149,999 7,117  
Number of stock issued for exercise of options       392,999    
Value of stock issued for exercise of options       $ 987,248    
Number of shares issued       15,000   143,985
Proceeds from issuance of notes payable           $ 799,341
Subscription receivable           $ 153,566
Shares issued as transactions fees, shares           222,965
Amounts payable, related party transactions           $ 1,000,000
Common Stock 2 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants       359,009 20,000  
Value of stock issued for exercise of warrants       $ 978,478 $ 50,000  
Number of stock issued for restrcited share units       298,661 2,040  
Number of stock issued for exercise of options       12,500    
Value of stock issued for exercise of options       $ 26,875    
Number of shares issued       356,901    
Common Stock 3 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         210,320  
Value of stock issued for exercise of warrants         $ 105,160  
Number of stock issued for restrcited share units         2,647  
Common Stock 4 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         73,000  
Value of stock issued for exercise of warrants         $ 36,500  
Number of stock issued for restrcited share units         188,194  
Common Stock 5 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         294,840  
Value of stock issued for exercise of warrants         $ 147,420  
Common Stock 6 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         121,840  
Value of stock issued for exercise of warrants         $ 60,920  
Common Stock 7 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         126,000  
Value of stock issued for exercise of warrants         $ 115,000  
Common Stock 8 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         12,000  
Value of stock issued for exercise of warrants         $ 30,000  
Common Stock 9 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         45,600  
Value of stock issued for exercise of warrants         $ 114,000  
Common Stock 10 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         2,000  
Value of stock issued for exercise of warrants         $ 5,000  
Common Stock 11 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         2,200  
Value of stock issued for exercise of warrants         $ 5,500  
Common Stock 12 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         637,975  
Value of stock issued for exercise of warrants         $ 1,594,938  
Common Stock 13 [Member]            
IfrsStatementLineItems [Line Items]            
Number of stock issued for exercise of warrants         15,000  
Value of stock issued for exercise of warrants         $ 37,500  
XML 148 R104.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Revenue  $ 7,053,865 $ 4,363,511 $ 1,380,427
Product Sales [member]      
IfrsStatementLineItems [Line Items]      
Revenue  5,103,399 3,087,223 248,939
Drone Service [member]      
IfrsStatementLineItems [Line Items]      
Revenue  1,304,799 630,532
Services [Member]      
IfrsStatementLineItems [Line Items]      
Revenue  $ 645,667 $ 645,756 $ 1,131,488
XML 149 R105.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF GEOGRAPHIC REVENUE (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Reserve Quantities [Line Items]      
Revenue  $ 7,053,865 $ 4,363,511 $ 1,380,427
CA Country [member]      
Reserve Quantities [Line Items]      
Revenue  4,937,935 2,270,862 127,118
US Country [member]      
Reserve Quantities [Line Items]      
Revenue  2,071,492 1,982,404 1,251,199
International [member]      
Reserve Quantities [Line Items]      
Revenue  $ 44,438 $ 110,245 $ 2,110
XML 150 R106.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF OPERATING SEGMENTS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Goodwill $ 5,940,409 $ 2,166,563
Property and equipment 297,043 153,870
Intangible assets 593,901 273,867
Investments 291,066
Notes receivable 964,006
Right of use assets 468,106 144,419
TOTAL ASSETS 42,113,240 $ 7,100,567
Canada [member]    
IfrsStatementLineItems [Line Items]    
Goodwill 2,166,564  
Property and equipment 297,043  
Intangible assets 219,093  
Investments 291,066  
Notes receivable  
Right of use assets 468,106  
TOTAL ASSETS 3,441,872  
United States [member]    
IfrsStatementLineItems [Line Items]    
Goodwill 3,773,845  
Property and equipment  
Intangible assets 374,808  
Investments  
Notes receivable 964,006  
Right of use assets  
TOTAL ASSETS 5,112,659  
International [member]    
IfrsStatementLineItems [Line Items]    
Goodwill  
Property and equipment  
Intangible assets  
Investments  
Notes receivable  
Right of use assets  
TOTAL ASSETS  
XML 151 R107.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE (Details Narrative)
12 Months Ended
Dec. 31, 2020
CAD ($)
Custom Engineering Services [member]  
IfrsStatementLineItems [Line Items]  
Service Revenue $ 474,701
XML 152 R108.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Office And Miscellaneous      
Advertising, Marketing, and Investor Relations $ 5,165,791 $ 2,610,930 $ 1,356,174
Compliance fees 432,874 122,916 80,525
Contract Work 300,975 399,546 438,601
Other 556,358 254,473 228,432
Office and Miscellaneous Expenses  $ 6,455,998 $ 3,387,865 $ 2,103,732
XML 153 R109.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Director fees $ 370,094
Management fees paid to a company 4,445,949 1,762,594 524,101
Salaries 722,068 655,799 179,429
Share-based payments 2,475,949 1,614,158 480,158
Total 4,564,102 3,485,742 1,189,647
CEO and Director [Member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company 290,225 737,164 186,000
President and Director [Member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company 205,691 227,524
Former Director [Member]      
IfrsStatementLineItems [Line Items]      
Management fees paid to a company 500,074 165,000 195,000
Former Owner [Member]      
IfrsStatementLineItems [Line Items]      
Salaries $ 86,097 $ 149,060
XML 154 R110.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Professional fees $ 4,445,949 $ 1,762,594 $ 524,101
Amounts payable, related party transactions 475,628 9,681
Business Service Agreement [Member] | Business Instincts Group [Member]      
IfrsStatementLineItems [Line Items]      
Professional fees 315,643 177,000 80,000
Consultant Agreement [Member] | Alberta Ltd [Member]      
IfrsStatementLineItems [Line Items]      
Professional fees 290,225 525,164 9,000
Amounts payable, related party transactions 321,741 $ 9,450
Executive Agreement [Member] | Scott Larson [Member]      
IfrsStatementLineItems [Line Items]      
Professional fees 205,191 227,524  
Amounts payable, related party transactions $ 153,887  
XML 155 R111.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Financial Instruments And Financial Risk Management    
Foreign exchange rate $ 150,715 $ 27,018
XML 156 R112.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies $ 291,066  
Notes receivable 1,154,176  
Derivative liability 5,560,002  
Total 7,005,244  
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies 164,286  
Notes receivable  
Derivative liability
Total 164,286
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies 126,780  
Notes receivable 1,154,176  
Derivative liability
Total 1,280,956
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Equity securities in investee companies  
Notes receivable  
Derivative liability 5,560,002 748,634
Total $ 5,560,002 $ 748,634
XML 157 R113.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF BREAKDOWN CAPITAL (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Financial Instruments And Financial Risk Management        
Cash $ 23,075,713 $ 1,982,416 $ 2,429,375 $ 101,787
Debt 93,317 97,916    
Equity $ 34,926,239 $ 3,848,205    
XML 158 R114.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF INCOME TAX (Details) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Loss before income taxes $ 16,202,972 $ 8,015,813 $ 11,095,507
Canadian statutory rates   27.00% 27.00%
Expected income tax recovery 4,196,600 $ 2,164,000 $ 2,996,000
Impact of different foreign statutory tax rates 34,900
Non-deductible items 116,400 (687,000) (2,043,000)
Share issue costs 887,600
Adjustments to prior years provision versus statutory tax returns 376,500 189,000 (388,000)
Differences between prior year provision and final tax return (206,000) (535,000) (18,000)
Change in deferred tax asset not recognized (5,406,000) (1,131,000) (547,000)
Income tax
XML 159 R115.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE OF DEFERRED TAXES (Details) - CAD ($)
Dec. 31, 2021
Dec. 31, 2020
Jan. 01, 2019
Share issuance costs $ 728,000 $ 30,000
Non-capital losses 7,043,000 3,656,000 2,439,000
Property and equipment 449,000 457,000 581,000
Capital gain reserve 74,000
Scientific Research and Experimental Development 291,000 57,000 49,000
Total deferred income tax assets 8,585,000 4,200,000 3,069,000
Deferred income tax not recognized (8,585,000) (4,200,000) (3,069,000)
Net deferred tax assets
XML 160 R116.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Details Narrative)
12 Months Ended
Dec. 31, 2021
CAD ($)
Tax effect of tax losses $ 25,487,000
XML 161 R117.htm IDEA: XBRL DOCUMENT v3.22.1
OTHER INCOME (Details Narrative) - Apr. 27, 2020
USD ($)
CAD ($)
Amount received from sale of investment $ 854,838 $ 1,179,513
XML 162 R118.htm IDEA: XBRL DOCUMENT v3.22.1
SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Debt settlement, amount $ 344,354    
Debt settlement, shares issued 111,082    
Gai on settlement of debt $ 28,614    
Accounts payable   $ 822,003  
Subscription receivable   153,566  
Convertible Debentures [member]      
IfrsStatementLineItems [Line Items]      
Debt settlement, amount   $ 740,000  
Vital Intelligence Inc [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares issued     1,200,000
[custom:WarrantsExercisePrice-0]     $ 13.35
Common Shares [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares issued   400,000 15,000
Price per share   $ 2.50  
Common Shares One [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares issued     356,901
Fair value of investments other comprehensive loss     $ 332,640
XML 163 R119.htm IDEA: XBRL DOCUMENT v3.22.1
GOVERNMENT ASSISTANCE (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
IfrsStatementLineItems [Line Items]      
Wages and salaries $ 2,768,010 $ 1,649,329 $ 989,083
Canada Emergency Wage Subsidy [member]      
IfrsStatementLineItems [Line Items]      
Wages and salaries 250,756 490,748  
Canada Emergency Rent Subsidy [Member]      
IfrsStatementLineItems [Line Items]      
Rental expense 22,668  
Other receivables  
Hardest Hit Business Recovery Program [Member]      
IfrsStatementLineItems [Line Items]      
Wages and salaries 50,756  
Rental expense 3,791  
Other receivables $ 54,548  
XML 164 form20-f_htm.xml IDEA: XBRL DOCUMENT 0001786286 2021-01-01 2021-12-31 0001786286 dei:BusinessContactMember 2021-01-01 2021-12-31 0001786286 2021-12-31 0001786286 2020-12-31 0001786286 2020-01-01 2020-12-31 0001786286 2019-01-01 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2018-12-31 0001786286 ifrs-full:CapitalReserveMember 2018-12-31 0001786286 ifrs-full:RetainedEarningsMember 2018-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2018-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001786286 2018-12-31 0001786286 ifrs-full:IssuedCapitalMember 2019-12-31 0001786286 ifrs-full:CapitalReserveMember 2019-12-31 0001786286 ifrs-full:RetainedEarningsMember 2019-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2019-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001786286 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-12-31 0001786286 ifrs-full:CapitalReserveMember 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2020-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2019-01-01 2019-12-31 0001786286 ifrs-full:CapitalReserveMember 2019-01-01 2019-12-31 0001786286 ifrs-full:RetainedEarningsMember 2019-01-01 2019-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:IssuedCapitalMember 2020-01-01 2020-12-31 0001786286 ifrs-full:CapitalReserveMember 2020-01-01 2020-12-31 0001786286 ifrs-full:RetainedEarningsMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001786286 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2021-12-31 0001786286 ifrs-full:CapitalReserveMember 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-12-31 0001786286 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001786286 DPRO:DraganflyInnovationsIncMember 2021-01-01 2021-12-31 0001786286 DPRO:DraganflyInnovationsUSAIncMember 2021-01-01 2021-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-01-01 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-01-01 2021-12-31 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-28 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-29 2020-04-30 0001786286 DPRO:EmployeeMember DPRO:DronelogicsSystemsIncMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember DPRO:FirstAndSecondAnniversaryMember 2020-04-29 2020-04-30 0001786286 DPRO:CertainDirectorsAndOfficersMember DPRO:DronelogicsSystemsIncMember DPRO:RestrictedStockUnitsMember 2020-04-29 2020-04-30 0001786286 DPRO:DronelogicsSystemsIncMember 2020-04-29 2020-12-31 0001786286 DPRO:AssetPurchaseAgreementMember DPRO:VitalIntelligenceIncMember 2021-03-24 2021-03-25 0001786286 DPRO:AssetPurchaseAgreementMember DPRO:VitalIntelligenceIncMember 2021-03-25 0001786286 srt:MaximumMember DPRO:AssetPurchaseAgreementMember DPRO:VitalIntelligenceIncMember 2021-08-19 0001786286 srt:MinimumMember DPRO:AssetPurchaseAgreementMember DPRO:VitalIntelligenceIncMember 2021-08-19 0001786286 DPRO:EscrowAgreementOneMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementTwoMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementThreeMember 2021-08-18 2021-08-19 0001786286 DPRO:EscrowAgreementFourMember 2021-08-18 2021-08-19 0001786286 2021-08-18 2021-08-19 0001786286 2021-08-19 0001786286 DPRO:BrandMember DPRO:VitalIntelligenceIncMember 2021-03-24 2021-03-25 0001786286 DPRO:SoftwareMember DPRO:VitalIntelligenceIncMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-26 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-24 2021-03-25 0001786286 DPRO:VitalIntelligenceIncMember 2021-03-25 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-08-01 2019-08-15 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-08-15 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-01-01 2019-01-31 0001786286 ifrs-full:WarrantReserveMember DPRO:DraganflyInnovationsSharesMember 2021-02-03 2021-02-04 0001786286 DPRO:DraganflyInnovationsSharesMember 2021-02-04 0001786286 DPRO:DraganflyInnovationsSharesMember 2021-02-03 2021-02-04 0001786286 2019-08-01 2019-08-15 0001786286 2019-08-15 0001786286 ifrs-full:WarrantReserveMember 2021-02-03 2021-02-04 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2020-03-26 2020-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-03-26 2021-03-27 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-05-26 2021-05-28 0001786286 DPRO:GuaranteedInvestmentCertificateMember 2021-12-20 2021-12-21 0001786286 DPRO:InventoryMember 2021-01-01 2021-12-31 0001786286 DPRO:InventoryMember 2020-01-01 2020-12-31 0001786286 DPRO:InventoryMember 2019-01-01 2019-12-31 0001786286 DPRO:NoteOneMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:NoteFourMember 2021-01-01 2021-12-31 0001786286 DPRO:PublicCompanySharesMember 2021-12-31 0001786286 DPRO:PublicCompanyWarrantsMember 2021-12-31 0001786286 DPRO:PrivateCompanySharesMember 2021-12-31 0001786286 2021-03-09 2021-03-10 0001786286 2021-03-10 0001786286 2021-10-25 2021-10-27 0001786286 DPRO:WarrantsMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember 2021-03-09 2021-03-10 0001786286 ifrs-full:ComputerEquipmentMember 2019-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2019-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2019-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2019-12-31 0001786286 ifrs-full:VehiclesMember 2019-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2020-01-01 2020-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2020-01-01 2020-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2020-01-01 2020-12-31 0001786286 ifrs-full:VehiclesMember 2020-01-01 2020-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2020-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2020-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2020-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2020-12-31 0001786286 ifrs-full:VehiclesMember 2020-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-12-31 0001786286 DPRO:PatentMember 2019-12-31 0001786286 DPRO:CustomerRelationshipMember 2019-12-31 0001786286 DPRO:BrandMember 2019-12-31 0001786286 DPRO:SoftwareMember 2019-12-31 0001786286 ifrs-full:GoodwillMember 2019-12-31 0001786286 DPRO:PatentMember 2020-01-01 2020-12-31 0001786286 DPRO:CustomerRelationshipMember 2020-01-01 2020-12-31 0001786286 DPRO:BrandMember 2020-01-01 2020-12-31 0001786286 DPRO:SoftwareMember 2020-01-01 2020-12-31 0001786286 ifrs-full:GoodwillMember 2020-01-01 2020-12-31 0001786286 DPRO:PatentMember 2020-12-31 0001786286 DPRO:CustomerRelationshipMember 2020-12-31 0001786286 DPRO:BrandMember 2020-12-31 0001786286 DPRO:SoftwareMember 2020-12-31 0001786286 ifrs-full:GoodwillMember 2020-12-31 0001786286 DPRO:PatentMember 2021-01-01 2021-12-31 0001786286 DPRO:CustomerRelationshipMember 2021-01-01 2021-12-31 0001786286 DPRO:BrandMember 2021-01-01 2021-12-31 0001786286 DPRO:SoftwareMember 2021-01-01 2021-12-31 0001786286 ifrs-full:GoodwillMember 2021-01-01 2021-12-31 0001786286 DPRO:PatentMember 2021-12-31 0001786286 DPRO:CustomerRelationshipMember 2021-12-31 0001786286 DPRO:BrandMember 2021-12-31 0001786286 DPRO:SoftwareMember 2021-12-31 0001786286 ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember DPRO:DronelogicsMember 2020-04-30 0001786286 DPRO:BrandMember DPRO:DronelogicsMember 2020-04-30 0001786286 DPRO:BrandMember DPRO:VitalMember 2021-03-25 0001786286 ifrs-full:ComputerSoftwareMember DPRO:VitalMember 2021-03-25 0001786286 ifrs-full:GoodwillMember DPRO:DronelogicsMember 2020-04-30 0001786286 ifrs-full:GoodwillMember DPRO:DronelogicsMember 2021-03-25 0001786286 DPRO:VitalAndDronelogicsMember 2021-12-31 0001786286 DPRO:DronelogicsMember 2021-12-31 0001786286 DPRO:VitalMember 2021-12-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2021-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2021-12-31 0001786286 ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001786286 DPRO:CustomersMember 2021-12-31 0001786286 DPRO:CustomersMember 2020-12-31 0001786286 DPRO:GoverenmentMember 2021-12-31 0001786286 DPRO:GoverenmentMember 2020-12-31 0001786286 DPRO:NoteReceivableAccretionMember 2021-12-31 0001786286 DPRO:NoteReceivableAccretionMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2021-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2020-12-31 0001786286 DPRO:VehicleLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:VehicleLoanMember 2021-12-31 0001786286 DPRO:VehicleLoanMember 2020-12-31 0001786286 DPRO:ShopifyLoanMember 2021-01-01 2021-12-31 0001786286 DPRO:ShopifyLoanMember 2021-12-31 0001786286 DPRO:ShopifyLoanMember 2020-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-19 0001786286 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-05-18 2020-05-19 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-01 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2020-12-04 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-23 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2021-04-22 2021-04-23 0001786286 DPRO:CommonStock1Member 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock1Member 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock2Member 2021-01-01 2021-12-31 0001786286 DPRO:CommonStock2Member 2021-12-31 0001786286 DPRO:CommonStock1Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock2Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock3Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock4Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock5Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock6Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock7Member 2020-01-01 2020-12-31 0001786286 DPRO:DronelogicsIncMember 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock8Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock9Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock10Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock11Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock12Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock13Member 2020-01-01 2020-12-31 0001786286 DPRO:CommonStock1Member 2019-12-31 0001786286 DPRO:CommonStock1Member 2019-01-01 2019-12-31 0001786286 DPRO:DraganflyInnovationsSharesMember 2019-01-01 2019-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2019-01-01 2019-12-31 0001786286 DPRO:EmployeeMember 2021-01-01 2021-12-31 0001786286 DPRO:ConsultantMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeesAndConsultantMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeOneMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantMember 2020-01-01 2020-12-31 0001786286 DPRO:EmployeeOneMember 2020-01-01 2020-12-31 0001786286 DPRO:EmployeeTwoMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantOneMember 2020-01-01 2020-12-31 0001786286 DPRO:StockOptionsMember 2021-01-01 2021-12-31 0001786286 DPRO:StockOptionsMember 2020-01-01 2020-12-31 0001786286 DPRO:StockOptionsMember 2019-01-01 2019-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2021-01-01 2021-12-31 0001786286 DPRO:EmployeeandConsultantMember DPRO:RestrictedStockUnitsMember 2020-01-01 2020-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2020-01-01 2020-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2019-01-01 2019-12-31 0001786286 2021-03-21 2021-03-22 0001786286 DPRO:ExercisePriceOneMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceOneMember 2021-12-31 0001786286 DPRO:ExercisePriceTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceTwoMember 2021-12-31 0001786286 DPRO:ExercisePriceThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceThreeMember 2021-12-31 0001786286 DPRO:ExercisePriceFourMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceFourMember 2021-12-31 0001786286 DPRO:ExercisePriceFiveMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceFiveMember 2021-12-31 0001786286 DPRO:ExercisePriceSixMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceSixMember 2021-12-31 0001786286 DPRO:ExercisePriceSevenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceSevenMember 2021-12-31 0001786286 DPRO:ExercisePriceEightMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceEightMember 2021-12-31 0001786286 DPRO:ExercisePriceNineMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceNineMember 2021-12-31 0001786286 DPRO:ExercisePriceTenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceTenMember 2021-12-31 0001786286 DPRO:ExercisePriceElevenMember 2021-01-01 2021-12-31 0001786286 DPRO:ExercisePriceElevenMember 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:TopOfRangeMember 2020-01-01 2020-12-31 0001786286 ifrs-full:BottomOfRangeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:TopOfRangeMember 2019-01-01 2019-12-31 0001786286 ifrs-full:BottomOfRangeMember 2021-12-31 0001786286 ifrs-full:TopOfRangeMember 2021-12-31 0001786286 ifrs-full:BottomOfRangeMember 2020-12-31 0001786286 ifrs-full:TopOfRangeMember 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2019-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2020-01-01 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2020-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-01-01 2021-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-12-31 0001786286 DPRO:WarrantsMember 2019-12-31 0001786286 DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2020-12-31 0001786286 DPRO:WarrantsMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:Range1Member 2021-01-01 2021-12-31 0001786286 DPRO:Range1Member 2021-12-31 0001786286 DPRO:Range1Member 2020-12-31 0001786286 DPRO:Range2Member 2021-01-01 2021-12-31 0001786286 DPRO:Range2Member 2021-12-31 0001786286 DPRO:Range2Member 2020-12-31 0001786286 DPRO:Range3Member 2021-01-01 2021-12-31 0001786286 DPRO:Range3Member 2021-12-31 0001786286 DPRO:Range3Member 2020-12-31 0001786286 DPRO:Range4Member 2021-01-01 2021-12-31 0001786286 DPRO:Range4Member 2021-12-31 0001786286 DPRO:Range4Member 2020-12-31 0001786286 DPRO:Range5Member 2021-01-01 2021-12-31 0001786286 DPRO:Range5Member 2021-12-31 0001786286 DPRO:Range5Member 2020-12-31 0001786286 DPRO:WarrantsMember ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantsMember ifrs-full:BottomOfRangeMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember ifrs-full:TopOfRangeMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2020-01-01 2020-12-31 0001786286 DPRO:WarrantsMember 2019-12-31 0001786286 DPRO:WarrantsMember 2020-12-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:WarrantOneMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantOneMember 2021-12-31 0001786286 DPRO:WarrantTwoMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantTwoMember 2021-12-31 0001786286 DPRO:WarrantThreeMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantThreeMember 2021-12-31 0001786286 DPRO:WarrantFourMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantFourMember 2021-12-31 0001786286 DPRO:WarrantFiveMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantFiveMember 2021-12-31 0001786286 DPRO:WarrantSixMember 2021-01-01 2021-12-31 0001786286 DPRO:WarrantSixMember 2021-12-31 0001786286 DPRO:ProductSalesMember 2021-01-01 2021-12-31 0001786286 DPRO:ProductSalesMember 2020-01-01 2020-12-31 0001786286 DPRO:ProductSalesMember 2019-01-01 2019-12-31 0001786286 DPRO:DroneServiceMember 2021-01-01 2021-12-31 0001786286 DPRO:DroneServiceMember 2020-01-01 2020-12-31 0001786286 DPRO:DroneServiceMember 2019-01-01 2019-12-31 0001786286 DPRO:ServicesMember 2021-01-01 2021-12-31 0001786286 DPRO:ServicesMember 2020-01-01 2020-12-31 0001786286 DPRO:ServicesMember 2019-01-01 2019-12-31 0001786286 DPRO:CustomEngineeringServicesMember 2020-01-01 2020-12-31 0001786286 DPRO:CACountryMember 2021-01-01 2021-12-31 0001786286 DPRO:CACountryMember 2020-01-01 2020-12-31 0001786286 DPRO:CACountryMember 2019-01-01 2019-12-31 0001786286 DPRO:USCountryMember 2021-01-01 2021-12-31 0001786286 DPRO:USCountryMember 2020-01-01 2020-12-31 0001786286 DPRO:USCountryMember 2019-01-01 2019-12-31 0001786286 DPRO:InternationalMember 2021-01-01 2021-12-31 0001786286 DPRO:InternationalMember 2020-01-01 2020-12-31 0001786286 DPRO:InternationalMember 2019-01-01 2019-12-31 0001786286 DPRO:CanadaMember 2021-12-31 0001786286 DPRO:UnitedStatesMember 2021-12-31 0001786286 DPRO:InternationalMember 2021-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2021-01-01 2021-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2020-01-01 2020-12-31 0001786286 DPRO:BusinessServiceAgreementMember DPRO:BusinessInstinctsGroupMember 2019-01-01 2019-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2021-01-01 2021-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2020-01-01 2020-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2019-01-01 2019-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2021-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2020-12-31 0001786286 DPRO:ConsultantAgreementMember DPRO:AlbertaLtdMember 2019-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2021-01-01 2021-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2020-01-01 2020-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2021-12-31 0001786286 DPRO:ExecutiveAgreementMember DPRO:ScottLarsonMember 2020-12-31 0001786286 DPRO:CEOAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:CEOAndDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:CEOAndDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:PresidentAndDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:PresidentAndDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:PresidentAndDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:FormerDirectorMember 2021-01-01 2021-12-31 0001786286 DPRO:FormerDirectorMember 2020-01-01 2020-12-31 0001786286 DPRO:FormerDirectorMember 2019-01-01 2019-12-31 0001786286 DPRO:FormerOwnerMember 2021-01-01 2021-12-31 0001786286 DPRO:FormerOwnerMember 2020-01-01 2020-12-31 0001786286 DPRO:FormerOwnerMember 2019-01-01 2019-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2020-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2020-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001786286 2019-01-01 0001786286 2020-04-25 2020-04-27 0001786286 DPRO:CommonSharesMember 2021-12-31 0001786286 DPRO:VitalIntelligenceIncMember 2021-12-31 0001786286 DPRO:CommonSharesOneMember 2021-12-31 0001786286 DPRO:CommonSharesMember 2019-12-31 0001786286 DPRO:ConvertibleDebenturesMember 2019-01-01 2019-12-31 0001786286 DPRO:CanadaEmergencyWageSubsidyMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyWageSubsidyMember 2020-01-01 2020-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2021-01-01 2021-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2020-01-01 2020-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2021-12-31 0001786286 DPRO:CanadaEmergencyRentSubsidyMember 2020-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2021-01-01 2021-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2020-01-01 2020-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2021-12-31 0001786286 DPRO:HardestHitBusinessRecoveryProgramMember 2020-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:CAD iso4217:CAD shares 0001786286 false FY 0001786286 false 20-F false true 2021-12-31 --12-31 2021 false false 001-40688 Draganfly Inc. Z4 2108 St. George Avenue Saskatoon SK S7M 0K7 CA Paul Sun 800 979.9794 paul.sun@draganfly.com 2108 St. George Avenue Saskatoon SK S7M 0K7 CA Common Shares DPRO NASDAQ 33197984 No No Yes Yes Non-accelerated Filer true false International Financial Reporting Standards false false 1173 DALE MATHESON CARR-HILTON LABONTE LLP Vancouver, Canada 23075713 1982416 1407127 810791 3390822 1233619 190170 5494877 335022 33558709 4361848 5940409 2166563 297043 153870 593901 273867 291066 964006 468106 144419 42113240 7100567 799139 1857177 172134 385449 73286 6745 62978 5560002 748634 110481 93239 6721787 3147477 5062 86572 34938 378642 64885 7187001 3252362 81038365 36943304 6406117 3024007 -52322182 -36119210 -196061 104 34926239 3848205 42113240 7100567 5103399 3087223 248939 1950466 1276288 1131488 7053865 4363511 1380427 4410777 2603911 218800 2643088 1759600 1161627 135966 43518 8386 175098 109108 41250 370094 2962767 39988 23900 6455998 3387865 2103732 4445949 1762594 524101 510895 567999 16883 3952595 2668464 761559 143904 25617 30896 2768010 1649329 989083 21921276 10254482 4499790 8149812 -748634 -5074 23117 171905 362448 -87104 5803 28651 -38879 198976 127711 24148 51627 7804859 13560 891471 4579763 4968 1197465 -16202972 -8015813 -11095057 136475 104 -332640 -16399137 -8015709 -11095057 -0.59 -0.48 -1.16 27647293 16558184 9529595 7869384 12561342 882180 -17576131 -4132609 258310 645775 645775 400000 1000000 1000000 2100000 5250001 1645193 6895194 9065 22662 22662 423698 1059246 1059246 63388 221741 -212908 8833 -567791 567791 2810300 7025750 7025750 761559 761559 -11095057 -11095057 13934145 27786517 2508233 -28103397 2191353 1584775 4007130 -1645193 2361937 645088 2178961 2178961 40000 100000 100000 111082 344354 344354 703607 2018845 2018845 199998 507497 -507497 2668464 2668464 -8015813 -8015813 104 104 17218695 36943304 3024007 -36119210 104 3848205 17218695 36943304 3024007 -36119210 104 3848205 17218695 36943304 3024007 -36119210 104 3848205 1200000 2303999 1241250 3545249 11584657 36092187 36092187 4678821 -864060 3814761 448660 1752052 -1752052 1939534 4929790 4929790 405499 1937866 -923743 1014123 371901 1757988 1757988 3952595 3952595 -16202972 -16202972 -332640 -332640 136475 136475 33168946 81038365 6406117 -52322182 -332640 136579 34926239 33168946 81038365 6406117 -52322182 -332640 136579 34926239 -16202972 -8015813 -11095057 135966 43518 8386 175098 109108 41250 -8149812 748634 891471 4579763 -926 23117 171905 -38879 198976 127711 28651 24148 21090 15389 7804859 -100000 3952595 2568464 761559 -14642965 -4532894 -2519336 596336 1481944 126799 2157203 555371 -12622 3401868 -31605 249325 -1044133 1261066 -1005121 -213315 139490 51186 5062 22004634 5132986 3887959 466643 457407 -28538 212579 23888 87785 31500 623706 2002678 997714 -3305606 516419 -27747 44255651 2018845 6534583 3814762 4929790 2361937 1014123 60000 129310 4319 5062 123000 1137978 486131 183000 882770 44428 192084 128996 83442 38000 46267059 4169504 6265660 136478 104 -22366 20956819 -447063 2349954 1982416 2429375 101787 23075713 1982416 2429375 22729212 1839871 2429375 346501 142545 23075713 1982416 2429375 <p id="xdx_804_ecustom--DisclosureOfNatureAndContinuanceOfOperationsExplanatory_zMR9SDrxnxHi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zzljTUPRHrjb">NATURE AND CONTINUANCE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company’s shares trade on the Canadian Securities Exchange (the “CSE”),” on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>COVID-19</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The outbreak of the coronavirus, also known as “COVID-19,” spread across the globe and is ‎impacting worldwide economic activity. Government authorities have implemented emergency ‎measures to mitigate the spread of the virus. These measures, which include the ‎implementation of travel bans, self-imposed quarantine periods, and social distancing, have ‎caused material disruption to business globally. ‎Governments and central banks reacted with significant monetary and fiscal interventions ‎designed to stabilize economic conditions.‎</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">‎ ‎</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will continue to monitor the impact of the COVID-19 pandemic, the duration and ‎impact of which is unknown at this time which may include further disruptions to global supply chains and the manufacturing and delivery of parts that the Company relies on for its products. Although it is not possible to reliably estimate the length and ‎severity of these developments and the impact on the financial results and condition of the ‎Company and its operations in future periods, such impacts are not expected to be ‎significant going forward. Aside from the acquisition of Dronelogics and being opportunistic ‎on ‎other partnerships or acquisitions, the Company has expanded its products and services offered ‎to include ‎health and telehealth applications relating to COVID-19, as a way to mitigate the ‎effects of COVID-19.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Share consolidation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021 in conjunction with its Regulation A financing, the Company underwent a share consolidation at a 5-1 ratio. All reference to share, per share amounts, warrants, RSU’s and stock options in these financial statements have been retroactively restated to reflect the consolidation.</span></p> <p id="xdx_80F_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zRc7FEUAq8Gd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zDROuecPAITk">BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Statement of Compliance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and interpretations issued by the International Reporting Interpretation Committee (“IFRIC”). The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements were authorized for issue by the Board of Directors on April 3, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Basis of consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z2rxQfzHmm9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z3Y9bxuqcos2" style="display: none">SCHEDULE OF RESULTS OF OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of Incorporation</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Interest</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zxTHRWi830B9" style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zL8MMWMclKFb" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zYnEh5xntYkj" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_983_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_zbkDcvtX3IB5" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_zQTIImEMQnm9" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_z6UPxoqoZFX6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zI4jBxnWc8ok" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zyZtVabhry93" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zHQmDwapIRk8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_ziIMI9RyAcqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All intercompany balances and transactions were eliminated on consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Significant estimates and assumptions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accordance with IFRS requires the Company to use judgment in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the consolidated financial statements and in the future. The Company’s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i>Impairment of Non-financial assets</i></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The CGU’s recoverable amount is evaluated using the higher of the value in use and fair value less costs to sell calculations. In calculating the recoverable amount, the Company utilizes discounted cash flow techniques. Management calculates the discounted cash flows based upon its best estimate of a number of economic, operating, engineering, environmental, political and social assumptions. Any changes in the assumptions due to changing circumstances may affect the calculation of the recoverable amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share-based payments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cost of share-based payment transactions with directors, officers and employees are measured by reference to the fair value of the equity instruments. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining and making assumptions about the most appropriate inputs to the valuation model including the expected life, volatility, risk-free interest rate, expected forfeiture rate and dividend yield of the stock option.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their recovery from the generation of taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zu34Pw4Ab7v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zG7NKyHEFtd4">Inventory</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices.</span></p> <p id="xdx_85E_zYxCYTAX3rn4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory_zXrU9wWJAX1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z6Ww2D7QgDb6">Contingencies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.</span></p> <p id="xdx_855_zc9e9W4KnxM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zATdioJVBtj2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zlCHhzwUebe8">Useful lives of equipment and intangible assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.</span></p> <p id="xdx_856_zdR1CGhcUBrg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--DescriptionOfSignificantJudgmentsExplanatory_z7c6fy1EFFi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_86A_z0AoF8lWqpif">Significant judgments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_856_z3puQaxW6AZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zuTMe3EGh6E3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zChy89IRTDG3">Business combinations</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.</span></p> <p id="xdx_858_zvHeiH6loMye" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForBusinessCombinationsVersusAssetAcquisitionExplanatory_z8nmj8CN2gh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zGGEqrBopyva">Business combination versus asset acquisition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to the Acquisitions (Notes 3, 4, and 5). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84F_ecustom--DescriptionOfOtherSignificantJudgmentsExplanatory_zpvUS8g6aW9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other significant judgments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the classification of financial instruments;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of whether a set of assets acquired and liabilities assumed constitute a business; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the functional currency of the company.</span></td></tr></table> <p id="xdx_854_zdSPIbGq1j12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_z61coWSMYki9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zBe6o17durJe">Foreign currency translation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currencies for the parent company and each subsidiary are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 65%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zMoJGsCN68na" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zB6qibhxPRPa">Share-based payments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.</span></p> <p id="xdx_853_z4YHqCSlspQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyRestrictedShareUnitsExplanatory_zBVbtSPOBb0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zriS25nt3Ze4">Restricted Share Units</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. RSUs are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.</span></p> <p id="xdx_853_zl1SHYWFS3L8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zQkkkumQNAQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z94dQOhiIwC6">Loss per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial assets</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Classification and measurement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTPL</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTOCI</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at amortized cost</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment of financial assets at amortized cost</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial liabilities</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial liabilities into one of two categories as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.</span></p> <p id="xdx_856_zDSWHuMkynTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zvkp7D5pESP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zugBLp5HBNk7">Impairment of non-financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Company’s non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset with an indefinite useful life;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset not yet available for use; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">goodwill recognized in a business combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in the statement of comprehensive loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.</span></p> <p id="xdx_85C_zsibbQcPI9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zERhCC8zRZmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zcXTpxX3X043">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.</span></p> <p id="xdx_85D_zYCzCNouzShi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--DescriptionOfAccountingPolicyMeasuringInventories_zyJhV2srkZbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span><span id="xdx_861_zhbAualVzQB8">Inventory</span></span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_znwcLbqB16xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zpIXZUMPB9g2">Revenue recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of goods</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.</span></p> <p id="xdx_85E_zfCxq1yehnK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory_zQIc84AHFRmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z33x1E2zg0X3">Cost of Goods Sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.</span></p> <p id="xdx_85C_zI83SQJIIpPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zcc7yYV4x1Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zk3Otkys8tTf">Intangible Assets and Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.</span></p> <p id="xdx_85F_zWl888cIlOR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zM4qDHNRyhD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zi05jEHcAiAl">Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p id="xdx_89D_ecustom--DisclosureOfClassOfEquipmentExplanatory_zSLvirtY7lV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zQLo3FhGRaTk" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class of equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zdndDespoiVb" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_zwDW20cinI5d" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DepreciationDescription_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zbCa4LrWKdM4" title="Depreciation rate, description">Over expected life of lease</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zwjMsTqlv9o4" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zovFcd2XYQA8" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zMwPKcHmFUJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_z8wXfHgr4LL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zosKN40HysAi">Research and development expenditures</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.</span></p> <p id="xdx_858_zngPxzchI31c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zfOrXd8arKd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zeor5iTnuqD7">Government Assistance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.</span></p> <p id="xdx_852_zDi9yRheUCD4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_zjilaFrloOFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z2ksoCmY4zWb">SR&amp;ED Investment tax credits</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&amp;ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company claims provincial investment tax credits as a result of incurring SR&amp;ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&amp;ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.</span></p> <p id="xdx_857_zO7llIOHMlbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zPRms5LkOhZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zc39ux5OGdH7">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z2rxQfzHmm9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z3Y9bxuqcos2" style="display: none">SCHEDULE OF RESULTS OF OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of Incorporation</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Interest</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zxTHRWi830B9" style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zL8MMWMclKFb" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsIncMember_zYnEh5xntYkj" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_983_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_zbkDcvtX3IB5" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_zQTIImEMQnm9" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DraganflyInnovationsUSAIncMember_z6UPxoqoZFX6" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_eifrs-full--NameOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zI4jBxnWc8ok" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zyZtVabhry93" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20210101__20211231__dei--LegalEntityAxis__custom--DronelogicsSystemsIncMember_zHQmDwapIRk8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> Draganfly Innovations Inc. Canada 1 Draganfly Innovations USA, Inc. US 1 Dronelogics Systems Inc. Canada 1 <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zu34Pw4Ab7v" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zG7NKyHEFtd4">Inventory</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost and net realizable value. Net realizable value is determined with reference to the estimated selling price. The Company estimates selling price based upon assumptions about future demand and current and anticipated retail market conditions. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices.</span></p> <p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory_zXrU9wWJAX1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z6Ww2D7QgDb6">Contingencies</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assessment of contingencies involves the exercise of significant judgment and estimates of the outcome of future events. In assessing loss contingencies related to legal proceedings that are pending against the Company and that may result in regulatory or government actions that may negatively impact the Company’s business or operations, the Company and its legal counsel evaluate the perceived merits of the legal proceeding or unasserted claim or action as well as the perceived merits of the nature and amount of relief sought or expected to be sought, when determining the amount, if any, to recognize as a contingent liability or when assessing the impact on the carrying value of the Company’s assets. Contingent assets are not recognized in the consolidated financial statements.</span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_zATdioJVBtj2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zlCHhzwUebe8">Useful lives of equipment and intangible assets</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates of the useful lives of equipment and intangible assets are based on the period over which the assets are expected to be available for use. The estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible, however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances. A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.</span></p> <p id="xdx_844_ecustom--DescriptionOfSignificantJudgmentsExplanatory_z7c6fy1EFFi6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_86A_z0AoF8lWqpif">Significant judgments</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s consolidated financial statements include:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zuTMe3EGh6E3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zChy89IRTDG3">Business combinations</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The definition of whether a set of assets acquired and liabilities assumed constitute a business may require the company to make certain judgements taking into account all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits.</span></p> <p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForBusinessCombinationsVersusAssetAcquisitionExplanatory_z8nmj8CN2gh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zGGEqrBopyva">Business combination versus asset acquisition</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considered the applicability of IFRS 3 – Business Combinations (“IFRS 3”) with respect to the Acquisitions (Notes 3, 4, and 5). IFRS 3 defines a business as having a system where inputs enter a process to produce outputs. The Company has determined that the acquisition of Dronelogics Systems Inc. and Vital Intelligence Inc. are business combinations and, accordingly, have accounted for as such.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84F_ecustom--DescriptionOfOtherSignificantJudgmentsExplanatory_zpvUS8g6aW9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other significant judgments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to significant uncertainty;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the classification of financial instruments;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of whether a set of assets acquired and liabilities assumed constitute a business; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">−</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the functional currency of the company.</span></td></tr></table> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_z61coWSMYki9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zBe6o17durJe">Foreign currency translation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in foreign currencies are translated into Canadian dollars at rates of exchange at the time of such transactions. Monetary assets and liabilities are translated at the reporting period rate of exchange. Non-monetary assets and liabilities are translated at historical exchange rates. Revenue and expenses denominated in a foreign currency are translated at the monthly average exchange rate. Gains and losses resulting from the translation adjustments are included in income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currencies for the parent company and each subsidiary are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 65%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draganfly Innovations USA, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US Dollar</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dronelogics Systems Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian Dollar</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Financial statements of subsidiaries for which the functional currency is not the Canadian dollar are translated into Canadian dollars as follows: all asset and liability accounts are translated at the year-end exchange rate and all earnings and expense accounts and cash flow statement items are translated at average exchange rates for the year. The resulting translation gains and losses are recorded as exchange differences on translating foreign operations in other comprehensive income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zMoJGsCN68na" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zB6qibhxPRPa">Share-based payments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates a stock option plan. Share-based payments to employees are measured at the fair value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at the fair value of goods or services received or the fair value of the equity instruments issued, if it is determined the fair value of the goods or services cannot be reliably measured, and are recorded at the date the goods or services are received. The corresponding amount is recorded to the option reserve. The fair value of options is determined using a Black–Scholes Option Pricing Model. The number of shares and options expected to vest is reviewed and adjusted at the end of each reporting period such that the amount recognized for services received as consideration for the equity instruments granted shall be based on the number of equity instruments that eventually vest. Amounts recorded for forfeited or expired unexercised options are transferred to deficit in the year of forfeiture or expiry. Amounts recorded for forfeited unvested options are reversed in the period the forfeiture occurs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment expense relating to cash-settled awards, including restricted share units is accrued over the vesting period of the units based on the quoted market value of Company’s common shares. As these awards will be settled in cash, the expense and liability are adjusted each reporting period for changes in the underlying share price.</span></p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyRestrictedShareUnitsExplanatory_zBVbtSPOBb0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zriS25nt3Ze4">Restricted Share Units</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The restricted share units (“RSUs”) entitle employees, directors, or officers to cash payments payable upon vesting based on vesting terms determined by the Company’s Board of Directors at the time of the grant. RSUs are measured at the fair value of awards on the grant date using the prior days closing price. Amounts recorded for forfeited unvested RSUs are reversed in the period the forfeiture occurs. The expense is recognized on a graded vesting basis over the vesting period, with a corresponding charge to profit or loss.</span></p> <p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zQkkkumQNAQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_z94dQOhiIwC6">Loss per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share is calculated by dividing the loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. For all periods presented, the loss attributable to common shareholders equals the reported loss attributable to owners of the Company. Diluted income per share is calculated by the treasury stock method. Under the treasury stock method, the weighted average number of common shares outstanding for the calculation of diluted loss per share assumes that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. For the periods presented, the Company incurred a loss and therefore basic loss per share equals diluted loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>a)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial assets</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Classification and measurement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial assets in the following categories: at fair value through profit or loss (“FVTPL”), at fair value through other comprehensive income (“FVTOCI”) or at amortized cost. The classification depends on the purpose for which the financial assets were acquired. Management determines the classification of its financial assets at initial recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of debt instruments is driven by the business model for managing the financial assets and their contractual cash flow characteristics. Debt instruments are measured at amortized cost if the business model is to hold the instrument for collection of contractual cash flows and those cash flows are solely principal and interest. If the business model is not to hold the debt instrument, it is classified as FVTPL. Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payments of principal and interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity instruments that are held for trading (including all equity derivative instruments) are classified as FVTPL, for other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument by-instrument basis) to designate them as at FVTOCI.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTPL</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the income statement. Realized and unrealized gains and losses arising from changes in the fair value of the financial asset held at FVTPL are included in the income statement in the period in which they arise. Derivatives are also categorized as FVTPL unless they are designated as hedges.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at FVTOCI</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses arising from changes in fair value recognized in other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no subsequent reclassification of fair value gains and losses to profit or loss following the derecognition of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Financial assets at amortized cost</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at amortized cost are initially recognized at fair value and subsequently carried at amortized cost less any impairment. They are classified as current assets or non-current assets based on their maturity date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Impairment of financial assets at amortized cost</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost. At each reporting date, the loss allowance for the financial asset is measured at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the loss allowance is measured for the financial asset at an amount equal to twelve month expected credit losses. For trade receivables the Company applies the simplified approach to providing for expected credit losses, which allows the use of a lifetime expected loss provision.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be objectively related to an event occurring after the impairment was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets are derecognized when they mature or are sold, and substantially all the risks and rewards of ownership have been transferred. Gains and losses on derecognition of financial assets classified as FVTPL or amortized cost are recognized in the income statement. Gains or losses on financial assets classified as FVTOCI remain within accumulated other comprehensive income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>b)</i></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial liabilities</i></b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company classifies its financial liabilities into one of two categories as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value through profit or loss (FVTPL) - This category comprises derivatives and financial liabilities incurred principally for the purpose of selling or repurchasing in the near term. They are carried at fair value with changes in fair value recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other financial liabilities - This category consists of liabilities carried at amortized cost using the effective interest method. Trade payables, customer deposits and loans are included in this category. The Company derecognizes a financial liability when its contractual obligations are discharged, cancelled or expire.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Derecognition of financial liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are derecognized when its contractual obligations are discharged, cancelled, or expire. The Company also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. Gains and losses on derecognition are generally recognized in profit or loss.</span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zvkp7D5pESP2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zugBLp5HBNk7">Impairment of non-financial assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Company’s non-financial assets are reviewed at each reporting date to determine whether there is any indication of impairment. If indicators exist, then the asset’s recoverable amount is estimated. The recoverable amounts of the following types of intangible assets are measured annually, whether or not there is any indication that it may be impaired:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset with an indefinite useful life;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an intangible asset not yet available for use; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">goodwill recognized in a business combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The recoverable amount of an asset or cash-generating unit (“CGU”) is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest identifiable group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in the statement of comprehensive loss. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the units, and then to reduce the carrying amounts of the other assets in the unit (group of units) on a pro rata basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In respect of assets other than goodwill and intangible assets that have indefinite useful lives, impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed in a subsequent period when there has been an increase in the recoverable amount of a previously impaired asset or CGU. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.</span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zERhCC8zRZmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zcXTpxX3X043">Income taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax assets and liabilities for the current period are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted, at the reporting date, in the countries where the Company operates and generates taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss. Management periodically evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation and establishes provisions where appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax is recognized, using the asset and liability method, on temporary differences at the reporting date arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting. The carrying amount of deferred income tax assets is reviewed at the end of each reporting period and recognized only to the extent that it is probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilized. Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred income tax assets and deferred income tax liabilities are offset, if a legally enforceable right exists to set off current tax assets against current income tax liabilities and the deferred income taxes relate to the same taxable entity and the same taxation authority.</span></p> <p id="xdx_84C_ecustom--DescriptionOfAccountingPolicyMeasuringInventories_zyJhV2srkZbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span><span id="xdx_861_zhbAualVzQB8">Inventory</span></span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consists of raw materials for manufacturing of multi-rotor helicopters, industrial areal video systems, civilian small unmanned aerial systems or vehicles, health monitoring equipment, and wireless video systems. Inventory is initially valued at cost and subsequently at the lower of cost and net realizable value. Net realizable value is determined as the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Cost is determined using the weighted average cost basis. The Company reviews inventory for obsolete and slow-moving goods and any such inventory is written-down to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForRecognitionOfRevenue_znwcLbqB16xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zpIXZUMPB9g2">Revenue recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue comprises the fair value of consideration received or receivable for the sale of goods and consulting services in the ordinary course of the Company’s business. Revenue is shown net of return allowances and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales of goods</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manufactures and sells a range of multi-rotor helicopters, industrial aerial video systems, and civilian small unmanned aerial systems or vehicles. Sales are recognized at a point-in-time when control of the products has transferred, being when the products are delivered to the customer and there is no unfulfilled obligation that could affect the customer’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location or picked up by the customer, the risks of obsolescence and loss have been transferred to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from these sales is recognized based on the price specified in the contract, net of the estimated discounts and returns. Accumulated experience is used to estimate and provide for the discounts and returns, using the expected value method, and revenue is only recognized to the extent that it is highly probable that a significant reversal will not occur. To date, returns have not been significant. No element of financing is deemed present as the sales are made with a credit term of 30 days, which is consistent with market practice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some contracts include multiple deliverables, such as the manufacturing of hardware and support. Support is performed by another party and does not include an integration service. It is therefore accounted for as a separate performance obligation. In this case, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expect cost plus margin.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A receivable is recognized when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting, custom engineering, drones as a service, and investigating and solving on a project-by-project basis under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the actual labour hours spend relative to the total expected labour hours. If contracts include the manufacturing of hardware, revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates of revenues, costs or extent of progress toward completion are revised if circumstances change. Any resulting increases or decreases in estimated revenues or costs are reflected in profit or loss in the period in which the circumstances that give rise to the revision become known by management.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D</b>)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the services rendered by the Company exceed the payment, a contract asset is recognized. If the payments exceed the services rendered, a contract liability is recognized. If the contract includes an hourly fee, revenue is recognized in the amount to which the Company has a right to invoice. Customers are invoiced on a monthly basis and consideration is payable when invoiced.</span></p> <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory_zQIc84AHFRmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z33x1E2zg0X3">Cost of Goods Sold</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of sales includes the expenses incurred to acquire and produce inventory for sale, including product costs, freight costs, as well as provisions for reserves related to product shrinkage, excess or obsolete inventory, or lower of cost and net realizable value adjustments as required.</span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zcc7yYV4x1Q6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zk3Otkys8tTf">Intangible Assets and Goodwill</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset is an identifiable asset without physical substance. An asset is identifiable if it is separable, or arises from contractual or legal rights, regardless of whether those rights are transferrable or separable from the Company or from other rights and obligations. Intangible assets include intellectual property, which consists of patent and trademark applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired externally are measured at cost less accumulated amortization and impairment losses. The cost of a group of intangible assets acquired is allocated to the individual intangible assets based on their relative fair values. The cost of intangible assets acquired externally comprises its purchase price and any directly attributable cost of preparing the asset for its intended use. Research and development costs incurred subsequent to the acquisition of externally acquired intangible assets and on internally generated intangible assets are accounted for as research and development costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets with finite useful lives are amortized on a straight line basis over the expected life of each intellectual property to write off the cost of the assets from the date they are available for use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the value of the consideration transferred over the fair value of the net identifiable assets and liabilities acquired in a business combination. Goodwill is allocated to the cash generating unit to which it relates.</span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zM4qDHNRyhD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zi05jEHcAiAl">Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment is stated at historical cost less accumulated depreciation and accumulated impairment losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statement of comprehensive loss during the financial period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized in the statement of comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is generally calculated on a declining balance method to write off the cost of the assets to their residual values over their estimated useful lives. Depreciation for leasehold improvements is fully expensed over the expected term of the lease. The depreciation rates applicable to each category of equipment are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PREPARATION (CONT’D)</b></span></p> <p id="xdx_89D_ecustom--DisclosureOfClassOfEquipmentExplanatory_zSLvirtY7lV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zQLo3FhGRaTk" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class of equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zdndDespoiVb" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_zwDW20cinI5d" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DepreciationDescription_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zbCa4LrWKdM4" title="Depreciation rate, description">Over expected life of lease</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zwjMsTqlv9o4" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zovFcd2XYQA8" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zMwPKcHmFUJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89D_ecustom--DisclosureOfClassOfEquipmentExplanatory_zSLvirtY7lV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zQLo3FhGRaTk" style="display: none">SCHEDULE OF CLASS OF EQUIPMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class of equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zdndDespoiVb" style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndEquipmentMember_zwDW20cinI5d" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DepreciationDescription_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zbCa4LrWKdM4" title="Depreciation rate, description">Over expected life of lease</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zwjMsTqlv9o4" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--DepreciationPercentage_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_zovFcd2XYQA8" style="font: 10pt Times New Roman, Times, Serif; text-align: left" title="Depreciation rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.30 0.20 Over expected life of lease 0.30 0.30 <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_z8wXfHgr4LL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zosKN40HysAi">Research and development expenditures</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures on research are expensed as incurred. Research activities include formulation, design, evaluation and final selection of possible alternatives, products, processes, systems or services. Development expenditures are expensed as incurred unless the Company can demonstrate all of the following: (i) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (ii) its intention to complete the intangible asset and use or sell it; (iii) its ability to use or sell the intangible asset; (iv) how the intangible asset will generate probable future economic benefits. Among other things, the Company can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (v) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (vi) its ability to measure reliably the expenditure attributable to the intangible asset during its development.</span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zfOrXd8arKd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zeor5iTnuqD7">Government Assistance</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants are recognized when there is reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the period that the related costs, for which it is intended to compensate, are expensed. When the grant relates to an asset, the cost of the asset is reduced by the amount of the grant and the grant is recognized as income in equal amounts over the expected useful life of the asset.</span></p> <p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_zjilaFrloOFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z2ksoCmY4zWb">SR&amp;ED Investment tax credits</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company claims federal investment tax credits as a result of incurring scientific research and experimental development (“SR&amp;ED”) expenditures. Federal investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Federal investment tax credits are accounted for as a reduction of research and development expense for items of a period expense nature or as a reduction of property and equipment for items of a capital nature. Management has made a number of estimates and assumptions in determining the expenditures eligible for the federal investment tax credit claim. It is possible that the allowed amount of the federal investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company claims provincial investment tax credits as a result of incurring SR&amp;ED expenditures. Provincial investment tax credits are recognized when the related expenditures are incurred and there is reasonable assurance of their realization. Management has made a number of estimates and assumptions in determining the expenditures eligible for the provincial investment tax credit claim. The provincial investment tax credits are refundable and have been recorded as a SR&amp;ED tax credit receivable, and as a reduction in research and development expenses on the statement of comprehensive loss. It is possible that the allowed amount of the provincial investment tax credit claim could be materially different from the recorded amount upon assessment by Canada Revenue Agency and the Alberta Tax and Revenue Administration.</span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zPRms5LkOhZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zc39ux5OGdH7">Leases</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. At the commencement date, the lease liability is recognized at the present value of the future lease payments and discounted using the interest rate implicit in the lease or the Company’s incremental borrowing rate. A corresponding right-of-use (“ROU”) asset will be recognized at the amount of the lease liability, adjusted for any lease incentives received and initial direct costs incurred. Over the term of the lease, financing expense is recognized on the lease liability using the effective interest rate method and charged to net income, lease payments are applied against the lease liability and depreciation on the ROU asset is recorded by class of underlying asset.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The lease term is the non-cancellable period of a lease and includes periods covered by an optional lease extension option if reasonably certain the Company will exercise the option to extend. Conversely, periods covered by an option to terminate are included if the Company does not expect to end the lease during that time frame. Leases with a term of less than twelve months or leases for underlying low value assets are recognized as an expense in net income on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A lease modification will be accounted for as a separate lease if it materially changes the scope of the lease. For a modification that is not a separate lease, on the effective date of the lease modification, the Company will remeasure the lease liability and corresponding ROU asset using the interest rate implicit in the lease or the Company’s incremental borrowing rate. Any variance between the remeasured ROU asset and lease liability will be recognized as a gain or loss in net income to reflect the change in scope.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80D_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zgNWkFkJUDNi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_z0zu6hKWOX3a">DRONELOGICS ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2020, the Company acquired all of the issued and outstanding shares of Dronelogics Systems Inc. (“Dronelogics”), excluding the cinematography division, </span> a leading drone reseller and services company based in Burnaby, BC. The purpose of the acquisition was to increase the Company’s scope of products and services to include the sale of third-party manufactured UAVs and drone-as-a-service type work while adding immediate revenue to the business, for consideration of $<span id="xdx_905_ecustom--AcquisitiondateFairValueOfTotalConsiderationCashTransferred_iI_c20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zbQDuuIAriSj" title="Acquisition date fair value of total consideration cash transferred">500,000</span> cash and <span id="xdx_907_ecustom--AcquisitionDateSharesTransferred_pid_c20200428__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zWd0y0ybBx1i" title="Acquisition date shares transferred">645,088</span> common shares (the “Transaction”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Transaction, the Company paid fees of $<span id="xdx_901_ecustom--AdvisorsFeesExpenses_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_pp0p0" title="Advisors fees expenses">160,000</span> to certain advisors consisting of $<span id="xdx_90D_ecustom--AdvisiorsFeesPaidInValueOfShares_pip0_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zUCoF5rO2m02" title="Advisiors fees paid in value of shares">100,000</span> by way of <span id="xdx_905_ecustom--AdvisoryFeesExpensesPaidInShares_pid_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zLf4RFOeIJed" title="Advisory fees expenses paid in shares">40,000</span> in shares at a price of $<span id="xdx_90D_ecustom--AdvisryFeesExpensesValuePerShare_pid_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zF93xoHdYd7j" title="Advisory fees expenses value per share">2.50</span> per share and $<span id="xdx_902_ecustom--AdvisorsFeesPaidInCash_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_pp0p0" title="Advisors fees paid in cash">60,000</span> in cash. At closing, the Company (i) granted <span id="xdx_90B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zQLcfYy7itLl" title="Number of share options granted in share-based payment arrangement">89,000</span> incentive stock options to certain employees of Dronelogics pursuant to the Company’s share compensation plan, exercisable at a price equal to closing price of the shares on the CSE on January 31, 2020. The options have a term of 10 years and <span id="xdx_907_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_uShares_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_ztRZYgzJJbE7" title="Number of other equity instruments exercised or vested in share-based payment arrangement">14,000</span> vest in three equal tranches, on the grant date and first and second anniversaries of the date of grant while <span id="xdx_908_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember__ifrs-full--MaturityAxis__custom--FirstAndSecondAnniversaryMember_zoRLgGP0eVrh" title="Number of other equity instruments exercised or vested in share-based payment arrangement">70,000</span> vest on the first anniversary of the grant date, and (ii) awarded <span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember__srt--TitleOfIndividualAxis__custom--CertainDirectorsAndOfficersMember__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z7HtQJfHnYMd" title="Number of other equity instruments exercised or vested in share-based payment arrangement">75,000</span> RSUs to certain directors and officers of Dronelogics. RSUs were awarded to certain directors and officers of Dronelogics pursuant to the Company’s share compensation plan. The RSUs vest in three equal tranches, on the first, second and third anniversaries of the date of award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock_zKZVIQJ3FRT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price allocation (“PPA”) is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zvtTKLaOkWt8" style="display: none">SCHEDULE OF PURCHASE PRICE ALLOCATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zaQrFRzh63n9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--NumberOfSharePurchased_zGigc0ITQ0vd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,088</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--CommonSharesFairValue_i_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of common shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--CommonSharesFairValueAmount_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of shares of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--CashPortionOfPurchasePrice_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash portion of purchase price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--TotalPurchasePriceAllocation_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,678,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DRONELOGICS ACQUISITION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tangible assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zHeHkqazWFGi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zeTDuvibx4Hc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--AccountsReceivableRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zo9CDz9v8Z61" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,852</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zTOJN1kzcwq4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">629,684</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--PrepaidsAndDepositsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zTabAeEKjS6a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaids and deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--OtherCurrentAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zROUoTptnVd7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--CapitalAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zFoCAAPBFu56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RightOfUSeAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zkHFUCsygUhi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zB9oHgXRj2Mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(222,766</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_ecustom--CustomerDepositsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zVL7xKuCKpQk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(245,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_ecustom--LoansRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_z25PwzTcu8Ye" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(245,752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_ecustom--OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zoNMaIgcGkE4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_ecustom--LeaseLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zxlFw6qzozo" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--TotalTangibleAssetsRecognisedAsOfAcquisitionDate_iTI_pp0p0_mtTTARAz7zD_maAFVOTz5Eo_zvsmRDYktZIg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tangible assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maIIARAzYtj_zGlhClvVHRig" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maIIARAzYtj_zoFyLvGSfrcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iTI_pp0p0_mtIIARAzYtj_maAFVOTz5Eo_zVntAdHlVrhl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pp0p0_maAFVOTz5Eo_zceCp7hnyPek" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--AcquisitiondateFairValuesOfTotalConsiderationTransferred_iTI_pp0p0_mtAFVOTz5Eo_zzDwFzQWguJc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,678,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zXmtWFXOhqYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimated the fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships based on an income approach, specifically multi-period excess earnings method, by identifying key customers, applying attribution rate of <span id="xdx_904_ecustom--AttributionRatePercentage_pid_dp_uPure_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zaorPwr3www8" title="Attribution rate percentage">15</span>% per annum and discount rate of <span id="xdx_90F_ecustom--DiscountRate_pid_dp_uPure_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zcvfxEfx8a7d" title="Discount rate">18</span>% per annum; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of <span id="xdx_902_ecustom--RoyaltyPercentage_pid_dp_uPure_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zKQrPIZDx61h" title="Royalty percentage">0.5</span>% and discount rate of <span id="xdx_906_ecustom--RoyaltyDiscountPercentage_pid_dp_uPure_c20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zZdr07nYZ66b" title="Royalty discount percentage">17</span>% per annum.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of the assembled workforce.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date of the acquisition to December 31, 2020, the acquired business contributed $<span id="xdx_906_eifrs-full--Revenue_pp0p0_c20200429__20201231__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zMv7309koImh">4,086,350 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of revenue and a net income of $<span id="xdx_900_eifrs-full--ProfitLoss_pp0p0_c20200429__20201231__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zJG9DqsQLIyi">434,528</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 500000 645088 160000 100000 40000 2.50 60000 89000 14000 70000 75000 <p id="xdx_89D_ecustom--DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock_zKZVIQJ3FRT3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price allocation (“PPA”) is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zvtTKLaOkWt8" style="display: none">SCHEDULE OF PURCHASE PRICE ALLOCATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_495_20200429__20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zaQrFRzh63n9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--NumberOfSharePurchased_zGigc0ITQ0vd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,088</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--CommonSharesFairValue_i_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of common shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--CommonSharesFairValueAmount_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of shares of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,178,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--CashPortionOfPurchasePrice_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash portion of purchase price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--TotalPurchasePriceAllocation_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,678,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DRONELOGICS ACQUISITION (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tangible assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200430__ifrs-full--BusinessCombinationsAxis__custom--DronelogicsSystemsIncMember_zHeHkqazWFGi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zeTDuvibx4Hc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,593</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--AccountsReceivableRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zo9CDz9v8Z61" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,852</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zTOJN1kzcwq4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">629,684</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--PrepaidsAndDepositsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zTabAeEKjS6a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaids and deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--OtherCurrentAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zROUoTptnVd7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--CapitalAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zFoCAAPBFu56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--RightOfUSeAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zkHFUCsygUhi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zB9oHgXRj2Mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(222,766</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_ecustom--CustomerDepositsRecognisedAsOfAcquisitionDate_iI_pp0p0_maTTARAz7zD_zVL7xKuCKpQk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(245,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_ecustom--LoansRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_z25PwzTcu8Ye" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(245,752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_ecustom--OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zoNMaIgcGkE4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_ecustom--LeaseLiabilitiesRecognisedAsOfAcquisitionDate_iNI_pp0p0_di_msTTARAz7zD_zxlFw6qzozo" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--TotalTangibleAssetsRecognisedAsOfAcquisitionDate_iTI_pp0p0_mtTTARAz7zD_maAFVOTz5Eo_zvsmRDYktZIg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tangible assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maIIARAzYtj_zGlhClvVHRig" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_maIIARAzYtj_zoFyLvGSfrcf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Website</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iTI_pp0p0_mtIIARAzYtj_maAFVOTz5Eo_zVntAdHlVrhl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Total identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_pp0p0_maAFVOTz5Eo_zceCp7hnyPek" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--AcquisitiondateFairValuesOfTotalConsiderationTransferred_iTI_pp0p0_mtAFVOTz5Eo_zzDwFzQWguJc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,678,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 645088 4.15 2178960 500000 2678960 42593 98852 629684 93997 3014 54946 83428 222766 -245959 245752 8437 87203 196397 197000 119000 316000 2166563 2678960 0.15 0.18 0.005 0.17 4086350 434528 <p id="xdx_807_ecustom--DisclosureOfVitalIntelligenceAcquisitionTextBlock_zxNbhOl4hDVl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zafu79QsuJad">VITAL INTELLIGENCE ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2021, the Company acquired the assets of Vital Intelligence Inc. (“Vital”), a company that had developed a health/telehealth platform that could detect a number of key underlying respiratory symptoms. The Company acquired it to diversify its existing product line as well as recognized opportunities that an initial focus on COVID-19 screening set of technologies would most likely lead to other facets within the healthcare field creating revenue growth from a new vertical, for consideration of: (a) a cash payment of $<span id="xdx_90D_ecustom--PaymentsToAcquireAssets_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_pp0p0">500,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (b) ‎<span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_z3TTHWQnuOt7">1,200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units of <span id="xdx_909_eifrs-full--ExplanationOfNatureAndAmountOfSignificantTransactions_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_zpPjnKVu5X27">the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $<span id="xdx_909_ecustom--WarrantExercisePricePerShare_iI_pid_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_zddmenUOgn7k">13.35</span> and the Company will be able ‎to accelerate the expiry date of the warrants after <span id="xdx_902_ecustom--WarrantExpirationTerm_dc_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_z4j66R4aoHP7">one year</span> in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with <span id="xdx_909_ecustom--EscrowDepositUnits_iI_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_z9C7bTjJUmog">300,000</span> units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets.</span> <span id="xdx_909_ecustom--DescriptionForNumberOfSharesIssued_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember_zy73pezVAMHf">The units were issued on March 22, 2021</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. On August 19, 2021 the parties agreed to reduce the final payment from $<span id="xdx_907_ecustom--FinalPayment_iI_pp0p0_c20210819__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zTTzWG4io507">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to $<span id="xdx_905_ecustom--FinalPayment_iI_pp0p0_c20210819__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--TypesOfContractsAxis__custom--AssetPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zKudAAc95h69">227,984 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">due to certain assets listed in the purchase agreement had not been delivered by Vital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The units of the Company are to be releasable from escrow in accordance with the terms and conditions of the agreement, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--StockIssuedDuringPeriodValueUnitsShares_pid_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementOneMember_zjlBGym5crPj" title="Stock issued, shares">300,000</span> units shall be released on the closing date;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--StockIssuedDuringPeriodValueUnitsShares_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementTwoMember_zuLPeLKOteXg" title="Stock issued, shares">300,000</span> units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $<span id="xdx_901_ecustom--StockIssuedDuringPeriodValueUnits_pp0p0_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementTwoMember_ziPO2edSKg17" title="Shares issued, amount">2,000,000</span>;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--StockIssuedDuringPeriodValueUnitsShares_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementThreeMember_zh2e875xaZfg" title="Stock issued, shares">300,000</span> units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueUnits_pp0p0_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementThreeMember_zDNWqwwUyY7l" title="Shares issued, amount">4,000,000</span>; and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StockIssuedDuringPeriodValueUnitsShares_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementFourMember_zI5FCAktGdU8" title="Stock issued, shares">300,000</span> units shall be released from escrow upon the Vital assets earning revenue in the aggregate amount of $<span id="xdx_907_ecustom--StockIssuedDuringPeriodValueUnits_pp0p0_c20210818__20210819__ifrs-full--TypesOfContractsAxis__custom--EscrowAgreementFourMember_zTVMzTEVOOqh" title="Shares issued, amount">6,000,000</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon acquisition, the <span id="xdx_90E_ecustom--SharesHeldInEscrow_pid_c20210818__20210819_z8cajWNZBpZ2" title="Shares held in escrow">900,000</span> shares held in escrow were classified as a derivative liability and were valued based upon:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20.15pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A weighted average probability of achieving the milestones necessary to release the shares held in escrow, and</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20.15pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted due to the lack of liquidity. </span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.15pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On acquisition, the fair value of the derivative liability (note 20) was $<span id="xdx_900_eifrs-full--DerivativeFinancialLiabilities_iI_pid_c20210819_zG3TVUtjlCoi">4,797,717</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. At December 31, 2021, the liability was revalued based upon new weighted average probabilities of achieving the revenue milestones. As a result, the fair value was adjusted to $<span id="xdx_90C_eifrs-full--IncreaseDecreaseInCreditDerivativeFairValue_c20210101__20211231_zQLIBH9TEB1k">694,230</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with the difference flowing through the consolidated statement of loss.</span></p> <p id="xdx_897_ecustom--DisclosureOfContingentConsiderationExplanatory_zUPTAy5doORc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_z8f3ih4xpZA6" style="display: none">SCHEDULE OF CONTINGENT CONSIDERATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20210101__20211231_zC6OL5t8BOv8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--FairValueOfContingentConsideration_zMWWIVy9c5wj" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; font-weight: bold">Fair value of contingent consideration</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">4,797,717</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ChangeInFairValueOfContingentConsideration_iN_di_za0UZWATHbZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Change in fair value of contingent consideration</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,103,487</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--BusinessAcquisitionContingentConsideration_zkpOQFbMPARg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Contingent consideration at December 31, 2021 (note 20)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">694,230</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zLlDWIVYoQIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89D_ecustom--ScheduleOfPurchasePriceAllocationForVitalIntelligence_zNXk94s0lqX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PPA is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z1yLAY4xC9Hl" style="display: none">SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of units of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NumberOfSharePurchased_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zYZUdcLXXBu1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of units of Draganfly Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,248</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of units</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--CommonSharesFairValue_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zZlW4oLAeEAi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of units"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.43</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of units of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--CommonSharesFairValueAmount_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zte35yAu42s5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of units of Draganfly Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,342,966</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">portion of purchase price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--CashPortionOfPurchasePrice_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z4sOGmvvSGNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash portion of purchase price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--TotalPurchasePriceAllocation_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zbJ57PRQTTzd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--IdentifiableIntangibleAssetsBrand_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zal66P52NQXj" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Identifiable intangible assets, Brand"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--IdentifiableIntangibleAssetsSoftware_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z0Ixk9gBy7Nk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Identifiable intangible assets, Software"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--TotalTangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zCYJrJA7HbUa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Identifiable intangible assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--Goodwill_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z21ZCvHP1La1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,353,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zm7SNFIgQ9ub" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zLDZ3S1yR3D5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VITAL INTELLIGENCE ACQUISITION (CONT’D)</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates are</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt">Number of units issued based upon a weighted average calculation for the Company achieving the revenue targets.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of <span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--IntangibleAssetsMaterialToEntityAxis__custom--BrandMember_zRNRdVWFKzI3">0.25</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and discount rate of <span id="xdx_907_ecustom--RoyaltyDiscountPercentage_pid_dp_uPure_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--IntangibleAssetsMaterialToEntityAxis__custom--BrandMember_zlmPeSL48UMh">14.4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software fair value based on an income approach, specifically relief from royalty methodology, using a reasonable royalty rate of <span id="xdx_90A_ecustom--RoyaltyPercentage_pid_dp_uPure_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--IntangibleAssetsMaterialToEntityAxis__custom--SoftwareMember_zcI3tj3gW8I9">5.0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and discount rate of <span id="xdx_907_ecustom--RoyaltyDiscountPercentage_pid_dp_uPure_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember__ifrs-full--IntangibleAssetsMaterialToEntityAxis__custom--SoftwareMember_zD1QjeJftVf3">14.4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, the excess of the consideration paid over the fair value of the identifiable assets (liabilities) acquired was recognized as goodwill, which primarily consisted of continued development of the technology platform integrating the latest technological developments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From the date of the acquisition to December 31, 2021, Vital contributed $<span id="xdx_901_eifrs-full--Revenue_pp0p0_c20210326__20211231__ifrs-full--BusinessCombinationsAxis__custom--VitalIntelligenceIncMember_zTneztEyeRt1">115,369 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of revenue and a net loss of $<span id="xdx_906_eifrs-full--ProfitLoss_pp0p0_c20210326__20211231__ifrs-full--BusinessCombinationsAxis__custom--VitalIntelligenceIncMember_zLdl0nTbggA7">203,231</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> 500000 1200000 the Company with each unit being comprised of one common share and one warrant (the “Acquisition”). Each warrant will entitle the holder to acquire one common share for a period of 24 ‎months following closing for $13.35 and the Company will be able ‎to accelerate the expiry date of the warrants after one year in the event the underlying common shares ‎have a value of at least 30% greater than the exercise price of the warrants. The units will be held in ‎escrow with 300,000 units being released at closing and the remainder to be released ‎upon the Company reaching certain revenue milestones received from the purchased assets. 13.35 P1Y 300000 The units were issued on March 22, 2021 250000 227984 300000 300000 2000000 300000 4000000 300000 6000000 900000 4797717 694230 <p id="xdx_897_ecustom--DisclosureOfContingentConsiderationExplanatory_zUPTAy5doORc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_z8f3ih4xpZA6" style="display: none">SCHEDULE OF CONTINGENT CONSIDERATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Contingent consideration</td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20210101__20211231_zC6OL5t8BOv8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--FairValueOfContingentConsideration_zMWWIVy9c5wj" style="vertical-align: bottom; background-color: White"> <td style="width: 82%; font-weight: bold">Fair value of contingent consideration</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">4,797,717</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--ChangeInFairValueOfContingentConsideration_iN_di_za0UZWATHbZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Change in fair value of contingent consideration</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,103,487</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--BusinessAcquisitionContingentConsideration_zkpOQFbMPARg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Contingent consideration at December 31, 2021 (note 20)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">694,230</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 4797717 4103487 694230 <p id="xdx_89D_ecustom--ScheduleOfPurchasePriceAllocationForVitalIntelligence_zNXk94s0lqX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PPA is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z1yLAY4xC9Hl" style="display: none">SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of units of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NumberOfSharePurchased_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zYZUdcLXXBu1" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of units of Draganfly Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">578,248</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of units</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--CommonSharesFairValue_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zZlW4oLAeEAi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of units"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.43</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of units of Draganfly Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--CommonSharesFairValueAmount_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zte35yAu42s5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value of units of Draganfly Inc."><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,342,966</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">portion of purchase price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--CashPortionOfPurchasePrice_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z4sOGmvvSGNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash portion of purchase price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--TotalPurchasePriceAllocation_pp0p0_c20210324__20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zbJ57PRQTTzd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--IdentifiableIntangibleAssetsBrand_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zal66P52NQXj" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Identifiable intangible assets, Brand"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--IdentifiableIntangibleAssetsSoftware_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z0Ixk9gBy7Nk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Identifiable intangible assets, Software"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--TotalTangibleAssetsRecognisedAsOfAcquisitionDate_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zCYJrJA7HbUa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Identifiable intangible assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--Goodwill_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z21ZCvHP1La1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,353,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consideration</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_pp0p0_c20210325__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zm7SNFIgQ9ub" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total consideration"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 578248 14.43 8342966 466643 8809609 23000 433000 456000 8353609 8809609 0.0025 0.144 0.050 0.144 115369 203231 <p id="xdx_803_eifrs-full--DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory_z4C2IQm1mva2" style="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><b>5. </b></span> <span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_822_zdPcjFZQa298">AMALGAMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 31, 2019, the Company and Draganfly Innovations entered into the BCA providing for a three-cornered amalgamation among the Company, Draganfly Innovations, and Merger Co. As of August 15, 2019, the Amalgamation closed and the Company acquired, on a one for 1.794 basis, all of the issued and outstanding Draganfly Innovations shares (the “Draganfly Innovations Shares”) in exchange for <span id="xdx_90B_ecustom--StockIssuedDuringPeriodValueUnitsShares_pid_c20190801__20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zm2Lq8GiSaYj" title="Exchange of common stocks">8,527,671</span> common shares of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This resulted in a reverse take-over, of the Company, by the shareholders of Draganfly Innovations. At the time of the Amalgamation, the Company did not constitute a business as defined under IFRS 3; therefore, the Amalgamation is accounted under IFRS 2, where the difference between the consideration given to acquire the Company and the net asset value of the Company is recorded as a listing expense to net loss. As Draganfly Innovations is deemed to be the accounting acquirer for accounting purposes, these consolidated financial statements present the historical financial information of Draganfly Innovations up to the date of the Amalgamation.</p> <p id="xdx_895_ecustom--DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock_zwA7mKcCePGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span id="xdx_8BD_z6d5495Fbn4b" style="display: none">SUMMARY OF HISTORICAL FINANCIAL INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20190801__20190815_zYXcbFa50GS3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--NumberOfSharesOfStructuredEntity_pid_zCwj6LRku6K4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Number of shares of Draganfly Inc.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">2,100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_pid_zH49ef7wBt58" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Fair value of common shares in concurrent financing</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FairValueOfSharesOfStructuredEntity_zRM8w06ynAmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fair value of shares of Draganfly Inc.</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,250,001</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfWarrants_z9K2a2malJT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Fair value of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,645,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--FeeAndCommissionExpense_zEtqGeGvL6f9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Fair value of shares issued for transaction fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseInFairValueMeasurementAssets_zTVpifOtqMkf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Net assets acquired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(90,335</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--ListingExpense_zfRIUWTDNFJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Listing expense</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,804,859</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Fair value of the Company acquired, net of liabilities</td><td style="font-size: 12pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20190815_zbvTk1qMLig7" style="font-size: 12pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 12pt"> </td></tr> <tr id="xdx_40D_eifrs-full--Cash_iI_zan7kTwUjtti" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">28,538</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--NoncurrentTradeReceivables_iI_zTkT5oZU6xEb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,991</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--LoansAndReceivables_iI_zrvzh6lC9k4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Loans receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">963,269</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iNI_di_zV3hYvjTdxVk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(406,463</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--SubscriptionsReceivable_iNI_di_zjlVLPQDGDN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Subscription receipts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eifrs-full--Liabilities_iI_z8u1Dvp731W4" style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; text-align: justify; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net of liabilities</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">90,335</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zVLe4sgcZcp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of <span id="xdx_90A_ecustom--StockIssuedDuringPeriodAtFairValueUnitsShares_pid_c20190801__20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zdeo10bIMI33" title="Common stock, issued">10,500,001</span> issued common shares of the Company was estimated to be $<span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zZI4sQ3YmwWj">2.50</span> per share using the price of a subscription receipts financing that was completed concurrently.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>5.</b></span> <span style="font-size: 10pt"><b>AMALGAMATION (CONT’D)</b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the closing of the Amalgamation, Draganfly Innovations issued <span id="xdx_903_ecustom--StockIssuedDuringPeriodAtFairValueUnitsShares_pid_c20190101__20190131__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zZVIKXiIAdd3">222,965</span> common shares with a value of $<span id="xdx_90F_eifrs-full--FeeAndCommissionExpense_c20190101__20190131__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_z8leyavlibhi" title="Transaction fees">1,000,000</span> as transaction fees for the Amalgamation to related parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company assumed <span id="xdx_903_ecustom--StockIssuedDuringPeriodAtFairValueUnitsShares_pid_c20210203__20210204__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zPdryZVXbZR">800,000</span> share purchase warrants exercisable at a price of $<span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20210204__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zblfobiLmlch" title="Exercisable warrant price">0.50</span> per share expiring on February 4, 2021. The fair value of share-purchase warrants was $<span id="xdx_90A_eifrs-full--ProceedsFromExerciseOfWarrants_c20210203__20210204__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zseMZkubzD23" title="Fair value of warrants">1,645,193</span>, estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b> </b></span></p> <p id="xdx_898_ecustom--DisclosureOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zJkralx0mT32" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_8B3_zgDl2s1aPQHk" style="display: none">SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zRYSmpmkaaI8" title="Risk-free interest rate">0.86</span>%</td><td style="width: 1%; text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Estimate life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt; letter-spacing: -0.1pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zRN3OFb599D5" title="Estimated life">1.48</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zlQw5tJCkYKg" title="Expected volatility">100</span>%</td><td style="text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Expected dividend yield</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zj9DsCQeKizf" title="Expected dividend yield">0</span>%</td><td style="padding-bottom: 1.5pt; text-align: left"/></tr> </table> <p id="xdx_8AD_zUwvY81jcml2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at August 15, 2019, the Company received $<span id="xdx_908_ecustom--ProceedsFromIssuanceOfSubscriptionReceipts_c20190801__20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_z0lxzW6QqOGa" title="Proceeds from subscription receipts">7,025,750</span> in proceeds to issue subscription receipts (the “Subscription Receipts”) at a price of $<span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_z505IvGMYuOb">2.50</span> per Subscription Receipt. Each Subscription Receipt was automatically converted, without payment of additional consideration and without any further action on the part of the holder, into one unit of the Company (a “Unit”) on completion of the Amalgamation and the Company becoming reporting issuer in the Province of Saskatchewan and obtaining conditional approval of a listing of the common shares on the CSE (the “Transaction”). Each Unit consists of one common share and one warrant. Each warrant will entitle the holder to purchase one common share at a price of $<span id="xdx_90D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20190815__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_zO82rn5u0esf">2.50</span> for a period of 12 months following the issuance of warrants. The proceeds of the private placement were released to the Company on November 5, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> 8527671 <p id="xdx_895_ecustom--DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock_zwA7mKcCePGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span id="xdx_8BD_z6d5495Fbn4b" style="display: none">SUMMARY OF HISTORICAL FINANCIAL INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_498_20190801__20190815_zYXcbFa50GS3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--NumberOfSharesOfStructuredEntity_pid_zCwj6LRku6K4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Number of shares of Draganfly Inc.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">2,100,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_pid_zH49ef7wBt58" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Fair value of common shares in concurrent financing</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FairValueOfSharesOfStructuredEntity_zRM8w06ynAmj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fair value of shares of Draganfly Inc.</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5,250,001</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfWarrants_z9K2a2malJT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Fair value of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,645,193</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--FeeAndCommissionExpense_zEtqGeGvL6f9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Fair value of shares issued for transaction fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseInFairValueMeasurementAssets_zTVpifOtqMkf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Net assets acquired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(90,335</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--ListingExpense_zfRIUWTDNFJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Listing expense</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,804,859</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Fair value of the Company acquired, net of liabilities</td><td style="font-size: 12pt; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20190815_zbvTk1qMLig7" style="font-size: 12pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 12pt"> </td></tr> <tr id="xdx_40D_eifrs-full--Cash_iI_zan7kTwUjtti" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">28,538</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--NoncurrentTradeReceivables_iI_zTkT5oZU6xEb" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,991</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--LoansAndReceivables_iI_zrvzh6lC9k4l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Loans receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">963,269</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iNI_di_zV3hYvjTdxVk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(406,463</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--SubscriptionsReceivable_iNI_di_zjlVLPQDGDN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Subscription receipts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eifrs-full--Liabilities_iI_z8u1Dvp731W4" style="vertical-align: bottom; background-color: White"> <td style="font-size: 12pt; text-align: justify; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net of liabilities</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">90,335</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 2100000 2.50 5250001 1645193 1000000 -90335 7804859 28538 4991 963269 406463 500000 90335 10500001 2.50 222965 1000000 800000 0.50 1645193 <p id="xdx_898_ecustom--DisclosureOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zJkralx0mT32" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_8B3_zgDl2s1aPQHk" style="display: none">SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zRYSmpmkaaI8" title="Risk-free interest rate">0.86</span>%</td><td style="width: 1%; text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Estimate life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt; letter-spacing: -0.1pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zRN3OFb599D5" title="Estimated life">1.48</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zlQw5tJCkYKg" title="Expected volatility">100</span>%</td><td style="text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Expected dividend yield</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20210203__20210204__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantReserveMember_zj9DsCQeKizf" title="Expected dividend yield">0</span>%</td><td style="padding-bottom: 1.5pt; text-align: left"/></tr> </table> 0.0086 1.48 1 0 7025750 2.50 2.50 <p id="xdx_80F_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zScmaV0cxhQ3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zrebBJO9hm9k">CASH AND CASH EQUIVALENTS</span></b></span></p> <p style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_897_ecustom--DisclosureOfCashAndCashEquivalents_ziSfiHuyig74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zmr3n0K9Ya4b" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20211231_zcKm7ixFrvlj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20201231_zP0FXRUcFcM2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--BalancesWithBanks_iI_pp0p0_maCACEz6Wj_z5dyAAkZmlI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in banks</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,729,212</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,839,871</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--OtherCashAndCashEquivalents_iI_pp0p0_maCACEz6Wj_zX3cmltRsFN3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranteed investment certificates</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,501</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--CashAndCashEquivalentsCarryingValue_iTI_pp0p0_mtCACEz6Wj_z1wf4s0q48Zj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and Cash Equivalents</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,075,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,416</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zZZwE667uOsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2020, the Company purchased a $<span id="xdx_905_ecustom--PurchaseOfFinancialInstruments_c20200326__20200327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_pp0p0" title="Purchase of financial instrument">142,000</span> guaranteed investment certificate (“GIC”) to secure its credit cards. The terms of the GIC are for <span id="xdx_904_ecustom--FinancialInstrumentTerm_dtY_c20200326__20200327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_z5Nc7HIoWY71" title="Financial instrument term">1</span> year at a rate of <span id="xdx_90E_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20200326__20200327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zBjG8xXQ00h3" title="Average effective Instrument rate">0.50</span>% per annum. On March 27, 2021 the company renewed the GIC for $<span id="xdx_901_ecustom--RenewOfFinancialInstruments_c20210326__20210327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_pp0p0" title="Renew of financial instruments">142,710</span> for <span id="xdx_904_ecustom--RenewedFinancialInstrumentTerm_dtY_c20210326__20210327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zg273n2ZyXib" title="Renewed financial instrument term">1</span> year at a rate of <span id="xdx_902_ecustom--RenewedEffectiveInstrumentRate_pid_dp_uPure_c20210326__20210327__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zNMQmZorVp41" title="Renewed effective instrument rate">0.10</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 28, 2021, the Company purchased an additional $<span id="xdx_903_ecustom--PurchaseOfFinancialInstruments_c20210526__20210528__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_pp0p0">140,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GIC to further secure its credit cards. The terms of the GIC are for <span id="xdx_909_ecustom--FinancialInstrumentTerm_dtY_c20210526__20210528__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zWzYGXY7lSpe">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year at a rate of <span id="xdx_904_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20210526__20210528__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zZRv55HY4tNd">0.35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2021, the Company purchased an additional $<span id="xdx_901_ecustom--PurchaseOfFinancialInstruments_pp0p0_c20211220__20211221__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zOaXj3IK8Kcl">50,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD GIC to further secure its credit cards. The terms of the GIC are for <span id="xdx_903_ecustom--FinancialInstrumentTerm_dtY_c20211220__20211221__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_z0yd4i6hDlna">1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year at <span id="xdx_903_ecustom--AverageEffectiveInstrumentRate_pid_dp_uPure_c20211220__20211221__ifrs-full--TypesOfContractsAxis__custom--GuaranteedInvestmentCertificateMember_zkK7RcjnTB6h">0.05</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">All GIC’s must be maintained and renewed upon maturity until such time as the associated credit cards are cancelled.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_897_ecustom--DisclosureOfCashAndCashEquivalents_ziSfiHuyig74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zmr3n0K9Ya4b" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20211231_zcKm7ixFrvlj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20201231_zP0FXRUcFcM2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--BalancesWithBanks_iI_pp0p0_maCACEz6Wj_z5dyAAkZmlI7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash held in banks</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,729,212</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,839,871</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--OtherCashAndCashEquivalents_iI_pp0p0_maCACEz6Wj_zX3cmltRsFN3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranteed investment certificates</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,501</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--CashAndCashEquivalentsCarryingValue_iTI_pp0p0_mtCACEz6Wj_z1wf4s0q48Zj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and Cash Equivalents</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,075,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,416</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 22729212 1839871 346501 142545 23075713 1982416 142000 P1Y 0.0050 142710 P1Y 0.0010 140000 P1Y 0.0035 50000 P1Y 0.0005 <p id="xdx_80B_ecustom--DisclosureOfAmountsReceivableTextBlock_z7V6xw5PN0f8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zq4T6OsqqYt3">RECEIVABLES</span></b></span></p> <p style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_893_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_ztlkQQS5eQF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrntGcASy1f4" style="display: none">SCHEDULE OF AMOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20211231_zSMtAxfS8Cta" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zLoUklV5xOyg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--TradeReceivables_iI_pp0p0_maTAORzb92_zBMISrjqg4zh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">951,314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">780,254</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pp0p0_maTAORzb92_zaOCPb1kAP74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Corporate taxes receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">182,820</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1190"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">-</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--GoodsAndServicesTaxReceivable_iI_pp0p0_maTAORzb92_zczdrHyCJUti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GST receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272,993</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--ScientificResearchAndExperimentalDevelopmentReceivable_iI_pp0p0_maTAORzb92_zVjoqwsnerGh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SR&amp;ED receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,537</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherReceivables_iTI_pp0p0_mtTAORzb92_z9iCPHoTlY13" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other receivables</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,407,127</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,791</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zP3n8dpNUUe6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_ztlkQQS5eQF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrntGcASy1f4" style="display: none">SCHEDULE OF AMOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20211231_zSMtAxfS8Cta" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zLoUklV5xOyg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--TradeReceivables_iI_pp0p0_maTAORzb92_zBMISrjqg4zh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">951,314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">780,254</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--ReceivablesFromTaxesOtherThanIncomeTax_iI_pp0p0_maTAORzb92_zaOCPb1kAP74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Corporate taxes receivable</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">182,820</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1190"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">-</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--GoodsAndServicesTaxReceivable_iI_pp0p0_maTAORzb92_zczdrHyCJUti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GST receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272,993</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1193">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--ScientificResearchAndExperimentalDevelopmentReceivable_iI_pp0p0_maTAORzb92_zVjoqwsnerGh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SR&amp;ED receivable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,537</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherReceivables_iTI_pp0p0_mtTAORzb92_z9iCPHoTlY13" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other receivables</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,407,127</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,791</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 951314 780254 182820 272993 30537 1407127 810791 <p id="xdx_801_eifrs-full--DisclosureOfInventoriesExplanatory_zhibEEYi1DEi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_zBupb0s12HT">INVENTORY</span></b></span></p> <p style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_893_ecustom--DisclosureOfInventoriesInformationExplanatory_zChX8OYn2e9b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLEDBpWp44ra" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zGFoePMlC2nc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20201231_z83HDjfGJCNa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td colspan="2" id="xdx_494_20191231_zRlcqlzGAMmb" style="text-align: center">December 31, 2019</td> <td> </td></tr> <tr id="xdx_40C_eifrs-full--FinishedGoods_iI_pp0p0_maIzdNU_zHtz3aJk3Ts4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,017,363</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,155,871</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 16%"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_pp0p0_maIzdNU_zPFZKKmyLfMf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parts</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,459</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">48,653</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eifrs-full--Inventories_iTI_pp0p0_mtIzdNU_z7NmcKdyMhKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Inventories<span style="font-size: 10pt"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,390,822</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233,619</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">48,653</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8AC_zgoWUHoeRGE9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, $<span id="xdx_90E_eifrs-full--CostOfSales_pp0p0_c20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_z3r4eOI9n0Nd">3,420,713 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020: $<span id="xdx_901_eifrs-full--CostOfSales_pp0p0_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_zRcWOrRCTVdg">2,257,797</span> 2019: $<span id="xdx_900_eifrs-full--CostOfSales_pp0p0_c20190101__20191231__ifrs-full--ProductsAndServicesAxis__custom--InventoryMember_zo9CvP3vCppc">118,826</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> of inventory was sold and recognized in cost of sales. During the year ended December 31, 2021, the Company recorded an allowance to value its inventory for obsolete and slow-moving inventory, recognizing an expense in cost of sales of $<span id="xdx_90B_eifrs-full--InventoryWritedown2011_dxL_c20210101__20211231_zAbw2EZmziRg" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1219">nil </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020: $<span id="xdx_90E_eifrs-full--InventoryWritedown2011_c20200101__20201231_zXk3qxBZKVa4">23,955</span>, 2019: $<span id="xdx_909_eifrs-full--InventoryWritedown2011_dxL_c20190101__20191231_zkeCwYei8i0f" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1221">nil</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p> <p id="xdx_895_eifrs-full--DisclosureOfCostOfSalesExplanatory_z9ZJRFsdGHJj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zXpcKxBcazoc" style="display: none">SCHEDULE OF COST OF SALES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"/><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210101__20211231_zSUDtL1QUoxb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zyLZyrs7H3hi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20190101__20191231_zBBGM1p7KLC1" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_ecustom--Inventory_maCOSzMrx_zFsVxPbqad3a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,420,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,257,797</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%">118,626</td> <td style="width: 1%"> </td></tr> <tr id="xdx_402_ecustom--ConsultingAndServices_maCOSzMrx_zxFkTUzHSTM7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting and services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">679,345</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,119</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">86,280</td> <td> </td></tr> <tr id="xdx_400_ecustom--Other_maCOSzMrx_zvV8fuaneXv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,719</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0; text-align: right">13,894</p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eifrs-full--CostOfSales_iT_mtCOSzMrx_zKbtwUw7xLp9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Cost of sales<span style="font-size: 10pt"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,410,777</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,603,911</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">218,800</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8A7_zvJjEWmeV5G5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_893_ecustom--DisclosureOfInventoriesInformationExplanatory_zChX8OYn2e9b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLEDBpWp44ra" style="display: none">SCHEDULE OF INVENTORIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zGFoePMlC2nc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20201231_z83HDjfGJCNa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td colspan="2" id="xdx_494_20191231_zRlcqlzGAMmb" style="text-align: center">December 31, 2019</td> <td> </td></tr> <tr id="xdx_40C_eifrs-full--FinishedGoods_iI_pp0p0_maIzdNU_zHtz3aJk3Ts4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished goods</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,017,363</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,155,871</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td> <td style="text-align: right; width: 16%"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_pp0p0_maIzdNU_zPFZKKmyLfMf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parts</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">373,459</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,748</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">48,653</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eifrs-full--Inventories_iTI_pp0p0_mtIzdNU_z7NmcKdyMhKe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Inventories<span style="font-size: 10pt"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,390,822</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233,619</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">48,653</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 3017363 1155871 373459 77748 48653 3390822 1233619 48653 3420713 2257797 118826 23955 <p id="xdx_895_eifrs-full--DisclosureOfCostOfSalesExplanatory_z9ZJRFsdGHJj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zXpcKxBcazoc" style="display: none">SCHEDULE OF COST OF SALES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"/><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210101__20211231_zSUDtL1QUoxb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zyLZyrs7H3hi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20190101__20191231_zBBGM1p7KLC1" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_ecustom--Inventory_maCOSzMrx_zFsVxPbqad3a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,420,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,257,797</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%">118,626</td> <td style="width: 1%"> </td></tr> <tr id="xdx_402_ecustom--ConsultingAndServices_maCOSzMrx_zxFkTUzHSTM7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting and services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">679,345</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,119</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">86,280</td> <td> </td></tr> <tr id="xdx_400_ecustom--Other_maCOSzMrx_zvV8fuaneXv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,719</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0; text-align: right">13,894</p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eifrs-full--CostOfSales_iT_mtCOSzMrx_zKbtwUw7xLp9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Cost of sales<span style="font-size: 10pt"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,410,777</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,603,911</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">218,800</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 3420713 2257797 118626 679345 164119 86280 310719 181995 13894 4410777 2603911 218800 <p id="xdx_801_ecustom--DisclosureOfNotesReceivable_zRLKF7kBlfY" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_z7LPxmom5xf8">NOTES RECEIVABLE</span></b></span></p> <p id="xdx_895_ecustom--DisclosureOfNotesReceivablesExplanatory_z71O7B71G04h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zLIFTxODelWi" style="display: none">DISCLOSURE OF NOTES RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Start Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt/110% Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>Impairment</b></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%"><span id="xdx_F4D_zOLkbYHlyCUb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z5bHBh6J1kZ8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-04-21</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7YyzfgdZZJ3" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022-10-21</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zMjhh5CRKQ5g" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z5D0XMVHCZHj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,597</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zj9pmlXv2tWd" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z9YdSd4qrIF5" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,573<span/></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zyuItInqjIe6" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1255">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td style="width: 1%">$</td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z20SvRP7vhk3" style="text-align: right; width: 7%" title="Note receivable">190,170</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F46_zQrk9fCiDkwf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zpHPpBwChRFi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-06-01</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zJWvcufboz2h" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023-06-01</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zq5oP6FgTPzb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_z1hnNKydcqY" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,833</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zY2nw8nL6Bhc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zAMB4W43WIBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1267">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zZvHhbSrLb5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,211</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zal5dOBGRYu1" style="text-align: right" title="Note receivable"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F4D_zKT6sxW0Ik1k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z3Hy9F59GXs7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-09-22</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z09ggOHMEcil" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024-09-22</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z06RgeD1Kvnl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zuQpUFwPIurd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">943,385</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z9YTBdGWozNb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zoeYOywzSrm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,465</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zv0gEDO3Yfs7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td id="xdx_988_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zizuGanAn6zd" style="text-align: right" title="Note receivable">964,006</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zpeA0KABJtNa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center" title="Start Date"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-11-17</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_fKDEp_zTvQxzutSNb2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center" title="Maturity Date"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022-04-26</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zIk64Jec1mG9" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Interest Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_ze3Xo1TaQSti" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zr3Dhj321xue" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NoteReceivableAccretionAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zg6QxyJszRZ8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1297">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_z7c65hCLvura" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(771,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zzMcQoPyFiI2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231_znm5pPkw06C4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,988,815</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231_z5GcOAUvmt9d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--NoteReceivableAccretionAmount_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,038</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231_zBa8j4HsI4g6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(891,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_989_ecustom--NoteReceivable_pp0p0_c20210101__20211231_zGBqr9pgLzJ4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable">1,154,176</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhBipOUIxgk7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zOdAPGTL5H25" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.</span></td></tr></table> <p id="xdx_8A5_zISW55AzZrTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 1 is non-interest bearing and is secured by intellectual property. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this loan which was the investee’s most recent financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 2 bears interest at <span id="xdx_90F_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_z6752mHkAZif" title="Note receivable interest rate">8</span>% and is secured by a general security agreement. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $<span id="xdx_90D_ecustom--LoansWrittenDown_dxL_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_zNL1MQJbfAF9" title="Loans written down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1316">Nil</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 3 bears interest at <span id="xdx_90B_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_z1wJsN3mI5fj">5</span>%, is unsecured, and contains a conversion feature upon sale of the recipient. This note is measured at fair value through profit or loss. The fair value was determined based on the price the company paid for this convertible loan which was the investee’s most recent financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Note 4 was issued pursuant to letter of intent on an acquisition that the Company is no longer pursuing. The loan is interest bearing at <span id="xdx_908_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zhSPWVLlRUog">8</span>% and is due April 26, 2022. Management has determined that it is unlikely that either the loan will be repaid or the Company will receive some other type of return. Therefore, the loan has been written down to $<span id="xdx_907_ecustom--LoansWrittenDown_dxL_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zqqP1asPPT1" title="Loans written down::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1320">Nil</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--DisclosureOfNotesReceivablesExplanatory_z71O7B71G04h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zLIFTxODelWi" style="display: none">DISCLOSURE OF NOTES RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Start Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt/110% Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>Impairment</b></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%"><span id="xdx_F4D_zOLkbYHlyCUb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z5bHBh6J1kZ8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-04-21</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z7YyzfgdZZJ3" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022-10-21</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zMjhh5CRKQ5g" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z5D0XMVHCZHj" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,597</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zj9pmlXv2tWd" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z9YdSd4qrIF5" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,573<span/></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_zyuItInqjIe6" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1255">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td style="width: 1%">$</td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteOneMember_fKDEp_z20SvRP7vhk3" style="text-align: right; width: 7%" title="Note receivable">190,170</td> <td style="width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F46_zQrk9fCiDkwf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zpHPpBwChRFi" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-06-01</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zJWvcufboz2h" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023-06-01</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zq5oP6FgTPzb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_z1hnNKydcqY" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,833</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zY2nw8nL6Bhc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,378</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zAMB4W43WIBf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1267">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zZvHhbSrLb5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,211</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteTwoMember_fKDEp_zal5dOBGRYu1" style="text-align: right" title="Note receivable"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F4D_zKT6sxW0Ik1k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z3Hy9F59GXs7" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-09-22</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z09ggOHMEcil" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024-09-22</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z06RgeD1Kvnl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zuQpUFwPIurd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">943,385</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_z9YTBdGWozNb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,156</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--NoteReceivableAccretionAmount_pdp0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zoeYOywzSrm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,465</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zv0gEDO3Yfs7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td id="xdx_988_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteThreeMember_fKDEp_zizuGanAn6zd" style="text-align: right" title="Note receivable">964,006</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 4</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--NoteReceivableStartDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zpeA0KABJtNa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center" title="Start Date"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-11-17</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--NoteReceivableMaturityDate_dd_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_fKDEp_zTvQxzutSNb2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center" title="Maturity Date"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022-04-26</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--NoteReceivableInterestRate_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zIk64Jec1mG9" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Interest Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_ze3Xo1TaQSti" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zr3Dhj321xue" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NoteReceivableAccretionAmount_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zg6QxyJszRZ8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1297">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_z7c65hCLvura" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(771,260</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="border-bottom: Black 1.5pt solid"> </td> <td id="xdx_98F_ecustom--NoteReceivable_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--NoteFourMember_zzMcQoPyFiI2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable"><span style="-sec-ix-hidden: xdx2ixbrl1301">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--NoteReceivableFaceAmount_pp0p0_c20210101__20211231_znm5pPkw06C4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,988,815</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--NoteReceivableInterestAmount_pp0p0_c20210101__20211231_z5GcOAUvmt9d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,794</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--NoteReceivableAccretionAmount_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,038</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ImpairmentLoss_iN_pp0p0_di_c20210101__20211231_zBa8j4HsI4g6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(891,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="border-bottom: Black 1.5pt solid">$</td> <td id="xdx_989_ecustom--NoteReceivable_pp0p0_c20210101__20211231_zGBqr9pgLzJ4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Note receivable">1,154,176</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhBipOUIxgk7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zOdAPGTL5H25" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date.</span></td></tr></table> 2021-04-21 2022-10-21 0 180597 9573 190170 2021-06-01 2023-06-01 0.08 114833 5378 120211 2021-09-22 2024-09-22 0.05 943385 13156 7465 964006 2021-11-17 2022-04-26 0.08 750000 21260 771260 1988815 39794 17038 891471 1154176 0.08 0.05 0.08 <p id="xdx_80B_eifrs-full--DisclosureOfPrepaymentsAndOtherAssetsExplanatory_zEomCcxa1Wya" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zl51010Bl2Eg">PREPAIDS</span></b></span></p> <p id="xdx_89A_ecustom--DisclosureOfPrepaidExpensesAndDepositsExplanatory_z7I6dB2c1cN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_ztrWlXHITA5b" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_z8AQkjLy1Fsb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20201231_zp6tHq1MzyGh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--CurrentInsuranceExpenses_iI_pp0p0_maCPEzQCZ_zOt71SNOiPNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,938,246</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">992</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--CurrentPrepaidDirectorFees_iI_pp0p0_maCPEzQCZ_zsMUFM1I1F8c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid director fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,763</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1330"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentPrepaidInterest_iI_pp0p0_maCPEzQCZ_z8anQIdpCt3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,969</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1333"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentPrepaidMarketingServices_iI_pp0p0_maCPEzQCZ_zjfXKCWqYqI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid marketing services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,179</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentPrepaidRent_iI_pp0p0_maCPEzQCZ_zbCaW0t5FEc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid rent</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1338"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--CurrentPrepaidSubscriptions_iI_pp0p0_maCPEzQCZ_z2Q9SWwCKBwb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid subscriptions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,687</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,953</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentDeposits_iI_pp0p0_maCPEzQCZ_zCr93XewuJdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">768,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,668</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iTI_pp0p0_mtCPEzQCZ_zq0Qr4YnCSg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Prepaid expenses and deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,494,877</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,022</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zAaJNZ3eraPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--DisclosureOfPrepaidExpensesAndDepositsExplanatory_z7I6dB2c1cN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_ztrWlXHITA5b" style="display: none">SCHEDULE OF PREPAID EXPENSES AND DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_z8AQkjLy1Fsb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20201231_zp6tHq1MzyGh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--CurrentInsuranceExpenses_iI_pp0p0_maCPEzQCZ_zOt71SNOiPNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,938,246</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">992</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--CurrentPrepaidDirectorFees_iI_pp0p0_maCPEzQCZ_zsMUFM1I1F8c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid director fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,763</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1330"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--CurrentPrepaidInterest_iI_pp0p0_maCPEzQCZ_z8anQIdpCt3l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid interest</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,969</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1333"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--CurrentPrepaidMarketingServices_iI_pp0p0_maCPEzQCZ_zjfXKCWqYqI6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid marketing services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,638,179</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentPrepaidRent_iI_pp0p0_maCPEzQCZ_zbCaW0t5FEc5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid rent</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1338"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--CurrentPrepaidSubscriptions_iI_pp0p0_maCPEzQCZ_z2Q9SWwCKBwb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid subscriptions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,687</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,953</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentDeposits_iI_pp0p0_maCPEzQCZ_zCr93XewuJdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">768,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,668</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentPrepaidExpenses_iTI_pp0p0_mtCPEzQCZ_zq0Qr4YnCSg5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> Prepaid expenses and deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,494,877</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335,022</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2938246 992 107763 6969 1638179 187826 3583 35687 5953 768033 136668 5494877 335022 <p id="xdx_80B_eifrs-full--DisclosureOfInvestmentPropertyExplanatory_zQfj4y2Znqr" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_828_zMt9jlzlSDw1">INVESTMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span/></b></span></p> <p id="xdx_897_ecustom--DisclosureOfInvestmentExplanatory_zNlMtL93QfA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGszogdEk4B7" style="display: none">SCHEDULE OF INVESTMENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49D_20210101__20211231_zcPjKa6qY8d6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eifrs-full--InvestmentProperty_iS_pp0p0_zYw2cMaT4Wq3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentInvestments1_zLuj2XK4REY" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>623,706</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_pp0p0_di_ziWJVfPG8rMk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in fair value</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(332,640</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td></tr> <tr id="xdx_403_eifrs-full--InvestmentProperty_iE_pp0p0_zV85Wx6nm9me" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>291,066</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of investments is comprised of:</span></p> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zNBXJ5TFo2H9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,857</span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanyWarrantsMember_zwONuZdhQo3b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,429</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_znAVlUB771V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,780</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr id="xdx_403_eifrs-full--InvestmentProperty_iE_pp0p0_z21lMdEucvV7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">291,066</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_z0m8tqGXean4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 10, 2021, the Company purchased <span id="xdx_905_ecustom--NumberOfSharesPurchased_pid_c20210309__20210310_zP3ttQmckMTi">1,428,571 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units of a publicly listed company for $<span id="xdx_904_ecustom--NumberOfSharesPurchasedValue_c20210309__20210310_pp0p0">500,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $<span id="xdx_90F_ecustom--WarrantExercisePrice_c20210310_pdd">0.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each and convert to one common share, and expire on <span id="xdx_908_ecustom--WarrantsExpirationDate_dd_c20210309__20210310_zswNu0QAgy3j">March 17, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_893_ecustom--DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory_zbwde9jR1xO4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zmNVahvggOA1">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 10, 2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk free interest rate</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHuFI1Fx8PUb" style="width: 16%; font-weight: bold; text-align: right" title="Risk free interest rate">0.91</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zNRbT93ejhBa" style="width: 16%; text-align: right">0.28</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right" title="Expected volatility"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHpsalyIk92d" style="font: 10pt Times New Roman, Times, Serif" title="Expected volatility">124.09</span></td><td style="font-weight: bold; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_znN4OXdcWx01" title="Expected volatility">150.88</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_ecustom--ExpectedLifeOfOptions_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zrX4twKeNZj6" title="Expected life">2 years</span></b></span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedLifeOfOptions_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z5lA9oPQpKO8">2 years</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Expected dividend yield</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ziLZ4vThfEGe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Expected dividend yield">0</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_za0nVVzAQim3" style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A8_zlzpWwGQUqhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility is calculated using the historical volatility method</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 27, 2021, the Company purchased <span id="xdx_90E_ecustom--NumberOfSharesPurchased_pid_c20211025__20211027_zhnruAe37zq3">50,000</span> common shares of a private company for USD$<span id="xdx_909_ecustom--NumberOfSharesPurchasedValue_pp0p0_c20211025__20211027_zdUUPOEBVmtf">100,000</span>. These assets have been recorded at the price of the company’s most recent private placement, and converted to Canadian dollars at the reporting date. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--DisclosureOfInvestmentExplanatory_zNlMtL93QfA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGszogdEk4B7" style="display: none">SCHEDULE OF INVESTMENTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49D_20210101__20211231_zcPjKa6qY8d6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_402_eifrs-full--InvestmentProperty_iS_pp0p0_zYw2cMaT4Wq3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--CurrentInvestments1_zLuj2XK4REY" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>623,706</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--LossesOnChangeInFairValueOfDerivatives_iN_pp0p0_di_ziWJVfPG8rMk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in fair value</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(332,640</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td></tr> <tr id="xdx_403_eifrs-full--InvestmentProperty_iE_pp0p0_zV85Wx6nm9me" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>291,066</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of investments is comprised of:</span></p> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanySharesMember_zNBXJ5TFo2H9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,857</span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PublicCompanyWarrantsMember_zwONuZdhQo3b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 82%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public company warrants</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,429</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--InvestmentProperty_iE_pp0p0_hifrs-full--TypesOfInvestmentPropertyAxis__custom--PrivateCompanySharesMember_znAVlUB771V3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private company shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,780</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr id="xdx_403_eifrs-full--InvestmentProperty_iE_pp0p0_z21lMdEucvV7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">291,066</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 623706 332640 291066 142857 21429 126780 291066 1428571 500000 0.50 2023-03-17 <p id="xdx_893_ecustom--DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory_zbwde9jR1xO4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zmNVahvggOA1">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 10, 2021</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Risk free interest rate</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_98D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHuFI1Fx8PUb" style="width: 16%; font-weight: bold; text-align: right" title="Risk free interest rate">0.91</td><td style="width: 1%; font-weight: bold; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zNRbT93ejhBa" style="width: 16%; text-align: right">0.28</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right" title="Expected volatility"><span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zHpsalyIk92d" style="font: 10pt Times New Roman, Times, Serif" title="Expected volatility">124.09</span></td><td style="font-weight: bold; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_znN4OXdcWx01" title="Expected volatility">150.88</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_ecustom--ExpectedLifeOfOptions_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zrX4twKeNZj6" title="Expected life">2 years</span></b></span></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ExpectedLifeOfOptions_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z5lA9oPQpKO8">2 years</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Expected dividend yield</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ziLZ4vThfEGe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Expected dividend yield">0</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210309__20210310__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_za0nVVzAQim3" style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> </table> 0.0091 0.0028 1.2409 1.5088 P2Y P2Y 0 0 50000 100000 <p id="xdx_805_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zKlfby3bk0f9" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zYUrHr89wcJg">EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_89B_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z9sZKXiUy7Bg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zproBXnpI2Jf" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerEquipmentMember_zEZbEfhhlzZk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--FurnitureAndEquipmentMember_zrCMtsfia9kb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B8_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zXra3Swxuogl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improvements</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_z8BonTKkCTg9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zQYKEmtTzHfc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B4_z2fJYAE58bD6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20200101__20201231_ecustom--PropertyPlantAndEquipmentCost_iS_zsMBFLBFfchj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,173</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1397">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,140</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,028</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,860</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1404"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1405"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,888</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets acquired in the <br/>Transaction</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,369</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,573</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1412"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iS_zN4PHupBuqed" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,606</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,974</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iS_zvpsbt1iUH79" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,606</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,974</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zpazrZxYtCab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,866</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1433"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,579</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--RevaluationIncreaseDecreasePropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revaluation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1437"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1438"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1439"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1440"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,619</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,619</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_432_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iE_zRg6uSgmEPEc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,110</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,472</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,934</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iE_zaf2xs0dn3C3" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,110</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,472</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,934</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20200101__20201231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zNRrjpntBth1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,761</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,294</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,999</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--PropertyServiceChargeIncomeExpense_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,019</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zkUKjM8eZUzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zyEGMsYzQHh2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--PropertyServiceChargeIncomeExpense_zHHiV7afg3Qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,899</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,132</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,241</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,201</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,787</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_z4eK2TAkvUD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,291</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">102,277</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,737</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,234</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,891</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zzL34AhcNLkj" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,291</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,277</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,737</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,234</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,891</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zOFqwRzjapQ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,005</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,132</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,619</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z2XdvneHEGKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">240,195</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1516">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,230</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">297,043</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_432_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_zewUbHyhEz25" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">240,195</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1523">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,230</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,043</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zzpYr9YQCWde" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_z9sZKXiUy7Bg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B8_zproBXnpI2Jf" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerEquipmentMember_zEZbEfhhlzZk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B3_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--FurnitureAndEquipmentMember_zrCMtsfia9kb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B8_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_zXra3Swxuogl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improvements</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ComputerSoftwareMember_z8BonTKkCTg9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zQYKEmtTzHfc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicles</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B4_z2fJYAE58bD6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20200101__20201231_ecustom--PropertyPlantAndEquipmentCost_iS_zsMBFLBFfchj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">142,173</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1397">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,140</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,028</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,860</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1404"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1405"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1406"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,888</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net assets acquired in the <br/>Transaction</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,369</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,573</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1412"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iS_zN4PHupBuqed" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,606</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,974</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iS_zvpsbt1iUH79" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,397</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,606</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,652</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,974</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zpazrZxYtCab" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,866</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1432"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1433"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">212,579</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--RevaluationIncreaseDecreasePropertyPlantAndEquipment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revaluation</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1437"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1438"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1439"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1440"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,619</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,619</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_432_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iE_zRg6uSgmEPEc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,110</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,472</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,934</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--PropertyPlantAndEquipmentCost_iE_zaf2xs0dn3C3" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,110</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,472</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,967</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,033</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,934</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20200101__20201231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zNRrjpntBth1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,761</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,294</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,999</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--PropertyServiceChargeIncomeExpense_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,019</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zkUKjM8eZUzf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_434_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iS_zyEGMsYzQHh2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,392</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,963</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,220</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,033</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104,104</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--PropertyServiceChargeIncomeExpense_zHHiV7afg3Qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,899</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,314</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,132</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,241</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,201</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,787</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_z4eK2TAkvUD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,291</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">102,277</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,737</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,234</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,891</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20210101__20211231_ecustom--AccumulateddepreciationPropertyPlantAndEquipment_iE_zzL34AhcNLkj" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation Property, plant and equipment, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,291</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,277</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,352</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,737</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,234</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,891</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zOFqwRzjapQ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,005</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,643</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,132</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,471</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,619</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z2XdvneHEGKi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">240,195</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1516">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,230</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">297,043</p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_432_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_zewUbHyhEz25" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Property, plant and equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">240,195</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1523">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,230</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,043</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 7000 142173 29967 179140 2028 21860 23888 15369 7573 4352 27652 54946 24397 171606 4352 29967 27652 257974 24397 171606 4352 29967 27652 257974 29713 170866 12000 212579 -3619 -3619 54110 342472 4352 29967 36033 466934 54110 342472 4352 29967 36033 466934 6761 37944 19294 63999 5631 22019 3220 3202 6033 40105 12392 59963 3220 22496 6033 104104 12392 59963 3220 22496 6033 104104 12899 42314 1132 2241 7201 65787 25291 102277 4352 24737 13234 169891 25291 102277 4352 24737 13234 169891 12005 111643 1132 7471 21619 153870 28819 240195 5230 22799 297043 28819 240195 5230 22799 297043 <p id="xdx_802_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zyFd6lMdf3o8" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zG0Q5vrCH7fk">INTANGIBLE ASSETS AND GOODWILL</span></b></span></p> <p id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zFXm3cXJoEp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zVKVZIWjFlij" style="display: none">SCHEDULE OF INTELLECTUAL PROPERTY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--PatentMember_z2xK8mTi75Ia" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--CustomerRelationshipMember_zGRnQctnrAah" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationships</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--BrandMember_zgfQtpTI13Gl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brand</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BF_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--SoftwareMember_zPxLAgo1wkX9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_ifrs-full--GoodwillMember_zqCray4iyymd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_zTYEvElMii93" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20200101__20201231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_z4ylwugPJPTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1533">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          <span style="-sec-ix-hidden: xdx2ixbrl1534"> </span>-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1535">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1536">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired in the Transaction</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1539"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1541"> </span></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_zPgo7obLf6kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1548">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,524,494</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_zNm2VhT187r1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual properties and goodwill, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1555">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,524,494</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_zGms7GzCQO7d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets acquired in the </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acquisition</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1560"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1561"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,353,609</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_iN_di_z2EjI0LvP2El" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><b>Impairment of goodwill</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1567"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1568"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl1569"> </span></b></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1570"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><b>(4,579,763</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><b>(4,579,763</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_zgiAJUazLv27" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>197,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>552,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,754,340</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_431_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_zwqK2eT03nla" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual properties and goodwill, Ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>197,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>552,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,754,340</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20200101__20201231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zLVBFTfB8Dw7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1589">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1590">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,385</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1597"> </span></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1599"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,518</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zQpscXupBjxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"/> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1606"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zttHikNo6gT6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1611"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif">-</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1613">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_zmJb7LI24ua4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for the year</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1616"> </span></b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>34,147</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>98,369</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1620"> </span></b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>135,966</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_43F_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zDzrdyvJ8slf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>60,414</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>$</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>114,235</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>220,030</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zK3ZXPESmL55" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,414</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,235</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1634">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,030</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20201231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zY9V0NHKro8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,733</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,134</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,440,430</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20211231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zZO220QtrSd6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1644">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>136,586</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19,550</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>437,765</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,534,310</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_432_c20211231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zznADrhJSEL4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual properties and goodwill</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>136,586</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19,550</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>437,765</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,534,310</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> </table> <p id="xdx_8A7_ztkvBunzKOy1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer relationships</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2020, the Company acquired a <span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zzm6COZKCgJd" title="Percentage of acquired">100%</span> interest in Dronelogics (note 3) and assigned $<span id="xdx_90F_eifrs-full--OtherIntangibleAssets_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_pp0p0" title="Customer relationships">197,000</span> to the fair value of customer relationships.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brand</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2020, the Company acquired a <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zkrgE8thu105">100% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest in Dronelogics and assigned $<span id="xdx_901_eifrs-full--OtherIntangibleAssets_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_pp0p0">119,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the fair value of the website/domain name.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2021, the Company acquired the assets of Vital (note 4) and assigned $<span id="xdx_907_eifrs-full--OtherIntangibleAssets_c20210325__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--BrandMember__ifrs-full--CounterpartiesAxis__custom--VitalMember_pp0p0">23,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the fair value of the brand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2021, the Company acquired the assets of Vital and assigned $<span id="xdx_900_eifrs-full--OtherIntangibleAssets_c20210325__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CounterpartiesAxis__custom--VitalMember_pp0p0" title="Customer relationships">433,000</span> to the fair value of the software.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2020, the Company acquired a <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zjAmKZrlI1J7">100%</span> interest in Dronelogics, which included goodwill. Goodwill was valued at $<span id="xdx_906_eifrs-full--Goodwill_c20200430__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_pp0p0" title="Goodwill">2,166,563</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2021, the Company acquired the assets of Vital, which included goodwill. Goodwill was valued at $<span id="xdx_902_eifrs-full--Goodwill_c20210325__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_pp0p0">8,353,609</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTELLECTUAL PROPERTIES AND GOODWILL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2021 the Company performed its annual goodwill impairment test on Vital and Dronelogics. The Company determined the recoverable amount based on a value in use calculation using the following key assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 year post tax cash flow projections expected to be generated based on a financial forecast with a terminal growth rate of <span id="xdx_902_eifrs-full--DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalAndDronelogicsMember_z1Iy0LSffTsa" title="Percentage of cash flow projection">2%</span></span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Budgeted cash flows calculated using a weighted average revenue EBITDA margin of <span id="xdx_902_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zzabRZwjqMl8">14% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for Drone</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> and <span id="xdx_905_ecustom--PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zDBnFjemB1b3">42</span>% for Vital </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively were estimated by management based on the past performance and future growth prospects as well as observed trends among comparable companies.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash flows were discounted at the weighted average cost of capital of <span id="xdx_908_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_ztJO0qPYmQc" title="Percentage of weighted average cost of capital">17%</span> for Dronelogics and <span id="xdx_90F_ecustom--PercentageOfWeightedAverageCostOfCapital_iI_pid_dp_uPure_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zXdPxRVoBaYb" title="Percentage of weighted average cost of capital">24%</span> for Vital based on peer group averages and adjusted for the Company’s risk factors.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 1.05pt 0 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Based on the annual goodwill impairment test, the Company deemed that the goodwill for Vital required impairment, as such the Company recorded an impairment of $<span id="xdx_90E_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_c20210101__20211231_zj8XPS7yDln5" title="Impairment of goodwill">4,579,763</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most sensitive inputs to the value in use model are the growth and discount rates. All else being equal:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt">A <span id="xdx_907_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_c20211231_zklLMSY23qMl" title="Assumption discount rates">10%</span> reduction in the Value in use for the discounted cash flow model would result in a reduction of <span id="xdx_904_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_c20211231__ifrs-full--CounterpartiesAxis__custom--DronelogicsMember_zckq7sNBGBa2" title="Reduction in value">$597,100</span> for Dronelogics and $<span id="xdx_90F_eifrs-full--ReserveOfChangeInValueOfTimeValueOfOptions_iI_c20211231__ifrs-full--CounterpartiesAxis__custom--VitalMember_zy6ZQnH5FDa3">570,133</span> for Vital.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0 1.05pt 0 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Changing the above assumption would result in an impairment for Dronelogics, and would result in additional impairment for Vital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key assumptions used in the calculations of the recoverable amounts include sales growth per year, changes in cost of sales and capital expenditures based on internal forecasts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zFXm3cXJoEp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zVKVZIWjFlij" style="display: none">SCHEDULE OF INTELLECTUAL PROPERTY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--PatentMember_z2xK8mTi75Ia" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--CustomerRelationshipMember_zGRnQctnrAah" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationships</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--BrandMember_zgfQtpTI13Gl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brand</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BF_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_custom--SoftwareMember_zPxLAgo1wkX9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis_ifrs-full--GoodwillMember_zqCray4iyymd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B1_zTYEvElMii93" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20200101__20201231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_z4ylwugPJPTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1533">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          <span style="-sec-ix-hidden: xdx2ixbrl1534"> </span>-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1535">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1536">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets acquired in the Transaction</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1539"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1541"> </span></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_zPgo7obLf6kc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1548">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,524,494</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_zNm2VhT187r1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual properties and goodwill, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1555">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,524,494</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_zGms7GzCQO7d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets acquired in the </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acquisition</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1560"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1561"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,353,609</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,809,609</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--ImpairmentLossRecognisedInProfitOrLossGoodwill_iN_di_z2EjI0LvP2El" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><b>Impairment of goodwill</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1567"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1568"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl1569"> </span></b></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b><span style="-sec-ix-hidden: xdx2ixbrl1570"> </span></b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><b>(4,579,763</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b> </b></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b> </b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><b>(4,579,763</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr id="xdx_43E_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_zgiAJUazLv27" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>197,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>552,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,754,340</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_431_c20210101__20211231_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_zwqK2eT03nla" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual properties and goodwill, Ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>197,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23,000</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>552,000</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,754,340</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20200101__20201231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zLVBFTfB8Dw7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1589">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1590">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1591">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1592">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,385</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1597"> </span></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1599"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,518</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zQpscXupBjxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"/> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1606"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iS_zttHikNo6gT6" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,267</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1611"> </span></span></td> <td style="font: 10pt Times New Roman, Times, Serif">-</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,866</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1613">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_zmJb7LI24ua4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for the year</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1616"> </span></b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>34,147</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>98,369</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1620"> </span></b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>135,966</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_43F_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zDzrdyvJ8slf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance at December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41,931</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>60,414</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>$</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>114,235</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>220,030</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_43C_c20210101__20211231_ecustom--AccumulatedAmortizationIntellectualPropertiesAndGoodwill_iE_zK3ZXPESmL55" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,931</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,414</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,450</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,235</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1634">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220,030</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20201231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zY9V0NHKro8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,733</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1639">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,134</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166,563</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,440,430</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_431_c20211231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zZO220QtrSd6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1644">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>136,586</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19,550</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>437,765</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,534,310</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_432_c20211231_ecustom--IntangibleAssetsIncludingGoodwill_iI_zznADrhJSEL4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual properties and goodwill</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>136,586</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19,550</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>437,765</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,940,409</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,534,310</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> </table> 41931 41931 197000 119000 2166563 2482563 41931 197000 119000 2166563 2524494 41931 197000 119000 2166563 2524494 23000 433000 8353609 8809609 4579763 4579763 41931 197000 23000 552000 5940409 6754340 41931 197000 23000 552000 5940409 6754340 40546 40546 1385 26267 15866 43518 41931 26267 15866 84064 41931 26267 15866 84064 34147 3450 98369 135966 41931 60414 3450 114235 220030 41931 60414 3450 114235 220030 170733 103134 2166563 2440430 136586 19550 437765 5940409 6534310 136586 19550 437765 5940409 6534310 1 197000 1 119000 23000 433000 1 2166563 8353609 0.02 0.14 0.42 0.17 0.24 4579763 0.10 597100 570133 <p id="xdx_801_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_zLVC4gl1wuR4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zNtgleIrwyo5">RIGHT OF USE ASSETS</span></b></span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssets_zCbeKgpDxdGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zhc8RCR8p2Be" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_pp0p0_c20200101__20201231_zfc4ojonXkw7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Right of use assets, at cost, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,539</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases acquired in the Acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--RightofuseAssetsLeasesAcquiredInAcquisition_pp0p0_c20200101__20201231_zxkM2JCpVdug" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leases acquired in the Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_pp0p0_c20210101__20211231_ztVzI9Vc2e6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets, at cost, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--AdditionsToRightofuseAssets_pp0p0_c20210101__20211231_zOB2vJXOckS4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,242</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease removal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--RightofuseAssetsLeaseRemoval_pp0p0_c20210101__20211231_z0eyIdIf7fi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease removal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,092</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iE_pp0p0_c20210101__20211231_zyRBlXVyDl52" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets, at cost, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,117</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--RightofuseAssetsAccumulatedAmortization_iS_pp0p0_c20200101__20201231_zhUWs0CuW8K" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationRightofuseAssets_pp0p0_c20200101__20201231_zezp71Ayp0n5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Charge for the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,003</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--RightofuseAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231_zy8ZEbqWM0v4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,548</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Historical correction</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--HistoricalCorrection_pp0p0_c20210101__20211231_zshxOlpQasg7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Historical correction">7,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationRightofuseAssets_pp0p0_c20210101__20211231_zvDirbVNquu" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Charge for the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,311</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--RightofuseAssetsAccumulatedAmortization_iE_pp0p0_c20210101__20211231_zX5ijd47KTR5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,011</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eifrs-full--RightofuseAssets_iI_pp0p0_c20201231_zPha0gIDk6I5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,419</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--RightofuseAssets_iI_pp0p0_c20211231_zp4DzmrSzxsf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,106</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zIPdpiGpiZ77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutOfRightOfUseAssets_zCbeKgpDxdGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zhc8RCR8p2Be" style="display: none">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_pp0p0_c20200101__20201231_zfc4ojonXkw7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Right of use assets, at cost, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">159,539</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases acquired in the Acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--RightofuseAssetsLeasesAcquiredInAcquisition_pp0p0_c20200101__20201231_zxkM2JCpVdug" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leases acquired in the Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iS_pp0p0_c20210101__20211231_ztVzI9Vc2e6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets, at cost, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">242,967</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--AdditionsToRightofuseAssets_pp0p0_c20210101__20211231_zOB2vJXOckS4" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,242</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease removal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--RightofuseAssetsLeaseRemoval_pp0p0_c20210101__20211231_z0eyIdIf7fi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease removal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,092</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--RightofuseAssetsRevaluedAssetsAtCost_iE_pp0p0_c20210101__20211231_zyRBlXVyDl52" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets, at cost, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,117</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--RightofuseAssetsAccumulatedAmortization_iS_pp0p0_c20200101__20201231_zhUWs0CuW8K" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,545</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationRightofuseAssets_pp0p0_c20200101__20201231_zezp71Ayp0n5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Charge for the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,003</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--RightofuseAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231_zy8ZEbqWM0v4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,548</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Historical correction</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--HistoricalCorrection_pp0p0_c20210101__20211231_zshxOlpQasg7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Historical correction">7,152</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charge for the year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationRightofuseAssets_pp0p0_c20210101__20211231_zvDirbVNquu" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Charge for the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,311</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_ecustom--RightofuseAssetsAccumulatedAmortization_iE_pp0p0_c20210101__20211231_zX5ijd47KTR5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,011</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eifrs-full--RightofuseAssets_iI_pp0p0_c20201231_zPha0gIDk6I5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,419</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--RightofuseAssets_iI_pp0p0_c20211231_zp4DzmrSzxsf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,106</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 159539 83428 242967 447242 -7092 683117 29545 69003 98548 7152 109311 215011 144419 468106 <p id="xdx_807_eifrs-full--DisclosureOfLeasesExplanatory_zXXw8tg08s8h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zoZVNRntMzcj">LEASE LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_901_ecustom--DepreciationLeaseLiability_c20210101__20211231_zYSDirnyUuVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%</span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities_zHRtCHtuL6F7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z97vm3YClngk" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--LeaseLiabilities_iS_pp0p0_c20200101__20201231_zjnXV2sJmL92" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases acquired in the Acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--LeasesAcquiredInAcquisition_pp0p0_c20200101__20201231_zQINv0xIuqw" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leases acquired in the Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20200101__20201231_zOytXY2LpF4h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,290</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20200101__20201231_zgqO0J4t1Wkd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(83,442</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pp0p0_c20210101__20211231_zUf9UqwiVUHi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addition</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--AdditionsLeaseLiabilities_pp0p0_c20210101__20211231_zjbYieCapcu8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,675</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span>s</td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20210101__20211231_zsFl9sMU58rk" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,964</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20210101__20211231_zaC7hi85mdIc" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(128,995</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease removal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--LeaseRemoval_pp0p0_c20210101__20211231_zpnnc5WzrtKb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease removal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,645</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iE_pp0p0_c20210101__20211231_z3t6xwuvyDmb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Balance - End of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Which consists of:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20211231_zZcNWSK465Ib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,481</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NoncurrentLeaseLiabilities_iI_pp0p0_c20211231_zywl3B3ufddc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-current lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,642</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pp0p0_c20211231_zMxUWPcJ4oP7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_ztEJqrEzSGb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4f5zS14q4e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zHH3DiPjNjO7" style="display: none">SCHEDULE OF OPERATING MATURITY ANALYSIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity analysis</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zJlmLb1Xn0Y9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zjR6VqsZFgc8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,276</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zT3pCta4Tg1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One to three years</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,765</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zbkORQS4fyUi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four to five years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">183,473</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z5kEzRC9cbC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greater than five years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,030</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zmREUo7q2hza" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total undiscounted lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><p style="margin: 0">590,544</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zN68KL6543Nc" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Maturity analysis</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><p style="margin: 0">590,544</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--LeaseImplicitInterest_iI_z0Ns3b4PdVC6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Amount representing implicit interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(101,421</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40E_eifrs-full--LeaseLiabilities_iI_zMPfuPDK7Wmg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zjyBf8BscQ82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5% <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities_zHRtCHtuL6F7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z97vm3YClngk" style="display: none">SCHEDULE OF OPERATING LEASE LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--LeaseLiabilities_iS_pp0p0_c20200101__20201231_zjnXV2sJmL92" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases acquired in the Acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--LeasesAcquiredInAcquisition_pp0p0_c20200101__20201231_zQINv0xIuqw" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leases acquired in the Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20200101__20201231_zOytXY2LpF4h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,290</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20200101__20201231_zgqO0J4t1Wkd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(83,442</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eifrs-full--LeaseLiabilities_iS_pp0p0_c20210101__20211231_zUf9UqwiVUHi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance - Beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addition</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--AdditionsLeaseLiabilities_pp0p0_c20210101__20211231_zjbYieCapcu8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,675</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span>s</td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20210101__20211231_zsFl9sMU58rk" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Interest expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,964</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pp0p0_di_c20210101__20211231_zaC7hi85mdIc" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(128,995</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease removal</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--LeaseRemoval_pp0p0_c20210101__20211231_zpnnc5WzrtKb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease removal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,645</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--LeaseLiabilities_iE_pp0p0_c20210101__20211231_z3t6xwuvyDmb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Balance - End of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Which consists of:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eifrs-full--CurrentLeaseLiabilities_iI_pp0p0_c20211231_zZcNWSK465Ib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,481</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NoncurrentLeaseLiabilities_iI_pp0p0_c20211231_zywl3B3ufddc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-current lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">378,642</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eifrs-full--LeaseLiabilities_iI_pp0p0_c20211231_zMxUWPcJ4oP7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 136073 87203 18290 83442 158124 440675 26964 128995 -7645 489123 110481 378642 489123 <p id="xdx_897_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_z4f5zS14q4e4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_zHH3DiPjNjO7" style="display: none">SCHEDULE OF OPERATING MATURITY ANALYSIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity analysis</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zJlmLb1Xn0Y9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zjR6VqsZFgc8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,276</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zT3pCta4Tg1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One to three years</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,765</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zbkORQS4fyUi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Four to five years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">183,473</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_hifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z5kEzRC9cbC4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greater than five years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,030</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zmREUo7q2hza" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total undiscounted lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><p style="margin: 0">590,544</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_zN68KL6543Nc" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Maturity analysis</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><p style="margin: 0">590,544</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--LeaseImplicitInterest_iI_z0Ns3b4PdVC6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Amount representing implicit interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(101,421</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40E_eifrs-full--LeaseLiabilities_iI_zMPfuPDK7Wmg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">489,123</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 150276 251765 183473 5030 590544 590544 -101421 489123 <p id="xdx_803_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_z8En18CowKq9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zUcIFdterxFl">TRADE PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p id="xdx_895_ecustom--DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory_zbNWXuK4Jpm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPGYy0jZKXwe" style="display: none">SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20211231_zZRyuFD1AaGb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zFcPjk761Mdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pp0p0_maTAOCPzzq7_zuEEHQZxTNF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">362,890</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">813,881</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--OtherCurrentLiabilities_iI_pp0p0_maTAOCPzzq7_zQtBrXX6T7Rg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">402,540</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">512,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pp0p0_maTAOCPzzq7_zmehNgaItG32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to related parties (Note 23)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1777"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">475,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--GovernmentGrants_iI_pp0p0_maTAOCPzzq7_zXEFVgMpAxi4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grant payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,709</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,709</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--OtherCurrentPayables_iI_pp0p0_maTAOCPzzq7_zwV932a6TZx1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GST/PST Payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1783"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,754</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayables_iTI_pp0p0_mtTAOCPzzq7_zq11yNO1gHv4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables and accrued liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">799,139</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,857,177</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zWYnrZyUIMw1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p id="xdx_895_ecustom--DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory_zbNWXuK4Jpm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPGYy0jZKXwe" style="display: none">SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20211231_zZRyuFD1AaGb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zFcPjk761Mdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pp0p0_maTAOCPzzq7_zuEEHQZxTNF1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade accounts payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">362,890</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">813,881</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--OtherCurrentLiabilities_iI_pp0p0_maTAOCPzzq7_zQtBrXX6T7Rg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">402,540</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">512,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_pp0p0_maTAOCPzzq7_zmehNgaItG32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to related parties (Note 23)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1777"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">475,628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--GovernmentGrants_iI_pp0p0_maTAOCPzzq7_zXEFVgMpAxi4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grant payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,709</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,709</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--OtherCurrentPayables_iI_pp0p0_maTAOCPzzq7_zwV932a6TZx1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GST/PST Payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1783"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,754</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayables_iTI_pp0p0_mtTAOCPzzq7_zq11yNO1gHv4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade payables and accrued liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">799,139</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,857,177</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 362890 813881 402540 512205 475628 33709 33709 21754 799139 1857177 <p id="xdx_809_eifrs-full--DisclosureOfDepositsFromCustomersExplanatory_zIERe7qegub3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>17.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_zEzkC7a1hT3g">CUSTOMER DEPOSITS</span></b></span></p> <p id="xdx_89E_ecustom--DisclosureOfCustomerDepositsExplanatory_zmhpPmmsyfjc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z3LlPe2UCZUc" style="display: none">SCHEDULE OF CUSTOMER DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20211231_zku6spVnHzca" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20201231_zAN5VUvP5oB1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--CurrentDepositsFromCustomers_iI_pp0p0_znQyeG7Cp3i6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172,134</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">385,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_z17ziIAAMkrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"> </p> <p id="xdx_89E_ecustom--DisclosureOfCustomerDepositsExplanatory_zmhpPmmsyfjc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_z3LlPe2UCZUc" style="display: none">SCHEDULE OF CUSTOMER DEPOSITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20211231_zku6spVnHzca" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20201231_zAN5VUvP5oB1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--CurrentDepositsFromCustomers_iI_pp0p0_znQyeG7Cp3i6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer deposits</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172,134</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">385,449</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 172134 385449 <p id="xdx_80E_eifrs-full--DisclosureOfDeferredIncomeExplanatory_zCyGCh10Tjg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>18. </b><b><span id="xdx_822_zJBlTFiNcUMe">DEFERRED INCOME</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.</span></p> <p id="xdx_89A_ecustom--ScheduleOfDeferredIncomeExplanatory_zRw36UparAOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zipWEZmpEe14" style="display: none">SCHEDULE OF DEFERRED INCOME</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zjrpCFlljIQa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zkIbTdh1hHY" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomersMember_z7N64nrREoq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from customers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--GoverenmentMember_zLkFQMjUJNEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from government</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,233</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,062</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--NoteReceivableAccretionMember_zKwjZpacYm85" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from note receivable accretion</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,947</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1807"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredIncomeLiabilities_iI_zSg3ITbQrQA5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Income</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,286</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,062</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_z01Y36uyu6y9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfDeferredIncomeExplanatory_zRw36UparAOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zipWEZmpEe14" style="display: none">SCHEDULE OF DEFERRED INCOME</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20211231_zjrpCFlljIQa" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20201231_zkIbTdh1hHY" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CustomersMember_z7N64nrREoq6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from customers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--GoverenmentMember_zLkFQMjUJNEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from government</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,233</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,062</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--DeferredIncomeLiabilities_iI_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--NoteReceivableAccretionMember_zKwjZpacYm85" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income from note receivable accretion</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,947</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1807"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--DeferredIncomeLiabilities_iI_zSg3ITbQrQA5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Income</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,286</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,062</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 80000 5233 5062 -11947 73286 5062 <p id="xdx_805_eifrs-full--DisclosureOfLoansAndAdvancesToCustomersExplanatory_zt6ptILt3WV3" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>19.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_zICOd7ZBoRVc">LOANS PAYABLE</span></b></span></p> <p id="xdx_892_ecustom--DisclosureOfLoansPayableExplanatory_zWQqvbFbkHrg" style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BD_zclZPT7qyqOa" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF LOANS PAYABLE</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--LoansPayableAmount_iS_c20210101__20211231_zAgZ39sbiexe" style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Opening balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--LoansPayableAmount_iS_c20200101__20201231_zTZIr6TPHlI9" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Opening balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition of loans</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--AcquisitionOfLoans_c20210101__20211231_zuO4NvDr42wc" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition of loans"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--AcquisitionOfLoans_c20200101__20201231_zNQjffrEFk45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition of loans"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,851</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of loans payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--IssuanceOfLoansPayable_c20210101__20211231_zPURxMoT2mA2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--IssuanceOfLoansPayable_c20200101__20201231_zMZYLsQ1uLF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value adjustment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--FairValueAdjustmentOnLoans_c20210101__20211231_zwGOxf7eFAwd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,576</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--FairValueAdjustmentOnLoans_c20200101__20201231_zTY6AOCuK379" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment of loans payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--RepaymentOfLoansPayable_c20210101__20211231_z9HuAPXZgHS" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Repayment of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44,428</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--RepaymentOfLoansPayable_c20200101__20201231_zJIXQuihKi5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Repayment of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57,873</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--AccretionExpenses_c20210101__20211231_z2vH2FCEIpB1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,405</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--AccretionExpenses_c20200101__20201231_znrTAxKXkEIg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--LoansPayableAmount_iE_c20210101__20211231_z1oXs5HpWdme" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--LoansPayableAmount_iE_c20200101__20201231_ze7vXOxSkAtb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_z5LOzo4m7tAh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zceQTIVFsRHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zpXE1ScRsgT7" style="display: none">SCHEDULE OF LOANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Start Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying Value December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying Value December 31, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEBA</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zSUntAFTDFgh" title="Start Date">2020-05-19</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z91Fhcc2QBr3" title="Maturity Date">2022-12-31</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zh1rfgbjZxIa" title="Rate">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z4NvvhB8SFxc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,384</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zA2Ye2yspWab" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,938</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEBA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zC6cqobcOtfk" title="Start Date">2021-04-23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zM4YkvgHCBZ9" title="Maturity Date">2022-12-31</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zfUfuCMTP5Tc" title="Rate">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zUavubpsJLyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,383</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zWMqob4xRD1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle loan</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z3L4Z71ZmIqg" title="Start Date">2019-08-30</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zh3JUhJtVOd1" title="Maturity Date">2024-09-11</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zh9l5HZnLuI9" title="Rate">6.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z3R0XylLzpra" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zPAjklUNxAhl" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,295</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Shopify loan</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_900_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_zARKXvz3Te6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020-08-05</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_z0S8jX8ADrXl">7.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_ztfOExv1DTm7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Carrying Value"><span style="-sec-ix-hidden: xdx2ixbrl1874">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><p id="xdx_984_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_zscbJTt5gBR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,683</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231_zdwsq00gcO4h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231_zifhXdRLPpI1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> </table> <p id="xdx_8A0_zvzH5GDz6Ni4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 19, 2020, Dronelogics received a $<span id="xdx_905_eifrs-full--LoansReceived_iI_pp0p0_c20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zeFFrJ1h7Czg" title="Loan received">40,000</span> CEBA loan. This loan is currently interest-free and <span id="xdx_90A_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20200519_zWHCsF4j7Lzh" title="Interest rate">25</span>% of the loan, up to $<span id="xdx_903_ecustom--LoansForgivableAmount_pp0p0_c20200518__20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zNbtJHSrpSWl" title="Loans forgivable amount">10,000</span>, is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a <span id="xdx_907_eifrs-full--BorrowingsMaturity_c20200518__20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zRvcKSgRm3pa" title="Maturity">three-year term</span> loan at an interest rate of <span id="xdx_90E_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20200519__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zVEeSiLbgEEi" title="Interest rate">5</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 4, 2020, the Government of Canada allowed for an expansion of the CEBA loan by $<span id="xdx_90D_eifrs-full--ProceedsFromIssueOfBondsNotesAndDebentures_pp0p0_c20201201__20201204__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zjA9p79KfKw" title="Proceeds from loan">20,000</span>, of which, an additional $<span id="xdx_90E_ecustom--LoanForgiveness_iI_pp0p0_c20201204__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zbeyMZx4iNI4" title="Loan forgiveness">10,000</span> is forgivable if the loan is repaid on or before December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 23, 2021, Draganfly Innovations Inc. received a $<span id="xdx_903_eifrs-full--UnsecuredBankLoansReceived_iI_pp0p0_c20210423__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zpfFj5w2NMQb" title="Unsecured loan received">60,000</span> CEBA loan. This loan is currently interest free and up to $<span id="xdx_90A_ecustom--LoansForgivableAmount_pp0p0_c20210422__20210423__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zTVZ5DOKNMrf" title="Loans forgivable amount">20,000</span> is forgivable if the loan is repaid on or before December 31, 2022. If the loan is not repaid by that date, the loan can be converted to a three-year term loan at an interest rate of <span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20210423__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zWPBB9sAYJVj" title="Interest rate">5</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The CEBA loans are unsecured and the vehicle loan is secured by the vehicle and the Shopify loan is secured by the Company’s accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--DisclosureOfLoansPayableExplanatory_zWQqvbFbkHrg" style="font: 10pt/107% Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BD_zclZPT7qyqOa" style="display: none; font-family: Times New Roman, Times, Serif">SCHEDULE OF LOANS PAYABLE</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opening balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--LoansPayableAmount_iS_c20210101__20211231_zAgZ39sbiexe" style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Opening balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--LoansPayableAmount_iS_c20200101__20201231_zTZIr6TPHlI9" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Opening balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition of loans</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--AcquisitionOfLoans_c20210101__20211231_zuO4NvDr42wc" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition of loans"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--AcquisitionOfLoans_c20200101__20201231_zNQjffrEFk45" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition of loans"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,851</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of loans payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--IssuanceOfLoansPayable_c20210101__20211231_zPURxMoT2mA2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--IssuanceOfLoansPayable_c20200101__20201231_zMZYLsQ1uLF6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value adjustment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--FairValueAdjustmentOnLoans_c20210101__20211231_zwGOxf7eFAwd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,576</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--FairValueAdjustmentOnLoans_c20200101__20201231_zTY6AOCuK379" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value adjustment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment of loans payable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--RepaymentOfLoansPayable_c20210101__20211231_z9HuAPXZgHS" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Repayment of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(44,428</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--RepaymentOfLoansPayable_c20200101__20201231_zJIXQuihKi5h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Repayment of loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57,873</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion expense</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--AccretionExpenses_c20210101__20211231_z2vH2FCEIpB1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Accretion expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,405</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--AccretionExpenses_c20200101__20201231_znrTAxKXkEIg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,090</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--LoansPayableAmount_iE_c20210101__20211231_z1oXs5HpWdme" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--LoansPayableAmount_iE_c20200101__20201231_ze7vXOxSkAtb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 97916 120851 60000 60000 -24576 -26152 -44428 -57873 4405 1090 93317 97916 <p id="xdx_893_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zceQTIVFsRHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zpXE1ScRsgT7" style="display: none">SCHEDULE OF LOANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Start Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying Value December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying Value December 31, 2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEBA</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zSUntAFTDFgh" title="Start Date">2020-05-19</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z91Fhcc2QBr3" title="Maturity Date">2022-12-31</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zh1rfgbjZxIa" title="Rate">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_z4NvvhB8SFxc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,384</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountMember_zA2Ye2yspWab" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,938</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEBA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zC6cqobcOtfk" title="Start Date">2021-04-23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zM4YkvgHCBZ9" title="Maturity Date">2022-12-31</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zfUfuCMTP5Tc" title="Rate">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zUavubpsJLyc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,383</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--CanadaEmergencyBusinessAccountLoanMember_zWMqob4xRD1l" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle loan</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z3L4Z71ZmIqg" title="Start Date">2019-08-30</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--BorrowingsMaturity_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zh3JUhJtVOd1" title="Maturity Date">2024-09-11</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zh9l5HZnLuI9" title="Rate">6.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_z3R0XylLzpra" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--VehicleLoanMember_zPAjklUNxAhl" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,295</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Shopify loan</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_900_ecustom--BorrowingsMaturityStartDay_dd_c20210101__20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_zARKXvz3Te6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020-08-05</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eifrs-full--BorrowingsInterestRate_iI_pid_dp_c20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_z0S8jX8ADrXl">7.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_ztfOExv1DTm7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Carrying Value"><span style="-sec-ix-hidden: xdx2ixbrl1874">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Interest"><p id="xdx_984_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231__ifrs-full--BorrowingsByNameAxis__custom--ShopifyLoanMember_zscbJTt5gBR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37,683</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20211231_zdwsq00gcO4h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Carrying Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--LoansAndAdvancesToBanks_iI_pp0p0_c20201231_zifhXdRLPpI1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> </table> 2020-05-19 2022-12-31 0 37384 34938 2021-04-23 2022-12-31 0 37383 2019-08-30 2024-09-11 0.0699 18550 25295 2020-08-05 0.0700 37683 93317 97916 40000 0.25 10000 three-year term 0.05 20000 10000 60000 20000 0.05 <p id="xdx_805_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z7OwdNxEuB18" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_zAwMJ8qODNm1">SHARE CAPITAL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized share capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited number of common shares without par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issued share capital</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_z9ryo5ymt0Hf" title="Number of stock issued for exercise of warrants">1,580,525</span> common shares for the exercise of warrants for $<span id="xdx_908_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zes13jako6y5" title="Value of stock issued for exercise of warrants">3,951,312</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zJGTYqqvCXoi" title="Number of stock issued for restrcited share units">149,999</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesExerciseOfOptions_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zQEtd1RxBTC8" title="Number of stock issued for exercise of options">392,999</span> common shares for the exercise of stock options for $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueExerciseOfOptions_pp0p0_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_z80faljFjMmh" title="Value of stock issued for exercise of options">987,248</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zFD2EJzEFq3g" title="Number of shares issued">15,000</span> common shares in lieu of cash.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_ecustom--StockUnitsIssuedDuringPeriodSharesRegulationFinancing_pid_c20210101__20211231_zoXxH0da90L6">6,488,691 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units for the Regulation A+ financing in the United States for proceeds of $<span id="xdx_90F_ecustom--StockUnitsIssuedDuringPeriodValueRegulationFinancing_pid_c20210101__20211231_zwKzMwBtFI12">18,815,485</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ShareCapitalIssuanceDescription_c20210101__20211231_zpzDaCDcRki5">Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. </span>The fair value of $<span id="xdx_901_eifrs-full--WarrantLiability_iI_c20211231_z3I26xTGkvob" title="Warrant derivative liability">8,261,511</span> was allocated to the warrant derivative liability.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90B_ecustom--StockUnitsIssuedDuringPeriodSharesAcquisition_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--VitalIntelligenceIncMember_zNTeKbCuF9Lg" title="Number of stock units issued for acquisition">1,200,000</span> units for the acquisition of Vital Intelligence. <span id="xdx_907_ecustom--ShareCapitalIssuanceDescription_c20210101__20211231__srt--ConsolidatedEntitiesAxis__custom--VitalIntelligenceIncMember_zvujFBhahsqk" title="Share capital issuance, description">Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years.</span></span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesPrivatePlacement_pid_c20210101__20211231_zSA1nJaA0I45" title="Number of stock issued for private placement">5,095,966</span> common shares in a private placement for $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValuePrivatePlacement_pp0p0_c20210101__20211231_zjIV7I49jqad" title="Value of stock issued for private placement">25,538,213</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zirYBrWKOFYb" title="Number of stock issued for exercise of warrants">359,009</span> common shares for the exercise of warrants for $<span id="xdx_901_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zCGQWDEzJyjk" title="Value of stock issued for exercise of warrants">978,478</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_pid_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zRbJZbrEQJla" title="Number of stock issued for restrcited share units">298,661</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesExerciseOfOptions_pid_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zUF3eTjWvGge" title="Number of stock issued for exercise of options">12,500</span> common shares for the exercise of stock options for $<span id="xdx_905_ecustom--StockIssuedDuringPeriodValueExerciseOfOptions_pp0p0_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zbHd2R4pRqob" title="Value of stock issued for exercise of options">26,875</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zvApaEkjzrXd" title="Number of shares issued">356,901</span> common shares in lieu of cash.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2020,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zzTQb4AIQHAk">24,000</span> common shares for the exercise of warrants for $<span id="xdx_90F_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zykGWWK4Ttq9">60,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_903_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_z1CMLJmu8lR4">20,000</span> common shares for the exercise of warrants for $<span id="xdx_906_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zG1OwA0VViqj">50,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_903_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock3Member_zzACWSSExjd6">210,320</span> common shares for the exercise of warrants for $<span id="xdx_906_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock3Member_z3cfqrhVp6i6">105,160</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock4Member_zP2iA2M86ZF1">73,000</span> common shares for the exercise of warrants for $<span id="xdx_906_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock4Member_zhgyoIxNSnk2">36,500</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock5Member_zU1ntDnjAn6b">294,840</span> common shares for the exercise of warrants for $<span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock5Member_znfWd8bFXPLe">147,420</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_903_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock6Member_zwgWoWOL4Y03">121,840</span> common shares for the exercise of warrants for $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock6Member_zf690Ap2VhCc">60,920</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock7Member_z8h8iSmZhCz">126,000</span> common shares for the exercise of warrants for $<span id="xdx_90D_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock7Member_zRJ9wTud5oq8">115,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_ecustom--StockUnitsIssuedDuringPeriodSharesAcquisition_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--DronelogicsIncMember_zTcKVVMebU16">645,088 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares for the acquisition of Dronelogics and an additional <span id="xdx_90E_ecustom--StockUnitsIssuedDuringPeriodSharesCommonSharesFinderFees_c20200101__20201231__srt--ConsolidatedEntitiesAxis__custom--DronelogicsIncMember_zJo659H2jDY2">40,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares as finder’s fees.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock8Member_zaZ4gSahbY9g">12,000</span> common shares for the exercise of warrants for $<span id="xdx_90C_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock8Member_z4Vy8q3fHm78">30,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock9Member_zFr7REuqXBO5">45,600</span> common shares for the exercise of warrants for $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock9Member_zDIemjjtCFyc">114,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesCashProceeds_pid_c20200101__20201231_zRmOeR8cVlW6" title="Number of stock issued for cash proceeds">192,308</span> common shares for cash proceeds of $<span id="xdx_90A_ecustom--StockIssuedDuringPeriodValueCashProceeds_pid_c20200101__20201231_zXBzXNofjXXl" title="Value of stock issued for cash proceeds">500,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_902_ecustom--StockIssuedDuringPeriodSharesDebtSettlement_pid_c20200101__20201231_zHSo2MPJCdfa" title="Number of stock issued for debt settlement">111,082</span> common shares for debt settlement of $<span id="xdx_908_ecustom--DebtSettlementRecognizedLoss_c20200101__20201231_zHaXwca8HBO2" title="Recongnized loss">344,354</span> and recognized a loss of $<span id="xdx_902_ecustom--DebtSettlementComprehensiveLoss_c20200101__20201231_z7pZjiQeiP4k" title="Comprehensive loss">38,879</span> in the statement of comprehensive loss.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock10Member_z6yFhoTCQFyi">2,000</span> common shares for the exercise of warrants for $<span id="xdx_90A_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock10Member_zrTw6rkh4ADa">5,000</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock11Member_zvi94mwThBf7">2,200</span> common shares for the exercise of warrants for $<span id="xdx_909_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock11Member_zFZ9Rng7aOZ8">5,500</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock12Member_zCSkq5dDX66e">637,975</span> common shares for the exercise of warrants for $<span id="xdx_90B_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock12Member_zcpfpsNgGek4">1,594,938</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_z8VG80Cts0X8">7,117</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_900_ecustom--StockUnitsIssuedDuringPeriodSharesRegulationFinancing_pid_c20200101__20201231_z3CyIQ8uVhZ">511,299</span> units for the Regulation A+ financing in the United States for proceeds of $<span id="xdx_903_ecustom--StockUnitsIssuedDuringPeriodValueRegulationFinancing_pid_c20200101__20201231_zax77lnyDaH3">1,518,845</span>. <span id="xdx_900_ecustom--ShareCapitalIssuanceDescription_c20200101__20201231_zy5FQq6KWhRb">Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022.</span></span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock2Member_zzyQfrS0NgSc">2,040</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock3Member_zaAilbzYkjPh">2,647</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesRestrcitedShareUnits_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock4Member_zBdMH1ZpEW3j">188,194</span> common shares for the vesting of Restricted Share Units.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesExerciseOfWarrants_pid_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock13Member_ztgJ4TnxrTWf">15,000</span> common shares for the exercise of warrants for $<span id="xdx_902_ecustom--StockIssuedDuringPeriodValueExerciseOfWarrants_pp0p0_c20200101__20201231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock13Member_zrWXC5e1ZGPk">37,500</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2019,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">-</td><td style="text-align: justify">The Company issued <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zKmNj9IHwKd3">143,985</span> common shares to a company controlled by a former director of the Company for settlement of $<span id="xdx_908_ecustom--ProceedsFromIssuanceOfNotesPayable_pid_c20190101__20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zGzuzVka5B2b">799,341</span> in accounts payable and application of $<span id="xdx_900_ecustom--SubscriptionReceivable_pp0p0_c20190101__20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zYMrYhIF0mw8">153,566</span> in subscription receivable.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_90D_ecustom--SharesIssuedAsTransactionsFeesShares_pid_c20190101__20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_z10ugwaYoegc">222,965</span> common shares with a value of $<span id="xdx_906_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonStock1Member_zG3GImL5rCFe">1,000,000</span> as transaction fees for the Draganfly Innovations amalgamation to related parties.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_907_ecustom--StockIssuedDuringPeriodValueUnitsShares_pid_c20190101__20191231__ifrs-full--ConsolidatedStructuredEntitiesAxis__custom--DraganflyInnovationsSharesMember_z7DJwhVbcxg6">8,517,671</span> common shares for the amalgamation with Draganfly Innovations.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_906_ecustom--SharesIssuedOfSettlementTradesPayableShares_pid_c20190101__20191231_zgV7fqlBcZ4j">9,065</span> common shares for settlement of $<span id="xdx_90E_ecustom--SharesIssuedOfSettlementTradesPayable_pp0p0_c20190101__20191231_zGTYGJjXePz9">22,662</span> in trades payables at a value of $<span id="xdx_904_ecustom--SharesIssuedOfSettlementTradesPayablePerShare_iI_pid_uCADPShares_c20191231_zmscEz4Sy6Ng" style="font: 10pt Times New Roman, Times, Serif" title="Trades payable per share">2.50</span> per share.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_90E_ecustom--SharesIssuedOfSettlementConvertibleDebenturesAndAccruedInterestShares_pid_c20190101__20191231_zyPGTNL4XIPe">423,698</span> common shares for settlement of $<span id="xdx_900_ecustom--SharesIssuedOfSettlementConvertibleDebentures_pp0p0_c20190101__20191231_zQ0Hijb8DPGa">740,000</span> in convertible debentures and interest. As a result of the settlement, the Company recognized loss on settlement of debt of $<span id="xdx_90B_ecustom--GainLossOnSettlementsOfDebt_pp0p0_c20190101__20191231_zzYaxPfrMNN" title="Gain loss on settlement of debt">319,246</span> in the statement of loss and comprehensive loss.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_904_ecustom--ProceedsFromExerciseOfWarrantsShares_pid_c20190101__20191231_zBpb8sVC3Via" title="Purchases of exercise of warrants, shares">63,388</span> common shares for exercise of share purchase warrants of the Company for proceeds of $<span id="xdx_900_eifrs-full--ProceedsFromExerciseOfWarrants_pp0p0_c20190101__20191231_zUC077husbn6" title="Purchases of exercise of warrants">8,833</span>. As a result of the exercise, $<span id="xdx_90D_eifrs-full--CapitalReserve_iI_pp0p0_c20191231_zvFhMKzSIIW1">212,908</span> from reserve was reclassification to share capital.</td></tr> <tr style="vertical-align: top"> <td/><td>-</td><td style="text-align: justify">The Company issued <span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesPrivatePlacement_pid_c20190101__20191231_zCN0f21rDPV2">2,810,300</span> units in a private placement. <span id="xdx_90A_ecustom--ShareCapitalIssuanceDescription_c20190101__20191231__srt--ConsolidatedEntitiesAxis__custom--VitalIntelligenceIncMember_zlv9Pt2jAda5">Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020</span>.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Options</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_ecustom--DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory_zBoH7nHQvBk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following options outstanding and exercisable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zL9tn0TT9uL6" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (years)</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zB6CI5ZxHxla" title="Grant date">October 30, 2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zmxOwyMjCPUh" title="Expiry date">October 30, 2029</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_z83N6XQkz0n3" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zPVQe3hshVuk" title="Remaining Contractual Life (years)">7.84</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zYoM6SFX0PHh" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zIhcj3CZkUr2" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zjbUrRr9WUl6" title="Grant date">November 19, 2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zP7WbSzj6mNf" title="Expiry date">November 19, 2029</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_znmLdjsPXv75" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zD12LMZbsuY7" title="Remaining Contractual Life (years)">7.89</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zOzPsFOlNrv7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zBJJt65lYIGl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_z7vrLuNSW2Fj" title="Grant date">April 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_z3MhR1JXYN3h" title="Expiry date">April 30, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zc6w1Ol9vnZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zBGuofQwv1p" title="Remaining Contractual Life (years)">8.33</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zVLjany2cs25" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zzrmFfVO73e2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_ziKxXhaXtFc1" title="Grant date">April 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zzisZW3hIBg9" title="Expiry date">April 30, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zajKVChGH91g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_ztBCIbU6Pogj" title="Remaining Contractual Life (years)">8.33</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zyN1x4cHYMJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zEFBcMzhLGpl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z8xqBYzmxt1e" title="Grant date">July 3, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zz7fxsjpM6Hh" title="Expiry date">July 3, 2025</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z70MoUqRVCFi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zEvq1mplkeec" title="Remaining Contractual Life (years)">3.51</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zbdoEgsNameg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z14FMqcMuQ74" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zFkxnlUe4L61" title="Grant date">November 24, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zttSpm6xY7Jh" title="Expiry date">November 24, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zlnF1mwPXt01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zclvfgCQkeRd" title="Remaining Contractual Life (years)">8.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zfUQ78WCZwsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_z77hKJGSf1jg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zvmIhYcd7aGg" title="Grant date">December 11, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zvBrK40w4dK1" title="Expiry date">December 11, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zjk44ZMMofD1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zOXfiDvt9N7i" title="Remaining Contractual Life (years)">8.95</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zqORDxM4uqV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_z7C0ref3dtnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zUJSrX01vB93" title="Grant date">February 2, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zLt2mJnOuo25" title="Expiry date">February 2, 2031</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zaDIPzRngF42" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zeAn9tI23Tu6" title="Remaining Contractual Life (years)">9.09</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_znkIFSKDgUYk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zROEP72sdFdb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zcGxY0bZhPdk" title="Grant date">March 8, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zCp2hyhriMAi" title="Expiry date">March 8, 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_z4NWo8ehkB46" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zLRiC89gIFzc" title="Remaining Contractual Life (years)">4.19</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zSZ1OJaWePmd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zqMgjMxFDTn3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zrPyPKwHlqe1" title="Grant date">April 27, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zA4vj5R0Dy78" title="Expiry date">April 27, 2031</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zU7VsdrAs6N4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_z7XHNQjomSw8" title="Remaining Contractual Life (years)">9.23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zBvI2PTdM0rg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_z037QCVclyvj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zadKZ3D48bKd" title="Grant date">September 9, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_z7mAT8P2oT3d" title="Expiry date">September 9, 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_z6rMloVHIdpi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zky7Qu0UaL04" title="Remaining Contractual Life (years)">4.69</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zqsAFCYHjOP8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zc9EJF13JLzb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231_zQVvlOg4o2s2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,035,991</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231_z8d7LY4xrffd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710,497</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_z2LozetpPg98" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zEGl8Pv7YJle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zmg0hpCh5Kue" style="display: none">SUMMARY OF CHANGES IN STOCK OPTIONS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20200101__20201231_z04lV3TFUhc2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">744,993</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20200101__20201231_zzmEoo1hVBm2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20200101__20201231_zo9UAQNx8Hgk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_c20200101__20201231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20200101__20201231_zZSMkve9HjHd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">492,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20200101__20201231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.08</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20210101__20211231_zzD1OQqrbyrc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,193,659</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20210101__20211231_zARM97n2jEZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231_zK3zHdPfx24a" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(405,494</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20210101__20211231_zvMIH9CuFCva" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231_z3Yjf6gvAHS6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,826</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231_zyq0VLTrtxd2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_c20210101__20211231_zBWmG7dWffX1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,035,991</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_c20210101__20211231_z6ZPA9sefSoi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.60</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_z7ieA2yDJDEi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeMember_zK8LYjVw7ES4" title="Number of options outstanding, Granted">30,000</span> options to an employee. Each option is exercisable at $<span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeMember_z9RhfsxQzSG7" title="Weighted average exercise price, Granted">13.20</span> per share for <span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeMember_zN678YswDM2f" title="Stock option exercisable year">10 years</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231__srt--TitleOfIndividualAxis__custom--ConsultantMember_zyUI7C9TzQH7">10,000</span> options to a consultant. Each option is exercisable at $<span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231__srt--TitleOfIndividualAxis__custom--ConsultantMember_zY3Rf8PdEw79">13.90</span> per share for <span id="xdx_903_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20210101__20211231__srt--TitleOfIndividualAxis__custom--ConsultantMember_z3IzSbRcSLRk" title="Stock option exercisable year">5 years</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_zY6a7emSENk9">182,000</span> options to employees and a consultant. Each option is exercisable at $<span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_zFlgUpIopPy8">10.15</span> per share for <span id="xdx_90E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_z7cv0rqEEY11">10 years</span>.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_zrVl3axAuc8b">25,826</span> options to an employee. Each option is exercisable at $<span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_zejShcdHqrV3">4.84</span> per share for <span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20210101__20211231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_z6ei9kojrwXl">5 years</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Options (cont’d)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_903_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeMember_zRtuBs4GYaB6" title="Number of options outstanding, Granted">89,000</span> options to employees. Each option is exercisable at $<span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeMember_zwrAGwYaBA6d" title="Weighted average exercise price, Granted">2.50</span> per share for a period of <span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeMember_zjTzpHvO10Oa" title="Stock option exercisable year">10 years</span> from the grant date.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="text-align: justify; width: 0.25in">-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantMember_zqEdyeQH7Oq">120,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to consultants. Each option is exercisable at $<span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantMember_zl0bSCx4D1Td">3.85 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share for a period of <span id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantMember_zXE74Q4EG43l">10 years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from the grant date.</span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_zCOiji4XYgJh" title="Number of options outstanding, Granted">200,000</span> options to employees. Each option is exercisable at $<span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_zy2ynvooejv2" title="Weighted average exercise price, Granted">3.20</span> per share for a period of <span id="xdx_900_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeOneMember_zPrtmEQY5kic" title="Stock option exercisable year">5 years</span> from the grant date.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeTwoMember_znB1ohVTh6p1" title="Number of options outstanding, Granted">33,000</span> options to employees. Each option is exercisable at $<span id="xdx_904_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeTwoMember_zFrQqzwEANgc" title="Weighted average exercise price, Granted">2.50</span> per share for a period of <span id="xdx_90E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeTwoMember_zrNYUrHAxsNh" title="Stock option exercisable year">10 years</span> from the grant date.</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 1.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zJnOhW1zDzpd" title="Number of options outstanding, Granted">50,000</span> options to a consultant. Each option is exercisable at $<span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zEVYKm3CsVzj" title="Weighted average exercise price, Granted">2.15</span> per share for a period of <span id="xdx_90A_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions_c20200101__20201231__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zjF5KQvJB6ik" title="Stock option exercisable year">10 years</span> from the grant date.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company recorded $<span id="xdx_903_eifrs-full--AdjustmentsForSharebasedPayments_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--StockOptionsMember_zBx7Z2xwnjKk">1,660,894</span> (2020 - $<span id="xdx_908_eifrs-full--AdjustmentsForSharebasedPayments_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--StockOptionsMember_zzHAW3kbKy5f">1,724,853</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2019 – $<span id="xdx_90F_eifrs-full--AdjustmentsForSharebasedPayments_c20190101__20191231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--StockOptionsMember_zgNsMvFR1Qek">599,701</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) in stock-based compensation for stock options, based on the fair values of stock options granted which were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</span></p> <p id="xdx_89A_ecustom--DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory_znqGODDlA4Q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zu6pKc0BbPik" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Risk free interest rate">0.69%</span>-<span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Risk free interest rate">1.40%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Risk free interest rate">0.43%</span>-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Risk free interest rate">0.66%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20190101__20191231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zn9x4IoQJ5Ie">1.45%</span>-<span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20190101__20191231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zO5AvPV4yNzg">1.46</span></td> <td>%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Expected volatility">62.84%</span>-<span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Expected volatility">113.16%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Expected volatility">113.53%</span>-<span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Expected volatility">119.03%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20190101__20191231_zNNgB3r6te4d">100</span></td> <td>%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_ecustom--ExpectedLifeOfOptions_dt_c20210101__20211231_zhiRtuoq0sV5">5 years</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvaUbxjXrbta" title="Expected life">5</span>-<span id="xdx_90B_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zytrOvLBwv36" title="Expected life">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20190101__20191231_zhg73NeZDu5" title="Expected life">7.5</span> years</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_c20210101__20211231_pp4d" title="Expected dividend yield">0</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_c20200101__20201231_pp4d" title="Expected dividend yield">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 2%"> </td> <td style="text-align: right; width: 14%"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pp4d_c20190101__20191231_ztfX2xAIc3Yh">0</span></td> <td style="width: 1%">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC9n6TRoZ6Be" title="Exercise price">4.84</span>-<span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztg8UkARSbVk" title="Exercise price">13.90</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfGkKcjQuFj8" title="Exercise price">2.15</span>-<span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkQShraap8b" title="Exercise price">3.85</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20191231_zQuAeHDYZgIh">2.50</span></td> <td style="padding-bottom: 1.5pt"/></tr> </table> <p id="xdx_8A7_zonGOnWF4RA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility is calculated using the historical volatility method based on a comparative company’s stock price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Share Units</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory_ztsPyOSMb5r4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following RSUs outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyHXX9wfV2A2" style="display: none">SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of RSUs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zQapQ5h1QONi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zfO4bu4aplb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(199,998</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zwkjuKf6eut8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(68,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zgXUw7CXPbA4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zhTZNwXgmrVh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">614,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_z8mcaWSB8SJh" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(448,660</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zJcVzqioCVN2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">348,826</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zLyefkW1JGpe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of RSUs outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">514,832</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zd3SFto2U9ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted Share Units (cont’d)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, <span id="xdx_909_ecustom--NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zAxoIZUSQVN1" title="Number of accelerated vesting shares">323,661</span> RSUs fully vested according to the terms and the Company accelerated the vesting of <span id="xdx_90C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zPYFhdOPwoq2" title="Number of shares vested">124,999</span> RSUs. The Company issued <span id="xdx_908_ecustom--NumberOfShareOptionsGrantedPostConsolidationInSharebasedPaymentArrangement_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z0gZIItWkMY" title="Number of shares granted post consolidation">348,826</span> RSUs to employees of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, the Company committed to grant <span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeeandConsultantMember__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zZu9Z15dwIil" title="Number of options outstanding, Granted">248,000</span> RSUs to employees and consultants of the Company with each RSU exercisable into one common share of the Company or the cash equivalent thereof upon the vesting conditions being met for a period of three years from the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company recorded share-based payment expense of $<span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pp0p0_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zZ4ze1bN90Fk" title="Share based payment expense">2,291,701</span> (2020: $<span id="xdx_902_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pp0p0_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zB0GpdTUDIPg" title="Share based payment expense">943,611</span>, 2019: $<span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pp0p0_c20190101__20191231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zVSJcLU5ufd8">161,858</span>) in stock-based compensation for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_ecustom--DisclosureOfWarrantDerivativeLiabilityExplanatory_zLBfBJYBWcm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Derivative Liability</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zoWlnGxZpFg5" style="display: none">SCHEDULE OF WARRANT DERIVATIVE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zNaSBt3LLDM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Warrant issuance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_987_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zBFbpMqaNr7d" style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0" title="Warrants issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281,732</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrants outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zs2HxpfMk4h4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Change in fair value of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,902</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zlIgSdzXG95a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><b>Warrant issuance</b></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_98B_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zWW1eQi8XbVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8,261,511</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b>Exercised</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_980_ecustom--SharesIssuedForExerciseOfBrokerWarrantsOfDerivatives_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zuoO1JtA9lx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(98,048</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrants outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zGhosVqc0l8b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,046,325</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td id="xdx_989_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zyhtOJEoc382" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="End of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,865,772</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Derivative liability</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="End of the period"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--Warrants_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zBMJyD8CSWH8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants">4,865,772</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Contingent consideration (note 4)</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zgShlQM7DVJh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Contingent consideration">694,230</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif">Contingent consideration at December 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--BusinessAcquisitionContingentConsideration_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zYZBxWxL8SRk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Contingent consideration at December 31, 2021">5,560,002</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zaRjWrXAF5k9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Details of these warrants and their fair values are as follows:</p> <p id="xdx_89E_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory_zZkydoxxmm24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_ztmpW9N6ic54" style="display: none">SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zmQakpnjrzCj" title="Issue Date">November 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zHFHrz77JaOe" style="font: 10pt Times New Roman, Times, Serif" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zImBWXgYdlbd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,425</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zkw3enxHKSF7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zyoJzaZ9twT3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zUOx97QUvr71" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_z3DxZv25Paxf">February 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zwgBvbvcd7G9">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zqpCExTthLPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,323,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zJtdDvWRUg9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">951,226</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zgikAGBLvFo8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zEIcxjkVKXd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2330">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_za6e8nDDRVC7">March 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zDmRajsVV8F4">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_z9CmWVsR8cS7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154,321</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zyH10Gd85TI7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,731,285</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zsTuWtZE9UM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2335">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zdvwhoeyHc6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2336">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zgL26T27lT06">July 29, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zKhbksTBiaWj">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zvy8QGt8b9Ga" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zGpHyrcQTSTk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,625</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zf5JlxaF7Znl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2341">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zcfFmQWFXMdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2342">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zcUnuQy1vNo8">September 14, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_905_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_z9UBZe81r9V5">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zapg0ES8YHze" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,798</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_z9Ec2I0AAHUl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zB44ER0DkqP8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2347">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zLJh7niPWFL1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231_z2YNQxusxlo3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,214,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231_zhooalNjh8Bj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,865,772</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231_zs2aNRDthCCj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231_zw0QwmbuHOFg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zMGHXZXojjpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>20.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants (cont’d)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory_z4ZzBvDzz3W3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zKhsrpjDsmG2" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zVrsdHtvHcS9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>0.23%</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zXOcORYeJeL2">0.95</span>%</span></b></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4nRjf8tU8Ee" title="Risk free interest rate">0.20%</span>-<span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zH12wXu7itmb" title="Risk free interest rate">0.24%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYMF3DB59Yl" title="Expected volatility">70.95%</span>-<span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zgiwPL6iRnkc" title="Expected volatility">144.59%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z0fvb7ZmvYI2" title="Expected volatility">72.76%</span>-<span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zZjcRbKs8OHh" title="Expected volatility">74.10%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_ecustom--ExpectedLifeOfOptions_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zXCDbrQM8LKh" title="Expected life">2</span>-<span id="xdx_906_ecustom--ExpectedLifeOfOptions_dtYp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zt8z1aReSZc5" title="Expected life">3</span> years</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zngYa7HvBla6" title="Expected life">2</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zzNclaxa7nWb" title="Expected dividend yield">0%</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYwtOFhRM0x" title="Expected dividend yield">0%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr> </table> <p id="xdx_8AE_zZHmEsNYCgzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility is calculated using the historical volatility method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--WarrantsExpirationDateDescription_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zviEyxECQCC6" title="Warrants Expiration Date Description">During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021.</span></span></p> <p id="xdx_89D_ecustom--DisclosureOfChangeInfWarrantsExplanatory_zw8DMolabnii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zwzYbVMEGCKh" style="display: none">SUMMARY OF CHANGES IN WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zw5WSnHsgw87" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,610,340</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOGjOELSq6qg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Exercise Price, Oustanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_pp0d_di_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOb1j9ZjLOua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,584,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z77ps6TsjxDe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zfbVMC9GqIw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4t3PSTnN548" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zZbhbzibSmwf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztphhZDiVdkg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.55</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYs59uh22QM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,416,864</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zohkagfsTz8k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Oustanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.95</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_pp0d_di_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z76UoK7ajLg7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,939,534</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zDdX91h7oeSf" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zFR8zIKR2q76" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zUaj5ph08yb3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z79D88zd1z0a" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,943,489</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z6qMpRfBU095" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zDu7EAMr0t3k" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,414,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zlXmyvkjCyge" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Oustanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.99</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zkA6d9VvcTF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <div id="xdx_896_ecustom--DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory_zmUJM7dS4X32" style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following warrants outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z1mFOFZbZQwa" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zQzVXgN0Ujnj" title="Date issued">November 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zhENHDCyohF2" title="Expiry Date">November 30, 2022</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_904_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zHHAhJH9c2q4" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zIqknoZzyGab" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,425</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zic4MhHXdHx3" title="Date issued">February 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zTkBt9KU7rx7" title="Expiry Date">February 5, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_906_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zRHuEdiyNJhk" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z5Z3X4Boz00d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,323,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zzlr90iGjht" title="Date issued">March 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zOOnvoQuxKPb" title="Expiry Date">March 5, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_900_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zUISFU8Fl3Ya" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_ziXG9xIbfWBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154,321</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zsZWCoGzj1sd" title="Date issued">March 22, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zaDEihUp4apd" title="Expiry Date">March 22, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDN$<span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zo957IscTdt4">13.35</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zGfpuxTCemN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zqGgQrSFOAki" title="Date issued">July 29, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zLgb19S2C9dj" title="Expiry Date">July 29, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90A_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zu1cWMkCUKe8" title="Exercise price">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zwDeVlNbU2rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zkU59MdNOALd" title="Date issued">September 14, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zPWQA7StLeh3" title="Expiry Date">September 14, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_901_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zkwxPuItapHh" title="Exercise price">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zW4wlpIvWnQj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,798</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOHeHPkLzD2c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,414,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_z9dXyTx6zEQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining contractual life of warrants outstanding as of December 31, 2021, was <span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zGfAGRFiUatc">1.20 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (December 31, 2020 – <span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200101__20201231_zanmZQ6v7eak">1.07 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of <span id="xdx_900_ecustom--WarrantsIssued_c20210321__20210322_zoWCUvNyy8hg" title="Warrants issued">1,200,000</span> warrants issued on March 22, 2021 to acquire Vital, <span id="xdx_908_ecustom--WarrantsHeldInEscrow_c20210321__20210322_zDc7qctTcii9" title="Warrants held in escrow">900,000</span> of the warrants are currently held in escrow, to be released upon completion of the milestones (note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1580525 3951312 149999 392999 987248 15000 6488691 18815485 Each unit is comprised of one common share and one share purchase warrant. These warrants had a fair value of $0.57 USD allocated to them, have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years. 8261511 1200000 Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $13.35 per warrant, each convert to one common share, and have a life of two years. 5095966 25538213 359009 978478 298661 12500 26875 356901 24000 60000 20000 50000 210320 105160 73000 36500 294840 147420 121840 60920 126000 115000 645088 40000 12000 30000 45600 114000 192308 500000 111082 344354 38879 2000 5000 2200 5500 637975 1594938 7117 511299 1518845 Each unit is comprised of one common share and one share purchase warrant. These warrants have an exercise price of $3.55 USD per warrant, each convert to one common share, and have a life of two years, expiring on November 30, 2022. 2040 2647 188194 15000 37500 143985 799341 153566 222965 1000000 8517671 9065 22662 2.50 423698 740000 319246 63388 8833 212908 2810300 Each unit consists of one common share and one warrant. These warrants have an exercise price of $2.50 per warrant, each convert to one common share, and have a life of one year, expiring on October 25, 2020 <p id="xdx_896_ecustom--DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory_zBoH7nHQvBk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following options outstanding and exercisable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zL9tn0TT9uL6" style="display: none">SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life (years)</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zB6CI5ZxHxla" title="Grant date">October 30, 2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zmxOwyMjCPUh" title="Expiry date">October 30, 2029</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_z83N6XQkz0n3" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zPVQe3hshVuk" title="Remaining Contractual Life (years)">7.84</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zYoM6SFX0PHh" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceOneMember_zIhcj3CZkUr2" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,665</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zjbUrRr9WUl6" title="Grant date">November 19, 2019</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zP7WbSzj6mNf" title="Expiry date">November 19, 2029</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_znmLdjsPXv75" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zD12LMZbsuY7" title="Remaining Contractual Life (years)">7.89</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zOzPsFOlNrv7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTwoMember_zBJJt65lYIGl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_z7vrLuNSW2Fj" title="Grant date">April 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_z3MhR1JXYN3h" title="Expiry date">April 30, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zc6w1Ol9vnZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zBGuofQwv1p" title="Remaining Contractual Life (years)">8.33</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zVLjany2cs25" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceThreeMember_zzrmFfVO73e2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_ziKxXhaXtFc1" title="Grant date">April 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zzisZW3hIBg9" title="Expiry date">April 30, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zajKVChGH91g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_ztBCIbU6Pogj" title="Remaining Contractual Life (years)">8.33</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zyN1x4cHYMJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFourMember_zEFBcMzhLGpl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z8xqBYzmxt1e" title="Grant date">July 3, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zz7fxsjpM6Hh" title="Expiry date">July 3, 2025</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z70MoUqRVCFi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zEvq1mplkeec" title="Remaining Contractual Life (years)">3.51</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_zbdoEgsNameg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceFiveMember_z14FMqcMuQ74" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zFkxnlUe4L61" title="Grant date">November 24, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zttSpm6xY7Jh" title="Expiry date">November 24, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zlnF1mwPXt01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zclvfgCQkeRd" title="Remaining Contractual Life (years)">8.90</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_zfUQ78WCZwsl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSixMember_z77hKJGSf1jg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zvmIhYcd7aGg" title="Grant date">December 11, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zvBrK40w4dK1" title="Expiry date">December 11, 2030</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zjk44ZMMofD1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zOXfiDvt9N7i" title="Remaining Contractual Life (years)">8.95</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_zqORDxM4uqV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceSevenMember_z7C0ref3dtnf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zUJSrX01vB93" title="Grant date">February 2, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zLt2mJnOuo25" title="Expiry date">February 2, 2031</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zaDIPzRngF42" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zeAn9tI23Tu6" title="Remaining Contractual Life (years)">9.09</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_znkIFSKDgUYk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceEightMember_zROEP72sdFdb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zcGxY0bZhPdk" title="Grant date">March 8, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zCp2hyhriMAi" title="Expiry date">March 8, 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_z4NWo8ehkB46" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zLRiC89gIFzc" title="Remaining Contractual Life (years)">4.19</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zSZ1OJaWePmd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceNineMember_zqMgjMxFDTn3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zrPyPKwHlqe1" title="Grant date">April 27, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zA4vj5R0Dy78" title="Expiry date">April 27, 2031</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zU7VsdrAs6N4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_z7XHNQjomSw8" title="Remaining Contractual Life (years)">9.23</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_zBvI2PTdM0rg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceTenMember_z037QCVclyvj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StockOptionsGrantDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zadKZ3D48bKd" title="Grant date">September 9, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--StockOptionsExpiryDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_z7mAT8P2oT3d" title="Expiry date">September 9, 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_z6rMloVHIdpi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zky7Qu0UaL04" title="Remaining Contractual Life (years)">4.69</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zqsAFCYHjOP8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,826</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--ExercisePriceElevenMember_zc9EJF13JLzb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2137">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iI_pp0d_uShares_c20211231_zQVvlOg4o2s2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,035,991</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pp0d_uShares_c20211231_z8d7LY4xrffd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710,497</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2019-10-30 2029-10-30 2.50 P7Y10M2D 296665 296665 2019-11-19 2029-11-19 2.50 P7Y10M20D 50000 50000 2020-04-30 2030-04-30 2.50 P8Y3M29D 87000 78666 2020-04-30 2030-04-30 3.85 P8Y3M29D 110000 70000 2020-07-03 2025-07-03 3.20 P3Y6M3D 200000 166666 2020-11-24 2030-11-24 2.50 P8Y10M24D 32000 21000 2020-12-11 2030-12-11 2.15 P8Y11M12D 12500 12500 2021-02-02 2031-02-02 13.20 P9Y1M2D 30000 10000 2021-03-08 2026-03-08 13.90 P4Y2M8D 10000 5000 2021-04-27 2031-04-27 10.15 P9Y2M23D 182000 2021-09-09 2026-09-09 4.84 P4Y8M8D 25826 1035991 710497 <p id="xdx_897_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zEGl8Pv7YJle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zmg0hpCh5Kue" style="display: none">SUMMARY OF CHANGES IN STOCK OPTIONS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20200101__20201231_z04lV3TFUhc2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">744,993</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20200101__20201231_zzmEoo1hVBm2" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20200101__20201231_zo9UAQNx8Hgk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_c20200101__20201231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20200101__20201231_zZSMkve9HjHd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">492,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20200101__20201231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.08</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_uShares_c20210101__20211231_zzD1OQqrbyrc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,193,659</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_c20210101__20211231_zARM97n2jEZ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231_zK3zHdPfx24a" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(405,494</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20210101__20211231_zvMIH9CuFCva" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20210101__20211231_z3Yjf6gvAHS6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,826</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231_zyq0VLTrtxd2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_uShares_c20210101__20211231_zBWmG7dWffX1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,035,991</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_c20210101__20211231_z6ZPA9sefSoi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.60</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 744993 2.50 43334 2.50 492000 3.08 1193659 2.75 405494 2.50 247826 10.12 1035991 4.60 30000 13.20 P10Y 10000 13.90 P5Y 182000 10.15 P10Y 25826 4.84 P5Y 89000 2.50 P10Y 120000 3.85 P10Y 200000 3.20 P5Y 33000 2.50 P10Y 50000 2.15 P10Y 1660894 1724853 599701 <p id="xdx_89A_ecustom--DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory_znqGODDlA4Q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zu6pKc0BbPik" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Risk free interest rate">0.69%</span>-<span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Risk free interest rate">1.40%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Risk free interest rate">0.43%</span>-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Risk free interest rate">0.66%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20190101__20191231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zn9x4IoQJ5Ie">1.45%</span>-<span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_c20190101__20191231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zO5AvPV4yNzg">1.46</span></td> <td>%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Expected volatility">62.84%</span>-<span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Expected volatility">113.16%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_pdd" title="Expected volatility">113.53%</span>-<span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_pdd" title="Expected volatility">119.03%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20190101__20191231_zNNgB3r6te4d">100</span></td> <td>%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_ecustom--ExpectedLifeOfOptions_dt_c20210101__20211231_zhiRtuoq0sV5">5 years</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvaUbxjXrbta" title="Expected life">5</span>-<span id="xdx_90B_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zytrOvLBwv36" title="Expected life">10</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="text-align: right"><span id="xdx_903_ecustom--ExpectedLifeOfOptions_dtY_c20190101__20191231_zhg73NeZDu5" title="Expected life">7.5</span> years</td> <td> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_c20210101__20211231_pp4d" title="Expected dividend yield">0</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_c20200101__20201231_pp4d" title="Expected dividend yield">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 2%"> </td> <td style="text-align: right; width: 14%"><span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pp4d_c20190101__20191231_ztfX2xAIc3Yh">0</span></td> <td style="width: 1%">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC9n6TRoZ6Be" title="Exercise price">4.84</span>-<span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztg8UkARSbVk" title="Exercise price">13.90</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfGkKcjQuFj8" title="Exercise price">2.15</span>-<span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zkQShraap8b" title="Exercise price">3.85</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_pid_uCADPShares_c20191231_zQuAeHDYZgIh">2.50</span></td> <td style="padding-bottom: 1.5pt"/></tr> </table> 0.0069 0.0140 0.0043 0.0066 0.0145 1.46 0.6284 1.1316 1.1353 1.1903 1 P5Y P5Y P10Y P7Y6M 0 0 0 4.84 13.90 2.15 3.85 2.50 <p id="xdx_89C_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory_ztsPyOSMb5r4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following RSUs outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyHXX9wfV2A2" style="display: none">SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of RSUs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zQapQ5h1QONi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634,997</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zfO4bu4aplb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(199,998</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_di_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zwkjuKf6eut8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(68,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zgXUw7CXPbA4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zhTZNwXgmrVh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of RSUs outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">614,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--NumberOfInstrumentsOtherEquityInstrumentsVested_iN_di_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_z8mcaWSB8SJh" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(448,660</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--NumberOfInstrumentsOtherEquityInstrumentsIssued_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zJcVzqioCVN2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">348,826</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--IfrsRestrictedStockUnitsRsuMember_zLyefkW1JGpe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of RSUs outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">514,832</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 634997 199998 68333 248000 614666 448660 348826 514832 323661 124999 348826 248000 2291701 943611 161858 <p id="xdx_89E_ecustom--DisclosureOfWarrantDerivativeLiabilityExplanatory_zLBfBJYBWcm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Derivative Liability</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zoWlnGxZpFg5" style="display: none">SCHEDULE OF WARRANT DERIVATIVE LIABILITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zNaSBt3LLDM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Warrant issuance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_987_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zBFbpMqaNr7d" style="font: 10pt/110% Times New Roman, Times, Serif; margin: 0" title="Warrants issuance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281,732</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrants outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_uUSD_c20200101__20201231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zs2HxpfMk4h4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Change in fair value of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,902</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iS_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zlIgSdzXG95a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><b>Warrant issuance</b></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_98B_ecustom--SharesIssuedForExerciseOfWarrantsOfDerivatives_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zWW1eQi8XbVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8,261,511</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><b>Exercised</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning of the period"><p id="xdx_980_ecustom--SharesIssuedForExerciseOfBrokerWarrantsOfDerivatives_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zuoO1JtA9lx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(98,048</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrants outstanding</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--ChangeInFairValueOfWarrantOfDerivativesOutstanding_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zGhosVqc0l8b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,046,325</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td id="xdx_989_ecustom--GainsLossesOnChangeInFairValueOfDerivative_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zyhtOJEoc382" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="End of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,865,772</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Derivative liability</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="End of the period"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--Warrants_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zBMJyD8CSWH8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants">4,865,772</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Contingent consideration (note 4)</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iE_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zgShlQM7DVJh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Contingent consideration">694,230</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif">Contingent consideration at December 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--BusinessAcquisitionContingentConsideration_uUSD_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--WarrantsMember_zYZBxWxL8SRk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Contingent consideration at December 31, 2021">5,560,002</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 281732 466902 748634 8261511 -98048 -4046325 4865772 4865772 694230 5560002 <p id="xdx_89E_ecustom--DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory_zZkydoxxmm24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_ztmpW9N6ic54" style="display: none">SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value at</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zmQakpnjrzCj" title="Issue Date">November 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zHFHrz77JaOe" style="font: 10pt Times New Roman, Times, Serif" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zImBWXgYdlbd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,425</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zkw3enxHKSF7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,262</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zyoJzaZ9twT3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range1Member_zUOx97QUvr71" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Fair Value of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_z3DxZv25Paxf">February 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zwgBvbvcd7G9">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zqpCExTthLPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,323,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zJtdDvWRUg9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">951,226</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zgikAGBLvFo8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2329">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range2Member_zEIcxjkVKXd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2330">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_za6e8nDDRVC7">March 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zDmRajsVV8F4">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_z9CmWVsR8cS7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154,321</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zyH10Gd85TI7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,731,285</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zsTuWtZE9UM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2335">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range3Member_zdvwhoeyHc6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2336">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zgL26T27lT06">July 29, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zKhbksTBiaWj">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zvy8QGt8b9Ga" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zGpHyrcQTSTk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,625</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zf5JlxaF7Znl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2341">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range4Member_zcfFmQWFXMdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2342">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantsIssuanceDate_dd_c20210101__20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zcUnuQy1vNo8">September 14, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_905_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_uUSDPShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_z9UBZe81r9V5">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zapg0ES8YHze" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,798</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_z9Ec2I0AAHUl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,685</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zB44ER0DkqP8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2347">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--Range5Member_zLJh7niPWFL1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20211231_z2YNQxusxlo3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,214,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--CurrentWarrantFairValue_iI_uUSD_c20211231_zhooalNjh8Bj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,865,772</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iI_uShares_c20201231_zs2aNRDthCCj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--CurrentWarrantFairValue_iI_uUSD_c20201231_zw0QwmbuHOFg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2020-11-30 3.55 482425 182262 511299 748634 2021-02-05 3.55 1323275 951226 2021-03-05 3.55 5154321 3731285 2021-07-29 5.00 250000 84625 2021-09-14 5.00 4798 1685 7214819 4865772 511299 748634 <p id="xdx_892_ecustom--DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory_z4ZzBvDzz3W3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zKhsrpjDsmG2" style="display: none">SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free interest rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zVrsdHtvHcS9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>0.23%</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zXOcORYeJeL2">0.95</span>%</span></b></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4nRjf8tU8Ee" title="Risk free interest rate">0.20%</span>-<span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zH12wXu7itmb" title="Risk free interest rate">0.24%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYMF3DB59Yl" title="Expected volatility">70.95%</span>-<span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zgiwPL6iRnkc" title="Expected volatility">144.59%</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z0fvb7ZmvYI2" title="Expected volatility">72.76%</span>-<span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zZjcRbKs8OHh" title="Expected volatility">74.10%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_ecustom--ExpectedLifeOfOptions_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zXCDbrQM8LKh" title="Expected life">2</span>-<span id="xdx_906_ecustom--ExpectedLifeOfOptions_dtYp_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zt8z1aReSZc5" title="Expected life">3</span> years</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ExpectedLifeOfOptions_dtY_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zngYa7HvBla6" title="Expected life">2</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected dividend yield</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zzNclaxa7nWb" title="Expected dividend yield">0%</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYwtOFhRM0x" title="Expected dividend yield">0%</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr> </table> 0.0023 0.0095 0.0020 0.0024 0.7095 1.4459 0.7276 0.7410 P2Y P3Y P2Y 0 0 During the year ended December 31, 2020, the Company amended the expiry date of the November 5, 2019 warrants from November 5, 2020 to November 5, 2021 provided that 25% of the warrants were exercised by October 21, 2020 and 25% were exercised by May 5, 2021. <p id="xdx_89D_ecustom--DisclosureOfChangeInfWarrantsExplanatory_zw8DMolabnii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zwzYbVMEGCKh" style="display: none">SUMMARY OF CHANGES IN WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zw5WSnHsgw87" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,610,340</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOGjOELSq6qg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted Average Exercise Price, Oustanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_pp0d_di_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOb1j9ZjLOua" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,584,775</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z77ps6TsjxDe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zfbVMC9GqIw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(120,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z4t3PSTnN548" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uCADPShares_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zZbhbzibSmwf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">511,299</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20200101__20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_ztphhZDiVdkg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.55</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zYs59uh22QM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Beginning of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,416,864</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zohkagfsTz8k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Oustanding, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.95</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--NumberOfInstrumentsOtherEquityInstrumentsExercised_iN_pp0d_di_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z76UoK7ajLg7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,939,534</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zDdX91h7oeSf" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pp0d_di_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zFR8zIKR2q76" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,000</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zUaj5ph08yb3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z79D88zd1z0a" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,943,489</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_z6qMpRfBU095" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uCADPShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zDu7EAMr0t3k" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending of the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,414,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zlXmyvkjCyge" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Oustanding, Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.99</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 3610340 2.05 1584775 1.50 120000 2.50 511299 3.55 2416864 2.95 1939534 2.54 6000 2.50 7943489 5.10 8414819 4.99 <div id="xdx_896_ecustom--DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory_zmUJM7dS4X32" style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had the following warrants outstanding:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z1mFOFZbZQwa" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date issued</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of warrants</span></p> <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zQzVXgN0Ujnj" title="Date issued">November 30, 2020</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zhENHDCyohF2" title="Expiry Date">November 30, 2022</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_904_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zHHAhJH9c2q4" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantOneMember_zIqknoZzyGab" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">482,425</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zic4MhHXdHx3" title="Date issued">February 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zTkBt9KU7rx7" title="Expiry Date">February 5, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_906_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_zRHuEdiyNJhk" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantTwoMember_z5Z3X4Boz00d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,323,275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zzlr90iGjht" title="Date issued">March 5, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zOOnvoQuxKPb" title="Expiry Date">March 5, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_900_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_zUISFU8Fl3Ya" title="Exercise price">3.55</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantThreeMember_ziXG9xIbfWBe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154,321</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zsZWCoGzj1sd" title="Date issued">March 22, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zaDEihUp4apd" title="Expiry Date">March 22, 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDN$<span id="xdx_908_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zo957IscTdt4">13.35</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFourMember_zGfpuxTCemN3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zqGgQrSFOAki" title="Date issued">July 29, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zLgb19S2C9dj" title="Expiry Date">July 29, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_90A_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zu1cWMkCUKe8" title="Exercise price">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantFiveMember_zwDeVlNbU2rf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--CompensationWarrantsIssuedDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zkU59MdNOALd" title="Date issued">September 14, 2021</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--WarrantExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zPWQA7StLeh3" title="Expiry Date">September 14, 2024</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ <span id="xdx_901_ecustom--CompensationWarrantsExercisePrice_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zkwxPuItapHh" title="Exercise price">5.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantSixMember_zW4wlpIvWnQj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,798</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--CompensationWarrantsNumberOfWarrants_iI_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantsMember_zOHeHPkLzD2c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,414,819</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2020-11-30 2022-11-30 3.55 482425 2021-02-05 2023-02-05 3.55 1323275 2021-03-05 2023-03-05 3.55 5154321 2021-03-22 2023-03-22 13.35 1200000 2021-07-29 2024-07-29 5.00 250000 2021-09-14 2024-09-14 5.00 4798 8414819 P1Y2M12D P1Y25D 1200000 900000 <p id="xdx_80E_eifrs-full--DisclosureOfRevenueExplanatory_zlNs2mvNusTk" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_828_zxpPEBT1Rm4d">REVENUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sub-classifies revenue within the following components: product revenue and services revenue. Product revenue comprises of sales of internally assembled multi-rotor helicopters, industrial aerial video systems, civilian small unmanned aerial systems or vehicles, and wireless video systems. Services revenue consists of fees charged for custom engineering, drone as a service work, and training and simulation consulting.</span></p> <p id="xdx_89C_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zNshi7bLTZ6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zSJUVJCMLlrb" style="display: none">SCHEDULE OF PRODUCT AND SERVICE REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20210101__20211231_zmLjzZnhHlql" style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_49C_20200101__20201231_zczWbAqcjJDe" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_496_20190101__20191231_zI8XBUfyyh22" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31,</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ProductSalesMember_ziAQQQpXgjH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product sales</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,103,399</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,087,223</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--DroneServiceMember_zLNssyf8rVgj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drone service</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,304,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">630,532</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ServicesMember_zYnmlcoAKAI2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,756</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,131,488</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zDMoaBWzrKx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,053,865</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,363,511</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zs1Xl1Qvto54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not derive significant revenue from any (2020 – 1) customers that exceeds 10% of total revenues for the year ended December 31, 2021 (2020 – $<span id="xdx_904_ecustom--RevenueFromRenderingOfEngineeringServices_c20200101__20201231__ifrs-full--ProductsAndServicesAxis__custom--CustomEngineeringServicesMember_pp0p0">474,701 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of custom engineering services revenue).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consulting revenue</i>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 22, 2017, the Company executed a standard consulting agreement, whereby the Company would provide consulting, custom engineering and investigating and solving on a project-by-project basis. The Company shall be responsible for the development, design, procurement, fabrication, assembly, integration, checkout, integration and test of hardware, software, and firmware necessary to produce a complete system per each project. The consideration for the services performed are based on the labor cost incurred on an hourly basis and minimal preapproved expenditures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfGeographicalAreasExplanatory_zrPj4dHm5MA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geographic revenue segmentation is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zylFimCkTqZe" style="display: none">SCHEDULE OF GEOGRAPHIC REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; padding-left: 0pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20210101__20211231_zKIoOFzfMMHc" style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20200101__20201231_zEtD3PyPhza" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_49C_20190101__20191231_z5ory3nSNF0e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--CACountryMember_z0HWGQqL6jk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,937,935</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,270,862</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,118</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--USCountryMember_zAm7xPLDB6o9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,071,492</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,404</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,251,199</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--InternationalMember_zLD1DLqT89Sg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,438</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,245</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,110</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--Revenue_zD9XaphzA8nb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,053,865</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,363,511</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zdMc22RwTsKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>21.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REVENUE (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zT9R4AVIP3P1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non current assets for each geographic segment are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_z8QoA0E1gLR2" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231__ifrs-full--GeographicalAreasAxis__custom--CanadaMember_zJNcaoinafCj" style="border-bottom: Black 1.5pt solid; text-align: right">Canada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zCnJLYjogEz" style="border-bottom: Black 1.5pt solid; text-align: right">United States</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231__ifrs-full--GeographicalAreasAxis__custom--InternationalMember_z1qKFHtmuYO" style="border-bottom: Black 1.5pt solid; text-align: right">International</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">Canada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">United States</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">International</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eifrs-full--Goodwill_iI_zCr4p1zlN4o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Goodwill</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">2,166,564</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,773,845</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipment_iI_zs9GrGoWXqL" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property and equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">297,043</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2517"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2518"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zHfSUYuxTU0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangible assets</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">219,093</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2522"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--InvestmentProperty_iI_zyRVtOwizHR6" style="vertical-align: bottom; background-color: White"> <td>Investments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">291,066</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2525"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2526"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--NotesReceivableNonCurrent_iI_zfqODTDXyH48" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes receivable</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2528"> </span></td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">964,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2530"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--RightofuseAssets_iI_zNGYzFIwslQi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">468,106</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2533"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2534"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eifrs-full--Assets_iI_zmek454Z9d4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL ASSETS</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,441,872</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,112,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2538">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zNshi7bLTZ6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zSJUVJCMLlrb" style="display: none">SCHEDULE OF PRODUCT AND SERVICE REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20210101__20211231_zmLjzZnhHlql" style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_49C_20200101__20201231_zczWbAqcjJDe" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_496_20190101__20191231_zI8XBUfyyh22" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended December 31,</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ProductSalesMember_ziAQQQpXgjH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product sales</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,103,399</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,087,223</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--DroneServiceMember_zLNssyf8rVgj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drone service</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,304,799</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">630,532</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ServicesMember_zYnmlcoAKAI2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645,756</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,131,488</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--Revenue_zDMoaBWzrKx6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,053,865</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,363,511</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5103399 3087223 248939 1304799 630532 645667 645756 1131488 7053865 4363511 1380427 474701 <p id="xdx_896_eifrs-full--DisclosureOfGeographicalAreasExplanatory_zrPj4dHm5MA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geographic revenue segmentation is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BB_zylFimCkTqZe" style="display: none">SCHEDULE OF GEOGRAPHIC REVENUE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; padding-left: 0pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20210101__20211231_zKIoOFzfMMHc" style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_499_20200101__20201231_zEtD3PyPhza" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none"> </td> <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td><td id="xdx_49C_20190101__20191231_z5ory3nSNF0e" style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--CACountryMember_z0HWGQqL6jk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,937,935</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,270,862</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,118</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--USCountryMember_zAm7xPLDB6o9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,071,492</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,404</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,251,199</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--Revenue_hsrt--StatementGeographicalAxis__custom--InternationalMember_zLD1DLqT89Sg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,438</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110,245</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,110</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--Revenue_zD9XaphzA8nb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,053,865</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,363,511</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,427</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 4937935 2270862 127118 2071492 1982404 1251199 44438 110245 2110 7053865 4363511 1380427 <p id="xdx_891_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zT9R4AVIP3P1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non current assets for each geographic segment are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_z8QoA0E1gLR2" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20211231__ifrs-full--GeographicalAreasAxis__custom--CanadaMember_zJNcaoinafCj" style="border-bottom: Black 1.5pt solid; text-align: right">Canada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesMember_zCnJLYjogEz" style="border-bottom: Black 1.5pt solid; text-align: right">United States</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20211231__ifrs-full--GeographicalAreasAxis__custom--InternationalMember_z1qKFHtmuYO" style="border-bottom: Black 1.5pt solid; text-align: right">International</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">Canada</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">United States</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">International</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eifrs-full--Goodwill_iI_zCr4p1zlN4o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Goodwill</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">2,166,564</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,773,845</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--PropertyPlantAndEquipment_iI_zs9GrGoWXqL" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property and equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">297,043</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2517"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2518"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--IntangibleAssetsOtherThanGoodwill_iI_zHfSUYuxTU0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangible assets</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">219,093</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">374,808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2522"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--InvestmentProperty_iI_zyRVtOwizHR6" style="vertical-align: bottom; background-color: White"> <td>Investments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">291,066</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2525"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2526"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--NotesReceivableNonCurrent_iI_zfqODTDXyH48" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Notes receivable</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2528"> </span></td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">964,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2530"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--RightofuseAssets_iI_zNGYzFIwslQi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">468,106</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2533"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2534"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eifrs-full--Assets_iI_zmek454Z9d4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL ASSETS</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,441,872</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,112,659</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2538">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2166564 3773845 297043 219093 374808 291066 964006 468106 3441872 5112659 <p id="xdx_800_eifrs-full--DisclosureOfOtherOperatingExpenseExplanatory_ziM2vAJ6sKK" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>22.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_zvKRkuWtJKm3">OFFICE AND MISCELLANEOUS</span></b></span></p> <p id="xdx_895_ecustom--DisclosureOfOtherAndMiscellaneousExplanatory_zdsKrjlCjvD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zkJLOz9dSHU5" style="display: none">SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_z0FJZPXfj6tg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20200101__20201231_zTMES5WNlQ91" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20190101__20191231_z97VmMFiJ5Gc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdvertisingExpense_maMOOEziuZ_zodqeUlarl2d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left; text-indent: -14.2pt; padding-left: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising, Marketing, and Investor Relations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,165,791</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,610,930</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,356,174</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--ComplianceFees_maMOOEziuZ_zMFkt3BxCYkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,874</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,525</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ContractWork_maMOOEziuZ_z9g8P0vLBAL5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract Work</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,975</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">438,601</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherExpenseByFunction_maMOOEziuZ_zuLNIUa7rAib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">556,358</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">254,473</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">228,432</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--MiscellaneousOtherOperatingExpense_iT_pp0p0_mtMOOEziuZ_zbexD8liydIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and Miscellaneous Expenses </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,455,998</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,387,865</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,103,732</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zachnJfUbo23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--DisclosureOfOtherAndMiscellaneousExplanatory_zdsKrjlCjvD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zkJLOz9dSHU5" style="display: none">SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_z0FJZPXfj6tg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20200101__20201231_zTMES5WNlQ91" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20190101__20191231_z97VmMFiJ5Gc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--AdvertisingExpense_maMOOEziuZ_zodqeUlarl2d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left; text-indent: -14.2pt; padding-left: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising, Marketing, and Investor Relations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,165,791</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,610,930</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,356,174</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--ComplianceFees_maMOOEziuZ_zMFkt3BxCYkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,874</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,525</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ContractWork_maMOOEziuZ_z9g8P0vLBAL5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract Work</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,975</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">438,601</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherExpenseByFunction_maMOOEziuZ_zuLNIUa7rAib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">556,358</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">254,473</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">228,432</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--MiscellaneousOtherOperatingExpense_iT_pp0p0_mtMOOEziuZ_zbexD8liydIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 5.4pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and Miscellaneous Expenses </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,455,998</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,387,865</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,103,732</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5165791 2610930 1356174 432874 122916 80525 300975 399546 438601 556358 254473 228432 6455998 3387865 2103732 <p id="xdx_803_eifrs-full--DisclosureOfRelatedPartyExplanatory_zz9M07IMjYMg" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zYmCmZn48n89">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consist of members of the Company’s Board of Directors and corporate officers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trade payables and accrued liabilities:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #222222; background-color: white">On Aug 1, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of up to six consultants and the costs of all charges are based on the fees set in the Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the company incurred fees of $<span id="xdx_90B_eifrs-full--ProfessionalFeesExpense_pp0p0_c20210101__20211231__custom--AgreementAxis__custom--BusinessServiceAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zjH9510KGKUc" title="Professional fees">315,643 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compared to $<span id="xdx_903_eifrs-full--ProfessionalFeesExpense_pp0p0_c20200101__20201231__custom--AgreementAxis__custom--BusinessServiceAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_zQuYn5GcJVn9" title="Professional fees">177,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in 2020, and $<span id="xdx_901_eifrs-full--ProfessionalFeesExpense_pp0p0_c20190101__20191231__custom--AgreementAxis__custom--BusinessServiceAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BusinessInstinctsGroupMember_ztzxcXY44L06" title="Professional fees">80,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $<span id="xdx_903_eifrs-full--ProfessionalFeesExpense_pp0p0_c20210101__20211231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zxBXJ3PH62ti" title="Professional fees">290,225</span> compared to $<span id="xdx_90E_eifrs-full--ProfessionalFeesExpense_pp0p0_c20200101__20201231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_znYW6EQKRF3" title="Professional fees">525,164</span> in 2020, and $<span id="xdx_903_eifrs-full--ProfessionalFeesExpense_pp0p0_c20190101__20191231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zwdBbp98ZdW" title="Professional fees">9,000</span> in 2019. As at December 31, 2021, the Company was indebted to this company in the amount of $<span id="xdx_90C_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_dxL_c20211231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zippWFj7x1U1" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2577">nil</span></span> (December 31, 2020 - $<span id="xdx_908_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20201231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zkRItpyFe3A2" title="Amounts payable, related party transactions">321,741</span>, December 31, 2019 $<span id="xdx_906_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20191231__custom--AgreementAxis__custom--ConsultantAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlbertaLtdMember_zVkuD9tCFbPi" title="Amounts payable, related party transactions">9,450</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. The costs of all charges are based on the fees set in the Executive Agreement and are settled on a monthly basis. The Company records these charges under Professional Fees. For the year ended December 31, 2021, the Company incurred fees of $<span id="xdx_901_eifrs-full--ProfessionalFeesExpense_pp0p0_c20210101__20211231__custom--AgreementAxis__custom--ExecutiveAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zvEIe2fkSITf" title="Professional fees">205,191</span> (December 31, 2020 – <span id="xdx_90D_eifrs-full--ProfessionalFeesExpense_pp0p0_c20200101__20201231__custom--AgreementAxis__custom--ExecutiveAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zt86i2nf67tl" title="Professional fees">227,524</span>). As at December 31, 2021, the Company was indebted to this company in the amount of $<span id="xdx_90D_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_dxL_c20211231__custom--AgreementAxis__custom--ExecutiveAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zdQ7ES4C7Hmh" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2586">nil</span></span> (December 31, 2020 - $<span id="xdx_90A_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20201231__custom--AgreementAxis__custom--ExecutiveAgreementMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ScottLarsonMember_zNQ6t5GGATtl">153,887</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2021, the Company had $<span id="xdx_906_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_dxL_c20211231_z71YVC7V9jll" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2588">nil</span></span> (December 31, 2020 - $<span id="xdx_90E_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20201231_zh4SruMPGYHd" title="Amounts payable, related party transactions">475,628</span>, December 31, 2019 $<span id="xdx_90E_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_pp0p0_c20191231_z2gK5K9Zs0Qe" title="Amounts payable, related party transactions">9,681</span>) payable to related parties outstanding that were included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>23.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED PARTY TRANSACTIONS (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key management compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zem8mgYAg6y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zuyybJLhhni5" style="display: none">SCHEDULE OF KEY MANAGEMENT TRANSACTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zl16zj4vLL4b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20200101__20201231_z9CFUtbyYpxj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20190101__20191231_zPkgYTCRv6ci" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--DirectorFeesExpense_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">370,094</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2598">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOAndDirectorMember_zlvWSJ7mxFWc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by CEO and director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,225</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">737,164</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--PresidentAndDirectorMember_zdZAexWB9SE3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by the President and director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,691</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,524</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2606"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerDirectorMember_zpvpAsukARXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by a former director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,074</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerDirectorMember_zT3m0CZKFrek" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,074</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--SalaryAndWages_zz7Frr0uytPi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722,068</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655,799</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--SalaryAndWages_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerOwnerMember_z7MANhAsHVve" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries paid to the former owner of the Company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2620"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--SalaryAndWages_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerOwnerMember_zyMnlT6UyYx7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2624"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,475,949</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,614,158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">480,158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--KeyManagementPersonnelCompensation_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,564,102</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,485,742</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189,647</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zt56cr7ChUM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 315643 177000 80000 290225 525164 9000 321741 9450 205191 227524 153887 475628 9681 <p id="xdx_892_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zem8mgYAg6y5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management includes the Company’s directors and members of the executive management team. Compensation awarded to key management for the year ended December 31, 2021 and 2020 included:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zuyybJLhhni5" style="display: none">SCHEDULE OF KEY MANAGEMENT TRANSACTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20210101__20211231_zl16zj4vLL4b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20200101__20201231_z9CFUtbyYpxj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20190101__20191231_zPkgYTCRv6ci" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--DirectorFeesExpense_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director fees</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">370,094</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2598">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--CEOAndDirectorMember_zlvWSJ7mxFWc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by CEO and director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,225</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">737,164</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--PresidentAndDirectorMember_zdZAexWB9SE3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by the President and director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205,691</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">227,524</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2606"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerDirectorMember_zpvpAsukARXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company controlled by a former director</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,074</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerDirectorMember_zT3m0CZKFrek" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fees paid to a company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,074</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">195,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--SalaryAndWages_zz7Frr0uytPi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">722,068</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655,799</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">179,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_ecustom--SalaryAndWages_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerOwnerMember_z7MANhAsHVve" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries paid to the former owner of the Company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2620"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--SalaryAndWages_hifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerOwnerMember_zyMnlT6UyYx7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2624"> </span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,097</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">149,060</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,475,949</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,614,158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">480,158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--KeyManagementPersonnelCompensation_i_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,564,102</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,485,742</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,189,647</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 370094 290225 737164 186000 205691 227524 500074 165000 195000 500074 165000 195000 722068 655799 179429 86097 149060 86097 149060 2475949 1614158 480158 4564102 3485742 1189647 <p id="xdx_80D_ecustom--DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory_zb1SXn0lSoBh" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_z46AM1ZfyAul">FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Credit risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables. The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does not have any past due outstanding receivables and the expected loss rate for undue balance is estimated to be nominal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company’s normal operating requirements on an ongoing basis. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash and cash equivalents. Historically, the Company’s sole source of funding has been the issuance of equity securities for cash, primarily through private placements. The Company’s access to financing is always uncertain. There can be no assurance of continued access to significant equity funding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign exchange risk </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_zF7lOMS2UE37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net income upon consolidation as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zEsHCOVi2IRk" style="display: none">SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20210101__20211231_zM96x7RYEUl6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200101__20201231_zakNgeZiDR82" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--NetForeignExchangeGain_zSEcOk0iOmw9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,715</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,018</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zQ18lNbfhg8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest rate risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its cash equivalents as these instruments have original maturities of three months or less and are therefore exposed to interest rate fluctuations on renewal.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair value</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities in investee companies and warrants are measured at fair value. The financial assets measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.</span></p> <p id="xdx_894_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zjW8jr5F2vya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_z4TE3eRw83kg">SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_z7iDmfFJGWD8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zlnfXqdHyLD7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zKYnx5gkyTk9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B4_zTfCFguWZsp2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_ziKQ6bOJGsy1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities in investee companies</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,286</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,780</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2647">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">291,066</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zrAjbfnnMcG7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Notes receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2650"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,154,176</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2652"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,154,176</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_430_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_ztLDat9AeAx" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2655"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2656"> </span>-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,560,002</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,560,002</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20211231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_z7kIp8dThUU7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,286</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280,956</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,560,002</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,005,244</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zOKzazw0q3nk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zKC9QgUOWp2b" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zngF7pFK9e55" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20201231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zA6Jcz678Syd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2665"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2666"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20201231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zULcHFYmMeS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl2669">-</span></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl2670">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>748,634</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>748,634</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> </table> <p id="xdx_8AC_zfxNMYmu8fa7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital Management</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages its capital to maintain its ability to continue as a going concern and to provide returns to shareholders and benefits to other stakeholders. The capital structure of the Company consists of cash, debt, and equity comprised of issued share capital, and share-based payment reserve.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company manages its capital structure and makes adjustments to it in light of economic conditions. The Company, upon approval from its board of directors, will balance its overall capital structure through new equity issuances or by undertaking other activities as deemed appropriate under the specific circumstances. The Company is not subject to externally imposed capital requirements and the Company’s overall strategy with respect to capital risk management remains unchanged from the year ended December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfBreakdownOfAssetsAndLiabilitiesAggregatedIntoSingleLineInvestmentBalanceTransitionFromProportionateConsolidationToEquityMethodExplanatory_zEwhwCxpxWqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The breakdown of the Company’s capital is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z3seJbLIAl6b" style="display: none">SCHEDULE OF BREAKDOWN CAPITAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zZVLYTFS9sge" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20201231_zv1eDizreNXj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iI_z5O3LIGBDDeb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,075,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,416</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--NetDebt_iI_zhc1g4xERj16" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--EquityAttributableToOwnersOfParent_iI_z9bIHiYX2lE" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,926,239</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,848,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zu2iUmkBNrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_zF7lOMS2UE37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net income upon consolidation as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zEsHCOVi2IRk" style="display: none">SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20210101__20211231_zM96x7RYEUl6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200101__20201231_zakNgeZiDR82" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--NetForeignExchangeGain_zSEcOk0iOmw9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange rate</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,715</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,018</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 150715 27018 <p id="xdx_894_eifrs-full--DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory_zjW8jr5F2vya" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_z4TE3eRw83kg">SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_z7iDmfFJGWD8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zlnfXqdHyLD7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zKYnx5gkyTk9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4B4_zTfCFguWZsp2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity_iI_ziKQ6bOJGsy1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities in investee companies</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,286</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,780</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2647">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">291,066</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable_iI_zrAjbfnnMcG7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Notes receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2650"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,154,176</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2652"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,154,176</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_430_c20211231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_ztLDat9AeAx" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2655"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2656"> </span>-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,560,002</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,560,002</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20211231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_z7kIp8dThUU7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">164,286</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,280,956</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5,560,002</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,005,244</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BD_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level1OfFairValueHierarchyMember_zOKzazw0q3nk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BE_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level2OfFairValueHierarchyMember_zKC9QgUOWp2b" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_4BB_ifrs-full--LevelsOfFairValueHierarchyAxis_ifrs-full--Level3OfFairValueHierarchyMember_zngF7pFK9e55" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20201231_ecustom--CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability_iI_zA6Jcz678Syd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2665"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2666"> </span></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">748,634</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20201231_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLoss_iI_zULcHFYmMeS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl2669">-</span></b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b><span style="-sec-ix-hidden: xdx2ixbrl2670">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>748,634</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>748,634</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> </table> 164286 126780 291066 1154176 1154176 5560002 5560002 164286 1280956 5560002 7005244 748634 748634 <p id="xdx_893_eifrs-full--DisclosureOfBreakdownOfAssetsAndLiabilitiesAggregatedIntoSingleLineInvestmentBalanceTransitionFromProportionateConsolidationToEquityMethodExplanatory_zEwhwCxpxWqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The breakdown of the Company’s capital is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_z3seJbLIAl6b" style="display: none">SCHEDULE OF BREAKDOWN CAPITAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20211231_zZVLYTFS9sge" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20201231_zv1eDizreNXj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--CashAndCashEquivalents_iI_z5O3LIGBDDeb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,075,713</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,982,416</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--NetDebt_iI_zhc1g4xERj16" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,317</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--EquityAttributableToOwnersOfParent_iI_z9bIHiYX2lE" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,926,239</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,848,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 23075713 1982416 93317 97916 34926239 3848205 <p id="xdx_804_eifrs-full--DisclosureOfIncomeTaxExplanatory_zZ5W4qNQzc34" style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_zxouetq8guUl">INCOME TAXES</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2021, 2020 and 2019:</span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutIncomeTax_zX8YtiL42Wme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zuLhOtP0ixm6" style="display: none">SCHEDULE OF INCOME TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210101__20211231_zn4zux0zhKvg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zEc4xkI7pXJ7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td id="xdx_490_20190101__20191231_zzKW4dk7mRbf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eifrs-full--AccountingProfit_zGzl6W9bK2d6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16,202,972</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,015,813</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%">11,095,507</td> <td style="width: 1%"> </td></tr> <tr id="xdx_401_eifrs-full--ApplicableTaxRate_pid_dp_uPure_z8vJmdpKY2X2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian statutory rates</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">27</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_zV9KlrBmBLo9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected income tax recovery</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>4,196,600</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,164,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">2,996,000</td> <td> </td></tr> <tr id="xdx_406_eifrs-full--TaxEffectOfForeignTaxRates_zBhnnbhF1039" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Impact of different foreign statutory tax rates</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>34,900</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2701"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2702">-</span></td> <td> </td></tr> <tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_di_z0884yJadvwi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible items</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>116,400</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(687,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right">(2,043,000</td> <td>)</td></tr> <tr id="xdx_40A_ecustom--TaxEffectRatesShareIssueCosts_zDDu2Hi9f3kj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share issue costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>887,600</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2709"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2710">-</span></td> <td> </td></tr> <tr id="xdx_401_ecustom--TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns_zfw9QVXBNni7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to prior years provision versus statutory tax returns</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>376,500</b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">(388,000</td> <td>)</td></tr> <tr id="xdx_40B_ecustom--TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn_z6xDkI0qgUz3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Differences between prior year provision and final tax return</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(206,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right">(18,000</td> <td>)</td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectFromChangeInTaxRate_zsGMySDXmxu6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in deferred tax asset not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(5,406,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(547,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zLGUWIivL1G6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8AD_zVNSmjFPnpve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>25.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCOME TAXES (CONT’D)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_z5C8UScSwHk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zWOSG0zX23w" style="display: none">SCHEDULE OF DEFERRED TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zdCQS688ZJ7d" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20201231_zUO3upYddC2j" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td id="xdx_499_20190101_zhnbZPldW1ec" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax assets (liabilities):</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsShareIssuanceCosts_maDTAzLpO_ze5C3MkUFXi5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issuance costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><b>728,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%"><span style="-sec-ix-hidden: xdx2ixbrl2732">-</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsNoncapitalLosses_iI_maDTAzLpO_zo7pPKaj4ril" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-capital losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>7,043,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,656,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">2,439,000</td> <td> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsPropertyAndEquipment_iI_maDTAzLpO_zcZilGHkhKCk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>449,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">457,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">581,000</td> <td> </td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalGainReserve_iI_maDTAzLpO_zhXfIqQU46Td" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital gain reserve</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>74,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2743"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2744">-</span></td> <td> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsScientificResearchAndExperimentalDevelopment_iI_maDTAzLpO_zoE4t3Ckd616" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scientific Research and Experimental Development</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>291,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt/110% Calibri, Helvetica, Sans-Serif; text-align: right; margin: 0">49,000</p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eifrs-full--DeferredTaxAssets_iTI_mtDTAzLpO_maNDTAzIOr_zbuf2oucJGJi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>8,585,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td>$</td> <td style="text-align: right">3,069,000</td> <td> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsDeferredIncomeTaxNotRecognized_iI_maNDTAzIOr_zMvYrDcmYjl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(8,585,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(3,069,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_408_eifrs-full--NetDeferredTaxAssets_iTI_mtNDTAzIOr_zRURHUZJUJgf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl2758">-</span></b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2759">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2760">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> <p id="xdx_8AF_z0BkDShxm7U8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has non-capital loss carry forward of approximately $<span id="xdx_904_eifrs-full--TaxEffectOfTaxLosses_c20210101__20211231_z8KM6EgiwIAd">25,487,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2040.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfDetailedInformationAboutIncomeTax_zX8YtiL42Wme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zuLhOtP0ixm6" style="display: none">SCHEDULE OF INCOME TAX</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20210101__20211231_zn4zux0zhKvg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zEc4xkI7pXJ7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td id="xdx_490_20190101__20191231_zzKW4dk7mRbf" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eifrs-full--AccountingProfit_zGzl6W9bK2d6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16,202,972</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,015,813</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%">11,095,507</td> <td style="width: 1%"> </td></tr> <tr id="xdx_401_eifrs-full--ApplicableTaxRate_pid_dp_uPure_z8vJmdpKY2X2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canadian statutory rates</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">27</td> <td style="padding-bottom: 1.5pt">%</td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfRevenuesExemptFromTaxation2011_zV9KlrBmBLo9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected income tax recovery</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>4,196,600</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,164,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">2,996,000</td> <td> </td></tr> <tr id="xdx_406_eifrs-full--TaxEffectOfForeignTaxRates_zBhnnbhF1039" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Impact of different foreign statutory tax rates</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>34,900</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2701"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2702">-</span></td> <td> </td></tr> <tr id="xdx_403_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_iN_di_z0884yJadvwi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible items</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>116,400</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(687,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right">(2,043,000</td> <td>)</td></tr> <tr id="xdx_40A_ecustom--TaxEffectRatesShareIssueCosts_zDDu2Hi9f3kj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share issue costs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>887,600</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl2709"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2710">-</span></td> <td> </td></tr> <tr id="xdx_401_ecustom--TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns_zfw9QVXBNni7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to prior years provision versus statutory tax returns</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>376,500</b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">(388,000</td> <td>)</td></tr> <tr id="xdx_40B_ecustom--TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn_z6xDkI0qgUz3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Differences between prior year provision and final tax return</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(206,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right">(18,000</td> <td>)</td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectFromChangeInTaxRate_zsGMySDXmxu6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in deferred tax asset not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(5,406,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(547,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zLGUWIivL1G6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 16202972 8015813 11095507 0.27 0.27 4196600 2164000 2996000 34900 -116400 687000 2043000 887600 376500 189000 -388000 -206000 -535000 -18000 -5406000 -1131000 -547000 <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory_z5C8UScSwHk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zWOSG0zX23w" style="display: none">SCHEDULE OF DEFERRED TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zdCQS688ZJ7d" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20201231_zUO3upYddC2j" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td id="xdx_499_20190101_zhnbZPldW1ec" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax assets (liabilities):</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr id="xdx_40B_ecustom--DeferredTaxAssetsShareIssuanceCosts_maDTAzLpO_ze5C3MkUFXi5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share issuance costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><b>728,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="text-align: right; width: 16%"><span style="-sec-ix-hidden: xdx2ixbrl2732">-</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsNoncapitalLosses_iI_maDTAzLpO_zo7pPKaj4ril" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-capital losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>7,043,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,656,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">2,439,000</td> <td> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsPropertyAndEquipment_iI_maDTAzLpO_zcZilGHkhKCk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>449,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">457,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right">581,000</td> <td> </td></tr> <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalGainReserve_iI_maDTAzLpO_zhXfIqQU46Td" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital gain reserve</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>74,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2743"> </span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2744">-</span></td> <td> </td></tr> <tr id="xdx_406_ecustom--DeferredTaxAssetsScientificResearchAndExperimentalDevelopment_iI_maDTAzLpO_zoE4t3Ckd616" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scientific Research and Experimental Development</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>291,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt/110% Calibri, Helvetica, Sans-Serif; text-align: right; margin: 0">49,000</p></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eifrs-full--DeferredTaxAssets_iTI_mtDTAzLpO_maNDTAzIOr_zbuf2oucJGJi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><b>8,585,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td>$</td> <td style="text-align: right">3,069,000</td> <td> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsDeferredIncomeTaxNotRecognized_iI_maNDTAzIOr_zMvYrDcmYjl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax not recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b>(8,585,000</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>)</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(3,069,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr id="xdx_408_eifrs-full--NetDeferredTaxAssets_iTI_mtNDTAzIOr_zRURHUZJUJgf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><b><span style="-sec-ix-hidden: xdx2ixbrl2758">-</span></b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2759">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">$</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2760">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> </table> 728000 30000 7043000 3656000 2439000 449000 457000 581000 74000 291000 57000 49000 8585000 4200000 3069000 -8585000 -4200000 -3069000 25487000 <p id="xdx_809_eifrs-full--DisclosureOfOtherOperatingIncomeExplanatory_zBgyEhtb2CSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>26.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_zkGI4erzAECd">OTHER INCOME</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company had previously written off an investment in a UK-based company. On April 27, 2020, this company was sold and the Company received $<span id="xdx_90A_eifrs-full--ProceedsFromSalesOfInvestmentProperty_uCAD_c20200425__20200427_zEJoTojhqvfi" style="font: 10pt Times New Roman, Times, Serif" title="Amount received from sale of investment">1,179,513 (US$<span id="xdx_90F_eifrs-full--ProceedsFromSalesOfInvestmentProperty_uUSD_c20200425__20200427_zLvCiOwjjpp1">854,838</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1179513 854838 <p id="xdx_80C_ecustom--DisclosureOfSupplementalCashFlowDisclosureExplanatory_zAj3jHqdDNNi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>27.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zDx7bAYbgyVb">SUPPLEMENTAL CASH FLOW DISCLOSURES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zQjvABLIZbrj" title="Number of shares issued">15,000</span> common shares in lieu of cash.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_c20211231__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_z2XaeRV91oid">1,200,000</span> units for the acquisition of Vital Intelligence. Each unit is comprised of one common share and one warrant. These warrants have an exercise price of $<span id="xdx_905_ecustom--WarrantsExercisePrice_iI_c20211231__dei--LegalEntityAxis__custom--VitalIntelligenceIncMember_zHjzWY04doyl">13.35</span> per warrant, each convert to one common share, and have a life of two years.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesOneMember_zNMuwZywu3Fg">356,901</span> common shares in lieu of cash.</span></td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td style="text-align: left">-</td> <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt">The <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company recorded a change in fair value of investments of $<span id="xdx_904_eifrs-full--FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_iI_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesOneMember_zpPTQrgVnPJ9" title="Fair value of investments other comprehensive loss">332,640</span> to other comprehensive loss.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, the Company settled debt of $<span id="xdx_908_ecustom--DebtSettlementAmount_c20200101__20201231_zAF8pZfTMqdj" title="Debt settlement, amount">344,354</span> with the issuance of <span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesDebtSettlements_c20200101__20201231_z16pbdDoZJQc" title="Debt settlement, shares issued">111,082</span> common shares and recognized a gain on settlement of debt of $<span id="xdx_90F_ecustom--DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet_c20200101__20201231_zTOWtCmakWL" title="Gai on settlement of debt">28,614</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2019:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement of $<span id="xdx_90C_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20191231_zUsVfvZFCAq5" title="Accounts payable">822,003</span> in accounts payable and application of $<span id="xdx_90E_ecustom--SubscriptionReceivable_c20190101__20191231_zvKfo73QW0X1" title="Subscription receivable">153,566</span> in subscription receivable through issuance of shares;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_c20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_z4p2dEODx0i5">400,000</span> common shares at $<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_c20191231__ifrs-full--ComponentsOfEquityAxis__custom--CommonSharesMember_zLXCKVoMCwp2" title="Price per share">2.50</span> per shares as finders’ fees, and;</span></td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement of $<span id="xdx_907_ecustom--DebtSettlementAmount_c20190101__20191231__ifrs-full--BorrowingsByNameAxis__custom--ConvertibleDebenturesMember_zeSqZiPdBTH6" title="Debt settlement, amount">740,000</span> of convertible debentures.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Draganfly Inc.</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial Statements</b></span></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For The Year Ended December 31, 2021</b></span></p> <p style="border-bottom: Black 1.5pt solid; font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expressed in Canadian Dollars</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 15000 1200000 13.35 356901 332640 344354 111082 28614 822003 153566 400000 2.50 740000 <p id="xdx_80F_ecustom--DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory_zfvMtFAyF3N8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>28.</b></span> <span id="xdx_82A_zkAjeyAfrcyd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GOVERNMENT ASSISTANCE</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In response to COVID-19, the Government of Canada announced the Canada Emergency Wage Subsidy (“CEWS”) program in April 2020. CEWS provides a wage subsidy on eligible remuneration, subject to a maximum per employee, to eligible employers based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. Included in the statement of comprehensive loss for the year ended December 31, 2021 is - $<span id="xdx_90C_eifrs-full--WagesAndSalaries_c20210101__20211231__srt--StatementScenarioAxis__custom--CanadaEmergencyWageSubsidyMember_z0CiiDGI86c2">250,756 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020 - $<span id="xdx_904_eifrs-full--WagesAndSalaries_c20200101__20201231__srt--StatementScenarioAxis__custom--CanadaEmergencyWageSubsidyMember_zyZLIXm3aah2">490,748</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) relating to the CEWS program of which was recorded as a reduction of wages and salaries included in operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2020, the Government of Canada announced the Canada Emergency Rent Subsidy (“CERS”) to provide a rent subsidy to eligible businesses based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy as well. The Company has recognized the government assistance as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $<span id="xdx_908_eifrs-full--RentalExpense_c20210101__20211231__srt--StatementScenarioAxis__custom--CanadaEmergencyRentSubsidyMember_zv7TdKbvGpp6">22,668 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020 - $<span id="xdx_907_eifrs-full--RentalExpense_dxL_c20200101__20201231__srt--StatementScenarioAxis__custom--CanadaEmergencyRentSubsidyMember_zLmnjIMgnHZd" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2796">nil</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) relating to the CERS program of which was recorded as a reduction of rent included in operating expenses. As at December 31, 2021, the Company had - $<span id="xdx_90D_eifrs-full--OtherReceivables_iI_dxL_c20211231__srt--StatementScenarioAxis__custom--CanadaEmergencyRentSubsidyMember_z4j8UkBu9RZh" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2797">nil </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020 - $<span id="xdx_902_eifrs-full--OtherReceivables_iI_dxL_c20201231__srt--StatementScenarioAxis__custom--CanadaEmergencyRentSubsidyMember_zG21kNNBWM7b" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2798">nil</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) included in amounts receivables for CERS subsidies receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021 the Government of Canada announced the Hardest Hit Business Recovery Program (“HHBRP”) to provide continued wage and rent subsidies to business’ severely affected by COVID-19, based on meeting certain eligibility criteria. The Company determined that it qualified for this subsidy. The Company has recognized the government grant as a reduction to expenses as it has complied with the eligibility criteria and the subsidy has been received. The amount included in the statement of comprehensive loss for the year ended December 31, 2021 is - $<span id="xdx_908_eifrs-full--WagesAndSalaries_c20210101__20211231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_zIjBna41knva">50,756 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in wage subsidies and $<span id="xdx_900_eifrs-full--RentalExpense_c20210101__20211231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_zkUolnelXv33">3,791 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in rent subsidies (2020 - $<span id="xdx_90E_eifrs-full--WagesAndSalaries_dxL_c20200101__20201231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_zTtujBx32aR2" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2801">nil</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and - $<span id="xdx_909_eifrs-full--RentalExpense_dxL_c20200101__20201231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_zltZy6z1t6Pl" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2802">nil </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively) relating to the HHBRP program of which were recorded as a reduction wages and salaries and rent expense respectively. As at December 31, 2021, the Company had - $<span id="xdx_908_eifrs-full--OtherReceivables_iI_c20211231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_z1FqB8x6rUq4">54,548 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2020 - $<span id="xdx_90A_eifrs-full--OtherReceivables_iI_dxL_c20201231__srt--StatementScenarioAxis__custom--HardestHitBusinessRecoveryProgramMember_z7AKLpjl7sA1" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2804">nil</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) included in amounts receivables for HHBRP subsidies receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> 250756 490748 22668 50756 3791 54548 These notes are denominated in US dollars and are converted to Canadian dollars at the reporting date. EXCEL 165 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 167 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 168 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 371 563 1 true 140 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://draganfly.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Statements of Financial Position Sheet http://draganfly.com/role/StatementsOfFinancialPosition Consolidated Statements of Financial Position Statements 2 false false R3.htm 00000003 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://draganfly.com/role/StatementsOfChangesInShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://draganfly.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS Sheet http://draganfly.com/role/NatureAndContinuanceOfOperations NATURE AND CONTINUANCE OF OPERATIONS Notes 6 false false R7.htm 00000007 - Disclosure - BASIS OF PREPARATION Sheet http://draganfly.com/role/BasisOfPreparation BASIS OF PREPARATION Notes 7 false false R8.htm 00000008 - Disclosure - DRONELOGICS ACQUISITION Sheet http://draganfly.com/role/DronelogicsAcquisition DRONELOGICS ACQUISITION Notes 8 false false R9.htm 00000009 - Disclosure - VITAL INTELLIGENCE ACQUISITION Sheet http://draganfly.com/role/VitalIntelligenceAcquisition VITAL INTELLIGENCE ACQUISITION Notes 9 false false R10.htm 00000010 - Disclosure - AMALGAMATION Sheet http://draganfly.com/role/Amalgamation AMALGAMATION Notes 10 false false R11.htm 00000011 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://draganfly.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 11 false false R12.htm 00000012 - Disclosure - RECEIVABLES Sheet http://draganfly.com/role/Receivables RECEIVABLES Notes 12 false false R13.htm 00000013 - Disclosure - INVENTORY Sheet http://draganfly.com/role/Inventory INVENTORY Notes 13 false false R14.htm 00000014 - Disclosure - NOTES RECEIVABLE Notes http://draganfly.com/role/NotesReceivable NOTES RECEIVABLE Notes 14 false false R15.htm 00000015 - Disclosure - PREPAIDS Sheet http://draganfly.com/role/Prepaids PREPAIDS Notes 15 false false R16.htm 00000016 - Disclosure - INVESTMENTS Sheet http://draganfly.com/role/Investments INVESTMENTS Notes 16 false false R17.htm 00000017 - Disclosure - EQUIPMENT Sheet http://draganfly.com/role/Equipment EQUIPMENT Notes 17 false false R18.htm 00000018 - Disclosure - INTANGIBLE ASSETS AND GOODWILL Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwill INTANGIBLE ASSETS AND GOODWILL Notes 18 false false R19.htm 00000019 - Disclosure - RIGHT OF USE ASSETS Sheet http://draganfly.com/role/RightOfUseAssets RIGHT OF USE ASSETS Notes 19 false false R20.htm 00000020 - Disclosure - LEASE LIABILITY Sheet http://draganfly.com/role/LeaseLiability LEASE LIABILITY Notes 20 false false R21.htm 00000021 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES Sheet http://draganfly.com/role/TradePayablesAndAccruedLiabilities TRADE PAYABLES AND ACCRUED LIABILITIES Notes 21 false false R22.htm 00000022 - Disclosure - CUSTOMER DEPOSITS Sheet http://draganfly.com/role/CustomerDeposits CUSTOMER DEPOSITS Notes 22 false false R23.htm 00000023 - Disclosure - DEFERRED INCOME Sheet http://draganfly.com/role/DeferredIncome DEFERRED INCOME Notes 23 false false R24.htm 00000024 - Disclosure - LOANS PAYABLE Sheet http://draganfly.com/role/LoansPayable LOANS PAYABLE Notes 24 false false R25.htm 00000025 - Disclosure - SHARE CAPITAL Sheet http://draganfly.com/role/ShareCapital SHARE CAPITAL Notes 25 false false R26.htm 00000026 - Disclosure - REVENUE Sheet http://draganfly.com/role/Revenue REVENUE Notes 26 false false R27.htm 00000027 - Disclosure - OFFICE AND MISCELLANEOUS Sheet http://draganfly.com/role/OfficeAndMiscellaneous OFFICE AND MISCELLANEOUS Notes 27 false false R28.htm 00000028 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://draganfly.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 28 false false R29.htm 00000029 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT Sheet http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT Notes 29 false false R30.htm 00000030 - Disclosure - INCOME TAXES Sheet http://draganfly.com/role/IncomeTaxes INCOME TAXES Notes 30 false false R31.htm 00000031 - Disclosure - OTHER INCOME Sheet http://draganfly.com/role/OtherIncome OTHER INCOME Notes 31 false false R32.htm 00000032 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES Sheet http://draganfly.com/role/SupplementalCashFlowDisclosures SUPPLEMENTAL CASH FLOW DISCLOSURES Notes 32 false false R33.htm 00000033 - Disclosure - GOVERNMENT ASSISTANCE Sheet http://draganfly.com/role/GovernmentAssistance GOVERNMENT ASSISTANCE Notes 33 false false R34.htm 00000034 - Disclosure - BASIS OF PREPARATION (Policies) Sheet http://draganfly.com/role/BasisOfPreparationPolicies BASIS OF PREPARATION (Policies) Policies 34 false false R35.htm 00000035 - Disclosure - BASIS OF PREPARATION (Tables) Sheet http://draganfly.com/role/BasisOfPreparationTables BASIS OF PREPARATION (Tables) Tables http://draganfly.com/role/BasisOfPreparation 35 false false R36.htm 00000036 - Disclosure - DRONELOGICS ACQUISITION (Tables) Sheet http://draganfly.com/role/DronelogicsAcquisitionTables DRONELOGICS ACQUISITION (Tables) Tables http://draganfly.com/role/DronelogicsAcquisition 36 false false R37.htm 00000037 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Tables) Sheet http://draganfly.com/role/VitalIntelligenceAcquisitionTables VITAL INTELLIGENCE ACQUISITION (Tables) Tables http://draganfly.com/role/VitalIntelligenceAcquisition 37 false false R38.htm 00000038 - Disclosure - AMALGAMATION (Tables) Sheet http://draganfly.com/role/AmalgamationTables AMALGAMATION (Tables) Tables http://draganfly.com/role/Amalgamation 38 false false R39.htm 00000039 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Sheet http://draganfly.com/role/CashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS (Tables) Tables http://draganfly.com/role/CashAndCashEquivalents 39 false false R40.htm 00000040 - Disclosure - RECEIVABLES (Tables) Sheet http://draganfly.com/role/ReceivablesTables RECEIVABLES (Tables) Tables http://draganfly.com/role/Receivables 40 false false R41.htm 00000041 - Disclosure - INVENTORY (Tables) Sheet http://draganfly.com/role/InventoryTables INVENTORY (Tables) Tables http://draganfly.com/role/Inventory 41 false false R42.htm 00000042 - Disclosure - NOTES RECEIVABLE (Tables) Notes http://draganfly.com/role/NotesReceivableTables NOTES RECEIVABLE (Tables) Tables http://draganfly.com/role/NotesReceivable 42 false false R43.htm 00000043 - Disclosure - PREPAIDS (Tables) Sheet http://draganfly.com/role/PrepaidsTables PREPAIDS (Tables) Tables http://draganfly.com/role/Prepaids 43 false false R44.htm 00000044 - Disclosure - INVESTMENTS (Tables) Sheet http://draganfly.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://draganfly.com/role/Investments 44 false false R45.htm 00000045 - Disclosure - EQUIPMENT (Tables) Sheet http://draganfly.com/role/EquipmentTables EQUIPMENT (Tables) Tables http://draganfly.com/role/Equipment 45 false false R46.htm 00000046 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables) Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwillTables INTANGIBLE ASSETS AND GOODWILL (Tables) Tables http://draganfly.com/role/IntangibleAssetsAndGoodwill 46 false false R47.htm 00000047 - Disclosure - RIGHT OF USE ASSETS (Tables) Sheet http://draganfly.com/role/RightOfUseAssetsTables RIGHT OF USE ASSETS (Tables) Tables http://draganfly.com/role/RightOfUseAssets 47 false false R48.htm 00000048 - Disclosure - LEASE LIABILITY (Tables) Sheet http://draganfly.com/role/LeaseLiabilityTables LEASE LIABILITY (Tables) Tables http://draganfly.com/role/LeaseLiability 48 false false R49.htm 00000049 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables TRADE PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://draganfly.com/role/TradePayablesAndAccruedLiabilities 49 false false R50.htm 00000050 - Disclosure - CUSTOMER DEPOSITS (Tables) Sheet http://draganfly.com/role/CustomerDepositsTables CUSTOMER DEPOSITS (Tables) Tables http://draganfly.com/role/CustomerDeposits 50 false false R51.htm 00000051 - Disclosure - DEFERRED INCOME (Tables) Sheet http://draganfly.com/role/DeferredIncomeTables DEFERRED INCOME (Tables) Tables http://draganfly.com/role/DeferredIncome 51 false false R52.htm 00000052 - Disclosure - LOANS PAYABLE (Tables) Sheet http://draganfly.com/role/LoansPayableTables LOANS PAYABLE (Tables) Tables http://draganfly.com/role/LoansPayable 52 false false R53.htm 00000053 - Disclosure - SHARE CAPITAL (Tables) Sheet http://draganfly.com/role/ShareCapitalTables SHARE CAPITAL (Tables) Tables http://draganfly.com/role/ShareCapital 53 false false R54.htm 00000054 - Disclosure - REVENUE (Tables) Sheet http://draganfly.com/role/RevenueTables REVENUE (Tables) Tables http://draganfly.com/role/Revenue 54 false false R55.htm 00000055 - Disclosure - OFFICE AND MISCELLANEOUS (Tables) Sheet http://draganfly.com/role/OfficeAndMiscellaneousTables OFFICE AND MISCELLANEOUS (Tables) Tables http://draganfly.com/role/OfficeAndMiscellaneous 55 false false R56.htm 00000056 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://draganfly.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://draganfly.com/role/RelatedPartyTransactions 56 false false R57.htm 00000057 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) Sheet http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) Tables http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement 57 false false R58.htm 00000058 - Disclosure - INCOME TAXES (Tables) Sheet http://draganfly.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://draganfly.com/role/IncomeTaxes 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF RESULTS OF OPERATIONS (Details) Sheet http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails SCHEDULE OF RESULTS OF OPERATIONS (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details) Sheet http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails SCHEDULE OF CLASS OF EQUIPMENT (Details) Details 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) Sheet http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails SCHEDULE OF PURCHASE PRICE ALLOCATION (Details) Details 61 false false R62.htm 00000062 - Disclosure - DRONELOGICS ACQUISITION (Details Narrative) Sheet http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative DRONELOGICS ACQUISITION (Details Narrative) Details http://draganfly.com/role/DronelogicsAcquisitionTables 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF CONTINGENT CONSIDERATION (Details) Sheet http://draganfly.com/role/ScheduleOfContingentConsiderationDetails SCHEDULE OF CONTINGENT CONSIDERATION (Details) Details 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details) Sheet http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details) Details 64 false false R65.htm 00000065 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Details Narrative) Sheet http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative VITAL INTELLIGENCE ACQUISITION (Details Narrative) Details http://draganfly.com/role/VitalIntelligenceAcquisitionTables 65 false false R66.htm 00000066 - Disclosure - SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details) Sheet http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details) Details 66 false false R67.htm 00000067 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) Sheet http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details) Details 67 false false R68.htm 00000068 - Disclosure - AMALGAMATION (Details Narrative) Sheet http://draganfly.com/role/AmalgamationDetailsNarrative AMALGAMATION (Details Narrative) Details http://draganfly.com/role/AmalgamationTables 68 false false R69.htm 00000069 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Sheet http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Details 69 false false R70.htm 00000070 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) Sheet http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative CASH AND CASH EQUIVALENTS (Details Narrative) Details http://draganfly.com/role/CashAndCashEquivalentsTables 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details) Sheet http://draganfly.com/role/ScheduleOfAmountsReceivableDetails SCHEDULE OF AMOUNTS RECEIVABLE (Details) Details 71 false false R72.htm 00000072 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://draganfly.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF COST OF SALES (Details) Sheet http://draganfly.com/role/ScheduleOfCostOfSalesDetails SCHEDULE OF COST OF SALES (Details) Details 73 false false R74.htm 00000074 - Disclosure - INVENTORY (Details Narrative) Sheet http://draganfly.com/role/InventoryDetailsNarrative INVENTORY (Details Narrative) Details http://draganfly.com/role/InventoryTables 74 false false R75.htm 00000075 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details) Notes http://draganfly.com/role/DisclosureOfNotesReceivableDetails DISCLOSURE OF NOTES RECEIVABLE (Details) Details 75 false false R76.htm 00000076 - Disclosure - NOTES RECEIVABLE (Details Narrative) Notes http://draganfly.com/role/NotesReceivableDetailsNarrative NOTES RECEIVABLE (Details Narrative) Details http://draganfly.com/role/NotesReceivableTables 76 false false R77.htm 00000077 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Sheet http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) Details 77 false false R78.htm 00000078 - Disclosure - SCHEDULE OF INVESTMENTS (Details) Sheet http://draganfly.com/role/ScheduleOfInvestmentsDetails SCHEDULE OF INVESTMENTS (Details) Details 78 false false R79.htm 00000079 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details) Details 79 false false R80.htm 00000080 - Disclosure - INVESTMENTS (Details Narrative) Sheet http://draganfly.com/role/InvestmentsDetailsNarrative INVESTMENTS (Details Narrative) Details http://draganfly.com/role/InvestmentsTables 80 false false R81.htm 00000081 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 81 false false R82.htm 00000082 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details) Sheet http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails SCHEDULE OF INTELLECTUAL PROPERTY (Details) Details 82 false false R83.htm 00000083 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Sheet http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative INTANGIBLE ASSETS AND GOODWILL (Details Narrative) Details http://draganfly.com/role/IntangibleAssetsAndGoodwillTables 83 false false R84.htm 00000084 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) Sheet http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails SCHEDULE OF RIGHT OF USE ASSETS (Details) Details 84 false false R85.htm 00000085 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Sheet http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails SCHEDULE OF OPERATING LEASE LIABILITIES (Details) Details 85 false false R86.htm 00000086 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) Sheet http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails SCHEDULE OF OPERATING MATURITY ANALYSIS (Details) Details 86 false false R87.htm 00000087 - Disclosure - LEASE LIABILITY (Details Narrative) Sheet http://draganfly.com/role/LeaseLiabilityDetailsNarrative LEASE LIABILITY (Details Narrative) Details http://draganfly.com/role/LeaseLiabilityTables 87 false false R88.htm 00000088 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details) Details 88 false false R89.htm 00000089 - Disclosure - SCHEDULE OF CUSTOMER DEPOSITS (Details) Sheet http://draganfly.com/role/ScheduleOfCustomerDepositsDetails SCHEDULE OF CUSTOMER DEPOSITS (Details) Details 89 false false R90.htm 00000090 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details) Sheet http://draganfly.com/role/ScheduleOfDeferredIncomeDetails SCHEDULE OF DEFERRED INCOME (Details) Details 90 false false R91.htm 00000091 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details) Sheet http://draganfly.com/role/ScheduleOfLoansPayableDetails SCHEDULE OF LOANS PAYABLE (Details) Details 91 false false R92.htm 00000092 - Disclosure - SCHEDULE OF LOANS (Details) Sheet http://draganfly.com/role/ScheduleOfLoansDetails SCHEDULE OF LOANS (Details) Details 92 false false R93.htm 00000093 - Disclosure - LOANS PAYABLE (Details Narrative) Sheet http://draganfly.com/role/LoansPayableDetailsNarrative LOANS PAYABLE (Details Narrative) Details http://draganfly.com/role/LoansPayableTables 93 false false R94.htm 00000094 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Sheet http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) Details 94 false false R95.htm 00000095 - Disclosure - SUMMARY OF CHANGES IN STOCK OPTIONS (Details) Sheet http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails SUMMARY OF CHANGES IN STOCK OPTIONS (Details) Details 95 false false R96.htm 00000096 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details) Details 96 false false R97.htm 00000097 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) Sheet http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details) Details 97 false false R98.htm 00000098 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details) Details 98 false false R99.htm 00000099 - Disclosure - SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details) Details 99 false false R100.htm 00000100 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) Sheet http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details) Details 100 false false R101.htm 00000101 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details) Sheet http://draganfly.com/role/SummaryOfChangesInWarrantsDetails SUMMARY OF CHANGES IN WARRANTS (Details) Details 101 false false R102.htm 00000102 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details) Sheet http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails SCHEDULE OF WARRANTS OUTSTANDING (Details) Details 102 false false R103.htm 00000103 - Disclosure - SHARE CAPITAL (Details Narrative) Sheet http://draganfly.com/role/ShareCapitalDetailsNarrative SHARE CAPITAL (Details Narrative) Details http://draganfly.com/role/ShareCapitalTables 103 false false R104.htm 00000104 - Disclosure - SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details) Sheet http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details) Details 104 false false R105.htm 00000105 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details) Sheet http://draganfly.com/role/ScheduleOfGeographicRevenueDetails SCHEDULE OF GEOGRAPHIC REVENUE (Details) Details 105 false false R106.htm 00000106 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) Sheet http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails SCHEDULE OF OPERATING SEGMENTS (Details) Details 106 false false R107.htm 00000107 - Disclosure - REVENUE (Details Narrative) Sheet http://draganfly.com/role/RevenueDetailsNarrative REVENUE (Details Narrative) Details http://draganfly.com/role/RevenueTables 107 false false R108.htm 00000108 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) Sheet http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details) Details 108 false false R109.htm 00000109 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) Sheet http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details) Details 109 false false R110.htm 00000110 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://draganfly.com/role/RelatedPartyTransactionsTables 110 false false R111.htm 00000111 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) Sheet http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details) Details 111 false false R112.htm 00000112 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) Sheet http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details) Details 112 false false R113.htm 00000113 - Disclosure - SCHEDULE OF BREAKDOWN CAPITAL (Details) Sheet http://draganfly.com/role/ScheduleOfBreakdownCapitalDetails SCHEDULE OF BREAKDOWN CAPITAL (Details) Details 113 false false R114.htm 00000114 - Disclosure - SCHEDULE OF INCOME TAX (Details) Sheet http://draganfly.com/role/ScheduleOfIncomeTaxDetails SCHEDULE OF INCOME TAX (Details) Details 114 false false R115.htm 00000115 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details) Sheet http://draganfly.com/role/ScheduleOfDeferredTaxesDetails SCHEDULE OF DEFERRED TAXES (Details) Details 115 false false R116.htm 00000116 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://draganfly.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://draganfly.com/role/IncomeTaxesTables 116 false false R117.htm 00000117 - Disclosure - OTHER INCOME (Details Narrative) Sheet http://draganfly.com/role/OtherIncomeDetailsNarrative OTHER INCOME (Details Narrative) Details http://draganfly.com/role/OtherIncome 117 false false R118.htm 00000118 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative) Sheet http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative) Details http://draganfly.com/role/SupplementalCashFlowDisclosures 118 false false R119.htm 00000119 - Disclosure - GOVERNMENT ASSISTANCE (Details Narrative) Sheet http://draganfly.com/role/GovernmentAssistanceDetailsNarrative GOVERNMENT ASSISTANCE (Details Narrative) Details http://draganfly.com/role/GovernmentAssistance 119 false false All Reports Book All Reports form20-f.htm dpro-20211231.xsd dpro-20211231_cal.xml dpro-20211231_def.xml dpro-20211231_lab.xml dpro-20211231_pre.xml ex1-1.htm ex1-3.htm ex11-1.htm ex12-1.htm ex12-2.htm ex13-1.htm ex13-2.htm ex15-1.htm ex15-2.htm ex15-3.htm ex2-1.htm ex2-2.htm ex2-3.htm ex2-4.htm ex2-5.htm ex4-1.htm ex4-10.htm ex4-2.htm ex4-3.htm ex4-4.htm ex4-5.htm ex4-6.htm ex4-7.htm ex4-8.htm ex4-9.htm ex8-1.htm form20-f_001.jpg fs_001.jpg http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full http://xbrl.sec.gov/dei/2021q4 true true JSON 170 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form20-f.htm": { "axisCustom": 1, "axisStandard": 26, "contextCount": 371, "dts": { "calculationLink": { "local": [ "dpro-20211231_cal.xml" ] }, "definitionLink": { "local": [ "dpro-20211231_def.xml" ] }, "inline": { "local": [ "form20-f.htm" ] }, "labelLink": { "local": [ "dpro-20211231_lab.xml" ] }, "presentationLink": { "local": [ "dpro-20211231_pre.xml" ] }, "schema": { "local": [ "dpro-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 836, "entityCount": 1, "hidden": { "http://draganfly.com/20211231": 200, "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 119, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 324 }, "keyCustom": 293, "keyStandard": 270, "memberCustom": 108, "memberStandard": 24, "nsprefix": "DPRO", "nsuri": "http://draganfly.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://draganfly.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - AMALGAMATION", "role": "http://draganfly.com/role/Amalgamation", "shortName": "AMALGAMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-01-012019-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000100 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)", "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_WarrantsMember_ifrs-full_BottomOfRangeMember", "decimals": "INF", "lang": null, "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000101 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details)", "role": "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails", "shortName": "SUMMARY OF CHANGES IN WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfChangeInfWarrantsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2019-12-31_custom_WarrantsMember273200078", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "CADPShares", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_WarrantOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:CompensationWarrantsIssuedDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000102 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)", "role": "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_WarrantOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:CompensationWarrantsIssuedDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:StockIssuedDuringPeriodValueExerciseOfWarrants", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000103 - Disclosure - SHARE CAPITAL (Details Narrative)", "role": "http://draganfly.com/role/ShareCapitalDetailsNarrative", "shortName": "SHARE CAPITAL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "lang": null, "name": "DPRO:StockUnitsIssuedDuringPeriodSharesRegulationFinancing", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000104 - Disclosure - SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details)", "role": "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails", "shortName": "SCHEDULE OF PRODUCT AND SERVICE REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_ProductSalesMember", "decimals": "0", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000105 - Disclosure - SCHEDULE OF GEOGRAPHIC REVENUE (Details)", "role": "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "shortName": "SCHEDULE OF GEOGRAPHIC REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_CACountryMember", "decimals": "0", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000106 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details)", "role": "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "shortName": "SCHEDULE OF OPERATING SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31_custom_CanadaMember", "decimals": "0", "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31_custom_CustomEngineeringServicesMember", "decimals": "0", "first": true, "lang": null, "name": "DPRO:RevenueFromRenderingOfEngineeringServices", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000107 - Disclosure - REVENUE (Details Narrative)", "role": "http://draganfly.com/role/RevenueDetailsNarrative", "shortName": "REVENUE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31_custom_CustomEngineeringServicesMember", "decimals": "0", "first": true, "lang": null, "name": "DPRO:RevenueFromRenderingOfEngineeringServices", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000108 - Disclosure - SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details)", "role": "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails", "shortName": "SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DirectorFeesExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000109 - Disclosure - SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details)", "role": "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails", "shortName": "SCHEDULE OF KEY MANAGEMENT TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DirectorFeesExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CASH AND CASH EQUIVALENTS", "role": "http://draganfly.com/role/CashAndCashEquivalents", "shortName": "CASH AND CASH EQUIVALENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfessionalFeesExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000110 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_BusinessServiceAgreementMember_custom_BusinessInstinctsGroupMember", "decimals": "0", "lang": null, "name": "ifrs-full:ProfessionalFeesExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NetForeignExchangeGain", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000111 - Disclosure - SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details)", "role": "http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails", "shortName": "SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NetForeignExchangeGain", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000112 - Disclosure - SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details)", "role": "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails", "shortName": "SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000113 - Disclosure - SCHEDULE OF BREAKDOWN CAPITAL (Details)", "role": "http://draganfly.com/role/ScheduleOfBreakdownCapitalDetails", "shortName": "SCHEDULE OF BREAKDOWN CAPITAL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfBreakdownOfAssetsAndLiabilitiesAggregatedIntoSingleLineInvestmentBalanceTransitionFromProportionateConsolidationToEquityMethodExplanatory", "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:NetDebt", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000114 - Disclosure - SCHEDULE OF INCOME TAX (Details)", "role": "http://draganfly.com/role/ScheduleOfIncomeTaxDetails", "shortName": "SCHEDULE OF INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:AccountingProfit", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "b", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DeferredTaxAssetsShareIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000115 - Disclosure - SCHEDULE OF DEFERRED TAXES (Details)", "role": "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails", "shortName": "SCHEDULE OF DEFERRED TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DeferredTaxAssetsShareIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TaxEffectOfTaxLosses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000116 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://draganfly.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TaxEffectOfTaxLosses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-04-252020-04-27", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProceedsFromSalesOfInvestmentProperty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000117 - Disclosure - OTHER INCOME (Details Narrative)", "role": "http://draganfly.com/role/OtherIncomeDetailsNarrative", "shortName": "OTHER INCOME (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-04-252020-04-27", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProceedsFromSalesOfInvestmentProperty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfSupplementalCashFlowDisclosureExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DebtSettlementAmount", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000118 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative)", "role": "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative", "shortName": "SUPPLEMENTAL CASH FLOW DISCLOSURES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfSupplementalCashFlowDisclosureExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DebtSettlementAmount", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:WagesAndSalaries", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000119 - Disclosure - GOVERNMENT ASSISTANCE (Details Narrative)", "role": "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative", "shortName": "GOVERNMENT ASSISTANCE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_CanadaEmergencyWageSubsidyMember", "decimals": "0", "lang": null, "name": "ifrs-full:WagesAndSalaries", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfAmountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - RECEIVABLES", "role": "http://draganfly.com/role/Receivables", "shortName": "RECEIVABLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfAmountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INVENTORY", "role": "http://draganfly.com/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNotesReceivable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - NOTES RECEIVABLE", "role": "http://draganfly.com/role/NotesReceivable", "shortName": "NOTES RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNotesReceivable", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PREPAIDS", "role": "http://draganfly.com/role/Prepaids", "shortName": "PREPAIDS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - INVESTMENTS", "role": "http://draganfly.com/role/Investments", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - EQUIPMENT", "role": "http://draganfly.com/role/Equipment", "shortName": "EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - INTANGIBLE ASSETS AND GOODWILL", "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwill", "shortName": "INTANGIBLE ASSETS AND GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - RIGHT OF USE ASSETS", "role": "http://draganfly.com/role/RightOfUseAssets", "shortName": "RIGHT OF USE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Statements of Financial Position", "role": "http://draganfly.com/role/StatementsOfFinancialPosition", "shortName": "Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:TradeAndOtherCurrentReceivables", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - LEASE LIABILITY", "role": "http://draganfly.com/role/LeaseLiability", "shortName": "LEASE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES", "role": "http://draganfly.com/role/TradePayablesAndAccruedLiabilities", "shortName": "TRADE PAYABLES AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDepositsFromCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - CUSTOMER DEPOSITS", "role": "http://draganfly.com/role/CustomerDeposits", "shortName": "CUSTOMER DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDepositsFromCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - DEFERRED INCOME", "role": "http://draganfly.com/role/DeferredIncome", "shortName": "DEFERRED INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - LOANS PAYABLE", "role": "http://draganfly.com/role/LoansPayable", "shortName": "LOANS PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SHARE CAPITAL", "role": "http://draganfly.com/role/ShareCapital", "shortName": "SHARE CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - REVENUE", "role": "http://draganfly.com/role/Revenue", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - OFFICE AND MISCELLANEOUS", "role": "http://draganfly.com/role/OfficeAndMiscellaneous", "shortName": "OFFICE AND MISCELLANEOUS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://draganfly.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT", "role": "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement", "shortName": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RevenueFromSaleOfGoods", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Statements of Comprehensive Income (Loss)", "role": "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RevenueFromSaleOfGoods", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INCOME TAXES", "role": "http://draganfly.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - OTHER INCOME", "role": "http://draganfly.com/role/OtherIncome", "shortName": "OTHER INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfSupplementalCashFlowDisclosureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SUPPLEMENTAL CASH FLOW DISCLOSURES", "role": "http://draganfly.com/role/SupplementalCashFlowDisclosures", "shortName": "SUPPLEMENTAL CASH FLOW DISCLOSURES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfSupplementalCashFlowDisclosureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - GOVERNMENT ASSISTANCE", "role": "http://draganfly.com/role/GovernmentAssistance", "shortName": "GOVERNMENT ASSISTANCE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - BASIS OF PREPARATION (Policies)", "role": "http://draganfly.com/role/BasisOfPreparationPolicies", "shortName": "BASIS OF PREPARATION (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - BASIS OF PREPARATION (Tables)", "role": "http://draganfly.com/role/BasisOfPreparationTables", "shortName": "BASIS OF PREPARATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - DRONELOGICS ACQUISITION (Tables)", "role": "http://draganfly.com/role/DronelogicsAcquisitionTables", "shortName": "DRONELOGICS ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfContingentConsiderationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Tables)", "role": "http://draganfly.com/role/VitalIntelligenceAcquisitionTables", "shortName": "VITAL INTELLIGENCE ACQUISITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfContingentConsiderationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - AMALGAMATION (Tables)", "role": "http://draganfly.com/role/AmalgamationTables", "shortName": "AMALGAMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)", "role": "http://draganfly.com/role/CashAndCashEquivalentsTables", "shortName": "CASH AND CASH EQUIVALENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2018-12-31_ifrs-full_IssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "role": "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2018-12-31_ifrs-full_IssuedCapitalMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "DPRO:DisclosureOfAmountsReceivableTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - RECEIVABLES (Tables)", "role": "http://draganfly.com/role/ReceivablesTables", "shortName": "RECEIVABLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "DPRO:DisclosureOfAmountsReceivableTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInventoriesInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - INVENTORY (Tables)", "role": "http://draganfly.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInventoriesInformationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "DPRO:DisclosureOfNotesReceivable", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNotesReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - NOTES RECEIVABLE (Tables)", "role": "http://draganfly.com/role/NotesReceivableTables", "shortName": "NOTES RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "DPRO:DisclosureOfNotesReceivable", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNotesReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - PREPAIDS (Tables)", "role": "http://draganfly.com/role/PrepaidsTables", "shortName": "PREPAIDS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInvestmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - INVESTMENTS (Tables)", "role": "http://draganfly.com/role/InvestmentsTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfInvestmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - EQUIPMENT (Tables)", "role": "http://draganfly.com/role/EquipmentTables", "shortName": "EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)", "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwillTables", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - RIGHT OF USE ASSETS (Tables)", "role": "http://draganfly.com/role/RightOfUseAssetsTables", "shortName": "RIGHT OF USE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - LEASE LIABILITY (Tables)", "role": "http://draganfly.com/role/LeaseLiabilityTables", "shortName": "LEASE LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)", "role": "http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables", "shortName": "TRADE PAYABLES AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:LossForAdjustments", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "role": "http://draganfly.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:LossForAdjustments", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDepositsFromCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCustomerDepositsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - CUSTOMER DEPOSITS (Tables)", "role": "http://draganfly.com/role/CustomerDepositsTables", "shortName": "CUSTOMER DEPOSITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDepositsFromCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfCustomerDepositsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:ScheduleOfDeferredIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - DEFERRED INCOME (Tables)", "role": "http://draganfly.com/role/DeferredIncomeTables", "shortName": "DEFERRED INCOME (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:ScheduleOfDeferredIncomeExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfLoansPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - LOANS PAYABLE (Tables)", "role": "http://draganfly.com/role/LoansPayableTables", "shortName": "LOANS PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfLoansPayableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SHARE CAPITAL (Tables)", "role": "http://draganfly.com/role/ShareCapitalTables", "shortName": "SHARE CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - REVENUE (Tables)", "role": "http://draganfly.com/role/RevenueTables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - OFFICE AND MISCELLANEOUS (Tables)", "role": "http://draganfly.com/role/OfficeAndMiscellaneousTables", "shortName": "OFFICE AND MISCELLANEOUS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfOtherAndMiscellaneousExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "role": "http://draganfly.com/role/RelatedPartyTransactionsTables", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)", "role": "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables", "shortName": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "DPRO:DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - INCOME TAXES (Tables)", "role": "http://draganfly.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfDetailedInformationAboutIncomeTax", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_DraganflyInnovationsIncMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - SCHEDULE OF RESULTS OF OPERATIONS (Details)", "role": "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails", "shortName": "SCHEDULE OF RESULTS OF OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_DraganflyInnovationsIncMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNatureAndContinuanceOfOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS", "role": "http://draganfly.com/role/NatureAndContinuanceOfOperations", "shortName": "NATURE AND CONTINUANCE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfNatureAndContinuanceOfOperationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfClassOfEquipmentExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_ifrs-full_ComputerEquipmentMember", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:DepreciationPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF CLASS OF EQUIPMENT (Details)", "role": "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "shortName": "SCHEDULE OF CLASS OF EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfClassOfEquipmentExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_ifrs-full_ComputerEquipmentMember", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:DepreciationPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-04-292020-04-30_custom_DronelogicsSystemsIncMember", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharePurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)", "role": "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "shortName": "SCHEDULE OF PURCHASE PRICE ALLOCATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-04-292020-04-30_custom_DronelogicsSystemsIncMember", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharePurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - DRONELOGICS ACQUISITION (Details Narrative)", "role": "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "shortName": "DRONELOGICS ACQUISITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-04-282020-04-30_custom_DronelogicsSystemsIncMember", "decimals": "INF", "lang": null, "name": "DPRO:AcquisitionDateSharesTransferred", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfContingentConsiderationExplanatory", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:FairValueOfContingentConsideration", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF CONTINGENT CONSIDERATION (Details)", "role": "http://draganfly.com/role/ScheduleOfContingentConsiderationDetails", "shortName": "SCHEDULE OF CONTINGENT CONSIDERATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfContingentConsiderationExplanatory", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:FairValueOfContingentConsideration", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details)", "role": "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "shortName": "SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:ScheduleOfPurchasePriceAllocationForVitalIntelligence", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-03-242021-03-25_custom_VitalIntelligenceIncMember", "decimals": "INF", "lang": null, "name": "DPRO:NumberOfSharePurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-08-182021-08-19", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:SharesHeldInEscrow", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - VITAL INTELLIGENCE ACQUISITION (Details Narrative)", "role": "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative", "shortName": "VITAL INTELLIGENCE ACQUISITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-08-182021-08-19", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:SharesHeldInEscrow", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-08-012019-08-15", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharesOfStructuredEntity", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details)", "role": "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails", "shortName": "SUMMARY OF HISTORICAL FINANCIAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-08-012019-08-15", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharesOfStructuredEntity", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-01-012019-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)", "role": "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails", "shortName": "SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-02-032021-02-04_ifrs-full_WarrantReserveMember", "decimals": "INF", "lang": null, "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-08-012019-08-15", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:FeeAndCommissionExpense", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - AMALGAMATION (Details Narrative)", "role": "http://draganfly.com/role/AmalgamationDetailsNarrative", "shortName": "AMALGAMATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-08-012019-08-15_custom_DraganflyInnovationsSharesMember", "decimals": "INF", "lang": null, "name": "DPRO:StockIssuedDuringPeriodAtFairValueUnitsShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfCashAndCashEquivalents", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:BalancesWithBanks", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "role": "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfCashAndCashEquivalents", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:BalancesWithBanks", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - BASIS OF PREPARATION", "role": "http://draganfly.com/role/BasisOfPreparation", "shortName": "BASIS OF PREPARATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-12-202021-12-21_custom_GuaranteedInvestmentCertificateMember", "decimals": "0", "first": true, "lang": null, "name": "DPRO:PurchaseOfFinancialInstruments", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)", "role": "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "shortName": "CASH AND CASH EQUIVALENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-12-202021-12-21_custom_GuaranteedInvestmentCertificateMember", "decimals": "0", "first": true, "lang": null, "name": "DPRO:PurchaseOfFinancialInstruments", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "DPRO:DisclosureOfAmountsReceivableTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeReceivables", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF AMOUNTS RECEIVABLE (Details)", "role": "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails", "shortName": "SCHEDULE OF AMOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "DPRO:DisclosureOfAmountsReceivableTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeReceivables", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfInventoriesInformationExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "role": "http://draganfly.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfInventoriesInformationExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:Inventory", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF COST OF SALES (Details)", "role": "http://draganfly.com/role/ScheduleOfCostOfSalesDetails", "shortName": "SCHEDULE OF COST OF SALES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:Inventory", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CostOfSales", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - INVENTORY (Details Narrative)", "role": "http://draganfly.com/role/InventoryDetailsNarrative", "shortName": "INVENTORY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:InventoryWritedown2011", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivable", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:NoteReceivableFaceAmount", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - DISCLOSURE OF NOTES RECEIVABLE (Details)", "role": "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "shortName": "DISCLOSURE OF NOTES RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivable", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:NoteReceivableFaceAmount", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNotesReceivablesExplanatory", "DPRO:DisclosureOfNotesReceivable", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_NoteTwoMember", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NoteReceivableInterestRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - NOTES RECEIVABLE (Details Narrative)", "role": "http://draganfly.com/role/NotesReceivableDetailsNarrative", "shortName": "NOTES RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentInsuranceExpenses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "role": "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "shortName": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfPrepaidExpensesAndDepositsExplanatory", "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentInsuranceExpenses", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "DPRO:DisclosureOfInvestmentExplanatory", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentInvestments1", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - SCHEDULE OF INVESTMENTS (Details)", "role": "http://draganfly.com/role/ScheduleOfInvestmentsDetails", "shortName": "SCHEDULE OF INVESTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "DPRO:DisclosureOfInvestmentExplanatory", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:CurrentInvestments1", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-01-012019-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)", "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - DRONELOGICS ACQUISITION", "role": "http://draganfly.com/role/DronelogicsAcquisition", "shortName": "DRONELOGICS ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-10-252021-10-27", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharesPurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - INVESTMENTS (Details Narrative)", "role": "http://draganfly.com/role/InvestmentsDetailsNarrative", "shortName": "INVESTMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-10-252021-10-27", "decimals": "INF", "first": true, "lang": null, "name": "DPRO:NumberOfSharesPurchased", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:PropertyPlantAndEquipmentCost", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "role": "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "lang": null, "name": "DPRO:PropertyPlantAndEquipmentCost", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:IntangibleAssetsOtherThanGoodwillGross", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - SCHEDULE OF INTELLECTUAL PROPERTY (Details)", "role": "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "shortName": "SCHEDULE OF INTELLECTUAL PROPERTY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Goodwill", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "role": "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "shortName": "INTANGIBLE ASSETS AND GOODWILL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000084 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details)", "role": "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:RightofuseAssetsRevaluedAssetsAtCost", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:LeaseLiabilities", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000085 - Disclosure - SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "role": "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "shortName": "SCHEDULE OF OPERATING LEASE LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "lang": null, "name": "DPRO:LeasesAcquiredInAcquisition", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000086 - Disclosure - SCHEDULE OF OPERATING MATURITY ANALYSIS (Details)", "role": "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails", "shortName": "SCHEDULE OF OPERATING MATURITY ANALYSIS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DepreciationLeaseLiability", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000087 - Disclosure - LEASE LIABILITY (Details Narrative)", "role": "http://draganfly.com/role/LeaseLiabilityDetailsNarrative", "shortName": "LEASE LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DepreciationLeaseLiability", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000088 - Disclosure - SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details)", "role": "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentDepositsFromCustomers", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000089 - Disclosure - SCHEDULE OF CUSTOMER DEPOSITS (Details)", "role": "http://draganfly.com/role/ScheduleOfCustomerDepositsDetails", "shortName": "SCHEDULE OF CUSTOMER DEPOSITS (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - VITAL INTELLIGENCE ACQUISITION", "role": "http://draganfly.com/role/VitalIntelligenceAcquisition", "shortName": "VITAL INTELLIGENCE ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:ScheduleOfDeferredIncomeExplanatory", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DeferredIncomeLiabilities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000090 - Disclosure - SCHEDULE OF DEFERRED INCOME (Details)", "role": "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "shortName": "SCHEDULE OF DEFERRED INCOME (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:ScheduleOfDeferredIncomeExplanatory", "ifrs-full:DisclosureOfDeferredIncomeExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:DeferredIncomeLiabilities", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfLoansPayableExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:LoansPayableAmount", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000091 - Disclosure - SCHEDULE OF LOANS PAYABLE (Details)", "role": "http://draganfly.com/role/ScheduleOfLoansPayableDetails", "shortName": "SCHEDULE OF LOANS PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfLoansPayableExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "lang": null, "name": "DPRO:AcquisitionOfLoans", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-05-19", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:BorrowingsInterestRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000092 - Disclosure - SCHEDULE OF LOANS (Details)", "role": "http://draganfly.com/role/ScheduleOfLoansDetails", "shortName": "SCHEDULE OF LOANS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:LoansAndAdvancesToBanks", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-05-19", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:BorrowingsInterestRate", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000093 - Disclosure - LOANS PAYABLE (Details Narrative)", "role": "http://draganfly.com/role/LoansPayableDetailsNarrative", "shortName": "LOANS PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-05-19_custom_CanadaEmergencyBusinessAccountMember", "decimals": "0", "lang": null, "name": "ifrs-full:LoansReceived", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000094 - Disclosure - SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "role": "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "shortName": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000095 - Disclosure - SUMMARY OF CHANGES IN STOCK OPTIONS (Details)", "role": "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails", "shortName": "SUMMARY OF CHANGES IN STOCK OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "reportCount": 1, "unique": true, "unitRef": "CADPShares", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2019-01-012019-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000096 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "role": "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "shortName": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "td", "tr", "table", "DPRO:DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31_ifrs-full_BottomOfRangeMember", "decimals": "INF", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "reportCount": 1, "unique": true, "unitRef": "CADPShares", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000097 - Disclosure - SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details)", "role": "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "shortName": "SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2019-12-31_custom_IfrsRestrictedStockUnitsRsuMember", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "DPRO:DisclosureOfContingentConsiderationExplanatory", "DPRO:DisclosureOfVitalIntelligenceAcquisitionTextBlock", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "DPRO:BusinessAcquisitionContingentConsideration", "reportCount": 1, "unitRef": "CAD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000098 - Disclosure - SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)", "role": "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "shortName": "SCHEDULE OF WARRANT DERIVATIVE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "p", "td", "tr", "table", "DPRO:DisclosureOfWarrantDerivativeLiabilityExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "From2021-01-012021-12-31_custom_WarrantsMember273199062", "decimals": "0", "lang": null, "name": "DPRO:SharesIssuedForExerciseOfWarrantsOfDerivatives", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000099 - Disclosure - SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details)", "role": "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails", "shortName": "SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "DPRO:DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "form20-f.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "DPRO:CurrentWarrantFairValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } } }, "segmentCount": 140, "tag": { "DPRO_AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 8.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts payable and accrued liabilities recognised as of acquisition date.", "label": "AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AccountsReceivableRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable recognised as of acquisition date.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AccretionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion expenses.", "label": "Accretion expense" } } }, "localname": "AccretionExpenses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AccumulatedAmortizationIntellectualPropertiesAndGoodwill": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amortization intellectual properties and goodwill.", "label": "AccumulatedAmortizationIntellectualPropertiesAndGoodwill", "periodEndLabel": "Accumulated amortization, ending balance", "periodStartLabel": "Accumulated amortization, beginning balance" } } }, "localname": "AccumulatedAmortizationIntellectualPropertiesAndGoodwill", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AccumulateddepreciationPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated depreciation property, plant and equipment.", "label": "AccumulateddepreciationPropertyPlantAndEquipment", "periodEndLabel": "Accumulated depreciation Property, plant and equipment, ending balance", "periodStartLabel": "Accumulated depreciation Property, plant and equipment, beginning balance" } } }, "localname": "AccumulateddepreciationPropertyPlantAndEquipment", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AcquisitionDateSharesTransferred": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition date shares transferred.", "label": "Acquisition date shares transferred" } } }, "localname": "AcquisitionDateSharesTransferred", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_AcquisitionOfLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisition of loans.", "label": "Acquisition of loans" } } }, "localname": "AcquisitionOfLoans", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AcquisitiondateFairValueOfTotalConsiderationCashTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisition date fair value of total consideration cash transferred.", "label": "Acquisition date fair value of total consideration cash transferred" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationCashTransferred", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_AcquisitiondateFairValuesOfTotalConsiderationTransferred": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "AcquisitiondateFairValuesOfTotalConsiderationTransferred", "totalLabel": "Total consideration" } } }, "localname": "AcquisitiondateFairValuesOfTotalConsiderationTransferred", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AdditionsLeaseLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions lease liabilities.", "label": "AdditionsLeaseLiabilities", "verboseLabel": "Additions" } } }, "localname": "AdditionsLeaseLiabilities", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_AdjustmentsForIncreaseDecreaseInInventories": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for increase decrease in inventories.", "label": "Adjustments for increase decrease in inventories", "negatedLabel": "Inventory" } } }, "localname": "AdjustmentsForIncreaseDecreaseInInventories", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_AdjustmentsForIncreaseDecreaseInPrepaidExpenses": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for increase decrease in prepaid expenses.", "label": "Adjustments for increase decrease in prepaid expenses", "negatedLabel": "Prepaids" } } }, "localname": "AdjustmentsForIncreaseDecreaseInPrepaidExpenses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_AdjustmentsForIncreaseDecreaseInTradeAccountReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for increase decrease in trade account receivable.", "label": "Adjustments for increase decrease in trade account receivable", "negatedLabel": "Receivables" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_AdvisiorsFeesPaidInValueOfShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Advisiors fees paid in value of shares.", "label": "Advisiors fees paid in value of shares" } } }, "localname": "AdvisiorsFeesPaidInValueOfShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_AdvisorsFeesExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advisors Fees Expense.", "label": "Advisors fees expenses" } } }, "localname": "AdvisorsFeesExpenses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_AdvisorsFeesPaidInCash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advisors fees paid in cash.", "label": "Advisors fees paid in cash" } } }, "localname": "AdvisorsFeesPaidInCash", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_AdvisoryFeesExpensesPaidInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Fees Expenses Paid in Shares.", "label": "Advisory fees expenses paid in shares" } } }, "localname": "AdvisoryFeesExpensesPaidInShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_AdvisryFeesExpensesValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisry fees expenses value per share.", "label": "Advisory fees expenses value per share" } } }, "localname": "AdvisryFeesExpensesValuePerShare", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "perShareItemType" }, "DPRO_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Axis]", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_AgreementDomain": { "auth_ref": [], "localname": "AgreementDomain", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_AlbertaLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alberta Ltd [Member]", "label": "Alberta Ltd [Member]" } } }, "localname": "AlbertaLtdMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Purchase Agreement [Member]", "label": "Asset Purchase Agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_AttributionRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Attribution rate percentage.", "label": "Attribution rate percentage" } } }, "localname": "AttributionRatePercentage", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "pureItemType" }, "DPRO_AverageEffectiveInstrumentRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average effective instrument rate.", "label": "Average effective Instrument rate" } } }, "localname": "AverageEffectiveInstrumentRate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "DPRO_BasicAndDilutedEarningsLossPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic and diluted earnings loss per share.", "label": "Basic & diluted" } } }, "localname": "BasicAndDilutedEarningsLossPerShare", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "DPRO_BorrowingsMaturityStartDay": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowings maturity start day.", "label": "BorrowingsMaturityStartDay", "verboseLabel": "Start Date" } } }, "localname": "BorrowingsMaturityStartDay", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "stringItemType" }, "DPRO_BrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brand [Member]", "label": "Brand [Member]" } } }, "localname": "BrandMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_BusinessAcquisitionContingentConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contingent consideration.", "label": "Contingent consideration at December 31, 2021 (note 20)", "verboseLabel": "Contingent consideration at December 31, 2021" } } }, "localname": "BusinessAcquisitionContingentConsideration", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfContingentConsiderationDetails", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_BusinessInstinctsGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Instincts Group [Member]", "label": "Business Instincts Group [Member]" } } }, "localname": "BusinessInstinctsGroupMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_BusinessServiceAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Service Agreement [Member]", "label": "Business Service Agreement [Member]" } } }, "localname": "BusinessServiceAgreementMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CACountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CA Country [member]", "label": "CA Country [member]" } } }, "localname": "CACountryMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "xbrltype": "domainItemType" }, "DPRO_CEOAndDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CEO and Director [Member]", "label": "CEO and Director [Member]" } } }, "localname": "CEOAndDirectorMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "domainItemType" }, "DPRO_CanadaEmergencyBusinessAccountLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CEBA [Member]", "label": "CEBA [Member] [Default Label]", "verboseLabel": "CEBA [Member]" } } }, "localname": "CanadaEmergencyBusinessAccountLoanMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "domainItemType" }, "DPRO_CanadaEmergencyBusinessAccountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CEBA [Member]", "label": "CEBA [Member]" } } }, "localname": "CanadaEmergencyBusinessAccountMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "domainItemType" }, "DPRO_CanadaEmergencyRentSubsidyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canada Emergency Rent Subsidy [Member]", "label": "Canada Emergency Rent Subsidy [Member]" } } }, "localname": "CanadaEmergencyRentSubsidyMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CanadaEmergencyWageSubsidyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canada Emergency Wage Subsidy [member]", "label": "Canada Emergency Wage Subsidy [member]" } } }, "localname": "CanadaEmergencyWageSubsidyMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CanadaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canada [member]", "label": "Canada [member]" } } }, "localname": "CanadaMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_CapitalAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 6.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital assets recognised as of acquisition date.", "label": "Capital assets" } } }, "localname": "CapitalAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CashAndCashEquivalent": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalents.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalent", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_CashAndCashEquivalentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash And Cash Equivalent [Abstract]", "label": "Cash and cash equivalents consist of the following:" } } }, "localname": "CashAndCashEquivalentAbstract", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "DPRO_CashAndCashEquivalentsCarryingValue": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "CashAndCashEquivalentsCarryingValue", "totalLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsCarryingValue", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CashAndCashGuaranteedInvestmentCertificate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "DPRO_CashAndCashEquivalent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and cash guaranteed investment certificate.", "label": "Guaranteed investment certificate" } } }, "localname": "CashAndCashGuaranteedInvestmentCertificate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_CashFlowFromUsedInOperatingActivities": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash flow from used in operating activities.", "label": "CashFlowFromUsedInOperatingActivities", "negatedTotalLabel": "Funds used in operating activities" } } }, "localname": "CashFlowFromUsedInOperatingActivities", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_CashHeldInBanks": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "DPRO_CashAndCashEquivalent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash held in banks.", "label": "Cash held in banks" } } }, "localname": "CashHeldInBanks", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_CashPortionOfPurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash portion of purchase price.", "label": "Cash portion of purchase price" } } }, "localname": "CashPortionOfPurchasePrice", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CertainDirectorsAndOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Certain Directors and Officers [Member]", "label": "Certain Directors and Officers [Member]" } } }, "localname": "CertainDirectorsAndOfficersMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ChangeInFairValueOfContingentConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Changes in fair value of contingent consideration.", "label": "ChangeInFairValueOfContingentConsideration", "negatedLabel": "Change in fair value of contingent consideration" } } }, "localname": "ChangeInFairValueOfContingentConsideration", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ChangeInFairValueOfDerivativeLiability": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of derivative liability.", "label": "ChangeInFairValueOfDerivativeLiability", "verboseLabel": "Change in fair value of derivative liability" } } }, "localname": "ChangeInFairValueOfDerivativeLiability", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ChangeInFairValueOfWarrantOfDerivativesOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant of derivatives outstanding.", "label": "Change in fair value of warrants outstanding" } } }, "localname": "ChangeInFairValueOfWarrantOfDerivativesOutstanding", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ChangesInItemsOfWorkingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes in items of working capital [Abstract]", "label": "Net changes in non-cash working capital items:" } } }, "localname": "ChangesInItemsOfWorkingCapitalAbstract", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "DPRO_CommonSharesFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares fair value.", "label": "Fair value of common shares", "verboseLabel": "Fair value of units" } } }, "localname": "CommonSharesFairValue", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "perShareItemType" }, "DPRO_CommonSharesFairValueAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common shares fair value amount.", "label": "Fair value of shares of Draganfly Inc.", "verboseLabel": "Fair value of units of Draganfly Inc." } } }, "localname": "CommonSharesFairValueAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares [Member]", "label": "Common Shares [Member]" } } }, "localname": "CommonSharesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonSharesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Shares One [Member]", "label": "Common Shares One [Member]" } } }, "localname": "CommonSharesOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock10Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 10 [Member]", "label": "Common Stock 10 [Member]" } } }, "localname": "CommonStock10Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock11Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 11 [Member]", "label": "Common Stock 11 [Member]" } } }, "localname": "CommonStock11Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock12Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 12 [Member]", "label": "Common Stock 12 [Member]" } } }, "localname": "CommonStock12Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock13Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 13 [Member]", "label": "Common Stock 13 [Member]" } } }, "localname": "CommonStock13Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 1 [Member]", "label": "Common Stock 1 [Member]" } } }, "localname": "CommonStock1Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 2 [Member]", "label": "Common Stock 2 [Member]" } } }, "localname": "CommonStock2Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 3 [Member]", "label": "Common Stock 3 [Member]" } } }, "localname": "CommonStock3Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 4 [Member]", "label": "Common Stock 4 [Member]" } } }, "localname": "CommonStock4Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 5 [Member]", "label": "Common Stock 5 [Member]" } } }, "localname": "CommonStock5Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 6 [Member]", "label": "Common Stock 6 [Member]" } } }, "localname": "CommonStock6Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 7 [Member]", "label": "Common Stock 7 [Member]" } } }, "localname": "CommonStock7Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock8Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 8 [Member]", "label": "Common Stock 8 [Member]" } } }, "localname": "CommonStock8Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CommonStock9Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock 9 [Member]", "label": "Common Stock 9 [Member]" } } }, "localname": "CommonStock9Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CompensationWarrantsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation warrants, exercise price.", "label": "CompensationWarrantsExercisePrice", "verboseLabel": "Exercise price" } } }, "localname": "CompensationWarrantsExercisePrice", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "DPRO_CompensationWarrantsIssuedDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation warrants issued date.", "label": "Date issued" } } }, "localname": "CompensationWarrantsIssuedDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "dateItemType" }, "DPRO_CompensationWarrantsNumberOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation warrants number of warrants.", "label": "Number of warrants outstanding" } } }, "localname": "CompensationWarrantsNumberOfWarrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "DPRO_ComplianceFees": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "order": 2.0, "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Compliance fees.", "label": "Compliance fees" } } }, "localname": "ComplianceFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ComponentsOfOtherComprehensiveIncomeThatMayBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items that may be reclassified to profit or loss" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatMayBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "DPRO_ConsultantAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant Agreement [Member]", "label": "Consultant Agreement [Member]" } } }, "localname": "ConsultantAgreementMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant [Member]", "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ConsultantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant One [Member]", "label": "Consultant One [Member]" } } }, "localname": "ConsultantOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ConsultingAndServices": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "order": 2.0, "parentTag": "ifrs-full_CostOfSales", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting and Services.", "label": "Consulting and services" } } }, "localname": "ConsultingAndServices", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ContractWork": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "order": 3.0, "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract work.", "label": "Contract Work" } } }, "localname": "ContractWork", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debentures [member]", "label": "Convertible Debentures [member]" } } }, "localname": "ConvertibleDebenturesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CurrentDeposits": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 7.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current deposits.", "label": "Deposits" } } }, "localname": "CurrentDeposits", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, derivative liability.", "label": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability", "verboseLabel": "Derivative liability" } } }, "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfDerivativeLiability", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current financial assets at fair value through profit or loss of equity.", "label": "Equity securities in investee companies" } } }, "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfEquity", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, notes receivable.", "label": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable", "verboseLabel": "Notes receivable" } } }, "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossOfNotesReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentInsuranceExpenses": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current insurance expenses.", "label": "CurrentInsuranceExpenses", "verboseLabel": "Insurance" } } }, "localname": "CurrentInsuranceExpenses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentInvestments1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current Investments.", "label": "CurrentInvestments1", "verboseLabel": "Investments" } } }, "localname": "CurrentInvestments1", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentLoansPayable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current Loans Payable.", "label": "Loans payable" } } }, "localname": "CurrentLoansPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentPrepaidDirectorFees": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current prepaid director fees.", "label": "Prepaid director fees" } } }, "localname": "CurrentPrepaidDirectorFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentPrepaidInterest": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 3.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current prepaid interest.", "label": "Prepaid interest" } } }, "localname": "CurrentPrepaidInterest", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentPrepaidMarketingServices": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 4.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current prepaid marketing services.", "label": "Prepaid marketing services" } } }, "localname": "CurrentPrepaidMarketingServices", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentPrepaidRent": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 5.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current prepaid rent.", "label": "Prepaid rent" } } }, "localname": "CurrentPrepaidRent", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentPrepaidSubscriptions": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 6.0, "parentTag": "ifrs-full_CurrentPrepaidExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Current prepaid subscriptions.", "label": "Prepaid subscriptions" } } }, "localname": "CurrentPrepaidSubscriptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CurrentWarrantFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current warrants fair value.", "label": "Fair Value of warrants" } } }, "localname": "CurrentWarrantFairValue", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CustomEngineeringServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Custom Engineering Services [member]", "label": "Custom Engineering Services [member]" } } }, "localname": "CustomEngineeringServicesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RevenueDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_CustomerDepositsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 9.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Customer deposits recognised as of acquisition date.", "label": "CustomerDepositsRecognisedAsOfAcquisitionDate", "verboseLabel": "Customer deposits" } } }, "localname": "CustomerDepositsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_CustomerRelationshipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Relationship [Member]", "label": "Customer Relationship [Member]" } } }, "localname": "CustomerRelationshipMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "DPRO_CustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customers [Member]", "label": "Customers [Member]" } } }, "localname": "CustomersMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "xbrltype": "domainItemType" }, "DPRO_DebtSettlementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt settlement amount.", "label": "Debt settlement, amount" } } }, "localname": "DebtSettlementAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_DebtSettlementComprehensiveLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt settlement comprehensive loss.", "label": "Comprehensive loss" } } }, "localname": "DebtSettlementComprehensiveLoss", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_DebtSettlementRecognizedLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Recongnized loss" } } }, "localname": "DebtSettlementRecognizedLoss", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gai on settlement of debt", "label": "Gai on settlement of debt" } } }, "localname": "DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredIncomeLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred income liabilities.", "label": "Deferred Income" } } }, "localname": "DeferredIncomeLiabilities", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredIncomeLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred income liabilities current.", "label": "Deferred income" } } }, "localname": "DeferredIncomeLiabilitiesCurrent", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredIncomeLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred income liabilities noncurrent.", "label": "DeferredIncomeLiabilitiesNoncurrent", "verboseLabel": "Deferred income" } } }, "localname": "DeferredIncomeLiabilitiesNoncurrent", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsCapitalGainReserve": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 4.0, "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital gain reserve.", "label": "Capital gain reserve" } } }, "localname": "DeferredTaxAssetsCapitalGainReserve", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsDeferredIncomeTaxNotRecognized": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 2.0, "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets deferred income tax not recognized.", "label": "Deferred income tax not recognized" } } }, "localname": "DeferredTaxAssetsDeferredIncomeTaxNotRecognized", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsNoncapitalLosses": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 2.0, "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets non-capital losses.", "label": "Non-capital losses" } } }, "localname": "DeferredTaxAssetsNoncapitalLosses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsPropertyAndEquipment": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 3.0, "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets property and equipment.", "label": "Property and equipment" } } }, "localname": "DeferredTaxAssetsPropertyAndEquipment", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsScientificResearchAndExperimentalDevelopment": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 5.0, "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets scientific research and experimental development.", "label": "Scientific Research and Experimental Development" } } }, "localname": "DeferredTaxAssetsScientificResearchAndExperimentalDevelopment", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DeferredTaxAssetsShareIssuanceCosts": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 1.0, "parentTag": "ifrs-full_DeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets share issuance costs.", "label": "Share issuance costs" } } }, "localname": "DeferredTaxAssetsShareIssuanceCosts", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DepreciationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Depreciation description.", "label": "Depreciation rate, description" } } }, "localname": "DepreciationDescription", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails" ], "xbrltype": "stringItemType" }, "DPRO_DepreciationLeaseLiability": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Depreciation Lease Liability.", "label": "Depreciation Lease Liability" } } }, "localname": "DepreciationLeaseLiability", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LeaseLiabilityDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_DepreciationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Depreciation Percentage.", "label": "Depreciation rate" } } }, "localname": "DepreciationPercentage", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails" ], "xbrltype": "percentItemType" }, "DPRO_DescriptionForNumberOfSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description for Number of Shares Issued.", "label": "Description for Number of Shares Issued" } } }, "localname": "DescriptionForNumberOfSharesIssued", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_DescriptionOfAccountingPolicyForBusinessCombinationsVersusAssetAcquisitionExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy for business combinations versus asset acquisition explanatory.", "label": "Business combination versus asset acquisition" } } }, "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsVersusAssetAcquisitionExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy for cost of goods sold explanatory", "label": "Cost of Goods Sold" } } }, "localname": "DescriptionOfAccountingPolicyForCostOfGoodsSoldExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DescriptionOfAccountingPolicyMeasuringInventories": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy measuring inventories", "label": "DescriptionOfAccountingPolicyMeasuringInventories", "verboseLabel": "Inventory" } } }, "localname": "DescriptionOfAccountingPolicyMeasuringInventories", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DescriptionOfAccountingPolicyRestrictedShareUnitsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of accounting policy restricted share units explanatory", "label": "Restricted Share Units" } } }, "localname": "DescriptionOfAccountingPolicyRestrictedShareUnitsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DescriptionOfOtherSignificantJudgmentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of other significant judgments explanatory.", "label": "Other significant judgments" } } }, "localname": "DescriptionOfOtherSignificantJudgmentsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DescriptionOfSignificantJudgmentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of other significant judgments explanatory.", "label": "Significant judgments" } } }, "localname": "DescriptionOfSignificantJudgmentsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "DPRO_DirectorFees": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Director Fees.", "label": "Director fees" } } }, "localname": "DirectorFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_DirectorFeesExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Director fees expense.", "label": "DirectorFeesExpense", "verboseLabel": "Director fees" } } }, "localname": "DirectorFeesExpense", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_DisclosureFinancialInstrumentsAndFinancialRiskManagementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments And Financial Risk Management", "terseLabel": "Schedule Of Breakdown Capital", "verboseLabel": "Schedule Of Changes In Foreign Exchange Rates" } } }, "localname": "DisclosureFinancialInstrumentsAndFinancialRiskManagementAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureGovernmentAssistanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Government Assistance" } } }, "localname": "DisclosureGovernmentAssistanceAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "verboseLabel": "Investments" } } }, "localname": "DisclosureInvestmentsAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Liability", "verboseLabel": "Schedule Of Operating Lease Liabilities" } } }, "localname": "DisclosureLeaseLiabilityAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureLoansPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loans Payable", "verboseLabel": "Schedule Of Loans Payable" } } }, "localname": "DisclosureLoansPayableAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureNatureAndContinuanceOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature And Continuance Of Operations" } } }, "localname": "DisclosureNatureAndContinuanceOfOperationsAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureNotesReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Receivable" } } }, "localname": "DisclosureNotesReceivableAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureOfAmountsReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of AmountsReceivable [Text Block]", "label": "RECEIVABLES" } } }, "localname": "DisclosureOfAmountsReceivableTextBlock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/Receivables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of canadian emergency wage subsidy disclosure explanatory [text block]", "label": "GOVERNMENT ASSISTANCE" } } }, "localname": "DisclosureOfCanadianEmergencyWageSubsidyDisclosureExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/GovernmentAssistance" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfCashAndCashEquivalents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Cash and Cash Equivalents.", "label": "SCHEDULE OF CASH AND CASH EQUIVALENTS" } } }, "localname": "DisclosureOfCashAndCashEquivalents", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfChangeInfWarrantsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Change in Warrants Explanatory [text block]", "label": "SUMMARY OF CHANGES IN WARRANTS" } } }, "localname": "DisclosureOfChangeInfWarrantsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfClassOfEquipmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of class of equipment explanatory.", "label": "SCHEDULE OF CLASS OF EQUIPMENT" } } }, "localname": "DisclosureOfClassOfEquipmentExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/BasisOfPreparationTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfContingentConsiderationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent consideration [table text block]", "label": "SCHEDULE OF CONTINGENT CONSIDERATION" } } }, "localname": "DisclosureOfContingentConsiderationExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfCustomerDepositsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Deposits", "verboseLabel": "Schedule Of Customer Deposits" } } }, "localname": "DisclosureOfCustomerDepositsAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureOfCustomerDepositsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of customer deposits explanatory.", "label": "SCHEDULE OF CUSTOMER DEPOSITS" } } }, "localname": "DisclosureOfCustomerDepositsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CustomerDepositsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about deferred taxes explanatory [text block]", "label": "SCHEDULE OF DEFERRED TAXES" } } }, "localname": "DisclosureOfDetailedInformationAboutDeferredTaxesExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfDetailedInformationAboutIncomeTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about income tax [text block]", "label": "SCHEDULE OF INCOME TAX" } } }, "localname": "DisclosureOfDetailedInformationAboutIncomeTax", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfDetailedInformationAboutOfRightOfUseAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about of right of use assets", "label": "SCHEDULE OF RIGHT OF USE ASSETS" } } }, "localname": "DisclosureOfDetailedInformationAboutOfRightOfUseAssets", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RightOfUseAssetsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about operating lease liabilities", "label": "SCHEDULE OF OPERATING LEASE LIABILITIES" } } }, "localname": "DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "SUMMARY OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES" } } }, "localname": "DisclosureOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS" } } }, "localname": "DisclosureOfFairValueOfWarrantsForWeightedAverageAssumptionsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT" } } }, "localname": "DisclosureOfInformationAboutEffectOfInterestRateReformOnEntitysFinancialInstrumentsAndRiskManagementStrategyExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagement" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfIntellectualPropertiesAndGoodwillAbstract": { "auth_ref": [], "localname": "DisclosureOfIntellectualPropertiesAndGoodwillAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureOfInventoriesInformationExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Inventories Information Explanatory [Text Block]", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "DisclosureOfInventoriesInformationExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfInvestmentExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of investment explanatory", "label": "SCHEDULE OF INVESTMENTS" } } }, "localname": "DisclosureOfInvestmentExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfLoansPayableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of loans payable explanatory.", "label": "SCHEDULE OF LOANS PAYABLE" } } }, "localname": "DisclosureOfLoansPayableExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LoansPayableTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Measurement Inputs and Validation Techniques for Weighted Average Assumptions Explanatory [text block]", "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS" } } }, "localname": "DisclosureOfMeasurementInputsAndValidationTechniquesForWeightedAverageAssumptionsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of measurement inputs and validation techniques for warrants explanatory [text block]", "label": "SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS" } } }, "localname": "DisclosureOfMeasurementInputsAndvalidationTechniquesForWarrantsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfNatureAndContinuanceOfOperationsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of nature and continuance of operations explanatory.", "label": "NATURE AND CONTINUANCE OF OPERATIONS" } } }, "localname": "DisclosureOfNatureAndContinuanceOfOperationsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/NatureAndContinuanceOfOperations" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfNotesReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of notes receivable.", "label": "NOTES RECEIVABLE" } } }, "localname": "DisclosureOfNotesReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/NotesReceivable" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfNotesReceivablesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of notes receivables explanatory [text block]", "label": "DISCLOSURE OF NOTES RECEIVABLE" } } }, "localname": "DisclosureOfNotesReceivablesExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/NotesReceivableTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of number and weighted average exercise prices of restricted stock units explanatory [member]", "label": "SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfRestrictedStockUnitsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Number and Weighted Average Exercise Prices of Warrants and Their Fair Values Explanatory [text block]", "label": "SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfWarrantsAndTheirFairValuesExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfOtherAndMiscellaneousExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of other and miscellaneous explanatory [text block]", "label": "SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES" } } }, "localname": "DisclosureOfOtherAndMiscellaneousExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/OfficeAndMiscellaneousTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfPrepaidExpensesAndDepositsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of prepaid expenses and deposits explanatory", "label": "SCHEDULE OF PREPAID EXPENSES AND DEPOSITS" } } }, "localname": "DisclosureOfPrepaidExpensesAndDepositsExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/PrepaidsTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of purchase price allocation explanatory table text block", "label": "SCHEDULE OF PURCHASE PRICE ALLOCATION" } } }, "localname": "DisclosureOfPurchasePriceAllocationExplanatoryTableTextBlock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Sharebased Payment Arrangements for Warrants Outstanding Explanatory [text block]", "label": "SCHEDULE OF WARRANTS OUTSTANDING" } } }, "localname": "DisclosureOfSharebasedPaymentArrangementsForWarrantsOutstandingExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of sharebased payment arrangements options outstanding and exercisable explanatory [text block]", "label": "SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE" } } }, "localname": "DisclosureOfSharebasedPaymentArrangementsOptionsOutstandingAndExercisableExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of structured entities financial information [TableTextBlock].", "label": "SUMMARY OF HISTORICAL FINANCIAL INFORMATION" } } }, "localname": "DisclosureOfStructuredEntitiesFinancialInformationTableTextBlock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfSupplementalCashFlowDisclosureExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW DISCLOSURES" } } }, "localname": "DisclosureOfSupplementalCashFlowDisclosureExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosures" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of trader payables and accrued liabilities explanatory", "label": "SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "DisclosureOfTraderPayablesAndAccruedLiabilitiesExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/TradePayablesAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfVitalIntelligenceAcquisitionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Vital Intelligence Acquisition [Text Block]", "label": "VITAL INTELLIGENCE ACQUISITION" } } }, "localname": "DisclosureOfVitalIntelligenceAcquisitionTextBlock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisition" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfWarrantDerivativeLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrant derivative liability explanatory.", "label": "SCHEDULE OF WARRANT DERIVATIVE LIABILITY" } } }, "localname": "DisclosureOfWarrantDerivativeLiabilityExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "DPRO_DisclosureOfficeAndMiscellanceousExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Office And Miscellaneous", "verboseLabel": "Schedule Of Office And Miscellaneous Expenses" } } }, "localname": "DisclosureOfficeAndMiscellanceousExpensesAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Amounts Receivable", "verboseLabel": "Receivables" } } }, "localname": "DisclosureReceivablesAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "localname": "DisclosureRevenueAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureRightOfUseAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right Of Use Assets", "verboseLabel": "Schedule Of Right Of Use Assets" } } }, "localname": "DisclosureRightOfUseAssetsAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital", "verboseLabel": "Summary Of Changes In Stock Options" } } }, "localname": "DisclosureShareCapitalAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureSupplementalCashFlowDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Disclosures" } } }, "localname": "DisclosureSupplementalCashFlowDisclosuresAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureTradePayableAndAccruedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Payables And Accrued Liabilities", "verboseLabel": "Schedule Of Trade Payables And Accrued Liabilities" } } }, "localname": "DisclosureTradePayableAndAccruedLiabilitiesAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DisclosureVitalIntelligenceAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vital Intelligence Acquisition", "verboseLabel": "Schedule Of Contingent Consideration" } } }, "localname": "DisclosureVitalIntelligenceAcquisitionAbstract", "nsuri": "http://draganfly.com/20211231", "xbrltype": "stringItemType" }, "DPRO_DiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount rate.", "label": "Discount rate" } } }, "localname": "DiscountRate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "pureItemType" }, "DPRO_DraganflyInnovationsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Draganfly Innovations Inc [Member]", "label": "Draganfly Innovations Inc [Member]" } } }, "localname": "DraganflyInnovationsIncMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "DPRO_DraganflyInnovationsSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Draganfly Innovations Shares [Member]" } } }, "localname": "DraganflyInnovationsSharesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_DraganflyInnovationsUSAIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Draganfly Innovations USA Inc [Member]", "label": "Draganfly Innovations USA Inc [Member]" } } }, "localname": "DraganflyInnovationsUSAIncMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "DPRO_DroneServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Drone Service [member]", "label": "Drone Service [member]" } } }, "localname": "DroneServiceMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "domainItemType" }, "DPRO_DronelogicsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dronelogics Inc [Member]", "label": "Dronelogics Inc [Member]" } } }, "localname": "DronelogicsIncMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_DronelogicsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dronelogics [Member]", "label": "Dronelogics [Member]" } } }, "localname": "DronelogicsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_DronelogicsSystemsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dronelogics Systems Inc [Member]", "label": "Dronelogics Systems Inc. [Member]" } } }, "localname": "DronelogicsSystemsIncMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "DPRO_EmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee [Member]", "label": "Employee [Member]" } } }, "localname": "EmployeeMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EmployeeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee One [Member]", "label": "Employee One [Member]" } } }, "localname": "EmployeeOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EmployeeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Two [Member]", "label": "Employee Two [Member]" } } }, "localname": "EmployeeTwoMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EmployeeandConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee and Consultant [Member]", "label": "Employee and Consultant [Member]" } } }, "localname": "EmployeeandConsultantMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EmployeesAndConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees and Consultant [Member]", "label": "Employees and Consultant [Member]" } } }, "localname": "EmployeesAndConsultantMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EscrowAgreementFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Escrow Agreement Four [Member]", "label": "Escrow Agreement Four [Member]" } } }, "localname": "EscrowAgreementFourMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EscrowAgreementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Escrow Agreement One [Member]", "label": "Escrow Agreement One [Member]" } } }, "localname": "EscrowAgreementOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EscrowAgreementThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Escrow Agreement Three [Member]", "label": "Escrow Agreement Three [Member]" } } }, "localname": "EscrowAgreementThreeMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EscrowAgreementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Escrow Agreement Two [Member]", "label": "Escrow Agreement Two [Member]" } } }, "localname": "EscrowAgreementTwoMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_EscrowDepositUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Escrow deposit units.", "label": "Escrow deposit units" } } }, "localname": "EscrowDepositUnits", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_ExecutiveAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executive Agreement [Member]", "label": "Executive Agreement [Member]" } } }, "localname": "ExecutiveAgreementMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Eight [Member]", "label": "Exercise Price Eight [Member]" } } }, "localname": "ExercisePriceEightMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Eleven [Member]", "label": "Exercise Price Eleven [Member]" } } }, "localname": "ExercisePriceElevenMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Five [Member]", "label": "Exercise Price Five [Member]" } } }, "localname": "ExercisePriceFiveMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Four [Member]", "label": "Exercise Price Four [Member]" } } }, "localname": "ExercisePriceFourMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Nine [Member]", "label": "Exercise Price Nine [Member]" } } }, "localname": "ExercisePriceNineMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price One [Member]", "label": "Exercise Price One [Member]" } } }, "localname": "ExercisePriceOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Seven [Member]", "label": "Exercise Price Seven [Member]" } } }, "localname": "ExercisePriceSevenMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Six [Member]", "label": "Exercise Price Six [Member]" } } }, "localname": "ExercisePriceSixMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Ten [Member]", "label": "Exercise Price Ten [Member]" } } }, "localname": "ExercisePriceTenMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Three [Member]", "label": "Exercise Price Three [Member]" } } }, "localname": "ExercisePriceThreeMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExercisePriceTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Two [Member]", "label": "Exercise Price Two [Member]" } } }, "localname": "ExercisePriceTwoMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "domainItemType" }, "DPRO_ExpectedLifeOfOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected life of options.", "label": "Expected life" } } }, "localname": "ExpectedLifeOfOptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "DPRO_ExpenseOfNonFinancialAsset": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense of non-financial asset.", "label": "Expense of non-financial asset" } } }, "localname": "ExpenseOfNonFinancialAsset", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_FairValueAdjustmentOnLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value adjustment on loans.", "label": "Fair value adjustment" } } }, "localname": "FairValueAdjustmentOnLoans", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_FairValueOfContingentConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of contingent consideration.", "label": "Fair value of contingent consideration" } } }, "localname": "FairValueOfContingentConsideration", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfContingentConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_FairValueOfSharesOfStructuredEntity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "FairValueOfSharesOfStructuredEntity", "verboseLabel": "Fair value of shares of Draganfly Inc." } } }, "localname": "FairValueOfSharesOfStructuredEntity", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_FairValueOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrants" } } }, "localname": "FairValueOfWarrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_FinalPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Final payment.", "label": "Final payment" } } }, "localname": "FinalPayment", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_FinanceAndOtherCosts": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance and other costs.", "label": "Finance and other costs" } } }, "localname": "FinanceAndOtherCosts", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_FinanceCost": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance and other costs.", "label": "FinanceCost", "negatedLabel": "Finance and other costs" } } }, "localname": "FinanceCost", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_FinancialInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial Instrument Term.", "label": "Financial instrument term" } } }, "localname": "FinancialInstrumentTerm", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "DPRO_FirstAndSecondAnniversaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First and Second Anniversary [Member]", "label": "First and Second Anniversary [Member]" } } }, "localname": "FirstAndSecondAnniversaryMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_FormerDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Director [Member]", "label": "Former Director [Member]" } } }, "localname": "FormerDirectorMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "domainItemType" }, "DPRO_FormerOwnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Owner [Member]", "label": "Former Owner [Member]" } } }, "localname": "FormerOwnerMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "domainItemType" }, "DPRO_FurnitureAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture and Equipment [Member]", "label": "Furniture and Equipment [Member]" } } }, "localname": "FurnitureAndEquipmentMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "DPRO_GainLossOnDisposalOfAssets": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on disposal of assets.", "label": "GainLossOnDisposalOfAssets", "negatedLabel": "Gain on disposal of assets" } } }, "localname": "GainLossOnDisposalOfAssets", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_GainLossOnSettlementOfDebt": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 7.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on settlement of debt.", "label": "Gain (loss) on settlement of debt" } } }, "localname": "GainLossOnSettlementOfDebt", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_GainLossOnSettlementsOfDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on settlements of debt.", "label": "Gain loss on settlement of debt" } } }, "localname": "GainLossOnSettlementsOfDebt", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_GainOnForgivenessOfDebt": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0 }, "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 8.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain on forgiveness of debt.", "label": "Gain on forgiveness of debt", "negatedLabel": "Gain on forgiveness of debt" } } }, "localname": "GainOnForgivenessOfDebt", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_GainOnSettlementOfDebt": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain on settlement of debt.", "label": "GainOnSettlementOfDebt", "negatedLabel": "Gain on settlement of debt" } } }, "localname": "GainOnSettlementOfDebt", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_GainsLossesOnChangeInFairValueOfDerivative": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gains losses on change in fair value of derivative.", "label": "Gains losses on change in fair value of derivative", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "GainsLossesOnChangeInFairValueOfDerivative", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_GoodsAndServicesTaxReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "order": 3.0, "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goods and services tax receivable.", "label": "GST receivable" } } }, "localname": "GoodsAndServicesTaxReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_GoverenmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government [Member]", "label": "Government [Member]" } } }, "localname": "GoverenmentMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "xbrltype": "domainItemType" }, "DPRO_GuaranteedInvestmentCertificateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guaranteed Investment Certificate [Member]", "label": "Guaranteed Investment Certificate [Member]" } } }, "localname": "GuaranteedInvestmentCertificateMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_HardestHitBusinessRecoveryProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hardest Hit Business Recovery Program [Member]", "label": "Hardest Hit Business Recovery Program [Member]" } } }, "localname": "HardestHitBusinessRecoveryProgramMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_HistoricalCorrection": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Historical correction.", "label": "Historical correction" } } }, "localname": "HistoricalCorrection", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_IdentifiableIntangibleAssetsBrand": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Identifiable intangible assets brand.", "label": "Identifiable intangible assets, Brand" } } }, "localname": "IdentifiableIntangibleAssetsBrand", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_IdentifiableIntangibleAssetsSoftware": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Identifiable intangible assets software.", "label": "Identifiable intangible assets, Software" } } }, "localname": "IdentifiableIntangibleAssetsSoftware", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_IfrsRestrictedStockUnitsRsuMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units Rsu [Member]", "label": "Restricted Stock Units Rsu [Member]" } } }, "localname": "IfrsRestrictedStockUnitsRsuMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "DPRO_IfrsStatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "localname": "IfrsStatementLineItems", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative", "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/RevenueDetailsNarrative", "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/ScheduleOfInvestmentsDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails", "http://draganfly.com/role/ScheduleOfLoansDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails", "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails", "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_IfrsStatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementTable [Table]" } } }, "localname": "IfrsStatementTable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_IncomeExpenseFromGovernmentAssistance": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income expense from government assistance.", "label": "IncomeExpenseFromGovernmentAssistance", "negatedLabel": "Income from government assistance" } } }, "localname": "IncomeExpenseFromGovernmentAssistance", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_IncreaseDecreaseInDeferredIncome": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred income.", "label": "IncreaseDecreaseInDeferredIncome", "verboseLabel": "Deferred income" } } }, "localname": "IncreaseDecreaseInDeferredIncome", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_IntangibleAssetsIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible Assets Including Goodwill.", "label": "Intellectual properties and goodwill" } } }, "localname": "IntangibleAssetsIncludingGoodwill", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_IntangibleAssetsOtherThanGoodwillGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible assets other-than goodwill gross.", "label": "IntangibleAssetsOtherThanGoodwillGross", "periodEndLabel": "Intellectual properties and goodwill, Ending balance", "periodStartLabel": "Intellectual properties and goodwill, beginning balance" } } }, "localname": "IntangibleAssetsOtherThanGoodwillGross", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_InternationalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International [member]", "label": "International [member]" } } }, "localname": "InternationalMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_Inventory": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "order": 1.0, "parentTag": "ifrs-full_CostOfSales", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory.", "label": "Inventory [Default Label]", "verboseLabel": "Inventory" } } }, "localname": "Inventory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_InventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inventory [Member]", "label": "Inventory [Member]" } } }, "localname": "InventoryMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_IssuanceOfLoansPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of loans payable.", "label": "Issuance of loans payable" } } }, "localname": "IssuanceOfLoansPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LeaseImplicitInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease implicit interest.", "label": "Amount representing implicit interest" } } }, "localname": "LeaseImplicitInterest", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LeaseLiabilitiesRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 12.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease liabilities recognised as of acquisition date.", "label": "LeaseLiabilitiesRecognisedAsOfAcquisitionDate", "negatedLabel": "Lease liabilities" } } }, "localname": "LeaseLiabilitiesRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LeaseRemoval": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease removal.", "label": "LeaseRemoval", "verboseLabel": "Lease removal" } } }, "localname": "LeaseRemoval", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LeasesAcquiredInAcquisition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Leases acquired in the acquisition.", "label": "LeasesAcquiredInAcquisition", "verboseLabel": "Leases acquired in the Acquisition" } } }, "localname": "LeasesAcquiredInAcquisition", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ListingExpense": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 }, "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 10.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Listing expense.", "label": "Listing expense", "negatedLabel": "Listing expense" } } }, "localname": "ListingExpense", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss", "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LoanForgiveness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loan forgiveness.", "label": "Loan forgiveness" } } }, "localname": "LoanForgiveness", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_LoansForgivableAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans forgivable amount.", "label": "Loans forgivable amount" } } }, "localname": "LoansForgivableAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_LoansPayableAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans payable amount.", "label": "LoansPayableAmount", "periodEndLabel": "Ending balance", "periodStartLabel": "Opening balance" } } }, "localname": "LoansPayableAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LoansRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 10.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans recognised as of acquisition date.", "label": "LoansRecognisedAsOfAcquisitionDate", "negatedLabel": "Loans" } } }, "localname": "LoansRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_LoansWrittenDown": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loans written down.", "label": "Loans written down" } } }, "localname": "LoansWrittenDown", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_LossForAdjustments": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss for adjustments.", "label": "Loss for adjustments", "verboseLabel": "Net loss" } } }, "localname": "LossForAdjustments", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_LossOnWriteOffOfLoanReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 11.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on write off of loan receivable.", "label": "LossOnWriteOffOfLoanReceivable", "negatedLabel": "Loss on write-off of loan receivable" } } }, "localname": "LossOnWriteOffOfLoanReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_LossOnWriteoffOfNotesReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 12.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on write-off of notes receivable.", "label": "LossOnWriteoffOfNotesReceivable", "negatedLabel": "Loss on write-off of notes receivable" } } }, "localname": "LossOnWriteoffOfNotesReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_NonCurrentLoansPayable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non-current Loans Payable.", "label": "NonCurrentLoansPayable", "verboseLabel": "Loans payable" } } }, "localname": "NonCurrentLoansPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_NoteFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Four [Member]", "label": "Note 4 [Member]" } } }, "localname": "NoteFourMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_NoteOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note One [Member]", "label": "Note One [Member]" } } }, "localname": "NoteOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "domainItemType" }, "DPRO_NoteReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable.", "label": "Note receivable" } } }, "localname": "NoteReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_NoteReceivableAccretionAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable accretion amount.", "label": "Accretion" } } }, "localname": "NoteReceivableAccretionAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_NoteReceivableAccretionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Receivable Accretion [Member]", "label": "Note Receivable Accretion [Member]" } } }, "localname": "NoteReceivableAccretionMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails" ], "xbrltype": "domainItemType" }, "DPRO_NoteReceivableFaceAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable face amount.", "label": "Principal" } } }, "localname": "NoteReceivableFaceAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_NoteReceivableInterestAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable interest amount.", "label": "Interest" } } }, "localname": "NoteReceivableInterestAmount", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_NoteReceivableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable interest rate.", "label": "Interest Rate", "verboseLabel": "Note receivable interest rate" } } }, "localname": "NoteReceivableInterestRate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "percentItemType" }, "DPRO_NoteReceivableMaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable maturity date.", "label": "Maturity Date" } } }, "localname": "NoteReceivableMaturityDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "dateItemType" }, "DPRO_NoteReceivableStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note receivable start date.", "label": "Start Date" } } }, "localname": "NoteReceivableStartDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "dateItemType" }, "DPRO_NoteThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Three [Member]", "label": "Note 3 [Member]" } } }, "localname": "NoteThreeMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_NoteTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Two [Member]", "label": "Note Two [Member]" } } }, "localname": "NoteTwoMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_NotesReceivableNonCurrent": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notes receivable.", "label": "NotesReceivableNonCurrent", "verboseLabel": "Notes receivable" } } }, "localname": "NotesReceivableNonCurrent", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_NotesReceivables": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Notes receivables.", "label": "Notes receivable" } } }, "localname": "NotesReceivables", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of instruments other equity instruments exercised.", "label": "NumberOfInstrumentsOtherEquityInstrumentsExercised", "negatedLabel": "Exercised" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsExercised", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "decimalItemType" }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of instruments other equity instruments issued.", "label": "Issued" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsIssued", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "decimalItemType" }, "DPRO_NumberOfInstrumentsOtherEquityInstrumentsVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of instruments other equity instruments vested.", "label": "Number of instruments other equity instruments vested", "negatedLabel": "Exercised" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsVested", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "decimalItemType" }, "DPRO_NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of other equity instruments vesting in share-based payment arrangement.", "label": "Number of accelerated vesting shares" } } }, "localname": "NumberOfOtherEquityInstrumentsVestingInSharebasedPaymentArrangement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "decimalItemType" }, "DPRO_NumberOfShareOptionsGrantedPostConsolidationInSharebasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share options granted post consolidation in share-based payment arrangement.", "label": "Number of shares granted post consolidation" } } }, "localname": "NumberOfShareOptionsGrantedPostConsolidationInSharebasedPaymentArrangement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "decimalItemType" }, "DPRO_NumberOfSharePurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share purchased.", "label": "Number of shares of Draganfly Inc.", "verboseLabel": "Number of units of Draganfly Inc." } } }, "localname": "NumberOfSharePurchased", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "sharesItemType" }, "DPRO_NumberOfSharesOfStructuredEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NumberOfSharesOfStructuredEntity", "verboseLabel": "Number of shares of Draganfly Inc." } } }, "localname": "NumberOfSharesOfStructuredEntity", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "sharesItemType" }, "DPRO_NumberOfSharesPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased.", "label": "Number of shares purchased" } } }, "localname": "NumberOfSharesPurchased", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_NumberOfSharesPurchasedValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Number of shares purchased, value.", "label": "Number of shares purchased, value" } } }, "localname": "NumberOfSharesPurchasedValue", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_OfficeAndMiscellaneousExpenses": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Office and Miscellaneous Expenses.", "label": "Office and miscellaneous" } } }, "localname": "OfficeAndMiscellaneousExpenses", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_OperatingExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpenseAbstract", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "DPRO_Other": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "order": 3.0, "parentTag": "ifrs-full_CostOfSales", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other" } } }, "localname": "Other", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfCostOfSalesDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_OtherCurrentAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 5.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other current assets recognised as of acquisition date", "label": "Other current assets" } } }, "localname": "OtherCurrentAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 11.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other current liabilities recognised as of acquisition date.", "label": "OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate", "negatedLabel": "Other current liabilities" } } }, "localname": "OtherCurrentLiabilitiesRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_OtherIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "localname": "OtherIncomeExpenseAbstract", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "DPRO_OtherIncomeLoss": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 14.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other income loss.", "label": "Other income (loss)" } } }, "localname": "OtherIncomeLoss", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "DPRO_PatentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patent [Member]", "label": "Patent [Member]" } } }, "localname": "PatentMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "DPRO_PaymentsForAcquisition": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for acquisition.", "label": "PaymentsForAcquisition", "negatedLabel": "Cash paid for acquisition, net of cash received" } } }, "localname": "PaymentsForAcquisition", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_PaymentsForInvestments": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for investments.", "label": "PaymentsForInvestments", "negatedLabel": "Purchase of investments" } } }, "localname": "PaymentsForInvestments", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_PaymentsForIssuanceOfNotesReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for issuance of notes receivable.", "label": "PaymentsForIssuanceOfNotesReceivable", "negatedLabel": "Issuance of notes receivable" } } }, "localname": "PaymentsForIssuanceOfNotesReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_PaymentsToAcquireAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments to acquire assets.", "label": "Payment to acquire assets" } } }, "localname": "PaymentsToAcquireAssets", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_PercentageOfWeightedAverageCostOfCapital": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of weighted average cost of capital.", "label": "Percentage of weighted average cost of capital" } } }, "localname": "PercentageOfWeightedAverageCostOfCapital", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "percentItemType" }, "DPRO_PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of weighted average revenue growth rate earnings before interest taxes depreciation and amortization.", "label": "[custom:PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization-0]" } } }, "localname": "PercentageOfWeightedAverageRevenueGrowthRateEarningsBeforeInterestTaxesDepreciationAndAmortization", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "percentItemType" }, "DPRO_PrepaidsAndDepositsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 4.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaids and deposits recognised as of acquisition date.", "label": "Prepaids and deposits" } } }, "localname": "PrepaidsAndDepositsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_PresidentAndDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "President and Director [Member]", "label": "President and Director [Member]" } } }, "localname": "PresidentAndDirectorMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "domainItemType" }, "DPRO_PrivateCompanySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Company Shares [Member]", "label": "Private Company Shares [Member]" } } }, "localname": "PrivateCompanySharesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_ProceedFromIssuanceOfCommonStock": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceed from issuance of common stock.", "label": "Proceeds from issuance of common shares for financing" } } }, "localname": "ProceedFromIssuanceOfCommonStock", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromDisposalOfEquipment": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from disposal of equipment.", "label": "Disposal of equipment" } } }, "localname": "ProceedsFromDisposalOfEquipment", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from exercise of warrants shares.", "label": "Purchases of exercise of warrants, shares" } } }, "localname": "ProceedsFromExerciseOfWarrantsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_ProceedsFromIssuanceOfCommonSharesForFinancing": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common shares for financing.", "label": "Proceeds from sales of investments" } } }, "localname": "ProceedsFromIssuanceOfCommonSharesForFinancing", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromIssuanceOfCommonSharesForStockOptionsExercised": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common shares for stock options exercised.", "label": "Proceeds from issuance of common shares for stock options exercised" } } }, "localname": "ProceedsFromIssuanceOfCommonSharesForStockOptionsExercised", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromIssuanceOfCommonSharesForWarrantsExercised": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common shares for warrants exercised.", "label": "Proceeds from issuance of common shares for warrants exercised" } } }, "localname": "ProceedsFromIssuanceOfCommonSharesForWarrantsExercised", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromIssuanceOfLoans": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of loans.", "label": "Proceeds from issuance of loans" } } }, "localname": "ProceedsFromIssuanceOfLoans", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromIssuanceOfNotesPayable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of notes payable.", "label": "Proceeds from issuance of notes payable" } } }, "localname": "ProceedsFromIssuanceOfNotesPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_ProceedsFromIssuanceOfSubscriptionReceipts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of subscription receipts.", "label": "Proceeds from subscription receipts" } } }, "localname": "ProceedsFromIssuanceOfSubscriptionReceipts", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_ProductSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Sales [member]", "label": "Product Sales [member]" } } }, "localname": "ProductSalesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "domainItemType" }, "DPRO_ProfitLossExcludeInvestmentLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Profit loss exclude investment loss.", "label": "Net loss" } } }, "localname": "ProfitLossExcludeInvestmentLoss", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_PropertyPlantAndEquipmentCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "PropertyPlantAndEquipmentCost", "periodEndLabel": "Property, plant and equipment, ending balance", "periodStartLabel": "Property, plant and equipment, beginning balance" } } }, "localname": "PropertyPlantAndEquipmentCost", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_PublicCompanySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Company Shares [Member]", "label": "Public Company Shares [Member]" } } }, "localname": "PublicCompanySharesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_PublicCompanyWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Company Warrants [Member]", "label": "Public Company Warrants [Member]" } } }, "localname": "PublicCompanyWarrantsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_PurchaseOfFinancialInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase of financial instruments.", "label": "Purchase of financial instrument" } } }, "localname": "PurchaseOfFinancialInstruments", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_Range1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 1 [member]", "label": "Range 1 [member]" } } }, "localname": "Range1Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_Range2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 2 [member]", "label": "Range 2 [member]" } } }, "localname": "Range2Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_Range3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 3 [member]", "label": "Range 3 [member]" } } }, "localname": "Range3Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_Range4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 4 [member]", "label": "Range 4 [member]" } } }, "localname": "Range4Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_Range5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 5 [member]", "label": "Range 5 [member]" } } }, "localname": "Range5Member", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_RecapitalizationOfEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recapitalization of equity.", "label": "Recapitalization of Draganfly Inc." } } }, "localname": "RecapitalizationOfEquity", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_RecapitalizationOfEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recapitalization of equity, shares", "label": "Recapitalization of Draganfly Inc., shares" } } }, "localname": "RecapitalizationOfEquityShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_ReclassificationOfUnexercisedConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reclassification of unexercised conversion feature.", "label": "Reclassification of unexercised conversion feature" } } }, "localname": "ReclassificationOfUnexercisedConversionFeature", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_RenewOfFinancialInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Renewed of financial instruments.", "label": "Renew of financial instruments" } } }, "localname": "RenewOfFinancialInstruments", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_RenewedEffectiveInstrumentRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Renewed effective instrument rate.", "label": "Renewed effective instrument rate" } } }, "localname": "RenewedEffectiveInstrumentRate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "DPRO_RenewedFinancialInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Renewed financial instrument term.", "label": "Renewed financial instrument term" } } }, "localname": "RenewedFinancialInstrumentTerm", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "durationItemType" }, "DPRO_RepaymentOfLeaseLiability": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of lease liability.", "label": "RepaymentOfLeaseLiability", "negatedLabel": "Repayment of lease liability" } } }, "localname": "RepaymentOfLeaseLiability", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_RepaymentOfLoans": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of loans.", "label": "Repayment of loans", "negatedLabel": "Repayment of loans" } } }, "localname": "RepaymentOfLoans", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_RepaymentOfLoansPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of loans payable.", "label": "Repayment of loans payable" } } }, "localname": "RepaymentOfLoansPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansPayableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_RepaymentOfNotesPayable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayment of notes payable.", "label": "RepaymentOfNotesPayable", "negatedLabel": "Repayment of notes payable" } } }, "localname": "RepaymentOfNotesPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_RestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units [Member]", "label": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_RevenueFromRenderingOfEngineeringServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Service Revenue.", "label": "Service Revenue" } } }, "localname": "RevenueFromRenderingOfEngineeringServices", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_RightOfUSeAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 7.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right of use assets recognised as of acquisition date.", "label": "Right-of-use assets" } } }, "localname": "RightOfUSeAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_RightofuseAssetsAccumulatedAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use Assets Accumulated Amortization.", "label": "RightofuseAssetsAccumulatedAmortization", "periodEndLabel": "Accumulated amortization, ending", "periodStartLabel": "Accumulated amortization, Beginning" } } }, "localname": "RightofuseAssetsAccumulatedAmortization", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_RightofuseAssetsLeaseRemoval": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use assets lease removal.", "label": "Lease removal" } } }, "localname": "RightofuseAssetsLeaseRemoval", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_RightofuseAssetsLeasesAcquiredInAcquisition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right of use assets leases acquired in acquisition.", "label": "Leases acquired in the Acquisition" } } }, "localname": "RightofuseAssetsLeasesAcquiredInAcquisition", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_RoyaltyDiscountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty discount percentage.", "label": "Royalty discount percentage" } } }, "localname": "RoyaltyDiscountPercentage", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "pureItemType" }, "DPRO_RoyaltyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty Percentage.", "label": "Royalty percentage", "verboseLabel": "Royalty Percentage" } } }, "localname": "RoyaltyPercentage", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "pureItemType" }, "DPRO_SalaryAndWages": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Salary and wages.", "label": "Salaries" } } }, "localname": "SalaryAndWages", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ScheduleOfDeferredIncomeExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of deferred income explanatory [Table Text Block]", "label": "SCHEDULE OF DEFERRED INCOME" } } }, "localname": "ScheduleOfDeferredIncomeExplanatory", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/DeferredIncomeTables" ], "xbrltype": "textBlockItemType" }, "DPRO_ScheduleOfPurchasePriceAllocationForVitalIntelligence": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Purchase Price Allocation for Vital Intelligence.", "label": "SCHEDULE OF PURCHASE PRICE ALLOCATION FOR VITAL INTELLIGENCE" } } }, "localname": "ScheduleOfPurchasePriceAllocationForVitalIntelligence", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "DPRO_ScientificResearchAndExperimentalDevelopmentReceivable": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "order": 4.0, "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Scientific research and experimental development receivable.", "label": "SR&ED receivable" } } }, "localname": "ScientificResearchAndExperimentalDevelopmentReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_ScottLarsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scott Larson [Member]", "label": "Scott Larson [Member]" } } }, "localname": "ScottLarsonMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_ServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Services [Member]", "label": "Services [Member]" } } }, "localname": "ServicesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "domainItemType" }, "DPRO_ShareCapitalIssuanceDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Capital Issuance Description.", "label": "Share capital issuance, description" } } }, "localname": "ShareCapitalIssuanceDescription", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_ShareConsolidationToEquityMethod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share consolidation to equity method.", "label": "Stock-based compensation" } } }, "localname": "ShareConsolidationToEquityMethod", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharebasedPayments": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]", "label": "SharebasedPayments", "verboseLabel": "Share-based payments" } } }, "localname": "SharebasedPayments", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesAndWarrantsIssuedOnPrivatePlacement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares and warrants issued on private placement.", "label": "Shares and warrants issued on private placement" } } }, "localname": "SharesAndWarrantsIssuedOnPrivatePlacement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesAndWarrantsIssuedOnPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares and warrants issued on private placement, shares.", "label": "Shares and warrants issued on private placement, shares" } } }, "localname": "SharesAndWarrantsIssuedOnPrivatePlacementShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesHeldInEscrow": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "shares held in escrow.", "label": "Shares held in escrow" } } }, "localname": "SharesHeldInEscrow", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedAsAcquisitionCost": { "auth_ref": [], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued as acquisition cost.", "label": "SharesIssuedAsAcquisitionCost", "negatedLabel": "Shares Issued as acquisition cost" } } }, "localname": "SharesIssuedAsAcquisitionCost", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedAsFindersFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued as finders fees.", "label": "Shares issued as finder\u2019s fees" } } }, "localname": "SharesIssuedAsFindersFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedAsFindersFeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued as finders fees, shares.", "label": "Shares issued as finder's fees, shares" } } }, "localname": "SharesIssuedAsFindersFeesShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedAsTransactionsFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued as transactions fees.", "label": "Shares issued as transactions fees" } } }, "localname": "SharesIssuedAsTransactionsFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedAsTransactionsFeesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued as transactions fees, shares.", "label": "Shares issued as transactions fees, shares" } } }, "localname": "SharesIssuedAsTransactionsFeesShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for acquisition.", "label": "Shares issued for acquisition" } } }, "localname": "SharesIssuedForAcquisition", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for acquisition, shares", "label": "Beginning balance, shares" } } }, "localname": "SharesIssuedForAcquisitionShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForDebtSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for debt settlement.", "label": "Shares issued for debt settlement" } } }, "localname": "SharesIssuedForDebtSettlement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForDebtSettlementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for debt settlement, shares.", "label": "Shares issued for debt settlement, shares" } } }, "localname": "SharesIssuedForDebtSettlementShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForExerciseOfBrokerWarrantsOfDerivatives": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of broker warrants of derivatives.", "label": "Shares issued for exercise of broker warrants of derivatives" } } }, "localname": "SharesIssuedForExerciseOfBrokerWarrantsOfDerivatives", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForExerciseOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of restricted stock units.", "label": "Shares issued for exercise of RSUs" } } }, "localname": "SharesIssuedForExerciseOfRestrictedStockUnits", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForExerciseOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of restricted stock units, shares.", "label": "Shares issued for exercise of RSUs, shares", "verboseLabel": "Beginning balance, shares" } } }, "localname": "SharesIssuedForExerciseOfRestrictedStockUnitsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForExerciseOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of stock options.", "label": "Shares issued for exercise of stock options" } } }, "localname": "SharesIssuedForExerciseOfStockOptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForExerciseOfStockOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of stock options, shares.", "label": "Shares issued for exercise of stock options, shares", "verboseLabel": "Beginning balance, shares" } } }, "localname": "SharesIssuedForExerciseOfStockOptionsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of warrants.", "label": "Shares issued for exercise of warrants" } } }, "localname": "SharesIssuedForExerciseOfWarrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForExerciseOfWarrantsOfDerivatives": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of warrants of derivatives.", "label": "Warrants issuance" } } }, "localname": "SharesIssuedForExerciseOfWarrantsOfDerivatives", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for exercise of warrants, shares.", "label": "Shares issued for exercise of warrants, shares" } } }, "localname": "SharesIssuedForExerciseOfWarrantsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForFinancing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for financing.", "label": "Shares issued for financing" } } }, "localname": "SharesIssuedForFinancing", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForFinancingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for financing, shares", "label": "Shares issued for financing, shares" } } }, "localname": "SharesIssuedForFinancingShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedForSettlementOfNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for settlement of notes payable.", "label": "Shares issued for settlement of notes payable" } } }, "localname": "SharesIssuedForSettlementOfNotesPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedForSettlementOfNotesPayableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for settlement of notes payable, shares", "label": "Shares issued for settlement of notes payable, shares" } } }, "localname": "SharesIssuedForSettlementOfNotesPayableShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedInLieuOfCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued in lieu of cash.", "label": "Shares issued in lieu of cash" } } }, "localname": "SharesIssuedInLieuOfCash", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedInLieuOfCashShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued in lieu of cash, shares.", "label": "Shares issued in lieu of cash, shares", "verboseLabel": "Beginning balance, shares" } } }, "localname": "SharesIssuedInLieuOfCashShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedOfSettlementConvertibleDebentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement convertible debentures.", "label": "Shares issued of settlement convertible debentures" } } }, "localname": "SharesIssuedOfSettlementConvertibleDebentures", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedOfSettlementConvertibleDebenturesAndAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement convertible debentures and accrued interest.", "label": "Shares issued for settlement of convertible debentures and accrued interest" } } }, "localname": "SharesIssuedOfSettlementConvertibleDebenturesAndAccruedInterest", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedOfSettlementConvertibleDebenturesAndAccruedInterestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement convertible debentures and accrued interest, shares.", "label": "Shares issued for settlement of convertible debentures and accrued interest, shares", "verboseLabel": "Shares issued of settlement convertible debentures and accrued interest, shares" } } }, "localname": "SharesIssuedOfSettlementConvertibleDebenturesAndAccruedInterestShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_SharesIssuedOfSettlementTradesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement trades payable.", "label": "Shares issued of settlement of trades payable", "verboseLabel": "[custom:SharesIssuedOfSettlementTradesPayable]" } } }, "localname": "SharesIssuedOfSettlementTradesPayable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_SharesIssuedOfSettlementTradesPayablePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement trades payable per share.", "label": "Trades payable per share" } } }, "localname": "SharesIssuedOfSettlementTradesPayablePerShare", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "perShareItemType" }, "DPRO_SharesIssuedOfSettlementTradesPayableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued of settlement trades payable, shares", "label": "Shares issued of settlement of trades payable, shares", "verboseLabel": "Shares issued of settlement trades payable, shares" } } }, "localname": "SharesIssuedOfSettlementTradesPayableShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_ShopifyLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shopify Loan [Member]", "label": "Shopify Loan [Member]" } } }, "localname": "ShopifyLoanMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "domainItemType" }, "DPRO_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software [Member]", "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_StockIssuedDuringPeriodAtFairValueUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period at fair value units shares.", "label": "Common stock, issued" } } }, "localname": "StockIssuedDuringPeriodAtFairValueUnitsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesCashProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares cash proceeds.", "label": "Number of stock issued for cash proceeds" } } }, "localname": "StockIssuedDuringPeriodSharesCashProceeds", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesDebtSettlement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares debt settlement.", "label": "Number of stock issued for debt settlement" } } }, "localname": "StockIssuedDuringPeriodSharesDebtSettlement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesDebtSettlements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares debt settlements.", "label": "Debt settlement, shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesDebtSettlements", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesExerciseOfOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued for exercise of options.", "label": "Number of stock issued for exercise of options" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfOptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued for exercise of warrants.", "label": "Shares isued for exercise of warrants, shares", "verboseLabel": "Number of stock issued for exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesPrivatePlacement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued for private placement", "label": "Number of stock issued for private placement" } } }, "localname": "StockIssuedDuringPeriodSharesPrivatePlacement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodSharesRestrcitedShareUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock issued for restrcited share units.", "label": "Number of stock issued for restrcited share units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrcitedShareUnits", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockIssuedDuringPeriodValueCashProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value cash proceeds.", "label": "Value of stock issued for cash proceeds" } } }, "localname": "StockIssuedDuringPeriodValueCashProceeds", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_StockIssuedDuringPeriodValueExerciseOfOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued for exercise of options.", "label": "Value of stock issued for exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfOptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_StockIssuedDuringPeriodValueExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued for exercise of warrants", "label": "Value of stock issued for exercise of warrants", "verboseLabel": "Shares issued for exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "DPRO_StockIssuedDuringPeriodValuePrivatePlacement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued for private placement.", "label": "Value of stock issued for private placement" } } }, "localname": "StockIssuedDuringPeriodValuePrivatePlacement", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_StockIssuedDuringPeriodValueUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value units.", "label": "Shares issued, amount" } } }, "localname": "StockIssuedDuringPeriodValueUnits", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_StockIssuedDuringPeriodValueUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value units, shares.", "label": "Stock issued, shares", "terseLabel": "Stock issued during period value units, shares", "verboseLabel": "Exchange of common stocks" } } }, "localname": "StockIssuedDuringPeriodValueUnitsShares", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockOptionsExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiry date for stock options.", "label": "Expiry date" } } }, "localname": "StockOptionsExpiryDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "dateItemType" }, "DPRO_StockOptionsGrantDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options grant date.", "label": "Grant date" } } }, "localname": "StockOptionsGrantDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "dateItemType" }, "DPRO_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options [Member]", "label": "Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_StockUnitsIssuedDuringPeriodSharesAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock units issued for acquisition.", "label": "Number of stock units issued for acquisition" } } }, "localname": "StockUnitsIssuedDuringPeriodSharesAcquisition", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockUnitsIssuedDuringPeriodSharesCommonSharesFinderFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock units issued during period shares common shares finder fees.", "label": "Stock units issued during period shares common shares finder fees" } } }, "localname": "StockUnitsIssuedDuringPeriodSharesCommonSharesFinderFees", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockUnitsIssuedDuringPeriodSharesRegulationFinancing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stock units issued for regulation financing.", "label": "Number of stock units issued for regulation financing" } } }, "localname": "StockUnitsIssuedDuringPeriodSharesRegulationFinancing", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_StockUnitsIssuedDuringPeriodValueRegulationFinancing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock units issued during period value regulation financing.", "label": "Stock units issued during period value regulation financing" } } }, "localname": "StockUnitsIssuedDuringPeriodValueRegulationFinancing", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_SubscriptionReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subscription receivable.", "label": "Subscription receivable" } } }, "localname": "SubscriptionReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "DPRO_SubscriptionsReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "subscription receipts.", "label": "Subscription receivable [Default Label]", "negatedLabel": "Subscription receipts" } } }, "localname": "SubscriptionsReceivable", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax effect of adjustments to prior years provision versus statutory tax returns.", "label": "Adjustments to prior years provision versus statutory tax returns" } } }, "localname": "TaxEffectOfAdjustmentsToPriorYearsProvisionVersusStatutoryTaxReturns", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Tax effect of differences between prior year provision and final tax return.", "label": "Differences between prior year provision and final tax return" } } }, "localname": "TaxEffectOfDifferencesBetweenPriorYearProvisionAndFinalTaxReturn", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_TaxEffectRatesShareIssueCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share issue costs.", "label": "Share issue costs" } } }, "localname": "TaxEffectRatesShareIssueCosts", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_TotalPurchasePriceAllocation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total purchase price allocation.", "label": "Total" } } }, "localname": "TotalPurchasePriceAllocation", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "DPRO_AcquisitiondateFairValuesOfTotalConsiderationTransferred", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total tangible assets recognised as of acquisition date.", "label": "Identifiable intangible assets", "totalLabel": "Total tangible assets acquired" } } }, "localname": "TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_USCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Country [member]", "label": "US Country [member]" } } }, "localname": "USCountryMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "xbrltype": "domainItemType" }, "DPRO_UnitedStatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United States [member]", "label": "United States [member]" } } }, "localname": "UnitedStatesMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "DPRO_VehicleLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vehicle Loan [Member]", "label": "Vehicle Loan [Member]" } } }, "localname": "VehicleLoanMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "domainItemType" }, "DPRO_VitalAndDronelogicsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vital and Dronelogics [Member]", "label": "Vital and Dronelogics [Member]" } } }, "localname": "VitalAndDronelogicsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_VitalIntelligenceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vital Intelligence Inc [Member]", "label": "Vital Intelligence Inc [Member]" } } }, "localname": "VitalIntelligenceIncMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_VitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vital [Member]", "label": "Vital [Member]" } } }, "localname": "VitalMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "DPRO_WarrantExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercise price.", "label": "warrant, exercise price" } } }, "localname": "WarrantExercisePrice", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "DPRO_WarrantExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercise price per share.", "label": "Warrant exercise price per share" } } }, "localname": "WarrantExercisePricePerShare", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "perShareItemType" }, "DPRO_WarrantExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiration term.", "label": "Warrant expiration term" } } }, "localname": "WarrantExpirationTerm", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "durationItemType" }, "DPRO_WarrantExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiry date.", "label": "Expiry Date" } } }, "localname": "WarrantExpiryDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "dateItemType" }, "DPRO_WarrantFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Five [Member]", "label": "Warrant Five [Member]" } } }, "localname": "WarrantFiveMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_WarrantFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Four [Member]", "label": "Warrant Four [Member]" } } }, "localname": "WarrantFourMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_WarrantOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant One [Member]", "label": "Warrant One [Member]" } } }, "localname": "WarrantOneMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_WarrantSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Six [Member]", "label": "Warrant Six [Member]" } } }, "localname": "WarrantSixMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_WarrantThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Three [Member]", "label": "Warrant Three [Member]" } } }, "localname": "WarrantThreeMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_WarrantTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Two [Member]", "label": "Warrant Two [Member]" } } }, "localname": "WarrantTwoMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails" ], "xbrltype": "domainItemType" }, "DPRO_Warrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants.", "label": "Warrants", "periodEndLabel": "Warrants" } } }, "localname": "Warrants", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "DPRO_WarrantsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Exercise Price", "label": "[custom:WarrantsExercisePrice-0]" } } }, "localname": "WarrantsExercisePrice", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "perShareItemType" }, "DPRO_WarrantsExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants expiration date.", "label": "Warrants expiration date" } } }, "localname": "WarrantsExpirationDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/InvestmentsDetailsNarrative" ], "xbrltype": "dateItemType" }, "DPRO_WarrantsExpirationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Expiration Date Description", "label": "Warrants Expiration Date Description" } } }, "localname": "WarrantsExpirationDateDescription", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "DPRO_WarrantsHeldInEscrow": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants held in escrow.", "label": "Warrants held in escrow" } } }, "localname": "WarrantsHeldInEscrow", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_WarrantsIssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issuance date.", "label": "Issue Date" } } }, "localname": "WarrantsIssuanceDate", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "dateItemType" }, "DPRO_WarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants issued.", "label": "Warrants issued" } } }, "localname": "WarrantsIssued", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "sharesItemType" }, "DPRO_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Member]", "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "domainItemType" }, "DPRO_WeightedAverageRemainingContractualLifeOfExercisableShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual life of exercisable share options.", "label": "Stock option exercisable year" } } }, "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions", "nsuri": "http://draganfly.com/20211231", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "durationItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r242", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r242", "r244", "r245" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r242", "r244", "r245" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelEmailAddress": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Email address of contact personnel.", "label": "Contact Personnel Email Address" } } }, "localname": "ContactPersonnelEmailAddress", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r242", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r243" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://draganfly.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ifrs-full_AccountingProfit": { "auth_ref": [ "r48", "r49" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Loss before income taxes" } } }, "localname": "AccountingProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income [member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "auth_ref": [ "r185" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Total consideration", "periodEndLabel": "Contingent consideration" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r100" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets acquired in the Acquisition" } } }, "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Net assets acquired in the Transaction" } } }, "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "auth_ref": [ "r62" ], "lang": { "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Assumption discount rates" } } }, "localname": "ActuarialAssumptionOfDiscountRates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsToRightofuseAssets": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Additions to right-of-use assets", "verboseLabel": "Additions" } } }, "localname": "AdditionsToRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForAmortisationExpense": { "auth_ref": [ "r121" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Adjustments for amortisation expense", "verboseLabel": "Amortization" } } }, "localname": "AdjustmentsForAmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationExpense": { "auth_ref": [ "r121" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for depreciation expense", "verboseLabel": "Depreciation" } } }, "localname": "AdjustmentsForDepreciationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromCustomers": { "auth_ref": [ "r121" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in deposits from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deposits from customers; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in deposits from customers", "verboseLabel": "Customer deposits" } } }, "localname": "AdjustmentsForIncreaseDecreaseInDepositsFromCustomers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r119" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade accounts payable", "verboseLabel": "Trade payables and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLoss": { "auth_ref": [ "r121" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "DPRO_CashFlowFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments to reconcile profit (loss)", "totalLabel": "Adjustment for profit loss" } } }, "localname": "AdjustmentsForReconcileProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments for:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r120" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 8.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Share-based payments", "verboseLabel": "Adjustments for share-based payments" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdvertisingExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "order": 1.0, "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from advertising." } }, "en-us": { "role": { "label": "Advertising, Marketing, and Investor Relations" } } }, "localname": "AdvertisingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r24", "r63", "r157", "r168", "r169", "r195", "r201", "r204", "r219", "r220", "r222", "r223" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "auth_ref": [ "r61", "r148" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "localname": "AllLevelsOfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AmortisationExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } }, "en-us": { "role": { "label": "Amortization" } } }, "localname": "AmortisationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r101" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Change for the year" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "auth_ref": [ "r76", "r79" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Amounts payable, related party transactions" } } }, "localname": "AmountsPayableRelatedPartyTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r49" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Canadian statutory rates" } } }, "localname": "ApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r21", "r147", "r148", "r149", "r209", "r212" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "TOTAL ASSETS", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_BalancesWithBanks": { "auth_ref": [ "r124" ], "calculation": { "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "DPRO_CashAndCashEquivalentsCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash balances held at banks." } }, "en-us": { "role": { "label": "Balances with banks", "verboseLabel": "Cash held in banks" } } }, "localname": "BalancesWithBanks", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BorrowingsByNameAxis": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Borrowings by name [axis]" } } }, "localname": "BorrowingsByNameAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameMember": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "localname": "BorrowingsByNameMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_BorrowingsInterestRate": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Rate", "verboseLabel": "Interest rate" } } }, "localname": "BorrowingsInterestRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_BorrowingsMaturity": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Maturity", "verboseLabel": "Maturity Date" } } }, "localname": "BorrowingsMaturity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r152", "r154", "r155", "r180", "r198", "r222" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r187" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CapitalReserve": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the capital reserves." } }, "en-us": { "role": { "label": "Reserves \u2013 share-based payments", "verboseLabel": "Capital reserve" } } }, "localname": "CapitalReserve", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CapitalReserveMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } }, "en-us": { "role": { "label": "Capital reserve [member]" } } }, "localname": "CapitalReserveMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash [Default Label]", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r17", "r124", "r143" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash, end of year", "periodStartLabel": "Cash, beginning of year", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfBreakdownCapitalDetails", "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r186" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash" } } }, "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r113", "r125" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Funds provided by financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r113", "r125" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Funds provided by (used in) investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r57" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalAxis": { "auth_ref": [ "r36" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of share capital [axis]" } } }, "localname": "ClassesOfShareCapitalAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalMember": { "auth_ref": [ "r36" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "localname": "ClassesOfShareCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items that will not be reclassified to profit or loss" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r3", "r38", "r127", "r129", "r138", "r141" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "COMPREHENSIVE LOSS" } } }, "localname": "ComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComputerEquipmentMember": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Computer equipment [member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ComputerSoftwareMember": { "auth_ref": [ "r104" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Computer software [member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ConsolidatedStructuredEntitiesAxis": { "auth_ref": [ "r146" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Consolidated structured entities [axis]" } } }, "localname": "ConsolidatedStructuredEntitiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r2", "r45" ], "calculation": { "http://draganfly.com/role/ScheduleOfCostOfSalesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of sales", "negatedLabel": "COST OF SALES", "totalLabel": "Cost of sales" } } }, "localname": "CostOfSales", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/ScheduleOfCostOfSalesDetails", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CounterpartiesAxis": { "auth_ref": [ "r205" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Counterparties [axis]" } } }, "localname": "CounterpartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CounterpartiesMember": { "auth_ref": [ "r205" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "localname": "CounterpartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r85", "r89", "r133", "r135" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Country of incorporation of subsidiary" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]" } }, "en-us": { "role": { "label": "Current accrued expenses and other current liabilities", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r25", "r138", "r139" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentDepositsFromCustomers": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]" } }, "en-us": { "role": { "label": "Customer deposits" } } }, "localname": "CurrentDepositsFromCustomers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfCustomerDepositsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } }, "en-us": { "role": { "label": "Derivative liability" } } }, "localname": "CurrentDerivativeFinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]" } }, "en-us": { "role": { "label": "Current financial assets at fair value through profit or loss", "verboseLabel": "Total" } } }, "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r161" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 6.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Lease liability", "verboseLabel": "Current lease liabilities" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r27", "r138", "r140" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Prepaids", "totalLabel": "Prepaid expenses and deposits" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } }, "en-us": { "role": { "label": "Customer-related intangible assets [member]" } } }, "localname": "CustomerrelatedIntangibleAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r186" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 1.0, "parentTag": "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for customer-related intangible assets acquired in a business combination. [Refer: Customer-related intangible assets [member]; Business combinations [member]]" } }, "en-us": { "role": { "label": "Customer relationships" } } }, "localname": "CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssets": { "auth_ref": [ "r19", "r22", "r50" ], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": 1.0, "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets", "totalLabel": "Total deferred income tax assets" } } }, "localname": "DeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } }, "en-us": { "role": { "label": "Depreciation" } } }, "localname": "DepreciationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r162" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "label": "Depreciation, right-of-use assets", "verboseLabel": "Charge for the year" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DerivativeFinancialLiabilities": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Derivative financial liabilities" } } }, "localname": "DerivativeFinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Business combinations" } } }, "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for contingent liabilities and contingent assets. [Refer: Contingent liabilities [member]; Description of nature of contingent assets]" } }, "en-us": { "role": { "label": "Contingencies" } } }, "localname": "DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for earnings per share." } }, "en-us": { "role": { "label": "Loss per share" } } }, "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for foreign currency translation." } }, "en-us": { "role": { "label": "Foreign currency translation" } } }, "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "auth_ref": [ "r70" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } }, "en-us": { "role": { "label": "Description of accounting policy for government grants [text block]", "verboseLabel": "Government Assistance" } } }, "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Impairment of non-financial assets" } } }, "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for income tax." } }, "en-us": { "role": { "label": "Income taxes" } } }, "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Useful lives of equipment and intangible assets" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible Assets and Goodwill" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for investment property. [Refer: Investment property]" } }, "en-us": { "role": { "label": "SR&ED Investment tax credits" } } }, "localname": "DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } }, "en-us": { "role": { "label": "Leases" } } }, "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": { "auth_ref": [ "r65" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Description of accounting policy for measuring inventories [text block]", "verboseLabel": "Inventory" } } }, "localname": "DescriptionOfAccountingPolicyForMeasuringInventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Description of accounting policy for property, plant and equipment [text block]", "verboseLabel": "Equipment" } } }, "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue recognition" } } }, "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]" } }, "en-us": { "role": { "label": "Research and development expenditures" } } }, "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of accounting policy for share-based payment transactions [text block]", "verboseLabel": "Share-based payments" } } }, "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r182" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": { "auth_ref": [ "r97", "r98" ], "lang": { "en": { "role": { "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Percentage of cash flow projection" } } }, "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "auth_ref": [ "r182" ], "lang": { "en": { "role": { "documentation": "The option life of share options granted." } }, "en-us": { "role": { "label": "Estimated life" } } }, "localname": "DescriptionOfOptionLifeShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r182" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk-free interest rate", "verboseLabel": "Risk free interest rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "auth_ref": [ "r24" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } }, "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } } }, "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "BASIS OF PREPARATION" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBreakdownOfAssetsAndLiabilitiesAggregatedIntoSingleLineInvestmentBalanceTransitionFromProportionateConsolidationToEquityMethodExplanatory": { "auth_ref": [ "r130" ], "lang": { "en": { "role": { "documentation": "The disclosure of the breakdown of assets and liabilities that have been aggregated into the single line investment balance for the transition from proportionate consolidation to the equity method." } }, "en-us": { "role": { "label": "SCHEDULE OF BREAKDOWN CAPITAL" } } }, "localname": "DisclosureOfBreakdownOfAssetsAndLiabilitiesAggregatedIntoSingleLineInvestmentBalanceTransitionFromProportionateConsolidationToEquityMethodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r192" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "DRONELOGICS ACQUISITION" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisition" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r187" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "CASH AND CASH EQUIVALENTS" } } }, "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r36" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "SHARE CAPITAL" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } }, "en-us": { "role": { "label": "SCHEDULE OF COST OF SALES" } } }, "localname": "DisclosureOfCostOfSalesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDeferredIncomeExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of deferred income. [Refer: Deferred income including contract liabilities]" } }, "en-us": { "role": { "label": "DEFERRED INCOME" } } }, "localname": "DisclosureOfDeferredIncomeExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DeferredIncome" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDepositsFromCustomersExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of deposits from customers. [Refer: Deposits from customers]" } }, "en-us": { "role": { "label": "CUSTOMER DEPOSITS" } } }, "localname": "DisclosureOfDepositsFromCustomersExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/CustomerDeposits" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "SCHEDULE OF LOANS" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "auth_ref": [ "r198" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative", "http://draganfly.com/role/ScheduleOfLoansDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "SCHEDULE OF INTELLECTUAL PROPERTY" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r57" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } } }, "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/EquipmentTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "auth_ref": [ "r156" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/RevenueDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": { "auth_ref": [ "r73" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for the effect of changes in foreign exchange rates." } }, "en-us": { "role": { "label": "SCHEDULE OF CHANGES IN FOREIGN EXCHANGE RATES" } } }, "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "auth_ref": [ "r150" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } }, "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } } }, "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of financial instruments designated at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS" } } }, "localname": "DisclosureOfFinancialInstrumentsDesignatedAtFairValueThroughProfitOrLossExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/FinancialInstrumentsAndFinancialRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "auth_ref": [ "r216" ], "lang": { "en": { "role": { "documentation": "The disclosure of geographical information." } }, "en-us": { "role": { "label": "SCHEDULE OF GEOGRAPHIC REVENUE" } } }, "localname": "DisclosureOfGeographicalAreasExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "INCOME TAXES" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable": { "auth_ref": [ "r146" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to consolidated structured entities." } }, "en-us": { "role": { "label": "Disclosure of information about consolidated structured entities [table]" } } }, "localname": "DisclosureOfInformationAboutConsolidatedStructuredEntitiesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory": { "auth_ref": [ "r137" ], "lang": { "en": { "role": { "documentation": "The disclosure of qualitative and quantitative information about the entity's interests in structured entities, including, but not limited to, the nature, purpose, size and activities of the structured entity and how the structured entity is financed." } }, "en-us": { "role": { "label": "AMALGAMATION" } } }, "localname": "DisclosureOfInformationAboutInterestsInStructuredEntityExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Amalgamation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r108" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "INTANGIBLE ASSETS AND GOODWILL" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwill" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInterestsInOtherEntitiesExplanatory": { "auth_ref": [ "r131" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for interests in other entities." } }, "en-us": { "role": { "label": "Disclosure of interests in other entities [text block]" } } }, "localname": "DisclosureOfInterestsInOtherEntitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "auth_ref": [ "r69" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for inventories." } }, "en-us": { "role": { "label": "INVENTORY" } } }, "localname": "DisclosureOfInventoriesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "auth_ref": [ "r112" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for investment property." } }, "en-us": { "role": { "label": "INVESTMENTS" } } }, "localname": "DisclosureOfInvestmentPropertyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInvestmentPropertyTable": { "auth_ref": [ "r109" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of investment property." } }, "en-us": { "role": { "label": "Disclosure of detailed information about investment property [table]" } } }, "localname": "DisclosureOfInvestmentPropertyTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfLeasesExplanatory": { "auth_ref": [ "r170", "r171" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for leases." } }, "en-us": { "role": { "label": "LEASE LIABILITY" } } }, "localname": "DisclosureOfLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LeaseLiability" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfLoansAndAdvancesToCustomersExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of loans and advances to customers. [Refer: Loans and advances to customers]" } }, "en-us": { "role": { "label": "LOANS PAYABLE" } } }, "localname": "DisclosureOfLoansAndAdvancesToCustomersExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayable" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": { "auth_ref": [ "r169" ], "lang": { "en": { "role": { "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } }, "en-us": { "role": { "label": "SCHEDULE OF OPERATING MATURITY ANALYSIS" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of notes and other explanatory information as part of a complete set of financial statements." } }, "en-us": { "role": { "label": "Disclosure of notes and other explanatory information [text block]" } } }, "localname": "DisclosureOfNotesAndOtherExplanatoryInformationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "auth_ref": [ "r178" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "SUMMARY OF CHANGES IN STOCK OPTIONS" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r209" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF OPERATING SEGMENTS" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "OFFICE AND MISCELLANEOUS" } } }, "localname": "DisclosureOfOtherOperatingExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/OfficeAndMiscellaneous" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "OTHER INCOME" } } }, "localname": "DisclosureOfOtherOperatingIncomeExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/OtherIncome" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]" } }, "en-us": { "role": { "label": "PREPAIDS" } } }, "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Prepaids" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfProductsAndServicesExplanatory": { "auth_ref": [ "r214" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF PRODUCT AND SERVICE REVENUE" } } }, "localname": "DisclosureOfProductsAndServicesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [abstract]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r59" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "EQUIPMENT" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Equipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r57" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "auth_ref": [ "r166" ], "lang": { "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "RIGHT OF USE ASSETS" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RightOfUseAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill." } }, "en-us": { "role": { "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]" } } }, "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r81" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue." } }, "en-us": { "role": { "label": "Disclosure of revenue [text block]", "verboseLabel": "REVENUE" } } }, "localname": "DisclosureOfRevenueExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "auth_ref": [ "r87", "r91", "r145" ], "lang": { "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF RESULTS OF OPERATIONS" } } }, "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/BasisOfPreparationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } }, "en-us": { "role": { "label": "TRADE PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/TradePayablesAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } }, "en-us": { "role": { "label": "SCHEDULE OF AMOUNTS RECEIVABLE" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "auth_ref": [ "r77" ], "lang": { "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF KEY MANAGEMENT TRANSACTIONS" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } }, "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r122", "r123" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effects of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r187", "r190" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForConsolidatedStructuredEntitiesMember": { "auth_ref": [ "r146" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Consolidated structured entities' axis if no other member is used." } } }, "localname": "EntitysTotalForConsolidatedStructuredEntitiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r78" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfDeferredIncomeDetails", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r21", "r32", "r126", "r128", "r147", "r148", "r149" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity [Default Label]", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "Equity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "EquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "EquityAndLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAttributableToOwnersOfParent": { "auth_ref": [ "r20" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } }, "en-us": { "role": { "label": "Equity", "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "EquityAttributableToOwnersOfParent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfBreakdownCapitalDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "localname": "EquityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "Exercisable warrant price", "terseLabel": "Exercise price", "verboseLabel": "Exercise Price" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r182" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Expected dividend yield" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "auth_ref": [ "r9" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Share based payment expense" } } }, "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExplanationOfNatureAndAmountOfSignificantTransactions": { "auth_ref": [ "r80" ], "lang": { "en": { "role": { "documentation": "The explanation of the nature and amount of individually significant transactions with a government that has control, joint control or significant influence over the reporting entity and entities under control, joint control or significant influence of that government." } }, "en-us": { "role": { "label": "Explanation of nature and amount of significant transactions" } } }, "localname": "ExplanationOfNatureAndAmountOfSignificantTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsNotRecognisedInOtherComprehensiveIncome": { "auth_ref": [ "r228" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value gains (losses) that would have been recognised in other comprehensive income if financial assets had not been reclassified out of the available-for-sale category. [Refer: Financial assets available-for-sale; Other comprehensive income]" } }, "en-us": { "role": { "label": "Change in fair value of equity investments at FVOCI" } } }, "localname": "FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsNotRecognisedInOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsRecognisedInOtherComprehensiveIncome": { "auth_ref": [ "r227" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value gains (losses) recognised in other comprehensive income on financial assets reclassified out of the available-for-sale category. [Refer: Financial assets available-for-sale; Other comprehensive income]" } }, "en-us": { "role": { "label": "Fair value gains (losses) on financial assets reclassified out of available-for-sale financial assets recognised in other comprehensive income", "verboseLabel": "Change in fair value of equity investments at FVOCI" } } }, "localname": "FairValueGainsLossesOnFinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsRecognisedInOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": { "auth_ref": [ "r194", "r200" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Fair value of investments other comprehensive loss" } } }, "localname": "FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FeeAndCommissionExpense": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to fees and commissions." } }, "en-us": { "role": { "label": "Fair value of shares issued for transaction fees", "verboseLabel": "Transaction fees" } } }, "localname": "FeeAndCommissionExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinishedGoods": { "auth_ref": [ "r31", "r68" ], "calculation": { "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Finished goods" } } }, "localname": "FinishedGoods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r41" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Change in fair value of derivative liability" } } }, "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "auth_ref": [ "r11", "r72" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Foreign exchange gain (loss)" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment": { "auth_ref": [ "r44" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gain on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Gain on disposal of assets" } } }, "localname": "GainsOnDisposalsOfPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r60", "r159", "r216", "r225" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r60", "r159", "r216", "r225" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "localname": "GeographicalAreasMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Goodwill": { "auth_ref": [ "r14", "r96", "r99", "r189" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GoodwillMember": { "auth_ref": [ "r93" ], "lang": { "en": { "role": { "documentation": "This member stands for goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Goodwill [member]" } } }, "localname": "GoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r187", "r191" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "DPRO_AcquisitiondateFairValuesOfTotalConsiderationTransferred", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill recognised as of acquisition date", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GovernmentGrants": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]" } }, "en-us": { "role": { "label": "Government grant payable" } } }, "localname": "GovernmentGrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r2" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r186", "r191" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "DPRO_AcquisitiondateFairValuesOfTotalConsiderationTransferred", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]" } }, "en-us": { "role": { "label": "Identifiable intangible assets recognised as of acquisition date", "totalLabel": "Total identifiable intangible assets" } } }, "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLoss": { "auth_ref": [ "r94", "r95" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } }, "en-us": { "role": { "label": "Impairment loss", "negatedLabel": "Impairment loss" } } }, "localname": "ImpairmentLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossOnFinancialAssets": { "auth_ref": [ "r229" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]" } }, "en-us": { "role": { "label": "Impairment of notes receivable" } } }, "localname": "ImpairmentLossOnFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": { "auth_ref": [ "r188" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0 }, "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 13.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "lang": { "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for goodwill. [Refer: Impairment loss recognised in profit or loss; Goodwill]" } }, "en-us": { "role": { "label": "Impairment of goodwill", "negatedLabel": "Loss on impairment of goodwill", "negatedTerseLabel": "Impairment of goodwill" } } }, "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails", "http://draganfly.com/role/StatementsOfCashFlows", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r40", "r47", "r48", "r49", "r83", "r144", "r208" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Income tax" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r124" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes", "totalLabel": "Change in cash" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCreditDerivativeFairValue": { "auth_ref": [ "r196" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value of a credit derivative. [Refer: Credit derivative, fair value]" } }, "en-us": { "role": { "label": "Increase (decrease) in credit derivative, fair value" } } }, "localname": "IncreaseDecreaseInCreditDerivativeFairValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInFairValueMeasurementAssets": { "auth_ref": [ "r149" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value measurement of assets. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Net assets acquired" } } }, "localname": "IncreaseDecreaseInFairValueMeasurementAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "verboseLabel": "Share-based payments" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InsuranceExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } }, "en-us": { "role": { "label": "Insurance" } } }, "localname": "InsuranceExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "localname": "IntangibleAssetsAndGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative", "http://draganfly.com/role/ScheduleOfIntellectualPropertyDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsMaterialToEntityAxis": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Intangible assets material to entity [axis]" } } }, "localname": "IntangibleAssetsMaterialToEntityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_IntangibleAssetsMaterialToEntityMember": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets material to the entity. It also represents the standard value for the 'Intangible assets material to entity' axis if no other member is used. [Refer: Intangible assets material to entity]" } } }, "localname": "IntangibleAssetsMaterialToEntityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r14", "r102" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r15", "r26", "r66" ], "calculation": { "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventory", "totalLabel": "Inventories" } } }, "localname": "Inventories", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r186", "r191" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 3.0, "parentTag": "DPRO_TotalTangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]" } }, "en-us": { "role": { "label": "Inventory recognised as of acquisition date", "verboseLabel": "Inventory" } } }, "localname": "InventoryRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoryWritedown2011": { "auth_ref": [ "r43", "r67" ], "lang": { "en": { "role": { "documentation": "The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventory write-down" } } }, "localname": "InventoryWritedown2011", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentProperty": { "auth_ref": [ "r13", "r110", "r111" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } }, "en-us": { "role": { "label": "Investments", "periodEndLabel": "Balance at December 31, 2021", "periodStartLabel": "Balance at December 31, 2020" } } }, "localname": "InvestmentProperty", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails", "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InvestmentPropertyMember": { "auth_ref": [ "r9", "r151", "r153" ], "lang": { "en": { "role": { "documentation": "This member stands for investment property. It also represents the standard value for the 'Types of investment property' axis if no other member is used. [Refer: Investment property]" } } }, "localname": "InvestmentPropertyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r32" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Share capital" } } }, "localname": "IssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "verboseLabel": "Total" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r74" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "verboseLabel": "Share-based payments" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LaterThanFiveYearsMember": { "auth_ref": [ "r168", "r169", "r201", "r203", "r206", "r223" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years." } }, "en-us": { "role": { "label": "Later than five years [member]" } } }, "localname": "LaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r9", "r168", "r169", "r201", "r206", "r223" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } }, "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } } }, "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r201", "r202", "r206" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than three years." } }, "en-us": { "role": { "label": "Later than one year and not later than three years [member]" } } }, "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LeaseLiabilities": { "auth_ref": [ "r161" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } }, "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Balance - End of period", "periodStartLabel": "Balance - Beginning of period", "verboseLabel": "Lease liability" } } }, "localname": "LeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LeaseholdImprovementsMember": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } }, "en-us": { "role": { "label": "Leasehold improvements [member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Level1OfFairValueHierarchyMember": { "auth_ref": [ "r61", "r148" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } }, "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } } }, "localname": "Level1OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Level2OfFairValueHierarchyMember": { "auth_ref": [ "r148" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } }, "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } } }, "localname": "Level2OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Level3OfFairValueHierarchyMember": { "auth_ref": [ "r148" ], "lang": { "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } }, "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } } }, "localname": "Level3OfFairValueHierarchyMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "auth_ref": [ "r61", "r148" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } } }, "localname": "LevelsOfFairValueHierarchyAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfFinancialAssetsMeasuredFairValueThroughProfitAndLossDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r21", "r147", "r148", "r149", "r209", "r213" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Net of liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition", "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LoansAndAdvancesToBanks": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of loans and advances the entity has made to banks." } }, "en-us": { "role": { "label": "Total Carrying Value" } } }, "localname": "LoansAndAdvancesToBanks", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfLoansDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LoansAndReceivables": { "auth_ref": [ "r230" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]" } }, "en-us": { "role": { "label": "Loans receivable" } } }, "localname": "LoansAndReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LoansReceived": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of loans received." } }, "en-us": { "role": { "label": "Loan received" } } }, "localname": "LoansReceived", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Losses on change in fair value of derivatives", "negatedLabel": "Change in fair value" } } }, "localname": "LossesOnChangeInFairValueOfDerivatives", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r24", "r63", "r157", "r168", "r169", "r195", "r197", "r201", "r219", "r220", "r222", "r223" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MiscellaneousOtherOperatingExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]" } }, "en-us": { "role": { "label": "Miscellaneous other operating expense", "totalLabel": "Office and Miscellaneous Expenses" } } }, "localname": "MiscellaneousOtherOperatingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NameOfSubsidiary": { "auth_ref": [ "r84", "r88", "r132", "r134" ], "lang": { "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Name of subsidiary" } } }, "localname": "NameOfSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NetDebt": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of net debt of the entity." } }, "en-us": { "role": { "label": "Debt" } } }, "localname": "NetDebt", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfBreakdownCapitalDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NetDeferredTaxAssets": { "auth_ref": [ "r50" ], "calculation": { "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } }, "en-us": { "role": { "label": "Net deferred tax assets", "totalLabel": "Net deferred tax assets" } } }, "localname": "NetDeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NetForeignExchangeGain": { "auth_ref": [ "r11", "r72" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]" } }, "en-us": { "role": { "label": "Foreign exchange rate" } } }, "localname": "NetForeignExchangeGain", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfChangesInForeignExchangeRatesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current Assets" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r161" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "verboseLabel": "Lease liability" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current Liabilities" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentTradeReceivables": { "auth_ref": [ "r30" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Non-current trade receivables", "verboseLabel": "Accounts receivable" } } }, "localname": "NoncurrentTradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NotLaterThanOneYearMember": { "auth_ref": [ "r23", "r168", "r169", "r201", "r206", "r223" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } }, "en-us": { "role": { "label": "Not later than one year [member]" } } }, "localname": "NotLaterThanOneYearMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "auth_ref": [ "r181", "r183" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Granted" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments exercised or vested in share-based payment arrangement", "verboseLabel": "Number of shares vested" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments forfeited in share-based payment arrangement", "negatedLabel": "Forfeited" } } }, "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of Warrants Outstanding", "periodEndLabel": "Number of RSUs outstanding, Ending of the period", "periodStartLabel": "Number of RSUs outstanding, Beginning of the period" } } }, "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r172", "r176", "r180" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of Options", "periodEndLabel": "Number of options outstanding, Ending Balance", "periodStartLabel": "Number of options outstanding, Beginning Balance" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r177" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Exercisable" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r175" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Number of options outstanding, Exercised" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "auth_ref": [ "r174" ], "lang": { "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options forfeited in share-based payment arrangement", "negatedLabel": "Number of options outstanding, forfeited" } } }, "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r173" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options granted in share-based payment arrangement", "verboseLabel": "Number of options outstanding, Granted" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued" } } }, "localname": "NumberOfSharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r35" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Beginning balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r41" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Operating expense", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OperatingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCashAndCashEquivalents": { "auth_ref": [ "r124" ], "calculation": { "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "order": 2.0, "parentTag": "DPRO_CashAndCashEquivalentsCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Guaranteed investment certificates" } } }, "localname": "OtherCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "OtherComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "auth_ref": [ "r28", "r42" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Foreign exchange translation", "verboseLabel": "Translation of foreign operations" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Accrued liabilities" } } }, "localname": "OtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentPayables": { "auth_ref": [ "r21" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "GST/PST Payable" } } }, "localname": "OtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherExpenseByFunction": { "auth_ref": [ "r2", "r45", "r82" ], "calculation": { "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails": { "order": 4.0, "parentTag": "ifrs-full_MiscellaneousOtherOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses." } }, "en-us": { "role": { "label": "Other expense, by function", "verboseLabel": "Other" } } }, "localname": "OtherExpenseByFunction", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOfficeAndMiscellaneousExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherIntangibleAssets": { "auth_ref": [ "r105" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Other intangible assets", "verboseLabel": "Customer relationships" } } }, "localname": "OtherIntangibleAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherReceivables": { "auth_ref": [ "r30" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ParValuePerShare": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "The nominal value per share." } }, "en-us": { "role": { "label": "Price per share" } } }, "localname": "ParValuePerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "perShareItemType" }, "ifrs-full_PaymentsForShareIssueCosts": { "auth_ref": [ "r117" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for share issue costs." } }, "en-us": { "role": { "label": "Payments for share issue costs", "negatedLabel": "Share issue costs" } } }, "localname": "PaymentsForShareIssueCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Lease Payments" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "auth_ref": [ "r184" ], "lang": { "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Percentage of acquired" } } }, "localname": "PercentageOfVotingEquityInterestsAcquired", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "auth_ref": [ "r117" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } }, "en-us": { "role": { "label": "Purchases of exercise of warrants", "verboseLabel": "Fair value of warrants" } } }, "localname": "ProceedsFromExerciseOfWarrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": { "auth_ref": [ "r117" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the issuing of bonds, notes and debentures." } }, "en-us": { "role": { "label": "Proceeds from loan" } } }, "localname": "ProceedsFromIssueOfBondsNotesAndDebentures", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfInvestmentProperty": { "auth_ref": [ "r115" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of investment property. [Refer: Investment property]" } }, "en-us": { "role": { "label": "Amount received from sale of investment" } } }, "localname": "ProceedsFromSalesOfInvestmentProperty", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/OtherIncomeDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r158", "r214" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/RevenueDetailsNarrative", "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r158", "r214" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "localname": "ProductsAndServicesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/InventoryDetailsNarrative", "http://draganfly.com/role/RevenueDetailsNarrative", "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfessionalFeesExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 6.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } }, "en-us": { "role": { "label": "Professional fees", "verboseLabel": "Management fees paid to a company" } } }, "localname": "ProfessionalFeesExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/RelatedPartyTransactionsDetailsNarrative", "http://draganfly.com/role/ScheduleOfKeyManagementTransactionsDetails", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r4", "r37", "r118", "r127", "r129", "r138", "r209", "r211", "r221", "r226" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Profit (loss)", "totalLabel": "NET LOSS" } } }, "localname": "ProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r12", "r56" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Equipment", "terseLabel": "Property and equipment", "verboseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r57", "r93", "r166" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_PropertyServiceChargeIncomeExpense": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income or expense arising from property service charge. [Refer: Property service charge expense; Property service charge income]" } }, "en-us": { "role": { "label": "Charge for the year" } } }, "localname": "PropertyServiceChargeIncomeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r86", "r90", "r136" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r114" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r152", "r154", "r155", "r180", "r198", "r222" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r152", "r154", "r155", "r180", "r198", "r222" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "localname": "RangesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ScheduleOfWarrantsAndFairValueOutstandingDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r30" ], "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "order": 2.0, "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of receivables from taxes other than income tax. Income taxes include all domestic and foreign taxes that are based on taxable profits. Income taxes also include taxes, such as withholding taxes, that are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity." } }, "en-us": { "role": { "label": "Corporate taxes receivable" } } }, "localname": "ReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RentalExpense": { "auth_ref": [ "r41" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense recognised on rental activities." } }, "en-us": { "role": { "label": "Rental expense" } } }, "localname": "RentalExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RepaymentsOfBondsNotesAndDebentures": { "auth_ref": [ "r117" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for repayments of bonds, notes and debentures." } }, "en-us": { "role": { "label": "Repayments of bonds, notes and debentures", "negatedLabel": "Repayment of convertible debentures" } } }, "localname": "RepaymentsOfBondsNotesAndDebentures", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "auth_ref": [ "r117" ], "calculation": { "http://draganfly.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Repayments of non-current borrowings", "negatedLabel": "Loans repayments" } } }, "localname": "RepaymentsOfNoncurrentBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r107" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 7.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptions": { "auth_ref": [ "r32", "r218" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the accumulated change in the value of the time value of options when separating the intrinsic value and time value of an option contract and designating as the hedging instrument only the changes in the intrinsic value." } }, "en-us": { "role": { "label": "Reduction in value" } } }, "localname": "ReserveOfChangeInValueOfTimeValueOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IntangibleAssetsAndGoodwillDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing the accumulated gains and losses on financial assets measured at fair value through other comprehensive income. [Refer: Financial assets measured at fair value through other comprehensive income; Other comprehensive income]" } }, "en-us": { "role": { "label": "Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member]" } } }, "localname": "ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r32", "r46" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Accumulated deficit" } } }, "localname": "RetainedEarnings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r7", "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_RevaluationIncreaseDecreasePropertyPlantAndEquipment": { "auth_ref": [ "r55", "r58" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from revaluations to fair value. [Refer: Property, plant and equipment; Revaluation surplus]" } }, "en-us": { "role": { "label": "Revaluation" } } }, "localname": "RevaluationIncreaseDecreasePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r1", "r2", "r39", "r138", "r142", "r193", "r207", "r210", "r214", "r215", "r217" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "totalLabel": "TOTAL REVENUE", "verboseLabel": "Revenue" } } }, "localname": "Revenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfProductAndServiceRevenueDetails", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "REVENUE" } } }, "localname": "RevenueAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_RevenueFromGovernmentGrants": { "auth_ref": [ "r71" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 9.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } }, "en-us": { "role": { "label": "Government income" } } }, "localname": "RevenueFromGovernmentGrants", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromRenderingOfServices": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue from provision of services" } } }, "localname": "RevenueFromRenderingOfServices", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromSaleOfGoods": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Revenue from sales of goods" } } }, "localname": "RevenueFromSaleOfGoods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r165" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 7.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right of use asset", "verboseLabel": "Right of use assets" } } }, "localname": "RightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingSegmentsDetails", "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssetsRevaluedAssetsAtCost": { "auth_ref": [ "r167" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of right-of-use assets that would have been recognised had the revalued assets been carried under the cost model. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Right-of-use assets, revalued assets, at cost", "periodEndLabel": "Right of use assets, at cost, ending", "periodStartLabel": "Right of use assets, at cost, beginning" } } }, "localname": "RightofuseAssetsRevaluedAssetsAtCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfRightOfUseAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ShareIssueRelatedCost": { "auth_ref": [ "r6" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } }, "en-us": { "role": { "label": "Share issue related cost", "negatedLabel": "Share issue costs" } } }, "localname": "ShareIssueRelatedCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharebasedPaymentArrangementsMember": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "localname": "SharebasedPaymentArrangementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_SpareParts": { "auth_ref": [ "r68" ], "calculation": { "http://draganfly.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "ifrs-full_Inventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of interchangeable parts that are kept in an inventory and are used for the repair or replacement of failed parts. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Parts" } } }, "localname": "SpareParts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "localname": "StatementOfChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWarrantsOutstandingDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForFairValuesWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/StatementsOfChangesInShareholdersEquity", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails", "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TaxEffectFromChangeInTaxRate": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Change in deferred tax asset not recognized" } } }, "localname": "TaxEffectFromChangeInTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)", "negatedLabel": "Non-deductible items" } } }, "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfForeignTaxRates": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Impact of different foreign statutory tax rates" } } }, "localname": "TaxEffectOfForeignTaxRates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Expected income tax recovery" } } }, "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfTaxLosses": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of tax losses" } } }, "localname": "TaxEffectOfTaxLosses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate": { "auth_ref": [ "r186" ], "calculation": { "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails": { "order": 2.0, "parentTag": "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as of the acquisition date for technology-based intangible assets acquired in a business combination. [Refer: Technology-based intangible assets [member]; Business combinations [member]]" } }, "en-us": { "role": { "label": "Website" } } }, "localname": "TechnologybasedIntangibleAssetsRecognisedAsOfAcquisitionDate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r152", "r154", "r155", "r180", "r198", "r222" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]" } } }, "localname": "TopOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionForWarrantsDetails", "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r18" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade payables and accrued liabilities", "totalLabel": "Trade payables and accrued liabilities" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails", "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "auth_ref": [ "r29", "r33" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } }, "en-us": { "role": { "label": "Trade accounts payable" } } }, "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivables": { "auth_ref": [ "r16", "r30" ], "calculation": { "http://draganfly.com/role/StatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } }, "en-us": { "role": { "label": "Receivables" } } }, "localname": "TradeAndOtherCurrentReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesToRelatedParties": { "auth_ref": [ "r33" ], "calculation": { "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of payables due to related parties. [Refer: Related parties [member]]" } }, "en-us": { "role": { "label": "Due to related parties (Note 23)" } } }, "localname": "TradeAndOtherPayablesToRelatedParties", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfTradePayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": { "auth_ref": [ "r33" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business." } }, "en-us": { "role": { "label": "Accounts payable" } } }, "localname": "TradeAndOtherPayablesToTradeSuppliers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SupplementalCashFlowDisclosuresDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherReceivables": { "auth_ref": [ "r16", "r30" ], "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } }, "en-us": { "role": { "label": "Trade and other receivables", "totalLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeReceivables": { "auth_ref": [ "r30" ], "calculation": { "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails": { "order": 1.0, "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } }, "en-us": { "role": { "label": "Trade accounts receivable" } } }, "localname": "TradeReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfAmountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TravelExpense": { "auth_ref": [ "r9" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 9.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from travel." } }, "en-us": { "role": { "label": "Travel" } } }, "localname": "TravelExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfContractsAxis": { "auth_ref": [ "r160", "r224" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of contracts [axis]" } } }, "localname": "TypesOfContractsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfContractsMember": { "auth_ref": [ "r160", "r224" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "localname": "TypesOfContractsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/CashAndCashEquivalentsDetailsNarrative", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfInvestmentPropertyAxis": { "auth_ref": [ "r9" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of investment property [axis]" } } }, "localname": "TypesOfInvestmentPropertyAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfInvestmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } } }, "localname": "TypesOfSharebasedPaymentArrangementsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/DisclosureOfNotesReceivableDetails", "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/NotesReceivableDetailsNarrative", "http://draganfly.com/role/ScheduleOfWarrantDerivativeLiabilityDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r169" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } }, "en-us": { "role": { "label": "Maturity analysis" } } }, "localname": "UndiscountedOperatingLeasePaymentsToBeReceived", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfOperatingMaturityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_UnsecuredBankLoansReceived": { "auth_ref": [ "r9" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of loans received from banks that have not been secured by collateral. [Refer: Loans received]" } }, "en-us": { "role": { "label": "Unsecured loan received" } } }, "localname": "UnsecuredBankLoansReceived", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/LoansPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_VehiclesMember": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Vehicles [member]" } } }, "localname": "VehiclesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfClassOfEquipmentDetails", "http://draganfly.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_WagesAndSalaries": { "auth_ref": [ "r64" ], "calculation": { "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss": { "order": 10.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Wages and salaries" } } }, "localname": "WagesAndSalaries", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative", "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WarrantLiability": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of warrant liabilities." } }, "en-us": { "role": { "label": "Warrant derivative liability" } } }, "localname": "WarrantLiability", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WarrantReserveMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]" } }, "en-us": { "role": { "label": "Warrant reserve [member]" } } }, "localname": "WarrantReserveMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/AmalgamationDetailsNarrative", "http://draganfly.com/role/SummaryOfFairValueMeasurementInputsAndValuationTechniquesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Forfeited" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r181" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Exercise price", "periodEndLabel": "Weighted Average Exercise Price, Oustanding, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Oustanding, Beginning Balance" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfWeightedAverageAssumptionsDetails", "http://draganfly.com/role/SummaryOfChangesInWarrantsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r175" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price, Exercised" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r174" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price, forfeited" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r173" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price, Granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative", "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": { "auth_ref": [ "r179" ], "lang": { "en": { "role": { "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Fair value of common shares in concurrent financing" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfHistoricalFinancialInformationDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r172", "r176" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price, Ending Balance", "periodStartLabel": "Weighted average exercise price, Beginning Balance" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/SummaryOfChangesInStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "auth_ref": [ "r180" ], "lang": { "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Remaining Contractual Life (years)", "verboseLabel": "Weighted average remaining contractual life of outstanding share options" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/ScheduleOfStockOptionsOutstandingAndExercisableDetails", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of common shares outstanding - basic & diluted" } } }, "localname": "WeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://draganfly.com/role/StatementsOfComprehensiveIncomeLoss" ], "xbrltype": "sharesItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]" } } }, "localname": "ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ReserveQuantitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reserve Quantities [Line Items]" } } }, "localname": "ReserveQuantitiesLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails", "http://draganfly.com/role/ScheduleOfPurchasePriceAllocationForVitalIntelligenceDetails", "http://draganfly.com/role/ScheduleOfResultsOfOperationsDetails", "http://draganfly.com/role/VitalIntelligenceAcquisitionDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/ScheduleOfGeographicRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/GovernmentAssistanceDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://draganfly.com/role/DronelogicsAcquisitionDetailsNarrative", "http://draganfly.com/role/ShareCapitalDetailsNarrative" ], "xbrltype": "domainItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2021-03-24" }, "r1": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard", "URIDate": "2021-03-24" }, "r10": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard", "URIDate": "2021-03-24" }, "r100": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r101": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r102": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2021-03-24" }, "r103": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r104": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "119", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2021-03-24" }, "r105": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "119", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard", "URIDate": "2021-03-24" }, "r106": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "122", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_122_b&doctype=Standard", "URIDate": "2021-03-24" }, "r107": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r108": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2021-03-24" }, "r109": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "32A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2021-03-24" }, "r11": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r110": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard", "URIDate": "2021-03-24" }, "r111": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2021-03-24" }, "r112": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2021-03-24" }, "r113": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard", "URIDate": "2021-03-24" }, "r114": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2021-03-24" }, "r115": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard", "URIDate": "2021-03-24" }, "r116": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r117": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r118": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r119": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2021-03-24" }, "r12": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2021-03-24" }, "r120": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2021-03-24" }, "r121": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r122": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r123": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r124": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r125": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2021-03-24" }, "r126": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r127": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2021-03-24" }, "r128": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r129": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r13": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2021-03-24" }, "r130": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "11", "Paragraph": "C5", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=11&code=ifrs-tx-2021-en-r&anchor=para_C5&doctype=Appendix&subtype=C", "URIDate": "2021-03-24" }, "r131": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "1", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_1&doctype=Standard", "URIDate": "2021-03-24" }, "r132": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2021-03-24" }, "r133": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2021-03-24" }, "r134": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r135": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2021-03-24" }, "r136": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2021-03-24" }, "r137": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "26", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_26&doctype=Standard", "URIDate": "2021-03-24" }, "r138": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r139": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r14": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2021-03-24" }, "r140": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r141": { "Clause": "ix", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r142": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r143": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r144": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r145": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r146": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Section": "Nature of the risks associated with an entity's interests in consolidated structured entities", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS12_g14-17_TI", "URIDate": "2021-03-24" }, "r147": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2021-03-24" }, "r148": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2021-03-24" }, "r149": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2021-03-24" }, "r15": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2021-03-24" }, "r150": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard", "URIDate": "2021-03-24" }, "r151": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r152": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r153": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE60", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r154": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r155": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r156": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "114", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard", "URIDate": "2021-03-24" }, "r157": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r158": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r159": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r16": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2021-03-24" }, "r160": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r161": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r162": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2021-03-24" }, "r163": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2021-03-24" }, "r164": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2021-03-24" }, "r165": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2021-03-24" }, "r166": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r167": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "57", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_57&doctype=Standard", "URIDate": "2021-03-24" }, "r168": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r169": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard", "URIDate": "2021-03-24" }, "r17": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2021-03-24" }, "r170": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2021-03-24" }, "r171": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Presentation", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2021-03-24" }, "r172": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r173": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r174": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r175": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r176": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r177": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r178": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2021-03-24" }, "r179": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard", "URIDate": "2021-03-24" }, "r18": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2021-03-24" }, "r180": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2021-03-24" }, "r181": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r182": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r183": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r184": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r185": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r186": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r187": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r188": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r189": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r19": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2021-03-24" }, "r190": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r191": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "IE72", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r192": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2021-03-24" }, "r193": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r194": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "11A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_11A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r195": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r196": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "24G", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_24G_a&doctype=Standard", "URIDate": "2021-03-24" }, "r197": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2021-03-24" }, "r198": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r199": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2021-03-24" }, "r2": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard", "URIDate": "2021-03-24" }, "r20": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "r", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2021-03-24" }, "r200": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8_h&doctype=Standard", "URIDate": "2021-03-24" }, "r201": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r202": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r203": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r204": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r205": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B52", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r206": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "IG31A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r207": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2021-03-24" }, "r208": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2021-03-24" }, "r209": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard", "URIDate": "2021-03-24" }, "r21": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r210": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2021-03-24" }, "r211": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2021-03-24" }, "r212": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2021-03-24" }, "r213": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2021-03-24" }, "r214": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r215": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r216": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r217": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r218": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "9", "Paragraph": "6.5.15", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_6.5.15&doctype=Standard", "URIDate": "2021-03-24" }, "r219": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard", "URIDate": "2021-03-24" }, "r22": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard", "URIDate": "2021-03-24" }, "r220": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2021-03-24" }, "r221": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2021-03-24" }, "r222": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard", "URIDate": "2021-03-24" }, "r223": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2021-03-24" }, "r224": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2021-03-24" }, "r225": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2021-03-24" }, "r226": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2021-03-24" }, "r227": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "12A", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_12A_d&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r228": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "12A", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_12A_e&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r229": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "20", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r23": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2021-03-24" }, "r230": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "8", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r231": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r232": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r233": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r234": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r235": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r236": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r237": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r238": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r239": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r24": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard", "URIDate": "2021-03-24" }, "r240": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r241": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r242": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r243": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r244": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r245": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r246": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r247": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r248": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r249": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r25": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r250": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r26": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard", "URIDate": "2021-03-24" }, "r27": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard", "URIDate": "2021-03-24" }, "r28": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r29": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "70", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard", "URIDate": "2021-03-24" }, "r3": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2021-03-24" }, "r30": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2021-03-24" }, "r31": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2021-03-24" }, "r32": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2021-03-24" }, "r33": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard", "URIDate": "2021-03-24" }, "r34": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r35": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r36": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2021-03-24" }, "r37": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2021-03-24" }, "r38": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r39": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2021-03-24" }, "r4": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2021-03-24" }, "r40": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2021-03-24" }, "r41": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard", "URIDate": "2021-03-24" }, "r42": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2021-03-24" }, "r43": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard", "URIDate": "2021-03-24" }, "r44": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "98", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_c&doctype=Standard", "URIDate": "2021-03-24" }, "r45": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard", "URIDate": "2021-03-24" }, "r46": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r47": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r48": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r49": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r5": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r50": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2021-03-24" }, "r51": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2021-03-24" }, "r52": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r53": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r54": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r55": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r56": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2021-03-24" }, "r57": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard", "URIDate": "2021-03-24" }, "r58": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "77", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_77_f&doctype=Standard", "URIDate": "2021-03-24" }, "r59": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2021-03-24" }, "r6": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2021-03-24" }, "r60": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2021-03-24" }, "r61": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "142", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard", "URIDate": "2021-03-24" }, "r62": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "144", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard", "URIDate": "2021-03-24" }, "r63": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2021-03-24" }, "r64": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "9", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard", "URIDate": "2021-03-24" }, "r65": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard", "URIDate": "2021-03-24" }, "r66": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2021-03-24" }, "r67": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_e&doctype=Standard", "URIDate": "2021-03-24" }, "r68": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r69": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "2", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI", "URIDate": "2021-03-24" }, "r7": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard", "URIDate": "2021-03-24" }, "r70": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "20", "Paragraph": "39", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2021-03-24" }, "r71": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "20", "Paragraph": "39", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2021-03-24" }, "r72": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2021-03-24" }, "r73": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI", "URIDate": "2021-03-24" }, "r74": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r75": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r76": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r77": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18&doctype=Standard", "URIDate": "2021-03-24" }, "r78": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard", "URIDate": "2021-03-24" }, "r79": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r8": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard", "URIDate": "2021-03-24" }, "r80": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "26", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_26_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r81": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2021-03-24" }, "r82": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r83": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r84": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r85": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r86": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r87": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r88": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r89": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r9": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2021-03-24" }, "r90": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r91": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r92": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2021-03-24" }, "r93": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r94": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2021-03-24" }, "r95": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r96": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2021-03-24" }, "r97": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r98": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r99": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "135", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2021-03-24" } }, "version": "2.1" } ZIP 171 0001493152-22-008934-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-008934-xbrl.zip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

/SKJQ?]5=2!TM;-[;HH";/:PDO$)5\>!P'OSG!PV0E MS79&7/Z)JX/SQ-%\G$'N:$]RD "FU>N&>QN@%1&W3YP M2D?B/X*"&Z)/DQ)&-63DGV IXH;/R&3 M;)XV>=RTM(%KD/04J[N=*33-QXB?<3F4"2:K]UBC4$3[-UJR;=1'YI?JKR[( M4[K5E6R"J:E:)<*E< ,RJ]J?&"TI*D(Y=;)YXI:^T&ION=21/ZX!;QBV[JS:P"''SG[B8R7'$C(> U6[V)0< M/%R+]N3I[AW:EEIO%_AOJ&Z39Y"T2,KK^[//Y.SN[N/]W8GF$#FB8-]U2R%= M!%N57&\_5H]%1?E_W-'FI9EW>[9,GN[95B8Q_F)_8F6O 9;O6_EJ4![]M#R9;2FLV@)>#8G!^+7 MU)D_T 9QL>5]DR^Y5@'3>O.NG*;P.M8.?W MVG.ZY"XD )Q^83T0OB,_9S\#"Z+&!PV))D MS2E6+6>E0YL4KAI_3FX =DRFM^B"Z)2II/J3F%_KYG_)!S1K'>2TTCM/$IYN1G'&M.(R;M> *("LPG#_^;OH[V>$.;MJXJ M6JI%?+7 %.M 6"1KW=7# ]CXP+._I<)Q+.".FYS7#<#YT\0 M2MR2JXIG[_03D+N$<,;>^L L9&OZY+;%^W-"Q[ZX+4N]2+N,BL:GBKO)YK!7V"476_%7?V](3WJ8BGK MVN*B)DY--$H$(LM=@EL_.NAE0!#GEDF1N1"?1SG\61N71'[K3IEQ[7S?-.Q[ MPY0@X)]U0^/NGYIZ_P@9];=%=]WPY"5;\1K+>&]PD+SU;F..T.SQ]N8 8LO=0=ED5W)JX\D&+FA M6SKB0(N?246U:#YFB[17=4!UQ,3;1[7YBZ'*FWANZ<9FP=9?UAS1XEN9I@20L(^$HK?@_9V76PR4D M3Q6.VQC72=F'AF:_;^JO%9%)PQ)F:&N?6*/@?V!USC:=]@Q*9MJ__XAPF+J1 MZIG;VB>\D\X7VAFRL1I^7_WT<9YO5?LQ^4[6ADA?AKC3IIZT)\6V^*SKFN)A MST]V[NOKKQ5S4]?;FZRQ7H[Z^5"]1XJ :SXXP#M$S_(CL2<&,"I$16:#-#0;67>2!;NN&DJ+*ZV=*F*(QWT"=[79ED?-1D7V# MVS)[%^B4*QN1#>K,BN9DF,S(@DU?&539IL@JTG99MV?F\,JOFA#;$6O/Q^V6 MYMWU5CZ^@[1HS[L.WO*Q'_GU_?=_>O_>VC<1$M:UN^BF3>TQF!V1G<9BUB;. M;SO&S(M<]$X0#AUKMHI&/)TJK98WO7*4V@]37"S)K-0"WFJ6,WJ<=F@&.3>\ MJ^<=/ ."B@0%8VQX&*Z\M1]]*3?'-^-/9<3QEYKM)#;[G!?HN*HN:$>;9YZ1 M!P8DE##B*Q/V'\[CO\,%)[/K@SK":OV+I*XS1OXJQDA%'R&AK/OLX4@MTB^, MJN\V@Q12=/3Y5!>E0POX .O;W!&Z03?- X0BL^##6^+*<=_59 <2>6&"EOU;RB0O7.A\R2'D MGGY@7,BU3T[;#[3[2FDUM'MHMKQ2*(?V>KIQH1!"%-&@C(0X)GJ%B0J(^ -K+IAGROBRJ_Z+8=_Y65D2K1:=C3 LA(V M<"0WX2B8VB&:B-$N*K*AS%@;NN$VR&-9255W_$3BL2K^=7@RR]-9Y!4_0('6 MBT4]9+HHJCWDQ1+/Q?7:2K',ZUIH3(.FEAK"B^8;T4F>YY52V[(K5T3R+VNX44U2+7(A&=XHR!?]S,G M"-U(6B8$3+<8I)R\7JBHAGW3%+GQP,5"F* NJ &HH1:H0I7<4+S0YC;Q6[YO MN_KYOXP\W_WIX%P^I_-CP]MF=02T5Y56?OV"ML5C!1&29ZW,?[31GT;S%-N0 M2["A3[1JV0 1:UCK2%SM^^OZTI6[=>J-5_IX\F&:JL5:PKHQH]=D"FA)#8)X M[J-!$E_9G.QHX*&[HUU7BD?K?*(R;SA-="MN\NTPE9V\3I3*:PO#1NKFEK)E95?R+A]Y MVR_4ZJ4.$+BJ.SNXX1._MU@:#@L^1A/F)LU825TI1LU?GWD2.R0^>6JR#91E MY.V[R5[A,5![7_,_W^WAC3)M'$=18=PKGTW%-&EV6!7"FMQ^E^'5C@A$'@,H M2_)ZC/Q_)SS&RL3"E\TQ?(*QGYAHA"L?3EF SLZA9E2([,D"38_E@;)3.[9K MX'/VB>;J*P8+WN)P3VI*3&VE6FU6M4,,)7\VY&M:ZO,$*<.HH)27*K<>.:6XV@(500X;44/G..N7+M2QV=,$'M M30-00]5-A0J1U5B@&4ML*FF)URYCQYWC+(.ROF.?$_Q]4^>K]3/[%C\H-!4P M"8!@&%J10C7FH62 YN@ED_VL."R MFF"\AI++DI%L!2?L@O.1%T)\J-.X3AVJ)8[&^U30!6UE&EUK;):- 9?* M'Z MHK#*D9'D@C.)MB3JSW56M7(WJX\JG0:73NP M7$C* DG)9(6US"!MT*Q(V7D MP:68<, QXZ4:F)-HCF$/&35F,ESZ<6(TOD[#,WZ4"LWZ0%%^Q-7C!F36BM) MDZ1O19'SLVHS*7'>5SC7>MM-CJO_@[!&%WT_U2J>GPA^4$K$:DJ8W! ZJ->[ ME?5"'N]@K:2X;,:+,Z1B;W\NDV9$B_H%_.6ZI@;E-US]K@/3(FP$!1^9?4Q- MVZ7I8O,EYCQ;OH<4EP*\. VWL14/9#+?R29:*(R5&GWES!RTN#3C!^HN-EG- MSJ%.-8$!MLOBA?Y$GQ]H8VK)G&*UB /P+K@:MN0JLM"LVH8C@G>)+)&)<"E:PLZ8VC71M+Q],J)]L8=O:Y<8VKX M%57C(\-[8J*PGN6-8:!#E>ONT$:5Q=PXCW2!ZTL M#O)M;=X4.\ O)EIW45@G^8H>SPM:<7Y66ERFX@>JN\2!HU_RA*YX3ND>[YG! MN1RD\CLN#9C!&9TD)TOJ)C\7+=0+,@1[&'[&U<]&;%JM(T'4GRHDL^9Q%%Y5 M'67]85YCV4EQ];T7I]'<1Z]""LGB7X(=N*NZ*[ZY-U4*P:I[*@W8Q B&7_'I M?0[-J&I&=.K]E'H58SSGG1&LIETCL-&EJK_BTJX)FEX\#FZT9&#VR0[T'>N>A7\%^#9,F&J3/:S)6T[JNS%.1 MG127-KPX'-[:NFG@ >7'H*!^P^LYZLKF#FZ+D13!Z766X[PK81XE*2 M!Z5O*&VS/.A4^Y3:N&2]XHJ)'7[&U_,:-G-,+*-*.HE\J)NF_@K+Y=[;RG6& M[J7LI+AZWXM3VT(,#./\T:^>TGBB<^8&-]G'9]H\TBI__;!O"X@PE#F[+",B MA F7IB(0:X^G/WXX2SIPW-AA4ERDII'Q+:E*0XU.7;_0IR(OJ4,O&@4N!=C@ MS7M:TO%7T8BV)WWX6M"*:DJ,2P\!2(/C\A*OKL9F#*J946/6CQFJ3T'9 M<)AUZJB./G+ 7 -M^ONJL75S6)/PG?Y'7)HW(#.%[ Q541(%2*FA(]=Q,3%S M,"7I9Y$S7N229Y#[JC37 MV[Y.C=;S7@Y*6<)DY!9*(X?F?H6@==&UAX.%\"+M2#OH*GJ@%W434//ZZJM MRV+#&VQ_BF:C7&UGY88ZV):9#)<).3'J%0/H=Q/JI"=34^=USXRSS7) %>*2 MY^2XM!*$U>N<.X4/G8?FD97+';2%'9D:EV#73H+[:G]!WAF1AH4]WM*V8R@[ M*O[[YZJ(G85-$MZ$GKWP(V;B9I BPB#)'N1@&M#S5<,4EV=^0HFW8 M%ZZW:B$$DXIGCBM2PV;N-Z%@)_1E#CNI>L%>S[-=T65E_XQ$26UC7CK9Z9&I M, BL;^0"DJQM>+T5=88U%=D(<>G&@U)_PC$EAW%#.4,Z MK\CG;_M<_[@O.5211I;];/:.L5)PJ?&0)OAF0[ZNF:Y\>E%PVB1D)5'_+]RC M5!TMRP*B9Z!2MRT(Q4J*2Y%>G-K<)MRCPL'^(T][#. U1N7)^(+1J'#C4MX2 MZ-&C+QM%)#]ROZR;:5%JW\W4E!J9]@*@^F^A-M/RV\E5=+T=&\'KUP9=(EJY M\*K,!]FM.AAOX_UAQ_F3WAXZ-[8W3?&2=?2FS'++L(OA1J;3!= C-O0[(8'L M>A&(E"MJ!"_4K9'Y3:C6A3Q\*Z\I%I7K52K^L8F%_6$/JX%J W&4>TCS(2)7 M@YURH#QD^C]*8V(IWU*-&+^WM_MWR/O]N_#N_W[DY<#4=XIWS1TEQ4;5]$R)WF2 M!*<6T,:7XS-:7 ;B!^I^*2YYPJK7%&GCEKDB%Z MT]3;@F>6_/@M+_<;ZLF>Z:''I:PPL'I$)7")%&=4\+$MXI!4TYMS]61K65&4 M^:IB?@ NPJTK%QLA+N5X4-I*NA<]?=IL:!*.=.K.*M5V4I0*L>.TJ:2?CS9] M1>MD<:W3)EB/U,QDF+7A.0";:R+IB=84^4]9\SN%&D9WM'DI?YYZ/M)(1@:9N3;LKG02S/A1\/A4TJ39%4\1W^X&1HZ"C@Q+A4$8 T?#R\$U6O< =S..>T8'Y<6EP&_L#P MCJ3SD6QH?[;!VIGKP]!$A$MQ#H1S[4C2\31F!\2IIZ ?_5/0C\BGH!_#IZ ? MDTY!_>#^^&U7-+QEQNI 9C)_$:+%\'F8DJ=,5!%(,Y\]^V_\S8&##)4)M M5R:RWU7F8CC*_Q()9A-F+YS>O#E325A)D>G5A]-_%_ M8ER76/$YEX3_B64E_E=_M_\5>;?_-;S;_XHHN;22&3\H_D2CQZ60,+!1R?\Q MQ85-/ JS0TX.FT4)N4-BY\POPL:'2=AG(%+VX <=8RZ?U MO8X464O&M,:(3--QJ"-&-(]_P#>@E;.=L-&K,2!38!C:J ,LM).J+]=I."\R M)48#CY]:L>5%G$((%S*%1D".FS+%/!E2*N& [%+.53K_\WG==L9, M4\&LJV6=BFQ,V+9JY$-M>![0\1LM\1O)04AR%W)5?2[H_GH+"Q6G^E1"O/HR MH'0KJ*A(R3C +< Z:VUO\#[& -\C&/'O@\?X>[Q68H(9,8Y)7;FCQ4X_;439 MC"S.V"P2TAN>LVG+3C[?BD&ZL)\\=N$49JIN0N/,<\:9WBR-38D[.7@K M9FC"C/SL0-W1> UM1IS$MHR O5M*Q!9D@HEB4_ESU5!(_T WD OTNAIS@[9G M+UE10KH R.N2C862U#9&L:]F2@L:-1A7!"\N".N\N)0;#_R *0E-T(WJ-0,TJI/C5:(5:]2L$*2I4V[A M!<&RC?S FW[Y:FE.;-(]Q N0 -2'I=U#L]%?8I)..>G-,Z"9AP0]O16S];?@ MF&%/25Y93F(,SNOG74.?:-46+]18A\!#CTNO86"U9YC3> EXA#?R^A@C"S)=],A;L- C\N2PL!B7DG- J[CK^+PW,#%7KQA-B8[V 6Q\*G?PKW_ M4T")Q3\A?Y8U ^@NLO@G+._AWH=4MT1?WC*FOF58@7EPUC0Z:9&,R:NC@S' %L&;M\(E=OR6:00,I>1!)%BO41.*#K[HDV MYH<1)B)<2G(@U%RH(.4.M ;BA&NY3UE175=J*1LXA-3ZWTR&2P-.C',= #%< M^D^K[\"#M5.=B@EX%T6[J]NLO-Z>M>S;QFG,1KG:7.:&.C.*.1E&H[!@M!G% M1I*#262U5==?2YO=[^ M6C>_%]7CN:C;>/;0=DV6&RJ6!['ATE(49O.93@N'.@6P\QA%(8#((I?DMUY& MDL/RL\T_]C*6_K)NV#S>T*RE%U3\[U7%*STRVZOW57=+EG[GK[_7>Z;:#> MQ@NZI4T#4;1PJF Z6W$RX%)H(%K#B8JNL8WD!'TRUG6\RPB\_]_/=589[T," M&1-Y$D]#+/[#PH7+R&(@^WR%8G"CY94@()F]P?_TU^?*\C.J!S09>*S0TKQP M@YP)>&.V:4:_S$SY/\I16*H%V'WV[0SJTF?EDDE>Y4:S[-*;%+[['U@QFV8 M[F6[_.P;[/%!3)(%UDWVVC?158_-3(9+84Z,<^7TQ%$EV [P"7TZ=+@[NZ40 MO\7;<;T=8B^-30K@6LT'A#=A-!LO"S(3"L6KF9-D%+>;S<@*6RC:,R<9X$J3 MQIOV,)49Z/'JRP[6K2PUE�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�@YK5&*%7'%%:^^&L>.8&\/8 YIVH&ABY5W( MP6([VBZP)_"U1M4)KYB;YS3.OJ<<;"SLF"B5@=T8V=O4 ]\1!9:5 =] /; E M"HH,++UQ8#DJC:WW!YP!S60IZ;S4-F7T!M-&IG-AZ(IVJ)CFVY?WD5=!_?4 MTV7%+KTGTELEAE3R>&C6. M5@; U2RI!$H(.M8 */]OQWY(;)U4@9..D7360WLN/^_4"X-?:P4(5GXC0]4_ M:8T3+LBAUZSV3TB]5J\OKZP%]E?$N[)&\@7_7+/TU&5U].%YC?YUA)_*#_&H M]LP07V+IC&F(>\-SY7&P?S0VCQ[BPW7]!RPJM?_+Q%WKM/22QK>?Q2H%*EPW#HA=/"5#]WY6 MA\^-F(N.LDW#V8BSR"$YGTOMGJOHE@[L^UDS:]07:TV103##$AGGFW2+["S; M!-@K'>3_6C/SM/'-?#K_WIP1\/]6J4#\,A$V0"X,V3%T\#UE,L ;CTEO;/<' M&N2":D,JE7QFVMT_C U74EA M[RJF!0'<$]:WYT6PR-XQ7YA+72]\O%I=:%;!7[GKEAQ>18\[K[[UE=2LXE? MN.^$P:^.^1=02P,$% @ $CB$5,R 2;./! GQ< H !E>#$S+3$N M:'1M[5AM;^(X$/Z.Q'^80]I5*_':7E>WD$6B$+9('"!(3]>/)G&(;QT[:SL+ MW*^_<4(H?5GM]:[M+M)6*H%D9OS,\XSM<9PK[_=QMUQRKMS> *]@_QQOY(W= MKM/(K_BTL7OL7$X'-[#P;L;NATHHA6E#JYD8\%A,-4SH&N8R)J*:WZC"@BH6 M5M 176=/]>M 3-2*B398T_U_!PS=F!KA;(6/%%M%IM)UAM.)=SA +20QX]OV MMX;(;#7[F^:(,-)E]ZU8ZJ3C-"Z1 AL7+[-CR\'=1&S)3+G4.J^W7B\5GPI# MU7/F4HAQG.A1B;X[]T;#4;_GC::38U8"?7+6;)Z]7N)_I=JP<'NL-?@"\+V(EDNI M"*C2. 0-JD TF(A"/V(T!'=#_=2P+Q2F8&@:"(5KDA2P%"J M&,NB-D2P*K,)F?;19DN) HI0 QA0G\9+1'/>JJ+M&7ZN(^9'0'Q?Q@D1.1H< M>0?.)X9)9"-,.<*V-MR:K)F)LB$4_9PR16.<&!I1A,B7;SV@=7Y"3@&!M"Y. M@M.,'9*@LT^6G%9M?M8=K5/%C WI;OR(",RTYV?IM]Z?_YJ[Q1GV:D:!=6(" M$XPS8(A(&,*0?[Q[P$NYE!,#_Y47" E3F'&BJ+:Y56U\PCE6&ZX +&->)YBK MKNY""B)\>Q\1!2S#AG@M#IURHVU&,J$J0ZT?*09BLC@!AM=9I@58=&(RT#A^ M8-6@01T\.Z!4="696-U5"E"ZF 3HEBJ=$F%L5;W5"+13+ME%I2">J"415->F M&TZW!>=V48&3UF]P75_4^_6=(VIYT3S-0.G((.G][O/Q_, :ZN]0S+O]A+%.)Q7G<:\:Z?^V5X ;_!CX+U7%P@+/^8_BC+[ M4KIHOGG9K(\ XFL(LYNL2VF,C-MPR8G_"5KU"XRO)6=!#O1?%NG\.7O94;>A M&SG>/N[:"I?I?D0Y=QJCVSYU_K_%3$@0X(:P9R#+_?AU_1Y+RTZFG6:Y5C]7 MO^\EACTYY$@>'!]^RO+=,CW!!@%;^\2>*BPA;0HL:*/1W&DA.P=,!NPU+;T[A<;U&^_H+YH9]P9Z_<;U8;6_B M.!#^CL1_F$/:52OQVEY7MY!%HA"N2!P@2$_7CR9QB&\=)VL["]ROO[%#*'U9 M[?74ET7:2B40>\;/\\R,,XYSY?TQ[I9+SI7;&^ 5S)_CC;RQVW4:^15'&[MA MYW(ZN(&%=S-V/U7"1.@VM)JI!H_%5,&$KF&>Q$14\QM56%#)P@H:HNGLJ78= MB(E<,=$&,W7_WP%--[I&.%OAD&2K2%>ZSG Z\0X7J(4D9GS;_MX2=JYB_] < M$7JZ[+X72Y5VG,8E2F#\XF5V;!S<3<263)=+K?/ZV>M1\:G05!YY/%Z$1-^= M>Z/AJ-_S1M/)D7.97<\7U[V)5RYY4UBX?4,)/C8_P'0(WI4+B][\LC=Q%[7I M7V/W!GI]SXR<-9NOF(E_9TJSJ./<,/]<1\R,@OI_$*1$Y&EQY!\XGFB6H1IAQA&WF M<#-ES71DEY#T2\8DC;$P%*((42_?6$#K_(2< @)I79P$IU8=DJ*Q3Y:<5@T_ M8XZS,\FT<>EN_(@(9-KS+?W6Q_-?<[/88J]:"8P1$T@PML 0D="$H?YX]T"7 MB"A@%AOB-3A4 MQK4RC)*42HM:/9(,1%L_ ;I7EFD!%HU8$BAX5 .^62V50*X8E<$D%5;;KA=%MH;C85.&G]!M?U1;U? MWQEB+"^:IQ:4BHP&(M&8BZ@ YD( 68K+&K1$;"%!Y](LGB:*YD@/B@3HQ@BJ M^+9<"C (G+!8Y79+K-2< 0+.4J-#+NPW>-*-3['0,3]V*8CEL05.UO6CW5(> MWQ&]WN78A;X['B]FO?YH\ONG2K-B?\]Z@T'Q^\D4URS0D9G:?->!92(Q1C4_ MX9RD"@$5WRJVBW6\^=,7^&K"A656"*:3M++KB1UO\/2V]_ET'F!NM7=(YMU> M*AF'\ZK3F'=-Z9_M ^ -?@R\]_("8>''_$>)S#Z5+IKO7I;U$4!\C<#LBG69 M:)W$;;CDQ/\,K?H%^E<)9T$.]#\FZ?PY>]E1MZ$:.=X9R3@L,N$T1KQ_E*K85%0'K3Q@;*B M'73P):/"-X8=F*;V,-6&,<$3EM"CQ3&W?,'IZ&UV&?<@>M;08L<*.+O M-%"<0J<#=1M&WES"8TH1IV%>H>?OU,VK]W\!4$L#!!0 ( !(XA%2$ZC_U M@B,! /]1"@ * 97@Q-2TQ+FAT;>R]:W/;1K8H^IU5_ \X/G9*K@TQ!-^, M,ZE2["3CLQ/;VW8R=>Z76TV@26(, DPW()KSZ\]:J[L!\"&)E$@*E'M7S8XE M 8W5W>O]_/&?G__X_:=Z[<=__G+U!O[KX/_]^/GMY]]_^>G'[]5_X:_?ZS__ M^//[-__7^?3Y__[^RS^>C9,X_<'QFO/4^1S.N'3>\87S,9FQV%6_<)U/7(3C M9_ BO/IAW_=>.3,F)F%\F2;S'QQX//_%*$G39*9_E_*OZ26+PDG\@^/S..7B MV4_?Q2,Y?_7C]Q].]VD13J;ILY]^_/FG7[Y.PU&8.EZWX?WX_<\_G10,?R]R[';!9&RQ_N^B(]*\/_< 4@[<@<)^X%UWV26WK[QV_.IX^O__%L M%C#O_V\VO<:_YY-GSM7OG__Q[)GY["(,TND/3F7SJ\ACX(?G ]P M_:]@@;\S'OOXHG-YJ67=CV_>_F7 V(1S8S\]W,\H$0$7^>]^CIC_Q?$:73@N MF41A +O[?/7S[[\XKW_Y_?O'WWVS^>-9_1SY\^7+TV/^OOZO7\)(K8 M7 )\YE^O',UNO&;SQ3:"_?S1K''-11KZ+#+PPXVL'GS$Q_3&F]MV6_I<<;"? MWZ F\!'_'^X*_@MGMN7X1H*S+YL($'2TN]U'8][)!B\8U@$Q:/HV6]]C;V&P=5 MA$ZVB9W$X"T;VQ4?*KCU'67BH;6>H]/J<9#OWYE,P_'RD&!_GH:R7BLP\#LA M_\Z25]*Y 1&=B^^B )_XX\UW;#9_=?72@5_.!9?(CP-Z-F#T+^DD8^=J+L+( M:=-%MNBOB),4]@^2SKD+JQK.9WCB=3*;LWAIMEVO[?[9 M*;OFL T>X_;G3,!S>%B./J!)$L837,;G(OY.T.^<$8,S=)W%-/2G=&H97E8+ND!0%!2Q.#^Z[6 C^ 1P &IJ /^F(9QAIA](YB M^$[ YTAE<8H4D&Z2E:,0AQQ7S%5%B X M]&?7"<> "TO7 2P!SAE/%*O4\HN017'C&5LB_XT!9Z1D8FG$5HI@&-3'+Y68 MM$$L)096^+]B_!993@3V510!LF1"\-@'#C5+,L0-+1.9[ZO[P_NY4:%(03$" MJ(U>1**VI \QHP\A^X.%7\,O@A#X3X"&,+"(+(X 4G(HG9=2@R>)-%,G&^Q,DB1EU5:VVOW__U]LVE-W2-QB;GI*8R M7R12TB*3*$&B!R0(\34Q>Q4".H'V"NBT2$04+$!(.!PH/YF%OH-_N0;9UZC7 M?DM U,:$3BQ+IXE0NAH)>E@C(DP#S@;_!9T.49>6GW$F428CCYG!*Q.4G@B) MADUOCK9%*PY)$2(Z>@0CL+Y(5(1]/"(R$R0@3PAZ (#FS)*8I\BH\9TQ M$"N\0NK1-;Q/.@"M'G!\"56H!"D>U9+_%)=%$@;T?WR^0<^?'=Z?,[D:N4K6 M3RY-$>N3.$RUP:*(+=="-;TZ\&+ X0I=^G60*0_EO:&:<"=+_"@0F4E1X2ZHCZ-^@382Q$1T<)4FNJH%3$!\ ,R/3#/=L+DWQ2&!!H8_7.AYS M=!+01V!K!KWHYRD8^/JB4AYQ\R.@%NQ9'1^Y.!!V>#<74V"?P&>@VCD?^030$2_H5X69SN])\@5_ M?AN/T0^#UWAVC/DX20:G@5[_8J&3 90S;-/G6?9UDE/S9F^GU@K)Z8G:A?+& M),8U0"Y-=!#D7LRPN'IC6.:?'2&[O^8 2XC4#?Q%J-4F($J %3CH[!&H6A%6 M&1V6S!HT<14K)A:GHR .!D&<"T7]2I\UCABES0(CTW_(WS%;4IX.^#KZ%[6J MN^[&,>P;=&%DT2B5P)@BI(_ J 9+-T70)?=+KB+:'');5_M1X!SBLKD%3\%# M(-\Q&EBOH=ATR0!'%0#7TYS^,M+T5'J7SA0%!QC8R@%KS@>]05*[C1#8DB<( MGY?9Z-_D(4ARL$4HOZ@'LEC_#O5S4-R53GT+&(:7EZ^;C<#\*&0TRA")_M[ M'&/I!I-,Y!JQ6S)*4%2W_EOEG=F ! ]D Q3"AO7?@B45A%M^ M#8P=0&&16Z(@E%CK&X7"R: M6S0_&9H7"GJP'YZO^!M1:[HIL<"BLT7GDZ$S7.T7GNZ'R6#9:].\E-V"H66> M\C+7)AY=F/1H(2JB=JKM>2W5Q:VME<6?L-5A.73,N?TROF\G,/WKP2HM/XKYQV; M<766[Q(\0&^E>,Z\A7\Y=#7B&A:0R[M\XWM6]!VM1.K<@BVV",\6X7UK17A6 M#[-ZV '!I/2]?94Q=LW"R/B)0 >#?R?"V@\6;T^&M]HK$R)O.8-Z;[>?SK@4_)K'&7Y%%::@'UUJWES*)J#V M!4[,>2#I.8OG%L^KRZ3O*$8TSO>59*Z;,U[PSQ;=+;J?3*NF5BQ[!D!5JDQ1 MF:*0>H8%\GG->RIX'$@G$"'P?)U!OX4ZX+_?8TB))QA?2E7YSSZPP/?&4>A3 M8P^JP*'ZE5)!;KEFUS6@7R<8B(JH9":$!9C.XH%MD%L&7XVPKV%KB%]5(?LLP<9*JD&)4_0G M(;@#UW0%NVE/NB@/2YUC5=UGBB.I+&8&=HON_4:%^%B-#%_@R=A5%88+KGI$ MQ$F1RZ^+[@*LI/E"?TI&$58RZV81V9S6 =($+1)AQ1#VS3!BTPM.1$C%T:IR M#B'"\';IL B?$%UCOKV@5@@)8"4V M&E,,'4-E#.4?MH.B'B?T+>SUH.QSK-)TG0CSG(D,3 ,8=S7;$U^98OVD+F1- M0%9AAX"\80JV>Q.ZI\'FLD!,.ZVKRP^1 PEJ,A,J[+V=RDT;&5W7ZE)!,YY3 M%,["5 O,+5YG.DPD?=X*!7!(G6N/8J_\J.P#-(-5;KU M6@[K*$OS7A*P?"I"W4W"EN ]22N@9=W;LMDUL$X?24!Q81:6?Q M3,7S&,4G 0'!FHEXT27YSZN_9-XA>;0LU8I;*K14>$KG*1K<>WI.)0TSR6>+ MH%V#,P#05&&BZ,!73 %0=LV"\@ 8=I+5(V:4350T!=\W[3\OM-)C!)#*I1HB MH&8(8+C"TI.EIPI+M5L4/<%)RGWA2X?/YE&RY#P7:C(!^1+=I2[NJ1$FNN>^ M8ZN^+.6< M4C:D)1Q+.*QI32E'*.34KK'1ZU/# MI9O3T\V?JWG<>Z'MFM6^-FTP$1R =JA21M@4/HO7U=?]4_95==NTZ&K1];3H M&N\[B:?DU3'Z@]!J"[I!DUB-]Q..8(N\K$DZ-!9:N67TC%R^39?9._^C-'/U MAA)@2U"6H$Y'4/_B#&M(]\_@5@7D,I(HH:P"'.,YPE')$ MY$.5B&,'@W 6SRV>5]AAM&ZTYKP;DV%'*[-9!8?;CI0043G?^,^ C]5XT^+5 M(DBVI^ H6=9FJ"=.45?-T[>9V,7T%EV[:JG-4MN9J&E4S59DFN_3H? <,7#F93Y?D6 M62IQF#LV6=@'C-GP^I/J)+%G^IIN M=[06Y^(16*"@2:4D7O5(KI%]-,A^MO8V)=[ MJ_&DRR!_3E5[-F6+LI3![\)K[(8^%]CW[.X&Z,<9(]>V8^0.,$:N=:YCY/9E M=S\<>\35WN/'[CVCZWPFN=EQ='O@0P6W;L?166W+:ELGB ?H_M;%!'8FTI@+ M:KD$-O0XC"BP'(I2-V;Z8T:>UB*]H4C[\-LS1-+,.?@7])VR5:?$O8R MC] JSU3EYARN'ELSP[]$R%,JYT9AJ4L<4L'VK0P%8A-\==1!.A5)-IDZK QE MJ8T4HS0H#.Y1>)Q_01?9M&1?61>8);T3DMZO"DOW+N!D ?5C1[E4:@&(@4*: M6U^23FH621Q0.ZIUK]F(X^/,F6?PAK^O!8#E JC**F46TT\=QU:5SON:$&8,CIY> 7Q?!"8%G'(( M,4>P-&K'=3B /E/2 9[Z=Q9,U)R,T5*W"5 ^EWW $#QB:L"$&FV(HB+B7\NP MP1=3;GNX69HZ)4W]2P#OOPR2Q;Y#.Y.Q,TF28($. #,)"0T<(-$0YTD!07$; M/;?(?$ID_IU/]FX$(!*?\WRZP_;>RR,.[!H''6'36MMQV2+U2;4>,[]R;_Z, M[B9,=95FYF0FG" 4G$:4J2(B;+-L=0Z+T2?%Z+_RV:KWUJ$1E>44![C-16A[ MN%C\/8_@P P;6##5 9\IPQ.=*J4^^.2'Q[&4R0QXML)QRYXM>I^!0U&-*>%8 M*3.'?P4A-C:-M:N%Z=),AQ)44)4&Q83&3ZW.5'/(H SXG._;U9LFNB)=S7&D M<.PV$,9D#U,;FDS,$SO-T]+/2>GG MSQ@C5OLA[Z=4CQ]"FD #N#Q5"SV617=]G$^$F4<^.?I1;O@@S"(G"E5:5(CB M8P)/RG3_+OJ:E"V]6'JIO+PI)MP"\622A$ULI T0!V+,1/?,7A,Q5B!8!#]E M.9$O.*CQ>\H$&GVKAFIA/#;$?L F#KOA;BI(0*=$Y',$,##E9KZ$#W6VO&S =PLAB6H]]/N?)F:HSXV90-T+ =8WR..!Q 3%F9,57EU6NMH6H- M'TKGCS??L=G\U57C:9SU3GCS^&5([Y+X\K>KJP_UVA\@1S.A_;&&O?2J3B++@3<.F+$'U#JD^V<=+@+6)F9RR!(:=\IAM#(N5G M<2:Q$B$1L'1\*;!0!P='-9S/E$J-SX F!*^@F1SP<8A<8K1TWF)@.69FS/6O M>;[UQSS?^E.>:'?Q]M>/GUXVG/>@0V422V;5$ AI%D<[_!IK'VB:J>HP@X^Q M()FGZH,JNTBI6V!\-YQ/<^Z'8]0JHJ7K_/CVI]]$(H&AS44R#E/7H1_U7?WX M_=N?Z!C@L==,3ITQSN&BCQ6MP-5#="AFHPHZW"YLP PH)O>;X&,XGQCGZ.%! MA7'#^1%8KG.E&&R(2R".J9BG)232-Q0#<>0@$RT MMSAU^#4E'NIJD%@RO]3%W!/?4)F/ZL#,[TJ>0[=>"Z6*@078D04#OGHJ3I%87TK._SL+ M ZS$Q+O'#G2EQG0SSE/ZG?E,J>?7 +O7!4*Q4.G^#2AAB6:J?I4@>ESR8\-)38*F9.C68G+2N?*I_GA MH$5)8J0"3%.)69,!BBU,CG2BQ*>U ?#6H-ETO@->(:>OG%ZO!XL* 8P#T198 ML>O\!;PER:ZY<)V?7\./O==.Z__K=_6T6+*.="#CC*Y(^ M<%E,?@&Y@*.5/_TWB(M/_3^53N[A5DT]8>B)PRC%^'A48!5Y(N0!RKNO$75U9.Y_3 M@5&!E;CFRR*]#350="Z!J0EPH>FVM7FZ'F",2B:+M::G"MJY\3)%Z?3[E$=< M_1/5!QX%6H_$5T'W(VH',TQ!YSI4YPMJ [ 94+JH&DRS'6EFF,-?T!"5<\$( M:JF[Q:M8 !U-0A D\23!'S<&&3;JM=6KS0\_$*#!Q*@R49H&0@0K ,43LS7C M;%&U+24M<49*('A MI4C0;U76265N1S&0.!-LPXI*+^HCH-0FURPW$66&?280(8RB8C089=P9A0G7 MDDD4K(UM*RD[">::=YO%[,XGHJ]4'^RRWX#%N;:ZHGUJJQ=S*=-0X,2F,"6\ MNN$^T35@M/R_,Q: 6C3'1!P7D/ K)^,(K(I0^(*-L<751.FV(Y7V(Q+@B_#; M*2PZ15M #_R(U H1,C6,H81Q;BK)9)PN*.:#ODPRT<"F^D)_1_77 1.'PP&9 MY]?\'0I;L($A8 G\#R?IP%A-$S MQ0K(_!/H"Y^"@BA*/__^]LW51Y?X/@8NU2%2TW&!?":*DH4LL2$D:+3\@(&D M(H-?9'$(6F1N^)"_/T);R-+YJ<#^5XC&=:NM)2,>@FB1E<4,5/DB=(<:5X%*5F:_&FHMDH67&EE9Y]5J^H,6 M$X&-R09,9X&4;Q&E<\2 )TT1+39=,KD#V+#)D%*(Q@EP%^48R7TG$I@7CY6_ MA?QJN>,L-')!>9Q1W"B'#KP>9Z0\PN-?^%)Y?J.EGK@W#P4&UI:.7,[FP,MD MP_DU$\B'REL@;B-O<_M@6SG*[Z3AFE2:27,V 1&5>VQ"TSOI'>5!P]:)J+<@ MHL(FLX!\3=G,>&U ,LFR?P==?T6.31[G+'>W+PH-$$+E0B;Z89,0>'^]=AT* M$ $R_[@Y6$LC)P+[GR%6E.AL%&7G8*5OT34W#_!J/RS3B9.% DU!9?WGW/^Y MZJ25NGF#$I5E58MT((?Y%-Z^9D*AA?$AYPFX:\$3I&"N.IH4LK?D3Z;>** > MD L9=1B3651H>!ANS9?7&EP*8*I0+R#K-8*"9(LDQ=T<16<8PT::P^ZC9BZ) M D_H4"TE3*138 V7P/&#'Q T=.# -R/L9H'I.;D?7+,)$#ZT%\K1T=E,^$+, MM.,::0GE32)-(]0X][7GH?'\A"BVO0CA;,V65/J.FF.=)MI3BB6OE$&0B;*M M$X&I&^O&,GB^%"@WNB]BB9[/.^+*S '(3!P]01,PE0Y*).J<7 UID*:VZ?E>EI$TH60Q3=]&N@<^[9G6%MV52 MQP45^:U\%&NIP<@&\VJT5&&CG..0DU8]3?F\2+T)FDA7FQ9:$3FHJ4(:2 M#Y:O))T&;_^- (L!E3F?!,;5'(>1MYJMYDKTC\316"EISDB M16Y&(CE MC!)VS;UIOLL#[>9$]=N/$JD3<1'O/O()II4A&E_]E_/>:&7PURPFO"3G9"9D MAJFZ*C)BMUB[[^AA M<:$6 []\]:E!*FYZ%E)L <3(:KH,&?%=U^MVW-:PK?>!NEV>&HG=\'+[G5J5 MLAFZ5W';S[VNVVUV7*_==2[^_/3<:[D>_*_7[+TT;ZP<9,/YA<&-X%=HT[@!E6@B&F;9JZ!U^4/^*'(]I9#(: M:*TIW!E.0D75#]D4?G=]:4Q1*EJ&P#[;C6X74T57'\-C(T\V;0>S.S"X(8LT M=A2&A$L2,03=VP2"]G'#0B#0="\2V*$&6II;0D4[B6-M!>8WGR,0(YS+>J 6S0+YRWZ$.CM-5T ROJM;[;;#;Q?QHM5#(5_FL#+95+ MTW=S"! O_KT(Z4-M RS/]IW2F M]3LF _:W\UKE-SM_J*Y491ZEGL@94Y%R)Y>S41*9Q]Y\^/A>/[3*A=;!*'L" M2M,DP6GW#M&.+AR$KCB$C.>%_HC M.\"M %NP,VGM>=]Q8Y>WP_E/*]LY%>@ZR^HVJB=U&OY5@H@/JT T?[S9W-V M9X>$9TH[Z.>D^+KR'U#ME"D*3Q7[U;0A M+!:-P%!H ]2,@VL/!T9'B?S3%7#-*ED17I0B4!9Q20I**^N+<]-E003"E7A+DF@,XE".;J@1+L3:W5'NF MRF[5$! *L&$=X$2Z%*..(JFVHGS>@:NB8HZ*BNG=E').\Q7R9_(SU^D=]=KO MX9NKCX[DL4R$;"@/G#"4%IIF?0C\\Y;;&S;==K>C'.?/.VZ[UW:[GD>^BF:K MB3M?ITR\LU$6?S8Y*=2-QBB7XGTVW!^*06\2Y5]ZD6D[EZGZ_9Z M?$+3<">8MY"I=$A15OE MX#&]^#<'OBCXZ90[*]%EM_N-[@OG6CJ=9J-M;K6)2/!?9OV"UCNXD7<#Y?S5X%YHL90$RE MD */SSL*$8.G#MZI3#*!;?CRDCDV+\8YY,F]'.V5-XE*&@IEGMTMM\/BDT+^ M!G^ MI1.2ZS75/.66+,O-O,K"XBKR*6\NQ%QMMH*239M96U,EZS65*XE)S@C#)9.7 M[%*OAFF1*DM8BU.$1N44@ST=P:Y1,4/Y2@I0#MO:$LDGAY.'T;MHQ-F(A2]:9P7%.J N6Q/@_ M]CM6=:'%>5K);"6SE_,I68 M^5N4C."W'S2CL*+ZL<#6W6]5\K]I[94GZ ;.7Y1*^)8J-<()I8+H'JG(A?]B M(D37+''@&,3O-)RO2K!\218$U'*9T*+4QTOU/:->R2%FU>KRN'E)U3/RR*3/ MFNQIZ@(&K!YK2'5QN<(SD%5Y^1Z6VI B@4^9.@0:J)RJ)V,X*\.6R)^+W57- M<@NNI%4B4J939Z^9R:HJ.3 Q['K-HR6M5O2. _T /D-Z0;X(/ 0X#UI"T=UV M0S/1I0YT&JK,SXQ\+I6A;6G!0"5N$T5;NCI/K60EGY5\5O*M23X:;+&?W/M8 MS!5Z7^H_;Z778TFO+44[RJ01166N8/,P +9+G'2EH>7GS?"A#LU1=UJ',P'O M2>PQ3B&BO(22YAM02O 5M:R&5?/R\75X1N4FR84!2;U6I$G-"4)L%IE%5 _" M0<9D@&>KX44?"Z'0=@39Q["A LK-(/15.@\<-%>53+J+/ @9^J!NY+1=:E _ M#V-A@BTUI@(:DR4/.D $UOD$KT#-C\&7L1:+BLG)^!X+2A%%L<9C:N9$Y:&C M4@]@:EQUTR5@ RB\)C4#X19AB%L+$MW(%?O/P"(_G!W&6K&VNTAZJK+MD!"! M2HYB:,^!8#++6].:&'IYPKT*?&BZL\,@+>H>!75U#>?>LQ8+/-6RFDI@+)I: M-#T2FDYQB,Q^:*H:;&*=BAZPBPUB-,ZB:,\8FF;69H2Y=D)%2Z/6(D3G, VX<9PPZ"1J.">.*6[8V-%C@$U%[*9I M(;F5$IIMB*.?X;(H?RP();9#P_ZSSCS"&$EI)K#N]Y,/)Z1P8C[M5T=EXB#/ M$C 3OY](+/[V9BP]VXSE ,U8NK89BQW,9=NPW+:)/VP;EF^D#KH9G0#32XJYA2I:2XFG0AX/_!R M #<,>#Z\0S%Y=Z7)\TKN$^5OZ0$WV%01TXIU)^D\@(=#<##+-__RGY]B4 MJ2;EC%J?-XK,0#Q'U^RBO$/Z=KTVY=%\Y11*TY0"7?NV)"!61D73S:E/ZGSJ M/)_+Y)IQJ6MV:)/: E4@3#- '&P>02558..JZXJI3X)$,>6JBMC-20/H39_K M!IBF*WO1I1L4YG!.*^E=1>.<5<:YI7(!OU6C[D M9V7:ROJ\J?R*BE(M=]O<; T\G2>59Z58OR2"A>I6K1+)98&X,E4=X#%7#1U< M@/'8K&&B_%4:C3 _4 4C5!:HA+.@'AF_AOJNUXNW5@LJ+CEG$27S) MMW2W4%*&ZH_1)?R%FP82L:23&&5+&M#W-:2Y$,4H%#C0)76L8+%Z+HR"(MV] M2*+?H$%L=D)]4",L8 MT"]QZ[1WU3G41%KJ/9,YCK+(WQO,J]<,GL4(/#_RU M:E'Z23?7I8G:5"*F!TS.$\Q9Q,S+4D'M[>;)>T9NJ5N< M=\JV?V:\5X7/;C?;_W+!42M2C)/\QLXM1O=Z]&*NE*'\([3\UH7-T<+[!:2O MW^,1OOO'L]:Z?_,6J#<<#UN_I[P#!X#VKO>/NC7:1W-_.!X=:&]X#Z#1X;L3 MM@/Q !AJS#(24"+@TY/11:O9<5OM@=OJ=E]NH0A-5MW6BVWN;M5UT33160=? MO]MZ<NL &7_:SS_EW>64ZK/]]:T?VXX-C[&-O&_>F<+O MN>U!T^VT^O>&_T&(_:\IR.XMV+SY2=4-3#<+NR"+Y 5:=P:G7VX+/N_"IV]Z M?/=[N^-5?=+8[VK/-]5'7YBW;H5_5V"WX7"ST;[ML1.!,>@T-JCH1C".S4XW M/_P.:PMCFE!R$0$N5A[A+KR>"Q+6'?9;]\*[E\>^\(N!V_2Z[L#; ?N.#XSG MN@,JL"1FHW6[ISQ*&K8C3CV)HRRE <6 MRRR6'5GMPFB"X%,>2Q4].#,%K#T1T2+CZ5CD6GAJB[ZG M9C1CM)?)J2JQQ']@(M0U=9S>"%_L$P6Z5^3G!M?ZO<)'-#3+'79[[L ;;@M\ M['Q2#P^)/?IA7'0Z?;?9VT#3G<]@@U&=U?9;;KLS!%SH' 0'#KT:N!Y@S\!KJ7Q#RBB<4XXA?GJ2)('* MDYW-83VJUL6W.FZW/W3[O;9*JUM0C@WE,RY">)72A9C: 4W6@F?[;1?G[9@- MF8W3 O4:/C+L@94[Z.6/;!X'#3W3&:C16E/;(+9M[JZI6JF_4ML(K:/7?8NE_&PFD\D)[;\CINN[]#LLHIV:@[[8VDQNK%GQ[0WWZ3%>PJ@=+M1A+RF+HK.MI9QW[!KN-?INKW-2+KU"ZNCZ7=W M=9D_ L_;X39N1-R5EC25QO][)/ONAOJE!CA/!/D/DQ=]8U.=;ST<4GVPB:KK M-=->>)?]YR>\.FV^YV<$Y1SVOT7SC4CG6F.@^F">7SJ5:CYDV: M%:\_&4HG@BUS]#@'JO7LUMGD13]1=%.1KA8ED]"7>0M1FEP7*2-@=?AZ/AB> M^C&'J3,"=@FH>\/'T#-C>K>NF!:EK<.^FU[/]?H]VG>WT7Z!NZ(#VK)_'-$$ M-PMWY.2;#$5 7527>5M=]1$S:3K0'8-+>WTJ;0PK#W8I#/)=)&:OWN9-D*6# M<9$<+R_T<)K\!:?TJ)Y1\U+?_M+Q-U5*TZO;60#:!,DL]&DJ3M[Y6CEJ&2"E MG&8I/+%0@0P""S L\['_IA/GB0S8#Q@0ZM_8S-$H(Z+3G4A#6;07=]@8VXX3)'\PX4]IN?(B M+%ZA>=6'>9M"3:YH8C](01;-3P3V%3:_3ITKP,_( 6.MN$#GK9097!8RLHAC MW2GBUG\CI1O#">CW=I(8J,04TI!VY,P L*GRB)>13G>X/VL& M>%Z^\]>)3.D:?DN20#J?$*#O'=7,[P_ZZ-.Z .MKM[YVZVO?Q]>.'$)-&44& M 3O9Z"IU5@[WBX[;\9INOW];;#VF"TN=O8P M*2DSIY:QWZ:#"2ZO@^&2C7X4W[B#R7/[W2$@]F[<\JBNU4,&&!3"*VW(N7AQ M=Q>7IQM5V-9M^2%(_^*1\/V T81M;9YWQO?UMLMGY4O=QV2J'O1$U?6:DF/H MWD2=.PC'9IKQB*<+[-J@7);*"2I #P^O]2 5]3S\*@6S02E;Y+?4#S><%;X1 MTN"T7'#B.+,P4+Y9_8*>;X4-(E+X[ASL<,Q%#]2#MML9#- 7W6TV6B\:SE7I3 4C]]Y*?".?AQ>6 C,1_,?,AT/O($!%\Z\ MVGTI'99 M:^3-N:OYW (=SLHU+C7$TW",1+("%S+!DD<\2N ]\Z?5& PQW)6IBSY-=@S4 M(*NS]DC>HW)K8"NW#E"YU;>56_?7"16Z%ELX (3/; F8+0&S)6"'CD;=3J./ M'^/ZQ*,(QSO7:WH(RF.@J4 M/T#M %'#8@XV>-7+27INI]MUA\.- ZY0.4G;;0_ZV_*OJQ7OH7JT,2>%$R=K M\^H7$W7<3@=NOU/E8B(/V%G+[6XVW:D$W7_DDE,*)%)^P*]YE,S1^JCZS7>] MICL8WF_2Z6GNO=OK U_:8>31X](\]7VX')$G?;^!V>H])]C]]%@PHNNK7Z77@0IM5[L'9ZKH];X=Y895,U_@7FYC"$A8Q ML4M3UJ>;L('&!8ZCVS4EI_JI2H=L$.CV.D.WW=H06I4N!;VM\+/2F'Z\?#P/ M^Z"[GF<3\M80' ZEZ;F#0Q<[VS2EJN6A&"^X&58C\RK'E004S\.\$5?ED#PO MT*.<2?*\(*=ZS2244%TH%8#*M*C]0;^MBM$7Y6,4Q/_"4RP;HX2F^!K>@2<% MCW1E'J9+25,ZEQ2>F%G9$Z-R#;"@;@&_PX2!-Y1LE0@EW)4'1^ ZVA.HTK!( M\&]1\AO.)QP\JM,Q5(G;YJG)#&U#E:65NP;&G$L\"G.0.C>A^ 7S?6#F^98C M/H&W* >#$9?'9*XY4QW$\IR.=TP&[&_8IE0O1@G\?TI;, O3&2TVU)E;"W!! MK"S2Z1/)=J@^V,!ZM#KI]JP?=_JYF*A^>]=A)3#8&96-0U:JZ^IU& MU*%P34H=(\\X0'7A#=U6?^!ZMX9TSJCP:N!VACA@9*/;564*K\K#6N]N*5MU M9U<^3O%>[JYC.[HN^IV!VVOOX+0\T4#?S0__&L:DW**&H;164I^K?N]=M]FO MLHOSHM4&"V<''^=I21_4$(YYXORK'EPZ85AT%BDELMI7WNZUW,[FD.XJ7?H M1\Q5F=I_*Z[; 5M1\C2-N)DR&_!1Y0.5EU6^?KB)07^'$.5I:?[MRBCA.$G! M>%*59FP4W=W#[Y$O_&(P]-S.YMB^_73"8UWY!CI6*XAU2!M^%8W,H.KUSU _L<[K(YXW?,5+XQ.?\]F%CW=[(Z..^P]G9CW03,[O&'?[>S< KH:F1T[4\$[GEH: MR#W4/;?5;+G#_H:+\2&4L'&DYT<$%YCXU74'WOW[TSR:'^1U-LLBY>I.!6C1 M*G6@U)^E\@Y0K]T#L[C**;L[><).GJ-_(Z?Z,Q8UPS.*B7T3)/-]N])AG$$1! "O ML 9D"31(MJ"/E6D8SW,4*>8/?)[R>BT&VX->IE96FVON,IO$S?O*,R7+=TIU M@-_7:\_SA ("@,4F=Y,^;+S>U)FJ<(8_S]VEVV;N.CARUX,_]]LNS06!1_#G M80^.9=!S<>Y*:<(NI<*J2/R6A%AI$C-I_^C 4O\J)\B6$V:#(G_5O3-SMEZC MV+^[-<%5M%+2O).011&>^5C" MC8^6!<3Y')IOHZG6T#;5.D!3K8%MJG4@I+6]L#;C8;87UA[X4,&M/W8OK!.K MEH\/YE663A.!SA0<6 7*A..S>4@5A$]!HE?2D=NYC\:/:&Y8B[LONH6PP*=F6L>QMW6TAMK-KIA7&3]/V"= MEEKH<)?WOX>]_O"V#++= #PRCI&'QMGC_XR?*"2>YWAN=]!TNZWNFB@R3AW^ ME0L?728@K!9,"!;K)N7/L4>-Y[:]5F,C:VC%-VCQW>)[A?"],\2F53=@.[K? MT'$&R/X1_BE"ZG5/':2BS0>@>SHYR>T// MR5#[R'GW:D0O#^/EP^GCD/26E*4XUN<7YD_W P._AG%+BO:&&',$ZDEP$E") MM%2!,OQ2_33/A#_%>*3IOXQ1G<$PP4JOXQB8KV ^:V_C&;8SB!MKWVHUV M%PE_/RCNQ24LX5O"/T?"QT&$&/UEJ ,42C!SNC]XF@*+1Y#\*=^>^?AOB^$6 MPZN/X5JT@;4W[+K#7F_3XF,H,ZZ! IQYQ'S53X/<&JVNV\5$;! D%M4MJI\+ MJK>[0]#A=G'EK09IAOV!V^E;+Y[%]?/!]=9PX/9ZG@W16%Q_\KCNM=SNAL=Z MQPA-J^<.^EV+[A;=SP;=V]V>.VRNL_;](C1GFO95>;!WR^V[CKD5_?*@ 6T\\'TYOWPO2NQ72+Z6>&Z5[3;;?V1W6OV76]GL5U MB^OG@^O81N$>7+W=0^>'Q72+Z6>#Z2T<)=.Y!U?O]-U.R^*ZQ?7SP76OY=T+ MU\$L'5I4MZA^5JC>NY<&XZF* XOK%M?/!M=['<#9P> &7%]+"WXCDIA'R23T MI>F^AOT"4^HVMA\8)@UY];M,8OE"P$4^SQ9;F%F"L@1U-@3EM>YG_5J?IL7T M\\)TD!R]>VE)'8OJ%M6KC>K^&E,?MMQV$TUTPPL/,+QP M:(<7'J;B7O]@1QBNH[P=8;@7/E1PZW:$X8G!+"4CUVM71:+RV?4D >0Q1WYL MFC\"].]C./VY""/CDVRN3B#WHP1]NI3JL>J[91/!5>8'3CHLGI@":G$AUQ+. M76&'L5&OLTC$%_S!P EP<1ZH]5(< M.I[FSZ\_>H'/?!<%F#[_N6CE^YV@W[QLU&LXOWP5]@7#D=]AD&>SX3EA\R77 MD=GHW]PG+_?ZEUB Z$07B*>]O9)@\\!+UU>O,7C7"1 -@I+7O=7H-LGC3HLT MG+=%G<$J>?+([Y8OD%JPB8,^-FJB:^\'/"1'!^\S//M'G4 MVQ@GU<-M^ J]#'F7\''U'@GY:%H]M757K6P0YWPP !AV\ V ]A(A7RG,S;T* MSSV-L$A5#,?5.YT<@Q4*[H9DJIY%XC=U)QU# TXB\O*4G;#U*B=.=Q79+\*7 MS@0-0WA],-3?0",%D]U66_J5MLYG\RA9ZK,I5^ (Y49K(8/E[Z3E\Z8YMZS M.8=3IYN81W![]9JV5=DHXK@GV@&%T/+OP[M19")88$3-\.-@35),2EUH7UG# MQL5#A X,W0'K" @=NXC[4P1:,0#:MV)N>-+C4$C0$?&?DL.5(L..X1B$9")4 M6\6WZ'GXMWH;V"8 3#PUKSIR5#8Y@8&A0_4U6KZTY-(L6("A8G078?@2P "# M'?4UO:6/G_YP\UOR*>&>FW!$9?T>ONN 5+C?G>J+H\ M4#>'QW'3E;@KI^06%X!2.A0!7LLM=T&;LZST1&"3SRI7F133@0M.?'7Y%UK2 M?_AP920\QM*QCBZ!IQ;R_%KTW:H.[^6!VGV'N_FJGI'CY1;WE+);83DP6R<" MU+X ETP$6)R3T46KV7%;V&V^VWWYS/AP"L^5_M ?6);C_A=/B=E&@/SQPTY>]%]M\:Z47M[S2>['5LM:ZX$UOW?DA=*C=^ZS_ M-0U3ON6 MQSJ*] \ M3W_?0K"_70]8VY[.N;NF&%VP[\;C?'YO$\ M7__N?HOHB^DTO.Y.&SCJ#>U #5LI8/56[J*"6Z]@AP/>+UT1'K(UEP1 GE=K_AS#^S>!*212\E3V7N>(";Q^CP?Z[A_/6C?Q MF;M7.SH'7STSCP[M3F4:6?DQU.4-RK]#4^ZTW.ZP72U%>=N!;CW$*]]'W[;$ MJE >7J,_Z=A:Q'#@#KJM:JD0.Y_7V_@:E+-$+(]]2KW6T.T-JJ"E[GPVH+FB M%UCYQP(^3V28RJ-C4]L=#OMGBDWO0;<7CI\)02$8XOK'/K"VVZR$\;/S(;TV MP:J3'$^WXPX[O3/%IX^XA\MD?)E)?J+S&K3=3FO#351E?,I%WIPM5?P$7>>^ M+S#H'(5L%$9A&O*CG]Q%J]5R^[T=<.UEQ=#L-?PCF7%Q,B9_T>ITW6%W>)JC M>C"&_9ZP^#1GTM]%D:H:^JQ*O5-2W,#MM'?0%2J 1#?Z1'[GZ*W:8#S=?C+(DN*K!E]-P?O1S\H;];7& *F'= M_AST7WP$VN83B-)XWK#:41HKZ[2SQ.M5XZ(.J7\_4;&W&R[O(>MNQ.[?DB18 MA-%CA28/B-\MU^OUW&[O_LKW66@MMT>85U/I'^E2SS7>_/A51%OCRW<4U7JV MJ/8 1;5>TU;5'C9)UI;5VK):6U9[V'K5U6X+U9-??V%T$W$[Y1'< G'0UUJE2]I!*TDK%#M^>L7!YRJ;RL@_Z>%W9@V>EZ MT>D/S@5[B<6HE)K*EHI)8%F:*>6D8JWO(C%[1?]/3\]6)7?9/*$>B7YF4EIS M^+;4Z;K.*%LPWXBSF3JM)LO'$!'AJNG4Q:OMM[)]UF&1=7&*6PQVYJ">H= MT<>X]$6RV#S%>HT0J;V";PJ9!$=P^ ;RXW<%GS&:8::))'^6/D845SYI@8A* M7]65@@)/";8-C(C+%(X0#D7EU\$:8Y',Z'6#AH'F)@WG?>Q<91-@;8XW++.@ M.1,8Z5-D3#6)P(XHMA7%%+% MI;[:+57]4Q8X<8+TQV,GX!&2.;PP6BJV9TL(3UE"N,(MVN^!00>?1M(7)9!.7JTE^E+%[0 M[46LU#"E*FD=A$U [$P [_>#0S7H66W@8RGG25".;RGG1)33R2D'-4-+/4^! M>@)+/2>BGIZAGEV[!)^7Q70LL&];_S4\/1*AZ_R31]<HT5KD'EEQEJOY+NQV!<4AH!J8^4'P'BA>.0O#S4>DR$UXS:A9D<;N6J MI*?)6Q8X(T)F1."=#.[JG-.1K.W6887%W2)@:PK)'=Q^IW=.U*_]R-=\M1^7 M5.DY2 %P\AB.GXMD9' ?78--[_PS!D)Y1X,CB 06P4?AB-V><:@HR;SG@4PX;[CT+@JP$@0\/97W96 MG?E]N)4_E*#;>4^'#GINB+759D/4.'";U,*6LV T](=]%P0A- -691N; 8_KCK>JB#*\[;;Z3?= MX;#KYJ[Q>BT(QV.0Q>@O'^MH4CH52391KG.,WF+"!77\79E\C;.N5R,B5MD[ M9CQDN!+5,W'!<2+&G.894G@#XQY1!#_A!:.ROTAT!U2-VL;9&J[&58($Y4^2 M.C/.TYNP[>S.[9RO>TNB!?"'(/-3[)^:PKW/J&\F1J-'8YGV(SU0_P!Y#SH'Y'"7;AII2#KRD7&$]-N3^-DRB9+%7P>42J1_[+>DV/ MN\PPC*V:BCL2]H^A6)&@VJ(8!\,>KGXBY@D&W27&P)4!RJ))(N"3,ZF> DP% M-IMBH^XI/),Z@CK<8G8D(N[D>V!J\Q!^F< ^U-]\9$K2K==F3'YQ,@DLTW5D MXH< 1!!BWW1?=3#FLSG&_#,<:YE\7<+A.1)_S,]H%"5)H-KITC]A#["##%LA MOZ;3Y/A7(+"49G0"\V/./ FIB%XDUV% 1?3 .U6(&#,7F,YJP^5A0Q'EB<#R M/,438[X/G_>7J)#AKL4LC%4+XG&YX_0U$V&2H<@H[1W+J#!JC5WB+0V>"NQM M66I3$*@!L,4(" GXK2.S4"62:,+$OR)1*'$[8U_#&:RHLD?4F"7DW 5586*! MY(($/*/+Y\I",#(YQ4U_X6F])OD$Y:X*8DO5E]E&IY^D<[6JOM4S&9E&SR$(-\4?M6V)9&+$)HE#8!U*8).,"J61Q@#@=<@$ M0P1 6J0-""]F.G95?OA\7^'B?P"'YPJ 37]B8P[? M3H$/1)ER_Y$!/4NN.66-?\%5G(N5>3W[RDXDSAD2L^$LFJ6X3L3F@&1*@<<9 M7R^1"1CM8?,U?$YP:MV-B=U[4?52@@VLT\CI:&BCN$5=UQ Q7R5"@TTAE@NV ME X-A26_'_V(@V X SS;0M[>C\X@(L$.-&,3"0,2 MY.5I:EF)9RAFPE%PU M<%X3 3N?B*HTD\%:_OF*Z4^L!!WD..0)E'9%]IH671K)ILX5%^MG!AR M#IREX5P5WCYD LZULJ5H(J"R8R*J7Z&B'C5J;*]#$?BE(E&X7[ :-ZO MOD>\1:)Z3564&,M"?[6"V7 MOZ./2LOV43E$'Q7/]E&Q?51L'Y4=-F'[J%2TCTKU@JN4-?+AP]6Y3U,]W_E9 MQQ^CFM?$5W2*:KQ.N!V!@.WM\O0DDH/2PUTHC_YU$(S_HQR8TU/F_/O M@WO1:KE-;P.K3SJ"PDY,51QFT!RZO>8&V=B)J4]7XZ,3./+LB=(@U%MX]LV] MT4_7:/]._?=G007ZA]=Q]QU]VFIOZXY_&NWV!/,F/B7C=,'$$Q@XT6EOO:GJ M#)SX%H=+=+KG,UQB5PZ]/AKA:&,GW7:_Z_9:W0H8(KN=S9W3)'1MHFKC:'7M MQQ[W]L!;?6J3):Q>?J32+:_1Q),_S0ZPI@/T9Y]A_(3#\C.J2L0NHL=SD9]T MA[:DZIS[59U)9HX*0.R=N*C\M52XNM+]@&VV2($;]S,U+Y"4@=5.]*8+@JY) MWS-Q$1 3VTW;5+;'HY@>?9Z4:'[VH, M>D$I KDOV_RE W^84\%ZG,TL15B*N"494_F"G@Q1= ]"%.>O&E9N'M"G; 9K M+VG(R?]D3*0X9L/Y2#V-Y!/)7JD\V)0\5,P3D1Q+78&4_\XO!.=NQ"I%&3.6 ML1<&C<,H^/1<\#D3JNQL?4@#MMD0JH<-9H#_FB_PT53 M.9^P9HZ)P+9 .1E.)-0"Q32",FIY.A6<.WJ0SPUI>I1.UHZS[W.T&UU M>YA$[C6)#ZMN0H0.NCN>9" L], @P!!8I:F2T\U2]5IIU$PHG0CU>D#,4H<] M\R@NH$N;]=@/&DH.T,+Q<56KA-GFYET?-A/&:*6P()GG78)0!&'AM=3"2!6" M(YVH840XPP<;(&5BGDCLQO9!EQM(%G$LOBJ?P:#G=II#/()^PWMA&O&.DTP M_FLRHTE)>'R[G4^]-AC_H-A0#?0##P59=B( M!6,'6/%"W;:*?HBD8-S8W1%[6J];8\= M>&ZSW7.'7F<%%.SGN,'4 MZGENO]4G =UN#+8*Z"W+?N+S5*_;=.LU7%BW+N&%("Z)[)*H+C\Q7Q&;JL.9 M%MXT"HX,QF0\QAF/HZ6V+?.W-V5[O8;"_79QW/* EI=VG'O7@(YG88BV'AP M12+3',E'$LF69'83QR6\\,AQMML]:U16@PF#33%82$'M%"F$8%&-S6A.HI)5 MV.YWAK;.?Y07W,B4$LVH3L*L//A4:C>-:C8I2!Z9P:UA>1[$2B/#4@OD@W;P M?1R,<#O),[[_:-13WC^ J9GA#UF(EXJ5K"+,M MJKLS5[LA4?*8P-Y:-[(G^!M29B?%^F";0QFCMO,_G;.]CWNA>#7QYKQ0IGV. MMW N<#XY;&F=XRV<"YQ/#EN\<[R%;84G#U7D'E"BLE>R77N]CO,(BM]'%=XX MC*91*FH]#64]",SM%:^' _SY00_5:VTOZCT+"]B)?GZ.)X /.I,MJ?!\9[K;8[[!S)D6J1W2)[E9"] MU6V[K?[0(KM%]J>/[,U6Q^VWG@"RGV,$Y,A1C]]$(O6,,DQ]#]-#:*S5MG#. MP'XY*D7W6CVWTQX<'M)*.MXJ*Y>J+76.BH']?MMM=IL'!=(B7U5.KNK(UQJX MW>'#T\,L\EGDVQN\KM=UF\W;W8*/?81/+(9P)&U9U0,XW\4!D]-76$R!)7IL MZ*8 MU^Y9S+.8]RB8UV[<7@CVV(?XXC&4YF-[FT\0[WD_ITD3V/ '(5]OL&9S<"H4 MLCJ;')RNVV^WW7[/YN!4 ??/'>W/ >,';K/9WC(]-&1W882MMH\NC7R!3;OO9T[V!#":>R78ULG M7K/OMN_(JJO$>3Y46%56*E5;YAP7__IN"ZSC8<5#T1;UGB#JM=R>UW+;W8Z[7[KJ#]NT&VV.?HL6_)XI_ M%QUWV.VZW7ZU\<_JST\1]9IN=SATVYV'3TUZ M\\.G,5>ITL'6;YZT[V@7M/9#C6!Z]+('6^-3=2GXR/C>;[N= \S$>01$?PJ# M*2VVG[JBK=EQ>\VSQ'?+V"VJ[[&!U@#;+9]EY>83&2)[Y/#"Z[(%9*LYJVG- M'#?&T**!L9W>&:2H6Q_O$W6TX?BE/B#A 9H$6/RS^+>_2C]PF\.NV^X^?%AF ME;5WBWH51+U.QQUZ8%!VSJF<_2QC#(<^DKN49UOL^>VIT\U&^PS:HEA%YHE* MDV;C (,=+>99S-M?CP'.5VWKS6K/3Q#K6HT[DF,?^P"?5H8[GLX)8D![:=8' MK!JM4GC+9NR<,-!U.+6]&J$N&]FMNEA\=(0_0#ZUQ76+ZV> ZX+E9__1ZW_>X?SUK/MGV)".)N*GKV M4ZO9:CK_T]D?E$K W3Y3N%MG"K=W#[BW^&D.ZGW15-KNO;B!,7WDUSS.^#KH M^KW6BQM.;O4Q[\4VOOW\AD6]UHNM LIS.X.>VVP.;WIOZU>V8\$CP=_%=O'= M,X5_V.JY713L9PE]9]AWFSC6ZY[0/X@2;\H?V*?R\'4B4R<9.Y,D"21REN A MK$V_%N;'$;("_/^P &P[;;Z7RSV^\,NZXWW$T) M>8+;[P[=_J#WT-T?6S_8JA/\)JAAIDC&86HV<.LQ[W"(6XZHW6ZZ76]PVY/; MA,P1(.GVFFZGMZ'G/P(DG;;GMCL;4NQ1(.F[K?X&]ZJ&$#4XJDQOY[LX8'+Z M"J-U/H]3-N'W/)CMZLR6TVFU&AMFRN9R+XX-1GO0V- V'P&,3J^QP>D> 8S! MH+&AO=X(QB-PUAM5O[Q?<6FL]SG+OK;K-8=NM[G!V[\5X8\'T )3]IO5?EIN M>]!W^^UO%@,\MP?63ZO]8 PXG4@MN!#FOAQ1M0#LZ/<'[G"X [=^>5PXNAW/ M[;8W/$XGAL-SA]V>V]XTE4\.1\OKN\/>#JK-8]HGJXBZK?KA>$?4;'@[:.=' MO275T_ZQ0=A@;"<'8=-17#DFNCU_T&*GQ<['9Z+8GFY+K^?CG4G?:[N#P2,C MQQ!D7*L*/J#_@Z2]NB0>'@OW3V]7X\>+E'X>VMGQ3.V'P!+VQN4LK/I M\/#(^*,? .JB[=TR 9ZB]=AV^YLR[!O9/;(C;[>DFZ,&=>\K65>*2HYN2[E.UW*@'AD.(:#UC;.<7)+NCELNJWA#E+UY";*)GZ>VH1N/;:C MHQ)&2G.'F,FQ0=A!$WX\(^665)E;,7C-T#Y+(;B52KX1!6 K>7X[>]_D"]_0 MWA\<,#I*5O\A$_A__#D__I]_6L_C7P-TYVK0HT'[>_AW%@9ANJS76!PXK]D\ M3%GD?.0RR82/@>I;-W N]1.5!_OSE-=K*/=8O/Q.R+^SY)5T(G,Y0$'RBQ-* M!X@.1&+@C$4R<\(4'DE8#,LRWP=Y##_/V9*-(@Z_@=N$WXH,GHY"-@JC, T1 M B;A1=C=TN$QO022-0C'X]#/(OA2$$I_2EN?U&OI-)'<24:P;9:&"7YIE*5. M.N6.AA46"3B[3H1TTL29P3?@20Y/L%0!G4Y!4YA,Z1T?Y/"9F%]+BO432,QU&R@),4M$*B'/, M8\/Y7,"7G^4B$5_0;6]>AY6>MWKNH-USAZT6G@I _(;[?#:" VE[KM-JMN#_ M+Y(L"NJU$7F?!&<2SA-V^KS=XVS0_8G0*..#Y@6$KKBU8-Y-I.( M(72]\(\)=$34!_0!'XY0V!*A3%E,R\0.!VB36>@3:8TR&<8<=&KX)3 71=;C M,&:Q3RE*\74HDAA7=7-2)%)&OL!\X!9? M8+E M,8UFB&4&L8!=1RRV;.E$8/^12]-Z+01QCL@$EZDHFALD1+F22!24@$@WH0-8 MW0'P"7@QC4!BA>G4(8$&F#XEA0+^1[_%]PLL":7,U+?&CN0^8!S26;TF,W^* M]$M/DTB$_X*ID(M^)'U8FQBC0D9@#>1V !T&E0)X#IE P_DU$Q@0#%C'BP MUEINT#E044-^)[/1O[F?(J1PU%P 74:@9X>S>2)+W$Z@#!!T)K#.U4V*R,W2 M0^D#[8Z+%5ZM]E#I?EL4AY5%2ORJO(H[Z S<5K.[7479\GX.!"I*P$R?FXS$&]!<13\^#T< M])8S'X%2_^5RQ$'^PN)SNBE]#[ MN@2 [L/J%1%N%5?_877U,E (K;KLBODI M5M!6__!A=__. QT8QZ'N@[?"^/'GG]X(-F%@:P*?>AO[C1V\.A7<1%E'> ,6 M?B8EB"T2%%<@EI8RE+=N;%=\J.#6?TV$$O]+S@2Y*X)-\7H6OKHSU4_?Q_7: MKWPD,B:63M>H,V6%S(]((6*H/)(I(D";G.9JUD<^R2+2LYRK_W+>C\><3!HT MF":FE-$'0XA,77(#E9IN-ZPZUS\^0FT&S6"?/ 2S,;WL?,' SO/ M&6Z#B<4Q+.*C>86^+#0CX2\13[FRB%&]C@ARLO2V09H82.&O68Q_QZIOAWQ9 MH&&3];G-[7?#*GXH?/B]<"[P^]]% 3Z=G\:;Q,^0OK\3]/N7 &#$2]KZGXU/ M#;@BHYP3Z?_R51MOK]$$)Y:P9DZ3FAS K7G=CML:MO4^F/(!YJ"!<@]B%TQ_ M)\E2U^TV.WA;]1I>G-=R/9PPU.R]-*^L7$##^87! M32)TJ'U3VEA(-OH8C!>^8F@8=X+9(WU; 1 'FT\;7P"JJ0(0$PP$.E2.']2_ M#D5EY# M'CP-1(Z>V^G2@D_$>*@^V,C3K[()6MSM';FGXO& 81N7""@%M]AJYFAAR%0C M RV!-N(6EE:OW>)EKR7>N?%+XA?0019%L% & MP@-P$+A6NG3Q7T'FISKVQ/UIG$3))-0.X,4T1$>6@\Y16#-W?,<@\'(\1J_2 MB#N9U.$=P&"01"Q:L*5<\Y<10A.9E '%;/UKKOSYR)09B3%\#/F_ I!9/#NJZ:$NP3'NM-X0X-Z;P" ML NX)8NX_!X._@M/*93, :!DR35%)5F!TA$2)P&R94LJ*DIKW[BXL[KV6+F* M,8K$8N+_0/1)OB HE+P!K#X0J(\1.>D_O<3/7+]T J L(0$K2/M!N' ES%(I M8F<*Z$1,6(R.L&BI0BG+&V(GL#(LG,T#Y8F?@>X("XAEO8;\@L &U,K&#/W5 MYK/Z@.!]?!VVCW<9QAG)1+@SEBI.$2?:I1H&G*DS0&=V<3&X&"P *P3\FD?) MW'Q!A[3I@D"*"ES/7$LA?I,\+@9[Q6!G' #5B) 0%SF9X.3OUBM$R ?-%3X9 MAV[UP?X\#:41DX!3FC*09R6\@7##"4N![>JU\)"84C]6PMRH/ERCAT0"?H1C8"I$20&G9_#=V(G!)A)( MA\@G$B$M:1TE?0\N]_)G%J$A#>;%E .>7*')K!RHMSM*OZV#/VW*#>J^,49] M,04%Z">+,5E-VY5P9R-U9V"GX96QTI4I.47Y)^A/ 'F%8B^)V0A(+ J_,"\F MCP_K7$Q+[D9]D>MHZ?QT8%^I;+(M:0^4RW"7/J!T69UJ(&9$ M@)E0"I!1V=U5*XN,A+SH2YPL8JT$Z50X2^HG=&3F6&?R:_$JWH.&A;_K;7-O M4@(#NJ_Y2-2;M14)22D1$$ M^&,VIS^#]HL!WD!'?\AUOV4IN66ML*11Y]Y?08:UHC7YP]DAQ7TR>KHVH^<0 M&3T=F]%S(+2UN3PVE\?F\GQ3N3Q>HXFW>!HA"=?Q$:^8%/<_02.X0A7A""1U MZEW=7+UY9E.8;N@31'M><+P[10DWUN'O.E1GRXH;G& 7M>ZW-_. ML[<._+Q%K-R&@[M(I&<_=3I]%PYZSY=/Q'MW.NR]F8C@L^1Z4\@^4"?8R[*X MYY4^>/&\3ZG;'.[:>7 G>$_406GW.[J%9VWT'*K4S=^CS\QNE]X#^>)M]DY^ MR*T?3^0\J"-L=97,/9N$J:]?^7XVP\0+T'L"#*_X(2MK/$_F=&Y3/&[0MX^A M=H 6W=FA==YC:QT[2ST%Z&OL:,/S.(4J53A_I;DW?- ,FB>G- \'@+U[-O^N MA,Z\[7;^&N6UW6;%;UZJUW?I>"\XRFLFWQQL(2*_W#^:M$>XQ$>51*MG>B- MFM*);^) 7?X[';?C;3CD*]GF?WUVSVWV-_P\IXEM[V-.;X+QN\IPWB%T M?2Q%?-!W6YL^LFHHXK>?W5M*,I>IJ1HZ]DEY .\N(WLK@5IWA#D_Z&3Y\S=F M+C S8C-&?=(QT[?E0SV2J]?K@@;:JL)0PSV3(JKNP>T &^AMSM>JG+_NV_*K MMUINL[,AQ<[:L7ZS@*OL)?3<86^#Y3P=RE"BN-7;S$TX@\2M'1'BJ86;CHL-G<$0%,!=DQ]LS.G$PNBG?U'//)J2 M0U,GQC\\N>T_S#7R6C<962O-/J;-Y.%@AAUFLSZVMK*S:'R'0AH/W+*0*[7/K#_Q]Z;-C=N7FW"WUG% M_X#*3%S=59!&^Q(_DRJY[<[3\\9NO^YV,E]!XJ:(- @P6"0SOW[.=F\ J*TI M"60C'YR61 +W>M;K7*>H5L'G(LK*:"HU+KM ;M'_8?]_:H5T/*9QY%(5);*6 MIZ:]'C>KY-^7R.5%_'PU_+I RA/F.2F7:)$("PH1JX-DRN"381 G% P24C^B M[\E3P^F.VWTC?:T:!/+$(7H[SU/E$T@C7UFL*E4LDDPS87]1NK]?8Q9B*2'? MRH($9)._UW"P_I!C/SMD-_R11IP7NG56LG)Z>D[B'E^O(F^#:&D)?PS=LJ)J\/AM7 M^K>FOP;Q-/V@O_XA0P9YI%G^&]A.R^"-?.^'#W_3WPC'(TOI3<+@781\GEGP M;J[2- S>_?213D\LUUK(O@T'6:+CI91%14)#;*NG;I":-UT9B:5BHH!>%OE- M$A,60 F(ESF",Q#V(]Y6[),Z(0Y9:(A.YUPL8,28:=$_DY1,UG7]ULR),E:?"FW=)XC_[R=OLT MUE.XPLX&KK!-<(6=#EQA0_>_MFL],(8-C&$#8UA?]".:XII+]1YS')N+961+ M(!$VVE+60'/-/;.)>0Q//C\YW!4S5AUZ7[+HNCG;R]VZFTO1XV=N4/3X_#BXOSC5_Y%[T[VW_[D>#__EC"/(KOVLN3 M\]/P[.CB;2#!5CP8!:=FN,L/GL>Z*BOIUL6-(ZD3'^<(8@IN1-,IM^:1Q_ % MDNXA_A/PYM59B2TF,:R6Y=F>B<)-X,;H;$%<8WO7(%:P%KM*WO_Z)G S!X3R M0&6E$ )M[^78_NO=W!FOLV$S@15[::M&MLOJ7N=Q&+K=I^?H[0ZBVP@[%J ( M\'-JX]'L >8KO9KDBA8-FVY3T(,3M&75CG<@0.X/@][CLVQ/"647)N9I%91/ M S]U3.VI\W@"@\%+E7V>77263>J,.MFV:VL_[UOYN\I!GP8[T@_H?/<:]-A! M>'#9JE9X[$BZS].S5L$>=5?![O6K_K7]2AME9<]H&26DGM;&FQH!IKX77$A$ MYZOK7YX/ 7Q^?([AI7X!7+_^H*!:,P&'[3HR!^"P73X$XOE:1T;B$CU C7_] M.8D0T+8 >V=;CL?I >BH\Z^OJ'O&FOBS4\1$]$.B_/53E$;8=KOO^WJ.Y:IG M+2+.'NWKV>EI>'[98J?JQ;77NVSN._>MI)N=WV;X7R]TW??3T#+<>G0.+L[ M2.Y9EX4'5[]\FD>%VN.4PH.K=G>W(O HQ/CPY>^8LC;5TQT&)X=GH2' MISULL?*(X$!/S_7S50F%IV>P:P<;;5?QJD=Z,^22Q^')!2CP31?';6.QU#U0 MT_,!:KH)J.G9 #7=[.D=L*8#UG3 FO8UT;Y=U;GD!XU'[Z)E0NRC6P:^>$+- MX^NO^;M\L+ #--S#2;!/3?JFDNL.E'#957[L7P":RR'?FI]<3 M*H>7Q^!7M]G$GOZN%V6$/CH/SR_.PM-V1\/728KSF=5J@'@5U!^JF"8EDA$$ MMU%11$YP\MFR->'IQ4EX?O[(!G;/-Z"3\.#@/#P\[DD"Z8Z<0VO_HI>CZ#X[ M.0T/+A[9M^T94\+AX?E%>'GVDD19]URHJ QFB(8O#(;2Q2<]V^D]>'SN\QDO M]\$3AM.'FX1%#%*^@6[QLZ_3X2' $# MZ]FA2@?'X=G!(S./SRGS#@XOPHN^MG[M2GRNM39^^_3[#O#^'UY>AI>7FTG7 M;?,ZG((!==).T;]^VG*MH_/DO@'(?' M!SW#7:[SK!_LI=SQH%?%TZ"7;@2)V]A@>'_:TE_"#1O$@GZJO M&W 8'G7;VSMTR(Y :,%!:\, 7_:0/87&UG\_L[P^/(L/&KC MT7HJP^X[4V65@[V6+X7VMN]+?[3CA^LPO#P\@#E^?77%*[37?9(OWM>=. M/ M+BXV5.?2USF"NW$.;L?)\=>C^E^S"QOGUNB0,4E+W]=]$^#YOL[MS='Y<7AX M]C0A_4*]>YX@NY(L2!-5H\J<1N6\[[MPV%GAM$/'[/#R8B,S[),GN36Z$0[7 MY6EX>=;J%;]+!^P\/#X_"<]?V]+?5"NR04WV:FYO3L+CR^/PI$VG\6**'E^$9Z+0?CN+75/P^ M*C[QE[5 M6@#09O@;MW/_CS&D>Q%>GK0B/CM^K9Z-!.+B,#R XWI\UM),O>X6^TK%>[VK ME/R$)MYX9&R\+2N1?(&.G"_*E/P9NPS,\C3-;Y&\/6&*ZK)>P(A6ZUJNNF:Z M[@2[V@]LJ:+L+I6Y\\W#J@W02TC*8 S^94'M8;A]P7A4$8?]1,%0N,7#/+_- ML-8#_KIBWGJ'BSY$YV&FP#J,P^ :HVCX#WRA?O[&*:R' MSUUH6+!'ZPS]$3 MBFE[;C]V>YY?6US;WZG_4U_.*[FSLTLQ$N6VWYT)41_2V[/3T[" MR\M6!&=;ZFWW3UMQCU>JM'VOE8 >SW,5&;Q!4/_Q T#];Y][)%VKWT,?\4]_ M_1MKY0<)D5X7W9Q<'G5!)KZYXJ/C_8,>$B;>*?-?H/HH/+P\#L].'\F>^^@! M/:3XZ&C_L<7^KY "T"9&2S#T+?[]YN3@-#QI-XUX3.*NO[/K4B/]B.T_W%Q> MHV&^TM[>IOCBT''T L'%;VA-#P_VVY5VVQ*O?_@^W:DV'Y) W]G]#P^. M3[M*27;\5CT?;_/^V4.-YV\D6/^ ,/(]3,87 Y/Q)IB,SPEL!Z6?+(:YAL7OQ783'QZU$]\L6NNQZ?O+HI+.D^^53 MJJUZN\W6@ ?,@>'<-V/F/VZ)6S@T." M8QT+!0C#BW9!ZK<=DM\2_/P_#67 3CBTO1_VCW4!=\+&_@8 G= MN(>N,M1,#\&;[](8(R&_?_HQT'OY74&_>@O.=C4/H@#_YJ/D]X,?% TCR;BO M/5S'+)C61:&RZ0I>&%48?\GRJC/H,JNS*2*;H]1\AT8)CW?'0<&60OV[3@I% MK;8G^.,4I0XU78@TT4Z4CD=I$DV2-*E6-'%\,WP"OXMQG2OOPX'Y[!UOO8E2 M7"B,)0?_KJ.B4D6Z KU08EPI#V914N#6?U%50!^EQ>)]F MX(+9X5=ST"[7C.1EA,CG3Q7\'\:SI[,_Y M>%2H:(H7KK6MW@$-X1.L:S]-YWD*;P$#9EJG$=6_P/&L,?1H?LDUQ?@ CE@: M41"E91Y4113#$W*.='[\_.[__V%_/,(SYK^"1[,$ >,,16*L6;"HTRI9I@F\ M:[*B)V6V^,::/5;LX-E;\TTM3=0??(]@66 20<2B!*2=7A,83)+'?*3QYQ^B M[ M=FBB+XF@XN"\T;#D+X]&/\($;.(0HJ;3XV+K9;&^<^[$!$*F/QHOU?Z*L MQAS)UP4_'H((;O'JO(+'9@/4;<]AK9/UKDNG.Y19KIA;&]=^D@OG1*$W%]=S M ^)/BO&=8^2E77_B#+9?X3[GM&\JV/>0\[YFF?H1IWB1P_\-Q3'@Y!T!+ V&JN\XSKU.Y+U?*#2\.+L-#P_'\)8NV#4$I8DM@9MAV<,QAJXY25* M/_9'VEY;EF=P^Q9+\-^C*@<#B_IQ!\NZ -<&7'4C/RE@,H]NVFP$^!<823*; MP0TSKDY' *4!<"$/"U^&80G!L933?$EC^W#U*3@^"B3T\][,[4-65D6-P8?R M+\&OA2KA7^152D1H'XW\*DK2TH8;FBX=K(%=" ZF8'],@N64 ^[E57N0=\B< M^S$H'XBU\T?PP7LJV!E];=.6W5P!VP#R,5$[)U5$_EF=KH*CRPVR5VW%PKQ' M.?(/$JC?[B+J7B$:TWG/WZM)07'84U_)/3@NM>XB/QN*+3P[/^PZWQOFFGCP M@"["BPLDP.C-@!X9[^[-0)Y;YW6<_[5&Q<\1N,O-.W&G2K];NG15;JYYS#J- MN(687(Q-'88G#Z8IW6':H!-LAQV>M_M/?G-+T9(*PPJ\/H'44V3DQK;C$<)Q M"R@DGANNC$ULP\O35CW)P,SQQ"3*67AZ<1%>7KS BFZ?K%KKB6V'U'["J7FX M._=U8GO[4VKWT+-<#O0LFZ!GN1CH639T; ="EH&092!DZ6M5SY:B-CYFXY&7 M)O1K7\#G4L4MEE9$@L28FLH+.J-5<#M/IO.@@M?0-PVX@4@^IFZ=!A6&G/[E MD$M"]H/?5%FG!@PR'C4>/< @!AC$UQ1+/S@EZJ,@@C>_YF6UYQW&^ZF >Y/? M?20TXD&SW=UL^!.@ L^X8B^4-C]YL;3Y&O(8S!$<[Y^VXNJOQF9S>G@8'K6# MV[W,.3_3%+8H9[OF%#U7'O 0NX:$QP\A_1D2DZ^8F!2A?T=>LDOF;%],\S0\ M/(4-:7I%,U-VW80LR)L^;B#KC/-1+,,1OW[U:8TM\ZPF#P7GO MO?.^RY[G-X3@OQND_@TMQ%#*,)0R/',IPZO'9-8,Z.3B*#PY6C>>OD/H#V'T M1V=;7<70KZ#84,/0HWC8T7%X]-@^E<\WH,M3.*AM#M0M"<_U9B"O$"=<$Q#L MZ\GGR-MQVP!]K1T^#L_!VCFZ>"1;3F^.7&\&\G+2OK,F^RD'_G3_X-DYUX]. M#[IHZ5]K4R].PK-!SF^AG%_K,GY2RXJ]F\.35TH*N?=H>T.V6)RUF<[NV[P* MA^'9Q5"M-Y2H#8G!(3'XQ,3@>7B$O17:K;:& K6>LOQMLZ#:9*;UQ==AJ$[[ MIDL'FGTUUK75\"L*8$S\.?QEFLP,\Z/)'3'!P[W@\]Y$.?PG@0FE%34X\&VR4 JR:/3/^N1%&H1)1D^:OV8,J5B MTV'#="\=CR:KX..TRO$[1UY;$7A\]W>0Q/_GR$1_I9X"!X@\F*FJ5#P0\_>Y M'ZZN![5)RLU[!P"9B36'#:92]WFN7"4GM ]-QB:Y_8(@+-U&?4VW& S M2?1MF/L_]>V\DMMY-[*HUVB"LRWJ)'PA,@/?16APDVN X/+N!Y5KG;WQ[91^')X5EX("']/$Y MVK]\)$)H:-;=5K27QY?A:3LZ]J!7WU^U_LKS ^7QM)F]I$G=L6@/;3O^RLM[ M'EZ>'(D MB#;-V;%-J]EEE>]>1[4[;:U^]U1[WNV_ #/P6\QA/^^JGNP_V -[^J4:$I?/ M/^RK;FO=]4-:\?8ZRW/<;,?]7#6C#W_1NH+'72,,^]KBU"VJ M+ESWI.-'/VD[ZA2WL RN\S&]WY\G5M.]W-7AU3PZVLRNR'.>O"WO?OSE?P:' MQ_O'+W!QC@Z>4/?U*A?GZ\KI.A]S\C47I[=5>:]>S/#LI5Z/'L##,,=#K=GS MU9H]M\AX[KJ:7CW_&PK%/7N WN3DZ&-K<;*+-S>70YF9H<^.*J*'- MS=#FIC=M;JQT$(W0>U5&E3BM@AE;F36%+Q31M*JCU%21=05TL6H&_M1:;"JP M.MP']8=;4@9OVGT>OLOBJ)Q_/QX=[A^<\\?>#I58+]67:,87QL0B[.YRS@;+ M_/P #6CQ:@Y'Y#HJXA*K[/#[_T@J."$?0,VG,%;2R5?3?]=)F6#?CC"XE*=+ M;9>MU\+F1751@+1"J3L'%8KE6:J<%OEM*#5\A4I55-)8TE50+V%(4K.'@DT> M"?-7995GJMS1P_/ZO;?>%0D9@>/1U70*+F*%%_]7T G31''IW4^P-(NH4N6S MS&78!Q[FSW ;ZD)4_.]PUXH*Q'6U"M[\7I*$-MOP=C>O0O^&37IT6:AE5$2N M5/(:L\V2+,JF"0A*4)L5[1\5H\*'P!=9)+"#)%L_O/_MDRZ;+F$BVIY#<;B( MOB@0C[*_=.DB$-2+);ZUI!KK\2B:S=2TDB+K95Z0;E_@C24M#5]0%4PF3<#+ M2N%.X\SP2:CMX4[CJYR_(>LO/@HG\?!YP?/&HZZW%^I&9;6,7?VQ5%D)/\14 MY>X,&7]:PFKG\;X]S_2=?]7QM;R#6]_!9^N\+D$WJ)LHK6E,M##PYTE$]>*P M(W8=34DQOKU(2%OAYW-X>Q',P-S)"ZQ?SZ9I3<8-?FY:1;S$,(597<']"W B M%:\YOTNE"?PN-FHK*O,,BXRYOQ]KVFE23.L%VDU34%7!?^>W\)4B#,3( IL* M=!O,=!IE09S 1A9U*H:0X/ M^(^*=;6Z>^/&H^XK5ZAMQ4G=,VRT+I/ITU0ON!7HN[[,;#[]]EVT6'[_TX]P MV:,_@FFAXJ2ZSQK:TDWIW[#IKL8*;M<"[H>KA_E>Z9\^1>67J)K.U2T(V4]@ MO8(*@;N*G5(5^3JTB<%/I![P;L$]^Q'$=)HOZ;*^^2Z-48.8W?ZNH)_?!G;3 M4?E-57)#\O\N90X&];1.1;E,Q,^!$X^F V0V*N>L<%%E&#XS0!4Q0OUVEU3RO MK^>L_"SHLPQJG"E.,[M48*SA6JUV5)]OC>"^0O0QWA\DIBE0K>=I M"N>=3TH1Q:Z): _7(-I?4K1K\8%RDP2(8XS!+V[G"LW\+Q2/U/N)K:T?L9\L M'@V+EO@3X"I$T[GS.4*VZRASP&:=. X@*>&C(. PDDK^COY2&"RC%0FY>5+" M1U?B=9&^8"L1I*N>#T_'E6L)N&Z9G1E),\VNQ8]JJSKSZ4' O+)EB&W=]\0= MU>< #F)6(J$5Z/[=W)_^#=N7)!Q**\7%*NG>E':K@JZ=8A-++99IOE+P75#J MA0)'G0()XLC-L&G2#35-DIN(%Q6JS04[KNDM 8+14B,T:B#07%B0AYDM6#, M'@4D?--(J2@M\^ZQX$.T-'9"5-$DKZON@2;9LJY J,D:-L;M!&1H/2DH ZN3 M)C<2&1)6-HS-%"2U9>"TED&N!P"?O,G1XDYQ0W3^("J^J,K;LO&(#-%TA:^D M9VQAV.6_?OCK?WTP=_7#7Y\Q_;E!86FC)^/1VFCGUNW%-DO,1G![72R[Z8CZ ML6S7!X1+CA:<QU<6OM MV'&8U[,(=>AX/'(\>?;RRF:(UKJR/"EWD 3(@/]>Y_@7D/)(F&J<_Z?$IOXTH @'%.& (NRO&;W[$93!!WA) M'^!Q 9(83'XQ6?,9.'.J$,R'"9R@(2@1F/A1493QR VC!*\818&1E.V\STM' M4< Q:H51@L=&468J=.(B(06D]V:%4IR(Q"P=1E5"^YU&O(7=LSBY26*,BJ_0 M)C(AF"H'!< AF.TS^AL1E-V0IV"4\-Y0(/ 8!I M:M+V, P.+/B9+R>F 0X_"*9HJD.EI7)&C0$ '2F0$ O>?4S@#=* MQP+Q.+*H MKN9Y01#&_>"?:V5@]"3J9T,EXQ+$3?HX':DE* M.B;[8);"TZFW#LZ78)T273'P,/)SSX/V&/Z?)%XSA$,!#OHX? M20J"LB!B8677X%IERH&Z1G]0.(G/Q2#?>R+?,0P(-V"0[B\U;+WD*S(+R0R- MM5A,0? 1(199T6@I90ICQS":_]#EH8_OP]O:OVW<7JG :1C+6DO$08E5."AS MD3-L?SSR( TF#.M]2A0'%=>T[4PMCM6"HNUHUW+1#D??LRJ9)DMZ-:+5DE1G MTZSU.\B$7LB$=QKA/QVDPLOZSKX%-G7W =0F^%TWDA\SW\9+ NT''S*Q_JB+8 KV5N/M&E@)8B15UV ;@5$R50I=1">'1'A3=$*O M(_2]?7QH)A;%(EII@PS,F4)=([ UQYYNA8]YG-IR%?I2!B_6.21XYM1[OJG7 MF*!=##/!Q^5+L3_*L#46- )Y*IA"!#EG@%S:Q$)(%AEZL&656<3F] -"CN'J M42J18++X.QX^8KQN%=ITI?_8P'\J&&VX'R0I#3:KP)3<#(L*KN>(OBB:UCS_ M)6RCP*P%&C(B;!7Z-AM"S[I*>6@7Z''F/-##9,%SR=U-HZ*@?*47=VEN!1N; M^\$[^Q['_LSRJJ.$(7OQT9:KRZB57#H+\\FKKW(*W)7X]KTM' MU\4U&;O+^:KD.N1;S-"0]H%_@!A4TWF&?T%)!^IP@9H4?YJ4>:K**5K+#)1E M28]JA+ 5:;(@@9WIM76*#KBX0=#R(E-[$V1(*L6)@ MPLY!VSM^*!6\:C*WA)7+,6;\PI[MP^>[UN M_2(1J35I#)CBX,KY2)9G>\9EX@W;.B'T&(WW^KG/CWBQQZ-/'1;TH+9>WK+H MPA ^J#C^48!"@@::;091#Z\S@=N< M?H:9$G9(18Z$$/.V"'+*PH(=CED)7> M][N,Y7LGBOE,S,IMO'[W1?=X \T.6IBTQTR9$5P'YD<-/CGPT&P/?VH'[@W) M+QM7=O>>.L"7D"/!(_[G MQUTZ75GQCD%^")F$^- ,SH7?3<$TX];R.PN%PR3@TLP,1 KC%1 M5V#D!T;B"AJ'8\#?'Q?P.-RUX:YM^*Y5C[UKTQ1N&YW:=IF ]@9#O%PB/M[ MB'V%(6Q%.IK)G"\F=#H#D;U75FK)2#%$/'!%!5FIAZ>F*%>JCT75/&Y "-BP MM#!22SS$.]?<.M3A8M.$4!:6J+ <9>%M>/ H<'?:&'=1G$?SVZEP&8H>/9X M9*P+JHMB(L+-7JNM3(^]* ^1B45W67V)I+E <,0)L@*CV2&P![>4+Z;]T?CW[)L[W%HY_,G&J,G- SH#D1F04%<7S&:97E9'0S M0"UJ+AYHF?9+N. NJ^8(D)!N&=[;]H._(3Z2QYMC*$D@%U2GJ4 MAN/SK,?G]T]7X7"&'H.CW_^T_^V='S#9T_PZF98\GD^KLE*+0?@\C_ QH?[M M-"I[/NCW&K M\$I#5KN<8AUMVU/D^CJ.*M=BP!/AKQF5^CG>L?-(1,]'Y3R8P2 L8G4\2NAN MM]_8Z15;'PH'HUM0:+?8]8:OF]ZSIC,@@'U4VNM%S2/EN@]TY0HUARDC]DY8+71WCZN/[S[HQAZ#"[[9U-]G)XS$M$&3**7J MC-WPF7L^Z#7!7QU)[!)-7=+- J$:MQUKMZ*$V 4Z>'>==^T'[:&8T-\Z$6/+ MU]IB;3_PHH?\",,QYH<)B8C!0'ZIS V&$14@V\U[&C+SGLG<\VZ'G(S%FN8H M[G@7Q63-RZALUWZ]9-H92PDQR*<7&/1/LC_CD4OK Z8 70--_>8H,S@BC=. M%8<98J"J5&F(8<=Y;]=.&\W+A3..VI*:_B9]D#5,5C1$XFV;*EC1VSF?':$. MPG:[W)J 0._$&C6C4A:K]V'82%:29#=*^M7-57P]!*;[>NJRMAQJ'ZL[3"#- M*/-'182)6*%@##,^;\TA8''5FK<*M^'#7NTR=7G/P_?C.>3#7C(GE7WBLLAG M2:4_$/KR%%\$S\FH0K9C./Z7M^U4/P"/<@^HZG@ 56T"5'7T38&J!DC5 *GJ MQR0&2-4 J>J#(GX!@O+!1+X/2B4Q/[1//=+I8)E&X*%_:A."U#Q6N1_8;/PK.$:0:G,!Z9.>A6*U?X)(H MX3D0S\7P(L6VF](#V),%@N?W+79]F5G784"_'LNHDE@S]LZTUN@X#$1/CQRB MSV\$D=)XW!>B%6?16FC+[+\=!F< MMTRG=;&+[F+?I]#92U6GKHC.DN+2.46P]CC:!M?@-BKBTNV?ACT-X$++<4=> MLHSZKE/SN:)>+\2U'.3/RT#DBOR[SO&!S7Z2;4Z8Q0)#@=Q6,KC2[>-XE$P6 MCC20,G@XB#@9'=B0+)V?!G1ZLXU'W0($#W^#HJO9XU)8@[?L2#QWJYMGG\!O MYBR.1W2^@]_Q<.WB-O1MT&0^KI$%.AG\VZ??2YT,#I#+#FZE-1I#K]E-8?O= MB RR9A[\@QLO(M&V%BI:Q8*%(K_A!C*.;8(]#3JX:W[(05J@>/E1O[^)VJ]L MRYDK1UB@(,CK"BGQ2!3B_*BO@!AME'YR#;_,/DFW98CQ"PB(H$A7A9!XMS6D M(V?+S>TRB= M"F0&1!#U=M(Y?_IP5('4G-05"35BT+)F#7A.,0I!D5VW"@-@:(@)1,@Z$YXQ M!):4(Y@\"YS@ H1:$F<:D08E!O#C\'%CPHXV:2GTG9*&;WV9.I'GMQE^P2!F];F2WI5"@EZ9AL'B2FB/V^PW'4! M(ZT(?.SD)6W;!GN!U]5E$._A()P+07[S95@KEJQ26 MUS*H.=S<[7Y337A1%ALV-HW@RC-N#Y'78)N!>+JFUD!_<;]6S8G/N6$,&2/X M_3\^__IW;06'V#FL]A!IY_B4XHB'VKDPV,1/YI5ZHX[/]T],-PP%^ M_^L[CTJ2,PCBF^)-O',?^[EI6ZF"O,R:D:8E==AI:2;-^4\%"PP@M%K&%\Z/ M4C3ZNSJ!\W1=@\Y#4]5(1K$!9R\3#M[IDD5 MMUO&([/ C_XL&Y$5"WEC*JQWKIMK#7L4+.S2>?:;/H^8LP/P3 QVH?@ M;2=8TJK[T^BDJ,GS)06%=@M5K=I]MQSN;]RJKNE:U >NV9JY;]D]V,K+^U.[ M2WQ@.MG-L2TY!4B*B((E;VQ&D KB.+-M3XM[U=[RR?'\"CI](8?4Z8BT<^.A M20_&$?$XDI(HF4_8;6(QC3+N8@'_GQ2%NLFGY%0H?1G?$++-O:V3U9[[$T;! MWW*:'$GD!6&Q('1_-1ZQ1MRV4_CU&.>3 >.\"8SS\8!Q?H'V20.X>0 W#^#F M;Q7T!M5"HCGA=(Z'N9V(3#&*7OIMDTG? M0":K4T+Y =HME%0[8D*U8^4/E$QX93WHJV.,-9Y(E@3&]I+%$AY@T*U",.W' M$OTFT42\T6H=[97D))A>J.J"0I9(@+-E>[)CP"BX\!_,-K.T[TCJ;?WUWX$B M(B^U;>XYEHTR#A2U+K6=GG$U&=?Q3<&^ .4LVAIKZ9K;:_(,ZQ-R^\%5$P4_ M'N'E=4&LWON[G*3$)Y>*,ET02-A670V9)C-5P4JLFX+D!OF7XQ'81%]TUKOE ME46E:7P?NQUJ0?R!)355G81;PT6_J7#QWD=8MY)K% MNU4ILBL1W?^:U6,\,N:1-$@6DS5^6W+L#)[([TI0 :G(>MTPDBT^P56O/VOA M>,0.+*KXO!$YC?8,(^0QAW/OD7)A%O%!DVC%"'TP=_I*)=KFW,%[Q07">,9 94H#)/EJ [;Q1<=)6Y%?/[XU&K)0TA MW!J!A+:@:H,<:)Q=0JM)5]@.'=,8J-K_+MG8?"7&B@JU0.XW#.(\F,1WVZ33 MCH&M'=C[((->W;E9B]MUBRK<$I'J-G>PNSO7T*CG@W[? 75NXJ1)&K\-]H+/ M-ME4/N,H"3"5Q6Z%O .?^C!C4>9\0OV!X8A0@ 93Y 'D^($W6P.=0'; 143$6M18 MAJBXW!%5M@&.AEG:7"B)#[ -F[]K2"^4S4H3$G:L/\(.:$!HA)$&02',THMP M$DA"27V;D(PK$1IC?V:P&/X8U.-[2.VN..S;H(5KM.MX:A:-4I@V550QS9L^ M)>:*.D%3 A=2> T.+T9IZ4;RWV#;:RQ[^,#?+RG^IO\T'M6E0'#,50AF-64C M&\7M:+K@( W%.KQ=>/?D<9HY'7Z[5T5_F&]PUSRR-PHUPQ)FH;\0/"-SO'&> MM"Q-Y;SA+S5%(M@&:F60#9P&+9=JBK @C72B-1*&0'VOZ-5QKIA80"Z63##) M>(HI6F4I58LS[8>Y\D3Y@>AP3C3R!JV5,#Z9O&7@*^=[S1L-([9]8WFD$Y7F MV?5P"5]BT%=P^CL$=YZ1P:@!.#-7&;F:QMC/S6JNY)+DR*^D MC_$\N69%'&6=:HMF?YO78%]:O(%S\.=1C(O07!OZ6-,:!Q,AKTL*/1 '.MXO M7!+LTXG/YG57,T3[$=QM5J<$=B.YA),$5P1!381CXG0#[Y'N.%$I;JZ09;5) M;CF&Q)9[S$^Q\C=JT/_R[N///XU'GZ_^[T^?MDP(;,4"OV-%2;%5:LP8_;&+ MR]RW09ME3\RRNVQ-;C3(Z'DQ::3^M*M[CT88.SUA)D:XH\E I@;85E%BFMG MFR-AP*O!("F$G?(S_TG:+9..@9_2Z-:J$#3P:VFO(V\F@4A6C0&IJRRBL6#C M&!W5(8"H_"%L8;QY?*DP-8LG M$TT8;C.>,X,2'JDO&(/-])V!L8 GDPD#&!+^BY$ 7Z@C:3MOHI4$T6>>)?[N MM7!F"[F7M3$(KP 3JJR5 08&?#,IY\H!W.O;0"C_99%L86'65NC''Z6+M5&0 MGP<%^1*#MNON"!1/!(0.WD?*;+QN19KC'OTIM0#=@DV>O0[7735#IFA[HJI; MI@SHE)9AHY'NGU4=!,EJ>Z# M0)5#A"4G(Z,P@$<$8SV;P!6K'& 6INF:EE\$AG2K:2H(!2+R;PWZXDS-C M@KHO)8*!ROQ)*^#6>TW-4&M\JI1B(;TO9<1_8%Y";(5D(W/F;ZP>Q61=[83N MNP?[=C9@WS:!?3L=L&]/!_/HP6\:@S5@WP;LVX!]VW[LVVN[:\@1E55YL=H% M>Z#O@S:+/1ZYQ1I%=(M5I_ E;( F]/3U#&%K5/N-V=8ZK9*](H'LECD57 1:I.-1]P-\'=T MIS3Y5(;I9G8AR'X57-DOJ@J:OVTD=*.RD2S7-5'(U4FJN2_BC^5@6@J2WPX6.)$$LXF=PH3>$<\_QWMS*NN MSGNT',043CZNRX."KFM)C&*\[,1J/D%^>^GY6<*B[BWR&WPXMVVG7!M\61 Y MSH;=@O$//NQ>G-]FU.&^8YEWPC?HFZ#]#1D=:H&:"#)R%]>Y;X,VZVXK,=N, MI[KO!#O)MKEBX7#(F+P27F_\DKUJ^'44T-BP6Q4WR525:Z0/H2R[,'Y:)"&C M*PV88B=SO*49!1,D?FZ)=/C5&M>SFS"5/D-G/\$Q*&D_Z2!LV?)O,Z^IIQ^M MJ20W HT +!LM"-#S5;83W>W'VT_[ 9V-)N:3 J=4D)"G.EZY+/*X1@P>0I$< MBI PF"AI<9/Y'^1:AS3A!#4' $&XP43R!2+B#+B)F4_K;%:GLX0+7TT!!$=: MIP09BJCT5S+F_!0CE:+I5"TKHNUJ#!@#JS2(%9,447I-P%/.I'0H%\E0EF:\ M%BB8YAI-7 3+9/H%C:2ECNOJX80.Q!#95(3IC")1PCVGP1CZ&?1%IGNS*K[SL6[^S*1(V(30J3/^M-'? E_4$S:GL9U& M0H@?->=RLTF1R[-GH8642<(,/5T\_3&7:Z"O@!OGKV&>!5Y=BWJ,F$ MB;01Z*C 'V*#(Q;OJC2B;(&<>I2]CS01'GHVN"G'!]A%"59(BA)*349 +&7X M%=,[&FFCI[OI8O1MT)\HL:1O4&EJ14@A+E.C1X@A,61G47:]%8"81T5\2PS] MY-@O,W '$SS\U[JJTL%@#WP'U!5/%-0])77(]H!5I MYBTL8S@R0+3K?':&J_,2>'3RT[7GURXAXH(0=@ ]@XSN3V)J1I9Y0CE>+IXP M,'7?WT2ME,&O8@H*1'@HIQ$QB6:8R*#G1&49L3E+3Z(1<5/3@+-J_#IN=DC2 M?$?C.'UV"=^9. #X!1((V,4]Z-N@/8=0;+G2B(^'/;;%O(O -&?R#BL9H M8!O<(QN9M0^=7\\>I][([.C"%T3=9TY M+C7S\G [0FW!KH?!])K/RX^5=(TJC25Z# M(X_A-'07R#)&;.B-@CQ$7&&ZA4E!9Q>Q@I8E70+$'Q79*-=XFS!8KJ\438(N,]@F"$/[ MDF%H>K+B3MIJ&SO=;.6Y_)!1MV_%_,"=TMV3(F 12L(#/ZP1LT:P1L9D+*=S M%=>8N)1.X$90:YVBPW*B:#&P@E7PKN$98FA 1N+B0PU%N7ZXZ>)X)(\TGQ293C6B*/.QQE"I=5I/*UDII73+@+5%09)8,)Y4<7"3DZ?Z M3A99D+7R>UE7:E*0KL10T%DBS^C7?(K,5B/?WK9;]/5]H,\'F.8F8)IG TRS MM^S2 UIS0&L.:,WM1VOV._A4,ZZEJ@/OP2:$\B=,*E$]G3R\,9@6!!_6/8)S>$LL0,G3; M:M<9@9?0IC;E0K%TMJ*'E?,BR;Z Y K)!B_)ES2P0C.@D#W(#M!F&YT9Q;B^ MTF\VLA'J'31IMTDP?#!D<./1U4#P]Y*,1@T:/DU) M-&C?( 6BJBJ225W13=-O6A9X^?PZ?J+0JOCJD!%.)(._@?:/"L1T<)WSC4IS MI@CED+$Q2IRNAIJX#P=?FD9D[CZ:-6W/.*,E(T(._K FF(D[=Z<+VU$X8PY: M0QXN].M<:$)P-2G?;B3E:'O*(/ '4Q8I?!()(:*4$#2$9#LZ^#-33^9"O@H7 MR>8SO(<:G<*4&^ M2[=M%^-MGR;6MG/_V+;SMFQ9MG(O/QG#3Y>]MKNTJ0;3=8M\J?":0WCP7/HF M1:@">4U/#3+%RAS0.3.T+R%Q^5X@!!I@Q8)F?&56C"2 M%ZFCM:@V+3LTJ$:,9_,-Z;]M/!(0W:@C5C[!%*@&CZH>%%8:88:7J)H(V^/F MMJ^0QXG]7H7'F54-MLH%LYQ-(:3REIXCNA3F;@KX("8X$H?9+2-6!XYCI3>/ MC/KA_KR$*<,=E!MMG)-RF9=8R<_(8(MF8__/.F]P[KF-@#G-SG=&,<"H5',TY$#K%O (1N+ \.%;2&S&60O'MK:$ M<%+O0TP.^!B6EYYJ%WY90^!)54]45F$ZE6)(P?8K0==NQ_H9/PJ$\O")/0RN M\B>"7C@(E8>_H(EEX:3TGS26PT)8'CWFNR [O4*"=!)V]6N([[![.&_)0__G MWKCFW @=U-S:!SMZRRC&)*798-K:9[QA,%A[&M]]Q OUR__^T]&?GCC\%D3B M02?VF30(3@O%ISO9K=H9 IEM6/K AL &8)P_BU'TY07LU/7DS='!27AT?!$> MG9Z^_2H)):+S'(%^';B]#2(%B/Z]X*&J5M"B:[,?,?ZC/[_4K7OJ" ^?>8$[ MSN/7K.?9GY\9075\L*FQ/O?*_ODU+OD_YV 6?]7-?LXE>5\768*!"AX?\5]U@M[]/47=N=NZ495\7.NSM^UV\OC*.MK8?^ MSQ:-8DLS\)HHRM'K6_]Z5OC7*NC-,O(_7_!46?,WMEV++K4UCW%.W>S'4[6ZB;O=\J-L= MZG:'NMVA;G>HV_TFZW9UF0;CB-R:!P)BQ!1D'DKV7@+:ZJSW>$2- '0U2J$L M+":RI3-ND8@ MB0BOGE(E#58>E2$5]Q*M=LC ,<2;A8%#/UX*?PY"?KH/T=IY!'5F6J%H["1" M)&.UR+.R8C GHAMG D0DL Y8V7\)WB1OF71-3><9P7]G*H+Q,U>/TT9%0&^M MFL@R-T3([1Z94ND12%7T]_ Z>%]";3T15I^!2ZT?@J62B<5/8B? M%&A>(7B,^Z&N)^'7;MX&G^64AF>@2Y[LL#6=9#6_> *%OA:4*/5'!:I M#._VL%2:C99< MP25E73Q !IEE3L5&:S5@M6[X<,B&FC,1Q6#FTG3TJ0D=<"L5D@F.MLSK0M@" MO3UVY22A?._:/#,>_.2;F_:^"P[8P(!M]3[?'+\4SU00-E:0H;KT;&=X.XG$ M[+-"_1OB%C,V[*Y*+!=&O.4N[D+?!NVN_'4198:7L,60J:DSHS+/=&U671 N MUI DTQ.,3C!->0@3#;^#*QDA9UU@F)-+\V$2%0EB81%:3838IV,\0EUF:L42IUI7 M9!L,@LHC7"5]S]"EP*(3-LS30'H1P]S'J')#R,I/U#42_-.ZN2/]Y+\1>:P[ M=+?!P09V/%/>0 8!^-)E/;]]%RV6W__T([KGR'&\T#VHN6W#X$R\-"?U-(T2 M,-)G"FM84V&>;NX*%T\Q$RQS"J!QCA:%V5#/FM\/WM_S/$_V@BS4HD1+II9O M8/P!KXU0IYCF&TXU"40#Q(T7[A\1EMNV&CJ0G-+^SUH. "VHF>Z O!ZT?T7N MZK^"PX066^>C3IFS&BI+>C!HFG>P6G%DJ,ZO MP!V:[D:_^;X/NDOF$"48^U6;$CN_WO_(PC:Z](C1GT_RW'5'R>+Y^DMJZ-_O M6U-]33][GR6&X/5R>E9G,<\4AF>[F=D+5SH;XKS+]BD)96:>U$NRM0*56V-E M4K?X@&+4QPJ>AZT3UAYC([IGDSW&Q/T,;\9_FS_'N.446<$SM&6W?>OM5$)D M#L;HR[0SLO3H919)U CACU\WC4X1\W2MCC#?FY[E\I(4"RERRC M'8DIS4@5N6P\"?F0Q!E/;0_H$QZMRWYPI9LC+188W:0[S9WM3+WI.AIXW5Y< M-Z_SB& D^LH/T,SSDFZ11G]>F/%$=L_6E;6.!0N'CU'8VF 2RSQF"%Q+F!76"*M++?3QB K(&2]A^\%%[ M_*TJX-!I)&BB*=[VY%GG'CH-%:D+*2H:O?I@0.#R2YDT$>A;Y@3B]J'(1-C8 M5ZXG7E+X)XBN\8A7G>]F9>@4+LL880/\U@6H,QF3EM%Z1:(;Q-KA^_ACKV,G< KOLACZAE+I]&D9>_HQ&E,"%"4CA7/REXZ MR4[SI?+TQG[PGNP$[VU, I3PJ6Z^(=12VNH+8@GT5*#[N+!]25%!<[IOG5KP M]/1X9#7"\]L(,$CJ'H>.[D3!)32.L^8JD_#($[%XZDT,^GLJN(S'*X*5DWV(LW;:UE[R&"T,-*'23 M3?$G#3'$:%V%5&_95'Q>^="*J.(4QZ;$R@:'D2Q@W<&W^38*0AFF-_.DP$3Y MF RNK+EU SJ_]-U%M,(D0H(&?$I-(S)U'S>J%IH"X[6F13. =_!2R%RBSU_UWBG^@ZTH31:9;_%R C:7SHL3_)^YP MOC\R&/PX>&PT ST&[APQCW#W;] SE#6D]BWX8@(U9Q**H@N/C^$KB-TCN$,O MX6)#=D6C*KA5SB>\]\&UTWY[2/4Y7A[%$L *(G+ ^S%/1'] *]9 M2C#?=#SE0;OH7GHK]IK";;E-2K5/O]FR*_2@>__:BIO4-6AMV_W+N>H)*EQA.Z9;;FYDE8)M9"BH&OB7M#?#?*-3Y*%[%B)8)6R5>'"= M"WP;E"&F;P6S%'+3)"7C@$?$(.]6.'.G68=9D*FH?X([P6>TAK-3W-(+M_52 M\&H\*M'61(XN51@S%'^DLAH_WX8F"AS\.$GKJI47 VNUQ,V.K-$DUBS9&F+2 MFCM0@D%;:*=)*MSHPNRN:=*W08NZX.5F;>&)7]QNVM2./;US.QT$B&XBB,_B M3760HN-1Y8>HJ% M$'M3"<4Y,(,J"1 X'F78OU7M*40NWI@>C>CHYUDF%:3)#S<>T6--:P.\?%'FOZLUI^[M 2T2%5AX MHN)0 #P)MPSCK:+18O3 ^1(Z6.9=Z"9IW]!Q*W%D-!L^,UV#<1?!\5'#EI2Q M[UI_]A"*R,?$0 82LM(FP",N>D7R>Y3\0X]5+<"[I!-E&(G14K'P!8(49>S M-*)4'@$@_9<6Y$5+H 7'P(N2UQ7J6SK0_/>* )S.LOI;K^^*9$RUMM3GBJZ/ M>/3N.?674@Y*\QX\Z-KBZB]S*O'53J,8,4YSPC+DL[=R7%:) S1&C*BFSB&; M3&ZYN\*^SUK?D_+&[LS9UF[:B7?TAM2_A2/C!Z+<$F*^R@Q69/@612D6"[P^ M""8G"S>#P>MB>Y;$4EEON]"B#>F\!:,\BCMY5Z4QZ"V@@-Z+)S13-US6+*=3 MS-*&:[Z[)[%W@Q9=;HZ@4>8B;-"A 7T:4V2<>)0EP6%_U'4_0YN4^TZ\"A MAG"N$1LY#[Y+U+V=>ERA$H-QJ!FX9CP/S6,A7VK=($4SI1=V3X.8LK-YI-WF MUFIY,\&2I!1G7+IN+VI$]Y+GRR6,#QLR:NWA5&=-3(@+/<3]X NV>F[@?O66>%G6%Y MK=_6D,; *EX7T8)S+!AXX&55:$8A:0B6Z++\$3,3![+^T.FGB+VRYO"!ID?W MN^) A&,E:?D&J]J*=OC2U &-@7+F@@]Z:7/^-K CRI)7SCA92P[HLE)FT\P M%6 P.RQ1MT6W6R\I%I K7$T\=^9Z+O)8I3I ,XN2%,6-/KT4Q#(Y!'!%ZB+; M88NM=X/&A7Z?@YL8E97I1]C<6A-DP[OG6T$SRO&V=YMX$.9*,E(FGV6MIIL< M4XVIK]_T&[&8F)HY=[RY-&W1F^^4T)%OOQ'R6=R5J#LA.I/YEVXV+EV%O!CW MG&4<3)Z1)%SDA4&L=HHX5Q3_+X?9*13)[83#",W)/I6_,.W\;C.>JO.O!4RI M@->AN9,I)8P494TZ-5@SM=!D9*WN71D2BC@A#Q//R<+699J7NA=96^?1+>P* ME?K1\CC:2K]9[=!]OQN.>GPPP%$W 4>]'."HO#>#4 9PZ@%.W'YRZ+?Z' M3963_\V8,8-7\E!5VN?%#PM1(<(2,VX53H7+8J4RRFUGK)+>#[H9K>O<5#?V MT[W!S0S/^LUF<[6YXPZFX2_C41I-$ 6'?;_K2I7?8Y]C-*GSY1PN1C2=4L 9 M?C]+"OSS),VG7Z+837U$:.S#<*F_?2H@WG+QO4#TI(@NT:5@UPB_1'20RFZ2 M(B?&O>_!Y&?@+/K56!1+''@49J.48!K=\NSE^QB$_)XICK"A_%QE.3PG"G6P M$.-?S&7+UONMBFBLEFXO#&9IGL?P_R#KJCFLW1>FP1=X;<[ID M>1?9GUYH=9US;;S>JWGTGZB()8J&&V6#YW&T0.NIRD-&?; ;PZ&%L-M#);[1 M/,VO$SQG<#A*.AKB"OVK+E;\*)AJZ*XN?(;?%NI(GL"4#75*\TWFY(42-@RQ MEE95$;R" 2:RTC;)E:IK_*]7BJC?=FVH%>5\8*82SR_LMAM&HXPM,@-ZHPQT M=K+3W910-[BV<]S16]Y0CDQJCF)VU\S>@P>V=<^\ Z!K^7FV[HL%8<5W-C LB\WYT@"):!G/$;4E MEZ],)"*&#AL)+E09ED1LD4Q1?6Z3,3N.H\)!,7 ME^MFOTW0>W?WOG>#7ILDK#/X/M8K1(PAO)$>5X%FK?Y"W8UE=,+R% MYQK%7+1,8K WFB>'HYTVKQ; 4^1O5!N/ARU"'">(SVL&;["I +,'-5Z8*#L( MZBE2F,"S-7/WG4>M><5C3NM;NOS=N;,VJ.@&$9M!QD=/S(LQKHU% M_FES[?6J?+F)[O$'^T>G2=;;+G3/-\K_<7EV?KF986YR7+H' P^FK%%Z)8KP M0 9Q _)$DOP+%!%H=GI)J^_]V[KQSHY?=_1Z>M:^A<,EN$W;^=V<'T%&$+YP M.#ZO/:S>'A^"T?!8,!],X7(--4.6'N/X#6?HM8?5TS,DR7PK@@J%67I-WCD< MG%.7::J70X::\] MK)Z>- OAP6PV#J@;,YRNM-GDPE"'8_7:P^KIL2*8/8]$8/68-L 4&8'(9EQ4F8"ZW4HOC0OJ?"F$T M6ST/B2J[:BYL4!_H9!Z7B[@9/4Z3=Z3T@MN.9AA8$:'BW D@A33L7 MU[+XT9U\3/-& N*XJ\A@HU*9[)=DX8@9?[:"12(&]YE3>;^L)W"+T=@'%S.F MSIIO= :C8)Y7I D+R[^[D[$CLA M(D@$?7J5T;HG93@>Z6.&&D3C.N3#/CN65%(ZE=5K3J)T@UOFV(L#9Z0?RSB, M4K?985_:@"6QQ,TF2YUAE5$JXXZQC1IV2$?=@4_(L/Z-Z379-S*E7ONT&%K/ ML,9+54159XW.=01WI;)BP?WY]CN8[5R[K.>!]\I2@+#% M_ZK!9T3HD^XR:7"IG0[%3IR >PH;#X?"Q@T4-AX?#(6-0V'C4-@X%#8.A8W? M;F&C#LRXAH5CSY"OPFR)V#@SFF(T^3\ MCS#._::?U;)./3*\E![[3$N.)/*@TJ%D^Q$YM>DS#EN==ULY]NS.F#TL3+(1 M\SE<^'F>EZ;/18&DLTB(1B$3.EUTLJ(4)%46<8=B.4_.0SC@EV19?A.UXGWN MZV% E1<8%%%E>,TXS&[V@Z2-*<8T?C^Q4-4%+a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�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ṵ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